Market Surveys /studien/globaldata Pharmaceuticals Health
| Title | Year | Price |
|---|---|---|
Terumo Acquires Onset Medical - A Move to Strengthen its Leadership Position in the Cardiovascular Devices Market - Deal Analysis from GlobalDataIntroduction / / GlobalData’s report, “Terumo Acquires Onset Medical - A Move to Strengthen its Leadership Position in the Cardio |
2012 | 500,00$ |
India Wound Care Management Market Outlook to 2017 - Advanced Wound Management, Wound Closure Devices, Pressure Relief Devices and OthersIntroduction / / GlobalData’s new report, “India Wound Care Management Market Outlook to 2017 - Advanced Wound Management, Wound |
2012 | 2.500,00$ |
Italy Wound Care Management Market Outlook to 2017 - Advanced Wound Management, Wound Closure Devices, Pressure Relief Devices and OthersIntroduction / / GlobalData’s new report, “Italy Wound Care Management Market Outlook to 2017 - Advanced Wound Management, Wound |
2012 | 2.500,00$ |
Australia Wound Care Management Market Outlook to 2017 - Advanced Wound Management, Wound Closure Devices, Pressure Relief Devices and OthersIntroduction / / GlobalData’s new report, “Australia Wound Care Management Market Outlook to 2017 - Advanced Wound Management, Wo |
2012 | 2.500,00$ |
Austria Wound Care Management Market Outlook to 2017 - Advanced Wound Management, Wound Closure Devices, Pressure Relief Devices and OthersIntroduction / / GlobalData’s new report, “Austria Wound Care Management Market Outlook to 2017 - Advanced Wound Management, Woun |
2012 | 2.500,00$ |
Japan Wound Care Management Market Outlook to 2017 - Advanced Wound Management, Wound Closure Devices, Pressure Relief Devices and OthersIntroduction / / GlobalData’s new report, “Japan Wound Care Management Market Outlook to 2017 - Advanced Wound Management, Wound |
2012 | 2.500,00$ |
France Wound Care Management Market Outlook to 2017 - Advanced Wound Management, Wound Closure Devices, Pressure Relief Devices and OthersIntroduction / / GlobalData’s new report, “France Wound Care Management Market Outlook to 2017 - Advanced Wound Management, Wound |
2012 | 2.500,00$ |
Mexico Wound Care Management Market Outlook to 2017 - Advanced Wound Management, Wound Closure Devices, Pressure Relief Devices and OthersIntroduction / / GlobalData’s new report, “Mexico Wound Care Management Market Outlook to 2017 - Advanced Wound Management, Wound |
2012 | 2.500,00$ |
Czech Republic Wound Care Management Market Outlook to 2017 - Advanced Wound Management, Wound Closure Devices, Pressure Relief Devices and OthersIntroduction / / GlobalData’s new report, “Czech Republic Wound Care Management Market Outlook to 2017 - Advanced Wound Managemen |
2012 | 2.500,00$ |
Transitional Cell Cancer (Urothelial Cell Cancer) Global Clinical Trials Review, H1, 2012Introduction / / GlobalData's clinical trial report, “Transitional Cell Cancer (Urothelial Cell Cancer) Global Clinical Trials Re |
2012 | 1.000,00$ |
Wilms’ Tumor (Nephroblastoma) Global Clinical Trials Review, H1, 2012Introduction / / GlobalData's clinical trial report, “Wilms’ Tumor (Nephroblastoma) Global Clinical Trials Review, H1, 2012" prov |
2012 | 1.000,00$ |
Cutaneous T-Cell Lymphoma Global Clinical Trials Review, H1, 2012Introduction / / GlobalData's clinical trial report, “Cutaneous T-Cell Lymphoma Global Clinical Trials Review, H1, 2012" provides |
2012 | 1.000,00$ |
Endophthalmitis Global Clinical Trials Review, H1, 2012Introduction / / GlobalData's clinical trial report, “Endophthalmitis Global Clinical Trials Review, H1, 2012" provides data on t |
2012 | 1.000,00$ |
Ependymoma Global Clinical Trials Review, H1, 2012Introduction / / GlobalData's clinical trial report, “Ependymoma Global Clinical Trials Review, H1, 2012" provides data on the Ep |
2012 | 1.000,00$ |
Anthrax Global Clinical Trials Review, H1, 2012Introduction / / GlobalData's clinical trial report, “Anthrax Global Clinical Trials Review, H1, 2012" provides data on the Anthr |
2012 | 1.000,00$ |
Bacteremia Global Clinical Trials Review, H1, 2012Introduction / / GlobalData's clinical trial report, “Bacteremia Global Clinical Trials Review, H1, 2012" provides data on the Ba |
2012 | 1.000,00$ |
Cancer Cachexia Global Clinical Trials Review, H1, 2012Introduction / / GlobalData's clinical trial report, “Cancer Cachexia Global Clinical Trials Review, H1, 2012" provides data on t |
2012 | 1.000,00$ |
Chordoma Global Clinical Trials Review, H1, 2012Introduction / / GlobalData's clinical trial report, “Chordoma Global Clinical Trials Review, H1, 2012" provides data on the Chor |
2012 | 1.000,00$ |
Gastroparesis Global Clinical Trials Review, H1, 2012Introduction / / GlobalData's clinical trial report, “Gastroparesis Global Clinical Trials Review, H1, 2012" provides data on the |
2012 | 1.000,00$ |
Pancreatitis Global Clinical Trials Review, H1, 2012Introduction / / GlobalData's clinical trial report, “Pancreatitis Global Clinical Trials Review, H1, 2012" provides data on the |
2012 | 1.000,00$ |
Penile Cancer Global Clinical Trials Review, H1, 2012Introduction / / GlobalData's clinical trial report, “Penile Cancer Global Clinical Trials Review, H1, 2012" provides data on the |
2012 | 1.000,00$ |
Stroke Global Clinical Trials Review, H1, 2012Introduction / / GlobalData's clinical trial report, “Stroke Global Clinical Trials Review, H1, 2012" provides data on the Stroke |
2012 | 1.000,00$ |
Peritonitis Global Clinical Trials Review, H1, 2012Introduction / / GlobalData's clinical trial report, “Peritonitis Global Clinical Trials Review, H1, 2012" provides data on the P |
2012 | 1.000,00$ |
Sezary Syndrome Global Clinical Trials Review, H1, 2012Introduction / / GlobalData's clinical trial report, “Sezary Syndrome Global Clinical Trials Review, H1, 2012" provides data on t |
2012 | 1.000,00$ |
Gliosarcoma Global Clinical Trials Review, H1, 2012Introduction / / GlobalData's clinical trial report, “Gliosarcoma Global Clinical Trials Review, H1, 2012" provides data on the G |
2012 | 1.000,00$ |
Heart Valve Disease Global Clinical Trials Review, H1, 2012Introduction / / GlobalData's clinical trial report, “Heart Valve Disease Global Clinical Trials Review, H1, 2012" provides data |
2012 | 1.000,00$ |
Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer Global Clinical Trials Review, H1, 2012Introduction / / GlobalData's clinical trial report, “Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Ca |
2012 | 1.000,00$ |
Hypertension Global Clinical Trials Review, H1, 2012Introduction / / GlobalData's clinical trial report, “Hypertension Global Clinical Trials Review, H1, 2012" provides data on the |
2012 | 1.000,00$ |
Onychomycosis (Tinea unguium) Global Clinical Trials Review, H1, 2012Introduction / / GlobalData's clinical trial report, “Onychomycosis (Tinea unguium) Global Clinical Trials Review, H1, 2012" prov |
2012 | 1.000,00$ |
Medical Equipment Quarterly Deals Analysis - M&A and Investment Trends, Q4 2011Introduction / / GlobalData's “Medical Equipment Quarterly Deals Analysis - M&A and Investment Trends, Q4 2011” report is an esse |
2012 | 1.500,00$ |
Canada Wound Care Management Market Outlook to 2017 - Advanced Wound Management, Wound Closure Devices, Pressure Relief Devices and OthersIntroduction / / GlobalData’s new report, “Canada Wound Care Management Market Outlook to 2017 - Advanced Wound Management, Wound |
2012 | 2.500,00$ |
Operating Room Solutions Market - An OverviewIntroduction / / GlobalData’s report, “Operating Room Solutions Market - An Overview” provides information and analysis on the gl |
2012 | 500,00$ |
Middle East and Africa Anesthesia and Respiratory Devices Market Outlook to 2017- Respiratory Devices, Respiratory Measurement Devices, Airway and Anesthesia Devices, Anesthesia Machines, Sleep Apnea Diagnostic Systems, Pain Management Devices and OthersIntroduction / / GlobalData’s new report, “Middle East and Africa Anesthesia and Respiratory Devices Market Outlook to 2017- Resp |
2011 | 3.500,00$ |
New Zealand Wound Care Management Market Outlook to 2017 - Advanced Wound Management, Wound Closure Devices, Pressure Relief Devices and OthersIntroduction / / GlobalData’s new report, “New Zealand Wound Care Management Market Outlook to 2017 - Advanced Wound Management, |
2012 | 2.500,00$ |
Saudi Arabia Wound Care Management Market Outlook to 2017 - Advanced Wound Management, Wound Closure Devices, Pressure Relief Devices and OthersIntroduction / / GlobalData’s new report, “Saudi Arabia Wound Care Management Market Outlook to 2017 - Advanced Wound Management, |
2012 | 2.500,00$ |
Belgium Wound Care Management Market Outlook to 2017 - Advanced Wound Management, Wound Closure Devices, Pressure Relief Devices and OthersIntroduction / / GlobalData’s new report, “Belgium Wound Care Management Market Outlook to 2017 - Advanced Wound Management, Woun |
2012 | 2.500,00$ |
Argentina Wound Care Management Market Outlook to 2017 - Advanced Wound Management, Wound Closure Devices, Pressure Relief Devices and OthersIntroduction / / GlobalData’s new report, “Argentina Wound Care Management Market Outlook to 2017 - Advanced Wound Management, Wo |
2012 | 2.500,00$ |
Taiwan Wound Care Management Market Outlook to 2017 - Advanced Wound Management, Wound Closure Devices, Pressure Relief Devices and OthersIntroduction / / GlobalData’s new report, “Taiwan Wound Care Management Market Outlook to 2017 - Advanced Wound Management, Wound |
2012 | 2.500,00$ |
Ankylosing Spondylitis Therapeutics - Pipeline Assessment and Market Forecasts to 2019Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Ankylosing Spondylitis Therapeutics |
2012 | 3.995,00$ |
Peptic Ulcer Therapeutics- Pipeline Assessment and Market Forecasts to 2018Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Peptic Ulcer Therapeutics- Pipeline |
2012 | 3.995,00$ |
Myasthenia Gravis Therapeutics - Pipeline Assessment and Market Forecasts to 2019Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Myasthenia Gravis Therapeutics - Pip |
2012 | 3.995,00$ |
Retinitis Pigmentosa (Retinitis) Global Clinical Trials Review, H1, 2012Introduction / / GlobalData's clinical trial report, “Retinitis Pigmentosa (Retinitis) Global Clinical Trials Review, H1, 2012" p |
2012 | 1.000,00$ |
Anaplastic Astrocytoma Global Clinical Trials Review, H1, 2012Introduction / / GlobalData's clinical trial report, “Anaplastic Astrocytoma Global Clinical Trials Review, H1, 2012" provides da |
2012 | 1.000,00$ |
Ewing Sarcoma Global Clinical Trials Review, H1, 2012Introduction / / GlobalData's clinical trial report, “Ewing Sarcoma Global Clinical Trials Review, H1, 2012" provides data on the |
2012 | 1.000,00$ |
Metastatic Pancreatic Cancer Global Clinical Trials Review, H1, 2012Introduction / / GlobalData's clinical trial report, “Metastatic Pancreatic Cancer Global Clinical Trials Review, H1, 2012" provi |
2012 | 1.000,00$ |
Neutropenia Global Clinical Trials Review, H1, 2012Introduction / / GlobalData's clinical trial report, “Neutropenia Global Clinical Trials Review, H1, 2012" provides data on the N |
2012 | 1.000,00$ |
Inflammatory Bowel Disease Global Clinical Trials Review, H1, 2012Introduction / / GlobalData's clinical trial report, “Inflammatory Bowel Disease Global Clinical Trials Review, H1, 2012" provide |
2012 | 1.000,00$ |
Metastatic Brain Tumor Global Clinical Trials Review, H1, 2012Introduction / / GlobalData's clinical trial report, “Metastatic Brain Tumor Global Clinical Trials Review, H1, 2012" provides da |
2012 | 1.000,00$ |
Metastatic Lung Cancer Global Clinical Trials Review, H1, 2012Introduction / / GlobalData's clinical trial report, “Metastatic Lung Cancer Global Clinical Trials Review, H1, 2012" provides da |
2012 | 1.000,00$ |
Plasma Cell Neoplasm Global Clinical Trials Review, H1, 2012Introduction / / GlobalData's clinical trial report, “Plasma Cell Carcinoma Global Clinical Trials Review, H1, 2012" provides dat |
2012 | 1.000,00$ |
Renal Cell Carcinoma Global Clinical Trials Review, H1, 2012Introduction / / GlobalData's clinical trial report, “Renal Cell Carcinoma Global Clinical Trials Review, H1, 2012" provides data |
2012 | 1.000,00$ |
B-Cell Lymphomas Global Clinical Trials Review, H1, 2012Introduction / / GlobalData's clinical trial report, “B-Cell Lymphomas Global Clinical Trials Review, H1, 2012" provides data on |
2012 | 1.000,00$ |
Dental Plaque Global Clinical Trials Review, H1, 2012Introduction / / GlobalData's clinical trial report, “Dental Plaque Global Clinical Trials Review, H1, 2012" provides data on the |
2012 | 1.000,00$ |
Venous Thromboembolism Global Clinical Trials Review, H1, 2012Introduction / / GlobalData's clinical trial report, “Venous Thromboembolism Global Clinical Trials Review, H1, 2012" provides da |
2012 | 1.000,00$ |
Vulvar Cancer Global Clinical Trials Review, H1, 2012Introduction / / GlobalData's clinical trial report, “Vulvar Cancer Global Clinical Trials Review, H1, 2012" provides data on the |
2012 | 1.000,00$ |
T-Cell Leukemia Global Clinical Trials Review, H1, 2012Introduction / / GlobalData's clinical trial report, “T-Cell Leukemia Global Clinical Trials Review, H1, 2012" provides data on t |
2012 | 1.000,00$ |
Rhabdomyosarcoma Global Clinical Trials Review, H1, 2012Introduction / / GlobalData's clinical trial report, “Rhabdomyosarcoma Global Clinical Trials Review, H1, 2012" provides data on |
2012 | 1.000,00$ |
Squamous Cell Carcinoma Global Clinical Trials Review, H1, 2012Introduction / / GlobalData's clinical trial report, “Squamous Cell Carcinoma Global Clinical Trials Review, H1, 2012" provides d |
2012 | 1.000,00$ |
T-Cell Lymphomas Global Clinical Trials Review, H1, 2012Introduction / / GlobalData's clinical trial report, “T-Cell Lymphomas Global Clinical Trials Review, H1, 2012" provides data on |
2012 | 1.000,00$ |
Throat Cancer Global Clinical Trials Review, H1, 2012Introduction / / GlobalData's clinical trial report, “Throat Cancer Global Clinical Trials Review, H1, 2012" provides data on the |
2012 | 1.000,00$ |
Vitiligo Therapeutics - Pipeline Assessment and Market Forecasts to 2019Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Vitiligo Therapeutics - Pipeline Ass |
2012 | 3.995,00$ |
Atrial Fibrillation Global Clinical Trials Review, H1, 2012Introduction / / GlobalData's clinical trial report, “Atrial Fibrillation Global Clinical Trials Review, H1, 2012" provides data |
2012 | 1.000,00$ |
Oligodendroglioma Global Clinical Trials Review, H1, 2012Introduction / / GlobalData's clinical trial report, “Oligodendroglioma Global Clinical Trials Review, H1, 2012" provides data on |
2012 | 1.000,00$ |
Oropharyngeal Cancer Global Clinical Trials Review, H1, 2012Introduction / / GlobalData's clinical trial report, “Oropharyngeal Cancer Global Clinical Trials Review, H1, 2012" provides data |
2012 | 1.000,00$ |
Tinnitus Global Clinical Trials Review, H1, 2012Introduction / / GlobalData's clinical trial report, “Tinnitus Global Clinical Trials Review, H1, 2012" provides data on the Tinn |
2012 | 1.000,00$ |
Tuberculosis Global Clinical Trials Review, H1, 2012Introduction / / GlobalData's clinical trial report, “Tuberculosis Global Clinical Trials Review, H1, 2012" provides data on the |
2012 | 1.000,00$ |
Depression Global Clinical Trials Review, H1, 2012Introduction / / GlobalData's clinical trial report, “Depression Global Clinical Trials Review, H1, 2012" provides data on the De |
2012 | 1.000,00$ |
Diabetic Macular Edema Global Clinical Trials Review, H1, 2012Introduction / / GlobalData's clinical trial report, “Diabetic Macular Edema Global Clinical Trials Review, H1, 2012" provides da |
2012 | 1.000,00$ |
Follicular Lymphoma Global Clinical Trials Review, H1, 2012Introduction / / GlobalData's clinical trial report, “Follicular Lymphoma Global Clinical Trials Review, H1, 2012" provides data |
2012 | 1.000,00$ |
Gall Stone Global Clinical Trials Review, H1, 2012Introduction / / GlobalData's clinical trial report, “Gall Stone Global Clinical Trials Review, H1, 2012" provides data on the Ga |
2012 | 1.000,00$ |
Gingivitis Global Clinical Trials Review, H1, 2012Introduction / / GlobalData's clinical trial report, “Gingivitis Global Clinical Trials Review, H1, 2012" provides data on the Gi |
2012 | 1.000,00$ |
Doxil/Caelyx (Ovarian Cancer) - Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “Doxil/Caelyx (Ovarian Cancer) - Analysis and Forecasts to 2020” provides D |
2012 | 2.000,00$ |
Anemia Global Clinical Trials Review, H1, 2012Introduction / / GlobalData's clinical trial report, “Anemia Global Clinical Trials Review, H1, 2012" provides data on the Anemia |
2012 | 1.000,00$ |
Mantle Cell Lymphoma Global Clinical Trials Review, H1, 2012Introduction / / GlobalData's clinical trial report, “Mantle Cell Lymphoma Global Clinical Trials Review, H1, 2012" provides data |
2012 | 1.000,00$ |
Metastatic Breast Cancer Global Clinical Trials Review, H1, 2012Introduction / / GlobalData's clinical trial report, “Metastatic Breast Cancer Global Clinical Trials Review, H1, 2012" provides |
2012 | 1.000,00$ |
Metastatic Liver Cancer Global Clinical Trials Review, H1, 2012Introduction / / GlobalData's clinical trial report, “Metastatic Liver Cancer Global Clinical Trials Review, H1, 2012" provides d |
2012 | 1.000,00$ |
Pruritus Global Clinical Trials Review, H1, 2012Introduction / / GlobalData's clinical trial report, “Pruritus Global Clinical Trials Review, H1, 2012" provides data on the Prur |
2012 | 1.000,00$ |
Pulmonary Hypertension Global Clinical Trials Review, H1, 2012Introduction / / GlobalData's clinical trial report, “Pulmonary Hypertension Global Clinical Trials Review, H1, 2012" provides da |
2012 | 1.000,00$ |
Abraxane (Breast Cancer) – Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “Abraxane (Breast Cancer) – Analysis and Forecasts to 2020” provides Abraxa |
2011 | 2.000,00$ |
Gallbladder Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2018Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Gallbladder Cancer Therapeutics - Pi |
2012 | 3.995,00$ |
Saudi Arabia In Vitro Diagnostics Market Outlook to 2017 - Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology CultureIntroduction / / GlobalData’s new report, “Saudi Arabia In Vitro Diagnostics Market Outlook to 2017 - Clinical Chemistry Genetic |
2012 | 2.500,00$ |
New Zealand In Vitro Diagnostics Market Outlook to 2017 - Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology CultureIntroduction / / GlobalData’s new report, “New Zealand In Vitro Diagnostics Market Outlook to 2017 - Clinical Chemistry Genetic T |
2012 | 2.500,00$ |
Sweden In Vitro Diagnostics Market Outlook to 2017 - Clinical Chemistry Genetic Testing, Haematology, Histology And Cytology, Immuno Chemistry, Infectious Immunology and Microbiology CultureIntroduction / / GlobalData’s new report, “Sweden In Vitro Diagnostics Market Outlook to 2017 - Clinical Chemistry Genetic Testin |
2012 | 2.500,00$ |
Russian Federation In Vitro Diagnostics Market Outlook to 2017 - Clinical Chemistry Genetic Testing, Haematology, Histology And Cytology, Immuno Chemistry, Infectious Immunology and Microbiology CultureIntroduction / / GlobalData’s new report, “Russian Federation In Vitro Diagnostics Market Outlook to 2017 - Clinical Chemistry Ge |
2012 | 2.500,00$ |
Israel In Vitro Diagnostics Market Outlook to 2017 - Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology CultureIntroduction / / GlobalData’s new report, “Israel In Vitro Diagnostics Market Outlook to 2017 - Clinical Chemistry Genetic Testin |
2012 | 2.500,00$ |
Brazil In Vitro Diagnostics Market Outlook to 2017 - Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology CultureIntroduction / / GlobalData’s new report, “Brazil In Vitro Diagnostics Market Outlook to 2017 - Clinical Chemistry Genetic Testin |
2012 | 2.500,00$ |
Canada In Vitro Diagnostics Market Outlook to 2017 - Clinical Chemistry Genetic Testing, Haematology, Histology And Cytology, Immuno Chemistry, Infectious Immunology and Microbiology CultureIntroduction / / GlobalData’s new report, “Canada In Vitro Diagnostics Market Outlook to 2017 - Clinical Chemistry Genetic Testin |
2012 | 2.500,00$ |
United States In Vitro Diagnostics Market Outlook to 2017 - Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology CultureIntroduction / / GlobalData’s new report, “United States In Vitro Diagnostics Market Outlook to 2017 - Clinical Chemistry Genetic |
2012 | 2.500,00$ |
Brazil Wound Care Management Market Outlook to 2017 - Advanced Wound Management, Wound Closure Devices, Pressure Relief Devices and OthersIntroduction / / GlobalData’s new report, “Brazil Wound Care Management Market Outlook to 2017 - Advanced Wound Management, Wound |
2012 | 2.500,00$ |
Spain Wound Care Management Market Outlook to 2017 - Advanced Wound Management, Wound Closure Devices, Pressure Relief Devices and OthersIntroduction / / GlobalData’s new report, “Spain Wound Care Management Market Outlook to 2017 - Advanced Wound Management, Wound |
2012 | 2.500,00$ |
China Wound Care Management Market Outlook to 2017 - Advanced Wound Management, Wound Closure Devices, Pressure Relief Devices and OthersIntroduction / / GlobalData’s new report, “China Wound Care Management Market Outlook to 2017 - Advanced Wound Management, Wound |
2012 | 2.500,00$ |
United Kingdom Wound Care Management Market Outlook to 2017 - Advanced Wound Management, Wound Closure Devices, Pressure Relief Devices and OthersIntroduction / / GlobalData’s new report, “United Kingdom Wound Care Management Market Outlook to 2017 - Advanced Wound Managemen |
2012 | 2.500,00$ |
United States Wound Care Management Market Outlook to 2017 - Advanced Wound Management, Wound Closure Devices, Pressure Relief Devices and OthersIntroduction / / GlobalData’s new report, “United States Wound Care Management Market Outlook to 2017 - Advanced Wound Management |
2012 | 2.500,00$ |
Immuno Chemistry Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017Introduction / / GlobalData’s new report, “Immuno Chemistry Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) |
2012 | 2.500,00$ |
Respiratory Measurement Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017Introduction / / GlobalData’s new report, “Respiratory Measurement Devices Market Outlook in BRICS (Brazil, Russia, India, China, |
2012 | 2.500,00$ |
Microbiology Culture Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017Introduction / / GlobalData’s new report, “Microbiology Culture Market Outlook in BRICS (Brazil, Russia, India, China, South Afri |
2012 | 2.500,00$ |
Central Venous Catheters - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017Introduction / / GlobalData’s new report, “Central Venous Catheters - Global Pipeline Analysis, Competitive Landscape and Market |
2012 | 3.995,00$ |
North America In Vitro Diagnostics Market Outlook to 2017 - Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology CultureIntroduction / / GlobalData’s new report, “North America In Vitro Diagnostics Market Outlook to 2017 - Clinical Chemistry Genetic |
2012 | 3.500,00$ |
Hearing Implants - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017Introduction / / GlobalData’s new report, “Hearing Implants - Global Pipeline Analysis, Competitive Landscape and Market Forecast |
2012 | 3.995,00$ |
Upper Respiratory Tract Infections Global Clinical Trials Review, H1, 2012Introduction / / GlobalData's clinical trial report, “Upper Respiratory Tract Infections Global Clinical Trials Review, H2, 2011" |
2012 | 1.000,00$ |
Tonsillitis Global Clinical Trials Review, H1, 2012Introduction / / GlobalData's clinical trial report, “Tonsillitis Global Clinical Trials Review, H2, 2011" provides data on the T |
2012 | 1.000,00$ |
Tetanus Global Clinical Trials Review, H1, 2012Introduction / / GlobalData's clinical trial report, “Tetanus Global Clinical Trials Review, H2, 2011" provides data on the Tetan |
2012 | 1.000,00$ |
Solid Tumor Global Clinical Trials Review, H1, 2012Introduction / / GlobalData's clinical trial report, “Solid Tumor Global Clinical Trials Review, H2, 2011" provides data on the S |
2012 | 1.000,00$ |
Small-Cell Lung Cancer Global Clinical Trials Review, H1, 2012Introduction / / GlobalData's clinical trial report, “Small Cell Lung Cancer Global Clinical Trials Review, H2, 2011" provides da |
2012 | 1.000,00$ |
Respiratory Distress Syndrome Global Clinical Trials Review, H1, 2012Introduction / / GlobalData's clinical trial report, “Respiratory Distress Syndrome Global Clinical Trials Review, H2, 2011" prov |
2012 | 1.000,00$ |
Pulmonary Fibrosis Global Clinical Trials Review, H1, 2012Introduction / / GlobalData's clinical trial report, “Pulmonary Fibrosis Global Clinical Trials Review, H2, 2011" provides data o |
2012 | 1.000,00$ |
Pneumonia Global Clinical Trials Review, H1, 2012Introduction / / GlobalData's clinical trial report, “Pneumonia Global Clinical Trials Review, H2, 2011" provides data on the Pne |
2012 | 1.000,00$ |
Non-Small Cell Lung Cancer Global Clinical Trials Review, H1, 2012Introduction / / GlobalData's clinical trial report, “Non-Small Cell Lung Cancer Global Clinical Trials Review, H2, 2011" provide |
2012 | 1.000,00$ |
Myocardial Infarction Global Clinical Trials Review, H1, 2012Introduction / / GlobalData's clinical trial report, “Myocardial Infarction Global Clinical Trials Review, H2, 2011" provides dat |
2012 | 1.000,00$ |
Gastrointestinal Stromal Tumor (GIST) Global Clinical Trials Review, H1, 2012Introduction / / GlobalData's clinical trial report, “Gastrointestinal Stromal Tumor (GIST) Global Clinical Trials Review, H2, 20 |
2012 | 1.000,00$ |
Gastrointestinal Hemorrhage Global Clinical Trials Review, H1, 2012Introduction / / GlobalData's clinical trial report, “Gastrointestinal Hemorrhage Global Clinical Trials Review, H2, 2011" provid |
2012 | 1.000,00$ |
Gastritis Global Clinical Trials Review, H1, 2012Introduction / / GlobalData's clinical trial report, “Gastritis Global Clinical Trials Review, H2, 2011" provides data on the Gas |
2012 | 1.000,00$ |
Esophagitis Global Clinical Trials Review, H1, 2012Introduction / / GlobalData's clinical trial report, “Esophagitis Global Clinical Trials Review, H2, 2011" provides data on the E |
2012 | 1.000,00$ |
Enterocolitis Global Clinical Trials Review, H1, 2012Introduction / / GlobalData's clinical trial report, “Enterocolitis Global Clinical Trials Review, H2, 2011" provides data on the |
2012 | 1.000,00$ |
Dyspnea Global Clinical Trials Review, H1, 2012Introduction / / GlobalData's clinical trial report, “Dyspnea Global Clinical Trials Review, H2, 2011" provides data on the Dyspn |
2012 | 1.000,00$ |
Cough Global Clinical Trials Review, H1, 2012Introduction / / GlobalData's clinical trial report, “Cough Global Clinical Trials Review, H2, 2011" provides data on the Cough c |
2012 | 1.000,00$ |
Chicken Pox Global Clinical Trials Review, H1, 2012Introduction / / GlobalData's clinical trial report, “Chicken Pox Global Clinical Trials Review, H2, 2011" provides data on the C |
2012 | 1.000,00$ |
Attention Deficit Hyperactivity Disorder (ADHD) Global Clinical Trials Review, H1, 2012Introduction / / GlobalData's clinical trial report, “Attention Deficit Hyperactivity Disorder (ADHD) Global Clinical Trials Revi |
2012 | 1.000,00$ |
Aspergillosis Global Clinical Trials Review, H1, 2012Introduction / / GlobalData's clinical trial report, “Aspergillosis Global Clinical Trials Review, H2, 2011" provides data on the |
2012 | 1.000,00$ |
Baxter Acquires Synovis - To Consolidate its Position in the Soft Tissue Repair Market - Deal Analysis from GlobalDataIntroduction / / GlobalData’s “Baxter Acquires Synovis - To Consolidate its Position in the Soft Tissue Repair Market” provides k |
2012 | 500,00$ |
C. R. Bard Acquires Lutonix - Set to Gain from a New Technology - Deal Analysis from GlobalDataIntroduction / / GlobalData’s report, “C. R. Bard Acquires Lutonix - Set to Gain from a New Technology” provides key information |
2012 | 500,00$ |
Non-Invasive Blood Pressure Monitors Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017Introduction / / GlobalData’s new report, “Non-Invasive Blood Pressure Monitors Market Outlook in BRICS (Brazil, Russia, India, C |
2012 | 2.500,00$ |
Patient Monitoring Accessories (Patient Monitoring Leads and Electrodes, Non-Invasive Blood Pressure Cuffs and Patient Monitoring Temperature Probes) Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017Introduction / / GlobalData’s new report, “Patient Monitoring Accessories (Patient Monitoring Leads and Electrodes, Non-Invasive |
2012 | 2.500,00$ |
Genetic Testing Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017Introduction / / GlobalData’s new report, “Genetic Testing Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) t |
2012 | 2.500,00$ |
Histology And Cytology Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017Introduction / / GlobalData’s new report, “Histology And Cytology Market Outlook in BRICS (Brazil, Russia, India, China, South Af |
2012 | 2.500,00$ |
Infectious Immunology Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017Introduction / / GlobalData’s new report, “Infectious Immunology Market Outlook in BRICS (Brazil, Russia, India, China, South Afr |
2012 | 2.500,00$ |
Haematology in BRICS Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017Introduction / / GlobalData’s new report, “Haematology in BRICS Market Outlook in BRICS (Brazil, Russia, India, China, South Afri |
2012 | 2.500,00$ |
Europe In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology CultureIntroduction / / GlobalData’s new report, “Europe In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Testing |
2012 | 3.500,00$ |
Middle East and Africa In Vitro Diagnostics Market Outlook to 2017 - Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology CultureIntroduction / / GlobalData’s new report, “Middle East and Africa In Vitro Diagnostics Market Outlook to 2017 - Clinical Chemistr |
2012 | 3.500,00$ |
South and Central America In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology CultureIntroduction / / GlobalData’s new report, “South and Central America In Vitro Diagnostics Market Outlook to 2017- Clinical Chemis |
2012 | 3.500,00$ |
Continuous Glucose Monitoring (CGM) Systems - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017Introduction / / GlobalData’s new report, “Continuous Glucose Monitoring (CGM) Systems - Global Pipeline Analysis, Competitive La |
2012 | 3.995,00$ |
Multiparameter Patient Monitoring - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017Introduction / / GlobalData’s new report, “Multiparameter Patient Monitoring - Global Pipeline Analysis, Competitive Landscape an |
2012 | 3.995,00$ |
Wire Sutures - A Market SnapshotIntroduction / / GlobalData’s report, “Wire Sutures - A Market Snapshot” provides information and analysis on the global wire sut |
2012 | 500,00$ |
Picture Archiving and Communication Systems (PACS) - Global Opportunity Assessment, Competitive Landscape and Market Forecasts to 2017Introduction / / GlobalData’s new report, “Picture Archiving and Communication Systems (PACS) - Global Opportunity Assessment, Co |
2012 | 3.995,00$ |
Insulin Delivery Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017Introduction / / GlobalData’s new report, “Insulin Delivery Devices - Global Pipeline Analysis, Competitive Landscape and Market |
2012 | 3.995,00$ |
Oral Cancer Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Oral Cancer Global Clinical Trials Review, H2, 2011" provides data on the O |
2011 | 1.000,00$ |
Pancreatic Cancer Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Pancreatic Cancer Global Clinical Trials Review, H2, 2011" provides data on |
2011 | 1.000,00$ |
Smallpox Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Smallpox Global Clinical Trials Review, H2, 2011" provides data on the Smal |
2011 | 1.000,00$ |
Peritoneal Cancer Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Peritoneal Cancer Global Clinical Trials Review, H2, 2011" provides data on |
2011 | 1.000,00$ |
Systemic Sclerosis (Scleroderma) Global Clinical Trials Review, H1, 2012Introduction / / GlobalData's clinical trial report, “Systemic Sclerosis (Scleroderma) Global Clinical Trials Review, H2, 2011" p |
2012 | 1.000,00$ |
Low Cardiac Output Syndrome Global Clinical Trials Review, H1, 2012Introduction / / GlobalData's clinical trial report, “Low Cardiac Output Syndrome Global Clinical Trials Review, H2, 2011" provid |
2012 | 1.000,00$ |
Liver Transplantation Global Clinical Trials Review, H1, 2012Introduction / / GlobalData's clinical trial report, “Liver Transplantation Global Clinical Trials Review, H2, 2011" provides dat |
2012 | 1.000,00$ |
Iliac Aneurysms Global Clinical Trials Review, H1, 2012Introduction / / GlobalData's clinical trial report, “Iliac Aneurysms Global Clinical Trials Review, H2, 2011" provides data on t |
2012 | 1.000,00$ |
Abdominal Aortic Aneurysms Global Clinical Trials Review, H1, 2012Introduction / / GlobalData's clinical trial report, “Abdominal Aortic Aneurysms Global Clinical Trials Review, H2, 2011" provide |
2012 | 1.000,00$ |
Pompe Disease Global Clinical Trials Review, H1, 2012Introduction / / GlobalData's clinical trial report, “Pompe Disease Global Clinical Trials Review, H2, 2011" provides data on the |
2012 | 1.000,00$ |
Filariasis Global Clinical Trials Review, H1, 2012Introduction / / GlobalData's clinical trial report, “Filariasis Global Clinical Trials Review, H2, 2011" provides data on the Fi |
2012 | 1.000,00$ |
Friedreich Ataxia Global Clinical Trials Review, H1, 2012Introduction / / GlobalData's clinical trial report, “Friedreich Ataxia Global Clinical Trials Review, H2, 2011" provides data on |
2012 | 1.000,00$ |
Cerebral Aneurysms Global Clinical Trials Review, H1, 2012Introduction / / GlobalData's clinical trial report, “Cerebral Aneurysms Global Clinical Trials Review, H2, 2011" provides data o |
2012 | 1.000,00$ |
Arteriosclerosis Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Arteriosclerosis Global Clinical Trials Review, H2, 2011" provides data on |
2011 | 1.000,00$ |
Hepatocellular Carcinoma Global Clinical Trials Review, H1, 2012Introduction / / GlobalData's clinical trial report, “Hepatocellular Carcinoma Global Clinical Trials Review, H2, 2011" provides |
2012 | 1.000,00$ |
Argentina In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology CultureIntroduction / / GlobalData’s new report, “Argentina In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Test |
2011 | 2.500,00$ |
Belgium In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology CultureIntroduction / / GlobalData’s new report, “Belgium In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Testin |
2011 | 2.500,00$ |
Netherlands In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Testing, Haematology, Histology And Cytology, Immuno Chemistry, Infectious Immunology and Microbiology CultureIntroduction / / GlobalData’s new report, “Netherlands In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Te |
2011 | 2.500,00$ |
Australia In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology CultureIntroduction / / GlobalData’s new report, “Australia In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Test |
2011 | 2.500,00$ |
Spain In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology CultureIntroduction / / GlobalData’s new report, “Spain In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Testing, |
2011 | 2.500,00$ |
Italy In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology CultureIntroduction / / GlobalData’s new report, “Italy In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Testing, |
2011 | 2.500,00$ |
France In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology CultureIntroduction / / GlobalData’s new report, “France In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Testing |
2011 | 2.500,00$ |
Germany In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology CultureIntroduction / / GlobalData’s new report, “Germany In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Testin |
2011 | 2.500,00$ |
China In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology CultureIntroduction / / GlobalData’s new report, “China In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Testing, |
2011 | 2.500,00$ |
India In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology CultureIntroduction / / GlobalData’s new report, “India In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Testing, |
2011 | 2.500,00$ |
Japan In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology CultureIntroduction / / GlobalData’s new report, “Japan In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Testing, |
2011 | 2.500,00$ |
United Kingdom In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology CultureIntroduction / / GlobalData’s new report, “United Kingdom In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic |
2011 | 2.500,00$ |
Blood Glucose Monitoring Devices (Meters, Test Strips, Lancets) - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017Introduction
/
/ GlobalData’s new report, “Blood Glucose Monitoring Devices (Meters, Test Strips, Lancets) - Global Pipeline An |
2012 | 3.995,00$ |
Vision Care Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017Introduction / / GlobalData’s new report, “Vision Care Devices - Global Pipeline Analysis, Competitive Landscape and Market Forec |
2012 | 3.500,00$ |
Cataract Surgery Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017Introduction / / GlobalData’s new report, “Cataract Surgery Devices - Global Pipeline Analysis, Competitive Landscape and Market |
2012 | 3.500,00$ |
Republic of Korea In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology CultureIntroduction / / GlobalData’s new report, “Republic of Korea In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Gene |
2011 | 2.500,00$ |
Airway and Anesthesia Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017Introduction / / GlobalData’s new report, “Airway and Anesthesia Devices Market Outlook in BRICS (Brazil, Russia, India, China, S |
2011 | 2.500,00$ |
Intraocular Lens (IOL) - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017Introduction / / GlobalData’s new report, “Intraocular Lens (IOL) - Global Pipeline Analysis, Competitive Landscape and Market Fo |
2012 | 3.500,00$ |
Refractive Surgery Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017Introduction / / GlobalData’s new report, “Refractive Surgery Devices - Global Pipeline Analysis, Competitive Landscape and Marke |
2012 | 3.500,00$ |
Full-Field Digital Mammography Equipment - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017Introduction / / GlobalData’s new report, “Full-Field Digital Mammography Equipment - Global Pipeline Analysis, Competitive Lands |
2012 | 3.500,00$ |
Hospital Wireless Patient Monitoring Devices - Global Opportunity Assessment, Competitive Landscape and Market Forecasts to 2017Introduction / / GlobalData’s new report, “Hospital Wireless Patient Monitoring Devices - Global Opportunity Assessment, Competit |
2011 | 3.500,00$ |
Regional Anesthesia Disposables Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017Introduction / / GlobalData’s new report, “Regional Anesthesia Disposables Market Outlook in BRICS (Brazil, Russia, India, China, |
2011 | 2.500,00$ |
Respiratory Disposables Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017Introduction / / GlobalData’s new report, “Respiratory Disposables Market Outlook in BRICS (Brazil, Russia, India, China, South A |
2011 | 2.500,00$ |
Insulin Delivery Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017Introduction / / GlobalData’s new report, “Insulin Delivery Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) |
2011 | 2.500,00$ |
Multiparameter Patient Monitoring Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017Introduction / / GlobalData’s new report, “Multiparameter Patient Monitoring Market Outlook in BRICS (Brazil, Russia, India, Chin |
2011 | 2.500,00$ |
Magnetic Resonance Imaging (MRI) Systems Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017Introduction / / GlobalData’s new report, “Magnetic Resonance Imaging (MRI) Systems Market Outlook in BRICS (Brazil, Russia, Indi |
2011 | 2.500,00$ |
Asia-Pacific In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology CultureIntroduction / / GlobalData’s new report, “Asia-Pacific In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic T |
2011 | 3.500,00$ |
Mexico In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology CultureIntroduction / / GlobalData’s new report, “Mexico In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Testing |
2011 | 2.500,00$ |
Taiwan In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology CultureIntroduction / / GlobalData’s new report, “Taiwan In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Testing |
2011 | 2.500,00$ |
South Africa In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology CultureIntroduction / / GlobalData’s new report, “South Africa In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic T |
2011 | 2.500,00$ |
Austria In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Testing, Haematology, Histology And Cytology, Immuno Chemistry, Infectious Immunology and Microbiology CultureIntroduction / / GlobalData’s new report, “Austria In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Testin |
2011 | 2.500,00$ |
Czech Republic In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology CultureIntroduction / / GlobalData’s new report, “Czech Republic In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic |
2011 | 2.500,00$ |
Denmark In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology CultureIntroduction / / GlobalData’s new report, “Denmark In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Testin |
2011 | 2.500,00$ |
Hepatitis B Vaccines - Pipeline Assessment and Market Forecasts to 2018Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Hepatitis B Vaccines - Pipeline Asse |
2011 | 3.500,00$ |
Fibromyalgia Therapeutics - Pipeline Assessment and Market Forecasts to 2018Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Fibromyalgia Therapeutics - Pipeline |
2011 | 3.500,00$ |
Eczema Therapeutics - Pipeline Assessment and Market Forecasts to 2018Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Eczema Therapeutics - Pipeline Asses |
2012 | 3.500,00$ |
Acute Coronary Syndrome (ACS) Therapeutics - Pipeline Assessment and Market Forecasts to 2018Introduction / / GlobalData, the industry analysis specialist, has released its new report “Acute Coronary Syndrome (ACS) Therape |
2011 | 3.500,00$ |
Addiction Control Therapeutics - Pipeline Assessment and Market Forecasts to 2018Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Addiction Control Therapeutics - Pip |
2011 | 3.500,00$ |
Thalassemia Therapeutics - Pipeline Assessment and Market Forecasts to 2018Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Thalassemia Therapeutics - Pipeline |
2011 | 3.500,00$ |
Lip and Oral Cavity Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2018Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Lip and Oral Cavity Cancer Therapeut |
2011 | 3.500,00$ |
Graft Versus Host Disease (GVHD) Therapeutics - Pipeline Assessment and Market Forecasts to 2018Introduction
/
/ GlobalData, the industry analysis specialist, has released its new report, “Graft Versus Host Disease (GVHD) T |
2012 | 3.995,00$ |
Anorexia Nervosa Therapeutics - Pipeline Assessment and Market Forecasts to 2018Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Anorexia Nervosa Therapeutics - Pipe |
2011 | 3.500,00$ |
Kawasaki Disease Therapeutics - Pipeline Assessment and Market Forecasts to 2018Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Kawasaki Disease Therapeutics - Pipe |
2011 | 3.500,00$ |
Testicular Cancer Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Testicular Cancer Global Clinical Trials Review, H2, 2011" provides data on |
2011 | 1.000,00$ |
Post-Traumatic Stress Disorder (PTSD) Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Post-Traumatic Stress Disorder (PTSD) Global Clinical Trials Review, H2, 2 |
2011 | 1.000,00$ |
Polio Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Polio Global Clinical Trials Review, H2, 2011" provides data on the Polio c |
2011 | 1.000,00$ |
Phlebitis Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Phlebitis Global Clinical Trials Review, H2, 2011" provides data on the Phl |
2011 | 1.000,00$ |
Non-Hodgkin Lymphoma Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Non-Hodgkin Lymphoma Global Clinical Trials Review, H2, 2011" provides data |
2011 | 1.000,00$ |
Hemostasis Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Hemostasis Global Clinical Trials Review, H2, 2011" provides data on the He |
2011 | 1.000,00$ |
Dengue Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Dengue Global Clinical Trials Review, H2, 2011" provides data on the Dengue |
2011 | 1.000,00$ |
Chronic Obstructive Pulmonary Disease (COPD) Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Chronic Obstructive Pulmonary Disease (COPD) Global Clinical Trials Review, |
2011 | 1.000,00$ |
Asthma Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Asthma Global Clinical Trials Review, H2, 2011" provides data on the Asthma |
2011 | 1.000,00$ |
Angina (Angina Pectoris) Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Angina (Angina Pectoris) Global Clinical Trials Review, H2, 2011" provides |
2011 | 1.000,00$ |
Osteoarthritis (OA) Therapeutics - Pipeline Assessment and Market Forecasts to 2018Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Osteoarthritis (OA) Therapeutics - P |
2011 | 3.500,00$ |
Bronchitis Therapeutics - Pipeline Assessment and Market Forecasts to 2018Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Bronchitis Therapeutics - Pipeline A |
2011 | 3.500,00$ |
Huntington’s Disease (HD) Therapeutics - Pipeline Assessment and Market Forecasts to 2018Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Huntington’s Disease (HD) Therapeuti |
2011 | 3.500,00$ |
Generalized Anxiety Disorders (GAD) Therapeutics - Pipeline Assessment and Market Forecasts to 2018Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Generalized Anxiety Disorders (GAD) |
2011 | 3.500,00$ |
Male Hypogonadism Therapeutics - Pipeline Assessment and Market Forecasts to 2019Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Male Hypogonadism Therapeutics - Pip |
2011 | 3.500,00$ |
Atherosclerosis or Coronary Artery Disease (CAD) Therapeutics - Pipeline Assessment and Market Forecasts to 2018Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Atherosclerosis or Coronary Artery D |
2012 | 3.500,00$ |
Gaucher’s Disease Therapeutics - Pipeline Assessment and Market Forecasts to 2018Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Gaucher’s Disease Therapeutics - Pip |
2012 | 3.500,00$ |
Myocardial Infarction (MI) Therapeutics - Pipeline Assessment and Market Forecasts to 2018Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Myocardial Infarction (MI) Therapeut |
2011 | 3.500,00$ |
Dyskinesia Therapeutics - Pipeline Assessment and Market Forecasts to 2019Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Dyskinesia Therapeutics - Pipeline A |
2011 | 3.500,00$ |
Overactive Bladder (OAB) Therapeutics - Pipeline Assessment and Market Forecasts to 2019Introduction
/
/ GlobalData, the industry analysis specialist, has released its new report, “Overactive Bladder (OAB) Therapeut |
2012 | 3.995,00$ |
Venous Thromboembolism (VTE) Therapeutics - Pipeline Assessment and Market Forecasts to 2018Introduction
/
/ GlobalData, the industry analysis specialist, has released its new report, “Venous Thromboembolism (VTE) Thera |
2012 | 3.995,00$ |
Thyroid Cancer Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Thyroid Cancer Global Clinical Trials Review, H2, 2011" provides data on th |
2011 | 1.000,00$ |
Rectal Cancer Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Rectal Cancer Global Clinical Trials Review, H2, 2011" provides data on the |
2011 | 1.000,00$ |
Peripheral Arterial Disease Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Peripheral Arterial Disease Global Clinical Trials Review, H2, 2011" provid |
2011 | 1.000,00$ |
Ovarian Cancer Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Ovarian Cancer Global Clinical Trials Review, H2, 2011" provides data on th |
2011 | 1.000,00$ |
Myelodysplastic Syndrome Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Myelodysplastic Syndrome Global Clinical Trials Review, H2, 2011" provides |
2011 | 1.000,00$ |
Meningitis Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Meningitis Global Clinical Trials Review, H2, 2011" provides data on the Me |
2011 | 1.000,00$ |
Insomnia Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Insomnia Global Clinical Trials Review, H2, 2011" provides data on the Inso |
2011 | 1.000,00$ |
Hepatic Tumor Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Hepatic Tumor Global Clinical Trials Review, H2, 2011" provides data on the |
2011 | 1.000,00$ |
Glioma Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Glioma Global Clinical Trials Review, H2, 2011" provides data on the Glioma |
2011 | 1.000,00$ |
Gallbladder Cancer Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Gallbladder Cancer Global Clinical Trials Review, H2, 2011" provides data o |
2011 | 1.000,00$ |
Burns Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Burns Global Clinical Trials Review, H2, 2011" provides data on the Burns c |
2011 | 1.000,00$ |
Allergic Rhinitis Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Allergic Rhinitis Global Clinical Trials Review, H2, 2011" provides data on |
2011 | 1.000,00$ |
Arthroscopy Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecast to 2017Introduction / / GlobalData’s new report, “Arthroscopy Devices - Global Pipeline Analysis, Opportunity Assessment and Market Fore |
2011 | 3.500,00$ |
Rigid Endoscopes - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017Introduction / / GlobalData’s new report, “Rigid Endoscopes - Global Pipeline Analysis, Competitive Landscape and Market Forecast |
2011 | 3.500,00$ |
Dysmenorrhea Therapeutics - Pipeline Assessment and Market Forecasts to 2018Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Dysmenorrhea Therapeutics - Pipeline |
2011 | 3.500,00$ |
Radiological Society of North America (RSNA) Conference 2011 - Review and AnalysisIntroduction / / GlobalData’s report, “Radiological Society of North America (RSNA) Conference 2011 - Review and Analysis” provid |
2011 | 1.000,00$ |
Hospital Information Systems Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017Introduction / / GlobalData’s new report, “Hospital Information Systems Market Outlook in BRICS (Brazil, Russia, India, China, So |
2011 | 2.500,00$ |
Glucose Monitoring Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017Introduction / / GlobalData’s new report, “Glucose Monitoring Market Outlook in BRICS (Brazil, Russia, India, China, South Africa |
2011 | 2.500,00$ |
Anesthesia Machines in BRICS Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017Introduction / / GlobalData’s new report, “Anesthesia Machines Market Outlook in BRICS (Brazil, Russia, India, China, South Afric |
2011 | 2.500,00$ |
Sleep Apnea Diagnostic Systems in BRICS Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017Introduction / / GlobalData’s new report, “Sleep Apnea Diagnostic Systems Market Outlook in BRICS (Brazil, Russia, India, China, |
2011 | 2.500,00$ |
North America Anesthesia and Respiratory Devices Market Outlook to 2017- Respiratory Devices, Respiratory Measurement Devices, Airway and Anesthesia Devices, Anesthesia Machines, Sleep Apnea Diagnostic Systems, Pain Management Devices and OthersIntroduction / / GlobalData’s new report, “North America Anesthesia and Respiratory Devices Market Outlook to 2017- Respiratory D |
2011 | 3.500,00$ |
Europe Anesthesia and Respiratory Devices Market Outlook to 2017- Respiratory Devices, Respiratory Measurement Devices, Airway and Anesthesia Devices, Anesthesia Machines, Sleep Apnea Diagnostic Systems, Pain Management Devices and OthersIntroduction / / GlobalData’s new report, “Europe Anesthesia and Respiratory Devices Market Outlook to 2017- Respiratory Devices, |
2011 | 3.500,00$ |
Asia-Pacific Anesthesia and Respiratory Devices Market Outlook to 2017- Respiratory Devices, Respiratory Measurement Devices, Airway and Anesthesia Devices, Anesthesia Machines, Sleep Apnea Diagnostic Systems, Pain Management Devices and OthersIntroduction / / GlobalData’s new report, “Asia-Pacific Anesthesia and Respiratory Devices Market Outlook to 2017- Respiratory De |
2011 | 3.500,00$ |
South and Central America Anesthesia and Respiratory Devices Market Outlook to 2017- Respiratory Devices, Respiratory Measurement Devices, Airway and Anesthesia Devices, Anesthesia Machines, Sleep Apnea Diagnostic Systems, Pain Management Devices and OtheIntroduction / / GlobalData’s new report, “South and Central America Anesthesia and Respiratory Devices Market Outlook to 2017- R |
2011 | 3.500,00$ |
North America Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin DeliveryIntroduction / / GlobalData’s new report, “North America Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Ins |
2011 | 3.500,00$ |
Europe Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin DeliveryIntroduction / / GlobalData’s new report, “Europe Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin De |
2011 | 3.500,00$ |
Asia-Pacific Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin DeliveryIntroduction / / GlobalData’s new report, “Asia-Pacific Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insu |
2011 | 3.500,00$ |
Middle East and Africa Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin DeliveryIntroduction / / GlobalData’s new report, “Middle East and Africa Diabetes Care Devices Market Outlook to 2017- Glucose Monitorin |
2011 | 3.500,00$ |
South and Central America Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin DeliveryIntroduction / / GlobalData’s new report, “South and Central America Diabetes Care Devices Market Outlook to 2017- Glucose Monito |
2011 | 3.500,00$ |
Sleep Apnea Diagnostic Systems - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017Introduction / / GlobalData’s new report, “Sleep Apnea Diagnostic Systems - Global Pipeline Analysis, Competitive Landscape and M |
2011 | 3.500,00$ |
Medical Equipment Monthly Deals Analysis - M&A and Investment Trends, December 2011Introduction / / GlobalData's “Medical Equipment Monthly Deals Analysis - M&A and Investment Trends, December 2011” report is an |
2011 | 1.000,00$ |
United States Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin DeliveryIntroduction / / GlobalData’s new report, “United States Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Ins |
2011 | 2.500,00$ |
United Kingdom Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin DeliveryIntroduction / / GlobalData’s new report, “United Kingdom Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and In |
2011 | 2.500,00$ |
Japan Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin DeliveryIntroduction / / GlobalData’s new report, “Japan Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Del |
2011 | 2.500,00$ |
India Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin DeliveryIntroduction / / GlobalData’s new report, “India Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Del |
2011 | 2.500,00$ |
China Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin DeliveryIntroduction / / GlobalData’s new report, “China Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Del |
2011 | 2.500,00$ |
Canada Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin DeliveryIntroduction / / GlobalData’s new report, “Canada Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin De |
2011 | 2.500,00$ |
Germany Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin DeliveryIntroduction / / GlobalData’s new report, “Germany Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin D |
2011 | 2.500,00$ |
France Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin DeliveryIntroduction / / GlobalData’s new report, “France Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin De |
2011 | 2.500,00$ |
Italy Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin DeliveryIntroduction / / GlobalData’s new report, “Italy Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin De |
2011 | 2.500,00$ |
Spain Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin DeliveryIntroduction / / GlobalData’s new report, “Spain Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Del |
2011 | 2.500,00$ |
Australia Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin DeliveryIntroduction / / GlobalData’s new report, “Australia Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin |
2011 | 2.500,00$ |
Brazil Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin DeliveryIntroduction / / GlobalData’s new report, “Brazil Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin De |
2011 | 2.500,00$ |
Netherlands Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin DeliveryIntroduction / / GlobalData’s new report, “Netherlands Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insul |
2011 | 2.500,00$ |
Belgium Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin DeliveryIntroduction / / GlobalData’s new report, “Belgium Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin D |
2011 | 2.500,00$ |
Argentina Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin DeliveryIntroduction / / GlobalData’s new report, “Argentina Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin |
2011 | 2.500,00$ |
Mexico Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin DeliveryIntroduction / / GlobalData’s new report, “Mexico Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin De |
2011 | 2.500,00$ |
Republic of Korea Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin DeliveryIntroduction / / GlobalData’s new report, “Republic of Korea Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and |
2011 | 2.500,00$ |
Taiwan Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin DeliveryIntroduction / / GlobalData’s new report, “Taiwan Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin De |
2011 | 2.500,00$ |
South Africa Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin DeliveryIntroduction / / GlobalData’s new report, “South Africa Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insu |
2011 | 2.500,00$ |
Israel Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin DeliveryIntroduction / / GlobalData’s new report, “Israel Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin De |
2011 | 2.500,00$ |
India Anesthesia and Respiratory Devices Market Outlook to 2017- Respiratory Devices, Respiratory Measurement Devices, Airway and Anesthesia Devices, Anesthesia Machines, Sleep Apnea Diagnostic Systems, Pain Management Devices and OthersIntroduction / / GlobalData’s new report, “India Anesthesia and Respiratory Devices Market Outlook to 2017- Respiratory Devices, |
2011 | 2.500,00$ |
France Anesthesia and Respiratory Devices Market Outlook to 2017- Respiratory Devices, Respiratory Measurement Devices, Airway and Anesthesia Devices, Anesthesia Machines, Sleep Apnea Diagnostic Systems, Pain Management Devices and OthersIntroduction / / GlobalData’s new report, “France Anesthesia and Respiratory Devices Market Outlook to 2017- Respiratory Devices, |
2011 | 2.500,00$ |
Italy Anesthesia and Respiratory Devices Market Outlook to 2017- Respiratory Devices, Respiratory Measurement Devices, Airway and Anesthesia Devices, Anesthesia Machines, Sleep Apnea Diagnostic Systems, Pain Management Devices and OthersIntroduction / / GlobalData’s new report, “Italy Anesthesia and Respiratory Devices Market Outlook to 2017- Respiratory Devices, |
2011 | 2.500,00$ |
Brazil Anesthesia and Respiratory Devices Market Outlook to 2017- Respiratory Devices, Respiratory Measurement Devices, Airway and Anesthesia Devices, Anesthesia Machines, Sleep Apnea Diagnostic Systems, Pain Management Devices and OthersIntroduction / / GlobalData’s new report, “Brazil Anesthesia and Respiratory Devices Market Outlook to 2017- Respiratory Devices, |
2011 | 2.500,00$ |
Argentina Anesthesia and Respiratory Devices Market Outlook to 2017- Respiratory Devices, Respiratory Measurement Devices, Airway and Anesthesia Devices, Anesthesia Machines, Sleep Apnea Diagnostic Systems, Pain Management Devices and OthersIntroduction / / GlobalData’s new report, “Argentina Anesthesia and Respiratory Devices Market Outlook to 2017- Respiratory Devic |
2011 | 2.500,00$ |
Mexico Anesthesia and Respiratory Devices Market Outlook to 2017- Respiratory Devices, Respiratory Measurement Devices, Airway and Anesthesia Devices, Anesthesia Machines, Sleep Apnea Diagnostic Systems, Pain Management Devices and OthersIntroduction / / GlobalData’s new report, “Mexico Anesthesia and Respiratory Devices Market Outlook to 2017- Respiratory Devices, |
2011 | 2.500,00$ |
Republic of Korea Anesthesia and Respiratory Devices Market Outlook to 2017- Respiratory Devices, Respiratory Measurement Devices, Airway and Anesthesia Devices, Anesthesia Machines, Sleep Apnea Diagnostic Systems, Pain Management Devices and OthersIntroduction / / GlobalData’s new report, “Republic of Korea Anesthesia and Respiratory Devices Market Outlook to 2017- Respirato |
2011 | 2.500,00$ |
Taiwan Anesthesia and Respiratory Devices Market Outlook to 2017- Respiratory Devices, Respiratory Measurement Devices, Airway and Anesthesia Devices, Anesthesia Machines, Sleep Apnea Diagnostic Systems, Pain Management Devices and OthersIntroduction / / GlobalData’s new report, “Taiwan Anesthesia and Respiratory Devices Market Outlook to 2017- Respiratory Devices, |
2011 | 2.500,00$ |
South Africa Anesthesia and Respiratory Devices Market Outlook to 2017- Respiratory Devices, Respiratory Measurement Devices, Airway and Anesthesia Devices, Anesthesia Machines, Sleep Apnea Diagnostic Systems, Pain Management Devices and OthersIntroduction / / GlobalData’s new report, “South Africa Anesthesia and Respiratory Devices Market Outlook to 2017- Respiratory De |
2011 | 2.500,00$ |
Israel Anesthesia and Respiratory Devices Market Outlook to 2017- Respiratory Devices, Respiratory Measurement Devices, Airway and Anesthesia Devices, Anesthesia Machines, Sleep Apnea Diagnostic Systems, Pain Management Devices and OthersIntroduction / / GlobalData’s new report, “Israel Anesthesia and Respiratory Devices Market Outlook to 2017- Respiratory Devices, |
2011 | 2.500,00$ |
New Zealand Anesthesia and Respiratory Devices Market Outlook to 2017- Respiratory Devices, Respiratory Measurement Devices, Airway and Anesthesia Devices, Anesthesia Machines, Sleep Apnea Diagnostic Systems, Pain Management Devices and OthersIntroduction / / GlobalData’s new report, “New Zealand Anesthesia and Respiratory Devices Market Outlook to 2017- Respiratory Dev |
2011 | 2.500,00$ |
Saudi Arabia Anesthesia and Respiratory Devices Market Outlook to 2017- Respiratory Devices, Respiratory Measurement Devices, Airway and Anesthesia Devices, Anesthesia Machines, Sleep Apnea Diagnostic Systems, Pain Management Devices and OthersIntroduction / / GlobalData’s new report, “Saudi Arabia Anesthesia and Respiratory Devices Market Outlook to 2017- Respiratory De |
2011 | 2.500,00$ |
Compression Hosiery Stockings - A Market SnapshotIntroduction / / GlobalData’s report, “Compression Hosiery Stockings - A Market Snapshot” provides key data, information and anal |
2011 | 500,00$ |
US Surgical Booms Market - An OverviewIntroduction / / GlobalData’s report, “US Surgical Booms Market - An Overview” provides key data, information and analysis on the |
2011 | 500,00$ |
European Debt Crisis - Impact on Healthcare IndustryIntroduction / / GlobalData’s report, “European Debt Crisis - Impact on Healthcare Industry” provides key information and analysi |
2011 | 500,00$ |
New Zealand Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin DeliveryIntroduction / / GlobalData’s new report, “New Zealand Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insul |
2011 | 2.500,00$ |
Saudi Arabia Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin DeliveryIntroduction / / GlobalData’s new report, “Saudi Arabia Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insu |
2011 | 2.500,00$ |
Sweden Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin DeliveryIntroduction / / GlobalData’s new report, “Sweden Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin De |
2011 | 2.500,00$ |
Austria Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin DeliveryIntroduction / / GlobalData’s new report, “Austria Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin D |
2011 | 2.500,00$ |
Denmark Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin DeliveryIntroduction / / GlobalData’s new report, “Denmark Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin D |
2011 | 2.500,00$ |
Russian Federation Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin DeliveryIntroduction / / GlobalData’s new report, “Russian Federation Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring an |
2011 | 2.500,00$ |
Czech Republic Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin DeliveryIntroduction / / GlobalData’s new report, “Czech Republic Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and In |
2011 | 2.500,00$ |
Czech Republic Anesthesia and Respiratory Devices Market Outlook to 2017- Respiratory Devices, Respiratory Measurement Devices, Airway and Anesthesia Devices, Anesthesia Machines, Sleep Apnea Diagnostic Systems, Pain Management Devices and OthersIntroduction / / GlobalData’s new report, “Czech Republic Anesthesia and Respiratory Devices Market Outlook to 2017- Respiratory |
2011 | 2.500,00$ |
Austria Anesthesia and Respiratory Devices Market Outlook to 2017- Respiratory Devices, Respiratory Measurement Devices, Airway and Anesthesia Devices, Anesthesia Machines, Sleep Apnea Diagnostic Systems, Pain Management Devices and OthersIntroduction / / GlobalData’s new report, “Austria Anesthesia and Respiratory Devices Market Outlook to 2017- Respiratory Devices |
2011 | 2.500,00$ |
Sweden Anesthesia and Respiratory Devices Market Outlook to 2017- Respiratory Devices, Respiratory Measurement Devices, Airway and Anesthesia Devices, Anesthesia Machines, Sleep Apnea Diagnostic Systems, Pain Management Devices and OthersIntroduction / / GlobalData’s new report, “Sweden Anesthesia and Respiratory Devices Market Outlook to 2017- Respiratory Devices, |
2011 | 2.500,00$ |
Osteoporosis Therapeutics - Pipeline Assessment and Market Forecasts to 2018Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Osteoporosis Therapeutics - Pipeline |
2011 | 3.500,00$ |
Epilepsy Therapeutics - Pipeline Assessment and Market Forecasts to 2018Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Epilepsy Therapeutics - Pipeline Ass |
2011 | 3.500,00$ |
Crohn’s Disease (CD) Therapeutics - Pipeline Assessment and Market Forecasts to 2018Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Crohn’s Disease (CD) Therapeutics - |
2011 | 3.500,00$ |
NovoLog (Type 2 Diabetes) – Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “NovoLog (Type 2 Diabetes) – Analysis and Forecasts to 2020” provides NovoL |
2011 | 2.000,00$ |
Candidiasis Therapeutics - Pipeline Assessment and Market Forecasts to 2018Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Candidiasis Therapeutics - Pipeline |
2011 | 3.500,00$ |
Cervical Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2018Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Cervical Cancer Therapeutics - Pipel |
2011 | 3.500,00$ |
Dystonia Therapeutics - Pipeline Assessment and Market Forecasts to 2018Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Dystonia Therapeutics - Pipeline Ass |
2011 | 3.500,00$ |
Sickle Cell Anemia Therapeutics - Pipeline Assessment and Market Forecasts to 2018Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Sickle Cell Anemia Therapeutics - Pi |
2011 | 3.500,00$ |
Fabry’s Disease Therapeutics - Pipeline Assessment and Market Forecasts to 2018Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Fabry’s Disease Therapeutics - Pipel |
2011 | 3.500,00$ |
Paget’s Disease of Bone (PDB) Therapeutics - Pipeline Assessment and Market Forecasts to 2018Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Paget’s Disease of Bone (PDB) Therap |
2011 | 3.500,00$ |
Ovarian Disease Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Ovarian Disease Global Clinical Trials Review, H2, 2011" provides data on t |
2011 | 1.000,00$ |
Aneurysmal Subarachnoid Hemorrhage (SAH) Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Aneurysmal Subarachnoid Hemorrhage (SAH) Global Clinical Trials Review, H2, |
2011 | 1.000,00$ |
Adult Respiratory Distress Syndrome Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Adult Respiratory Distress Syndrome Global Clinical Trials Review, H2, 2011 |
2011 | 1.000,00$ |
Fragile X Syndrome Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Fragile X Syndrome Global Clinical Trials Review, H2, 2011" provides data o |
2011 | 1.000,00$ |
Amblyopia Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Amblyopia Global Clinical Trials Review, H2, 2011" provides data on the Amb |
2011 | 1.000,00$ |
Iliac Aneurysms Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Iliac Aneurysms Global Clinical Trials Review, H2, 2011" provides data on t |
2011 | 1.000,00$ |
Dermatitis Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Dermatitis Global Clinical Trials Review, H2, 2011" provides data on the De |
2011 | 1.000,00$ |
Stomatitis (Sore Mouth) Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Stomatitis (Sore Mouth) Global Clinical Trials Review, H2, 2011" provides d |
2011 | 1.000,00$ |
Aphasia Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Aphasia Global Clinical Trials Review, H2, 2011" provides data on the Aphas |
2011 | 1.000,00$ |
Psoriatic Arthritis Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Psoriatic Arthritis Global Clinical Trials Review, H2, 2011" provides data |
2011 | 1.000,00$ |
Biliary Tract Disease Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Biliary Tract Disease Global Clinical Trials Review, H2, 2011" provides dat |
2011 | 1.000,00$ |
Neonatal Respiratory Distress Syndrome Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Neonatal Respiratory Distress Syndrome Global Clinical Trials Review, H2, 2 |
2011 | 1.000,00$ |
Anal Cancer Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Anal Cancer Global Clinical Trials Review, H2, 2011" provides data on the A |
2011 | 1.000,00$ |
Astrocytoma Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Astrocytoma Global Clinical Trials Review, H2, 2011" provides data on the A |
2011 | 1.000,00$ |
Osteosarcoma Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Osteosarcoma Global Clinical Trials Review, H2, 2011" provides data on the |
2011 | 1.000,00$ |
Staphylococcal Infections Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Staphylococcal Infections Global Clinical Trials Review, H2, 2011" provides |
2011 | 1.000,00$ |
Kidney Cancer Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Kidney Cancer Global Clinical Trials Review, H2, 2011" provides data on the |
2011 | 1.000,00$ |
Opium Addiction Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Opium Addiction Global Clinical Trials Review, H2, 2011" provides data on t |
2011 | 1.000,00$ |
Subarachnoid Hemorrhage Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Subarachnoid Hemorrhage Global Clinical Trials Review, H2, 2011" provides d |
2011 | 1.000,00$ |
Laryngeal Cancer Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Laryngeal Cancer Global Clinical Trials Review, H2, 2011" provides data on |
2011 | 1.000,00$ |
Lung Cancer Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Lung Cancer Global Clinical Trials Review, H2, 2011" provides data on the L |
2011 | 1.000,00$ |
Acute Coronary Syndrome Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Acute Coronary Syndrome Global Clinical Trials Review, H2, 2011" provides d |
2011 | 1.000,00$ |
Leukemia Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Leukemia Global Clinical Trials Review, H2, 2011" provides data on the Leuk |
2011 | 1.000,00$ |
Head and Neck Cancer Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Head and Neck Cancer Global Clinical Trials Review, H2, 2011" provides data |
2011 | 1.000,00$ |
Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections Global Clinic |
2011 | 1.000,00$ |
Endometrial Cancer Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Endometrial Cancer Global Clinical Trials Review, H2, 2011" provides data o |
2011 | 1.000,00$ |
Staphylococcus Aureus Infections Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Staphylococcus Aureus Infections Global Clinical Trials Review, H2, 2011" p |
2011 | 1.000,00$ |
Esophageal Cancer Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Esophageal Cancer Global Clinical Trials Review, H2, 2011" provides data on |
2011 | 1.000,00$ |
Fallopian Tube Cancer Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Fallopian Tube Cancer Global Clinical Trials Review, H2, 2011" provides dat |
2011 | 1.000,00$ |
Prostate Cancer Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Prostate Cancer Global Clinical Trials Review, H2, 2011" provides data on t |
2011 | 1.000,00$ |
Hodgkin Lymphoma Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Hodgkin Lymphoma Global Clinical Trials Review, H2, 2011" provides data on |
2011 | 1.000,00$ |
HIV / AIDS Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “HIV / AIDS Global Clinical Trials Review, H2, 2011" provides data on the HI |
2011 | 1.000,00$ |
Colorectal Cancer Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Colorectal Cancer Global Clinical Trials Review, H2, 2011" provides data on |
2011 | 1.000,00$ |
Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - December 2011Introduction / / GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - December 2011” |
2011 | 1.000,00$ |
BioClinica (BIOC) - Financial and Strategic SWOT Analysis ReviewBioClinica is a health information technology company, which provides clinical research services in health industry. The company i |
2011 | 125,00$ |
Kawasumi Laboratories, Inc. (7703) - Financial and Strategic SWOT Analysis ReviewKawasumi Laboratories, Inc. (Kawasumi) is a medical device company engaged in the blood purifying business. The company develops a |
2011 | 125,00$ |
Calypte Biomedical Corporation (CBMC) - Financial and Strategic SWOT Analysis ReviewCalypte Biomedical Corporation (Calypte) is a diagnostic company engaged in the development, manufacture and marketing of in-vitro |
2011 | 125,00$ |
CAS Medical Systems, Inc. (CASM) - Financial and Strategic SWOT Analysis ReviewCAS Medical Systems, Inc. (CASMED) is a medical device company engaged in designing, developing, manufacturing and marketing of in |
2011 | 125,00$ |
Imaging Diagnostic Systems, Inc. (IMDS) - Financial and Strategic SWOT Analysis ReviewImaging Diagnostic Systems, Inc. (IDSI) is a development stage medical technology company, which commercializes medical imaging eq |
2011 | 125,00$ |
International Isotopes Inc. (INIS) - Financial and Strategic SWOT Analysis ReviewInternational Isotopes Inc. (INIS) is a holding company engaged in the development and manufacture of nuclear medicine calibration |
2011 | 125,00$ |
PC Group, Inc. (PCGR) - Financial and Strategic SWOT Analysis ReviewPC Group, Inc. (PC Group) formerly Langer, Inc., is engaged in the design, manufacture and distribution of medical products and se |
2011 | 125,00$ |
Arrhythmia Research Technology, Inc. (HRT) - Financial and Strategic SWOT Analysis ReviewArrhythmia Research Technology ( ART ) is a medical technology company. It is principally engaged in delivering state-of-the-art s |
2011 | 250,00$ |
Biohit Oyj (BIOBV) - Financial and Strategic SWOT Analysis ReviewBiohit Oyj (Biohit), is engaged in the manufacturing, developing and marketing of liquid handling products and accessories. The co |
2011 | 250,00$ |
Corin Group PLC (CRG) - Financial and Strategic SWOT Analysis ReviewCorin Group plc (Corin Group) is a medical device company engaged in the development, manufacture and sale of a wide variety of pr |
2011 | 125,00$ |
Del Global Technologies Corp. (DGTC) - Financial and Strategic SWOT Analysis ReviewDel Global Technologies Corp. (Del Global Technologies) is a medical device company engaged in the design, manufacture and marketi |
2011 | 125,00$ |
Digirad Corporation (DRAD) - Financial and Strategic SWOT Analysis ReviewDigirad Corporation (Digirad) is a medical technology company that is engaged in the research, development and manufacture of soli |
2011 | 125,00$ |
Fonar Corporation (FONR) - Financial and Strategic SWOT Analysis ReviewFonar Corporation (Fonar) is a medical device company engaged in the development, production and marketing of medical scanning equ |
2011 | 125,00$ |
Hemagen Diagnostics, Inc. (HMGN) - Financial and Strategic SWOT Analysis ReviewHemagen Diagnostics, Inc. (Hemagen) is a biotechnology company engaged in the research, development, production and marketing of m |
2011 | 250,00$ |
MTS Systems Corporation (MTSC) - Financial and Strategic SWOT Analysis ReviewMTS Systems Corporation (MTS) is a supplier of mechanical testing systems and industrial position sensors. The company carries out |
2011 | 250,00$ |
NeuroMetrix, Inc. (NURO) - Financial and Strategic SWOT Analysis ReviewNeuroMetrix, Inc. (NeuroMetrix) is a science-based medical device company. It is engaged in the design, development and commercial |
2011 | 250,00$ |
Ophthalmic Imaging Systems Inc. (OISI) - Financial and Strategic SWOT Analysis ReviewOphthalmic Imaging Systems Inc. (Ophthalmic Imaging) is a division of MediVision Medical Imaging Ltd. The company is engaged in th |
2011 | 250,00$ |
Retractable Technologies, Inc. (RVP) - Financial and Strategic SWOT Analysis ReviewRetractable Technologies, Inc. (Retractable) is a medical devices company. It is involved in the design, develop, manufacture and |
2011 | 250,00$ |
The Spectranetics Corporation (SPNC) - Financial and Strategic SWOT Analysis ReviewThe Spectranetics Corporation (Spectranetics) is engaged in the marketing of Excimer Laser System used in minimally invasive inter |
2011 | 250,00$ |
AtCor Medical Holdings Limited (ACG) - Financial and Strategic SWOT Analysis ReviewAtCor Medical Holdings Limited (AtCor Medical) is a medical device company, engaged in the design, manufacture and marketing of me |
2011 | 125,00$ |
MacKay Life Sciences, Inc. (BZEC) - Financial and Strategic SWOT Analysis ReviewMacKay Life Sciences, Inc. (MLS) is formerly known as Biofield. The company is a US based, listed corporation which develops, manu |
2011 | 250,00$ |
Conceptus, Inc. (CPTS) - Financial and Strategic SWOT Analysis ReviewConceptus, Inc. (Conceptus) is a medical device company engaged in developing, manufacturing and marketing medical devices and pro |
2011 | 125,00$ |
Lombard Medical Technologies PLC (LMT) - Financial and Strategic SWOT Analysis ReviewLombard Medical Technologies PLC (LMT) is a medical equipment company engaged in the discovery, manufacture and marketing of speci |
2011 | 125,00$ |
Magna-Lab Inc. (MAGAA) - Financial and Strategic SWOT Analysis ReviewMagna-Lab is a medical device company which is focused on the development and commercialization of disposable medical devices. The |
2011 | 125,00$ |
MedTox Scientific, Inc. (MTOX) - Financial and Strategic SWOT Analysis ReviewMEDTOX Scientific, Inc. (MedTox) is medical device company that is engaged in providing forensic and laboratory services to corp |
2011 | 125,00$ |
Akers Biosciences, Inc. (AKR) - Financial and Strategic SWOT Analysis ReviewAkers Biosciences, Inc. (ABI) is engaged in the development, manufacture and supply of rapid point care screening and testing prod |
2011 | 125,00$ |
Ametek, Inc. (AME) - Financial and Strategic SWOT Analysis ReviewAmetek, Inc. (Ametek) is a one of the largest manufacturer of electronic instruments and electromechanical devices company. The co |
2011 | 250,00$ |
AMICAS, Inc. (AMCS) - Financial and Strategic SWOT Analysis ReviewAmicas, Inc. (Amicas) is engaged in providing radiology, medical image and information management solutions. The company's product |
2011 | 125,00$ |
Angeion Corporation (ANGN) - Financial and Strategic SWOT Analysis ReviewAngeion Corporation (Angeion) is engaged in the design, development, manufacture and distribution of cardiorespiratory diagnostic |
2011 | 250,00$ |
Biotel Incorporated (BTEL) - Financial and Strategic SWOT Analysis ReviewBiotel Incorporated (Biotel) is engaged in the design, manufacture and marketing of patient-worn diagnostic electrocardiology devi |
2011 | 250,00$ |
Cardima, Inc. (CADMQ) - Financial and Strategic SWOT Analysis ReviewCardima, Inc. (Cardima) designs, develops, manufactures and markets minimally invasive, single-use, micro-catheter systems for the |
2011 | 250,00$ |
AdvanSource Biomaterials Corporation (ASNB) - Financial and Strategic SWOT Analysis ReviewAdvanSource Biomaterials Corporation (AdvanSource) is engaged in developing polymer based materials for the medical and pharmaceut |
2011 | 125,00$ |
China Medical Technologies, Inc. (CMED) - Financial and Strategic SWOT Analysis ReviewChina Medical Technologies, (China Medical) is engaged in the development, manufacture and marketing of in-vitro diagnostics (IVD) |
2011 | 250,00$ |
Chindex International, Inc. (CHDX) - Financial and Strategic SWOT Analysis ReviewChindex International, Inc. (Chindex) is a healthcare service and medical equipment company, is focused on providing healthcare se |
2011 | 250,00$ |
Hamamatsu Photonics K.K. (6965) - Financial and Strategic SWOT Analysis ReviewHamamatsu Photonics K.K. (Hamamatsu) is an optical electronic devices manufacturing company. It is principally engaged in the desi |
2011 | 125,00$ |
HEI, Inc. (HEII) - Financial and Strategic SWOT Analysis ReviewHEI Inc., an electronic device and medical equipment manufacturer, focuses on specialized services in Electronic Manufacturing Ser |
2011 | 250,00$ |
Hydromer, Inc. (HYDI) - Financial and Strategic SWOT Analysis ReviewHydromer, Inc. (Hydromer) is a biotechnology company engaged in developing, patenting, licensing, manufacture and commercializing |
2011 | 250,00$ |
IntegraMed America, Inc. (INMD) - Financial and Strategic SWOT Analysis ReviewIntegraMed America, Inc. (IntegraMed) is a specialty healthcare service company focused in providing products and services in the |
2011 | 250,00$ |
International Brachytherapy S.A. (EZBG) - Financial and Strategic SWOT Analysis ReviewInternational Brachytherapy S.A. (IBT Bebig) is a Europe-based medical device company, focusing on cancer treatment by radiation t |
2011 | 250,00$ |
IRIDEX Corporation (IRIX) - Financial and Strategic SWOT Analysis ReviewIRIDEX Corporation (IRIDEX) is a medical devices company. It is engaged in development, manufacture, marketing and sale of medical |
2011 | 250,00$ |
Landauer, Inc. (LDR) - Financial and Strategic SWOT Analysis ReviewLandauer, Inc. (Landauer) is a medical device company focused on providing analytical services to determine the exposure of enviro |
2011 | 250,00$ |
MedMira Inc. (MIR) - Financial and Strategic SWOT Analysis ReviewMedMira, Inc (MedMira) is a diagnostic company principally engaged in the developing, manufacturing and commercializing of rapid d |
2011 | 250,00$ |
Capstone Therapeutics Corp. (CAPS) - Financial and Strategic SWOT Analysis ReviewCapstone Therapeutics Corp. (Capstone) formerly known as OrthoLogic Corp. is a biotechnology company engaged in the development an |
2011 | 250,00$ |
PhotoMedex, Inc. (PHMD) - Financial and Strategic SWOT Analysis ReviewPhotoMedex, Inc. (PhotoMedex) is engaged in the development, manufacture and marketing of proprietary laser and fiber optic system |
2011 | 250,00$ |
Somanetics Corporation (SMTS) - Financial and Strategic SWOT Analysis ReviewSomanetics Corporation (Somanetics) is a medical device company principally engaged in the development, manufacture and marketing |
2011 | 250,00$ |
ALR Technologies Inc. (ALRT) - Financial and Strategic SWOT Analysis ReviewALR Technologies Inc. (ALRT), formerly Mo Betta Corp. is a medical device company engaged in the business of designing, marketing, |
2011 | 125,00$ |
CompuMed, Inc. (CMPD) - Financial and Strategic SWOT Analysis ReviewCompuMed, Inc. (CompuMed) is a medical diagnostics equipment company. It is engaged in developing and marketing products and servi |
2011 | 125,00$ |
MediVision Medical Imaging Ltd. (MEDV) - Financial and Strategic SWOT Analysis ReviewMediVision Medical Imaging (MediVision) is a medical device company engaged in manufacturing clinically advanced digital imaging |
2011 | 125,00$ |
Micrus Endovascular Corporation - Financial and Strategic SWOT Analysis ReviewMicrus Endovascular Corporation (Mircus) engaged in the developing, manufacturing and marketing of implantable and disposable medi |
2011 | 250,00$ |
NxStage Medical, Inc. (NXTM) - Financial and Strategic SWOT Analysis ReviewNxStage Medical, Inc. (NxStage) is a medical device company engaged in the design, development, manufacture and commercialization |
2011 | 250,00$ |
STAAR Surgical Company (YORW) - Financial and Strategic SWOT Analysis ReviewSTAAR Surgical Company (STAAR Surgical) is a medical devices company. It is principally engaged in developing, manufacturing and c |
2011 | 250,00$ |
Synovis Life Technologies, Inc. (SYNO) - Financial and Strategic SWOT Analysis ReviewSynovis Life Technologies, Inc. (Synovis) is a diversified medical device company. It is engaged in the development, manufacture a |
2011 | 125,00$ |
Pathfinder Cell Therapy, Inc. (SYMD) - Financial and Strategic SWOT Analysis ReviewPathfinder Cell Therapy, Inc. (Pathfinder Cell Therapy), formerly known as SyntheMed, Inc., is a biomaterial company principally e |
2011 | 250,00$ |
Utah Medical Products, Inc. (UTMD) - Financial and Strategic SWOT Analysis ReviewUtah Medical Products, Inc. (Utah Medical) is engaged in the development, manufacture and marketing of disposable and reusable spe |
2011 | 250,00$ |
biolitec AG (BIB) - Financial and Strategic SWOT Analysis ReviewBiolitec AG (Biolitec) is a medical device company, engaged in the research, development, production and marketing of medical las |
2011 | 125,00$ |
Medisana AG (MHH) - Financial and Strategic SWOT Analysis ReviewMedisana AG (Medisana) is engaged in the development, manufacture and marketing of home care products for the healthcare markets. |
2011 | 250,00$ |
Ortivus AB (ORTI B) - Financial and Strategic SWOT Analysis ReviewOrtivus AB (Ortivus) is a medical technology company which is involved in providing information and tech device which give decisi |
2011 | 125,00$ |
Apex Medical Corporation (4106) - Financial and Strategic SWOT Analysis ReviewApex Medical Corporation (Apex Medical) is engaged in providing medical device manufacturing services for the OEM and healthcare i |
2011 | 250,00$ |
American Bio Medica Corporation (ABMC) - Financial and Strategic SWOT Analysis ReviewAmerican Bio Medica Corporation (ABMC) is a biotechnology company engaged in the development, manufacturing and marketing of immu |
2011 | 125,00$ |
SHOFU INC. (7979) - Financial and Strategic SWOT Analysis ReviewSHOFU INC. (SHOFU) is a medical device company which is mainly into manufacturing and marketing of dental materials and equipments |
2011 | 125,00$ |
RTI Biologics, Inc. (RTIX) - Financial and Strategic SWOT Analysis ReviewRTI Biologics, Inc. (RTI) provides tissue-based solutions to repair and promote the natural healing of human bone and other human |
2011 | 125,00$ |
United-Guardian, Inc. (UG) - Financial and Strategic SWOT Analysis ReviewUnited-Guardian, Inc. (United-Guardian) is a diversified company engaged in the manufacture and distribution of pharmaceuticals, c |
2011 | 250,00$ |
TearLab Corporation (TEAR) - Financial and Strategic SWOT Analysis ReviewTearLab Corporation (TearLab) formerly OccuLogix, Inc., is an in-vitro diagnostic company, engaged in the development and marketin |
2011 | 125,00$ |
Prism Medical Ltd. (PM) - Financial and Strategic SWOT Analysis ReviewPrism Medical Ltd. (Prism) is engaged in providing durable medical equipment and related services to the mobility disadvantaged pe |
2011 | 125,00$ |
Pro-Dex, Inc. (PDEX) - Financial and Strategic SWOT Analysis ReviewPro-Dex, Inc. (Pro-Dex) is engaged in the design, development, manufacture and marketing of rotary drive systems which are used in |
2011 | 125,00$ |
Synergy Health plc (SYR) - Financial and Strategic SWOT Analysis ReviewSynergy Health plc (Synergy Health) is a medical equipment company, engaged in providing healthcare support services. The company |
2011 | 125,00$ |
Cyberonics, Inc. (CYBX) - Financial and Strategic SWOT Analysis ReviewCyberonics, Inc. (Cyberonics) is a neuromodulation company that designs, develops and markets medical devices for the treatment of |
2011 | 125,00$ |
LiDCO Group Plc (LID) - Financial and Strategic SWOT Analysis ReviewLiDCO Group Plc (LiDCO) is a medical device company, engaged in research, development and manufacture and marketing of medical dev |
2011 | 125,00$ |
Mesa Laboratories, Inc. (MLAB) - Financial and Strategic SWOT Analysis ReviewMesa Laboratories, Inc. (Mesa) is engaged in the development, manufacture and marketing of electronic instruments and disposable p |
2011 | 125,00$ |
Signature Eyewear, Inc. (SEYE) - Financial and Strategic SWOT Analysis ReviewSignature Eyewear, Inc. (Signature) is a eyewear company, engaged in the design, marketing and distribution of prescription eyegla |
2011 | 125,00$ |
CTS Corporation (CTS) - Financial and Strategic SWOT Analysis ReviewCTS Corporation (CTS) is engaged in the design, manufacture and sale of electronic components, sensors and actuators. It operates |
2011 | 125,00$ |
Cynosure, Inc. (CYNO) - Financial and Strategic SWOT Analysis ReviewCynosure, Inc. (Cynosure) is a medical device company engaged in the development, manufacture and distribution of lasers and light |
2011 | 125,00$ |
Encision Inc. (ECIA) - Financial and Strategic SWOT Analysis ReviewEncision Inc.(Encision) is a medical device company engaged in designing, developing, manufacturing and marketing patented surgica |
2011 | 125,00$ |
Hypertension Diagnostics, Inc. (HDII) - Financial and Strategic SWOT Analysis ReviewHypertension Diagnostics, Inc. (Hypertension) is engaged in the design, development, manufacture and marketing of proprietary devi |
2011 | 125,00$ |
Neovasc Inc. (NVC) - Financial and Strategic SWOT Analysis ReviewNeovasc Inc. (Neovasc), formerly known as Medical Ventures Corp., is a medical device company engaged in the development and manuf |
2011 | 125,00$ |
Apogee Technology, Inc. (ATCS) - Financial and Strategic SWOT Analysis ReviewApogee Technology, Inc. (Apogee) is a biotechnology company, engaged in the development of advanced vaccine delivery systems. The |
2011 | 125,00$ |
BSD Medical Corporation (BSDM) - Financial and Strategic SWOT Analysis ReviewBSD Medical Corporation (BSD) is engaged in the development, manufacture and marketing of treatment systems, which are used for t |
2011 | 125,00$ |
ASAHI INTECC CO., LTD. (7747) - Financial and Strategic SWOT Analysis ReviewASAHI INTECC CO., LTD. (ASAHI) is engaged in the development, manufacture and supply of medical devices, OEM products, percutaneou |
2011 | 125,00$ |
Astro-Med, Inc. (ALOT) - Financial and Strategic SWOT Analysis ReviewAstro-Med, Inc. (Astro-Med) is engaged in the design, development, manufacture and marketing of printers and data acquisition and |
2011 | 125,00$ |
Artimplant AB (ARTI B) - Financial and Strategic SWOT Analysis ReviewArtimplant AB (Artimplant) is a biomaterials company providing solutions for the treatment of orthopedic, reconstructive surgery a |
2011 | 125,00$ |
Medical Action Industries, Inc. (MDCI) - Financial and Strategic SWOT Analysis ReviewMedical Action Industries, Inc. (Medical Action) is a manufacturer of medical products in the US. The company is principally engag |
2011 | 125,00$ |
AGA Medical Holdings, Inc. - Financial and Strategic SWOT Analysis ReviewAGA Medical Holdings, Inc. (AGA Medical), a medical device company, is engaged in the designing, development, manufacturing and ma |
2011 | 125,00$ |
Cardiogenesis Corporation (CGCP) - Financial and Strategic SWOT Analysis ReviewCardiogenesis Corporation (Cardiogenesis) is engaged in the development, design and distribution of laser-based surgical products |
2011 | 250,00$ |
BIONIME Corporation (4737) - Financial and Strategic SWOT Analysis ReviewBIONIME Corporation (BIONIME), a privately-held medical testing company. The company is principally engaged in the design, manufac |
2011 | 250,00$ |
Dynatronics Corporation (DYNT) - Financial and Strategic SWOT Analysis ReviewDynatronics Corporation (Dynatronics) is engaged in the manufacture and distribution of broad line therapy devices, medical suppli |
2011 | 250,00$ |
Exactech, Inc. (EXAC) - Financial and Strategic SWOT Analysis ReviewExactech, Inc. (Exactech) is engaged in the development, manufacture, marketing and distribution of orthopedic implant devices, su |
2011 | 125,00$ |
Japan Medical Dynamic Marketing, INC. (7600) - Financial and Strategic SWOT Analysis ReviewJapan Medical Dynamic Marketing, INC. (Japan MDM) is a medical device company, engaged in developing, manufacturing and marketing |
2011 | 125,00$ |
DiaSorin S.p.A (DIA) - Financial and Strategic SWOT Analysis ReviewDiaSorin S.p.A. (DiaSorin) is a medical device company, engaged in the manufacture and development of reagents pertaining to in-vi |
2011 | 125,00$ |
AcuNetx, Inc. (ANTX) - Financial and Strategic SWOT Analysis ReviewAcuNetx, Inc. (AcuNetx) is a medical device company that provides products and services for the three broad markets, namely, Medic |
2011 | 250,00$ |
aap Implantate AG (AAQ) - Financial and Strategic SWOT Analysis Reviewaap Implantate AG (aap) is a medical technology company principally engaged in the development, manufacture and distribution of jo |
2011 | 125,00$ |
Anteo Diagnostics Limited (ADO) - Financial and Strategic SWOT Analysis ReviewAnteo Diagnostics Limited (Anteo) formerly known as BioLayer Corporation Limited has developed a platform for the rapid design of |
2011 | 125,00$ |
Hansen Medical, Inc. (HNSN) - Financial and Strategic SWOT Analysis ReviewHansen Medical, Inc. (Hansen Medical), formerly Autocath, Inc. is a medical technology company engages principally in the design, |
2011 | 125,00$ |
HORIBA, Ltd. (6856) - Financial and Strategic SWOT Analysis ReviewHORIBA, Ltd. (HORIBA) is a medical device manufacturing company, engaged in the manufacture and sale of measuring equipment. It op |
2011 | 250,00$ |
Imaging Dynamics Company, Ltd. (IDL) - Financial and Strategic SWOT Analysis ReviewImaging Dynamics Company, Ltd. (IDC) is a medical technology services provider, engaged in the manufacture of Digital Radiography |
2011 | 250,00$ |
Cellestis Limited (CST) - Financial and Strategic SWOT Analysis ReviewCellestis Limited (Cellestis) is engaged in the development, manufacture and marketing of medical diagnostic products. The company |
2011 | 250,00$ |
DiagnoCure Inc. (CUR) - Financial and Strategic SWOT Analysis ReviewDiagnoCure Inc. (DiagnoCure) is engaged in the development, production and commercialization of immunoassay and molecular tests fo |
2011 | 250,00$ |
Montvale Technologies, Inc. (IVVI) - Financial and Strategic SWOT Analysis ReviewMontvale Technologies, Inc. (Montvale Technologies) formerly known as Ivivi Technologies, Inc., an early-stage medical technology |
2011 | 250,00$ |
MAKO Surgical Corp. (MAKO) - Financial and Strategic SWOT Analysis ReviewMAKO Surgical Corp. (MAKO Surgical) is a medical device company, based in the US. The company is engaged in the development of adv |
2011 | 250,00$ |
Pyng Medical Corporation (PYT) - Financial and Strategic SWOT Analysis ReviewPyng Medical Corp. (Pyng) is engaged in the production and sale of the FAST1 Intraosseous Infusion System, TPOD Pelvic Stabilizer, |
2011 | 250,00$ |
SQI Diagnostics Inc. (SQD) - Financial and Strategic SWOT Analysis ReviewSQI Diagnostics Inc. (SQI) is a privately-held medical device company engaged in the development and marketing of immunoassay syst |
2011 | 250,00$ |
Cardiovascular Systems, Inc. (CSII) - Financial and Strategic SWOT Analysis ReviewCardiovascular Systems, Inc. (CSI) is an independent medical device organization. It is engaged in the designing, development and |
2011 | 250,00$ |
Medgenics Inc. (MEDG) - Financial and Strategic SWOT Analysis ReviewMedgenics Inc. (Medgenics) is a clinical-stage biopharmaceutical company, engaged in developing ultra sustained action protein dru |
2011 | 250,00$ |
Medicsight PLC (MDST) - Financial and Strategic SWOT Analysis ReviewMedicsight PLC (Medicsight) is engaged in the development of Computer Aided Detection (CAD) and image analysis software . by using |
2011 | 250,00$ |
NuSep Ltd (NSP) - Financial and Strategic SWOT Analysis ReviewNuSep Ltd (NuSep) is a Life Science Separations company. It is engaged in producing precast gels and laboratory separation process |
2011 | 250,00$ |
American Homepatient, Inc. (AHOM) - Financial and Strategic SWOT Analysis ReviewAmerican HomePatient, Inc. (American HomePatient) is a medical device company. The company along with its subsidiaries, engaged in |
2011 | 125,00$ |
Uroplasty, Inc. (UPI) - Financial and Strategic SWOT Analysis ReviewUroplasty, Inc. (Uroplasty), a medical device company, is engaged in the development, manufacturing and marketing of innovative pr |
2011 | 250,00$ |
Vision-Sciences, Inc. (VSCI) - Financial and Strategic SWOT Analysis ReviewVision-Sciences, Inc. (Vision-Sciences) is a medical device company engaged in the development, manufacturing and marketing of inn |
2011 | 250,00$ |
CardioNet, Inc. (BEAT) - Financial and Strategic SWOT Analysis ReviewCardioNet, Inc, (CardioNet) is a medical device company which deals with the development and marketing of mobile cardiac outpatien |
2011 | 125,00$ |
GSI Group Inc. (GSIGQ) - Financial and Strategic SWOT Analysis ReviewGSI Group Inc. (GSI) is a provider of precision technology components, lasers and laser-based advanced manufacturing systems to th |
2011 | 125,00$ |
Non-Invasive Monitoring Systems, Inc. (NIMU) - Financial and Strategic SWOT Analysis ReviewNon-Invasive Monitoring Systems, Inc. (NIMS) is engaged in the research, development, manufactureand marketing of non-invasive, wh |
2011 | 125,00$ |
Merge Healthcare Incorporated (MRGE) - Financial and Strategic SWOT Analysis ReviewMerge Healthcare Incorporated (Merge Healthcare) is a market leading company, which engages in the development of medical imaging |
2011 | 250,00$ |
pSivida Corp. (PSDV) - Financial and Strategic SWOT Analysis ReviewpSivida Limited (pSivida) is engaged in the manufacture and development of drug delivery products for the healthcare markets. It d |
2011 | 125,00$ |
Seikagaku Corporation (4548) - Financial and Strategic SWOT Analysis ReviewSeikagaku Corporation (Seikagaku), is principally engaged in the development and manufacturing of medical devices and pharmaceutic |
2011 | 125,00$ |
MAZOR Surgical Technologies Ltd. (MZOR) - Financial and Strategic SWOT Analysis ReviewMAZOR Surgical Technologies Ltd. (MAZOR) is engaged in the development and marketing of surgical positioning systems for the spina |
2011 | 250,00$ |
Greatbatch, Inc. (GB) - Financial and Strategic SWOT Analysis ReviewGreatbatch, Inc. (GB) is a medical device company that designs, develops and manufactures various systems, components and devices |
2011 | 125,00$ |
Beijing Wandong Medical Equipment Co., Ltd. (600055) - Financial and Strategic SWOT Analysis ReviewBeijing Wandong Medical Equipment Co., Ltd. (Wandong Medical) is a Chinese medical equipment company. The company develops, manufa |
2011 | 125,00$ |
Compumedics Limited (CMP) - Financial and Strategic SWOT Analysis ReviewCompumedics Limited (Compumedics) is a medical diagnostic technology company, engaged in the designing, development and marketing |
2011 | 125,00$ |
Paradigm Medical Industries, Inc. (PDMI) - Financial and Strategic SWOT Analysis ReviewParadigm Medical Industries, Inc. (Paradigm Medical) is a medical device company engaged in the development, manufacture and marke |
2011 | 125,00$ |
Acme United Corporation (ACU) - Financial and Strategic SWOT Analysis ReviewAcme United Corporation (AUC) is a supplier of products used for cutting, measuring and safety to school, home, office and industr |
2011 | 250,00$ |
Sunshine Heart Company, Pty. Ltd. (SHC) - Financial and Strategic SWOT Analysis ReviewSunshine Heart Company, Pty. Ltd. (Sunshine Heart) is engaged in the design, development and marketing of medical devices for the |
2011 | 250,00$ |
BioCurex, Inc. (BOCX) - Financial and Strategic SWOT Analysis ReviewBioCurex, Inc. (BioCurex) is a biotechnology company, principally engaged in the development and marketing of cancer diagnostic te |
2011 | 250,00$ |
Urologix Inc. (ULGX) - Financial and Strategic SWOT Analysis ReviewUrologix, Inc. (Urologix) is engaged in the research, development, manufacture and marketing of catheter based therapies. The comp |
2011 | 125,00$ |
Milestone Scientific Inc. (MLSS) - Financial and Strategic SWOT Analysis ReviewMilestone Scientific Inc. (Milestone Scientific) is engaged in the development, manufacture and distribution of proprietary, compu |
2011 | 250,00$ |
Deltex Medical Group plc (DEMG) - Financial and Strategic SWOT Analysis ReviewDeltex Medical Group plc (Deltex) is a medical device company, manufacturing and selling of oesophageal Doppler monitor. The compa |
2011 | 125,00$ |
Goodman Co., Ltd. (7535) - Financial and Strategic SWOT Analysis ReviewGoodman Co., Ltd. (Goodman) is a medical device company engaged in the development, manufacture and selling of cardiology products |
2011 | 250,00$ |
JMS CO., LTD. (7702) - Financial and Strategic SWOT Analysis ReviewJMS CO., LTD. (JMS) is engaged in the research, development, manufacture and distribution of medical equipments and pharmaceutical |
2011 | 125,00$ |
Medikit Co., Ltd. (7749) - Financial and Strategic SWOT Analysis ReviewMedikit Co., Ltd. (Medikit) is a global technology and product development company. It is engaged in manufacturing and marketing o |
2011 | 250,00$ |
Itamar Medical Ltd. (ITMR) - Financial and Strategic SWOT Analysis ReviewItamar Medical Ltd. (Itamar Medical) is a medical technology company. It is engaged in the development and marketing of cardio mon |
2011 | 250,00$ |
Bovie Medical Corporation (BVX) - Financial and Strategic SWOT Analysis ReviewBovie Medical Corporation (Bovie Medical) is a medical device company principally engaged in the development, manufacture and dist |
2011 | 125,00$ |
Medical Australia Limited (MLA) - Financial and Strategic SWOT Analysis ReviewMedical Australia Limited (Medical Australia) formerly BMDi TUTA Healthcare is a medical device company, engaged in the developmen |
2011 | 125,00$ |
BIOQUELL (BQE) - Financial and Strategic SWOT Analysis ReviewBIOQUELL is a privately-held medical device company, engaged in the development of biodecontamination systems for the life science |
2011 | 250,00$ |
Neogen Corporation (NEOG) - Financial and Strategic SWOT Analysis ReviewNeogen Corporation (Neogen) is a medical device company engaged in the development, manufacture, and marketing of diverse line of |
2011 | 125,00$ |
BIOTEQUE CORPORATION (4107) - Financial and Strategic SWOT Analysis ReviewBioteque Corporation (Bioteque) is a privately held medical device company. The company is engaged in the development, manufacture |
2011 | 250,00$ |
Cutera, Inc. (CUTR) - Financial and Strategic SWOT Analysis ReviewCutera, Inc. (Cutera) engages in the designing, manufacturing and marketing of laser and other light-based aesthetics systems for |
2011 | 125,00$ |
OSSTEM IMPLANT Co., Ltd. (048260) - Financial and Strategic SWOT Analysis ReviewOSSTEM IMPLANT Co., Ltd. (Osstem) is a medical equipment company specialized in the designing, manufacturing and marketing of dent |
2011 | 250,00$ |
RION Co., Ltd. (6823) - Financial and Strategic SWOT Analysis ReviewRION Co., Ltd. (Rion) is engaged in the development and marketing of products that are used in government institutions, schools an |
2011 | 250,00$ |
DexCom, Inc. (DXCM) - Financial and Strategic SWOT Analysis ReviewDexCom, Inc. (DexCom) is a medical device company engaged in the development, manufacture, and distribution of continuous glucose |
2011 | 125,00$ |
Biological Signal Processing Ltd. (BSP) - Financial and Strategic SWOT Analysis ReviewBiological Signal Processing Ltd. (BSP) is engaged in the development of innovative non-invasive solution for the diagnosis and mo |
2011 | 250,00$ |
VirtualScopics, Inc. (VSCP) - Financial and Strategic SWOT Analysis ReviewVirtualScopics, Inc. (VirtualScopics) is a service provider company engaged in offering central reads and quantitative imaging sol |
2011 | 125,00$ |
Holista CollTech Limited (HCT) - Financial and Strategic SWOT Analysis ReviewHolista CollTech Limited (Holista CollTech) is a biotechnology and a medical equipment company, which is engaged in the developmen |
2011 | 125,00$ |
ContextVision AB (COV) - Financial and Strategic SWOT Analysis ReviewContextVision AB (ContextVision) is a medical technology company engaged in the development and marketing of imaging devices and r |
2011 | 125,00$ |
Oncoprobe Biotech Inc. (4113) - Financial and Strategic SWOT Analysis ReviewOncoprobe Biotech Inc. (Oncoprobe) is a public company which is a distributor of medical devices and test reagents. The company is |
2011 | 250,00$ |
CardioComm Solutions, Inc. (EKG) - Financial and Strategic SWOT Analysis ReviewCardioComm Solutions, Inc. (CardioComm) is a medical software company, which is engaged in the development and marketing of advanc |
2011 | 125,00$ |
National Dentex Corporation - Financial and Strategic SWOT Analysis ReviewNational Dentex Corporation (National Dentex) is a dental devices company engaged in the design, fabrication and marketing of cust |
2011 | 125,00$ |
Tyrian Diagnostics Limited (TDX) - Financial and Strategic SWOT Analysis ReviewTyrian Diagnostics Limited (Tyrian) is a diagnostics company, which is engaged in the manufacture, development and distribution of |
2011 | 125,00$ |
CarePayment Technologies, Inc. (CPYT) - Financial and Strategic SWOT Analysis ReviewCarePayment Technologies, Inc., formerly, Microhelix, Inc. (Microhelix) is a public company that is engaged in the design, manufac |
2011 | 250,00$ |
Helicos BioSciences Corporation (HLCS) - Financial and Strategic SWOT Analysis ReviewHelicos BioSciences Corporation (Helicos) is a life sciences company focused on developing genetic analysis technologies for the r |
2011 | 125,00$ |
NISSAN MEDICAL INDUSTRIES LTD. (NISA) - Financial and Strategic SWOT Analysis ReviewNISSAN MEDICAL INDUSTRIES LTD. (NISSAN MEDICAL) is engaged in the development and manufacture of surgical dressing products for wo |
2011 | 250,00$ |
United Orthopedic Corporation (4129) - Financial and Strategic SWOT Analysis ReviewUnited Orthopedic Corporation (UOC) is a medical device company, it manufactures, develops and distributes medical equipments such |
2011 | 125,00$ |
MEDICREA INTERNATIONAL (ALMED) - Financial and Strategic SWOT Analysis ReviewMEDICREA INTERNATIONAL (Medicrea) is a medical device company, engaged in the design, manufacturing and distribution of implant sy |
2011 | 250,00$ |
Solco Biomedical Co., Ltd. (043100) - Financial and Strategic SWOT Analysis ReviewSolco Biomedical Co., Ltd. (Solco) is a medical device company engaged in the development and marketing of medical appliances for |
2011 | 125,00$ |
Biocoral, Inc. (BCRA) - Financial and Strategic SWOT Analysis ReviewBiocoral, Inc. (Biocoral) is a medical device company, engaged in the design, research, development, commercialization and manufac |
2011 | 250,00$ |
Applied NeuroSolutions, Inc. (APSN) - Financial and Strategic SWOT Analysis ReviewApplied NeuroSolutions, Inc. (APNS) is a development stage biopharmaceutical company engaged in the research and development of pr |
2011 | 125,00$ |
ZoomMed Inc. (ZMD) - Financial and Strategic SWOT Analysis ReviewZoomMed Inc. (ZoomMed) is engaged in the development of paramedical equipments for the healthcare industry. The company has come u |
2011 | 250,00$ |
MCS Medical Compression Systems (DBN) Ltd. (MDCL) - Financial and Strategic SWOT Analysis ReviewMCS Medical Compression Systems (DBN) Ltd. (MCS Medical) is engaged in the development, manufacture and marketing of non-invasive |
2011 | 250,00$ |
NorDiag ASA (NORD) - Financial and Strategic SWOT Analysis ReviewNorDiag ASA (NorDiag) is a biotechnology company engages in the development, manufacture and marketing of automated nucleic acid p |
2011 | 125,00$ |
Noveko International Inc. (EKO) - Financial and Strategic SWOT Analysis ReviewNoveko International Inc. (Noveko) is engaged in the design, development and distribution of ultrasound products and medical devic |
2011 | 250,00$ |
Fermiscan Holdings Limited (FER) - Financial and Strategic SWOT Analysis ReviewFermiscan Holdings Limited (Fermiscan) is a medical device company engaged in the development of products and technology for use i |
2011 | 125,00$ |
Amplifon S.p.A. (AMP) - Financial and Strategic SWOT Analysis ReviewAmplifon S.p.A. (Amplifon) is a multinational company based in Italy. The company is engaged in the distribution and application o |
2011 | 125,00$ |
Topspin Medical Inc. (TOPMD) - Financial and Strategic SWOT Analysis ReviewTopspin Medical Inc. (TopSpin) is a medical device company that is engaged in the development of medical devices for the cardiovas |
2011 | 250,00$ |
Applied Visual Sciences, Inc. (APVS) - Financial and Strategic SWOT Analysis ReviewApplied Visual Sciences, Inc. (Formerly known as Guardian Technologies International, Inc.) is a technology company engaged in the |
2011 | 125,00$ |
Cosmo Bio Co., Ltd. (3386) - Financial and Strategic SWOT Analysis ReviewCosmo Bio Co., Ltd. (Cosmo Bio) is engaged in the development and marketing of products for the in-vitro diagnostic markets. The c |
2011 | 250,00$ |
Exonhit S.A. (ALEHT) - Financial and Strategic SWOT Analysis ReviewExonHit is a medical diagnostic company. It is engaged in development and marketing of genomic profiling technology, diagnostic so |
2011 | 250,00$ |
European Institute of Science AB (EURI B) - Financial and Strategic SWOT Analysis ReviewEuropean Institute of Science AB (European Institute) is an investment company, engaged in biotechnological and medical research, |
2011 | 250,00$ |
LifeAssays AB (LIFE B) - Financial and Strategic SWOT Analysis ReviewLifeAssays AB (LifeAssays) is a diagnostic company, engaged in the development, manufacture and marketing of in-vitro diagnostic p |
2011 | 250,00$ |
MagForce Nanotechnologies AG (MF6) - Financial and Strategic SWOT Analysis ReviewMagForce Nanotechnologies AG (MagForce) is a medical device company principally engaged in providing niche technologies to the dru |
2011 | 250,00$ |
CytoSorbents Corporation (CTSO) - Financial and Strategic SWOT Analysis ReviewCytoSorbents Corporation(CytoSorbents) is a medical device company engaged in design and developing hemoperfusion technology to th |
2011 | 250,00$ |
CRH Medical Corporation (CRM) - Financial and Strategic SWOT Analysis ReviewCRH Medical Corporation (CRH Medical) is a medical device technology company principally engaged in the development of medical dev |
2011 | 250,00$ |
Precision Optics Corporation, Inc. (PEYE) - Financial and Strategic SWOT Analysis ReviewPrecision Optics Corporation, Inc. (Precision Optics) is engaged in the design, development, manufacture and distribution of optic |
2011 | 250,00$ |
Rossmax International Ltd. (4121) - Financial and Strategic SWOT Analysis ReviewRossmax International Ltd. (Rossmax International) is a medical device manufacturing company principally engaged in the manufactur |
2011 | 250,00$ |
Eckert & Ziegler Strahlen- und Medizintechnik AG (EUZ) - Financial and Strategic SWOT Analysis ReviewEckert & Ziegler Strahlen- und Medizintechnik AG (Eckert & Ziegler) is a producer of radioactive components. The company is engage |
2011 | 125,00$ |
OPTOPOL Technology S.A. (OPL) - Financial and Strategic SWOT Analysis ReviewOPTOPOL Technology S.A (OPTOPOL) is a medical device company, engaged in the development, production and distribution of medical d |
2011 | 250,00$ |
Medtechnica Ltd. (MEDI) - Financial and Strategic SWOT Analysis ReviewMedtechnica Ltd. (Medtechnica) is a medical device company engaged in the distribution of medical equipments for the health care m |
2011 | 250,00$ |
Elbit Imaging Ltd. (EMITF) - Financial and Strategic SWOT Analysis ReviewElbit Imaging Ltd. (Elbit) is a diversified company. It is engaged in the initiation, construction, operation, management, and sal |
2011 | 125,00$ |
Global Health Limited (GLH) - Financial and Strategic SWOT Analysis ReviewGlobal Health Pty Ltd (Global Health) is an information technology company engaged in providing e-health solutions to the healthca |
2011 | 125,00$ |
Nightingale Informatix Corporation (NGH) - Financial and Strategic SWOT Analysis ReviewNightingale Informatix Corporation (Nightingale) is a healthcare IT company engaged in the developing, marketing and licensing of |
2011 | 125,00$ |
CompuGroup Medical AG. (COP) - Financial and Strategic SWOT Analysis ReviewCompuGroup Medical AG (CompuGROUP Medical), formerly CompuGROUP Holding AG, is a medical device company that is engaged in the dev |
2011 | 125,00$ |
CathRx Ltd (CXD) - Financial and Strategic SWOT Analysis ReviewCathRx Ltd (CathRx) is a medical device company engaged in the research, development and commercialization of a wide range of card |
2011 | 125,00$ |
Nanosphere, Inc. (NSPH) - Financial and Strategic SWOT Analysis ReviewNanosphere, Inc. (Nanosphere) is a nanotechnology-based molecular diagnostics company, offering proprietary breakthrough technolog |
2011 | 250,00$ |
AuthentiDate Holding Corporation (ADAT) - Financial and Strategic SWOT Analysis ReviewAuthentidate Holding Corporation (Authentidate) is a provider of secure enterprise workflow management applications and related ad |
2011 | 250,00$ |
Matrix I.T. Ltd. (MTRX) - Financial and Strategic SWOT Analysis ReviewMatrix I.T. Ltd. (Matrix I.T) is a medical device company engaged in the design and distribution of information technology (IT) se |
2011 | 125,00$ |
Advanced Micronic Devices Limited (517552) - Financial and Strategic SWOT Analysis ReviewAdvanced Micronic Devices Limited (AMDL) is engaged in the development, manufacture and marketing of the healthcare products. The |
2011 | 250,00$ |
Elk Corporation (9833) - Financial and Strategic SWOT Analysis ReviewElk Corporation (Elk) is a medical device company engaged in offering autoclaves, bone densitometers, X-ray protective aprons, X-r |
2011 | 250,00$ |
Hogy Medical Co., Ltd. (3593) - Financial and Strategic SWOT Analysis ReviewHogy Medical Co., Ltd. (Hogy) is a medical device manufacturing company, which operates through a single wholly-owned subsidiary; |
2011 | 125,00$ |
CustomVis Plc (CUS) - Financial and Strategic SWOT Analysis ReviewCustomVis Plc (CustomVis) is a medical technology company. It is engaged in the research, design, development, manufacture and sal |
2011 | 125,00$ |
HTL-STREFA S.A. (HTL) - Financial and Strategic SWOT Analysis ReviewHTL-STREFA S.A (HTL) is engaged in the development, manufacture and marketing of medical disposable products for the healthcare ma |
2011 | 250,00$ |
Japan Lifeline Co., Ltd. (7575) - Financial and Strategic SWOT Analysis ReviewJapan Lifeline Co., Ltd. (Japan Lifeline) is a medical device distributor engaged in providing cardiovascular devices. Japan Lifel |
2011 | 125,00$ |
Kawamoto Corporation (3604) - Financial and Strategic SWOT Analysis ReviewKawamoto Corporation (Kawamoto) is a Japan based company principally engaged in the development, manufacture, marketing and sale o |
2011 | 125,00$ |
Mochida Pharmaceutical Co., Ltd. (4534) - Financial and Strategic SWOT Analysis ReviewMochida Pharmaceutical Co., Ltd (Mochida) is a Japan- based healthcare company. The company principally manufactures and sells pha |
2011 | 125,00$ |
Noritake Co., Limited (5331) - Financial and Strategic SWOT Analysis ReviewNoritake Co., Limited (Noritake) is a medical device company engaged in manufacture and distribution of medical devices for the de |
2011 | 250,00$ |
Response Biomedical Corporation (RBM) - Financial and Strategic SWOT Analysis ReviewResponse Biomedical Corporation (Response Biomedical) is a Canadian company, which is engaged in the research, development, manufa |
2011 | 125,00$ |
IVAX Diagnostics, Inc. (IVD) - Financial and Strategic SWOT Analysis ReviewIVAX Diagnostics, Inc. (IVAX), is a medical device company engaged in develops, manufactures and markets diagnostic test kits, or |
2011 | 250,00$ |
Vitrolife AB (VITR) - Financial and Strategic SWOT Analysis ReviewVitrolife AB (Vitrolife) is a public limited company, which is engaged in the development, production and sale of superior quality |
2011 | 125,00$ |
EnteroMedics Inc. (ETRM) - Financial and Strategic SWOT Analysis ReviewEnteroMedics Inc. (Enteromedics) is a medical device company. It is engaged in the design and development of medical devices for t |
2011 | 250,00$ |
Shandong Weigao Group Medical Polymer Company Limited (8199) - Financial and Strategic SWOT Analysis ReviewShandong Weigao Group Medical Polymer Co.,Ltd. ( Weigao) is principally engaged in the research and development, production and sa |
2011 | 125,00$ |
Ahlstrom Corporation (AHL1V) - Financial and Strategic SWOT Analysis ReviewAhlstrom Corporation (Ahlstrom) is one of the leading companies in Finland fiber industry. The company, along with its subsidiarie |
2011 | 125,00$ |
Medi-Stim ASA (MEDI) - Financial and Strategic SWOT Analysis ReviewMedi-Stim ASA (Medi-Stim) is a medical device company principally engaged in the development, manufacture, distribution and sale o |
2011 | 125,00$ |
Pacific Hospital Supply Co., Ltd. (4126) - Financial and Strategic SWOT Analysis ReviewPacific Hospital Supply Co., Ltd. (PAHSCO) is a medical equipment manufacturer. It is engaged in the manufacture, processing and s |
2011 | 125,00$ |
Quick-Med Technologies, Inc. (QMDT) - Financial and Strategic SWOT Analysis ReviewQuick-Med Technologies, Inc. (Quick-Med) is a publicly traded life sciences company, which is engaged in the research, development |
2011 | 125,00$ |
PuriCore plc (PURI) - Financial and Strategic SWOT Analysis ReviewPuriCore plc (PuriCore) is a medical device company principally engaged in the research, development, marketing and sale of propri |
2011 | 125,00$ |
Imaging3, Inc. (IMGG) - Financial and Strategic SWOT Analysis ReviewImaging3, Inc. (Imaging3) is a medical device company, based in the US. The company is engaged in manufacturing medical imaging de |
2011 | 250,00$ |
BioPorto Diagnostics A/S (BIOPOR) - Financial and Strategic SWOT Analysis ReviewBioPorto Diagnostics A/S (BioPorto Diagnostics) is a biotechnology company engaged in developing and marketing antibodies and anti |
2011 | 250,00$ |
DiaGenic ASA (DIAG) - Financial and Strategic SWOT Analysis ReviewDiaGenic ASA (DiaGenic) is a life sciences company, primarily engaged in research, development and sale of modern and user friendl |
2011 | 125,00$ |
Nyer Medical Group, Inc. (NYER) - Financial and Strategic SWOT Analysis ReviewNyer Medical Group, Inc. (Nyer Medical Group) is engaged in the development of medical supplies for the healthcare markets. It ope |
2011 | 250,00$ |
SPO Medical Inc. (SPOM) - Financial and Strategic SWOT Analysis ReviewSPO Medical Inc. (SPO Medical) is a medical device company, engaged in the development and marketing of the non-invasive monitorin |
2011 | 250,00$ |
Power3 Medical Products, Inc. (PWRM) - Financial and Strategic SWOT Analysis ReviewPower3 Medical Products, Inc. (Power3 Medical) is a biotechnology company engaged in the detection, monitoring, and targeting of d |
2011 | 125,00$ |
Optiscan Imaging Limited (OIL) - Financial and Strategic SWOT Analysis ReviewOptiscan Imaging Limited (Optiscan Imaging) is a medical device company, which is engaged in the development, manufacture and sale |
2011 | 250,00$ |
Zecotek Photonics Inc. (ZMS) - Financial and Strategic SWOT Analysis ReviewZecotek Photonics Inc. (Zecotek Photonics) is a photonics technology company, engaged in development and sales of advanced technol |
2011 | 125,00$ |
InfoLogix, Inc. (IFLG) - Financial and Strategic SWOT Analysis ReviewInfoLogix, Inc. (InfoLogix) is a mobility solution company, engaged in the development, sales and marketing of mobile intelligence |
2011 | 125,00$ |
Ceragenix Pharmaceuticals, Inc. (CGXP) - Financial and Strategic SWOT Analysis ReviewCeragenix Pharmaceuticals, Inc. (Ceragenix) is a medical device company engaged in discovery, development and commercialization of |
2011 | 250,00$ |
Exiqon A/S (EXQ) - Financial and Strategic SWOT Analysis ReviewExiqon A/S (Exiqon) is a biotechnology company principally engaged in the development, manufacture and distribution of products fo |
2011 | 125,00$ |
Rosetta Genomics, Ltd. (ROSG) - Financial and Strategic SWOT Analysis ReviewRosetta Genomics, Ltd. (RGL) is a medical device company engaged in the development and commercialization of new diagnostic and th |
2011 | 250,00$ |
Eizo Nanao Corporation (6737) - Financial and Strategic SWOT Analysis ReviewEizo Nanao Corporation (Eizo) is engaged in the design, development, manufacture and marketing of monitors and peripherals, amusem |
2011 | 250,00$ |
QuantRx Biomedical Corporation (QTXB) - Financial and Strategic SWOT Analysis ReviewQuantRx Biomedical Corporation (QuantRx Biomedical) is a medical device company engaged in the development of products for advance |
2011 | 250,00$ |
BioView Ltd. (BIOV) - Financial and Strategic SWOT Analysis ReviewBioView Ltd. (BioView) is a medical diagnostics company, based in Israel. The company is engaged in development, manufacturing, ma |
2011 | 250,00$ |
Response Genetics, Inc. (RGDX) - Financial and Strategic SWOT Analysis ReviewResponse Genetics, Inc. (RGI) is engaged in the research and development of pharmacogenomic cancer diagnostic tests. The company u |
2011 | 250,00$ |
HealthLinx Limited (HTX) - Financial and Strategic SWOT Analysis ReviewHealthLinx Limited (HealthLinx) is a developing biomarker and diagnostic company with an integrated platform in biomarker and bioa |
2011 | 125,00$ |
Avacta Group PLC (AVCT) - Financial and Strategic SWOT Analysis ReviewAvacta Group PLC (Avacta) is a biophysics company specializing in solving high value problems. It was formed in 2004, as a spin-ou |
2011 | 250,00$ |
Medical International Technology, Inc. (MDLH) - Financial and Strategic SWOT Analysis ReviewMedical International Technology Inc. (MIT) is a Canada based medical devices company. It is specialized in the research, developm |
2011 | 250,00$ |
DVx, Inc. (3079) - Financial and Strategic SWOT Analysis ReviewDVx Inc. (DVx) is a medical device company, which is engaged in the development and marketing of medical devices for the cardiovas |
2011 | 250,00$ |
Nephros, Inc. (NEPH) - Financial and Strategic SWOT Analysis ReviewNephros, Inc. (Nephros) is US-based medical device company, engaged in developing and marketing of filtration products for therape |
2011 | 250,00$ |
Scivanta Medical Corporation (SCVM) - Financial and Strategic SWOT Analysis ReviewScivanta Medical Corporation (Scivanta Medical) formerlly known as Medi-Hut Co. is a medical device company, focuses on the acquis |
2011 | 125,00$ |
Moria SA (MLMOR) - Financial and Strategic SWOT Analysis ReviewMoria SA (Moria) is a medical device company engaged in designing, manufacturing and marketing of instruments and equipment for op |
2011 | 250,00$ |
Eiken Chemical Co.,Ltd. (4549) - Financial and Strategic SWOT Analysis ReviewEiken Chemical Co., Ltd (Eiken Chemical) is a diagnostic company engaged in the development, manufacture and distribution of clini |
2011 | 250,00$ |
Accelerator Nordic AB (ACCE B) - Financial and Strategic SWOT Analysis ReviewAccelerator Nordic AB (Accelerator) is a group of Life Science companies, focuses on pharmaceutical drug development and medical |
2011 | 125,00$ |
Advanced Integrated Manufacturing Corp. Ltd (A54) - Financial and Strategic SWOT Analysis ReviewAdvanced Integrated Manufacturing Corp. Ltd. (AIM) is a Singapore based company. It is a holding company of an integrated group of |
2011 | 125,00$ |
Arkimedica S.P.A (AKM) - Financial and Strategic SWOT Analysis ReviewArkimedica S.P.A (Arkimedica) is a medical device company, engaged in the manufacture and distribution of medical products, hospit |
2011 | 125,00$ |
Beijing Aerospace Changfeng Co., Ltd (600855) - Financial and Strategic SWOT Analysis ReviewBeijing Aerospace Changfeng Co. Ltd. (Aerospace Changfeng) is a medical device company principally engaged in the development, man |
2011 | 250,00$ |
Biospace Co.,Ltd. (041830) - Financial and Strategic SWOT Analysis ReviewBiospace Co., Ltd. (Biospace) is a medical device company engaged in providing body composition analyzers for the healthcare marke |
2011 | 250,00$ |
Cogstate Limited (CGS) - Financial and Strategic SWOT Analysis ReviewCogState Limited (CogState) is engaged in providing cognitive testing products and services. The company operates its business in |
2011 | 250,00$ |
Create Medic Co., Ltd. (5187) - Financial and Strategic SWOT Analysis ReviewCreate Medic Co., Ltd. (CMCL) is a medical equipment company which is engaged in the production and distribution of medical equipm |
2011 | 250,00$ |
Diagnostic Medical Systems (DGM) - Financial and Strategic SWOT Analysis ReviewDiagnostic Medical Systems (DMS) is a medical device company, engaged in designing, manufacturing and distribution of imaging syst |
2011 | 250,00$ |
Eastland Medical Systems Limited (EMS) - Financial and Strategic SWOT Analysis ReviewEastland Medical Systems Ltd (Eastland Medical) is a health care company engaged in the research, development and manufacture of p |
2011 | 125,00$ |
elexxion AG (E8X) - Financial and Strategic SWOT Analysis Reviewelexxion AG (elexxion) is engaged in the design, manufacture and distribution of dental laser systems. The company uses latest and |
2011 | 250,00$ |
EXCELSIOR MEDICAL CO.,LTD (4104) - Financial and Strategic SWOT Analysis ReviewEXCELSIOR MEDICAL CO.,LTD (Excelsior) formerly Enfield Medical Co., Ltd., is a medical device company engaged in the distribution |
2011 | 250,00$ |
Etropal Ad (5EO) - Financial and Strategic SWOT Analysis ReviewEtropal Ad (Etropal) is a medical device company based in Bulgaria. It specializes in the scientific research, experimental and de |
2011 | 250,00$ |
Geratherm Medical AG (GME) - Financial and Strategic SWOT Analysis ReviewGeratherm Medical AG (Geratherm) is an internationally aligned medical technology company, which is engaged in the manufacturing a |
2011 | 250,00$ |
Golden Meditech Holdings Limited (0801) - Financial and Strategic SWOT Analysis ReviewGolden Meditech Holdings Limited (Golden Meditech), formerly Golden Meditech Company Limited is a leading integrated medical devic |
2011 | 250,00$ |
Hamilton Thorne Ltd. (HTL) - Financial and Strategic SWOT Analysis ReviewHamilton Thorne Ltd. (Hamilton Thorne) is a provider of advanced laser systems and instruments. The company is engaged in the prov |
2011 | 250,00$ |
Health & Life Co., Ltd. (1781) - Financial and Strategic SWOT Analysis ReviewHealth & Life Co., Ltd. (H&L) is a medical device company that is engaged in the manufacture and marketing of medical equipments f |
2011 | 125,00$ |
Hi-Clearance Inc. (1788) - Financial and Strategic SWOT Analysis ReviewHi-Clearance Inc. (HCI) is a medical device company engaged in providing medical apparatus and medical materials for the nephrolog |
2011 | 250,00$ |
Infopia Co., Ltd. (036220) - Financial and Strategic SWOT Analysis ReviewInfopia Co., Ltd. (Infopia) is engaged in the design, development and distribution of high performance blood glucose monitoring sy |
2011 | 250,00$ |
Medigard Limited (MGZ) - Financial and Strategic SWOT Analysis ReviewMedigard Limited (Medigard) is engaged in the design, development and marketing of safety engineered medical devices for the healt |
2011 | 250,00$ |
Medivac Limited (MDV) - Financial and Strategic SWOT Analysis ReviewMediVac Limited (MediVac), formerly Nautilis Australia is a biomedical waste management company engaged in offering healthcare sol |
2011 | 250,00$ |
Microlife Corporation (4103) - Financial and Strategic SWOT Analysis ReviewMicrolife Corporation (Microlife) is a medical equipment company, it designs, develops, manufactures and distributes medical diag |
2011 | 125,00$ |
Palomar Medical Technologies, Inc. (PMTI) - Financial and Strategic SWOT Analysis ReviewPalomar Medical Technologies, Inc. (PMTI) is engaged in the research and development of advanced laser and light based systems for |
2011 | 250,00$ |
Precision System Science Co., Ltd. (7707) - Financial and Strategic SWOT Analysis ReviewPrecision System Science Co., Ltd. (PSS) is engaged in the biotechnology related business. The company is engaged in the developme |
2011 | 250,00$ |
Radiant Innovation Inc. (3373) - Financial and Strategic SWOT Analysis ReviewRadiant Innovation Inc. (Radiant) is a medical device company engaged in the design and development of Infrared technology product |
2011 | 250,00$ |
Sonomax Technologies Inc (SHH) - Financial and Strategic SWOT Analysis ReviewSonomax Technologies Inc (Sonomax) is a medical device company engaged in the research, development and manufacturing of intra-ear |
2011 | 250,00$ |
STRATEC Biomedical Systems AG (SBS) - Financial and Strategic SWOT Analysis ReviewSTRATEC Biomedical Systems AG (STRATEC Biomedical Systems) is a medical device company. It is principally engaged in the design, d |
2011 | 250,00$ |
Morepen Laboratories Limited (MOREPENLAB) - Financial and Strategic SWOT Analysis ReviewMorepen Laboratories Limited (Morepen Laboratories) is a publically held company based in India. The company is primarily engaged |
2011 | 250,00$ |
Luna Innovations Incorporated (LUNA) - Financial and Strategic SWOT Analysis ReviewLuna Innovations Incorporated (Luna Innovations) is engaged in the research, development and commercialization of new-generation p |
2011 | 250,00$ |
NewCardio, Inc. (NWCI) - Financial and Strategic SWOT Analysis ReviewNewCardio, Inc. (NewCardio) is a medical technology company. It is primarily engaged in design, development and commercializing a |
2011 | 250,00$ |
Remedent, Inc. (REMI) - Financial and Strategic SWOT Analysis ReviewRemedent, Inc. (Remedent), formerly Remedent USA, Inc. is a company that provides solutions for dentistry. It is principally engag |
2011 | 250,00$ |
HARBIN PHARMACEUTICAL GROUP CO., LTD. (600664) - Financial and Strategic SWOT Analysis ReviewHARBIN PHARMACEUTICAL GROUP CO., LTD. (Harbin Pharmaceutical Group) is a healthcare company engaged in the research, development a |
2011 | 250,00$ |
ProUroCare Medical Inc. (PUMD) - Financial and Strategic SWOT Analysis ReviewProUroCare Medical, Inc. (ProUroCare) is a medical device company. The company is engaged in developing diagnostic and imaging tec |
2011 | 250,00$ |
Opto Circuits India Limited (OPTOCIRCUI) - Financial and Strategic SWOT Analysis ReviewOpto Circuits India Limited (OCI) is a India-based technology company engaged in the design, development, manufacturing, marketing |
2011 | 125,00$ |
Tyson Bioresearch, Inc. (4134) - Financial and Strategic SWOT Analysis ReviewTyson Bioresearch, Inc., (Tyson) is an innovative medical diagnostic manufacturing company, principally engaged in manufacturing a |
2011 | 250,00$ |
Vatech Co., Ltd. (043150) - Financial and Strategic SWOT Analysis ReviewVatech Co., Ltd. (Vatech) is a medical equipment company. It is engaged in research and development of novel technologies in the f |
2011 | 250,00$ |
Bio-Light - Israeli Life Sciences Investments Ltd. (BOLT) - Financial and Strategic SWOT Analysis ReviewBio-Light - Israeli Life Sciences Investments Ltd. (Bio-Light) is engaged in the development of life science technology. The produ |
2011 | 250,00$ |
IPSOGEN SA (ALIPS) - Financial and Strategic SWOT Analysis ReviewIPSOGEN SA (Ipsogen) is an immunodiagnostic company engaged in designing, manufacturing and distributing of molecular diagnostic t |
2011 | 250,00$ |
Patni Computer Systems Ltd. (PATNI) - Financial and Strategic SWOT Analysis ReviewPatni Computer Systems Ltd. (Patni) is an Indian based IT consulting and software services provider that is principally engaged in |
2011 | 125,00$ |
IDEX Corporation (IEX) - Financial and Strategic SWOT Analysis ReviewIDEX Corporation (IDEX) is engaged in design and distributing of fluid and metering technologies systems for fluid-handling applic |
2011 | 250,00$ |
MedX Health Corp. (MDX) - Financial and Strategic SWOT Analysis ReviewMedX Health Corp. (MedX) is a medical device company engaged in designing, manufacturing and distributing of low level laser and l |
2011 | 250,00$ |
GeneNews Limited (GEN) - Financial and Strategic SWOT Analysis ReviewGeneNews Limited (GeneNews) is a Canada based molecular diagnostics company. Through its subsidiaries, it is principally engaged i |
2011 | 250,00$ |
Competitive Technologies, Inc. (CTT) - Financial and Strategic SWOT Analysis ReviewCompetitive Technologies, Inc., (CTT) is engaged in identifying, developing, and commercializing innovative products technologies |
2011 | 250,00$ |
Occupational & Medical Innovations Limited (OMI) - Financial and Strategic SWOT Analysis ReviewOccupational & Medical Innovations Limited (OMI) is a medical device company, based in Australia. The company is principally engag |
2011 | 250,00$ |
TTK Healthcare Limited (TTKHEALTH) - Financial and Strategic SWOT Analysis ReviewTTK Healthcare Limited (TTK Healthcare) is an Indian-based company engaged in providing innovative pharmaceutical and consumer sol |
2011 | 250,00$ |
AMERIGROUP Corporation (AGP) - Financial and Strategic SWOT Analysis ReviewAMERIGROUP Corporation (AMERIGROUP) is a multi-state managed healthcare company. The company principally concentrates on serving p |
2011 | 125,00$ |
SafeStitch Medical, Inc. (SFES) - Financial and Strategic SWOT Analysis ReviewSafeStitch Medical, Inc. (SafeStitch) formerly known as Cellular Technical Services Company, Inc., a shell company, is a developme |
2011 | 250,00$ |
Vision Eye Institute Limited (VEI) - Financial and Strategic SWOT Analysis ReviewVision Group Holdings Limited (Vision Group) is engaged in providing ophthalmic care services. The company operates 29 dedicated o |
2011 | 250,00$ |
Tiger X Medical, Inc. (CDOM) - Financial and Strategic SWOT Analysis ReviewTiger X Medical, Inc. (Tiger X) formerly Cardo Medical, Inc., is an development-stage orthopedic medical device company. It engage |
2011 | 250,00$ |
Daiken Medical Co., Ltd. (7775) - Financial and Strategic SWOT Analysis ReviewDaiken Medical Co., Ltd. (Daiken Medical) is a medical equipment company. It is engaged in the manufacturing and distribution of m |
2011 | 250,00$ |
Kelyniam Global, Inc. (KLYG) - Financial and Strategic SWOT Analysis ReviewKelyniam Global, Inc (Kelyniam) is an engineering consulting services company. The company is engaged in providing services in the |
2011 | 250,00$ |
Human Care HC AB (HUMA) - Financial and Strategic SWOT Analysis ReviewHuman Care HC AB (Human Care) is a medical device company engaged in the manufacture and marketing of medical aid devices for the |
2011 | 250,00$ |
INVO Bioscience, Inc. (IVOB) - Financial and Strategic SWOT Analysis ReviewINVO Bioscience, Inc. (INVO) is a US based medical device company. The company was formerly known as Bio X Cell, Inc. Moreover, it |
2011 | 250,00$ |
MabCure Inc. (MBCI) - Financial and Strategic SWOT Analysis ReviewMabCure Inc. (MabCure), formerly Smartec Holdings Inc. is a development stage medical device company engaged in the development of |
2011 | 250,00$ |
Qatari German Company for Medical Devices (QGMD) - Financial and Strategic SWOT Analysis ReviewQatari German Company for Medical Devices (QGMD) is a medical device company engaged in the manufacturing and distribution of medi |
2011 | 250,00$ |
Gerresheimer AG (GXI) - Financial and Strategic SWOT Analysis ReviewGerresheimer AG (Gerresheimer) is a publicly held Germany-based company engaged in manufacture and supply of specialty glass and p |
2011 | 250,00$ |
BioMedical Technology Solutions Holdings, Inc. (BMTL) - Financial and Strategic SWOT Analysis ReviewBioMedical Technology Solutions Holdings, Inc. (Biomedical) is principally engaged in providing economic and environment friendly |
2011 | 250,00$ |
Arcam AB (ARCM) - Financial and Strategic SWOT Analysis ReviewArcam AB (Arcam) is engaged in providing machines for direct manufacturing of fully dense parts from metal powder by utilizing its |
2011 | 250,00$ |
Elder Pharmaceuticals Ltd. (ELDERPHARM) - Financial and Strategic SWOT Analysis ReviewElder Pharmaceuticals Ltd. (Elder) is a publically held company based in India. The company is primarily engaged in the manufactur |
2011 | 250,00$ |
Harvard Bioscience, Inc. (HBIO) - Financial and Strategic SWOT Analysis ReviewHarvard Bioscience, Inc. (HBIO) is engaged in development, manufacture and distributing apparatus and scientific instruments. The |
2011 | 250,00$ |
SXC Health Solutions Corp. (SXC) - Financial and Strategic SWOT Analysis ReviewSXC Health Solutions Corp. (SXC) is a leading provider of pharmacy benefit management services and healthcare information technolo |
2011 | 125,00$ |
Ceradyne, Inc. (CRDN) - Financial and Strategic SWOT Analysis ReviewCeradyne, Inc. (Ceradyne) is an integrated developer and manufacturer of advanced technical ceramic products and components for us |
2011 | 125,00$ |
PAION AG (PA8) - Financial and Strategic SWOT Analysis ReviewPAION AG (PAION) is a biopharmaceutical holding company. It develops and commercializes drugs for the hospital-based treatment of |
2011 | 250,00$ |
Medy-Tox Inc. (086900) - Financial and Strategic SWOT Analysis ReviewMedy-tox Inc. (Medy-tox) is a privately-held biopharmaceutical manufacturing company. The company is principally engaged in the re |
2011 | 250,00$ |
Transcu Group Limited (E15) - Financial and Strategic SWOT Analysis ReviewTranscu Group Limited (TGL) is a life sciences company that is engaged in the research, development and commercialization of trans |
2011 | 250,00$ |
Visiodent SA (SDT) - Financial and Strategic SWOT Analysis ReviewVisiodent SA (Visiodent) is a medical technology company that specializes in the development and marketing of software solutions f |
2011 | 125,00$ |
CDEX, Inc. (CEXI) - Financial and Strategic SWOT Analysis ReviewCDEX, Inc. (CDEX) is a technology development company. It is engaged in applying its patented and patents pending chemical detecti |
2011 | 250,00$ |
Da An Gene Co., Ltd. (002030) - Financial and Strategic SWOT Analysis ReviewDa An Gene Co., Ltd. (Da An Gene) is a medical company engaged in the research, development, manufacture and marketing of biomedic |
2011 | 250,00$ |
Jiangsu Yuyue Medical Equipment Inc. (002223) - Financial and Strategic SWOT Analysis ReviewJiangsu Yuyue Medical Equipment Inc. (Jiangsu Yuyue Medical) is a medical equipment manufacturing company principally engaged in t |
2011 | 250,00$ |
Shinva Medical Instrument Co., Ltd. (600587) - Financial and Strategic SWOT Analysis ReviewShinva Medical Instrument Co., Ltd. (Shinva Medical) is a medical device company engaged in the manufacture and marketing of medic |
2011 | 250,00$ |
Huiheng Medical, Inc. (HHGM) - Financial and Strategic SWOT Analysis ReviewHuiheng Medical, Inc. (Huiheng Medical) is engaged in the design, development, manufacture and marketing of radiation therapy syst |
2011 | 250,00$ |
Elegance International Holdings Ltd (0907) - Financial and Strategic SWOT Analysis ReviewElegance International Holdings Ltd (Elegance International) is a medical device company engaged in the design, manufacture and sa |
2011 | 250,00$ |
Medidata Solutions, Inc. (MDSO) - Financial and Strategic SWOT Analysis ReviewMedidata Solutions, Inc. (Medidata) is a global provider of software as a service based clincal technology solutions. It provides |
2011 | 250,00$ |
Sirtex Medical Limited (SRX) - Financial and Strategic SWOT Analysis ReviewSirtex Medical Limited (Sirtex), a biotechnology and medical device company is engaged in the developing, manufacturing and market |
2011 | 250,00$ |
KM Corporation (083550) - Financial and Strategic SWOT Analysis ReviewKM Corporation (KM) is a health care company, offering medical equipments. The company is specialized in equipment for clean rooms |
2011 | 250,00$ |
Ergoresearch Ltd. (ERG) - Financial and Strategic SWOT Analysis ReviewErgoresearch Ltd. (Ergoresearch) is a Canada-based company that specializes in research and alleviating foot pain. The company, th |
2011 | 250,00$ |
Streamline Health Solutions, Inc. (STRM) - Financial and Strategic SWOT Analysis ReviewStreamline Health Solutions, Inc. (Streamline) is a provider of workflow and document management tools, applications and services |
2011 | 250,00$ |
Nolato AB (NOLA B) - Financial and Strategic SWOT Analysis ReviewNolato AB (Nolato) is a pharmaceutical company, principally engaged in the development and manufacture of polymer components and p |
2011 | 250,00$ |
Hamai Industries Ltd. (6497) - Financial and Strategic SWOT Analysis ReviewHamai Industries Ltd. (Hamai) is a Japan based company. It is engaged in manufacture and marketing of precision machine equipment, |
2011 | 250,00$ |
OmniComm Systems, Inc. (OMCM) - Financial and Strategic SWOT Analysis ReviewOmniComm Systems, Inc., (OmniComm) is a healthcare service provider company, based in the US. The company is engaged in providing |
2011 | 125,00$ |
Flexpoint Sensor Systems, Inc. (FLXT) - Financial and Strategic SWOT Analysis ReviewFlexpoint Sensor Systems, Inc. (FLXT) is the US based thin film sensing technology supplying company. It is engaged in supplying t |
2011 | 250,00$ |
D. Medical Industries Limited (DMDC) - Financial and Strategic SWOT Analysis ReviewD. Medical Industries Limited (D. Medical) is a medical devices holding company operating through its subsidiaries in the product |
2011 | 250,00$ |
Craneware plc (CRW) - Financial and Strategic SWOT Analysis ReviewCraneware plc is a supplier of business intelligence and revenue cycle software that provides clients with chargemaster management |
2011 | 125,00$ |
VentriPoint Diagnostics Ltd. (VPT) - Financial and Strategic SWOT Analysis ReviewVentriPoint Diagnostics, Ltd. (Ventripoint) is a medical device company engaged in the development of diagnostic tools to monitor |
2011 | 250,00$ |
GEOMC Co., Ltd. (033030) - Financial and Strategic SWOT Analysis ReviewGEOMC Co, Ltd. (GEOMC) is engaged in manufacturing and marketing technology devices. The company is formerly known as Daeyang E&C, |
2011 | 250,00$ |
Wound Management Technologies, Inc. (WNDM) - Financial and Strategic SWOT Analysis ReviewWound Management Technologies, Inc. (WMT) is a medical device company, engaged in marketing and distributing products for the woun |
2011 | 250,00$ |
Bioland co., Ltd (052260) - Financial and Strategic SWOT Analysis ReviewBioland co., Ltd (Bioland) is a privately held company engaged in providing natural products, tissue engineering solutions and dia |
2011 | 250,00$ |
Medtronic CryoCath, LP. - Strategic SWOT Analysis ReviewMedtronic CryoCath, LP. (Medtronic CryoCath), formerly CryoCath Technologies Inc. is a medical device company engaged in developin |
2011 | 125,00$ |
Alertis Medical AS - Strategic SWOT Analysis ReviewAlertis Medical AS (Alertis) is a Norwegian specialty medical devices company, engaged in the development of new technologies for |
2011 | 125,00$ |
Blood Cell Storage, Inc. - Strategic SWOT Analysis ReviewBlood Cell Storage, Inc. (BCS) is a Netherland-based medical device company. It engages in the development and manufacturing of pr |
2011 | 125,00$ |
MicroMed Cardiovascular, Inc. (MMCO) - Strategic SWOT Analysis ReviewMicroMed Cardiovascular ( MicroMed ) is a medical device company engaged in development of medical products for the cardiovascular |
2011 | 250,00$ |
Miraculins Inc. (MOM) - Strategic SWOT Analysis ReviewMiraculins Inc (Miraculins) is a research and development company engaged in the discovery and validation of cancer biomarkers, wh |
2011 | 250,00$ |
Spacelabs Healthcare, Inc. - Strategic SWOT Analysis ReviewSpacelabs Healthcare, Inc. (Spacelabs Healthcare) is a medical device company engaged in the development, manufacturing and sellin |
2011 | 125,00$ |
CIBA Vision Corporation - Strategic SWOT Analysis ReviewCIBA Vision Corporation (CIBA) is an ophthalmic device company engaged in the research, development and manufacturing of optical p |
2011 | 125,00$ |
Planmeca Oy - Strategic SWOT Analysis ReviewPlanmeca Oy (Planmeca) is a medical device company engaged in the design, manufacturing and marketing of high-tech dental equipmen |
2011 | 125,00$ |
AMG Medical Inc. - Strategic SWOT Analysis ReviewAMG Medical Inc. (AMG), formerly AMG Sales Agency Inc. is a medical device company engaged in the development, manufacture and dis |
2011 | 125,00$ |
CooperVision, Inc. - Strategic SWOT Analysis ReviewCooperVision, Inc. (CVI) is a medical device company principally engaged in the development, manufacturing and marketing of contac |
2011 | 125,00$ |
Johnson & Johnson Vision Care, Inc. - Strategic SWOT Analysis ReviewJohnson & Johnson Vision Care, Inc. (J&J Vision Care) is a opthalmic device company principally engaged in the design and manufact |
2011 | 125,00$ |
GE Measurement & Control Solutions - Strategic SWOT Analysis ReviewGE Measurement & Control Solutions is a technology instruments company, engaged in the design, manufacture and sale of the advance |
2011 | 125,00$ |
Glidewell Dental Laboratories - Strategic SWOT Analysis ReviewGlidewell Dental Laboratories (Glidewell) is a dental company principally engaged in the development, manufacturing and marketing |
2011 | 125,00$ |
Sunrise Medical, Inc. - Strategic SWOT Analysis ReviewSunrise Medical, Inc. (Sunrise Medical) is a medical device company principally engaged in the design, manufacture, distribution a |
2011 | 125,00$ |
DeRoyal Industries, Inc. - Strategic SWOT Analysis ReviewDeRoyal Industries, Inc. (DeRoyal) is engaged in the manufacture and distribution of medical products and services for the healthc |
2011 | 125,00$ |
TORNIER, Inc. - Strategic SWOT Analysis ReviewTORNIER, Inc. (Tornier) is a medical device company, principally engaged in the design, development, manufacture and sale of ortho |
2011 | 125,00$ |
Ventana Medical Systems, Inc. - Strategic SWOT Analysis ReviewVentana Medical Systems, Inc. (Ventana Medical) is engaged in the development, manufacture and marketing of medical diagnostic ins |
2011 | 125,00$ |
Atritech, Inc. - Strategic SWOT Analysis ReviewAtritech, Inc. (Atritech) is a clinical stage medical device company engaged in the development, manufacture and sales of medical |
2011 | 125,00$ |
Medikro Oy. - Strategic SWOT Analysis ReviewMedikro Oy. (Medikro) is a medical equipment manufacturing company. The company is engaged in the development, manufacture and mar |
2011 | 125,00$ |
KaVo Dental Corporation - Strategic SWOT Analysis ReviewKaVo Dental Corporation (KaVo Dental) is a dental equipments manufacturing company, which is engaged in the design, manufacture an |
2011 | 125,00$ |
A-dec Inc. - Strategic SWOT Analysis ReviewA-dec Inc. (A-dec) is a dental equipment manufacturing company engaged in the design, development, production and sales of dental |
2011 | 125,00$ |
Ortho-Clinical Diagnostics Inc. - Strategic SWOT Analysis ReviewOrtho-Clinical Diagnostics, Inc., (Ortho-Clinical) is a subsidiary of Johnson & Johnson company. The company principally engages i |
2011 | 125,00$ |
Gendex Dental Systems - Strategic SWOT Analysis ReviewGendex Dental Systems (Gendex) is a dental X-ray equipment company engaged in the research and development, manufacture and distri |
2011 | 125,00$ |
Mennen Medical Ltd. - Strategic SWOT Analysis ReviewMennen Medical Ltd. (Mennen Medical) is a global medical device company principally engaged in the design, development and marketi |
2011 | 125,00$ |
Hollister Incorporated - Strategic SWOT Analysis ReviewHollister Incorporated (Hollister), formerly JDS Printer Craftsman, Inc. is a specialty medical products company. It is engaged in |
2011 | 125,00$ |
Microtek Medical Holdings, Inc. - Strategic SWOT Analysis ReviewMicrotek Medical Holdings, Inc. (Microtek Medical) is involved in the design, manufacture and marketing of a wide range of infecti |
2011 | 125,00$ |
Esaote North America, Inc. - Strategic SWOT Analysis ReviewEsaote North America, Inc. (Esaote NA) formerlly Biosound Esaote, Inc., is a medical device company engaged in developing advanced |
2011 | 125,00$ |
Excel-Tech Ltd. - Strategic SWOT Analysis ReviewExcel-Tech Ltd. is a medical technology company that designs, develops and sells proprietary medical devices, based in Canada. The |
2011 | 250,00$ |
Inovise Medical, Inc. - Strategic SWOT Analysis ReviewInovise Medical, Inc. (Inovise Medical) is a cardiac diagnostic medical technology company engaged in the development of portable |
2011 | 125,00$ |
ADInstruments Pty Ltd - Strategic SWOT Analysis ReviewADInstruments Pty Ltd (ADI) is a medical equipment company, provides computer-based data acquisition and analysis systems for life |
2011 | 125,00$ |
ALung Technologies, Inc. - Strategic SWOT Analysis ReviewALung Technologies, Inc. (ALung) is an US-based company. It is a pioneer in the development of respiratory assist technologies whi |
2011 | 125,00$ |
Amedica Corporation - Strategic SWOT Analysis ReviewAmedica Corporation (Amedica) is a medical device company, operates as a orthopedic implant and spine company, engaged in the deve |
2011 | 125,00$ |
LifeWatch Corp. - Strategic SWOT Analysis ReviewLifeWatch Corp. (LWC) is an ambulatory health monitoring solutions provider principally engaged in the development, marketing and |
2011 | 125,00$ |
Integra Spine - Strategic SWOT Analysis ReviewIntegra Spine formerly Theken Spine, LLC is a medical device company engaged in the design, development, manufacture and sale of s |
2011 | 125,00$ |
IMPAC Medical Systems, Inc. - Strategic SWOT Analysis ReviewIMPAC Medical Systems, Inc. (IMPAC) is engaged in providing oncology charting, practice management, clinical laboratory, anatomic |
2011 | 125,00$ |
Mercury Medical, Inc. - Strategic SWOT Analysis ReviewMercury Medical, Inc. (Mercury Medical) is a privately-held medical device company, engaged in the development, manufacture and ma |
2011 | 125,00$ |
American Diagnostic Corporation - Strategic SWOT Analysis ReviewAmerican Diagnostic Corporation (ADC), a medical device company, is engaged in the development, manufacturing and marketing of dia |
2011 | 125,00$ |
Advanced Bionics, LLC - Strategic SWOT Analysis ReviewAdvanced Bionics, LLC (Advanced Bionics) is engaged in the development, manufacture and marketing of bionic technologies and impla |
2011 | 125,00$ |
Showa Best Glove, Inc. - Strategic SWOT Analysis ReviewShowa Best Glove, Inc (Showa Best) is engaged in the design, development, manufacture and marketing of hand protection for industr |
2011 | 125,00$ |
ViOptix Inc. - Strategic SWOT Analysis ReviewViOptix Inc. (ViOptix) is engaged in the design, development, manufacture and marketing of non-invasive local tissue oxygen measur |
2011 | 125,00$ |
Universal Medical Technologies Inc. - Strategic SWOT Analysis ReviewUniversal Medical Technologies Inc., (Universal Medical) is engaged in the design, manufacture and development of intravenous (IV) |
2011 | 125,00$ |
Kibow Biotech Inc. - Strategic SWOT Analysis ReviewKibow Biotech Inc. (Kibow) is a biotechnology company. It engages in the development and commercialization of scientifically-formu |
2011 | 125,00$ |
Alara, Inc. - Strategic SWOT Analysis ReviewAlara, Inc. (Alara) is engaged in the design, development, manufacture and marketing of high quality imaging products based on Co |
2011 | 125,00$ |
ApaTech Limited - Strategic SWOT Analysis ReviewApaTech Limited (ApaTech) is an orthobiologics company, which is engaged in the manufacture and development of synthetic bone graf |
2011 | 125,00$ |
HydroCision, Inc. - Strategic SWOT Analysis ReviewHydroCision, Inc. (HydroCision) is a medical device company engaged in the development, manufacturing and marketing of surgical pr |
2011 | 125,00$ |
Current Technology Corporation - Strategic SWOT Analysis ReviewCurrent Technology Corporation (CTC) is a medical device company engaged in the development, manufacture and marketing of electrot |
2011 | 250,00$ |
Fallbrook Engineering, Inc. - Strategic SWOT Analysis ReviewFallbrook Engineering, Inc. (Fallbrook Engineering) is engaged in providing consulting services related to contract product develo |
2011 | 125,00$ |
InfraReDx, Inc. - Strategic SWOT Analysis ReviewInfraReDx, Inc. (InfraReDx) is an US based medical device company. It develops and commercializes imaging technologies for the d |
2011 | 125,00$ |
Tyco Healthcare/Kendall - Strategic SWOT Analysis ReviewTyco Healthcare/Kendall (Kendall) is a medical device company principally engaged in the manufacture, development, distribution an |
2011 | 125,00$ |
Nexgen Spine Inc. - Strategic SWOT Analysis ReviewNexgen Spine Inc. (Nexgen) is a privately held medical device company engaged in the design; development and manufacturing of adva |
2011 | 125,00$ |
Larsen & Toubro Medical Equipment & Systems - Strategic SWOT Analysis ReviewLarsen & Toubro Medical Equipment and Systems (L&T Medical), a sub-division of Larsen & Toubro Limited’s Electrical & Electronics |
2011 | 125,00$ |
Aniara Corporation - Strategic SWOT Analysis ReviewAniara Corporation (Aniara) is an invitro diagnostics company engaged in the manufacture marketing and distribution of screening t |
2011 | 125,00$ |
Aperio Technologies, Inc. - Strategic SWOT Analysis ReviewAperio Technologies, Inc. (Aperio) is engaged in the design, development, manufacture and sale of systems and services pertaining |
2011 | 125,00$ |
Applied Spectral Imaging, Ltd. - Strategic SWOT Analysis ReviewApplied Spectral Imaging, Ltd. (ASI), is engaged in the design, manufacture and marketing of various healthcare imaging and data m |
2011 | 125,00$ |
ERBLAN Surgical, Inc. - Strategic SWOT Analysis ReviewERBLAN Surgical, Inc. (ERBLAN Surgical) is engaged in the design, development and commercialization of medical devices and surgica |
2011 | 125,00$ |
LifeSync Corporation - Strategic SWOT Analysis ReviewLifeSync Corporation (LifeSync) is a privately owned medical device company engaged in the development and sale of its flagship pr |
2011 | 125,00$ |
HD Medical Group Limited - Strategic SWOT Analysis ReviewHD Medical Group Limited (HD Medical) is principally engaged in the development of proprietary and patented heart sound technology |
2011 | 125,00$ |
Sensors for Medicine and Science, Inc. - Strategic SWOT Analysis ReviewSensors for Medicine and Science, Inc. (SMSI), is a medical technology company engaged in the research, development and commercial |
2011 | 125,00$ |
NsGene A/S - Strategic SWOT Analysis ReviewNsGene A/S (NsGene) is a Danish biotech company, engaged in providing biological products for the treatment of neurological diseas |
2011 | 125,00$ |
NovoSci Corporation - Strategic SWOT Analysis ReviewNovoSci Corporation (NovoSci) is a medical device company engaged in the development and manufacture of products that are used by |
2011 | 125,00$ |
Access Bio, Inc. - Strategic SWOT Analysis ReviewAccess Bio, Inc. (Access Bio) is a medical technology company. It is engaged in the development, manufacture and marketing of In-V |
2011 | 125,00$ |
Active Implants Corporation - Strategic SWOT Analysis ReviewActive Implants Corporation (AIC) is an orthopedic medical device company engaged in the development of advanced polymer orthopedi |
2011 | 125,00$ |
Medtrode Inc. - Strategic SWOT Analysis ReviewMedtrode Inc. (Medtrode) is a medical device company, engaged in the development of neuromodulation therapy for cognitive and memo |
2011 | 125,00$ |
Valleylab, Inc. - Strategic SWOT Analysis ReviewValleylab, Inc. (Valleylab) is engaged in the design, manufacture and marketing of electrosurgery systems for the surgical markets |
2011 | 125,00$ |
Bone Biologics, Inc. - Strategic SWOT Analysis ReviewBone Biologics, Inc. (Bone Biologics) is an US-based biotechnology company. It develops and manufactures bone regeneration techno |
2011 | 125,00$ |
BoneSupport AB - Strategic SWOT Analysis ReviewBoneSupport AB (BoneSupport) is a Swedish medical technology company. It engages in the development of bone substitute products fo |
2011 | 125,00$ |
Boule Diagnostics International AB - Strategic SWOT Analysis ReviewBoule Diagnostics International AB (Boule Diagnostics) is a diagnostic company, engaged in the development and marketing of in pro |
2011 | 125,00$ |
Dornier MedTech GmbH - Strategic SWOT Analysis ReviewDornier MedTech GmbH (Dornier MedTech) is a privately held medical device company, principally engaged in the development, manufac |
2011 | 125,00$ |
PENTAX of America, Inc. - Strategic SWOT Analysis ReviewPENTAX of America, Inc. (PENTAX) operates in two business divisions, namely, PENTAX Medical Company and PENTAX Imaging Company. It |
2011 | 125,00$ |
Ethicon Endo-Surgery, Inc. - Strategic SWOT Analysis ReviewEthicon Endo-Surgery, Inc. (EES) is a medical device company engaged in the development and distribution of advanced medical devic |
2011 | 125,00$ |
Berlin Heart GmbH - Strategic SWOT Analysis ReviewBerlin Heart GmbH (Berlin Heart) is engaged in development, manufacture, sale and commercialization of cardiovascular devices. The |
2011 | 125,00$ |
Kuros Biosurgery AG - Strategic SWOT Analysis ReviewKuros Biosurgery AG (Kuros) is a biomedical company engaged in the development of biomaterial products. It develops a broad range |
2011 | 125,00$ |
Planmed Oy - Strategic SWOT Analysis ReviewPlanmed Oy (Planmed) is a Finnish medical equipment manufacturer. The company is engaged in the research and development of novel |
2011 | 125,00$ |
m2m Imaging Corporation - Strategic SWOT Analysis Reviewm2m Imaging Corporation (m2m Imaging) is engaged in the manufacture and development of magnetic resonance imaging (MRI) coils and |
2011 | 125,00$ |
Oxford Immunotec Limited - Strategic SWOT Analysis ReviewOxford Immunotec Limited (Oxford Immunotec) is an international T cell measurement company engaged in the development and commerci |
2011 | 125,00$ |
Oxford Biomedical Research, Inc. - Strategic SWOT Analysis ReviewOxford Biomedical Research, Inc. (OBR) is engaged in the development and manufacture of immunoassay products, such as ELISA kits f |
2011 | 125,00$ |
Optovue, Inc. - Strategic SWOT Analysis ReviewOptovue, Inc. (Optovue) is an ophthalmic device company engaged in the development, designing, production, marketing and commercia |
2011 | 125,00$ |
Otto Bock HealthCare GmbH - Strategic SWOT Analysis ReviewOtto Bock HealthCare GmbH (Otto Bock) is a medical device company engaged in the production and distribution of prosthetic and ort |
2011 | 125,00$ |
FASgen, Inc. - Strategic SWOT Analysis ReviewFASgen, Inc. (FASgen) is a medical company principally engaged in the manufacturing and development of new drugs and therapeutic p |
2011 | 125,00$ |
Finsbury Orthopaedics Limited - Strategic SWOT Analysis ReviewFinsbury Orthopedic Limited (Finsbury) is a medical device company, engaged in the design, development, manufacture and supply of |
2011 | 125,00$ |
TeraRecon, Inc. - Strategic SWOT Analysis ReviewTeraRecon, Inc. (TeraRecon) is a provider of technological solutions for professional imaging applications with a focus on medical |
2011 | 125,00$ |
Hai Kang Life Corporation Limited - Strategic SWOT Analysis ReviewHai Kang Life Corporation Limited (Hai Kang Life) is a biotechnology company engaged in the research, development and manufacture |
2011 | 125,00$ |
ARKRAY, Inc. - Strategic SWOT Analysis ReviewARKRAY, Inc. (ARKRAY) formerlly known as KDK Corporation is medical equipment company, engaged in the development and manufacture |
2011 | 125,00$ |
Globus Medical, Inc. - Strategic SWOT Analysis ReviewGlobus Medical, Inc. (Globus Medical) is a privately-held medical device company, which is principally engaged in the research and |
2011 | 125,00$ |
Evolved Digital Systems Inc. (EVD) - Strategic SWOT Analysis ReviewEvolved Digital Systems Inc. (Evolved Digital) is a healthcare technology solutions company, which specializes in delivering manag |
2011 | 125,00$ |
Coherex Medical, Inc. - Strategic SWOT Analysis ReviewCoherex Medical, Inc. (Coherex) is a medical device company engaged in the development of innovative medical devices for the cardi |
2011 | 125,00$ |
Deep Breeze Ltd. - Strategic SWOT Analysis ReviewDeep Breeze Ltd. (Deep Breeze) is a privately owned medical device company engaged in the development, manufacturing and distribut |
2011 | 125,00$ |
Hemosystem - Strategic SWOT Analysis ReviewHemosystem is a French based biotechnology company, which is principally engaged in the development of solutions that improves saf |
2011 | 125,00$ |
Kyungwon Medical Co., Ltd. - Strategic SWOT Analysis ReviewKyungwon Medical Co., Ltd. (Kyungwon Medical) is a medical device company principally engaged in the manufacture and distribution |
2011 | 125,00$ |
dbMotion Inc. - Strategic SWOT Analysis ReviewdbMotion Inc. (dbMotion) is a privately-held healthcare information technology company that provides clinical information integrat |
2011 | 125,00$ |
Doxa AB - Strategic SWOT Analysis ReviewDoxa AB (Doxa) is a dental device company engaged in the manufacture and development of bioceramic dental products. Their products |
2011 | 125,00$ |
Gene Express, Inc. - Strategic SWOT Analysis ReviewGene Express, Inc. (Gene Express) is principally engaged in the development and marketing of molecular diagnostic products and sta |
2011 | 125,00$ |
Integrated Sensing Systems, Inc. - Strategic SWOT Analysis ReviewIntegrated Sensing Systems, Inc. (ISSYS) is engaged in the design, manufacture, development and distribution of microelectromechan |
2011 | 125,00$ |
Intelligent Medical Devices, Inc. - Strategic SWOT Analysis ReviewIntelligent Medical Devices, Inc. (Intelligent Medical) is a molecular diagnostics company, engaged in the design, development and |
2011 | 125,00$ |
Scanlan International, Inc. - Strategic SWOT Analysis ReviewScanlan International (Scanlan) is a medical device company principally engaged in the design, development, manufacture and distri |
2011 | 125,00$ |
Boss Instruments, Ltd. - Strategic SWOT Analysis ReviewBoss Instruments, Ltd. (Boss Instruments) is a privately-held medical device company engaged in the development, manufacture and m |
2011 | 125,00$ |
InterGenetics Incorporated - Strategic SWOT Analysis ReviewInterGenetics Incorporated (InterGenetics) is a biotechnology company engaged in the development and manufacture of genetic medici |
2011 | 125,00$ |
MEDICON eG - Strategic SWOT Analysis ReviewMEDICON eG (MEDICON) is a medical device company principally engaged in the design, manufacture and distribution of surgical produ |
2011 | 125,00$ |
ESAOTE S.p.A. - Strategic SWOT Analysis ReviewESAOTE S.p.A. (Esaote) is a medical device company engaged in the manufacturing of the non-invasive diagnostic equipment and syste |
2011 | 125,00$ |
Bayer MaterialScience AG - Strategic SWOT Analysis ReviewBayer MaterialScience AG (BMS) is a material science company, primarily engaged in the development and production of polymer and p |
2011 | 125,00$ |
Prosonic Co., Ltd. - Strategic SWOT Analysis ReviewProsonic Co., Ltd. (Prosonic) is a medical equipment company, engaged in providing equipments and accessories manufacturing servic |
2011 | 125,00$ |
Shofu Dental Corporation (7979) - Strategic SWOT Analysis ReviewShofu Dental Corporation (Shofu) is a medical device company principally engaged in manufacturing of dental materials and equipmen |
2011 | 250,00$ |
LipoScience, Inc. - Strategic SWOT Analysis ReviewLipoSceince, Inc. (LipoScience) is a medical technology company engaged in the research, development and marketing of clinical dia |
2011 | 125,00$ |
ADVANCE CO., LTD. - Strategic SWOT Analysis ReviewADVANCE CO., LTD. (Advance) is a medical device company, engaged in the development, manufacture, sale and import and export of me |
2011 | 125,00$ |
Healthnostics, Inc. (HNSS) - Strategic SWOT Analysis ReviewHealthnostics, Inc. (Healthnostics) is a medical and biotechnology analytics company which is principally engaged in providing pat |
2011 | 250,00$ |
iSOFT Group PLC - Strategic SWOT Analysis ReviewiSOFT Group plc (iSOFT) is a Healthcare Information Technology company engages in the design, development and marketing of advanc |
2011 | 125,00$ |
CLINICARE Corporation - Strategic SWOT Analysis ReviewCLINICARE Corporation (CLINICARE) is a healthcare IT company, engaged in the development, marketing and providing computerized inf |
2011 | 125,00$ |
VEPRO AG - Strategic SWOT Analysis ReviewVEPRO AG (VEPRO) is healthcare company that is engaged in the development, manufacture and distribution of storage and communicati |
2011 | 125,00$ |
Healthphone Solutions Limited - Strategic SWOT Analysis ReviewHealthphone Solutions Limited (Healthphone Solutions) is a healthcare IT company, which is principally engaged in the development, |
2011 | 125,00$ |
Spinal Restoration, Inc. - Strategic SWOT Analysis ReviewSpinal Restoration, Inc. (Spinal Restoration) is a medical device company principally engaged in the development, manufacture and |
2011 | 125,00$ |
ATMOS MedizinTechnik GmbH & Co. KG - Strategic SWOT Analysis ReviewATMOS MedizinTechnik GmbH & Co. KG (ATMOS) is a medical devices company that principally specializes in the development and manufa |
2011 | 125,00$ |
Spine Smith, LP - Strategic SWOT Analysis ReviewSpine Smith, LP (SpineSmith) is a medical device company, which is engaged in the design, manufacture and marketing of surgical im |
2011 | 125,00$ |
BioTex, Inc. - Strategic SWOT Analysis ReviewBioTex, Inc. (BioTex) is engaged in the research, development and marketing of novel optical solutions and technologies for medica |
2011 | 125,00$ |
Focal Corporation - Strategic SWOT Analysis ReviewFocal Corporation (Focal) is engaged in the supply of medical products for the healthcare industry to its overseas customers. The |
2011 | 125,00$ |
Lantis Laser, Inc. (LLSR) - Strategic SWOT Analysis ReviewLantis Laser Inc. (Lantis Laser) is a medical device company, engaged in the development, manufacture and distribution of dental t |
2011 | 250,00$ |
IDMoS plc - Strategic SWOT Analysis ReviewIDMoS plc (IDMoS) is a medical technology company, which is engaged in the development and providing of innovative technologies an |
2011 | 125,00$ |
SOLOS Endoscopy, Inc. (SNDY) - Strategic SWOT Analysis ReviewSOLOS Endoscopy, Inc. (SOLOS) is a medical technology company, engaged in development and marketing of medical devices and technol |
2011 | 250,00$ |
Leonhard Lang GmbH - Strategic SWOT Analysis ReviewLeonhard Lang GmbH (Leonhard) is a privately held medical device company that is engaged in the design, manufacture and distributi |
2011 | 125,00$ |
Alltracel Pharmaceuticals plc - Strategic SWOT Analysis ReviewAlltracel Pharmaceuticals plc (Alltracel) is a medical technology company, which is principally engaged in the manufacture, distri |
2011 | 250,00$ |
Visicu, Inc. - Strategic SWOT Analysis ReviewVISICU, Inc. (VISICU) is a Healthcare Information Technology company principally engaged in the development, marketing and sale of |
2011 | 125,00$ |
XTend Medical Corporation - Strategic SWOT Analysis ReviewXTend Medical Corporation (XTend Medical) is a healthcare IT company, which is engaged in the development, manufacturing and distr |
2011 | 250,00$ |
Glide Pharmaceutical Technologies Limited - Strategic SWOT Analysis ReviewGlide Pharmaceutical Technologies Limited (Glide Pharma) formerly Caretek Medical Ltd. is a specialty pharmaceutical company, whic |
2011 | 125,00$ |
Aquamatrix, Inc. (AQMT) - Strategic SWOT Analysis ReviewAquamatrix, Inc. (formerly known as Nesco Industries, Inc.) is a medical device company, which is engaged in developing, manufactu |
2011 | 250,00$ |
Sorin Group USA Inc. - Strategic SWOT Analysis ReviewSorin Group USA, Inc. (Sorin USA) formerly COBE Cardiovascular, Inc. is the US-based company. It develops, manufactures and marke |
2011 | 125,00$ |
Transasia Bio-Medicals Ltd. - Strategic SWOT Analysis ReviewTransasia Bio-Medicals Ltd. (Transasia) is a medical device company, engaged in the designing, manufacturing and distribution of i |
2011 | 125,00$ |
Teijin Pharma Limited - Strategic SWOT Analysis ReviewTeijin Pharma Limited (Teijin Pharma) is engaged in the manufacturing and marketing of pharmaceuticals and medical devices. Teijin |
2011 | 125,00$ |
Shree Pacetronix Ltd. (527005) - Strategic SWOT Analysis ReviewShree Pacetronix Ltd. (Pacetronix) is a medical device company engaged in the designing, development and manufacturing of quality |
2011 | 250,00$ |
PulmoBioTech Inc (PLMO) - Strategic SWOT Analysis ReviewPulmoBioTech Inc (Pulmo) is engaged in designing, development and distributing of medial technology for diagnostic and research ap |
2011 | 250,00$ |
SIGVARIS MANAGEMENT AG - Strategic SWOT Analysis ReviewSIGVARIS MANAGEMENT AG (SIGVARIS) previously called GANZONI MANAGEMENT AG is part of the medical device manufacturing company, kno |
2011 | 125,00$ |
OrthoPediatrics Corp. - Strategic SWOT Analysis ReviewOrthoPediatrics Corp. (OrthoPediatrics) is a medical device company, engaged in inventing, designing and distributing anatomically |
2011 | 125,00$ |
OsteoRad, Co., Ltd. - Strategic SWOT Analysis ReviewShan Xiao Rui Biological Material Co., Ltd. (Shan Xiao Rui) which was previously called OsteoRad, Co., Ltd. is a medical device co |
2011 | 125,00$ |
HoMedics, Inc. - Strategic SWOT Analysis ReviewHoMedics, Inc. (HoMedics) is a US-based company, which is engaged in providing health and care services also provides a diverse ra |
2011 | 125,00$ |
BREG Incorporated - Strategic SWOT Analysis ReviewBREG Incorporated (BREG) is a medical device company engaged in the designing, manufacturing and distribution of orthopedic, recon |
2011 | 125,00$ |
Aspect Imaging - Strategic SWOT Analysis ReviewAspect Imaging (Aspect), formerlly known as Aspect Magnet Technologies Ltd. is a medical device company. It is engaged in designin |
2011 | 125,00$ |
Biomagnetics Diagnostics Corporation (BMGP) - Strategic SWOT Analysis ReviewBiomagnetics Diagnostics Corporation (Biomagnetics Diagnostics) is a medical devices company that is principally engaged in provid |
2011 | 250,00$ |
Sialo Technology Ltd. (SALO) - Strategic SWOT Analysis ReviewSialo Technology Ltd. (Sialo Technology) is a developer of medical devices for the treatment of temporomandibular joint (TMJ) synd |
2011 | 250,00$ |
Julius Zorn, Inc. - Strategic SWOT Analysis ReviewJulius Zorn, Inc. (Juzo) is a healthcare company engaged in the manufacture of medical compression and support therapy garments. T |
2011 | 125,00$ |
Bauerfeind USA, Inc. - Strategic SWOT Analysis ReviewBauerfeind USA, Inc. (Bauerfeind USA) is an US-based company manufacturing orthopedic supports and orthoses. The company is a spec |
2011 | 125,00$ |
Kronos Incorporated - Strategic SWOT Analysis ReviewKronos Incorporated (Kronos) is a privately-held technology company engaged in providing human capital management solutions. The c |
2011 | 125,00$ |
Unomedical Inc. - Strategic SWOT Analysis ReviewUnomedical Inc. (Unomedical), is a medical device company engaged in the manufacture and distribution of single use respiratory an |
2011 | 125,00$ |
Diagnostic Imaging International Corp. (DIIG) - Strategic SWOT Analysis ReviewDiagnostic Imaging International Corp. (DIIC) is a US based medical device company. The company was formerly known as Galloway Inv |
2011 | 250,00$ |
Xion GmbH - Strategic SWOT Analysis ReviewXion GmbH (Xion) is a German-based privately held medical devices company engaged in the developing, manufacturing and sales of v |
2011 | 125,00$ |
ChromoCure, Inc. (KKUR) - Strategic SWOT Analysis ReviewChromoCure, Inc.,(ChromoCure) formerly known as Cyberhand Technologies International, Inc., is engaged in developing and providing |
2011 | 250,00$ |
Allocade, Inc. - Strategic SWOT Analysis ReviewAllocade, Inc. (Allocade) is a privately owned software technology company, which focuses on the development and marketing of capa |
2011 | 125,00$ |
InStar Systems International, LLC - Strategic SWOT Analysis ReviewInStar Systems International, LLC (InStar Systems) is a privately-held company, which is engaged in providing a wide range of radi |
2011 | 125,00$ |
eClinicalWorks, LLC - Strategic SWOT Analysis RevieweClinicalWorks, LLC (eClinicalWorks) is a US-based privately-held healthcare IT company. The company is engaged in providing the t |
2011 | 125,00$ |
Materialise NV - Strategic SWOT Analysis ReviewThe Materialise NV(Materialise) is a privately held diversified business company. It is engaged in providing innovative software s |
2011 | 125,00$ |
Medixsysteme - Strategic SWOT Analysis ReviewMedixsysteme is a medical device company, which is engaged in the development, manufacture and sales of medical equipments related |
2011 | 125,00$ |
Healthpoint Biotherapeutics - Strategic SWOT Analysis ReviewHealthpoint Biotherapeutics (Healthpoint) is an US-based biopharmaceutical company. It engages in development and marketing of pha |
2011 | 125,00$ |
JN-International Medical Corporation - Strategic SWOT Analysis ReviewJN-International Medical Corporation (JNI Medical) is a biopharmaceutical corporation engaged in developing vaccines for infectiou |
2011 | 125,00$ |
American Scientific Resources, Inc. (ASFX) - Strategic SWOT Analysis ReviewAmerican Scientific Resources, Inc. (ASR) is a provider of medical products and healthcare supplements through retail drug chains, |
2011 | 250,00$ |
Barco Medical Imaging - Strategic SWOT Analysis ReviewBarco Medical Imaging (Barco Medical) is engaged in the design, development, manufacture and supply of visualization products for |
2011 | 125,00$ |
Dr. Langer Medical GmbH - Strategic SWOT Analysis ReviewDr. Langer Medical GmbH (Langer Medical) is engaged in the design and development of devices for intraoperative neurological monit |
2011 | 125,00$ |
ATEK Medical, LLC - Strategic SWOT Analysis ReviewATEK Medical, LLC (ATEK Medical) is a privately-owned contract manufacturer of medical devices. The company offers complete produc |
2011 | 125,00$ |
Nobel Biocare AB - Strategic SWOT Analysis ReviewNobel Biocare AB (Nobel Biocare) is a medical device company engaged in the production of pioneer dental solutions using CAD (comp |
2011 | 250,00$ |
Bederra Corporation (ZICX) - Strategic SWOT Analysis ReviewBederra Corporation is a diversified medical services provider and is engaged in financing of equipment and other assets to doctor |
2011 | 250,00$ |
Metiscan, Inc. (MTIZ) - Strategic SWOT Analysis ReviewMetiscan, Inc. (Metiscan) is a public company that is focused on healthcare related businesses. The company is a provider of web-b |
2011 | 250,00$ |
Capsule Technologie S.A. - Strategic SWOT Analysis ReviewCapsule Technologie S.A. (Capsule) is a medical device company, provides Enterprise Medical Device Connectivity solutions. It offe |
2011 | 125,00$ |
Dimensional Insight, Inc. - Strategic SWOT Analysis ReviewDimensional Insight, Inc. (DI) is specialty service providing company that specializes in the development and marketing of multidi |
2011 | 125,00$ |
Peter-Brehm GMBH - Strategic SWOT Analysis ReviewPeter-Brehm GMBH (Peter-Brehm) is engaged in the research, development, manufacture, marketing and export of medical devices for t |
2011 | 125,00$ |
Futuremed Health Care Products L.P. - Strategic SWOT Analysis ReviewFuturemed Health Care Products L.P. (Futuremed) is a privately-held medical devices company, based in Canada. It is engaged in the |
2011 | 250,00$ |
Sonic Innovations, Inc. - Strategic SWOT Analysis ReviewSonic Innovations, Inc. (Sonic) is a hearing aid company, which is engaged in the design, development, manufacture and marketing o |
2011 | 125,00$ |
Arthro Kinetics plc - Strategic SWOT Analysis ReviewArthro Kinetics plc (Arthro Kinetics) is an orthopedic company engaged in the development and commercialization of biological cart |
2011 | 125,00$ |
ESTECH - Strategic SWOT Analysis ReviewESTECH is a medical device company engaged in the manufacture and distribution of least invasive products for cardiac surgery. The |
2011 | 250,00$ |
Atto Corporation - Strategic SWOT Analysis ReviewAtto Corporation (Atto) is a medical device manufacturing company principally engaged in developing, manufacturing and marketing o |
2011 | 250,00$ |
Health Science Products, Inc. - Strategic SWOT Analysis ReviewHealth Science Products Inc.( Health Science Products Inc.) is a US Based Dental equipment manufacturer company, that design and |
2011 | 250,00$ |
DOBI Medical International, Inc. - Strategic SWOT Analysis ReviewDOBI Medical International, Inc. (DOBI Medical) is an independent medical equipment company. The company is engaged in developing |
2011 | 250,00$ |
The Medical House PLC (MLH) - Strategic SWOT Analysis ReviewThe Medical House PLC (TMH) is engaged in the development and supply of innovative delivery systems for injectable drugs. Its prod |
2011 | 250,00$ |
Healthcare Integrated Services, Inc. - Strategic SWOT Analysis ReviewHealthcare Integrated Services, Inc. is engaged in manufacture and sale of medical devices Relating to Diagnostic Imaging and Also |
2011 | 250,00$ |
National Quality Care, Inc. (NQCI) - Strategic SWOT Analysis ReviewNational Quality Care, Inc provides wearable artificial kidney for dialysis and other medical applications. / / This comprehensiv |
2011 | 250,00$ |
HealtheTech, Inc. - Strategic SWOT Analysis ReviewThis comprehensive SWOT profile of HealtheTech, Inc. provides you with an in-depth strategic analysis of the company's businesses |
2011 | 250,00$ |
Cell Robotics International, Inc. (CRII) - Strategic SWOT Analysis ReviewCell Robotics International, Inc. manufactures, markets and sells laser-based medical devices and scientific research instruments. |
2011 | 250,00$ |
Ichimaru Sangyo Co., Ltd. - Strategic SWOT Analysis ReviewIchimaru Sangyo Co., Ltd. is Japan-based medical device company that engages in offering Formalin gas sterilizers, vacuum steriliz |
2011 | 250,00$ |
SurgiLight, Inc. - Strategic SWOT Analysis ReviewThis comprehensive SWOT profile of SurgiLight, Inc. provides you with an in-depth strategic analysis of the company's businesses a |
2011 | 250,00$ |
InforMedix Holdings, Inc. (IFMX) - Strategic SWOT Analysis ReviewInforMedix Holdings, Inc. is engaged in the development, patenting and integrating of Med-eXpert system, an integrated Internet-ba |
2011 | 250,00$ |
Synbiotics Corporation - Strategic SWOT Analysis ReviewSynbiotics Corporation, based in Kansas City,United States, is a developer, manufacturer and marketer of diagnostic products dedi |
2011 | 250,00$ |
Bb Medtech Ag - Strategic SWOT Analysis ReviewBB MEDTECH AG is an investment company. The company participates in companies in the growth market of medical technology. / / Thi |
2011 | 250,00$ |
Biomerge Industries Ltd. (BIL.H) - Strategic SWOT Analysis ReviewThis comprehensive SWOT profile of Biomerge Industries Ltd. provides you with an in-depth strategic analysis of the company's busi |
2011 | 250,00$ |
Cul 2 Inc. - Strategic SWOT Analysis ReviewThis comprehensive SWOT profile of Cul 2 Inc. provides you with an in-depth strategic analysis of the company's businesses and ope |
2011 | 250,00$ |
Egm International, Inc. - Strategic SWOT Analysis ReviewThis comprehensive SWOT profile of Egm International, Inc. provides you with an in-depth strategic analysis of the company's busin |
2011 | 250,00$ |
Jawon Medical Co.,Ltd. - Strategic SWOT Analysis ReviewJawon Medical Co.,Ltd. (Jawon Medical) is a Korea based medical equipment company, engaged in the designing, development, manufact |
2011 | 250,00$ |
Kmh Co Ltd - Strategic SWOT Analysis ReviewThis comprehensive SWOT profile of Kmh Co Ltd provides you with an in-depth strategic analysis of the company's businesses and ope |
2011 | 250,00$ |
Liberating Technologies Inc - Strategic SWOT Analysis ReviewLiberating Technologies Inc is a manufacturer and distributor of upper-limb prosthetic devices for adult and children. The company |
2011 | 250,00$ |
Lifeport, Inc - Strategic SWOT Analysis ReviewLifeport, Inc is a company engaged in the manufacture and supply of general hospital supplies like Whell chairs ,Tables,Stetchers |
2011 | 250,00$ |
Medical Resources - Strategic SWOT Analysis ReviewThis comprehensive SWOT profile of Medical Resources provides you with an in-depth strategic analysis of the company's businesses |
2011 | 250,00$ |
Monogen, Inc. - Strategic SWOT Analysis ReviewMonogen, Inc. (Monogen) is a medical devices and diagnostics company that offers cytological screening and diagnostic products for |
2011 | 250,00$ |
Oculus Innovative Sciences Netherlands B.V. - Strategic SWOT Analysis ReviewOculus Innovative Sciences Netherlands B.V. is a wholly owned subsidiary of Oculus Innovative Sciences, Inc. was founded at the en |
2011 | 250,00$ |
Polartechnics Limited - Strategic SWOT Analysis ReviewPolartechnics Limited is a life sciences company involved in the research, development, manufacture and marketing of innovative me |
2011 | 125,00$ |
Roesch Ag Medizintechnik - Strategic SWOT Analysis ReviewThis comprehensive SWOT profile of Roesch Ag Medizintechnik provides you with an in-depth strategic analysis of the company's busi |
2011 | 250,00$ |
Scantek Medical, Inc. - Strategic SWOT Analysis ReviewScantek Medical, Inc. (Scantek) is engaged in the design and marketing of BreastCare Differential Temperature Sensor (DTS). The pr |
2011 | 250,00$ |
Shanghai Pudong Jinhuan Medical Products Co., Ltd. - Strategic SWOT Analysis ReviewShanghai Pudong Jinhuan Medical Products Co., Ltd. (Jinhuan) is engaged in manufacturing and marketing of single use medical instr |
2011 | 250,00$ |
Sound Health Solutions Inc. - Strategic SWOT Analysis ReviewThis comprehensive SWOT profile of Sound Health Solutions Inc. provides you with an in-depth strategic analysis of the company's b |
2011 | 250,00$ |
CLX Medical, Inc. (CLXM) - Strategic SWOT Analysis ReviewCLX Medical, Inc. is engaged in the distribution of medical diagnostic testing products. The company is headquartered in Californi |
2011 | 250,00$ |
American HealthChoice, Inc. - Strategic SWOT Analysis ReviewThis comprehensive SWOT profile of American HealthChoice, Inc. provides you with an in-depth strategic analysis of the company's b |
2011 | 250,00$ |
Advanced Optics Electronics Inc. (ADOT) - Strategic SWOT Analysis ReviewThis comprehensive SWOT profile of Advanced Optics Electronics Inc. provides you with an in-depth strategic analysis of the compan |
2011 | 250,00$ |
American Biomed, Inc. - Strategic SWOT Analysis ReviewThis comprehensive SWOT profile of American Biomed, Inc. provides you with an in-depth strategic analysis of the company's busines |
2011 | 250,00$ |
Electronic Sensor Technology (ESNR) - Strategic SWOT Analysis ReviewThis comprehensive SWOT profile of Electronic Sensor Technology provides you with an in-depth strategic analysis of the company's |
2011 | 250,00$ |
MDwerks, Inc. (MDWK) - Strategic SWOT Analysis ReviewMDwerks, Inc. provides healthcare professionals with automated electronic insurance claims management solutions and advance fundin |
2011 | 250,00$ |
Invivosense ASA (INVIVO) - Strategic SWOT Analysis ReviewThis comprehensive SWOT profile of Invivosense ASA provides you with an in-depth strategic analysis of the company's businesses an |
2011 | 250,00$ |
Cryonic Medical SA (MLCRY) - Strategic SWOT Analysis ReviewThis comprehensive SWOT profile of Cryonic Medical SA provides you with an in-depth strategic analysis of the company's businesses |
2011 | 250,00$ |
Pharma Plast Co. S.A.E - Strategic SWOT Analysis ReviewThis comprehensive SWOT profile of Pharma Plast Co. S.A.E provides you with an in-depth strategic analysis of the company's busine |
2011 | 250,00$ |
EchoCath, Inc. (ECHTA) - Strategic SWOT Analysis ReviewThis comprehensive SWOT profile of EchoCath, Inc. provides you with an in-depth strategic analysis of the company's businesses and |
2011 | 250,00$ |
Photoelectron Corporation (PECN) - Strategic SWOT Analysis ReviewThis comprehensive SWOT profile of Photoelectron Corporation provides you with an in-depth strategic analysis of the company's bus |
2011 | 250,00$ |
MZT Holdings, Inc. (MZT) - Strategic SWOT Analysis ReviewMZT Holdings, Inc. (formerly Matritech, Inc.), is engaged in development of proteomics-based diagnostic products for the early det |
2011 | 250,00$ |
DATATRAK International, Inc. (DATA) - Financial and Strategic SWOT Analysis ReviewDATATRAK International, Inc. (DATATRAK International, Inc.) is engaged in the Electronic Data Capture industry. It operates as a w |
2011 | 250,00$ |
CPC of America, Inc. (CPCF) - Financial and Strategic SWOT Analysis ReviewCPC of America, Inc. (CPC of America, Inc.) is a development stage company in the medical device and healthcare sector. It engages |
2011 | 250,00$ |
Vyteris, Inc. (VYTR) - Financial and Strategic SWOT Analysis ReviewVyteris, Inc. (Vyteris) is a publicly held research focused biotechnology company that is engaged in the research and development |
2011 | 250,00$ |
Norwood Abbey Limited (SLE) - Financial and Strategic SWOT Analysis ReviewNorwood Abbey Limited (Norwood Abbey) is a publicly held pharmaceuticals and health care company. It is principally engaged in the |
2011 | 250,00$ |
Viralytics Ltd. (VLA) - Financial and Strategic SWOT Analysis ReviewViralytics Ltd. (Viralytics), formerly Psiron Limited, is a publicly held anti-cancer biotechnology company. The company is princi |
2011 | 250,00$ |
Questcor Pharmaceuticals, Inc. (QCOR) - Financial and Strategic SWOT Analysis ReviewQuestcor Pharmaceuticals, Inc. (Questcor Pharma) is a publicly held bio pharmaceutical company. It is specialized in the provision |
2011 | 250,00$ |
Cambrex Corporation (CBM) - Financial and Strategic SWOT Analysis ReviewCambrex Corporation (Cambrex) is a US based life sciences company. Cambrex is principally engaged in providing a range of products |
2011 | 125,00$ |
Biotec Pharmacon ASA (BIOTEC) - Financial and Strategic SWOT Analysis ReviewBiotec Pharmacon ASA (Biotec Pharmacon) is a publicly held Norway-based bio-pharmaceutical company. The company is principally eng |
2011 | 250,00$ |
Herbalife Ltd. (HLF) - Financial and Strategic SWOT Analysis ReviewHerbalife Ltd. (Herbalife) is a health care related products manufacturer and supplier company. The product portfolio of the compa |
2011 | 125,00$ |
Bavarian Nordic A/S (BAVA) - Financial and Strategic SWOT Analysis ReviewBavarian Nordic A/S (Bavarian Nordic) is a publicly held bio pharmaceutical company engaged in developing and producing vaccines f |
2011 | 250,00$ |
GUIDED THERAPEUTICS, INC. (GTHP) - Financial and Strategic SWOT Analysis ReviewGuided Therapeutics, Inc. (GTI) is a publicly held medical technology company that is engaged in developing and marketing of produ |
2011 | 250,00$ |
Urodynamix Technologies Ltd. (VVV) - Financial and Strategic SWOT Analysis ReviewUrodynamix Technologies Ltd. (Urodynamix) is a publicly held Canadian based medical device company that ie engaged in developing a |
2011 | 250,00$ |
Hiran Orgochem Ltd. (506170) - Financial and Strategic SWOT Analysis ReviewHiran Orgochem Ltd. (Hiran), is a publicly held India-based company. The company is principally engaged in the production and sale |
2011 | 250,00$ |
PULSION Medical Systems AG (PUS) - Financial and Strategic SWOT Analysis ReviewPULSION Medical Systems AG (Pulsion) is a publicly held biotechnology company that is engaged in the development, manufacture, and |
2011 | 250,00$ |
NovaMed, Inc. (NOVA) - Financial and Strategic SWOT Analysis ReviewNovaMed, Inc. (NovaMed) is a publicly held US-based healthcare services company. The company is principally engaged in the ownersh |
2011 | 250,00$ |
HealthSouth Corporation (HLS) - Financial and Strategic SWOT Analysis ReviewHealthSouth Corporation (HealthSouth) is an US based healthcare company. HealthSouth is principally engaged in providing inpatient |
2011 | 125,00$ |
Santen Pharmaceutical Co., Ltd. (4536) - Financial and Strategic SWOT Analysis ReviewSanten Pharmaceutical Co., Ltd. (Santen) is a pharmaceutical company based in Japan. The company together with its subsidiaries en |
2011 | 125,00$ |
Taisho Pharmaceutical Co., Ltd. (4535) - Financial and Strategic SWOT Analysis ReviewTaisho Pharmaceutical Co., Ltd. (Taisho) is a Japan-based pharmaceutical company that is engaged in the manufacturing and selling |
2011 | 125,00$ |
Dechra Pharmaceuticals plc (DPH) - Financial and Strategic SWOT Analysis ReviewDechra Pharmaceuticals PLC (Dechra) is engaged in the manufacture and distribution of veterinary medicines. It also sells various |
2011 | 125,00$ |
Cangene Corporation (CNJ) - Financial and Strategic SWOT Analysis ReviewCangene Corporation (Cangene) is a biopharmaceutical company. It is engaged in the development, manufacture, and marketing of spec |
2011 | 125,00$ |
NeoGenomics, Inc. (NGNM) - Financial and Strategic SWOT Analysis ReviewNeoGenomics, Inc., (NeoGenomics) is a publicly held pharmaceutical company. It is principally engaged in providing cancer-related |
2011 | 250,00$ |
Covalon Technologies Ltd. (COV) - Financial and Strategic SWOT Analysis ReviewCovalon Technologies, Ltd. (Covalon) is a publicly held Canada-based advanced medical products company. The company is principally |
2011 | 250,00$ |
Span-America Medical Systems, Inc. (SPAN) - Financial and Strategic SWOT Analysis ReviewSpan-America Medical Systems, Inc. (Span America) is a publicly held US-based pharmaceutical company. The company is primarily eng |
2011 | 250,00$ |
Jilin Leading Technology Development Co (000669) - Financial and Strategic SWOT Analysis ReviewJilin Leading Technology Development Co., Ltd. (Jilin Leading) is a healthcare product and machinery manufacturing and distributio |
2011 | 250,00$ |
ICON plc (ICON) - Financial and Strategic SWOT Analysis ReviewICON plc (ICON) is a contract research organization that is engaged in offering outsourced development services to the biotechnolo |
2011 | 125,00$ |
YM BioSciences Inc. (YM) - Financial and Strategic SWOT Analysis ReviewYM BioSciences Inc. (YM BioSciences) is a life sciences product development company. The company currently has three late-stage pr |
2011 | 250,00$ |
Kaigen Co., Ltd. (8000) - Financial and Strategic SWOT Analysis ReviewKaigen Co., Ltd. (Kaigen) is a pharmaceutical drug distribution company. It has products in the areas of OTC, diagnostic drugs for |
2011 | 250,00$ |
Quality Systems, Inc. (QSII) - Financial and Strategic SWOT Analysis ReviewQuality Systems, Inc. (QSI) is a publicly held US-based company. The company is principally engaged in the development and marketi |
2011 | 125,00$ |
ULURU Inc. (ULU) - Financial and Strategic SWOT Analysis ReviewUluru Inc. (Uluru) is a publicly held specialty pharmaceutical company that is engaged in the research, development and commercial |
2011 | 250,00$ |
Oculus Innovative Sciences, Inc. (OCLS) - Financial and Strategic SWOT Analysis ReviewOculus Innovative Sciences, Inc. (Oculus), formerly Micromed Laboratories, Inc. is a publicly held bio-pharmaceutical company. It |
2011 | 250,00$ |
Tissue Therapies Limited (TIS) - Financial and Strategic SWOT Analysis ReviewTissue Therapies Limited (TTL) is a publicly held Australian based biotechnology company. The company is principally involved in t |
2011 | 250,00$ |
Vermillion, Inc. (VRML) - Financial and Strategic SWOT Analysis ReviewVermillion, Inc. (VRML) is a pharmaceutical company that discovers, develops and commercializes diagnostic tests to improve patien |
2011 | 125,00$ |
Fuso Pharmaceutical Industries, Ltd. (4538) - Financial and Strategic SWOT Analysis ReviewFuso Pharmaceutical Industries, Ltd. (Fuso Pharmaceutical Industries, Ltd.) is an independent research and biotechnology organizat |
2011 | 250,00$ |
Piramal Healthcare Limited (PIRHEALTH) - Financial and Strategic SWOT Analysis ReviewPiramal Healthcare Limited (PHL) is an integrated healthcare company engaged in providing products for unmet medical needs across |
2011 | 125,00$ |
Bio-Path Holdings, Inc. (BPTH) - Financial and Strategic SWOT Analysis ReviewBio-Path Holdings, Inc. (Bio-Path) is a publicly held biotechnology company. It is engaged in financing and facilitating the devel |
2011 | 250,00$ |
Ilex Medical Ltd. (ILX) - Financial and Strategic SWOT Analysis ReviewIlex Medical Ltd. (Ilex Medical Ltd.) is an independent health care pharmaceutical industry. Ilex Medical is involved in supplying |
2011 | 250,00$ |
Biolife Solutions, Inc. (BLFS) - Financial and Strategic SWOT Analysis ReviewBioLife Solutions, Inc. (BioLife Solutions, Inc.) is an independent biopharmaceutical organization in the US. The company is invol |
2011 | 250,00$ |
Eau Technologies, Inc. (EAUI) - Financial and Strategic SWOT Analysis ReviewEau Technologies, Inc. (Eau Technologies, Inc.) is a United State’s largest pharmaceutical company. The company is involved in sup |
2011 | 125,00$ |
Mts Medication Technologies, Inc. (MTSI) - Financial and Strategic SWOT Analysis ReviewMTS Medication Technologies, Inc. (MTS) is a publicly held US-based medical device company. The company is principally engaged in |
2011 | 250,00$ |
PTS, Inc. (PTSH) - Financial and Strategic SWOT Analysis ReviewPTS, Inc. (PTS) is a publicly held consulting company that is engaged in offering consulting services and automated software to bo |
2011 | 250,00$ |
Repro-Med Systems, Inc. (REPR) - Financial and Strategic SWOT Analysis ReviewRepro-Med Systems, Inc. (RMS) is a publicly held US-based traded medical device company. The company is principally engaged in pro |
2011 | 250,00$ |
WeiDa Medical Applied Technology Co., Ltd (000603) - Financial and Strategic SWOT Analysis ReviewWeiDa Medical Applied Technology Co., Ltd. (WeiDa) is a publicly held China-based company. The company is principally engaged in t |
2011 | 250,00$ |
Biofrontera AG (B8F) - Financial and Strategic SWOT Analysis ReviewBiofrontera AG (Biofrontera) is a publicly held pharmaceutical company, engaged in the development of drugs for the treatment of d |
2011 | 250,00$ |
TiGenix NV (TIG) - Financial and Strategic SWOT Analysis ReviewTiGenix NV (TiGenix) is a publicly held Belgium-based biomedical company. TiGenix is engaged in the development of innovative loca |
2011 | 125,00$ |
Medial Saude S.A. (MEDI3) - Financial and Strategic SWOT Analysis ReviewMedial Saude S.A.(Medial) is a health insurance company engaged in providing health insurance services. The company offers its hea |
2011 | 125,00$ |
ZIOPHARM Oncology, Inc. (ZIOP) - Financial and Strategic SWOT Analysis ReviewZIOPHARM Oncology, Inc. (ZIOPHARM Oncology) is an independent health care pharmaceutical organization. The company is mainly invol |
2011 | 250,00$ |
Sun Healthcare Group, Inc. (SUNH) - Financial and Strategic SWOT Analysis ReviewSun Healthcare Group, Inc. (Sun Healthcare) is a healthcare company based in the US. Sun Healthcare is principally engaged in prov |
2011 | 125,00$ |
Cipher Pharmaceuticals Inc. (DND) - Financial and Strategic SWOT Analysis ReviewCipher Pharmaceuticals Inc. (v Cipher Pharmaceuticals Inc.) is Canada’s largest pharmaceutical organization. The company is involv |
2011 | 250,00$ |
Neptune Technologies & Bioressources Inc. (NTB) - Financial and Strategic SWOT Analysis ReviewNeptune Technologies & Bioressources Inc. (Neptune) is a publicly held research focused company that is engaged in the development |
2011 | 250,00$ |
Universal Health Services, Inc. (UHS) - Financial and Strategic SWOT Analysis ReviewUniversal Health Services, Inc. (UHS) is a publicly held US-based traded specialty health care organization. It is principally eng |
2011 | 125,00$ |
Southern Petrochemical Industries Corporation Ltd. (SPIC) - Financial and Strategic SWOT Analysis ReviewSouthern Petrochemical Industries Corporation Ltd. (SPIC) is a bio-pharmaceutical company that operates its businesses in four seg |
2011 | 125,00$ |
Health Discovery Corporation (HDVY) - Financial and Strategic SWOT Analysis ReviewHealth Discovery Corporation (HDC) is a publicly held company specialized in medicine and biomarker discovery. The company mainly |
2011 | 250,00$ |
American Oriental Bioengineering, Inc. (AOB) - Financial and Strategic SWOT Analysis ReviewAmerican Oriental Bioengineering, Inc. (American Oriental Bioengineering, Inc.) is china based independent health care pharmaceuti |
2011 | 125,00$ |
Standard Diagnostics, Inc. (066930) - Financial and Strategic SWOT Analysis ReviewStandard Diagnostics Incorporation (SD) is a publicly held diagnostic services company. It is engaged in the manufacture and distr |
2011 | 250,00$ |
A&D Pharma Holdings N.V. (ADPH) - Financial and Strategic SWOT Analysis ReviewA&D Pharma Holdings N.V. (A&D Pharma Holdings) is the Dutch holding company of A&D Pharma Holdings S.R.L., a pharmaceutical wholes |
2011 | 125,00$ |
AIN Pharmaciez Inc. (9627) - Financial and Strategic SWOT Analysis ReviewAIN Pharmaciez Inc. (AIN Pharmaciez) is a Japan-based company, which is engaged in the management and franchising of pharmacies an |
2011 | 125,00$ |
Alfresa Holdings Corporation (2784) - Financial and Strategic SWOT Analysis ReviewAlfresa Holdings Corporation (Alfresa) is a Japan-based holding company. It is principally engaged in the field of medical and nur |
2011 | 125,00$ |
Allied Healthcare International, Inc. (AHCI) - Financial and Strategic SWOT Analysis ReviewAllied Healthcare International Inc. (Allied Healthcare) is one of the leading providers of flexible healthcare staffing to the he |
2011 | 125,00$ |
Amedisys, Inc. (AMED) - Financial and Strategic SWOT Analysis ReviewAmedisys Inc. (Amedisys) is one of the leading provider of home health care and hospice service in the US and Puerto Rico. The com |
2011 | 125,00$ |
AmSurg Corp. (AMSG) - Financial and Strategic SWOT Analysis ReviewAmsurg Corp. (AmSurg) is the operator of single specialty surgery centers in the US. Through its subsidiaries, the company is enga |
2011 | 125,00$ |
Andreae-Noris Zahn AG (ANZ) - Financial and Strategic SWOT Analysis ReviewAndreae-Noris Zahn AG (Anzag) is a German pharmaceutical wholesaler. It is principaly engaged in production, processing and distri |
2011 | 125,00$ |
Arseus NV (RCUS) - Financial and Strategic SWOT Analysis ReviewArseus NV (Arseus) offers a range of health care products and services to the healthcare professionals and institutions based in E |
2011 | 125,00$ |
ASKA Pharmaceutical Co., Ltd (4514) - Financial and Strategic SWOT Analysis ReviewASKA Pharmaceutical Co., Ltd. (ASKA Pharmaceutical) is engaged in manufacturing medicines for human and animal health. ASKA Pharma |
2011 | 125,00$ |
Assisted Living Concepts, Inc. (ALC) - Financial and Strategic SWOT Analysis ReviewAssisted Living Concepts, Inc. (Assisted Living Concepts) is a US based assisted living facilities provider. It operates assisted |
2011 | 125,00$ |
Aurobindo Pharma Ltd (AUROPHARMA) - Financial and Strategic SWOT Analysis ReviewAurobindo Pharma Limited (Aurobindo Pharma) is a pharmaceutical company. The company is engaged in manufacturing active pharmaceut |
2011 | 125,00$ |
BB BIOTECH AG (BION) - Financial and Strategic SWOT Analysis ReviewBB BIOTECH AG (BB BIOTECH) is an investment company, principally engaged in investing in biotech companies related to oncology, ca |
2011 | 125,00$ |
BML Inc. (4694) - Financial and Strategic SWOT Analysis ReviewBML, INC. is a Japan-based company engaged in improving medical services and health through modern technologies, systems, and serv |
2011 | 125,00$ |
Bruker Corporation (BRKR) - Financial and Strategic SWOT Analysis ReviewBruker Corporation (Bruker) is one of the leading suppliers of life science and materials research systems across the world. It is |
2011 | 125,00$ |
Caraco Pharmaceutical Laboratories, Ltd. (CPD) - Financial and Strategic SWOT Analysis ReviewCaraco Pharmaceutical Laboratories, Ltd. (Caraco) is one of the fastest growing companies in the generic pharmaceutical industry. |
2011 | 125,00$ |
Care UK plc (CUK) - Financial and Strategic SWOT Analysis ReviewCare UK Plc is an Independent provider of health and social care. It works with partner companies such as local authorities, PCTs |
2011 | 125,00$ |
Chemed Corporation (CHE) - Financial and Strategic SWOT Analysis ReviewChemed Corporation (formerly known as Roto-Rooter, Inc.) is a diversified US based pharmaceutical company, engaged in providing of |
2011 | 125,00$ |
China HealthCare Holdings Limited (0673) - Financial and Strategic SWOT Analysis ReviewChina HealthCare Holdings Limited (CHHL) is a provider of healthcare and consumer services. It operates through its subsidiaries a |
2011 | 125,00$ |
China Pharmaceutical Group Limited (1093) - Financial and Strategic SWOT Analysis ReviewChina Pharmaceutical Group Limited (China Pharm) is engaged in the manufacture and distribution of bulk drug products and antibiot |
2011 | 125,00$ |
Cipla Ltd. (CIPLA) - Financial and Strategic SWOT Analysis ReviewCipla Ltd. (Cipla) is a pharmaceutical company. The company offers various drugs and healthcare products. The company manufactures |
2011 | 125,00$ |
Corporativo Fragua S.A.B. de C.V. (FRAGUAB) - Financial and Strategic SWOT Analysis ReviewCorporativo Fragua S.A.B. de C.V. (Corporativo Fragua) is a Mexico based Pharmaceutical company. The company operates a chain of p |
2011 | 125,00$ |
Curanum AG (BHS) - Financial and Strategic SWOT Analysis ReviewCuranum AG (Curanum) is a Germany based company operator of care homes. The company is engaged in the development and operation of |
2011 | 125,00$ |
Diagnosticos da America S.A. (DASA3) - Financial and Strategic SWOT Analysis ReviewDiagnosticos da America S.A. (DASA) is a private medical diagnostics company. The company is the largest provider of diagnostic me |
2011 | 125,00$ |
Dksh Holdings (Malaysia) Berhad (DITHELM) - Financial and Strategic SWOT Analysis ReviewDKSH Holdings (Malaysia) Berhad (DKSH(M)) operates as a subsidiary of DKSH Group of Switzerland. The company offers services such |
2011 | 125,00$ |
Dr. Reddy's Laboratories Limited (DRREDDY) - Financial and Strategic SWOT Analysis ReviewDr. Reddy's Laboratories Limited (RL) is a pharmaceutical company engaged in offering pharmaceutical services and developing activ |
2011 | 125,00$ |
Drogasil S.A. (DROG3) - Financial and Strategic SWOT Analysis ReviewDrogasil S.A (Drogasil) is a Brazil based retail drugstore company. The company is principally engaged in the retail sale of pharm |
2011 | 125,00$ |
Emergency Medical Services Corporation (EMS) - Financial and Strategic SWOT Analysis ReviewEmergency Medical Services Corporation (EMS) is a US based company, engaged in providing of emergency medical services. The compan |
2011 | 125,00$ |
Emeritus Corp. (ESC) - Financial and Strategic SWOT Analysis ReviewEmeritus Corporation (Emeritus) is largest operators of assisted living and Alzheimer’s care residential communities in the US. Th |
2011 | 125,00$ |
PT Enseval Putera Megatrading Tbk (EPMT) - Financial and Strategic SWOT Analysis ReviewPT Enseval Putera Megatrading Tbk (Enseval) is an Indonesia-based trading and distribution company. The company is a part of Kalbe |
2011 | 125,00$ |
Euromedica SA (EUROM) - Financial and Strategic SWOT Analysis ReviewEuromedica SA (Euromedica) is one of the largest providers of primary and secondary health care services in Greece. Its range of a |
2011 | 125,00$ |
Fosun International Limited (0656) - Financial and Strategic SWOT Analysis ReviewFosun International Limited (Fosun) is a Hong Kong based conglomerate, operating in pharmaceuticals, property development, steel, |
2011 | 125,00$ |
Galenica Ltd. (GALN) - Financial and Strategic SWOT Analysis ReviewGalenica Ltd (Galenica) is a diversified healthcare company engaged in the development, manufacture and marketing of pharmaceutica |
2011 | 125,00$ |
Generale de Sante (GDS) - Financial and Strategic SWOT Analysis ReviewGenerale de Sante is a French healthcare system. The company principally operates in France and Europe. It is engaged in providing |
2011 | 125,00$ |
Gentiva Health Services, Inc. (GTIV) - Financial and Strategic SWOT Analysis ReviewGentiva Health Services, Inc. (Gentiva) is a US based health care services provider. The company offers various healthcare service |
2011 | 125,00$ |
Genus plc (GNS) - Financial and Strategic SWOT Analysis ReviewGenus plc (Genus) is a global company engaged in the application of quantitative genetics and biotechnology to animal breeding in |
2011 | 125,00$ |
Glenmark Pharmaceuticals Ltd. (GLENMARK) - Financial and Strategic SWOT Analysis ReviewGlenmark Pharmaceuticals Limited (Glenmark Pharmaceuticals) is an integrated pharmaceutical company. The company is engaged in man |
2011 | 125,00$ |
Ship Healthcare Holdings, Inc. (3360) - Financial and Strategic SWOT Analysis ReviewShip Healthcare Holdings, Inc. (Ship Healthcare), formerly Green Hospital Supply, Inc., is engaged in marketing of medical instrum |
2011 | 125,00$ |
Hanmi Holdings Co., Ltd. (008930) - Financial and Strategic SWOT Analysis ReviewHanmi Holdings Co., Ltd. (Hanmi) is a manufacturer and supplier of pharmaceuticals. It was formerly known as Hanmi Pharmaceutical |
2011 | 125,00$ |
Healthcare Services Group, Inc. (HCSG) - Financial and Strategic SWOT Analysis ReviewHealthcare Services Group, Inc. (Healthcare Services Group) is a Pennsylvania based corporation, engaged in providing on-site mana |
2011 | 125,00$ |
Catalyst Health Solutions, Inc. (CHSI) - Financial and Strategic SWOT Analysis ReviewCatalyst Health Solutions, Inc (Catalyst Health Solutions) was formerly known as HelathExtras, Inc. is a full-service pharmacy ben |
2011 | 125,00$ |
HealthSpring, Inc. (HS) - Financial and Strategic SWOT Analysis ReviewHealthSpring, Inc. (HealthSpring) is a US-based managed care organization. The company offers commercial health plans to employer |
2011 | 125,00$ |
Hooper Holmes, Inc. (HH) - Financial and Strategic SWOT Analysis ReviewHooper Holmes, Inc. (Hooper Holmes) is one of the leading providers of risk assessment services for the insurance industry. The co |
2011 | 125,00$ |
Ildong Pharmaceutical Co., Ltd. (000230) - Financial and Strategic SWOT Analysis ReviewIldong Pharmaceutical Co., Ltd. (Ildong Pharmaceutical) is a Korea-based pharmaceutical company engaged in the production of pharm |
2011 | 125,00$ |
Integrated Healthcare Holdings Inc. (IHCH) - Financial and Strategic SWOT Analysis ReviewIntegrated Healthcare Holdings Inc. (Integrated Healthcare Holdings) is a US-based hospital management company which operates gene |
2011 | 125,00$ |
Inter Parfums, Inc. (IPAR) - Financial and Strategic SWOT Analysis ReviewInter Parfums, Inc (Inter Parfums), together with its subsidiaries develops, manufactures, markets and distributes fragrances, pre |
2011 | 125,00$ |
inVentiv Health, Inc - Financial and Strategic SWOT Analysis ReviewinVentiv Health, Inc (inVentiv Health) is one of the leading providers of value-added services to the pharmaceutical, life science |
2011 | 125,00$ |
Iwaki & Co. Ltd. (8095) - Financial and Strategic SWOT Analysis ReviewIWAKI & CO., LTD. (Iwaki & Co) is a Japan-based company principally engaged in the manufacture trade and wholesale of pharmaceutic |
2011 | 125,00$ |
Jeil Pharmaceutical Co., Ltd. (002620) - Financial and Strategic SWOT Analysis ReviewJeil Pharmaceutical Co., Ltd (Jeil Pharmaceutical Co) is a Korea-based company. It is involved in the manufacture and sale of phar |
2011 | 125,00$ |
Jenburkt Pharmaceuticals Limited (524731) - Financial and Strategic SWOT Analysis ReviewJenburkt Pharmaceuticals Limited (JPL) is an India based pharmaceutical company. The company is principally engaged in the manufac |
2011 | 125,00$ |
Kawanishi Holdings, Inc. (2689) - Financial and Strategic SWOT Analysis ReviewKawanishi Holdings, Inc. (Kawanishi) is a Japan-based holding company. It is engaged in the wholesale distribution of medical diag |
2011 | 125,00$ |
KPJ Healthcare Berhad (KPJ) - Financial and Strategic SWOT Analysis ReviewKPJ Healthcare Berhad (KPJ Healthcare) is a private healthcare providers in Malaysia. The company has its network in the region wi |
2011 | 125,00$ |
LHC Group, Inc. (LHCG) - Financial and Strategic SWOT Analysis ReviewLHC Group, Inc. (LHC Group) provides post-acute healthcare services principally to Medicare beneficiaries in rural markets in the |
2011 | 125,00$ |
Mannatech, Incorporated (MTEX) - Financial and Strategic SWOT Analysis ReviewMannatech, Incorporated (Mannatech) is a global wellness solution provider. The company develops and sells a range of nutritional |
2011 | 125,00$ |
Marseille-Kliniken AG (MKA) - Financial and Strategic SWOT Analysis ReviewMarseille-Kliniken AG (Marseille-Kliniken) is a German-based healthcare service provider engaged in the provision of nursing care |
2011 | 125,00$ |
Mylan Laboratories Limited (524794) - Financial and Strategic SWOT Analysis ReviewMylan Laboratories Limited (Mylan Laboratories) is an India-based company. The company is engaged in the manufacture of Active Pha |
2011 | 125,00$ |
Meda AB (MEDA A) - Financial and Strategic SWOT Analysis ReviewMeda AB (Meda) is a Sweden-based specialty pharmaceutical company. Its operations concentrate on offering cost-effective pharmaceu |
2011 | 125,00$ |
Medical Staffing Network Holdings, Inc. (MSNWQ) - Financial and Strategic SWOT Analysis ReviewMedical Staffing Network Holdings Inc (MSN) is an US based temporary healthcare staffing company. The company principally provides |
2011 | 125,00$ |
MediPal Holdings Corporation (7459) - Financial and Strategic SWOT Analysis ReviewMediPal Holdings Corporation (MediPal Holdings), formerly Mediceo Paltac Holdings Co., Ltd is the Japan based pharmaceutical compa |
2011 | 125,00$ |
Mediclin AG (MED) - Financial and Strategic SWOT Analysis ReviewMediclin AG (Mediclin) is a German medical services company. Mediclin is principally engaged in the provision of medical rehabilit |
2011 | 125,00$ |
Medi-Clinic Corporation Limited (MDC) - Financial and Strategic SWOT Analysis ReviewMedi-Clinic Corporation Limited (Medi-Clinic Corporation) engages in the operation of multi-disciplinary private hospitals. The co |
2011 | 125,00$ |
Metropolitan Health Networks, Inc. (MDF) - Financial and Strategic SWOT Analysis ReviewMetropolitan Health Networks, Inc (MHN) is a US- based health care service provider. Through provider service network (PSN), the c |
2011 | 125,00$ |
Mettler-Toledo International Inc (MTD) - Financial and Strategic SWOT Analysis ReviewMettler-Toledo International Inc (MTI) engages in supplying of precision instruments and services. The company principally provide |
2011 | 125,00$ |
National HealthCare Corporation (NHC) - Financial and Strategic SWOT Analysis ReviewNational HealthCare Corporation (NHC) is an US based long-term health care service provider, principally engaged in the operation |
2011 | 125,00$ |
Netcare Limited (NTC) - Financial and Strategic SWOT Analysis ReviewNetcare Limited (Netcare) is an investment holding company. The company with its subsidiaries operates as a private health care pr |
2011 | 125,00$ |
Nichii Gakkan Co., Inc. (9792) - Financial and Strategic SWOT Analysis ReviewNichii Gakkan Co., Inc. (Nichii Gakkan) is a Japanese health care company. The company is principally engaged in offering medical |
2011 | 125,00$ |
Noevir Co., Ltd. (4916) - Financial and Strategic SWOT Analysis ReviewNoevir Co., Ltd. (Noevir) is Japan based company principally engaged in developing, manufacturing and marketing of pharmaceuticals |
2011 | 125,00$ |
Odyssey HealthCare, Inc. (ODSY) - Financial and Strategic SWOT Analysis ReviewOdyssey HealthCare, Inc. (Odyssey) is one of the largest hospice providers in the US. The company offers Medicare-certified hospic |
2011 | 125,00$ |
Pharmaniaga Berhad (PHARMA) - Financial and Strategic SWOT Analysis ReviewPharmaniaga Berhad (Pharmaniaga) is an integrated healthcare company in Malaysia. The company's principal activities include manuf |
2011 | 125,00$ |
PIGEON CORPORATION (7956) - Financial and Strategic SWOT Analysis ReviewPigeon Corporation (Pigeon) is a Japan-based pharmaceutical company, principally engaged in the manufacturing, sales, import and e |
2011 | 125,00$ |
Podravka d.d. (PODR-R-A) - Financial and Strategic SWOT Analysis ReviewPodravka d.d. is involved in providing food products, medicines, pharmaceutical and cosmetic products to its customers across Croa |
2011 | 125,00$ |
Primary Health Care Ltd (PRY) - Financial and Strategic SWOT Analysis ReviewPrimary Health Care Limited (PHC) is an Australia based healthcare service provider, primary engaged in offering medical-related s |
2011 | 125,00$ |
Psychiatric Solutions, Inc. (PSYS) - Financial and Strategic SWOT Analysis ReviewPsychiatric Solutions, Inc. (PSI) is an US based inpatient behavioral health care service and treatment centre provider. The compa |
2011 | 125,00$ |
Recordati S.p.A. (REC) - Financial and Strategic SWOT Analysis ReviewRecordati S.p.A (Recordati) is an Italy-based European pharmaceutical group engaged in the research, manufacturing, development an |
2011 | 125,00$ |
Rhon-Klinikum AG (RHK) - Financial and Strategic SWOT Analysis ReviewRhon-Klinikum AG (Rhon-Klinikum) is a healthcare company based in Germany. Rhon-Klinikum, together with its subsidiaries, is princ |
2011 | 125,00$ |
Sartorius AG (SRT) - Financial and Strategic SWOT Analysis ReviewSartorius AG (Sartorius) is a German company which is principally engaged in manufacturing, distribution and sale of laboratory an |
2011 | 125,00$ |
Sino Biopharmaceutical Limited (1177) - Financial and Strategic SWOT Analysis ReviewSino Biopharmaceutical Limited (Sino) is a pharmaceutical company engaged in the development, manufacturing and marketing of Chine |
2011 | 125,00$ |
Sonic Healthcare Limited (SHL) - Financial and Strategic SWOT Analysis ReviewSonic Healthcare Limited (Sonic Healthcare) is an Australian medical diagnostics company. The company together with its subsidiari |
2011 | 125,00$ |
Strides Arcolab Limited (STAR) - Financial and Strategic SWOT Analysis ReviewStrides Arcolab Limited (Strides Arcolab) is an Indian pharmaceutical company, engaged in the manufacturing and export of finished |
2011 | 125,00$ |
Sud-Chemie AG (SUC) - Financial and Strategic SWOT Analysis ReviewSud-Chemie AG (Sud-Chemie) is one of the Germany’s leading manufacturers of chemicals. The company is principally engaged in the f |
2011 | 125,00$ |
Sunrise Senior Living, Inc. (SRZ) - Financial and Strategic SWOT Analysis ReviewSunrise Senior Living, Inc. (Sunrise) is a healthcare company based in the US, principally engaged in the provision of senior livi |
2011 | 125,00$ |
Suzuken Co., Ltd. (9987) - Financial and Strategic SWOT Analysis ReviewSuzuken Co., Ltd. (Suzuken) is a Japanese pharmaceutical and healthcare company, engaged in the manufacturing, distribution and sa |
2011 | 125,00$ |
Taro Pharmaceuticals Industries Ltd. (TAROF) - Financial and Strategic SWOT Analysis ReviewTaro Pharmaceutical Industries Ltd. (Taro) is a pharmaceutical company. It involves in developing, manufacturing and marketing of |
2011 | 125,00$ |
Tecan Group Ltd (TECN) - Financial and Strategic SWOT Analysis ReviewTecan Group Ltd (Tecan) is engaged in the development, manufacturing and distribution of automation solutions for life science lab |
2011 | 125,00$ |
Tiger Brands Limited (TBS) - Financial and Strategic SWOT Analysis ReviewTiger Brands Limited (Tiger) is engaged in providing branded consumer packaged goods to its customers. The company operates throug |
2011 | 125,00$ |
USANA Health Sciences, Inc. (USNA) - Financial and Strategic SWOT Analysis ReviewUSANA Health Sciences, Inc. (USANA) is a personal care products manufacturing company. The company is principally engaged in the d |
2011 | 125,00$ |
WellCare Health Plans, Inc (WCG) - Financial and Strategic SWOT Analysis ReviewWellCare Health Plans, Inc. (WellCare) is a provider of managed care services to government sponsored healthcare programs. The com |
2011 | 125,00$ |
Wockhardt Limited (WOCKPHARMA) - Financial and Strategic SWOT Analysis ReviewWockhardt Limited (Wockhardt) is an Indian-based pharmaceutical and biotechnology company. The company is principally engaged in r |
2011 | 125,00$ |
Zynex Medical, Inc. (ZYXI) - Financial and Strategic SWOT Analysis ReviewZynex Medical, Inc. (Zynex) is a medical device company that is engaged in developing, distributing and marketing of pain manageme |
2011 | 250,00$ |
YaSheng Group Ltd. (YHGG) - Financial and Strategic SWOT Analysis ReviewYaSheng Group Ltd. (YaSheng) is a US based holding company, engaged in agricultural operations in China. The company is one of the |
2011 | 125,00$ |
Zeria Pharmaceutical Co Ltd (4559) - Financial and Strategic SWOT Analysis ReviewZeria pharmceutical co., Ltd. (Zeria) is a pharmaceutical services provider to its customers across Japan. The company operates th |
2011 | 125,00$ |
Zydus Cadila Healthcare Limited (CADILAHC) - Financial and Strategic SWOT Analysis ReviewZydus Cadila Healthcare Limited (Zydus Cadila) is a Indian-based integrated healthcare company. It engages in discovery, developme |
2011 | 125,00$ |
Kobayashi Pharmaceutical Co Ltd (4967) - Financial and Strategic SWOT Analysis ReviewKobayashi Pharmaceutical Co Ltd (Kobayashi Pharmaceutical) is a Japan-based company engaged in the manufacture and sale of pharmac |
2011 | 125,00$ |
ROHTO Pharmaceutical Co.,Ltd. (4527) - Financial and Strategic SWOT Analysis ReviewROHTO Pharmaceutical Co., Ltd. (ROHTO Pharmaceutical) is a manufacturer of ophthalmic medicines in Japan. The company engages in m |
2011 | 125,00$ |
InSight Health Services Holdings Corp. (ISGTQ) - Financial and Strategic SWOT Analysis ReviewInSight Health Services Holdings Corp (InSight Imaging) is a diagnostic imaging services provider, primarily in California. The co |
2011 | 125,00$ |
Chemical Company of Malaysia Berhad (CCM) - Financial and Strategic SWOT Analysis ReviewChemical Company of Malaysia Berhad (CCM) manufacture and markets and supplies fertilizers, chemicals and pharmaceutical products. |
2011 | 125,00$ |
Sun Pharmaceutical Industries Limited (SUNPHARMA) - Financial and Strategic SWOT Analysis ReviewSun Pharmaceutical Industries Limited (Sun Pharma) is an Indian pharmaceutical company. Sun Pharma, together with its subsidiaries |
2011 | 125,00$ |
Apollo Hospitals Enterprise Limited (508869) - Financial and Strategic SWOT Analysis ReviewApollo Hospitals Enterprise Limited (Apollo Hospitals) is one of the leading healthcare groups in Asia. The company provides a ran |
2011 | 125,00$ |
Stone Group Holdings Limited (0409) - Financial and Strategic SWOT Analysis ReviewStone Group Holdings Limited (Stone Group) is a publicly held Hong Kong-based investment holding company. The company is principal |
2011 | 250,00$ |
Eurofins Scientific SE (ERF) - Financial and Strategic SWOT Analysis ReviewEurofins Scientific SE (ES) is a France based pharmaceutical company engaged in providing bioanalytical testing of drugs, food and |
2011 | 125,00$ |
Lavipharm Group (LAVI) - Financial and Strategic SWOT Analysis ReviewLavipharm Group (Lavipharm) is a Greek Group of companies, engaged in developement, manufacturing, marketing and distribution of p |
2011 | 125,00$ |
Axon Holdings S.A. (AXON) - Financial and Strategic SWOT Analysis ReviewAxon Holdings S.A (Axon) is a Greece-based holding company engaged in the healthcare, technology, financial services and real esta |
2011 | 125,00$ |
Guangzhou Pharmaceutical Company Limited (600332) - Financial and Strategic SWOT Analysis ReviewGuangzhou Pharmaceutical Company Limited (Guangzhou Pharmaceutical Company) is a China based pharmaceutical company. It is princip |
2011 | 125,00$ |
Albert David Limited (524075) - Financial and Strategic SWOT Analysis ReviewAlbert David Limited (Albert David Limited) is an independent health care pharmaceutical company in India. The company is involved |
2011 | 250,00$ |
Parenteral Drug India Ltd. (524689) - Financial and Strategic SWOT Analysis ReviewParenteral Drug India Ltd. (PDPL) is a publicly held India-based pharmaceutical company. The company is principally engaged in the |
2011 | 250,00$ |
Dharamsi Morarji Chemical Co Ltd (506405) - Financial and Strategic SWOT Analysis ReviewDharamsi Morarji Chemical Co Ltd (Dharamsi Morarji Chemical Co Ltd) is Mumbai based a publicly held Indian based company. Dharamsi |
2011 | 250,00$ |
Venus Remedies Limited (VENUSREM) - Financial and Strategic SWOT Analysis ReviewVenus Remedies Limited (Venus) is a publicly held Indian based pharmaceutical company. It is primarily focused on the business of |
2011 | 250,00$ |
Neuland Laboratories Limited (524558) - Financial and Strategic SWOT Analysis ReviewNeuland Laboratories Limited (Neuland) is a publicly held Indian based company. The company is principally engaged in the producti |
2011 | 250,00$ |
Trimeris, Inc. (TRMS) - Financial and Strategic SWOT Analysis ReviewTrimeris, Inc. (Trimeris) is a publicly held biopharmaceutical company engaged in the research against human immunodeficiency viru |
2011 | 250,00$ |
Nanosonics Limited (NAN) - Financial and Strategic SWOT Analysis ReviewNanosonics Limited (Nanosonics) is a publicly held company, specialized in developing infection control solutions for the global h |
2011 | 250,00$ |
Talecris Biotherapeutics Holdings Corp (TLCR) - Financial and Strategic SWOT Analysis ReviewTalecris Biotherapeutics Holdings Corp (Talecris) is a US-based publicly held pharmaceutical company. It engages in development, p |
2011 | 125,00$ |
Silence Therapeutics plc (SLN) - Financial and Strategic SWOT Analysis ReviewSilence Therapeutics plc. (Silence Therapeutics) is a biotechnology company. The company is involved in discovering and developing |
2011 | 250,00$ |
Optimer Pharmaceuticals, Inc. (OPTR) - Financial and Strategic SWOT Analysis ReviewOptimer Pharmaceuticals, Inc. (Optimer) is a publicly held US-based biopharmaceutical company. The company is principally engaged |
2011 | 250,00$ |
Sangui BioTech International, Inc. (SGBI) - Financial and Strategic SWOT Analysis ReviewSangui Biotech International, Inc. (SGBI) is a publicly held company engaged in the development of pharmaceutical, medical and cos |
2011 | 250,00$ |
Cyclacel Pharmaceuticals Inc. (CYCC) - Financial and Strategic SWOT Analysis ReviewCyclacel Pharmaceuticals, Inc. (Cyclacel Pharmaceuticals) is an independent biotechnology pharmaceutical organization. The company |
2011 | 250,00$ |
United American Healthcare Corporation (UAHC) - Financial and Strategic SWOT Analysis ReviewUnited American Healthcare Corporation,( UAHC) is a publicly held US-based company. The company is principally engaged in providin |
2011 | 250,00$ |
AES Chemunex SA (AESCH) - Financial and Strategic SWOT Analysis ReviewAES Chemunex SA (AES Chemunex SA) is an independent pharmaceutical laboratories company in France. The company is engaged manufact |
2011 | 250,00$ |
Arvind Remedies Ltd (ARL) - Financial and Strategic SWOT Analysis ReviewArvind Remedies Ltd (Arvind Remedies Ltd) is an independent health care pharmaceutical organization. The company is involved in de |
2011 | 250,00$ |
OPKO Health, Inc. (OPK) - Financial and Strategic SWOT Analysis ReviewOPKO Health, Inc. (OPKO) is a publicly held US-based specialty healthcare company. The company is principally engaged in the disc |
2011 | 250,00$ |
BrainStorm Cell Therapeutics Inc. (BCLI) - Financial and Strategic SWOT Analysis ReviewBrainStorm Cell Therapeutics Inc. (BrainStorm Cell Therapeutics Inc.) is an independent biotechnology company. The company is invo |
2011 | 250,00$ |
XTL Biopharmaceuticals Ltd. (XTLBY) - Financial and Strategic SWOT Analysis ReviewXTL Biopharmaceuticals Ltd. (XTL) is a publicly held engaged in the acquisition, development and commercialization of therapeutics |
2011 | 250,00$ |
Healthscreen Solutions Inc. (MDU) - Financial and Strategic SWOT Analysis ReviewHealthscreen Solutions Inc. (Healthscreen) is a publicly held Canada-based healthcare company. The company is principally engaged |
2011 | 250,00$ |
Alembic Limited (ALEMBICLTD) - Financial and Strategic SWOT Analysis ReviewAlembic Limited (Alembic Limited) is an Indian based pharmaceutical company engaged in manufacturing of fermentation and chemistry |
2011 | 125,00$ |
Transcat, Inc. (TRNS) - Financial and Strategic SWOT Analysis ReviewTranscat, Inc. (Transcat) is a publicly held US-based company. The company is principally engaged in distribution of calibrators, |
2011 | 250,00$ |
Bone Medical Limited (BNE) - Financial and Strategic SWOT Analysis ReviewBone Medical Limited (Bone Medical) is a publicly held US-based bio pharmaceutical development stage company. The company is princ |
2011 | 250,00$ |
Transgenomic, Inc. (TBIO) - Financial and Strategic SWOT Analysis ReviewTransgenomic, Inc.(Transgenomic) is a publicly held US-based biotechnology company. The company is principally engaged in providin |
2011 | 250,00$ |
ALDA Pharmaceuticals Corp. (APH) - Financial and Strategic SWOT Analysis ReviewALDA Pharmaceuticals Corp. (ALDA) is a British Columbia based disinfectant manufacturing company. It focuses on the production and |
2011 | 125,00$ |
Genera Biosystems Limited (GBI) - Financial and Strategic SWOT Analysis ReviewGenera Biosystems Limited (Genera) is an Australia-based company. It is engaged in development and commercialization of multiplexe |
2011 | 125,00$ |
Genesis Research and Development Corporation Ltd. (GEN) - Financial and Strategic SWOT Analysis ReviewGenesis Research and Development Corporation Ltd. (Genesis) is a publicly held NewZealand-based biotechnology company. The company |
2011 | 250,00$ |
Genoptix, Inc. (GXDX) - Financial and Strategic SWOT Analysis ReviewGenoptix, Inc (Genoptix) is a specialized laboratory service provider engaged in delivering personalized and comprehensive diagnos |
2011 | 125,00$ |
HearUSA, Inc. (HEARQ) - Financial and Strategic SWOT Analysis ReviewHearUSA, Inc. (HearUSA, Inc.) is an independent diagnostic organization. The company is involved in providing hearing care product |
2011 | 250,00$ |
Advitech Inc. (AVI) - Financial and Strategic SWOT Analysis ReviewAdvitech Inc. (Advitech) is a publicly held pharmaceutical company that is engaged in research, development and marketing of natur |
2011 | 250,00$ |
IBEX Technologies Inc. (IBT) - Financial and Strategic SWOT Analysis ReviewIBEX Technologies, Inc. (IBEX Technologies, Inc.) is a Canada based pharmaceutical organization. The company is mainly involved in |
2011 | 250,00$ |
iCo Therapeutics Inc. (ICO) - Financial and Strategic SWOT Analysis ReviewiCo Therapeutics Inc. (iCo) is a biotechnology company engaged in developing and commercializing drug candidates for treating ocul |
2011 | 250,00$ |
Nutex Plc (NUTEX) - Financial and Strategic SWOT Analysis ReviewNutex Plc (Nutex) formerly known as Humet Nyrt. is a privately held specialty pharmaceutical company that is engaged in research, |
2011 | 250,00$ |
Pressure BioSciences, Inc. (PBIO) - Financial and Strategic SWOT Analysis ReviewPressure BioSciences, Inc. (PBI) is a publicly held life sciences company. It is engaged in the development and commercialization |
2011 | 250,00$ |
ValiRx Plc (VAL) - Financial and Strategic SWOT Analysis ReviewValiRx Plc (ValiRx) is a publicly held biopharmaceutical company engaged in the development of novel technologies and products for |
2011 | 250,00$ |
Neuralstem, Inc. (CUR) - Financial and Strategic SWOT Analysis ReviewNeuralstem, Inc. (Neuralstem) is a publicly held research focused biotechnology company, engaged in research, development and comm |
2011 | 250,00$ |
IMMUNOSYN CORPORATION (IMYN) - Financial and Strategic SWOT Analysis ReviewImmunosyn Corporation (Immunosyn) is a publicly held company that is engaged in marketing and distributng pharmaceuticals. The com |
2011 | 250,00$ |
Integrated BioPharma, Inc. (INBP) - Financial and Strategic SWOT Analysis ReviewIntegrated BioPharma, Inc. (Integrated BioPharma) is a publicly held US-based bio pharmaceutical company. The company is principal |
2011 | 250,00$ |
IntelGenx Corp. (IGXT) - Financial and Strategic SWOT Analysis ReviewIntelGenx Corp. (IntelGenx) is a publicly held drug delivery company. It is engaged in the development of therapeutics using orall |
2011 | 125,00$ |
Genfit (ALGFT) - Financial and Strategic SWOT Analysis ReviewGenfit (Genfit) is a publicly held biopharmaceutical company specialized in developing medicines for the early prevention and trea |
2011 | 250,00$ |
Antibiotice SA (ATB) - Financial and Strategic SWOT Analysis ReviewAntibiotice SA (Antibiotice SA) is an independent health care pharmaceutical organization. The industry is mainly involved in manu |
2011 | 250,00$ |
Apex Healthcare Berhad (AHEALTH) - Financial and Strategic SWOT Analysis ReviewApex Healthcare Berhad (APEX) is a publicly held Malaysia-based pharmaceutical company. The company is principally engaged in manu |
2011 | 250,00$ |
Can-Fite BioPharma Ltd. (CFBI) - Financial and Strategic SWOT Analysis ReviewCan-Fite BioPharma Ltd.(Can-Fite) is a publicly held biopharmaceutical company engaged in development of molecule-based drugs for |
2011 | 250,00$ |
Ascent Pharmahealth Limited (APH) - Financial and Strategic SWOT Analysis ReviewAscent Pharmahealth Limited (Ascent Pharmahealth Limited) is an independent health care pharmaceutical organization. This organiza |
2011 | 250,00$ |
International Stem Cell Corporation (ISCO) - Financial and Strategic SWOT Analysis ReviewInternational Stem Cell Corporation (International Stem Cell) is a publicly held biotechnology company. It is focused on developin |
2011 | 250,00$ |
IsoRay, Inc. (ISR) - Financial and Strategic SWOT Analysis ReviewIsoRay, Inc., (IsoRay) is a publicly traded US-based pharmaceutical company. The company is principally engaged in producing thera |
2011 | 250,00$ |
Arrowhead Research Corporation (ARWR) - Financial and Strategic SWOT Analysis ReviewArrowhead Research Corporation (Arrowhead) is a public nanotechnology company. It is principally focusing on the development, comm |
2011 | 250,00$ |
Krka d.d. Novo Mesto (KRKG) - Financial and Strategic SWOT Analysis ReviewKrka d.d. Novo Mesto (Krka) is a Slovenia-based pharmaceutical company. It engages in the development, production, sale and distri |
2011 | 125,00$ |
LAB Research Inc (LRI) - Financial and Strategic SWOT Analysis ReviewLAB Research Inc. (LAB Research) is a publicly held Canadian, in-vivo nonclinical contract research organization. The company has |
2011 | 250,00$ |
Livzon Pharmaceutical Group Inc. (200513) - Financial and Strategic SWOT Analysis ReviewLivzon Pharmaceutical Group Inc. (Livzon) is a publicly held China-based company. The company is principally engaged in the develo |
2011 | 125,00$ |
Marshall Edwards, Inc. (MSHL) - Financial and Strategic SWOT Analysis ReviewMarshall Edwards Inc. (MEI) is a publicly held Australian-based pharmaceutical company. The company is principally involved in th |
2011 | 250,00$ |
Medicure Inc. (MPH) - Financial and Strategic SWOT Analysis ReviewMedicure Inc. (Medicure), is a publicly held bio-pharmaceutical company. It is involved in research, development and commercializa |
2011 | 250,00$ |
Basilea Pharmaceutica Ltd. (BSLN) - Financial and Strategic SWOT Analysis ReviewBasilea Pharmaceutica Ltd. (Basilea) is a publicly held Switzerland-based pharmaceutical company. The company is principally engag |
2011 | 250,00$ |
Medivir AB (MVIRB) - Financial and Strategic SWOT Analysis ReviewMedivir AB (Medivir) is a research focused pharmaceuticals company engaged in the development of products for high-value treatment |
2011 | 125,00$ |
Benda Pharmaceutical, Inc. (BPMA) - Financial and Strategic SWOT Analysis ReviewBenda Pharmaceutical, Inc. (Benda Pharmaceutical, Inc) is an independent China based health care pharmaceutical organization. The |
2011 | 250,00$ |
Calzada Limited (CZD) - Financial and Strategic SWOT Analysis ReviewCalzada Limited (Calzada), formerly Metabolic Pharmaceuticals Limited is an Australian based biotechnology company which developed |
2011 | 125,00$ |
Microbix Biosystems Inc. (MBX) - Financial and Strategic SWOT Analysis ReviewMicrobix Biosystems Inc. (Microbix) is a biotechnology company engaged in the development, manufacturing and distribution of cell- |
2011 | 125,00$ |
Medwell Capital Corp. (MWC) - Financial and Strategic SWOT Analysis ReviewMedwell Capital Corp. (Medwell) is a publicly held biotechnology company. It is engaged in the development and commercialization o |
2011 | 250,00$ |
Bionomics Limited (BNO) - Financial and Strategic SWOT Analysis ReviewBionomics Limited is a pharmaceuticals company engaged in research and development of innovative therapeutics for cancer and disea |
2011 | 125,00$ |
Biosignal Limited (BOSDA) - Financial and Strategic SWOT Analysis ReviewBiosignal Limited (Biosignal) is a publicly held Australia-based biotechnology company. The company primarily focused on research |
2011 | 250,00$ |
BIOTON S.A. (BIO) - Financial and Strategic SWOT Analysis ReviewBIOTON S.A.(BIOTON) is a publicly held biotechnological company engaged in the manufacture and distribution of pharmaceutical prod |
2011 | 250,00$ |
BMP Sunstone Corp. (BJGP) - Financial and Strategic SWOT Analysis ReviewBMP Sunstone Corp. (BMP Sunstone) is a publicly held US-based pharmaceutical company. The company is principally engaged in the ma |
2011 | 250,00$ |
Neurobiological Technologies, Inc. (NTII) - Financial and Strategic SWOT Analysis ReviewNeurobiological Technologies, Inc. (NTI) is a publicly held US-based drug development company. The company is principally engaged |
2011 | 250,00$ |
NeuroDiscovery Ltd (NDL) - Financial and Strategic SWOT Analysis ReviewNeuroDiscovery Ltd (NeuroDiscovery) is a publicly held Australian-based pharmaceutical company. The company is principally engaged |
2011 | 250,00$ |
NeurogesX, Inc. (NGSX) - Financial and Strategic SWOT Analysis ReviewNeurogesX, Inc. (NeurogesX) is a publicly held US-based bio-pharmaceutical company. The company is principally engaged in the deve |
2011 | 250,00$ |
NicOx SA (COX) - Financial and Strategic SWOT Analysis ReviewNicOx SA (NicOx) is an independent one of the largest pharmaceutical company of the France. The company is mainly involved in the |
2011 | 250,00$ |
Northstar Healthcare Inc. (NHC) - Financial and Strategic SWOT Analysis ReviewNorthstar Healthcare Inc. (Northstar Healthcare) is a publicly held US-based full-scale ASC development and management company. Th |
2011 | 250,00$ |
NovaBay Pharmaceuticals, Inc. (NBY) - Financial and Strategic SWOT Analysis ReviewNovaBay Pharmaceuticals, Inc. (NovaBay) is a publicly held biopharmaceutical company. It is focused on developing innovative produ |
2011 | 250,00$ |
ChemGenex Pharmaceuticals Limited (CXS) - Financial and Strategic SWOT Analysis ReviewChemGenex Pharmaceuticals Limited (ChemGenex Pharmaceuticals) is an Australia based genomics-driven pharmaceutical development com |
2011 | 250,00$ |
Chengzhi Co., Ltd (000990) - Financial and Strategic SWOT Analysis ReviewChengzhi Co., Ltd (Chengzhi) is a pharmaceutical company based in China. The company is involved in offering biological products a |
2011 | 125,00$ |
Nuvo Research Inc. (NRI) - Financial and Strategic SWOT Analysis ReviewNuvo Research Inc. (Nuvo Research) is a publicly held pharmaceutical company. It is engaged in the research and development(R&D) o |
2011 | 250,00$ |
Chongqing Huapont Pharm. Co., Ltd. (002004) - Financial and Strategic SWOT Analysis ReviewChongqing Huapont Pharm. Co., Ltd. (Chongqing Huapont) is a publicly held China-based pharmaceutical company. The company is princ |
2011 | 250,00$ |
Circadian Technologies Limited (CIR) - Financial and Strategic SWOT Analysis ReviewCircadian Technologies Limited (Circadian Technologies Limited) is an independent united based pharmaceutical organization. The co |
2011 | 250,00$ |
Cleveland BioLabs, Inc. (CBLI) - Financial and Strategic SWOT Analysis ReviewCleveland BioLabs, Inc. (Cleveland) is a publicly held research based biotechnology company. It is engaged in the development of i |
2011 | 250,00$ |
Omega Pharma NV (OME) - Financial and Strategic SWOT Analysis ReviewOmega Pharma NV (Omega Pharma) is a Belgium based healthcare products and services provider engaged mainly in OTC and personal car |
2011 | 125,00$ |
Oncothyreon Inc. (ONTY) - Financial and Strategic SWOT Analysis ReviewOncothyreon Inc. (Oncothyreon) is a publicly held clinical-stage biopharmaceutical company. It is principally engaged in the devel |
2011 | 250,00$ |
Opexa Therapeutics, Inc. (OPXA) - Financial and Strategic SWOT Analysis ReviewOpexa Therapeutics, Inc. (Opexa) is a publicly held pharmaceutical company. It is engaged in the development of autologous cellula |
2011 | 250,00$ |
Compugen Ltd. (CGEN) - Financial and Strategic SWOT Analysis ReviewCompugen, Ltd. (Compugen) is a biotechnology company based in Israel. The company is involved in developing, producing and marketi |
2011 | 250,00$ |
OPMEDIC Group Inc. (OMG) - Financial and Strategic SWOT Analysis ReviewOPMEDIC Group Inc. (OPMEDIC Group) is a publicly held Canada-based healthcare services company. The company is principally engaged |
2011 | 250,00$ |
Ore Pharmaceuticals Inc (ORXE) - Financial and Strategic SWOT Analysis ReviewOre Pharmaceuticals Inc (Ore Pharmaceuticals) is a US-based public drug development company. The company engages in development of |
2011 | 250,00$ |
Osta Biotechnologies Inc. (OBI) - Financial and Strategic SWOT Analysis ReviewOsta Biotechnologies Inc. (Osta) is a publicly held biopharmaceutical company. It is engaged in the research and development work |
2011 | 250,00$ |
OXiGENE, Inc. (OXGN) - Financial and Strategic SWOT Analysis ReviewOXiGENE, Inc. (OXiGENE) is a US-based biopharmaceutical company. It engages in development of therapeutics to treat cancer and e |
2011 | 250,00$ |
Pacgen Biopharmaceuticals Corporation (PGA) - Financial and Strategic SWOT Analysis ReviewPacgen Biopharmaceuticals Corporation (Pacgen) is Canada-based life science company. It is engages in developing therapeutics wh |
2011 | 250,00$ |
Pacific Biomarkers, Inc. (PBMC) - Financial and Strategic SWOT Analysis ReviewPacific Biomarkers, Inc. (PBI) is a publicly held US-based healthcare service provider company. The company is principally engaged |
2011 | 250,00$ |
Patrys Limited (PAB) - Financial and Strategic SWOT Analysis ReviewPatrys Limited (Patrys) is a publicly held Australia-based company. The company is principally engaged in the commercialization of |
2011 | 250,00$ |
ConjuChem Biotechnologies Inc. (CJB) - Financial and Strategic SWOT Analysis ReviewConjuChem Biotechnologies Inc. (ConjuChem) is a publicly held Canada-based biotechnology company. The company is principally engag |
2011 | 250,00$ |
Medigen Biotechnology Corp. (3176) - Financial and Strategic SWOT Analysis ReviewMedigen Biotechnology Corp. (MBC) is a publicly held pharmaceutical company. It is engaged in the research and development of new |
2011 | 250,00$ |
Cosmo Pharmaceuticals S.p.A (CQ1) - Financial and Strategic SWOT Analysis ReviewCosmo Pharmaceuticals S.p.A (Cosmo) is a publicly held speciality pharmaceutical company engaged in developing therapies for selec |
2011 | 250,00$ |
Peregrine Pharmaceuticals, Inc. (PPHM) - Financial and Strategic SWOT Analysis ReviewPeregrine Pharmaceuticals, Inc. (Peregrine) is a publicly held pharmaceutical company. It is engaged in the development and manufa |
2011 | 250,00$ |
Critical Outcome Technologies Inc. (COT) - Financial and Strategic SWOT Analysis ReviewCritical Outcome Technologies Inc. (Critical Outcome Technologies) is Canada-based pharmaceutical biotechnology industry. The comp |
2011 | 250,00$ |
Pharmanet Group Ltd (PNO) - Financial and Strategic SWOT Analysis ReviewPharmanet Group Limited (Pharmanet) is a biotechnology and pharmaceutical company which is principally engaged in research, develo |
2011 | 250,00$ |
Pharmasset, Inc (VRUS) - Financial and Strategic SWOT Analysis ReviewPharmasset, Inc. (Pharmasset.) is a health care pharmaceutical company. The company is engaged in discovering, producing and comme |
2011 | 250,00$ |
PharmAthene, Inc. (PIP) - Financial and Strategic SWOT Analysis ReviewPharmAthene, Inc. (PharmAthene), was formerly known as Healthcare Acquisition Corp. It is a bio-defense company. It deals with the |
2011 | 250,00$ |
PharmAust Limited (PAA) - Financial and Strategic SWOT Analysis ReviewPharmAust Limited (PharmAust) is an Australia-based biopharmaceutical company that is engaged in the development of drug discovery |
2011 | 125,00$ |
Cytopia Limited (CYT) - Financial and Strategic SWOT Analysis ReviewCytopia Limited (Cytopia) is principally engaged in the development of targeted small molecule therapeutics for cancer. In additio |
2011 | 250,00$ |
Pharmaxis Ltd. (PXS) - Financial and Strategic SWOT Analysis ReviewPharmaxis Ltd. (Pharmaxis) is a publicly held Australian-based pharmaceutical company. The company is principally engaged in the d |
2011 | 250,00$ |
Symyx Technologies, Inc. (SMMX) - Financial and Strategic SWOT Analysis ReviewSymyx Technologies, Inc. (Symyx) is a public scientific company. The company's product portfolio comprises of software, databases, |
2011 | 250,00$ |
Transcept Pharmaceuticals, Inc. (TSPT) - Financial and Strategic SWOT Analysis ReviewTranscept Pharmaceuticals, Inc. (Transcept) is a publicly held US based specialty pharmaceutical company. The company deals with t |
2011 | 250,00$ |
Stellar Pharmaceuticals Inc. (SLXCF) - Financial and Strategic SWOT Analysis ReviewStellar Pharmaceuticals Inc. (Stellar) is a publicly held Canadian based health care company. It is engaged in the development of |
2011 | 250,00$ |
Gujarat Themis Biosyn Ltd. (506879) - Financial and Strategic SWOT Analysis ReviewGujarat Themis Biosyn Ltd. (Gujarat Themis Biosyn Ltd.) is an independent pharmaceutical heath care industry. The industry is prin |
2011 | 250,00$ |
TopoTarget A/S (TOPO) - Financial and Strategic SWOT Analysis ReviewTopoTarget A/S (TopoTarget) is a biotechnology company engaged in the discovery, development and commercialization of treatments f |
2011 | 250,00$ |
Phase Forward Incorporated (PFWD) - Financial and Strategic SWOT Analysis ReviewPhase Forward Incorporated (Phase Forward) is a publicly held US-based company. The company is principally engaged in providing i |
2011 | 125,00$ |
Shandong Donge E-jiao Co.,Ltd (000423) - Financial and Strategic SWOT Analysis ReviewShandong Donge E-jiao Co.,Ltd (Shandong) is a publicly held China based pharmaceutical company. It is engaged in the production of |
2011 | 125,00$ |
Hubei Guangji Pharmaceutical Co.,Ltd. (000952) - Financial and Strategic SWOT Analysis ReviewHubei Guangji Pharmaceutical Co., Ltd. (Hubei Guangji Pharmaceutical Co., Ltd.) is an independent health cared pharmaceutical indu |
2011 | 250,00$ |
Somaxon Pharmaceuticals, Inc. (SOMX) - Financial and Strategic SWOT Analysis ReviewSomaxon Pharmaceuticals, Inc. (Somaxon) is a publicly held research focused specialty pharmaceutical company. It is engaged in res |
2011 | 250,00$ |
XELR8, Inc (XELR) - Financial and Strategic SWOT Analysis ReviewXELR8, Inc (XELR8) is a publicly held US based pharmaceutical company. It is engaged delivering products related to nutritional su |
2011 | 250,00$ |
Senetek PLC (SNKTY) - Financial and Strategic SWOT Analysis ReviewSenetek PLC (Senetek) is a public biotechnology company. It is engaged in the development of technologies, targeting skin care an |
2011 | 250,00$ |
Puleva Biotech S.A. (BIO) - Financial and Strategic SWOT Analysis ReviewPuleva Biotech S.A. (Puleva) is a publicly held Spain based pharmaceutical company engaged in production of functional foods. The |
2011 | 250,00$ |
Orient Europharma Co., Ltd. (4120) - Financial and Strategic SWOT Analysis ReviewOrient Europharma Co., Ltd. (Orient Europharma) is a publicly held Taiwan-based company. It engages in the production of pharmaceu |
2011 | 250,00$ |
Quality Healthcare Asia Limited (0593) - Financial and Strategic SWOT Analysis ReviewQuality Healthcare Asia Limited (Quality HealthCare) is a publicly held company that is engaged in providing healthcare services, |
2011 | 250,00$ |
China Yongxin Pharmaceuticals Inc. (CYXN) - Financial and Strategic SWOT Analysis ReviewChina Yongxin Pharmaceuticals Inc (China Yongxin) also known as Changchun Yongxin Dirui Medical Company is a publicly held Chinese |
2011 | 250,00$ |
Lend Lease Primelife Group (LLP) - Financial and Strategic SWOT Analysis ReviewLend Lease Primelife Group (LLPG) is a publicy held company which was formerly known as Babcock & Brown Communities Limited is eng |
2011 | 250,00$ |
Zhejiang NHU Company Ltd. (002001) - Financial and Strategic SWOT Analysis ReviewZhejiang Nhu Company Ltd. (NHU), is a publicly held pharmaceutical company that is engaged in production and distribution of natur |
2011 | 125,00$ |
Vinati Organics Limited (VINATIORGA) - Financial and Strategic SWOT Analysis ReviewVinati Organics Ltd. (VOL) is publicly held company engaged in manufacturing organic intermediates, monomers and polymers and othe |
2011 | 250,00$ |
Shanghai RAAS Blood Products Co., Ltd. (002252) - Financial and Strategic SWOT Analysis ReviewShanghai RAAS Blood Products Co., Ltd (Shanghai RAAS) is a publicly held biotechnology company. It is engaged in the production of |
2011 | 250,00$ |
RehabCare Group, Inc. (RHB) - Financial and Strategic SWOT Analysis ReviewRehabCare Group, Inc. (RehabCare) is one of the leading providers of physical rehabilitation program management services in the US |
2011 | 125,00$ |
Longlife Group Holdings Limited (8037) - Financial and Strategic SWOT Analysis ReviewLonglife Group Holdings Limited (LGH) is a publicly held company engaged in manufacturing, distributing, research and development |
2011 | 250,00$ |
The Ensign Group, Inc. (ENSG) - Financial and Strategic SWOT Analysis ReviewThe Ensign Group, Inc. (Ensign Group) is a public company that is engaged in providing health care facility and long-term care. Th |
2011 | 125,00$ |
Nestor Healthcare Group plc (NSR) - Financial and Strategic SWOT Analysis ReviewNestor Healthcare Group plc (Nestor) is an UK based holding company. The company principally provides managed services for health |
2011 | 125,00$ |
Aceto Corporation (ACET) - Financial and Strategic SWOT Analysis ReviewAceto Corporation (Aceto) is a pharmaceutical company engaged in sourcing, quality assurance, regulatory support, marketing and di |
2011 | 125,00$ |
Yungjin Pharm Ind. Co., Ltd. (003520) - Financial and Strategic SWOT Analysis ReviewYungjin Pharm Ind. Co., Ltd. (Yungjin) is a publicly held pharmaceutical company that is engaged in developing, manufacturing and |
2011 | 250,00$ |
Yuyu Pharma, Inc. (000220) - Financial and Strategic SWOT Analysis ReviewYuyu Pharma, Inc. (Yuyu) is a publicly held research focused pharmaceuticals company engaged in manufacturing of pharmaceuticals. |
2011 | 250,00$ |
Zentiva S.A. (SCD) - Financial and Strategic SWOT Analysis ReviewZentiva S.A. (Zentiva) is a publicly held pharmaceutical company that is engaged in developing, manufacturing and commercializatio |
2011 | 250,00$ |
Toho Holdings Company Ltd. (8129) - Financial and Strategic SWOT Analysis ReviewToho Holdings Company Ltd. (Toho Pharmaceutical) is a pharmaceutical wholesaler, operating as a subsidiary of the Kyoso Mirai Grou |
2011 | 125,00$ |
Sogo Clinical Holdings Co., Ltd. (2399) - Financial and Strategic SWOT Analysis ReviewSogo Clinical Holdings Co., Ltd. (Sogo) is a Japan-based pharmaceutical company. It engages in providing clinical trials to hospit |
2011 | 250,00$ |
Bioanalytical Systems, Inc. (BASI) - Financial and Strategic SWOT Analysis ReviewBioanalytical Systems, Inc. (Bioanalytical Systems, Inc.) is an independent biomedical pharmaceutical industry. The company is eng |
2011 | 250,00$ |
Health Management International Ltd. (588) - Financial and Strategic SWOT Analysis ReviewHealth Management International Ltd. (HMI) is public company that is principally engaged in providing healthcare and educational s |
2011 | 250,00$ |
Procter & Gamble Hygiene & Health Care Limited (500459) - Financial and Strategic SWOT Analysis ReviewProcter & Gamble Hygiene & Health Care Limited (PGHHCL) is a public company that is engaged in providing consumer goods (FMCG) in |
2011 | 125,00$ |
Wanbury Limited (524212) - Financial and Strategic SWOT Analysis ReviewWanbury Limited (Wanbury) is a publicly held pharmaceutical company that offers domestic branded drugs and pharmaceuticals as well |
2011 | 250,00$ |
Kilitch Drugs (India) Ltd. (KILITCH) - Financial and Strategic SWOT Analysis ReviewKilitch Drugs (India) Ltd. (Kilitch) is a publicly held pharmaceutical company engaged in manufacturing and marketing of various r |
2011 | 250,00$ |
VITA 34 International AG (V3V) - Financial and Strategic SWOT Analysis ReviewVita 34 International AG (Vita 34) is a publicly held biotechnology company. It operates as a umbilical cord blood bank. The compa |
2011 | 250,00$ |
Wakamoto Pharmaceutical Co., Ltd. (4512) - Financial and Strategic SWOT Analysis ReviewWakamoto Pharmaceutical Co., Ltd. (Wakamoto) is a publicly held pharmaceutical company that is engaged in manufacturing of over th |
2011 | 250,00$ |
Dishman Pharmaceuticals & Chemicals Ltd. (532526) - Financial and Strategic SWOT Analysis ReviewDishman Pharmaceuticals & Chemicals Ltd. (Dishman) is a public company that is engaged in manufacturing and commercialization of b |
2011 | 125,00$ |
William Ransom & Son PLC (RNSM) - Financial and Strategic SWOT Analysis ReviewWilliam Ransom & Son PLC (William Ransom) is publicly held company engaged in supply of branded medicines, vitamins, and food supp |
2011 | 250,00$ |
Goldshield Group plc (GSD) - Financial and Strategic SWOT Analysis ReviewGoldshield Group Plc (Goldshield Group Plc.) is UK based pharmaceutical industry. The company is involved in development and comme |
2011 | 125,00$ |
Sinclair Pharma Plc (SPH) - Financial and Strategic SWOT Analysis ReviewSinclair Pharma Plc (Sinclair) is a public company operating as a global specialty pharmaceutical company that focuses on developi |
2011 | 250,00$ |
Yamane Medical Co., Ltd. (2144) - Financial and Strategic SWOT Analysis ReviewYamane Medical Co., Ltd. (Yamane Medical) is a publicly held company providing services in nursing and home care. The company oper |
2011 | 250,00$ |
PT Bristol-Myers Squibb Indonesia Tbk (SQBB) - Financial and Strategic SWOT Analysis ReviewPT Bristol-Myers Squibb Indonesia Tbk (PT Bristol) is a publicly held Indonesia based pharmaceutical company. It is engaged in th |
2011 | 250,00$ |
Y.S.P. Southeast Asia Holding Berhad (YSPSAH) - Financial and Strategic SWOT Analysis ReviewY.S.P. Southeast Asia Holding Berhad (Y.S.P SAH) is a pharmaceutical company, which is engaged in producing, importing, exporting |
2011 | 250,00$ |
Dynacq Healthcare, Inc. (DYII) - Financial and Strategic SWOT Analysis ReviewDynacq Healthcare, Inc. (DHI) is a US based public company. The company is involved in the development, management of general acut |
2011 | 250,00$ |
HYGEIA Hospital S.A. (HYGEIA) - Financial and Strategic SWOT Analysis ReviewHYGEIA Hospital S.A. (Hygeia) is a Greece based hospital involved in offering healthcare services. The hospital offers a range of |
2011 | 125,00$ |
Guangzhou Baiyunshan Pharmaceutical Co., Ltd. (000522) - Financial and Strategic SWOT Analysis ReviewGuangzhou Baiyunshan Pharmaceutical Co., Ltd. (BYS) is a biopharmaceutical company. The company is involved in the research and de |
2011 | 125,00$ |
Manchester International Hlgs Unltd Corp (MIHB) - Financial and Strategic SWOT Analysis ReviewManchester International Holdings Unlimited Corporation (Manchester International) is a publicly held Philippines-based pharmaceut |
2011 | 250,00$ |
EASY BIO System, Inc. (035810) - Financial and Strategic SWOT Analysis ReviewEASY BIO System, Inc. (EASY BIO System) is a fully integrated biotechnology company. The company is involved in the research and d |
2011 | 125,00$ |
OAO VEROPHARM (VRPH) - Financial and Strategic SWOT Analysis ReviewOAO VEROPHARM (Verofarm) is a publicly held Russia based generic pharmaceutical company. It is engaged in the development and manu |
2011 | 125,00$ |
WhanIn Pharmaceutical Co., Ltd. (016580) - Financial and Strategic SWOT Analysis ReviewWhanIn Pharmaceutical Co., Ltd. (WhanIn) is a publicly held Korea based pharmaceutical company. It is engaged in the development, |
2011 | 250,00$ |
Wooridul Life Sciences Ltd (118000) - Financial and Strategic SWOT Analysis ReviewWooridul Life Sciences Ltd (Wooridul Life) is a publicly held Korean based pharmaceutical company. It is engaged in manufacturing |
2011 | 250,00$ |
Cipla Medpro South Africa Limited (CMP) - Financial and Strategic SWOT Analysis ReviewCipla Medpro South Africa Limited (Cipla Medpro) is a pharmaceutical company. It is engaged in the manufacturing, marketing and su |
2011 | 250,00$ |
Midelfart Sonesson AB (MSON B) - Financial and Strategic SWOT Analysis ReviewMidelfart Sonesson AB (Midelfart Sonesson) is a publicly held Swedan based pharmaceutical company. It is engaged in the developme |
2011 | 125,00$ |
Krungdhon Hospital Public Company Ltd. (KDH) - Financial and Strategic SWOT Analysis ReviewKrungdhon Hospital Public Company Ltd. (KDH) is a publicly held healthcare services company. The company operates two general hosp |
2011 | 250,00$ |
Wattana Karnpaet PCL (NEW) - Financial and Strategic SWOT Analysis ReviewWattana Karnpaet PCL (Wattana) is a publicly held Thailand based pharmaceutical company. It is engaged in providing health care fa |
2011 | 250,00$ |
Vibhavadi Medical Center Public Co. Ltd. (VIBHA) - Financial and Strategic SWOT Analysis ReviewVibhavadi Medical Center Public Co. Ltd. (Vibhavadi) is a publicly held Thailand based hospital, engaged in providing health care |
2011 | 250,00$ |
Ramkhamhaeng Hospital (RAM) - Financial and Strategic SWOT Analysis ReviewRamkhamhaeng Hospital (Ramkhamhaeng) is publicly held hospital providing specialty healthcare services. The hospital offers specia |
2011 | 250,00$ |
Nonthavej Hospital Public Company Ltd. (NTV) - Financial and Strategic SWOT Analysis ReviewNonthavej Hospital Public Company Ltd. (Nonthavej Hospital) is a publicly held hospital that is engaged in providing a broad range |
2011 | 250,00$ |
TECHNE Corporation (TECH) - Financial and Strategic SWOT Analysis ReviewTECHNE Corporation (TECHNE) is a holding company engaged in the development, production and sale of biotechnology products and hem |
2011 | 125,00$ |
Medical Care Service Company Inc. (2494) - Financial and Strategic SWOT Analysis ReviewMedical Care Service Company Inc. (MCSC) is a publicly held long term care service provider company that operates assisted living |
2011 | 250,00$ |
J. Bridge Corp. (9318) - Financial and Strategic SWOT Analysis ReviewJ. Bridge Corp. (J. Bridge) is a Japan based publicly held company that is engaged in providing outsourcing services to medical an |
2011 | 250,00$ |
Khimiko-farmatsevticheskiy kombinat Akrikhin OAO (AKPH) - Financial and Strategic SWOT Analysis ReviewKhimiko-farmatsevticheskiy kombinat Akrikhin OAO (Akrikhin) is a publicly held Russia based company. It is engaged in the developm |
2011 | 250,00$ |
Selcuk Ecza Deposu Ticaret ve Sanayi A.S (SELEC) - Financial and Strategic SWOT Analysis ReviewSelcuk Ecza Deposu Ticaret ve Sanayi A.S (Selcuk Ecza) is a public company that operates as a distribution channel between drug ma |
2011 | 125,00$ |
HemaCare Corporation (HEMA) - Financial and Strategic SWOT Analysis ReviewHemaCare Corporation (HemaCare) is a public company based in the US. The company in mainly focusing in offering blood related prod |
2011 | 250,00$ |
Igene Biotechnology, Inc. (IGNE) - Financial and Strategic SWOT Analysis ReviewIgene Biotechnology, Inc. (Igene) is a biotechnology company based in the US. The company is involved in developing and commercial |
2011 | 250,00$ |
IGI Laboratories, Inc. (IG) - Financial and Strategic SWOT Analysis ReviewIGI Laboratories, Inc. (IGI) is a pharmacuetical company. The company is involved in developing, manufacturing, filling and packag |
2011 | 250,00$ |
Natural Alternatives International, Inc. (NAII) - Financial and Strategic SWOT Analysis ReviewNatural Alternatives International, Inc. (NAI) is a publicly held company engaged in formulation and manufacturing of customized n |
2011 | 250,00$ |
Poniard Pharmaceuticals, Inc. (PARD) - Financial and Strategic SWOT Analysis ReviewPoniard Pharmaceuticals, Inc. (Poniard) is a publicly held bio-pharmaceutical company engaged in developing and commercializing ca |
2011 | 250,00$ |
Psychemedics Corporation (PMD) - Financial and Strategic SWOT Analysis ReviewPsychemedics Corporation (Psychemedics) engages in providing drug testing services for the identification of abused substances by |
2011 | 125,00$ |
Repligen Corporation (RGEN) - Financial and Strategic SWOT Analysis ReviewRepligen Corporation (Repligen) is a US-based research focused bio pharmaceutical company. The company is engaged in developing i |
2011 | 250,00$ |
HST Global Inc. (HSTC) - Financial and Strategic SWOT Analysis ReviewHST Global, Inc. (HST Global) is public healthcare services company. It is primarily involved in the acquisition, development and |
2011 | 250,00$ |
Champions Biotechnology, Inc. (CSBR) - Financial and Strategic SWOT Analysis ReviewChampions Biotechnology, Inc. (Champions Biotechnology) is a biotechnology company. It is involved in developing potential drugs. |
2011 | 250,00$ |
U.S. Physical Therapy, Inc. (USPH) - Financial and Strategic SWOT Analysis ReviewU.S. Physical Therapy, Inc. (USPh) is a publicly held pharmaceutical company engaged in providing physical and occupational therap |
2011 | 125,00$ |
Repros Therapeutics Inc. (RPRX) - Financial and Strategic SWOT Analysis ReviewRepros Therapeutics, Inc., (Repros) is US- based public biopharmaceutical company. The company is involved in the development of m |
2011 | 250,00$ |
Advocat Inc. (AVCA) - Financial and Strategic SWOT Analysis ReviewAdvocat Inc. (Advocat) is a public company offering a wide range of long-term care services to nursing home patients. Advocat is o |
2011 | 125,00$ |
NeoStem, Inc. (NBS) - Financial and Strategic SWOT Analysis ReviewNeoStem, Inc. (NeoStem), is a US based company acts as a adult stem cell bank. It is formerly known as Phase III Medical, Inc. Th |
2011 | 250,00$ |
Oncogenex Pharmaceuticals, Inc. (OGXI) - Financial and Strategic SWOT Analysis ReviewOncogenex Pharmaceuticals, Inc. (OncoGenex) is involved in developing research focused biopharmaceutical products. It is involved |
2011 | 250,00$ |
Conmed Healthcare Management, Inc. (CONM) - Financial and Strategic SWOT Analysis ReviewConmed Healthcare Management, Inc. (Conmed) is a US based healthcare services provider. The company is engaged in offering healthc |
2011 | 250,00$ |
Cadus Corporation (KDUS) - Financial and Strategic SWOT Analysis ReviewCadus Corporation (Cadus) is the US based pharmaceutical pharmaceutical company develop products related using genetically enginee |
2011 | 250,00$ |
PHC, Inc. (PHC) - Financial and Strategic SWOT Analysis ReviewPHC, Inc., (Pioneer Behavioral Health) is a healthcare company that is engaged in offering behavioral healthcare services to its c |
2011 | 250,00$ |
Titan Pharmaceuticals, Inc. (TTNP) - Financial and Strategic SWOT Analysis ReviewTitan Pharmaceuticals, Inc. (Titan Pharmaceuticals) is a US based biopharmaceutical company. The company is engaged in the develop |
2011 | 250,00$ |
Continucare Corporation (CNU) - Financial and Strategic SWOT Analysis ReviewContinucare Corporation (Continucare) is a publicly held company that is engaged in providing primary care physician services. It |
2011 | 125,00$ |
Symbollon Pharmaceuticals, Inc. (SYMBA) - Financial and Strategic SWOT Analysis ReviewSymbollon Pharmaceuticals, Inc. (Symbollon) is a pharmaceutical company that is focused on the development and commercialization o |
2011 | 250,00$ |
UCI Medical Affiliates, Inc. (UCIA) - Financial and Strategic SWOT Analysis ReviewUCI Medical Affiliates, Inc. (UCI Medical) is a publicly traded specialty pharmaceutical company. This company is engaged in prov |
2011 | 250,00$ |
Encorium Group, Inc. (ENCO) - Financial and Strategic SWOT Analysis ReviewEncorium Group, Inc. (Encorium) is a US based service contract research organization. Encorium has specialization in the therapeut |
2011 | 250,00$ |
Capital Senior Living Corporation (CSU) - Financial and Strategic SWOT Analysis ReviewCapital Senior Living Corporation (Capital Senior Living) is a US based service providing company. It is involved in offering livi |
2011 | 125,00$ |
SIGA Technologies, Inc. (SIGA) - Financial and Strategic SWOT Analysis ReviewSIGA Technologies, Inc. (SIGA) is a US- based public company. The company engages in research, development and commercialization o |
2011 | 250,00$ |
Sanguine Corporation (SGUI) - Financial and Strategic SWOT Analysis ReviewSanguine Corporation (Sanguine) is a pharmaceutical company, engaged in the development of oxygen carriers used by the medical pro |
2011 | 250,00$ |
CRYO-CELL International, Inc. (CCEL) - Financial and Strategic SWOT Analysis ReviewCryo-Cell International, Inc. (Cryo-Cell) is a public trade biotechnology company. It is involved in cellular processing and cryop |
2011 | 250,00$ |
Birner Dental Management Services, Inc. (BDMS) - Financial and Strategic SWOT Analysis ReviewBirner Dental Management Services, Inc. (BDMS) is a US based medical device company. It is involved in providing common dentistry |
2011 | 250,00$ |
Mera Pharmaceuticals, Inc. (MRPI) - Financial and Strategic SWOT Analysis ReviewMera Pharmaceuticals, Inc. (Mera) is a publicly held biotechnology company involved in developing natural astaxanthin derived from |
2011 | 250,00$ |
Proteonomix, Inc. (PROT) - Financial and Strategic SWOT Analysis ReviewProteonomix, Inc. (Proteonomix) is a start-up stage biotechnology company engaged in providing regenerative stem cell therapies an |
2011 | 250,00$ |
Protalix BioTherapeutics, Inc. (PLX) - Financial and Strategic SWOT Analysis ReviewProtalix BioTherapeutics, Inc. (Protalix) is a Israel-basedpublic biopharmaceutical company. The company is engages in developin |
2011 | 250,00$ |
PhytoMedical Technologies, Inc. (PYTO) - Financial and Strategic SWOT Analysis ReviewPhytoMedical Technologies, Inc. (PhytoMedical) is a publicly held biopharmaceutical company. It is engaged in discovery, acquisiti |
2011 | 250,00$ |
Sharps Compliance Corp. (SMED) - Financial and Strategic SWOT Analysis ReviewSharps Compliance Corp. (Sharps) is engaged in developing and providing medical disposal solutions to diverse customers. The compa |
2011 | 250,00$ |
U.S. Neurosurgical, Inc. (USNU) - Financial and Strategic SWOT Analysis ReviewU.S. NeuroSurgical, Inc., (USN) is a medical service provider based in the US. The company owns and operates a stereotactic radios |
2011 | 250,00$ |
Deltagen, Inc. (DGEN) - Financial and Strategic SWOT Analysis ReviewDeltagen, Inc. (Deltagen, Inc.) is a biopharmaceutical company which provides drug discovery tools and services to the biopharmace |
2011 | 250,00$ |
Tikcro Technologies, Ltd. (TIKRF) - Financial and Strategic SWOT Analysis ReviewTikcro Technologies Ltd. (Tikcro) is developmental stage company engaged in the process of acquiring or merging a domestic/foreign |
2011 | 250,00$ |
China Botanic Pharmaceutical Inc. (CBP) - Financial and Strategic SWOT Analysis ReviewChina Botanic Pharmaceutical Inc. (China Botanic Pharmaceutical Inc.) is a pharmaceutical company engaged in the development, manu |
2011 | 250,00$ |
Dynavax Technologies Corporation (DVAX) - Financial and Strategic SWOT Analysis ReviewDynavax Technologies Corporation (Dynavax Technologies) is a US-based biopharmaceutical company. The company engages in discoverin |
2011 | 250,00$ |
Senomyx, Inc. (SNMX) - Financial and Strategic SWOT Analysis ReviewSenomyx, Inc. (Senomyx) is a publicly traded chemical company, engaged in discovering and developing novel flavor ingredients. It |
2011 | 250,00$ |
Epicore BioNetworks Inc. (EBN) - Financial and Strategic SWOT Analysis ReviewEpicore BioNetworks Inc. (Epicore BioNetworks Inc.) is a New Jersey based company engaged in the development, manufacture, and mar |
2011 | 250,00$ |
ProMetic Life Sciences Inc. (PLI) - Financial and Strategic SWOT Analysis ReviewProMetic Life Sciences Inc. (ProMetic Life Sciences) a Canada based biopharmaceutical company. It engages in the research, develop |
2011 | 250,00$ |
Phytopharm Plc (PYM) - Financial and Strategic SWOT Analysis ReviewPhytopharm Plc (Phytopharm) a U.K based pharmaceutical company,. The company is engaged in developing novel treatments targeting d |
2011 | 250,00$ |
Indo Internacional SA (IDO) - Financial and Strategic SWOT Analysis ReviewIndo Internacional, S.A. (Indo Internacional) is a Spain based company engaged in manufacturing and retailing lenses, ophthalmic e |
2011 | 250,00$ |
Source BioScience Plc (SBS) - Financial and Strategic SWOT Analysis ReviewSource BioScience Plc. (Source BioScience) is a healthcare and biotechnology company that operates businesses in three sectors nam |
2011 | 250,00$ |
Reliance GeneMedix Plc (GMX) - Financial and Strategic SWOT Analysis ReviewReliance GeneMedix Plc (Reliance GeneMedix), formerly GeneMedix plc is a publicly held biopharmaceutical company. It is involved i |
2011 | 125,00$ |
FuturaGene, Plc (FGN) - Financial and Strategic SWOT Analysis ReviewFuturaGene, Plc. (Futuragene) is a UK based biotechnology research and development company, engaged in plant genetic research and |
2011 | 250,00$ |
Fulcrum Pharma plc (FUL) - Financial and Strategic SWOT Analysis ReviewFulcrum Pharma plc (Fulcrum Pharma) is a service provider to pharmaceutical company. Fulcrum Pharma offers a range of drug develop |
2011 | 250,00$ |
LVL Medical Groupe SA (LVL) - Financial and Strategic SWOT Analysis ReviewLVL Medical Groupe SA (LVL Medical) is a healthcare services company, engaged in providing home-based medical assistance services. |
2011 | 125,00$ |
Semperit AG Holding (SEM) - Financial and Strategic SWOT Analysis ReviewSemperit AG Holding is a holding company, operating through its subsidiaries. The company is engaged in the manufacturing of indus |
2011 | 125,00$ |
Audika SA (ADI) - Financial and Strategic SWOT Analysis ReviewAudika SA (Audika SA) is a France based company which offers hearing correction solutions. The company also engaged in the sale an |
2011 | 250,00$ |
MorphoSys AG (MOR) - Financial and Strategic SWOT Analysis ReviewMorphoSys AG (MorphoSys) is a Germany based biotechnology company. The company engages in developing antibodies for therapeutic, d |
2011 | 250,00$ |
Aker BioMarine ASA (AKBM) - Financial and Strategic SWOT Analysis ReviewAker BioMarine ASA (Aker BioMarine ASA) a Norway based marine biotechnology company, engaged in the manufacture and sale of biomar |
2011 | 250,00$ |
Fornix BioSciences N.V. (FORBI) - Financial and Strategic SWOT Analysis ReviewFornix BioSciences N.V. (Fornix BioSciences N.V.) is engaged in the research and development, production, marketing and sale relat |
2011 | 250,00$ |
Athens Medical C.S.A. (IATR) - Financial and Strategic SWOT Analysis ReviewAthens Medical C.S.A. (Athens Medical C.S.A.) is a Greece based pharmaceutical company engaged in the provision of healthcare serv |
2011 | 125,00$ |
IASO S.A. (IASO) - Financial and Strategic SWOT Analysis ReviewIASO S.A. (IASO S.A.) is a Greece based pharmaceutical company which provides various health care services. The company offers a r |
2011 | 125,00$ |
Green Cross Holdings Corporation (005250) - Financial and Strategic SWOT Analysis ReviewGreen Cross Holdings Corporation (Green Cross) is a biotechnology company engaged in the development of ethical drugs in the field |
2011 | 125,00$ |
Eu Yan Sang International Ltd. (E02) - Financial and Strategic SWOT Analysis ReviewEu Yan Sang International Ltd. (Eu Yan Sang International Ltd.) is a Singapore based investment holding company, engages in the ma |
2011 | 250,00$ |
Kwang Dong Pharmaceutical Co., Ltd. (009290) - Financial and Strategic SWOT Analysis ReviewKwang Dong Pharmaceutical Co., Ltd. (Kwang Dong), is a Korean based health care company. It is involved in the production of orien |
2011 | 125,00$ |
PT Tempo Scan Pacific Tbk. (TSPC) - Financial and Strategic SWOT Analysis ReviewPT Tempo Scan Pacific Tbk (TSP), formerly PT Scanchemie, is a pharmaceutical company that manufactures generic and specialty produ |
2011 | 125,00$ |
Macrogen Incorporation (038290) - Financial and Strategic SWOT Analysis ReviewMacrogen Incorporation (Macrogen) is engaged in providing customized transgenic and other services in the biomedical research. The |
2011 | 250,00$ |
EXCON Co.,Ltd. (038120) - Financial and Strategic SWOT Analysis ReviewEXCON Co., Ltd., (EXCON) previously known as RINOCELL Co., Ltd. is a medical equipment company engaged in the manufacture and dist |
2011 | 250,00$ |
Hepahope Korea, Inc. (039350) - Financial and Strategic SWOT Analysis ReviewHepahope Korea, Inc. (Hepahope) is a biotechnology company, principally engaged in the development of products pertaining to the b |
2011 | 250,00$ |
Ryman Healthcare Ltd. (RYM) - Financial and Strategic SWOT Analysis ReviewRyman Healthcare Ltd. (Ryman Healthcare) is a healthcare service provider engaged in the development and operating of retirement |
2011 | 250,00$ |
Transgene SA (TNG) - Financial and Strategic SWOT Analysis ReviewTransgene SA (Transgene) is a France based biopharmaceutical company. The company engages in the discovery and development of gene |
2011 | 250,00$ |
SYGNIS Pharma AG (LIOK) - Financial and Strategic SWOT Analysis ReviewSYGNIS Pharma AG (SYGNIS Pharma) is a Germany based pharmaceutical company. The company engates in research, development and mark |
2011 | 250,00$ |
Senesco Technologies, Inc. (SNT) - Financial and Strategic SWOT Analysis ReviewSenesco Technologies, Inc. (Senesco) is a bio-pharmaceutical company that is engaged in the research and development of genetic te |
2011 | 250,00$ |
China Agrotech Holdings Limited (1073) - Financial and Strategic SWOT Analysis ReviewChina Agrotech Holdings Limited (China Agrotech Holdings Limited) is an investment holding company that trades in fertilizers, pes |
2011 | 125,00$ |
Prana Biotechnology Limited (PBT) - Financial and Strategic SWOT Analysis ReviewPrana Biotechnology Limited (Prana Biotechnology) is a publicly held company engaged in development of stage biotechnology, resear |
2011 | 250,00$ |
Sawai Pharmaceutical Co., Ltd. (4555) - Financial and Strategic SWOT Analysis ReviewSawai Pharmaceutical Co., Ltd. (Sawai Pharmaceutical) is a publicly held pharmaceutical company that is engaged in the manufacture |
2011 | 125,00$ |
Feelgood Svenska AB (FEEL) - Financial and Strategic SWOT Analysis ReviewFeelgood Svenska AB (Feelgood Svenska AB) is a Sweden based healthcare service provider. It provides healthcare services to busine |
2011 | 250,00$ |
Forest Place Group Limited (FPG) - Financial and Strategic SWOT Analysis ReviewForest Place Group Limited (Forest Place Group Limited) owns, develops and operates retirement villages and an aged care facility |
2011 | 250,00$ |
Prima BioMed Limited (PRR) - Financial and Strategic SWOT Analysis ReviewPrima BioMed Limited (Prima) is a publicly held biomedical company. It is engaged in the development of anti-cancer therapeutics b |
2011 | 250,00$ |
Oral Hammaslaakarit Oyj (ORA1V) - Financial and Strategic SWOT Analysis ReviewOral Hammaslaakarit Oyj (Oral Hammaslaakarit) is engaged in providing dental care related services. The company offers a range of |
2011 | 250,00$ |
Dragon Pharmaceuticals Inc. (DDD) - Financial and Strategic SWOT Analysis ReviewDragon Pharmaceuticals Inc. (Dragon Pharmaceuticals Inc.) was acquired by Oriental Wave Holding Ltd., in a reverse merger transact |
2011 | 250,00$ |
Immuron Limited (IMC) - Financial and Strategic SWOT Analysis ReviewImmuron Limited (Immuron Limited) operates in the biopharmaceutical sector and focuses on the research and development of polyclon |
2011 | 125,00$ |
Nissui Pharmaceutical Co., Ltd. (4550) - Financial and Strategic SWOT Analysis ReviewNissui Pharmaceutical Co., Ltd. (Nissui Pharmaceutical) is a publicly held pharmaceutical company. It is engaged in the developmen |
2011 | 250,00$ |
MATERNUS Kliniken AG (MAK) - Financial and Strategic SWOT Analysis ReviewMATERNUS Kliniken AG (MATERNUS) is a German based company involved in the operations of care centers for senior citizens and long- |
2011 | 250,00$ |
Nippon Chemiphar Co., Ltd. (4539) - Financial and Strategic SWOT Analysis ReviewNippon Chemiphar Co., Ltd. (Nippon Chemiphar) is a publicly held company engaged in manufacture and marketing of pharmaceuticals, |
2011 | 125,00$ |
Eifelhoehen-Klinik AG (EIF) - Financial and Strategic SWOT Analysis ReviewEifelhoehen-Klinik AG (Eifelhoehen-Klinik AG) operates rehabilitation and outpatient medical care centers primarily for elderly pe |
2011 | 250,00$ |
Prim S.A. (PRIM) - Financial and Strategic SWOT Analysis ReviewPrim S.A. (Prim) is a pharmaceutical provider services company engaged in manufacturing and commercializing hospital supplies and |
2011 | 250,00$ |
Kopran Limited (KOPRAN) - Financial and Strategic SWOT Analysis ReviewKopran Limited (Kopran) is a group company of Parijat Enterprises. Kopran is an integrated pharmaceutical company engaged in the r |
2011 | 250,00$ |
Pfizer Limited (PFIZER) - Financial and Strategic SWOT Analysis ReviewPfizer Limited (Pfizer) is a research based pharmaceutical company. It engages in the research and development of medicines for hu |
2011 | 250,00$ |
Tokiwa Yakuhin Co., Ltd. (7644) - Financial and Strategic SWOT Analysis ReviewTokiwa Yakuhin Co., Ltd. (Tokiwa Yakuhin) is principally engaged in the wholesale of pharmaceuticals to hospitals, medical practi |
2011 | 125,00$ |
Fulford (India) Limited (506803) - Financial and Strategic SWOT Analysis ReviewFulford (India) Limited (Fulford) is a publicly held research focused biotechnology company. It is engaged in research, developmen |
2011 | 250,00$ |
Lyka Labs Limited (LYKALABS) - Financial and Strategic SWOT Analysis ReviewLyka Labs Limited (Lyka Labs), a publicly-held healthcare company engaged in the manufacturing, marketing, and exports of pharmace |
2011 | 250,00$ |
JAPAN CARE SERVICE GROUP CORPORATION (7566) - Financial and Strategic SWOT Analysis ReviewJapan Care Service Group Corporation (Japan Care Service) is a holding company, engaged in the provision of nursing and residentia |
2011 | 125,00$ |
Unichem Laboratories Ltd. (UNICHEMLAB) - Financial and Strategic SWOT Analysis ReviewUnichem Laboratories Limited (Unichem) is a publicly held pharmaceutical company engaged in the manufacture and sale of formulatio |
2011 | 250,00$ |
Torrent Pharmaceuticals Limited (TORNTPHARM) - Financial and Strategic SWOT Analysis ReviewTorrent Pharmaceuticals Limited (Torrent) is a public company engaged in the research, development and marketing of active pharmac |
2011 | 125,00$ |
Merck Limited (MERCK) - Financial and Strategic SWOT Analysis ReviewMerck Limited (formerly E. Merck Limited) is a publicly held company engaged in the manufacture of pharmaceuticals and chemicals. |
2011 | 250,00$ |
Progen Pharmaceuticals Limited (PGL) - Financial and Strategic SWOT Analysis ReviewProgen Pharmaceuticals Limited (Progen Pharmaceuticals) is an Australian based pharmaceutical company. The company engages in clin |
2011 | 250,00$ |
Metlifecare Limited (MET) - Financial and Strategic SWOT Analysis ReviewMetlifecare Limited (Metlifecare) is a healthcare services provider, principally engaged in operating lifestyle retirement village |
2011 | 250,00$ |
FDC Limited (FDC) - Financial and Strategic SWOT Analysis ReviewFDC Limited (FDC Limited) is an Indian based pharmaceutical company. It pioneered the manufacture of specialized ophthalmic formul |
2011 | 250,00$ |
Katakura Industries Co., Ltd. (3001) - Financial and Strategic SWOT Analysis ReviewKatakura Industries Co., Ltd. (Katakura) is a research institute of biological science, operates through its business segment. The |
2011 | 125,00$ |
IPCA Laboratories Limited (IPCALAB) - Financial and Strategic SWOT Analysis ReviewIPCA Laboratories Limited (IPCA) is a publicly held pharmaceutical company. It is engaged in the development and manufacture of ac |
2011 | 125,00$ |
Novartis India Limited (500672) - Financial and Strategic SWOT Analysis ReviewNovartis India Limited (Novartis India) is a pharmaceutical company. It is a 51% subsidiary of Novartis AG, Switzerland. The compa |
2011 | 250,00$ |
MATSUDA SANGYO Co., Ltd. (7456) - Financial and Strategic SWOT Analysis ReviewMatsuda Sangyo Co., Ltd. (Matsuda) is a publicly held company. It is principally engaged in the Metals and Food Product segments r |
2011 | 125,00$ |
Xenetic Biosciences plc (XEN) - Financial and Strategic SWOT Analysis ReviewXenetic Biosciences plc (Xenetic), formerly Lipoxen PLC is a UK-based bio-pharmaceutical company. It engages in the development of |
2011 | 250,00$ |
Extrawell Pharmaceutical Holdings Limited (0858) - Financial and Strategic SWOT Analysis ReviewExtrawell Pharmaceutical Holdings Limited (Extrawell) is an investment holding company that operates through four business segment |
2011 | 250,00$ |
Torii Pharmaceutical Co., Ltd. (4551) - Financial and Strategic SWOT Analysis ReviewTorii Pharmaceutical Co., Ltd. (Torii), is a publicly held Japan based company and formerly known as Torii Shoten K.K.,. The compa |
2011 | 125,00$ |
Telesso Technologies Limited (TEO) - Financial and Strategic SWOT Analysis ReviewTelesso Technologies Limited (Telesso Technologies) is a publicly traded biotechnology company, engaged in providing research and |
2011 | 250,00$ |
Daewoong Co., Ltd. (003090) - Financial and Strategic SWOT Analysis ReviewDaewoong Co., Ltd. (Daewoong Co., Ltd.) is a Korea based company which operates as an industrial corporation offering diversified |
2011 | 125,00$ |
Biotika, a.s. (1BSL01A) - Financial and Strategic SWOT Analysis ReviewBiotika, a.s. (Biotika) is a pharmaceutical company that is engaged in the biotechnological production of substances of penicillin |
2011 | 250,00$ |
Bukwang Pharmaceutical Co., Ltd. (003000) - Financial and Strategic SWOT Analysis ReviewBukwang Pharmaceutical Co., Ltd. (Bukwang Pharmaceutical Co., Ltd.) is engaged as a manufacturer of pharmaceutical products. The p |
2011 | 250,00$ |
TapImmune Inc. (TPIV) - Financial and Strategic SWOT Analysis ReviewTapImmune Inc. (Taplummune) is engaged in the development of vaccines and therapeutics pertaining to the areas of oncology and inf |
2011 | 250,00$ |
BIOFERMIN PHARMACEUTICAL CO., LTD. (4517) - Financial and Strategic SWOT Analysis ReviewBIOFERMIN PHARMACEUTICAL CO., LTD. (Biofermin Pharmaceutical) is an independent pharmaceutical health care industry. The industry |
2011 | 250,00$ |
JW Pharmaceutical (001060) - Financial and Strategic SWOT Analysis ReviewThis comprehensive SWOT profile of JW Pharmaceutical provides you an in-depth strategic analysis of the company’s businesses and |
2011 | 125,00$ |
HANDOK Pharmaceuticals Co., Ltd. (002390) - Financial and Strategic SWOT Analysis ReviewHANDOK Pharmaceuticals Co., Ltd. (HANDOK Pharmaceuticals Co., Ltd) is a South Korea based pharmaceutical industry.The company is i |
2011 | 125,00$ |
ILSUNG PHARMACEUTICAL CO.,LTD (003120) - Financial and Strategic SWOT Analysis ReviewILSUNG PHARMACEUTICAL CO., LTD (ILSUNG PHARMACEUTICAL) is an independent publicly held health care pharmaceutical industry. Its ma |
2011 | 250,00$ |
Dongwha Pharm Co., Ltd. (000020) - Financial and Strategic SWOT Analysis ReviewDongwha Pharm Co., Ltd. (Dongwha Pharm) is a South Korea based health care pharmaceutical industry. The company is engages in the |
2011 | 125,00$ |
Boryung Pharmaceutical Co., Ltd. (003850) - Financial and Strategic SWOT Analysis ReviewBoryung Pharmaceutical Co., Ltd. (Boryung Pharmaceutical Co., Ltd.) is a South Korea based health care pharmaceutical industry. |
2011 | 250,00$ |
Samil Pharmaceutical Co., Ltd. (000520) - Financial and Strategic SWOT Analysis ReviewSamil Pharmaceutical Co., Ltd. (Samil Pharmaceutical) is a publicly held pharmaceutical company. It is engaged in the discovery an |
2011 | 250,00$ |
Samjin Pharmaceutical Co., Ltd. (005500) - Financial and Strategic SWOT Analysis ReviewSamjin Pharmaceutical Co., Ltd. (Samjin) is a publicly held Korean based pharmaceutical company. It is engaged in research and dev |
2011 | 250,00$ |
Fuji Pharma Co., Ltd. (4554) - Financial and Strategic SWOT Analysis ReviewFuji Pharma Co., Ltd. (Fuji Pharma) is a publicly held pharmaceutical company. It is engaged in the development, manufacture and m |
2011 | 125,00$ |
IVF Hartmann Holding AG (VBSN) - Financial and Strategic SWOT Analysis ReviewIVF Hartmann Holding AG (IVF) is a Switzerland-based company. It is engaged in the development, production, and marketing of medic |
2011 | 250,00$ |
Sun Biomedical Limited (SBN) - Financial and Strategic SWOT Analysis ReviewSun Biomedical Limited (Sun Biomedical) is a publicly held Australia-based pharmaceutical company. The company through its subsidi |
2011 | 250,00$ |
KunWha Pharmaceutical Co., Ltd. (002250) - Financial and Strategic SWOT Analysis ReviewKunWha Pharmaceutical Co., Ltd. (KunWha) is a publicly held Korean based company, that is involved in the production of pharmaceut |
2011 | 250,00$ |
Ilyang Pharmaceutical Co., Ltd (007570) - Financial and Strategic SWOT Analysis ReviewIlyang Pharmaceutical Co., Ltd (Ilyang Pharmaceutical Co., Ltd.) is a Korea based heath care pharmaceutical company. It is engaged |
2011 | 250,00$ |
Miraca Holdings Inc. (4544) - Financial and Strategic SWOT Analysis ReviewMiraca Holdings Inc. (Miraca Holdings) is a Japan based health care pharmaceutical industry. The company operates through its sub |
2011 | 125,00$ |
J. B. Chemicals & Pharmaceuticals Ltd. (506943) - Financial and Strategic SWOT Analysis ReviewJ. B. Chemicals & Pharmaceuticals Ltd. (JBCPL) is a pharmaceutical company that is engaged in the manufacture and marketing of var |
2011 | 125,00$ |
IMI Co., Ltd. (7503) - Financial and Strategic SWOT Analysis ReviewIMI Co., Ltd. (IMI Co., Ltd.) is a Japan based pharmaceutical company which imports, sells, rents, and maintains medical equipment |
2011 | 250,00$ |
Solvay Pharma India Ltd. (532447) - Financial and Strategic SWOT Analysis ReviewSolvay Pharma India Ltd. (Solvay), an India-based public shareholding company. It is engaged in the production and sale of pharmac |
2011 | 250,00$ |
Shinpoong Pharmaceutical Co., Ltd. (019170) - Financial and Strategic SWOT Analysis ReviewShinpoong Pharmaceutical Co., Ltd. (Shinpoong) is a pharmaceutical company that is principally engaged in the manufacture of phar |
2011 | 125,00$ |
Green Cross Corporation (006280) - Financial and Strategic SWOT Analysis ReviewGreen Cross Corporation (Green Cross) is a Korean pharmaceutical company. Its activities include research, development, productio |
2011 | 125,00$ |
Pacific Pharmaceutical Co., Ltd. (016570) - Financial and Strategic SWOT Analysis ReviewPacific Pharmaceutical Co., Ltd. (PPCL) is a publicly held pharmaceutical company. It is engaged in the development and manufactur |
2011 | 250,00$ |
HanAll Biopharma Co., Ltd. (009420) - Financial and Strategic SWOT Analysis ReviewHanall Pharmaceutical Co., Ltd. (HanAll), is a public shareholder company. It is engaged in the production and sale of pharmaceuti |
2011 | 250,00$ |
KAINOS Laboratories, Inc. (4556) - Financial and Strategic SWOT Analysis ReviewKainos Laboratories, Inc. (Kainos), is a publicly held Japan based company. It is involved in developing, manufacturing, marketing |
2011 | 250,00$ |
Shenzhen Accord Pharmaceutical Co., Ltd. (200028) - Financial and Strategic SWOT Analysis ReviewShenzhen Accord Pharmaceutical Co., Ltd. (Shenzhen Accord) is a publicly held pharmaceutical company that is engaged in the resear |
2011 | 125,00$ |
Samsung Pharmaceutical Industry Corporation Limited (001360) - Financial and Strategic SWOT Analysis ReviewSamsung Pharmaceutical Industry Corporation Limited. (SPICO) is a publicly held pharmaceutical manufacturing company. It is engage |
2011 | 250,00$ |
Kukje Pharmaceutical Industry Co., Ltd. (002720) - Financial and Strategic SWOT Analysis ReviewKukje Pharmaceutical Industry Co., Ltd. (Kukje) is a publicly held Korean based company. It is involved in the production, sale an |
2011 | 250,00$ |
Galectin Therapeutics, Inc. (GALT) - Financial and Strategic SWOT Analysis ReviewGalectin Therapeutics, Inc. (Galectin Therapeutics) is a pharmaceutical company that is engaged discovering, developing and commer |
2011 | 250,00$ |
MOLOGEN AG (MGN) - Financial and Strategic SWOT Analysis ReviewMOLOGEN AG (Mologen) a German based bio-pharmaceutical company which specializes in the research and development of innovative med |
2011 | 250,00$ |
Searainbow Holding Co., Ltd (000503) - Financial and Strategic SWOT Analysis ReviewSearainbow Holding Co., Ltd (Searainbow) is a provider services company engaged in three major businesses namely, medical e-commer |
2011 | 250,00$ |
TOWA PHARMACEUTICAL CO., LTD. (4553) - Financial and Strategic SWOT Analysis ReviewTowa Pharmaceutical Co. Ltd (Towa) is a publicly held pharmaceutical company. It is involved in the development and distribution o |
2011 | 125,00$ |
Nanoen Tek, Inc. (039860) - Financial and Strategic SWOT Analysis ReviewNanoen Tek, Inc. (Nanoen Tek) is a publicly traded nano-biotechnology company. It is principally engaged in the realization of Na |
2011 | 250,00$ |
Kyung Dong Pharmaceutical Co., Ltd. (011040) - Financial and Strategic SWOT Analysis ReviewKyung Dong Pharmaceutical Co., Ltd. (Kyung Dong) is a publicly held pharmaceutical company. It is engaged in the development of ra |
2011 | 250,00$ |
Ahn-Gook Pharmaceutical Co., Ltd. (001540) - Financial and Strategic SWOT Analysis ReviewAhn-Gook Pharmaceutical Co., Ltd. (Ahn-Gook Pharmaceutical) is a publicly held pharmaceutical company. It specializes in the produ |
2011 | 250,00$ |
Nichi-Iko Pharmaceutical Co., Ltd. (4541) - Financial and Strategic SWOT Analysis ReviewNichi-Iko Pharmaceutical Co., Ltd. (Nichi-Iko) is a publicly held pharmaceutical company. It is focused on the manufacture and mar |
2011 | 125,00$ |
PT Indofarma (Persero) Tbk (INAF) - Financial and Strategic SWOT Analysis ReviewPt Indofarma (Persero) Tbk (Indofarma), a medical equipment and pharmaceutical company, that is engaged in the manufacture, market |
2011 | 250,00$ |
PT Kimia Farma (Persero) Tbk (KAEF) - Financial and Strategic SWOT Analysis ReviewPT Kimia Farma Tbk (Kimia Farma) is pharmaceutical company that is engaged in the manufacture, development and sale of chemical an |
2011 | 125,00$ |
TTY Biopharm Company Limited (4105) - Financial and Strategic SWOT Analysis ReviewTTY Biopharm Company Limited (TTY) is a Taiwan based bio-pharmaceutical company, engaged in research and development of drugs for |
2011 | 250,00$ |
Standard Chemical & Pharmaceutical Co. (1720) - Financial and Strategic SWOT Analysis ReviewStandard Chemical & Pharmaceutical Co. (Standard Chemical) is engaged in the activities including product innovation, manufacturin |
2011 | 250,00$ |
PhytoHealth Corporation (4108) - Financial and Strategic SWOT Analysis ReviewPhytoHealth Corporation (PhytoHealth) is a pharmaceutical company engaged in developing, manufacturing and commercializing drugs f |
2011 | 250,00$ |
Pihsiang Machinery Mfg. Co., Ltd. (1729) - Financial and Strategic SWOT Analysis ReviewPihsiang Machinery Mfg. Co., Ltd. (Pihsiang Machinery) is a public limited company principally engaged in the research, developmen |
2011 | 250,00$ |
Hyundai Pharmaceutical Co., Ltd. (004310) - Financial and Strategic SWOT Analysis ReviewHyundai Pharmaceutical Co., Ltd. (Hyundai Pharma) is publically held pharmaceutical company. The company is involved in manufactur |
2011 | 250,00$ |
Chi Sheng Chemical Corporation (4111) - Financial and Strategic SWOT Analysis ReviewChi Sheng Chemical Corporation (Chi Sheng) is a publicly held healthcare company. The company is involved in manufacturing and dis |
2011 | 250,00$ |
LG Life Sciences, Ltd (068870) - Financial and Strategic SWOT Analysis ReviewLG Life Sciences, Ltd. (LGLS) engages in the development and marketing of pharmaceutical products. The operational business of the |
2011 | 250,00$ |
CCM Duopharma Biotech Bhd. (CCMDBIO) - Financial and Strategic SWOT Analysis ReviewCCM Duopharma Biotech Bhd. (CCM Duopharma) is a publicly held investment holding company. The company is involved in manufacturing |
2011 | 250,00$ |
China Chemical & Pharmaceutical Co. Ltd. (1701) - Financial and Strategic SWOT Analysis ReviewChina Chemical & Pharmaceutical Co. Ltd. (China Chemical) is publically held pharmaceutical company. The company is involved in in |
2011 | 250,00$ |
Pelion SA (PGF) - Financial and Strategic SWOT Analysis ReviewPelion SA (Pelion), formerly Polska Grupa Farmaceutyczna S.A., is a publicly held healthcare company. It is engaged in the distrib |
2011 | 125,00$ |
CMIC Co., Ltd. (2309) - Financial and Strategic SWOT Analysis ReviewCMIC Co., Ltd. (CMIC) is a publicly held healthcare company. The company is involved in providing services related to pharmaceutic |
2011 | 125,00$ |
Ohki Co., Ltd. (8120) - Financial and Strategic SWOT Analysis ReviewOhki Co Ltd. (Ohki) is a publicly held pharmaceutical company. It is principally engaged in the wholesale distribution of pharmace |
2011 | 125,00$ |
Shigematsu Works Co., Ltd. (7980) - Financial and Strategic SWOT Analysis ReviewShigematsu Works Co., Ltd. (Shigematsu) is a publicly held respiratory device company. It is, principally involved in the producti |
2011 | 250,00$ |
Hua Han Bio-Pharmaceutical Holdings Ltd. (587) - Financial and Strategic SWOT Analysis ReviewHua Han Bio-Pharmaceutical Holdings Ltd. (Hua Han) is a Hong Kong based public share holding company. It is engaged in the manufac |
2011 | 250,00$ |
Tong Ren Tang Technologies Co., Ltd. (1666) - Financial and Strategic SWOT Analysis ReviewTong Ren Tang Technologies Co., Ltd. (TRTT) is a publicly held pharmaceutical company. It is engaged in the development, productio |
2011 | 125,00$ |
Deva Holding A.S. (DEVA) - Financial and Strategic SWOT Analysis ReviewDeva Holding A.S. (Deva) is a pharmaceutical company. The company is involved in manufacturing and marketing of branded generic ph |
2011 | 125,00$ |
PT Darya-Varia Laboratoria Tbk (DVLA) - Financial and Strategic SWOT Analysis ReviewPt Darya-Varia Laboratoria Tbk (Darya-Varia), an Indonesia-based pharmaceutical company. It is engaged in the manufacture, trade a |
2011 | 250,00$ |
LONGLIFE HOLDING Co., Ltd. (4355) - Financial and Strategic SWOT Analysis ReviewLONGLIFE HOLDING Co., Ltd. (LHCL) is a provider of nursing care services. It is principally engaged in operating nursing home and |
2011 | 250,00$ |
Sapporo Clinical Laboratory Inc. (9776) - Financial and Strategic SWOT Analysis ReviewSapporo Clinical Laboratory Inc. (Sapporo) is a publicly held pharmaceutical research company. It is engaged in public health and |
2011 | 250,00$ |
Medical System Network Co., Ltd. (4350) - Financial and Strategic SWOT Analysis ReviewMedical System Network Co., Ltd. (MSNW) is a publicly held Japan based pharmaceutical company. It is engaged in the pharmaceutical |
2011 | 125,00$ |
Biotie Therapies Corp. (BTH1V) - Financial and Strategic SWOT Analysis ReviewBiotie Therapies Corp. (Biotie) is a biotechnology company, engaged in the discovery and development of therapeutics for the treat |
2011 | 250,00$ |
Abano Healthcare Group Limited (ABA) - Financial and Strategic SWOT Analysis ReviewAbano Healthcare Group Limited (Abano Healthcare) is publicly held healthcare and medical services provider. The company operates |
2011 | 250,00$ |
Euro-Med Laboratories Phil., Inc. (EURO) - Financial and Strategic SWOT Analysis ReviewEuro-Med Laboratories Phil., Inc. (Euro-Med) is publicly held bio Technology Company. The company is involved in manufacturing and |
2011 | 250,00$ |
ALKALOID AD - Skopje (ALK) - Financial and Strategic SWOT Analysis ReviewALKALOID AD Skopje (ALKALOID) is a pharmaceutical company involved in the production of drugs, cosmetics and chemical products, as |
2011 | 250,00$ |
Sam Chun Dang Pharm Co., Ltd. (000250) - Financial and Strategic SWOT Analysis ReviewSam Chun Dang Pharm Co., Ltd. (Sam Chun) is a Korea-based pharmaceutical company. The company is engaged in the so engaged in the |
2011 | 250,00$ |
Schnell Biopharmaceuticals, Inc. (003060) - Financial and Strategic SWOT Analysis ReviewSchnell Biopharmaceuticals, Inc. (Schnell) is a publicly held pharmaceutical product manufacturing company. It is engaged in the p |
2011 | 250,00$ |
Daewon Pharmaceutical Co., Ltd. (003220) - Financial and Strategic SWOT Analysis ReviewDaewon Pharmaceutical Co., Ltd. (Daewon) is a korea based pharmaceutical company and involved in the development, production and |
2011 | 250,00$ |
Les Trois Chenes SA (MLTRC) - Financial and Strategic SWOT Analysis ReviewLes Trois Chenes SA (Les Trois) is a France-based food supplements and cosmetic products manufacturing company. The company is pri |
2011 | 250,00$ |
Innocell Corporation (031390) - Financial and Strategic SWOT Analysis ReviewInnocell Corporation (Innocell) operates as a biotechnology company. The company is involved in the development of immune cell tre |
2011 | 250,00$ |
BLIS Technologies Ltd (BLT) - Financial and Strategic SWOT Analysis ReviewBLIS Technologies Ltd (BLIS) is pharmaceutical company involved in oral health care market. The service portfolio includes develop |
2011 | 250,00$ |
Botry-Zen Limited (BOZ) - Financial and Strategic SWOT Analysis ReviewBotry-Zen Limited (Botry-Zen) is a biotechnology company engaged in developing and commercializing biological control agents that |
2011 | 250,00$ |
BioPhausia AB (BIOP) - Financial and Strategic SWOT Analysis ReviewBioPhausia AB (BioPhausia) operates as a Sweden based pharmaceutical company. The company is involved in the provision of cost-eff |
2011 | 250,00$ |
Komipharm International Co., Ltd. (041960) - Financial and Strategic SWOT Analysis ReviewKomipharm International Co., Ltd. (Komipharm) is a publicly held pharmaceutical company. It is engaged in manufacturing veterinary |
2011 | 250,00$ |
Jin Yang Pharmaceutical Co., Ltd. (007370) - Financial and Strategic SWOT Analysis ReviewJin Yang Pharmaceutical Co., Ltd. (Jin Yang) is a pharmaceutical company engaged in the development and production of pharmaceutic |
2011 | 250,00$ |
PharmswellBio Co., Ltd. (043090) - Financial and Strategic SWOT Analysis ReviewPharmswellBio Co., Ltd. (PharmswellBio) is a publicly held company that is largely focused on bioengineering industry. The company |
2011 | 250,00$ |
F. Reichelt AG (RCH) - Financial and Strategic SWOT Analysis ReviewF. Reichelt AG (Reichelt) is involved in distribution of pharmaceutical products. The company is engaged in supplying of drugs, me |
2011 | 250,00$ |
Korea United Pharm, Inc. (033270) - Financial and Strategic SWOT Analysis ReviewKorea United Pharm, Inc., is a South Korean based company which is involved in the production, marketing, selling and distributing |
2011 | 250,00$ |
Sam-A Pharm. Co., Ltd. (009300) - Financial and Strategic SWOT Analysis ReviewSam-A Pharm. Co., Ltd. (Sam-A) is principally engaged in the manufacture and sale of pharmaceuticals. The company has recently com |
2011 | 250,00$ |
Eagle Veterinary Technology Co., Ltd. (044960) - Financial and Strategic SWOT Analysis ReviewEagle Veterinary Technology Co., Ltd. (Eagle Vet) is involved in exporting and manufacturing of veterinary health care products.Th |
2011 | 250,00$ |
CHO-A PHARM.Co.,LTD. (034940) - Financial and Strategic SWOT Analysis ReviewCHO-A PHARM.Co., LTD. (CHO-A) is a public pharmaceutical company, that is involved in distribution and manufacturing of pharmaceut |
2011 | 250,00$ |
Medica Sur SAB de CV (MEDICAB) - Financial and Strategic SWOT Analysis ReviewMedica Sur SAB de CV (Medica) is a non-governmental institution, engaged in healthcare sector. Medica operates its own clinic comp |
2011 | 250,00$ |
Supermax Corporation Berhad (SUPERMX) - Financial and Strategic SWOT Analysis ReviewSupermax Corporation Berhad (Supermax Corp) is a publicly held medical appliance provider, principally engaged in the manufacturin |
2011 | 125,00$ |
Dawnrays Pharmaceutical (Holdings) Limited (2348) - Financial and Strategic SWOT Analysis ReviewDawnrays Pharmaceutical (Holdings) Limited (Dawnrays) is a pharmaceutical company, that engaged in the development, manufacturing |
2011 | 250,00$ |
MEDINET Co., Ltd. (2370) - Financial and Strategic SWOT Analysis ReviewMEDINET Co., Ltd. (Medinet) is a publicly held research focused biotechnology company that is engaged in developing immuno cell th |
2011 | 250,00$ |
AquaCarotene Limited (AQL) - Financial and Strategic SWOT Analysis ReviewAquaCarotene Limited (AquaCarotene) is engaged in growing and commercializing natural micro algae products. The company is princip |
2011 | 250,00$ |
Daesung Microbiological Labs, Co., Ltd. (036480) - Financial and Strategic SWOT Analysis ReviewDaesung Microbiological Labs, Co., Ltd., (Daesung Microbiological) is an animal pharmaceuticals product development and manufactur |
2011 | 250,00$ |
Cheil Bio Co., Ltd. (052670) - Financial and Strategic SWOT Analysis ReviewCheil Bio Co., Ltd.(Cheil Bio) is health care company, principally engaged in the manufacture and marketing of veterinary products |
2011 | 250,00$ |
Daehan New Pharm Co., Ltd. (054670) - Financial and Strategic SWOT Analysis ReviewDaehan New Pharm Co., Ltd. (Daehan New Pharm) is a South Korea based pharmaceutical health care industry. The company is involved |
2011 | 250,00$ |
CTCBIO INC. (060590) - Financial and Strategic SWOT Analysis ReviewCTCBIO INC (CTCBIO) is a South Korea based health care organization. The company is involved in the provision of pharmaceuticals, |
2011 | 250,00$ |
Skynewpharm Inc. (058820) - Financial and Strategic SWOT Analysis ReviewSkynewpharm Inc. (Skynewpharm) is a pharmaceutical company engaged in drug manufacturing and research activities. The product port |
2011 | 250,00$ |
CKD Bio Corporation (063160) - Financial and Strategic SWOT Analysis ReviewCKD Bio Corporation (CKD Bio Corporation) is a health care pharmaceutical organization in Korea. The company is engaged in the dev |
2011 | 250,00$ |
Daihan Pharmaceutical Co., Ltd. (023910) - Financial and Strategic SWOT Analysis ReviewDai Han Pharmaceutical Co., Ltd., (Dai Han) is a Korea based medical terminology pharmaceutical organization. The company is invol |
2011 | 250,00$ |
Hwail Pharma Co., Ltd. (061250) - Financial and Strategic SWOT Analysis ReviewHwail Pharma Co., Ltd. (Hwail Pharma Co., Ltd.) is Korea based medical terminology pharmaceutical organization. The company is inv |
2011 | 250,00$ |
DAE HWA Pharm Co., Ltd. (067080) - Financial and Strategic SWOT Analysis ReviewDAE HWA Pharm. Co., Ltd. (DAE HWA) is a South Korea based medical health care pharmaceutical organization. The company is involved |
2011 | 250,00$ |
Kyung Nam Pharm. Co., Ltd. (053950) - Financial and Strategic SWOT Analysis ReviewThis comprehensive SWOT profile of Kyung Nam Pharm. Co., Ltd. provides you an in-depth strategic analysis of the company’s busine |
2011 | 250,00$ |
Soiken Holdings Inc. (2385) - Financial and Strategic SWOT Analysis ReviewSoiken Holdings Inc. (Soiken Holdings) is a publicly held biotechnology company that operates its businesses in four segments name |
2011 | 250,00$ |
Shinil Pharmaceutical Co., Ltd. (012790) - Financial and Strategic SWOT Analysis ReviewShinil Pharmaceutical Co., Ltd., is a publicly held South Korea based pharmaceutical company. It is engaged in the production and |
2011 | 250,00$ |
Seoul Pharma Co., Ltd. (018680) - Financial and Strategic SWOT Analysis ReviewSeoul Pharma Co., Ltd. (Seoul Pharma) is a pharmaceutical company engaged in the manufacture and sale of pharmaceutical formulatio |
2011 | 250,00$ |
Korean Drug Co., Ltd. (014570) - Financial and Strategic SWOT Analysis ReviewKorean Drug Co., Ltd. (KDC) is pharmaceutical products manufacturer company. The company is engaged in manufacturing over the co |
2011 | 250,00$ |
OncoTherapy Science, Inc. (4564) - Financial and Strategic SWOT Analysis ReviewOncoTherapy Science, Inc. (OncoTherapy Science) is a Japan-based health care biotechnology organization. The company engages in th |
2011 | 250,00$ |
Goldis Berhad (GOLDIS) - Financial and Strategic SWOT Analysis ReviewGoldis Berhad (Goldis) is a publicly held investment holding company. It focuses on the fields of life sciences, information commu |
2011 | 250,00$ |
Joincare Pharmaceutical Group Industry Co., Ltd. (600380) - Financial and Strategic SWOT Analysis ReviewJoincare Pharmaceutical Group Industry Co., Ltd. (Joincare) is a publicly held pharmaceutical company engaged in the manufacture |
2011 | 125,00$ |
Stirling Products Limited (STI) - Financial and Strategic SWOT Analysis ReviewStirling Products Limited (Stirling) is a publicly held pharmaceutical company. It focuses on the development and commercializati |
2011 | 250,00$ |
EstechPharma Co., Ltd. (041910) - Financial and Strategic SWOT Analysis ReviewEstechPharma Co., Ltd. (EstechPharma) is a pharmaceutical company that is engaged in manufacturing and supplying active pharmaceut |
2011 | 250,00$ |
Select Vaccines Limited (SLT) - Financial and Strategic SWOT Analysis ReviewSelect Vaccines Limited (SVL) is a publicly held pharmaceutical company, engaged in the development of vaccines based on its virus |
2011 | 250,00$ |
SciGen Limited (SIE) - Financial and Strategic SWOT Analysis ReviewSciGen Limited (SciGen) is a bio-pharmaceutical company engaged in the development, manufacturing and marketing of recombinant hum |
2011 | 250,00$ |
Transition Therapeutics Inc. (TTH) - Financial and Strategic SWOT Analysis ReviewTransition Therapeutics Inc. (Transition Therapeutics) is Canada based health care biopharmaceutical company. The organization i |
2011 | 250,00$ |
Beijing Double-Crane Pharmaceutical Co., Ltd. (600062) - Financial and Strategic SWOT Analysis ReviewBeijing Double-Crane Pharmaceutical Co., Ltd.(Beijing Double-Crane Pharmaceutical Co., Ltd.) is China based pharmaceutical organiz |
2011 | 125,00$ |
Bio-Treat Technology Ltd. (B22) - Financial and Strategic SWOT Analysis ReviewBio-Treat Technology Ltd. (Bio-Treat) is engaged in the development and application of biotechnology for the treatment of waste an |
2011 | 250,00$ |
DNA Chip Research Inc. (2397) - Financial and Strategic SWOT Analysis ReviewDNA Chip Research Inc. (DNA Chip Research Inc.) is a Japan based medical research organization. The company is involved in manufac |
2011 | 250,00$ |
ChoongAng Vaccine Laboratory (072020) - Financial and Strategic SWOT Analysis ReviewChoongAng Vaccine Laboratory (ChoongAng Vaccine Laboratory) is a South Korea based pharmaceutical research Laboratory. The company |
2011 | 250,00$ |
GuiZhou YiBai Pharmaceutical Co., Ltd. (600594) - Financial and Strategic SWOT Analysis ReviewGuiZhou YiBai Pharmaceutical Co., Ltd. (GuiZhou YiBai Pharmaceutical Co., Ltd.) is China based pharmaceutical company. The company |
2011 | 125,00$ |
PharmaGap Inc. (GAP) - Financial and Strategic SWOT Analysis ReviewPharmagap Inc. (Pharmagap) is biotechnology company, that is engaged in clinical development of innovative therapeutics for severa |
2011 | 250,00$ |
DR. Chip Biotech Inc. (4131) - Financial and Strategic SWOT Analysis ReviewDr. Chip Biotechnology, Inc. (Dr. Chip Biotechnology, Inc.) is a Taiwan based biotechnology organization. The company is involved |
2011 | 250,00$ |
TSUKUI CORPORATION (2398) - Financial and Strategic SWOT Analysis ReviewTsukui Corporation (Tsukui) is a publicly held, Japan based health care services company. It is engaged in providing broad range o |
2011 | 125,00$ |
Catasys, Inc. (CATS) - Financial and Strategic SWOT Analysis ReviewCatasys, Inc. (Catasys) is a managed healthcare services organization engaged in providing health care plans and rehabilitation se |
2011 | 250,00$ |
Allon Therapeutics Inc. (NPC) - Financial and Strategic SWOT Analysis ReviewAllon Therapeutics Inc. (Allon), formerly Neuro Discovery Inc. is a clinical-stage biotechnology company, engaged in the developme |
2011 | 250,00$ |
Medtecs International Corporation Limited (546) - Financial and Strategic SWOT Analysis ReviewMEDTECS INTERNATIONAL CORPORATION LIMITED (Medtecs) is a publicly held medical device company. It is engaged in providing integrat |
2011 | 250,00$ |
Sopharma AD Sofia (3JR) - Financial and Strategic SWOT Analysis ReviewSopharma AD Sofia (Sopharma), is a public share holding company. It is engaged in the manufacture and trade of active substances a |
2011 | 125,00$ |
AS Olainfarm (OLF1R) - Financial and Strategic SWOT Analysis ReviewAS Olainfarm (AS Olainfarm) is a health care pharmaceutical joint stock organization. The company is involved in the developmentof |
2011 | 250,00$ |
Bangkok Dusit Medical Services PCL (BGH) - Financial and Strategic SWOT Analysis ReviewBangkok Dusit Medical Services PCL (BDMS) is a publicly held health care services company. The hospital network consists of over 7 |
2011 | 125,00$ |
Prasit Patana Public Company Limited (PYT) - Financial and Strategic SWOT Analysis ReviewPrasit Patana Public Company Limited (Prasit Patana) is a pharmaceutical provider service company engaged into hospital business u |
2011 | 250,00$ |
Samitivej PCL (SVH) - Financial and Strategic SWOT Analysis ReviewSamitivej PCL (Samitivej) is a publicly held health care services company.It is engaged in providing integrated medical services i |
2011 | 250,00$ |
Sikarin PCL (SKR) - Financial and Strategic SWOT Analysis ReviewSikarin PCL (Sikarin) is a publicly held healthcare service provider company owned by Sikarin Public Company limited. It is engage |
2011 | 250,00$ |
Jinling Pharmaceutical Co., Ltd. (000919) - Financial and Strategic SWOT Analysis ReviewJinling Pharmaceutical Co., Ltd. (Jinling) is a pharmaceutical company engaged in the research, development, manufacture and sale |
2011 | 125,00$ |
Medical Facilities Corporation (DR) - Financial and Strategic SWOT Analysis ReviewMedical Facilities Corporation (MFC) is a publicly held hospital that operates four specialty surgical hospitals (SSHs) located in |
2011 | 125,00$ |
Message Co., Ltd. (2400) - Financial and Strategic SWOT Analysis ReviewMessage Co., Ltd. (Message Co.) is a health care company, engaged in providing nursing care services to old people. It operates el |
2011 | 125,00$ |
Chiang Mai Ram Medical Business PCL (CMR) - Financial and Strategic SWOT Analysis ReviewChiang Mai Ram Medical Business PCL (Chiang Mai Ram Medical Business PCL) is one of the largest medical health care services provi |
2011 | 250,00$ |
Quest PharmaTech Inc. (QPT) - Financial and Strategic SWOT Analysis ReviewQuest PharmaTech Inc. (Quest) is a Canada based company which is involved in discovering, developing and commercializing pharmaceu |
2011 | 250,00$ |
Imagin Molecular Corporation (IMGM) - Financial and Strategic SWOT Analysis ReviewImagin Molecular Corporation (Imagin) is a medical devices company engaged in the manufacture of positron emission tomography (PET |
2011 | 250,00$ |
MaYinglong Pharmaceutical Group Co., Ltd (600993) - Financial and Strategic SWOT Analysis ReviewMaYinglong Pharmaceutical Group Co., Ltd (MaYinglong Pharmaceutical) is china based pharmaceutical company. It is engaged in the |
2011 | 250,00$ |
PT Merck Tbk (MERK) - Financial and Strategic SWOT Analysis ReviewPT Merck Tbk (Merck Tbk) is engaged in the manufacture of prescriptions drugs and over-the-counter products. The numerous products |
2011 | 250,00$ |
Pluristem Therapeutics Inc. (PSTI) - Financial and Strategic SWOT Analysis ReviewPluristem Therapeutics Inc. (Pluristem Therapeutics Inc.) is a Israel based bio-therapeutics organization. The company is involved |
2011 | 250,00$ |
PT Schering Plough Indonesia Tbk (SCPI) - Financial and Strategic SWOT Analysis ReviewPT Schering Plough Indonesia Tbk (PT Schering) is an outsourcing company engaged in activities like processing and marketing of ph |
2011 | 250,00$ |
Mahachai Hospital Public Company Limited (M-CHAI) - Financial and Strategic SWOT Analysis ReviewMahachai Hospital Public Company Limited (Mahachai) is a public listed health care company that is engaged in providing health car |
2011 | 250,00$ |
Gesundheitswelt Chiemgau AG (JTH) - Financial and Strategic SWOT Analysis ReviewGesundheitswelt Chiemgau AG (Gesundheitswelt Chiemgau AG) is Germany based health resorts and Clinics Company. The company is main |
2011 | 250,00$ |
Theravance, Inc. (THRX) - Financial and Strategic SWOT Analysis ReviewTheravance, Inc. (Theravance) formerly known as Advanced Medicine, Inc. is a US-based health care pharmaceutical company. The comp |
2011 | 250,00$ |
Resverlogix Corp. (RVX) - Financial and Strategic SWOT Analysis ReviewResverlogix Corp. (Resverlogix Corp.) is Canada based clinical biotechnology organization. The company is involved in the developm |
2011 | 250,00$ |
Ondine Biopharma Corporation (OBP) - Financial and Strategic SWOT Analysis ReviewOndine Biopharma Corporation (now known as Ondine Biomedical Inc.) is a biotechnology company, that is engaged on the development |
2011 | 250,00$ |
Aikchol Hospital Public Company Limited (AHC) - Financial and Strategic SWOT Analysis ReviewAikchol Hospital Public Company Limited (Aikchol Hospital Public Company Limited) is Thailand based health care services Provider |
2011 | 250,00$ |
Propharex (PROP) - Financial and Strategic SWOT Analysis ReviewPropharex is a specialty pharmaceutical company specialized in the conception, the construction, the delivery and the assembly of |
2011 | 125,00$ |
LTT Bio-Pharma Co., Ltd. (4566) - Financial and Strategic SWOT Analysis ReviewLTT Bio-Pharma Co., Ltd. (LTT Bio-Pharma) is a biotech company, engaged in research and development of drugs and new technologies. |
2011 | 250,00$ |
Care Service Co., Ltd. (2425) - Financial and Strategic SWOT Analysis ReviewCare Service Co., Ltd. (Care Service Co., Ltd.) is Japan based healthcare Services industry. The company is involved in the condit |
2011 | 250,00$ |
Takara Bio Inc. (4974) - Financial and Strategic SWOT Analysis ReviewTakara Bio Inc. (Takara) is a biotechnological company which is focused on developing genomics and biotechnology research reagents |
2011 | 125,00$ |
Henan Topfond Pharmaceutical Co., Ltd (600253) - Financial and Strategic SWOT Analysis ReviewHenan Topfond Pharmaceutical Co., Ltd (Henan Topfond Pharmaceutical Co., Ltd) is China based pharmaceutical company. The company w |
2011 | 125,00$ |
Jiangsu Hengrui Medicine Co., Ltd. (600276) - Financial and Strategic SWOT Analysis ReviewJiangsu Hengrui Medicine Co., Ltd. (Jiangsu Hengrui) is a biopharmaceutical company engaged in the manufacturing and distribution |
2011 | 125,00$ |
Threshold Pharmaceuticals, Inc. (THLD) - Financial and Strategic SWOT Analysis ReviewThreshold Pharmaceuticals, Inc.(Threshold Pharmaceuticals) is a biotechnology company, engaged in the discovery and development of |
2011 | 250,00$ |
Provectus Pharmaceuticals, Inc. (PVCT) - Financial and Strategic SWOT Analysis ReviewProvectus Pharmaceuticals, Inc. (Provectus) is a biotechnology company, that is engaged in the development of oncology and dermato |
2011 | 250,00$ |
Tianjin Tianyao Pharmaceutical Co., Ltd (600488) - Financial and Strategic SWOT Analysis ReviewTianjin Tianyao Pharmaceutical Co., Ltd. (TJPC) is a pharmaceutical company, engaged in the development and production of pharmace |
2011 | 250,00$ |
JiLin AoDong Medicine Industry Group Co., Ltd. (000623) - Financial and Strategic SWOT Analysis ReviewJiLin AoDong Medicine Industry Group Co., Ltd. (Jilin Aodong) is a pharmaceutical company engaged, that is engaged in the manufact |
2011 | 250,00$ |
Guangxi Beisheng Pharmaceutical Co., Ltd (600556) - Financial and Strategic SWOT Analysis ReviewGuangxi Beisheng Pharmaceutical Co., Ltd (Guangxi Beisheng Pharmaceutical Co., Ltd.) is China medicine manufacturing organization. |
2011 | 250,00$ |
Care Twentyone Corporation (2373) - Financial and Strategic SWOT Analysis ReviewCare Twentyone Corporation (Care Twentyone Corporation) is Japan based health care pharmaceutical organization. The company is mai |
2011 | 250,00$ |
CEDAR Co., Ltd. (2435) - Financial and Strategic SWOT Analysis ReviewCEDAR. Co., Ltd. (CEDAR. Co., Ltd) is a Japan based healthcare organization. The company is involved in providing nursing care ser |
2011 | 250,00$ |
Indoco Remedies Limited (INDOCO) - Financial and Strategic SWOT Analysis ReviewIndoco Remedies Limited (Indoco Remedies) is india based pharmaceutical health care organization. The company is involved in the d |
2011 | 250,00$ |
United Envirotech Ltd. (U19) - Financial and Strategic SWOT Analysis ReviewUnited Envirotech Ltd (United Envirotech) is a holding company. It is an environmental solution provider, which is focused on wate |
2011 | 250,00$ |
Hovid Berhad (HOVID) - Financial and Strategic SWOT Analysis ReviewHovid Berhad (Hovid), formerly Ho Yan Hor, is a pharmaceutical company. It carries out the manufacture and commercialization of ph |
2011 | 250,00$ |
Taiko Pharmaceutical Co.,Ltd. (4574) - Financial and Strategic SWOT Analysis ReviewTaiko Pharmaceutical Co.,Ltd. (Taiko) is a pharmaceutical company that is engaged in the manufacture, sale and export of gastroint |
2011 | 250,00$ |
Swissmed Centrum Zdrowia S.A. (SWD) - Financial and Strategic SWOT Analysis ReviewSwissmed Centrum Zdrowia SA (Swissmed) is a Poland based medical organization, engaged in offering a range of medical services fro |
2011 | 250,00$ |
Neuca SA (TFM) - Financial and Strategic SWOT Analysis ReviewThis comprehensive SWOT profile of Neuca SA provides you an in-depth strategic analysis of the company’s businesses and operation |
2011 | 125,00$ |
Essex Bio-Technology Limited (8151) - Financial and Strategic SWOT Analysis ReviewEssex Bio-Technology Limited (Essex) is a Hong Kong based investment holding drug development company. It principally focuses on t |
2011 | 250,00$ |
LifeVantage Corporation (LFVN) - Financial and Strategic SWOT Analysis ReviewLifeVantage Corporation (LifeVantage) is a publicly traded company engaged in the manufacture, marketing and distribution of its d |
2011 | 250,00$ |
Lipidviro Tech, Inc. (LPVO) - Financial and Strategic SWOT Analysis ReviewLipidViro Tech, Inc. (LTI) was engaged in providing research and development for d-OSAB Therapy, a treatment specifically for card |
2011 | 250,00$ |
PT. Pyridam Farma Tbk. (PYFA) - Financial and Strategic SWOT Analysis ReviewPT. Pyridam Farma Tbk. (Pyridam) is a pharmaceutical company engaged in the manufacture of cosmetics, food supplements, over the c |
2011 | 250,00$ |
SemBiosys Genetics Inc. (SBS) - Financial and Strategic SWOT Analysis ReviewSemBioSys Genetics Inc. (SemBioSys) is a plant biotechnology company, that is engaged in the development of pharmaceutical and non |
2011 | 250,00$ |
Pharmesis International Ltd. (P31) - Financial and Strategic SWOT Analysis ReviewPharmesis International Ltd. (Pharmesis) is a pharmaceutical company that manufactures western medicine and traditional Chinese me |
2011 | 250,00$ |
Suven Life Sciences Ltd. (SUVEN) - Financial and Strategic SWOT Analysis ReviewSuven Life Sciences Ltd. (Suven) is a biotechnology company engaged in the business of design, manufacture and supply of bulk acti |
2011 | 250,00$ |
Galapagos NV (GLPG) - Financial and Strategic SWOT Analysis ReviewGalapagos NV (Galapagos) is Belgium based health care pharmaceutical company. The company is involved in discovery and manufacture |
2011 | 250,00$ |
EMC Instytut Medyczny SA (EMCINSMED) - Financial and Strategic SWOT Analysis ReviewEMC Instytut Medyczny SA (EMC Instytut Medyczny SA) is a Poland based health care pharmaceutical organization. The company is invo |
2011 | 250,00$ |
Uni-Bio Science Group Ltd. (0690) - Financial and Strategic SWOT Analysis ReviewUni-Bio Science Group Limited (Uni-Bio Science) is a publicly held pharmaceutical company. It is engaged in the development of nex |
2011 | 250,00$ |
Ruyan Group (Holdings) Limited (329) - Financial and Strategic SWOT Analysis ReviewRuyan Group (Holdings) Limited (Ruyan), is formally the company was known as Golden Dragon Group (Holdings) Limited, the main boar |
2011 | 250,00$ |
Thomson Medical Centre Limited (5FV) - Financial and Strategic SWOT Analysis ReviewThomson Medical Centre Limited (TMC) is a publicly held health care service provider company that is principally engaged in provid |
2011 | 250,00$ |
Apollo Consolidated Limited (AOP) - Financial and Strategic SWOT Analysis ReviewApollo Consolidated Limited (Apollo Consolidated Limited) is an Australia based skin care organization. Apollo Consolidated Limite |
2011 | 250,00$ |
Broad Intelligence International Pharmaceutical Holdings Limited (1149) - Financial and Strategic SWOT Analysis ReviewBroad Intelligence International Pharmaceutical Holdings Limited (Broad Intelligence) is a pharmaceutical company that is engaged |
2011 | 250,00$ |
Jiwa Bio-Pharm Holdings Limited (2327) - Financial and Strategic SWOT Analysis ReviewJiwa Bio-Pharm Holdings Limited (Jiwa) is a publicly held pharmaceutical company that is engaged in the producing, selling and dis |
2011 | 250,00$ |
INS Bioscience Berhad (INSBIO) - Financial and Strategic SWOT Analysis ReviewINS Bioscience Berhad (INSBio) is a publicly held healthcare company engaged in the research and development of food base health s |
2011 | 250,00$ |
Hualan Biological Engineering, Inc. (002007) - Financial and Strategic SWOT Analysis ReviewHualan Biological Engineering, Inc. (Hualan Biological) is a publicly held bio-pharmaceutical company that is involved in the rese |
2011 | 250,00$ |
MediPost Co., Ltd. (078160) - Financial and Strategic SWOT Analysis ReviewMedipost Co, Ltd. (Medipost) is a South Korea based health care organization. The company is involved in the provision of cell rep |
2011 | 250,00$ |
Byotrol Plc (BYOT) - Financial and Strategic SWOT Analysis ReviewByotrol plc (Byotrol) is a publicly held biotechnology company engaged in the development of biocides through hygiene technology. |
2011 | 250,00$ |
Medi-Flex Limited (5FF) - Financial and Strategic SWOT Analysis ReviewMedi-Flex Limited (Medi-Flex) is a publicly held cleanroom medical disposal glove manufacturer company is engaged in the business |
2011 | 250,00$ |
Fuhua Group Co. Ltd. Zhuhai S.E.Z. (000507) - Financial and Strategic SWOT Analysis ReviewFuhua Group Co. Ltd. Zhuhai S.E.Z. (Fuhua Group Co. Ltd. Zhuhai S.E.Z.) is China based pharmaceutical industry. The company is eng |
2011 | 125,00$ |
Carotech Bhd. (CAROTEC) - Financial and Strategic SWOT Analysis ReviewCarotech Berhad (Carotech) publicly held company that is engaged in the extraction and processing of nutrients from virgin crude p |
2011 | 250,00$ |
TMC Life Sciences Berhad (TMCLIFE) - Financial and Strategic SWOT Analysis ReviewTMC Life Sciences Berhad (TMC Life) is a publicly held healthcare company engaged in the provision of specialist healthcare servic |
2011 | 250,00$ |
Jiuzhitang Co.,Ltd. (000989) - Financial and Strategic SWOT Analysis ReviewJiuzhitang Co., Ltd. (Jiuzhitang) is a China based company which is engaged in the production of Chinese traditional medicines. Th |
2011 | 125,00$ |
HENAN TALOPH PHARMACEUTICAL STOCK CO., LTD (600222) - Financial and Strategic SWOT Analysis ReviewHenan Taloph Pharmaceutical Stock Co., Ltd (Henan Taloph Pharmaceutical Stock Co) is Chinese medicine based pharmaceutical company |
2011 | 250,00$ |
Reyoung Pharmaceutical Holdings Limited (R12) - Financial and Strategic SWOT Analysis ReviewReyoung Pharmaceutical Holdings Limited (RPHL) is a publicly held manufacturer and distributor of personal hygiene and pharmaceuti |
2011 | 250,00$ |
Topsun Science and Technology Co., Ltd. (600771) - Financial and Strategic SWOT Analysis ReviewTopsun Science and Technology Co., Ltd. (Topsun) is a pharmaceutical company which is engaged in the production and sale of prescr |
2011 | 250,00$ |
C & O Pharmaceutical Technology (Holdings) Limited (E92) - Financial and Strategic SWOT Analysis ReviewC & O Pharmaceutical Technology (C & O Pharmaceutical Technology) is Hong Kong based health care pharmaceutical industry. The comp |
2011 | 250,00$ |
CareTech Holdings PLC (CTH) - Financial and Strategic SWOT Analysis ReviewCareTech Holdings PLC (CareTech) is a publicly held company that is engaged in providing a range of specialist care and housing s |
2011 | 250,00$ |
Sichuan Joint-Wit Med. & Pharm. Ind. (000809) - Financial and Strategic SWOT Analysis ReviewSichuan Joint-Wit Med. & Pharm. Ind. (SJWMPI) is a pharmaceutical company engaged in the research, development, production and dis |
2011 | 250,00$ |
Henan Lingrui Pharmaceutical Co., Ltd. (600285) - Financial and Strategic SWOT Analysis ReviewHenan Lingrui Pharmaceutical Co., Ltd. (Lingrui) is a china-based public shareholding company which is engaged in the production a |
2011 | 250,00$ |
Guilinjiqi Pharmaceutical Co., Ltd. (000750) - Financial and Strategic SWOT Analysis ReviewGuilinjiqi Pharmaceutical Co., Ltd. (Guilinjiqi) is a pharmaceutical company engaged in the manufacturing and sale of pharmaceutic |
2011 | 250,00$ |
Angel Biotechnology Holdings plc (ABH) - Financial and Strategic SWOT Analysis ReviewAngel Biotechnology Holdings PLC (Angel Biotechnology) is a contract biomanufacturing company engaged in providing process develop |
2011 | 250,00$ |
Sanitas AB (SAN1L) - Financial and Strategic SWOT Analysis ReviewSanitas AB (Sanitas) is a publicly held pharmaceutical company engaged in the manufacture, development, and sale of generic medici |
2011 | 125,00$ |
Qinghai Gelatin Company Limited (000606) - Financial and Strategic SWOT Analysis ReviewQinghai Gelatin Company Limited (QGCL) is a publicly held pharmaceutical company which is principally engaged in the manufacturi |
2011 | 250,00$ |
Beximco Pharmaceuticals Ltd. (BXP) - Financial and Strategic SWOT Analysis ReviewBeximco Pharmaceuticals Ltd. (Beximco Pharmaceuticals) is a leading edge pharmaceutical company which is engaged in the supply of |
2011 | 250,00$ |
S&P Pharmaceutical Co., Ltd. (600869) - Financial and Strategic SWOT Analysis ReviewS&P Pharmaceutical Co., Ltd. (S&P Pharmaceutical) is a pharmaceutical company engaged in the development, manufacture and sale of |
2011 | 250,00$ |
Mebix, Inc. (3780) - Financial and Strategic SWOT Analysis ReviewMebix, Inc. (Mebix) is a publicly held pharmaceutical company involved in four different business segments which include Evidence |
2011 | 250,00$ |
Medicare Group QSC (MCGS) - Financial and Strategic SWOT Analysis ReviewMedicare Group QSC (Medicare Group) is engaged in providing healthcare and hospital services. The company is principally involved |
2011 | 250,00$ |
Sichuan Di Kang Sci&Tech Pharm. Ind. Co. (600466) - Financial and Strategic SWOT Analysis ReviewSichuan Dikang Sci&Tech Pharmaceutical Industry Co., Ltd. (Dikang) is a pharmaceutical company engaged in the research, manufactur |
2011 | 250,00$ |
Clinica Las Condes S.A. (LASCONDES) - Financial and Strategic SWOT Analysis ReviewClinica Las Condes S.A. (CLC) operates Clinica Las Condes is a publicly held hospital that is engaged in providing health care ser |
2011 | 125,00$ |
Summit Corporation plc (SUMM) - Financial and Strategic SWOT Analysis ReviewSummit Corporation plc (Summit Corp) is a publicly held drug discovery company that is engaged in the discovery and development of |
2011 | 250,00$ |
SeouLin Bioscience Co., Ltd. (038070) - Financial and Strategic SWOT Analysis ReviewSeouLin Bioscience Co., Ltd. (SeouLin Bioscience) is a publicly held biotechnology company principally engaged in the research and |
2011 | 250,00$ |
CrystalGenomics, Inc. (083790) - Financial and Strategic SWOT Analysis ReviewCrystalGenomics, Inc. (CrystalGenomics) is a publicly held pharmaceutical company engaged in the structure-based drug discovery an |
2011 | 250,00$ |
Gulf Pharmaceutical Industries PSC (JULPHUR) - Financial and Strategic SWOT Analysis ReviewGulf Pharmaceutical Industries PSC, also known as Julphar, is a publicly held pharmaceutical company focusing on the manufacture o |
2011 | 125,00$ |
Tibet Rhodiola Pharmaceutical Holding Co., Ltd. (600211) - Financial and Strategic SWOT Analysis ReviewTibet Rhodiola Pharmaceutical Holding Co., Ltd. (TRPHCL) is a publicly held pharmaceutical company engaged in the manufacture and |
2011 | 250,00$ |
Ginwa Enterprise (Group) Inc. (600080) - Financial and Strategic SWOT Analysis ReviewGinwa Enterprise (Group) Inc. (Ginwa) is a well-diversified group engaged in the business of pharmaceuticals and property leasing. |
2011 | 250,00$ |
Hainan Hai Pharmaceutical Co., Ltd. (000566) - Financial and Strategic SWOT Analysis ReviewHainan Haiyao Co., Ltd. (Haiyao) is a china-based public share holding company, engaged in the production and sale of traditional |
2011 | 250,00$ |
Biofarm S.A. (BIO) - Financial and Strategic SWOT Analysis ReviewBiofarm S.A. (Biofarm) is a specialty pharmaceutical company engaged in developing over-the-counter pharmaceuticals. The product p |
2011 | 250,00$ |
Sanjiu Yigong Biopharmaceutical & Chem (000403) - Financial and Strategic SWOT Analysis ReviewSanjiu Yigong Biopharmaceutical & Chemical Inc. (Sanjiu Yigong) is engaged in the development, manufacture and sale of pharmaceuti |
2011 | 250,00$ |
Tonghua Golden-Horse Pharmaceutical Industry Co. Ltd. (000766) - Financial and Strategic SWOT Analysis ReviewTonghua Golden-Horse Pharmaceutical Industry Co. Ltd. (Tonghua) is engaged in the manufacture and commercialization of pharmaceuti |
2011 | 250,00$ |
Unisplendour Guhan Group Corporation Ltd (000590) - Financial and Strategic SWOT Analysis ReviewUnisplendour Guhan Group Corporation Ltd. (Unisplendour) is a publicly held China based pharmaceutical company that is engaged in |
2011 | 250,00$ |
Jiangzhong Pharmaceutical Co.,Ltd (600750) - Financial and Strategic SWOT Analysis ReviewJiangzhong Pharmaceutical Co., Ltd (JZJT) is a pharmaceutical company, engaged in the production and sale of pharmaceuticals produ |
2011 | 125,00$ |
Guangxi Wuzhou Zhongheng Group Co.,Ltd (600252) - Financial and Strategic SWOT Analysis ReviewGuangxi Wuzhou Zhongheng Group Co., Ltd (Zhongheng Group) is a diversified company, principally engaged in research and developmen |
2011 | 250,00$ |
Along Tibet Co., Ltd. PLC (600773) - Financial and Strategic SWOT Analysis ReviewAlong Tibet Co., Ltd. PLC (Along Tibet Co) is principally engaged in the production and sale of pharmaceuticals and agricultural c |
2011 | 250,00$ |
Chang An Info Industry (Group) Co.,Ltd (600706) - Financial and Strategic SWOT Analysis ReviewChang An Info Industry (Group) Co., Ltd (Chang An) is engaged in manufacture and distribution of drugs and medical equipments. The |
2011 | 250,00$ |
NextGen Group PLC (NGG) - Financial and Strategic SWOT Analysis ReviewNextGen Group PLC (NextGen) is a biotechnology company which is engaged in providing protein biomarker services for pharmaceutical |
2011 | 250,00$ |
Jilin Pharmaceutical Co., Ltd (000545) - Financial and Strategic SWOT Analysis ReviewJilin Pharmaceutical Co., Ltd. (Jilin) is a pharmaceutical manufacturing and commercialization company principally engaged in the |
2011 | 250,00$ |
Renhe Pharmacy Co., Ltd. (000650) - Financial and Strategic SWOT Analysis ReviewRenhe Pharmacy Co., Ltd. (RPCL) is a publicly held pharmaceutical company. It mainly focuses on the manufacturing and marketing of |
2011 | 250,00$ |
Sihuan Pharmaceutical Co.,Ltd. (000605) - Financial and Strategic SWOT Analysis ReviewSihuan Pharmaceutical Co., Ltd. (Sihuan Pharmaceutical) engages in the production, marketing and commercial wholesaling of pharmac |
2011 | 250,00$ |
DongGuan Fangda Renew Reso Indu Co., Ltd (600656) - Financial and Strategic SWOT Analysis ReviewDongGuan Fangda Renew Reso Indu Co., Ltd (DongGuan Fangda) is engaged in manufacturing and distribution of bulk drugs, chemicals a |
2011 | 250,00$ |
Anhui Koyo (Group) Co., Ltd. (000979) - Financial and Strategic SWOT Analysis ReviewAnhui Koyo (Group) Co., Ltd. (Koyo) is a China-based diversified company. The company is principally engaged in providing high qua |
2011 | 250,00$ |
Latvijas Juras medicinas centrs AS (LJM1R) - Financial and Strategic SWOT Analysis ReviewLatvijas Juras medicinas centrs AS (LJMC) is a health care service provider based in Latvia. LJMC along with its subsidiary provid |
2011 | 250,00$ |
Clinica de Marly S.A. (MARLY) - Financial and Strategic SWOT Analysis ReviewClinica de Marly S.A. (Clinica de Marly S.A.) is a Colombia based pharmaceutical industy. The company handles the Marly Clinic in |
2011 | 250,00$ |
Hikal Limited (HIKAL) - Financial and Strategic SWOT Analysis ReviewHikal Limited (Hikal Limited) is an India based health care pharmaceutical Industry. The company is involved in the research and d |
2011 | 125,00$ |
Adinotec AG (N1N) - Financial and Strategic SWOT Analysis ReviewAdinotec AG (Adinotec AG) is Germany based engaged health care organization. The company is involved in the development, productio |
2011 | 250,00$ |
Rigas Farmaceitiska Fabrika AS (FRM1R) - Financial and Strategic SWOT Analysis ReviewRigas Farmaceitiska Fabrika AS (RFF) is a pharmaceutical company engaged in the manufacture and distribution of galenical preparat |
2011 | 250,00$ |
Nectar Lifesciences Ltd. (NECLIFE) - Financial and Strategic SWOT Analysis ReviewNectar Lifesciences Ltd (NecLife) is engaged in the manufacture of cephalosporin active pharmaceutical ingredients and finished do |
2011 | 250,00$ |
Celestial Labs Limited (CELESTIAL) - Financial and Strategic SWOT Analysis ReviewCelestial Labs Limited (CLL) is a Hydrabad(india) based herbal product organization. The company is engaged in manufacturing, dist |
2011 | 250,00$ |
Golden House Ltd. (GOHO) - Financial and Strategic SWOT Analysis ReviewGolden House Ltd. (Golden House Ltd.) is Israel based Nursing care medical terminology organization. The company is involved in tw |
2011 | 250,00$ |
GlaxoSmithKline S.A.E. (BIOC) - Financial and Strategic SWOT Analysis ReviewGlaxoSmithKline S.A.E. is an Egypt based member of GlaxoSmithKline plc. The company principally engages in the manufacture, packa |
2011 | 250,00$ |
AdCare Health Systems, Inc. (ADK) - Financial and Strategic SWOT Analysis ReviewAdCare Health Systems, Inc. (AdCare) is a healthcare and medical services provider. AdCare is engaged in developing and managing h |
2011 | 250,00$ |
STAR Pharmaceutical Limited (X64) - Financial and Strategic SWOT Analysis ReviewSTAR Pharmaceutical Limited (STAR Pharmaceutical) is a pharmaceutical company, engaged in the development, manufacturing and mark |
2011 | 250,00$ |
Plethora Solutions Holdings plc (PLE) - Financial and Strategic SWOT Analysis ReviewPlethora Solutions Holdings plc (Plethora) is a biotechnology company, engaged in the development and marketing of drugs and medic |
2011 | 250,00$ |
Aqua Bounty Technologies, Inc. (ABTX) - Financial and Strategic SWOT Analysis ReviewAqua Bounty Technologies, Inc. (Aqua Bounty) is a publicly held biotechnology company, engaged in the research, development, and c |
2011 | 250,00$ |
Millet Innovation SA (ALINN) - Financial and Strategic SWOT Analysis ReviewMillet Innovation SA (Millet Innovation) is a pharmaceutical company based in France. Millet Innovation is engaged in developing, |
2011 | 250,00$ |
Protalex, Inc. (PRTX) - Financial and Strategic SWOT Analysis ReviewProtalex, Inc. (Protalex) is a publicly traded development stage bio pharmaceutical company, engaged in developing a novel, new cl |
2011 | 250,00$ |
Plethico Pharmaceuticals Limited (532739) - Financial and Strategic SWOT Analysis ReviewPlethico Pharmaceuticals Limited (Plethico) is a publicly held global healthcare and pharmaceutical company engaged in the manufac |
2011 | 125,00$ |
PCB SA (PCBB) - Financial and Strategic SWOT Analysis ReviewPCB SA (PCB) is a publicly held company that is engaged in the distribution of pharmaceutical products. The company’s activities a |
2011 | 125,00$ |
Pharma Foods International Co., Ltd. (2929) - Financial and Strategic SWOT Analysis ReviewPharma Foods International Co., Ltd. (PFI) is a publicly held venture business company, focused on providing functional food ingre |
2011 | 250,00$ |
Geneart AG (G6A) - Financial and Strategic SWOT Analysis ReviewGeneart AG (Geneart) is a publicly held service provider that is engaged in providing solutions for DNA engineering and processing |
2011 | 250,00$ |
atect corporation (4241) - Financial and Strategic SWOT Analysis ReviewAtect Corporation (Atect Corporation) is biotechnology pharmaceutical organization in Japan. The company is involved in polymer, p |
2011 | 250,00$ |
Oriola-KD Oyj (OKDBV) - Financial and Strategic SWOT Analysis ReviewOriola-KD Oyj (Oriola-KD) is a publicly held pharmaceutical company that is engaged in distribution of pharmaceuticals and healthc |
2011 | 125,00$ |
MDxHealth SA (ONCOB) - Financial and Strategic SWOT Analysis ReviewMDxHealth SA (MDxHealth) is a publicly held molecular diagnostics company that is engaged in developing gene methylation tests for |
2011 | 250,00$ |
Le Noble Age S.A. (LNA) - Financial and Strategic SWOT Analysis ReviewLe Noble Age S.A. (Le Noble Age) is a France-based, provider of retirement homes and complexes for elderly residents. The company |
2011 | 125,00$ |
JVM Co., Ltd. (054950) - Financial and Strategic SWOT Analysis ReviewJVM Co., Ltd. (JVM Co) is a publicly held health care IT company engaged in the development and manufacture of medical automation |
2011 | 250,00$ |
Granules India Limited (532482) - Financial and Strategic SWOT Analysis ReviewGranules India Ltd. (Granules) is a publicly held research based pharmaceutical manufacturing company that engaged in the producti |
2011 | 250,00$ |
Starwin Products Limited (SPL) - Financial and Strategic SWOT Analysis ReviewStarwin Products Limited (SPL) is a pharmaceutical manufacturing company, engaged in the manufacturing as well as in importing and |
2011 | 250,00$ |
Microbio Co., Ltd. (4128) - Financial and Strategic SWOT Analysis ReviewMicrobio Co., Ltd. (Microbio) is a botanical and biotransformation drug development and manufacturing company, engaged in research |
2011 | 250,00$ |
Marksans Pharma Limited (MARKSANS) - Financial and Strategic SWOT Analysis ReviewMarksans Pharma Limited (Marksans Pharma) is engaged in the manufacture of prescription drugs for the oncology, gastroenterology, |
2011 | 250,00$ |
Sucampo Pharmaceuticals, Inc. (SCMP) - Financial and Strategic SWOT Analysis ReviewSucampo Pharmaceuticals, Inc. (Sucampo) is a publicly held biopharmaceutical company engaged in the development and commercializat |
2011 | 250,00$ |
Innate Pharma SA (IPH) - Financial and Strategic SWOT Analysis ReviewInnate Pharma SA (Innate Pharma) is a biopharmaceutical company. It is engaged in developing drugs, principally targeting cancer i |
2011 | 250,00$ |
HumanOptics AG (H9O) - Financial and Strategic SWOT Analysis ReviewHumanOptics AG (HumanOptics) is a specialty pharmaceutical company engaged in developing, manufacturing and selling of intraocular |
2011 | 250,00$ |
Phylogica Limited (PYC) - Financial and Strategic SWOT Analysis ReviewPhylogica Limited (Phylogica) is an Australia-based pharmaceutical company, engaged in the discovery and development of therapeuti |
2011 | 250,00$ |
Conpharm AB (CONP A) - Financial and Strategic SWOT Analysis ReviewConpharm AB (Conpharm AB) is a Sweden based pharmaceutical company. It markets, through licenses, pharmaceutical products based on |
2011 | 250,00$ |
Oman Medical Projects Company SAOG (OMPS) - Financial and Strategic SWOT Analysis ReviewOman Medical Projects Company SAOG (OMPC) is principally engaged in establishing hospitals, clinics and medical centers to offer m |
2011 | 250,00$ |
IDL Biotech AB (publ) (IDL B) - Financial and Strategic SWOT Analysis ReviewIDL Biotech AB (IDL Biotech AB) is a Sweden based biotechnology company engaged in developing, manufacturing and marketing of in v |
2011 | 250,00$ |
Creative Antibiotics Sweden AB (INPH) - Financial and Strategic SWOT Analysis ReviewCreative Antibiotics Sweden AB (Creative Antibiotics) is a Sweden based biotechnogy company which develops anti-infective agents. |
2011 | 250,00$ |
Proximagen Group plc (PRX) - Financial and Strategic SWOT Analysis ReviewProximagen Group plc, (Proximagen) formerly known as Proximagen Neuroscience plc, is a London-based neuroscience research company. |
2011 | 250,00$ |
Immunotec Inc. (IMM) - Financial and Strategic SWOT Analysis ReviewImmunotec Inc. (Immunotec) is engaged in the development, manufacturing and marketing of natural health products, dietary suppleme |
2011 | 250,00$ |
Kamada Ltd. (KMDA) - Financial and Strategic SWOT Analysis ReviewKamada Ltd. (Kamada) is a publicly traded, biopharmaceutical company that is engaged in development, production and marketing of s |
2011 | 250,00$ |
Affymax, Inc. (AFFY) - Financial and Strategic SWOT Analysis ReviewAffymax, Inc.(Affymax) is a biopharmaceutical company, principally engaged in the development of novel drugs for the treatment of |
2011 | 250,00$ |
Personalized Nursing Services SA (PNSB) - Financial and Strategic SWOT Analysis ReviewPersonalized Nursing Services SA (PNS) is a healthcare service provider that is focused on the provision of paramedical care at pa |
2011 | 250,00$ |
Khimfarm AO (CHFM) - Financial and Strategic SWOT Analysis ReviewKhimfarm AO (Khimfarm) is a publicly held pharmaceutical company, engaged in the production and marketing of pharmaceutical produc |
2011 | 250,00$ |
Luis Cassanello SAICECA (CAS) - Financial and Strategic SWOT Analysis ReviewLuis Cassanello SAICECA (Luis Cassanello) is a publicly traded Paraguay based company. The company is principally engaged in buyin |
2011 | 250,00$ |
Al-Bilad Medical Services Co. (ABMS) - Financial and Strategic SWOT Analysis ReviewAl-Bilad Medical Services Co. (Al-Bilad Medical) is an integrated health service offering company. The company owns and operates t |
2011 | 250,00$ |
Arab Center for Pharmaceutical and Chemical Industries Co. (APHC) - Financial and Strategic SWOT Analysis ReviewArab Center for Pharmaceutical and Chemical Industries Co. (ACPC) is a pharmaceutical company principally engaged in the manufactu |
2011 | 250,00$ |
Hayat Pharmaceutical Industries (HPIC) - Financial and Strategic SWOT Analysis ReviewHayat Pharmaceutical Industries (HPI) is a pharmaceutical company, engaged in manufacturing and distribution of general pharmaceut |
2011 | 250,00$ |
Pinnacle Staffing Group plc (PCL) - Financial and Strategic SWOT Analysis ReviewPinnacle Staffing Group plc (Pinnacle Staffing) is a contract service provider engaged in providing recruitment services for the h |
2011 | 250,00$ |
Tien Liang BioTech Co., Ltd. (4127) - Financial and Strategic SWOT Analysis ReviewTien Liang BioTech Co., Ltd. (Tien Liang BioTech) is a pharmaceutical company engaged in the production and marketing of chemicals |
2011 | 250,00$ |
Nang Kuang Pharmaceutical Co., Ltd. (1752) - Financial and Strategic SWOT Analysis ReviewNang Kuang Pharmaceutical Co., Ltd. (Nang Kuang) is focused on the manufacture, processing and trading of western medicines. The c |
2011 | 250,00$ |
Avonova Sverige AB (AVON) - Financial and Strategic SWOT Analysis ReviewAvonova Sverige AB (Avonova, formerly known as Curera Sverige AB) is a healthcare service provider company. The company is engaged |
2011 | 250,00$ |
Biosensor Applications Sweden AB (BIAP A) - Financial and Strategic SWOT Analysis ReviewBiosensor Applications Sweden AB (Biosensor Applications) is a biotechnology company engaged in developing, manufacturing and sell |
2011 | 250,00$ |
Ocean Bright Co., Ltd. (3266) - Financial and Strategic SWOT Analysis ReviewOcean Bright Co., Ltd. (Ocean Bright) is a Taiwan based drug manufacturing company. The company is principally engaged in research |
2011 | 250,00$ |
Genovate Biotechnology Co., LTD. (4130) - Financial and Strategic SWOT Analysis ReviewGenovate Biotechnology Co., Ltd. (GBL), a fully integrated biopharmaceutical company located in Taiwan. The company is engaged in |
2011 | 250,00$ |
SCI Pharmtech, Inc. (4119) - Financial and Strategic SWOT Analysis ReviewSCI Pharmtech, Inc. ( SCI) is a pharmaceutical manufacturing company. It is principally engaged in the research, development, manu |
2011 | 250,00$ |
Syn-Tech Chem. & Pharm. Co., Ltd. (1777) - Financial and Strategic SWOT Analysis ReviewSyn-Tech Chem. & Pharm. Co., Ltd. (Syn-Tech) is a pharmaceutical company, engaged in the manufacture of pharmaceutical raw materia |
2011 | 250,00$ |
Panion & Bf Biotech Inc. (1760) - Financial and Strategic SWOT Analysis ReviewPanion & Bf Biotech Inc. (Panion) is a public traded biotechnology and pharmaceutical company. The company focuses on development |
2011 | 250,00$ |
Replek AD Skopje (REPL) - Financial and Strategic SWOT Analysis ReviewReplek AD Skopje (Replek AD) is a healthcare company, engaged in the manufacture, marketing and distribution of pharmaceuticals, m |
2011 | 250,00$ |
Sagittarius Life Science Corp. (3205) - Financial and Strategic SWOT Analysis ReviewSagittarius Life Science Corp. (SLSC) is a pharmaceutical company engaged in the discovery, development and production of herbal t |
2011 | 250,00$ |
OctoPlus N.V. (OCTO) - Financial and Strategic SWOT Analysis ReviewOctoPlus N.V. (OctoPlus) operates as a drug delivery company, engaged in the development of improved pharmaceutical products. The |
2011 | 250,00$ |
Asiri Surgical Hospital PLC (AMSLN) - Financial and Strategic SWOT Analysis ReviewAsiri Surgical Hospital PLC (Asiri Surgical) is principally engaged in providing a range of healthcare services related to surgica |
2011 | 250,00$ |
Center Laboratories, Inc. (4123) - Financial and Strategic SWOT Analysis ReviewCenter Laboratories, Inc. (Center Laboratories) is a Tiwan based company, engaged in the manufacture and marketing of pastilles an |
2011 | 250,00$ |
Level Biotechnology Inc. (3118) - Financial and Strategic SWOT Analysis ReviewLevel Biotechnology Inc., (LBI) is a biomedical products marketing and distribution company, based in Taiwan. The company engages |
2011 | 250,00$ |
BIONET Corp. (1784) - Financial and Strategic SWOT Analysis ReviewBIONET Corp. (BIONET) is a publicly held stem cell bank engaged in the collection, processing, storage and commercialization of ne |
2011 | 250,00$ |
GenMont Biotech Inc. (3164) - Financial and Strategic SWOT Analysis ReviewGenmont Biotech Inc. (Genmont Biotech) is principally engaged in to researching, developing, manufacturing and selling functional |
2011 | 250,00$ |
Trident Medical Corp. (4116) - Financial and Strategic SWOT Analysis ReviewTrident Medical Corp. (Trident Medical) is engaged in the manufacturing and commercialization of medical equipment. The company's |
2011 | 250,00$ |
ChronTech Pharma AB (CTEC) - Financial and Strategic SWOT Analysis ReviewChronTech Pharma AB (ChronTech Pharma), formerly known as Tripep AB, is a publicly held biotechnology research company. The compan |
2011 | 250,00$ |
NeutraHealth Plc (NUT) - Financial and Strategic SWOT Analysis ReviewNeutraHealth Plc is a UK based holding company. The company is engaged in production, distribution and sale of nutraceutical produ |
2011 | 250,00$ |
Probiotec Limited (PBP) - Financial and Strategic SWOT Analysis ReviewProbiotec Limited (Probiotec) is engaged in the manufacture, market, and distribution of various prescription and over-the-counter |
2011 | 250,00$ |
CytoTools AG (T5O) - Financial and Strategic SWOT Analysis ReviewCytoTools AG (CytoTools) is an publicly held investment and holding company in the technology sector. The company holds its share |
2011 | 250,00$ |
Advanta India Limited (ADVANTA) - Financial and Strategic SWOT Analysis ReviewAdvanta India Limited (AIL) is a research focused biotechnology company. The company is engaged in research and development, produ |
2011 | 250,00$ |
Astek Group Plc (AKG) - Financial and Strategic SWOT Analysis ReviewAstek Group plc (Astek) is engaged in the manufacture and supply of dental products and dental consumables. It also produces and s |
2011 | 250,00$ |
China-Biotics, Inc. (CHBT) - Financial and Strategic SWOT Analysis ReviewChina-Biotics Inc. (China-Biotics) is engaged in the research, development, production, marketing and distribution of probiotic pr |
2011 | 250,00$ |
Bosnalijek d.d. Sarajevo (BSNLR) - Financial and Strategic SWOT Analysis ReviewBosnalijek d.d. Sarajevo (Bosnalijek) is a pharmaceutical company engaged in the manufacture of drugs and disinfecting agents in t |
2011 | 250,00$ |
Synopsis Ltd. (SYNO) - Financial and Strategic SWOT Analysis ReviewSynopsis Ltd. (Synopsis) is an Israel-based health care services company. Synopsis provides services through its subsidiaries name |
2011 | 250,00$ |
T.R.D. Instrum Ltd. (TRD) - Financial and Strategic SWOT Analysis ReviewT.R.D. Instrum Ltd. (TRD) is engaged in developing, marketing and manufacture of dental products. Its main products include: OrbO, |
2011 | 250,00$ |
InterCure Ltd. (INCR) - Financial and Strategic SWOT Analysis ReviewInterCure Ltd. (InterCure) is a medical device company engaged in the manufacture and sale of RESPeRATE. The company’s product RES |
2011 | 250,00$ |
Societe des Industries Pharmaceutiques de Tunisie S.A. (SIPHA) - Financial and Strategic SWOT Analysis ReviewSociete des Industries Pharmaceutiques de Tunisie S.A. (SIPHAT) is a drug manufacturing company. The company is a subsidiary of th |
2011 | 250,00$ |
Sothema (SOT) - Financial and Strategic SWOT Analysis ReviewSothema is a publicly traded pharmaceutical company that specializes in manufacturing and marketing of drugs. The company offers a |
2011 | 250,00$ |
Oasmia Pharmaceutical AB (OASM) - Financial and Strategic SWOT Analysis ReviewOasmia Pharmaceutical AB (Oasmia Pharmaceutical) is a pharmaceutical company engaged in the development of second and third genera |
2011 | 250,00$ |
European Lifecare Group A/S (DLVS) - Financial and Strategic SWOT Analysis ReviewEuropean Lifecare Group A/S (European Lifecare) formerly known as Danske Laegers Vaccinations Service A/S, is one of the largest p |
2011 | 250,00$ |
Taihua plc (TAIH) - Financial and Strategic SWOT Analysis ReviewTaihua plc (Taihua) is an investment holding company, engaged in development, manufacture and commercialization of pharmaceutical |
2011 | 250,00$ |
Cyclopharm Limited (CYC) - Financial and Strategic SWOT Analysis ReviewCyclopharm Limited (CL) is a medical and health care equipments manufacturing company. The company is engaged in the manufacturing |
2011 | 250,00$ |
Imexpharm Pharmaceutical JSC (IMP) - Financial and Strategic SWOT Analysis ReviewImexpharm Pharmaceutical JSC (Imexpharm) is a publicly held pharmaceutical company engaged in manufacturing and distributing pharm |
2011 | 250,00$ |
Ferozsons Laboratories Limited (FEROZ) - Financial and Strategic SWOT Analysis ReviewFerozsons Laboratories Limited (Ferozsons Laboratories) is a publicly held pharmaceutical company, engaged in the manufacturing an |
2011 | 250,00$ |
Shifa International Hospitals Limited (SHFA) - Financial and Strategic SWOT Analysis ReviewShifa International Hospitals Ltd. (Shifa International) is publicly held company that is principally engaged in providing a broad |
2011 | 250,00$ |
DiaMedica Inc. (DMA) - Financial and Strategic SWOT Analysis ReviewDiaMedica Inc. (DiaMedica) is a publicly held biopharmaceutical company principally involved in the discovery and development of p |
2011 | 250,00$ |
Nawaloka Hospitals Private Limited (NHL) - Financial and Strategic SWOT Analysis ReviewNawaloka Hospitals Private Limited (Nawaloka Hospitals) is principally engaged in providing a range of healthcare and hospital ser |
2011 | 250,00$ |
New Nordic Healthbrands AB (NNH) - Financial and Strategic SWOT Analysis ReviewNew Nordic Healthbrands AB (New Nordic) is a Sweden based pharmaceutical company. The company is principally engaged in developmen |
2011 | 250,00$ |
Oscotec Inc. (039200) - Financial and Strategic SWOT Analysis ReviewOscotec Inc. (Oscotec) is a publicly held pharmaceutical company that is engaged in manufacturing drug candidates for the treatmen |
2011 | 250,00$ |
Cremer SA (CREM3) - Financial and Strategic SWOT Analysis ReviewCremer SA (Cremer) is a manufacturing and distribution company of disposable healthcare textile and adhesive products. The product |
2011 | 125,00$ |
Hikari Heights-Varus Co., Ltd. (2137) - Financial and Strategic SWOT Analysis ReviewHikari Heights-Varus Co., Ltd. (Hikari Heights) is a public company that is engaged in the establishment, operation and management |
2011 | 250,00$ |
OPC Pharmaceutical Joint Stock Company (OPC) - Financial and Strategic SWOT Analysis ReviewOPC Pharmaceutical Joint Stock Company (OPC Pharmaceutical) is engaged in manufacturing pharmaceutical products from medicinal her |
2011 | 250,00$ |
Immuno-Biological Laboratories Co., Ltd. (4570) - Financial and Strategic SWOT Analysis ReviewImmuno-Biological Laboratories Co., Ltd. (IBL) is engaged in the research, development, manufacture and sale of pharmaceutical pro |
2011 | 250,00$ |
Jilin Zixin Pharmaceutical Ind. Co., Ltd (002118) - Financial and Strategic SWOT Analysis ReviewJilin Zixin Pharmaceutical Industrial Co., Ltd (Jilin Zixin) is a publicly held company that is engaged in research, development, |
2011 | 250,00$ |
Aptilon Corporation (APZ) - Financial and Strategic SWOT Analysis ReviewAptilon Corporation (Aptilon) is a Canada-based healthcare IT company. The company is principally engaged in providing a range of |
2011 | 250,00$ |
Clinica Baviera SA (CBAV) - Financial and Strategic SWOT Analysis ReviewClinica Baviera SA (Clinica Baviera) is a Spain-based ophthalmic company. Clinica Baviera is engaged in providing laser surgery se |
2011 | 250,00$ |
Servizi Italia S.p.A. (SRI) - Financial and Strategic SWOT Analysis ReviewServizi Italia S.p.A. (Servizi Italia) is a conglomerate company principally engaged in the operations of design, construction and |
2011 | 125,00$ |
Simcere Pharmaceutical Group (SCR) - Financial and Strategic SWOT Analysis ReviewSimcere Pharmaceutical Group (Simcere) is a publicly held company that is principally engaged in the manufacture and supply of gen |
2011 | 125,00$ |
Ankur Drugs and Pharma Ltd. (ANKURDRUGS) - Financial and Strategic SWOT Analysis ReviewAnkur Drugs and Pharma Ltd. (Ankur Drugs) is a publicly held pharmaceutical company principally engaged in contract manufacturing |
2011 | 125,00$ |
Transgene Biotek Limited (526139) - Financial and Strategic SWOT Analysis ReviewTransgene Biotek Limited. (TBL) is a biotechnology company that focused on the development of medical diagnostics products such as |
2011 | 250,00$ |
Jupiter Bioscience Limited (524826) - Financial and Strategic SWOT Analysis ReviewJupiter Bioscience Limited. (Jupiter Bioscience) is a publicly held company that is engaged in the production and selling of pepti |
2011 | 250,00$ |
Themis Medicare Ltd. (530199) - Financial and Strategic SWOT Analysis ReviewThemis Medicare Ltd. (Themis Medicare) is a public traded pharmaceutical company engaged in the manufacture of active pharmaceutic |
2011 | 125,00$ |
DHG Pharmaceutical JSC (DHG) - Financial and Strategic SWOT Analysis ReviewDHG Pharmaceutical JSC (DHG) is a publicly held pharmaceutical company engaged in the production and trade of pharmaceutical produ |
2011 | 250,00$ |
Protox Therapeutics Inc. (PRX) - Financial and Strategic SWOT Analysis ReviewProtox Therapeutics Inc. (Protox) is a publicly held development stage bio-pharmaceutical company principally engaged in the resea |
2011 | 250,00$ |
MetrioPharm AG (MP5) - Financial and Strategic SWOT Analysis ReviewMetrioPharm AG (MetrioPharm) is a pharmaceutical company engaged in the development and marketing of therapies against bacterial a |
2011 | 250,00$ |
Aureum Realwert AG (TRH) - Financial and Strategic SWOT Analysis ReviewAureum Realwert AG, (formerly known as HELIO Biotech AG) is a biotechnology company that mainly focuses on the development, manufa |
2011 | 250,00$ |
Skilled Healthcare Group, Inc. (SKH) - Financial and Strategic SWOT Analysis ReviewSkilled Healthcare Group, Inc. (Skilled Healthcare Group) is a holding company that owns subsidiaries and is engaged in providing |
2011 | 125,00$ |
Domesco Medical Import-Export JS Corp (DMC) - Financial and Strategic SWOT Analysis ReviewDomesco Medical Import-Export JS Corp (Domesco Medical) is a publicly held pharmaceutical company that is engaged in the manufactu |
2011 | 250,00$ |
DONGKOOK Pharmaceutical Co., Ltd. (086450) - Financial and Strategic SWOT Analysis ReviewDONGKOOK Pharmaceutical Co., Ltd. (Dongkook) is a publicly held pharmaceutical company engaged in the development and manufacturin |
2011 | 250,00$ |
Medical Nutrition USA, Inc. (MDNU) - Financial and Strategic SWOT Analysis ReviewMedical Nutrition USA, Inc. (MNI) is engaged in the manufacturing, marketing and distribution of nutritional and health care produ |
2011 | 250,00$ |
Farmstandart OAO (PHST) - Financial and Strategic SWOT Analysis ReviewFarmstandart OAO (Farmstandart) is a publicly held research focused biotechnology company that is principally engaged in research, |
2011 | 125,00$ |
Avvaa World Health Care Products, Inc. (AVVH) - Financial and Strategic SWOT Analysis ReviewAvvaa World Health Care Products, Inc. (Avvaa) is a biotechnology company, based in Canada. The company focused on the manufacturi |
2011 | 250,00$ |
Huifeng BioPharmaceutical Technology Inc. (HFGB) - Financial and Strategic SWOT Analysis ReviewHuifeng BioPharmaceutical Technology Inc. (Huifeng) is a publicly held company that is principally engaged in development, product |
2011 | 250,00$ |
Cord Blood America, Inc. (CBAI) - Financial and Strategic SWOT Analysis ReviewCord Blood America, Inc. (Cord Blood) is a biotechnology company engaged in providing private cord blood stem cell preservation se |
2011 | 250,00$ |
Raptor Pharmaceuticals Corp. (RPTP) - Financial and Strategic SWOT Analysis ReviewRaptor Pharmaceuticals Corp. (Raptor) is a biotechnology company that is involved in the acquisition, development, and commerciali |
2011 | 250,00$ |
Choongwae Holdings Co., Ltd (096760) - Financial and Strategic SWOT Analysis ReviewChoongwae Holdings Co., Ltd (Choongwae) is a publicly held company that is principally engaged in the drug distribution and export |
2011 | 125,00$ |
Ost Japan Group Inc. (2757) - Financial and Strategic SWOT Analysis ReviewOst Japan Group Inc. (Ost Japan) is a public holding company, engaged in wholesale pharmaceuticals business and real estate relate |
2011 | 250,00$ |
Redpoint Bio Corporation (RPBC) - Financial and Strategic SWOT Analysis ReviewRedpoint Bio Corporation (Redpoint) is a privately held biotechnology company engaged in the discovery of novel small molecules, w |
2011 | 250,00$ |
Societe Adwya SA (ADWYA) - Financial and Strategic SWOT Analysis ReviewSociete Adwya SA (Societe Adwya) is engaged in the manufacturing and commercialization of pharmaceutical products. The company foc |
2011 | 250,00$ |
Sunway Global Inc. (SUWG) - Financial and Strategic SWOT Analysis ReviewSunway Global Inc. (Sunway Global) is a medical equipment company engaged in the development and manufacture of medicine dispensin |
2011 | 250,00$ |
Guilin Layn Natural Ingredients Corp. (002166) - Financial and Strategic SWOT Analysis ReviewGuilin Layn Natural Ingredients Corp. (Layn) is a publicly traded pharmaceutical company which is engaged in the research, develop |
2011 | 250,00$ |
IPC The Hospitalist Company, Inc. (IPCM) - Financial and Strategic SWOT Analysis ReviewIPC The Hospitalist Company, Inc. (IPC) is a national hospitalist physician group practice company, engaged in the delivery of hos |
2011 | 125,00$ |
Aqua Bio Technology ASA (ATB) - Financial and Strategic SWOT Analysis ReviewAqua Bio Technology ASA (ABT) is a Norway based pharmaceutical company. The company is principally engaged in research and develop |
2011 | 250,00$ |
Biotoxtech Co., Ltd (086040) - Financial and Strategic SWOT Analysis ReviewBiotoxtech Co., Ltd (Biotoxtech) is a publicly held pharmaceutical company principally engaged in providing non-clinical drug tria |
2011 | 250,00$ |
China Kangtai Cactus Bio-Tech Inc. (CKGT) - Financial and Strategic SWOT Analysis ReviewChina Kangtai Cactus Bio-Tech Inc. (China Kangtai) is a vertically integrated manufacturer and marketer of cactus based consumer p |
2011 | 250,00$ |
Highnoon Laboratories Limited (HINOON) - Financial and Strategic SWOT Analysis ReviewHighnoon Laboratories Limited (HNL) is a pharmaceutical company focused on the manufacture, import, sale, and marketing of pharmac |
2011 | 250,00$ |
Sun Pharma Advanced Research Company (SPARC) - Financial and Strategic SWOT Analysis ReviewSun Pharma Advanced Research Company (SPARC) is a publicly held pharmaceutical research and drug discovery company engaged in the |
2011 | 250,00$ |
Imuniti Holdings Limited (IMU) - Financial and Strategic SWOT Analysis ReviewImuniti Holdings Limited (Imuniti) is a publicly held pharmaceutical company that is engaged in the formulation and manufacturing |
2011 | 250,00$ |
Stem Cell Therapeutics Corp. (SSS) - Financial and Strategic SWOT Analysis ReviewStem Cell Therapeutics Corp. (SCT) is a publicly held biotechnology company, based in Canada. The company is primarily focusing on |
2011 | 250,00$ |
Neimeth International Pharmaceutical PLC (NEIMETH) - Financial and Strategic SWOT Analysis ReviewNeimeth International Pharmaceutical PLC (Neimeth) is a Nigeria based drug manufacturing company. The company is principally engag |
2011 | 250,00$ |
CPEX Pharmaceuticals, Inc. (CPEX) - Financial and Strategic SWOT Analysis ReviewCPEX Pharmaceuticals, Inc. (CPEX) is a publicly held development stage specialty pharmaceutical company that is principally engage |
2011 | 250,00$ |
MIC Medical Corporation (2166) - Financial and Strategic SWOT Analysis ReviewMIC Medical Corporation (MIC Medical) is a publicly held company that is engaged in providing development support services to the |
2011 | 250,00$ |
Galena Biopharma, Inc. (GALE) - Financial and Strategic SWOT Analysis ReviewGalena Biopharma, Inc. (Galena), formerly known as RXi Pharmaceuticals Corporation, is a discovery-stage biotechnology company. It |
2011 | 250,00$ |
ProMD Biotech Co., Ltd. (4731) - Financial and Strategic SWOT Analysis ReviewProMD Biotech Co., Ltd. (ProMD) is a pharmaceutical company engaged in the research, development and commercialization of probioti |
2011 | 250,00$ |
Nattopharma ASA (NATTO) - Financial and Strategic SWOT Analysis ReviewNattopharma ASA (Nattopharma) is a publicly held company focusing primarily on research, developing and selling of vitamin K2. Its |
2011 | 250,00$ |
Nepentes SA (NEP) - Financial and Strategic SWOT Analysis ReviewNepentes S.A. (Nepentes) is a publicly held pharmaceutical company that is engaged in manufacturing and marketing of dermocosmetic |
2011 | 250,00$ |
Transdermal Cosmetics Plc (TRCP) - Financial and Strategic SWOT Analysis ReviewTransdermal Cosmetics Plc (Transdermal Cosmetics) is a publicly held biopharmaceutical company engaged in the manufacture, distrib |
2011 | 250,00$ |
Japan Tissue Engineering Co., Ltd. (7774) - Financial and Strategic SWOT Analysis ReviewJapan Tissue Engineering Co., Ltd. (J-TEC) is engaged in the development, manufacture and commercialization of tissue-engineered m |
2011 | 250,00$ |
EastPharma Ltd. (EAST) - Financial and Strategic SWOT Analysis ReviewEastPharma Ltd. (EastPharma) is a publicly held pharmaceutical company that is principally engaged in the manufacturing and market |
2011 | 125,00$ |
B.M.P. Pharma Trading AG (BMP) - Financial and Strategic SWOT Analysis ReviewB.M.P. Pharma Trading AG (B.M.P) is engaged in the trade of nutraceutical products and pharmaceutical raw materials. The company o |
2011 | 250,00$ |
NatureWise Biotech & Medicals Corp (4732) - Financial and Strategic SWOT Analysis ReviewNatureWise Biotech & Medicals Corp. (NBM) is principally engaged in drug discovery and development. Also, the company offers healt |
2011 | 250,00$ |
InfuSystem Holdings, Inc. (INFU) - Financial and Strategic SWOT Analysis ReviewInfuSystem Holdings, Inc. (InfuSystem) is one of the largest providers of ambulatory infusion pumps and related services for oncol |
2011 | 250,00$ |
Aoxing Pharmaceutical Company, Inc (AXN) - Financial and Strategic SWOT Analysis ReviewAoxing Pharmaceutical Company Inc. (Aoxing) is a specialized pharmaceutical company engaged in the research, development, manufact |
2011 | 250,00$ |
Skystar Bio-Pharmaceutical Company (SKBI) - Financial and Strategic SWOT Analysis ReviewSkystar Bio-Pharmaceutical Company (Skystar Bio-Pharmaceutical) is a biopharmaceutical company that develops, manufactures and dis |
2011 | 250,00$ |
China Health Resource, Inc. (CHRI) - Financial and Strategic SWOT Analysis ReviewChina Health Resource, Inc. (CHR) is a pharmaceutical company, engaged in the processing, manufacturing, development and commercia |
2011 | 250,00$ |
Gansu Duyiwei Biological Pharmaceutical Co., Ltd. (002219) - Financial and Strategic SWOT Analysis ReviewGansu Duyiwei Biological Pharmaceutical Co., Ltd. (Gansu Duyiwei) is a traditional drug manufacturing company, based in China. The |
2011 | 250,00$ |
NanoCarrier Co., Ltd. (4571) - Financial and Strategic SWOT Analysis ReviewNanoCarrier Co., Ltd. (NanoCarrier) is a biotechnology company, engaged in the research, development and manufacturing of anticanc |
2011 | 250,00$ |
Lotus Eye Care Hospital Limited (LOTUSEYE) - Financial and Strategic SWOT Analysis ReviewLotus Eye Care Hospital Limited (Lotus Eye Care) operates as an eye hospital, engaged in providing eye care facilities. In additio |
2011 | 250,00$ |
Carna Biosciences, Inc. (4572) - Financial and Strategic SWOT Analysis ReviewCarna Biosciences, Inc. (Carna Biosciences) is a biotechnology company, based in Japan. The company is principally engaged in the |
2011 | 250,00$ |
Senzime AB (SEZI) - Financial and Strategic SWOT Analysis ReviewSenzime AB (Senzime) is a Sweden-based biotechnology company. The company is principally engaged in the development, manufacture a |
2011 | 250,00$ |
R-Tech Ueno, Ltd. (4573) - Financial and Strategic SWOT Analysis ReviewR-Tech Ueno, Ltd. (R-Tech) is principally engaged in the research, development, manufacturing, selling, exporting and importing ph |
2011 | 250,00$ |
Hartalega Holdings Berhad (HARTA) - Financial and Strategic SWOT Analysis ReviewHartalega Holdings Berhad (Hartalega) is a medical devices company, engaged in the manufacture of latex gloves and nitrile gloves. |
2011 | 250,00$ |
G&E Herbal Biotechnology Co., Ltd. (4911) - Financial and Strategic SWOT Analysis ReviewG&E Herbal Biotechnology Co., Ltd. (G&E Herbal) is a Taiwan based biotechnology company, engaged in developing new botanic drugs. |
2011 | 250,00$ |
Ambalal Sarabhai Enterprises Limited (500009) - Financial and Strategic SWOT Analysis ReviewAmbalal Sarabhai Enterprises Limited (ASE) is a pharmaceutical company, principally engaged in the development of wide range of bu |
2011 | 250,00$ |
Rexahn Pharmaceuticals, Inc. (RNN) - Financial and Strategic SWOT Analysis ReviewRexahn Pharmaceuticals, Inc., (Rexahn Pharmaceuticals) is a biopharmaceutical company that is engaged in the discovery, manufactur |
2011 | 250,00$ |
Myungmoon pharmaceutical Co.,Ltd. (017180) - Financial and Strategic SWOT Analysis ReviewMyungmoon pharmaceutical Co.,Ltd. (Myungmoon pharmaceutical) is engaged in the manufacture and marketing of pharmaceutical and che |
2011 | 250,00$ |
NeuroVive Pharmaceutical AB (NVP) - Financial and Strategic SWOT Analysis ReviewNeuroVive Pharmaceutical AB (NeuroVive) is a drug manufacturing company. The company is principally engaged in the development and |
2011 | 250,00$ |
Piramal Life Sciences Limited (PIRLIFE) - Financial and Strategic SWOT Analysis ReviewPiramal Life Sciences Limited (PLSL) is a research focused pharmaceutical company. The company is principally engaged in the drug |
2011 | 250,00$ |
Abnova Corporation (4133) - Financial and Strategic SWOT Analysis ReviewAbnova Corporation (Abnova) is a biotechnology company that is engaged in the manufacturing of antibodies and proteins. The compan |
2011 | 250,00$ |
Unipharm AD (59X) - Financial and Strategic SWOT Analysis ReviewUnipharm AD (Unipharm) is engaged in the manufacturing and commercialization of medicinal products for human healthcare. The compa |
2011 | 250,00$ |
Ina Research Inc. (2176) - Financial and Strategic SWOT Analysis ReviewIna Research Inc. (INA) is a public traded, contract research laboratory. The company is principally engaged in the development of |
2011 | 250,00$ |
Qualitas Medical Group Sdn Bhd. (5NN) - Financial and Strategic SWOT Analysis ReviewQualitas Medical Group Sdn Bhd. (Qualitas) is a contract service providing company engaged in providing well-integrated network of |
2011 | 250,00$ |
Jiangsu Nhwa Pharma Corporation (002262) - Financial and Strategic SWOT Analysis ReviewJiangsu Nhwa Pharma Corporation (Jiangsu) is a pharmaceutical company that is engaged in the research, development and manufacture |
2011 | 125,00$ |
Enervit S.p.A. (ENV) - Financial and Strategic SWOT Analysis ReviewEnervit S.p.A. (Enervit) is a healthcare company engaged in the research, development, production and commercialization of product |
2011 | 250,00$ |
Growell Holdings Co., Ltd. (3141) - Financial and Strategic SWOT Analysis ReviewGrowell Holdings Co., Ltd. (Growell) is a holding company, engaged in the management of subsidiaries as well as a group of compani |
2011 | 125,00$ |
Gamma Pharmaceuticals Inc. (GMPM) - Financial and Strategic SWOT Analysis ReviewGamma Pharmaceuticals Inc. (Gamma Pharmaceuticals) is a US-based drug manufacturing company. The company is engaged in product for |
2011 | 250,00$ |
PuraMed BioScience Inc. (PMBS) - Financial and Strategic SWOT Analysis ReviewPuraMed BioScience Inc. (PuraMed) is a US-based pharmaceutical company. The company is specialized in the manufacture of over th |
2011 | 250,00$ |
Fluorotechnics Limited (FLS) - Financial and Strategic SWOT Analysis ReviewFluorotechnics Limited (Fluorotechnics) is a Austraian-based pharmaceutical and healthcare company. The company is engaged in dev |
2011 | 250,00$ |
Medizone International, Inc. (MZEI) - Financial and Strategic SWOT Analysis ReviewMedizone International, Inc. (Medizone) is a US-based research and development company. The company is engaged in development of n |
2011 | 250,00$ |
Merrion Pharmaceuticals Plc (3MP) - Financial and Strategic SWOT Analysis ReviewMerrion Pharmaceuticals Plc (Merrion) is a specialty pharmaceutical company engaged in developing oral dosage forms of drugs that |
2011 | 250,00$ |
Scancell Holdings Plc (SCLP) - Financial and Strategic SWOT Analysis ReviewScancell Holdings plc (Scancell) is a biopharmaceutical company, engaged in developing novel therapeutic cancer vaccines for the t |
2011 | 250,00$ |
Sunzen Biotech Berhad (SUNZEN) - Financial and Strategic SWOT Analysis ReviewSunzen Biotech Berhad (Sunzen Biotech) is a healthcare company engaged in the development manufacture and marketing of animal heal |
2011 | 250,00$ |
Clinique du Rond-Point des Champs Elysees SA (MLCRP) - Financial and Strategic SWOT Analysis ReviewClinique du Rond-Point des Champs Elysees SA (CRPCE) is engaged medical and surgical services. Its operations are focused on the a |
2011 | 250,00$ |
Tiens Biotech Group (USA), Inc. (TBV) - Financial and Strategic SWOT Analysis ReviewTiens Biotech Group (USA), Inc. (Tiens) is a public traded biotechnology company engaged in the research, development, manufacturi |
2011 | 250,00$ |
Kovai Medical Center & Hospital Limited (523323) - Financial and Strategic SWOT Analysis ReviewKovai Medical Center & Hospital Limited (Kovai Medical) is a medical and healthcare services provider that provides hospital facil |
2011 | 250,00$ |
Indraprastha Medical Corporation Limited (INDRAMEDCO) - Financial and Strategic SWOT Analysis ReviewIndraprastha Medical Corporation Limited (Indraprastha Medical) is a medical and healthcare services provider, based in India. Ind |
2011 | 250,00$ |
Fortis Malar Hospitals Limited (523696) - Financial and Strategic SWOT Analysis ReviewThis comprehensive SWOT profile of Fortis Malar Hospitals Limited provides you an in-depth strategic analysis of the company’s bu |
2011 | 250,00$ |
Sanacorp Pharmaholding AG (SNC3) - Financial and Strategic SWOT Analysis ReviewSanacorp Pharmaholding AG (Sanacorp Pharmaholding) formerly known as Sanacorp Pharmahandel AG, is engaged in the wholesale of phar |
2011 | 250,00$ |
Gufic BioSciences Limited (GUFICBIO) - Financial and Strategic SWOT Analysis ReviewGufic BioSciences Limited (Gufic BioSciences) is a pharmaceutical company based in India. Gufic BioSciences is one of the leading |
2011 | 250,00$ |
Aventis Pharma Limited (AVENTIS) - Financial and Strategic SWOT Analysis ReviewAventis Pharma Limited (Aventis) is an India based pharmaceuticals manufacturing company. The company provides medicines for the t |
2011 | 125,00$ |
Prospect Medical Holdings Inc (PZZ) - Financial and Strategic SWOT Analysis ReviewProspect Medical Holdings, Inc. (Prospect) is a provider of healthcare services, based in the US. The company provides healthcare |
2011 | 125,00$ |
MiMedx Group, Inc (MDXG) - Financial and Strategic SWOT Analysis ReviewMiMedx Group, Inc.(MiMedx Group) is engaged in the development, manufacture and marketing of patent protected biomaterial-based pr |
2011 | 250,00$ |
Hawkley Oil And Gas Limited (ICV) - Financial and Strategic SWOT Analysis ReviewHawkley Oil And Gas Limited (formerly known as Incitive Ltd.) is a research focused biotechnology company. The company is engaged |
2011 | 250,00$ |
Genolier Swiss Medical Network SA (GSMN) - Financial and Strategic SWOT Analysis ReviewGenolier Swiss Medical Network SA (Genolier Swiss) is the leading hospital network in the French speaking region of Switzerland (R |
2011 | 250,00$ |
Cumberland Pharmaceuticals, Inc. (CPIX) - Financial and Strategic SWOT Analysis ReviewCumberland Pharmaceuticals, Inc. (CPI) is a specialty pharmaceutical company, engaged in the acquisition, development and commerci |
2011 | 250,00$ |
Logibec Groupe Informatique Ltd. (LGI) - Financial and Strategic SWOT Analysis ReviewLogibec Groupe Informatique Ltd. (LGI) is engaged in the development, marketing, implementation and support of information systems |
2011 | 125,00$ |
Zandu Realty Limited (506720) - Financial and Strategic SWOT Analysis ReviewZandu Realty Limited is formerly known as Zandu Pharmaceutical Works Ltd. (Zandu Pharma) is an India based pharmaceutical company. |
2011 | 250,00$ |
HOV Services Limited (HOVS) - Financial and Strategic SWOT Analysis ReviewHOV Services Limited is engaged in offering business process outsourcing services to various sectors including financial, telecom |
2011 | 125,00$ |
Magic Software Enterprises Ltd. (MGIC) - Financial and Strategic SWOT Analysis ReviewMagic Software Enterprises Ltd. (MSEL) is engaged in providing application platforms and business integration solutions. The compa |
2011 | 125,00$ |
PCI Biotech Holding ASA (PCIB) - Financial and Strategic SWOT Analysis ReviewPCI Biotech Holding ASA (PCI Biotech) is a Norway-based company focused on the commercialization of a patented photochemical drug |
2011 | 250,00$ |
Grupo Estrella SA (QUES) - Financial and Strategic SWOT Analysis ReviewGrupo Estrella SA (Estrella) is focused on the manufacture of consumer goods. The company is principally involved in production an |
2011 | 250,00$ |
Instituto Rosenbusch S.A. (ROSE) - Financial and Strategic SWOT Analysis ReviewInstituto Rosenbusch S.A. (Instituto Rosenbusch) is a healthcare institute engaged in the production and sale of veterinary produc |
2011 | 250,00$ |
Medical Union Pharmaceuticals Company (MEDU) - Financial and Strategic SWOT Analysis ReviewMedical Union Pharmaceuticals Company (MUP) is a pharmaceutical manufacturing facility, engaged in providing a wide range of produ |
2011 | 250,00$ |
The Nile Co. for Pharm & Chemical Ind. (NIPH) - Financial and Strategic SWOT Analysis ReviewThe Nile Co. for Pharm & Chemical Ind. (EL-Nile) is a pharmaceutical company engaged in the manufacturing and trading of pharmaceu |
2011 | 250,00$ |
Cairo Pharmaceuticals and Chemical Industries (CPCI) - Financial and Strategic SWOT Analysis ReviewCairo Pharmaceuticals and Chemical Industries (Cairo Pharmaceuticals), also known as Kahira Pharmaceuticals & Chemical Industries |
2011 | 250,00$ |
Alexandria Pharmaceutical and Chemical Industries Company (AXPH) - Financial and Strategic SWOT Analysis ReviewAlexandria Pharmaceutical and Chemical Industries Company (APCIC) is an Egyptian pharmaceutical company, engaged in the manufactur |
2011 | 250,00$ |
GlaxoSmithKline Pharmaceuticals Limited (GLAXO) - Financial and Strategic SWOT Analysis ReviewGlaxoSmithKline Pharmaceuticals Limited (GSK) is a research-focused healthcare and pharmaceutical company. The company offers a di |
2011 | 125,00$ |
Jagsonpal Pharmaceuticals Limited (507789) - Financial and Strategic SWOT Analysis ReviewJagsonpal Pharmaceuticals Limited (Jagsonpal) is an India based pharmaceutical company. It is engaged in the research, development |
2011 | 250,00$ |
Affitech A/S (AFFI) - Financial and Strategic SWOT Analysis ReviewAffitech A/S (Affitech) is a pharmaceutical company, based in Denmark. The company operates in the discovery and development of hu |
2011 | 250,00$ |
Fresenius Kabi Oncology Limited (FKONCO) - Financial and Strategic SWOT Analysis ReviewFresenius Kabi Oncology Limited (Fresenius Kabi) is a drug developing and manufacturing company engages in cancer research and ant |
2011 | 250,00$ |
Wyeth Limited (WYETH) - Financial and Strategic SWOT Analysis ReviewWyeth Limited is a pharmaceutical company, engaged in the development, manufacture, and sale of pharmaceutical products. It operat |
2011 | 250,00$ |
Sharon Bio-Medicine Ltd. (590034) - Financial and Strategic SWOT Analysis ReviewSharon Bio-Medicine Ltd. (Sharon) is an India-based pharmaceutical company. The company is principally engaged in research & devel |
2011 | 250,00$ |
Aarti Drugs Ltd. (AARTIDRUGS) - Financial and Strategic SWOT Analysis ReviewAarti Drugs Ltd. (Aarti Drugs) is an India based drugs manufacturing company. Aarti Drugs is a part of Aarti Group of Industries. |
2011 | 250,00$ |
Astrazeneca Pharma India Limited (ASTRAZEN) - Financial and Strategic SWOT Analysis ReviewAstraZeneca Pharma India Limited (AZPIL) is pharmaceutical company engaged in the research, production and commercialization of ph |
2011 | 250,00$ |
The Lanka Hospitals Corporation PLC (LHCL) - Financial and Strategic SWOT Analysis ReviewThe Lanka Hospitals Corporation PLC (Lanka Hospitals Corporation) is a healthcare company engaged in the provision of healthcare s |
2011 | 250,00$ |
EIS Eczacibasi Ilac Sinai ve Finansal Yatirmlar Sanayi Ve Ticaret A.S. (ECILC) - Financial and Strategic SWOT Analysis ReviewEIS Eczacibasi Ilac Sinai ve Finansal Yatirmlar Sanayi Ve Ticaret A.S. (EIS Eczacibasi) is engaged in production, marketing and se |
2011 | 125,00$ |
StemCells, Inc. (STEMD) - Financial and Strategic SWOT Analysis ReviewStemCells, Inc. (StemCells) is a biopharmaceutical company engaged in the discovery and development of cell-based therapeutics to |
2011 | 250,00$ |
Egyptian International Pharmaceutical Industries Company (PHAR) - Financial and Strategic SWOT Analysis ReviewEgyptian International Pharmaceutical Industries Company (EIPIC) is a pharmaceutical company, engaged in the production, sale and |
2011 | 125,00$ |
Cardica, Inc. (CRDC) - Financial and Strategic SWOT Analysis ReviewCardica, Inc. (Cardica) is a manufacturing company, engaged in the research and development of novel technologies in the field of |
2011 | 250,00$ |
Deepak Nitrite Ltd. (506401) - Financial and Strategic SWOT Analysis ReviewDeepak Nitrite Ltd. (DNL) is engaged in manufacturing inorganic, organic and fine & specialty chemicals that are used as intermedi |
2011 | 250,00$ |
Halcygen Pharmaceuticals Limited (MYX) - Financial and Strategic SWOT Analysis ReviewHalcygen Pharmaceuticals Limited (Halcygen) is focused on the improvement and reformulation of existing drugs. The company has two |
2011 | 250,00$ |
Hadasit Bio-Holdings Ltd. (HDST) - Financial and Strategic SWOT Analysis ReviewHadasit Bio-Holdings Ltd. (HBL) is subsidiary of Hadasit Ltd. The company through its subsidiaries is engaged in serving the medic |
2011 | 250,00$ |
Abbott Laboratories (Pakistan) Limited (ABOT) - Financial and Strategic SWOT Analysis ReviewAbbott Laboratories (Pakistan) Limited (Abbott Pakistan) is a health care company. It is a subsidiary of Abbott Laboratories, the |
2011 | 250,00$ |
ZhuZhou QianJin Pharmaceutical Co., Ltd (600479) - Financial and Strategic SWOT Analysis ReviewZhuZhou QianJin Pharmaceutical Co., Ltd (QianJin), a China-based public shareholding company is engaged in the production and sale |
2011 | 250,00$ |
Maywufa Company Limited (1731) - Financial and Strategic SWOT Analysis ReviewMaywufa Company Limited (Maywufa) is engaged in the manufacture and marketing of pharmaceuticals, hair and skin care products. It |
2011 | 250,00$ |
Ham-Let (Israel-Canada) Ltd. (HAML) - Financial and Strategic SWOT Analysis ReviewHam-Let (Israel-Canada) Ltd. (Ham-Let) is an Israel-based company. Ham-Let is engaged in the development, manufacture and marketin |
2011 | 250,00$ |
Znomics, Inc. (ZNOM) - Financial and Strategic SWOT Analysis ReviewZnomics, Inc. is a biotechnology company engaged in drug discovery by combining medicinal chemistry with Zebrafish Technologies. I |
2011 | 250,00$ |
Abl Biotechnologies Limited (526955) - Financial and Strategic SWOT Analysis ReviewAbl biotechnologies Limited (ABL), is a public company involved in the production and research and development of bio-chemicals. T |
2011 | 250,00$ |
Mavens Biotech Ltd (590083) - Financial and Strategic SWOT Analysis ReviewMavens Biotech Ltd. (Mavens) is a biotechnology company. It is principally engaged in the development, testing and validation of i |
2011 | 250,00$ |
BioSyent Inc. (RX) - Financial and Strategic SWOT Analysis ReviewBioSyent Inc. (BioSyent) is a specialty pharmaceutical company that is engaged in development, acquisition and marketing of pharma |
2011 | 250,00$ |
Phosphagenics Limited (POH) - Financial and Strategic SWOT Analysis ReviewPhosphagenics Limited (Phosphagenics), formerly known as Vital Capital Limited, is a biopharmaceutical company. It is principally |
2011 | 250,00$ |
Mammatech Corporation (MAMM) - Financial and Strategic SWOT Analysis ReviewMammatech Corporation (MammaCare) is a company engaged in the sale of the breast examination systems. The systems are sold in the |
2011 | 250,00$ |
Simulations Plus, Inc. (SLP) - Financial and Strategic SWOT Analysis ReviewSimulations Plus, Inc. (Simulations Plus) is a public company that develops and produces software for use in pharmaceutical resear |
2011 | 125,00$ |
HMS Holdings Corp. (HMSY) - Financial and Strategic SWOT Analysis ReviewHMS Holdings Corp. (HMS) is a healthcare service company engaged in providing a variety of cost management services to government- |
2011 | 125,00$ |
Viropro Inc. (VPRO) - Financial and Strategic SWOT Analysis ReviewViropro, Inc. (Viropro) is a publicaly held pharmaceutical company engaged in cell line and business development process. The comp |
2011 | 250,00$ |
Vivalis SA (VLS) - Financial and Strategic SWOT Analysis ReviewVivalis SA (Vivalis) is a public bio-pharmaceutical company, engaged in the provision of cell based solutions for the industrial m |
2011 | 250,00$ |
MOCON Inc. (MOCO) - Financial and Strategic SWOT Analysis ReviewMocon Inc (Mocon) is a publicly traded company engaged in providing innovative instruments, testing services and consulting for th |
2011 | 250,00$ |
Natural Capsules Limited (524654) - Financial and Strategic SWOT Analysis ReviewNatural Capsules Limited (Natural Capsules) is public limited company, principally engaged in the manufacturing of capsule shells |
2011 | 250,00$ |
CordLife Pte. Ltd. (CBB) - Financial and Strategic SWOT Analysis ReviewCordLife Pte. Ltd. (Cordlife) is a publicly held healthcare company engaged in collection, processing and storing cord blood stem |
2011 | 250,00$ |
Kedem Pharmaceuticals Inc. (GHLV) - Financial and Strategic SWOT Analysis ReviewThis comprehensive SWOT profile of Kedem Pharmaceuticals Inc. provides you an in-depth strategic analysis of the company’s busine |
2011 | 250,00$ |
Cellectis S.A. (ALCLS) - Financial and Strategic SWOT Analysis ReviewCellectis S.A. (Cellectis) is a biotechnology company, engaged in the development of high-precision, high-performance systems for |
2011 | 250,00$ |
Protokinetix Inc. (PKTX) - Financial and Strategic SWOT Analysis ReviewProtoKinetix, Inc. (ProtoKinetix) is a biotechnology company, engaged in the development of patented synthetic anti-aging glycopep |
2011 | 250,00$ |
Applied DNA Sciences, Inc. (APDN) - Financial and Strategic SWOT Analysis ReviewApplied DNA Sciences, Inc. (APDN) is a biotechnology company, engaged in the commercialization of patented DNA security solutions |
2011 | 250,00$ |
Tremont Fair, Inc. (VCAN) - Financial and Strategic SWOT Analysis ReviewTremont Fair, Inc. (Tremont) is the publicly held US based biotechnology company which is principally engaged in developing immuno |
2011 | 250,00$ |
XenaCare Holdings, Inc. (XCHO) - Financial and Strategic SWOT Analysis ReviewXenaCare Holdings, Inc. (XenaCare) is a publicly held pharmaceutical company. It engages in the formulation, marketing and distrib |
2011 | 250,00$ |
Nkbio Co., Ltd. (019260) - Financial and Strategic SWOT Analysis ReviewNkbio Co., Ltd. (Nkbio) is a research focused biopharmaceuticals company, engaged in manufacturing and commercialization of fiber |
2011 | 250,00$ |
ARCA biopharma, Inc. (ABIO) - Financial and Strategic SWOT Analysis ReviewARCA biopharma, Inc. (ARCA biopharma) is a bio pharmaceutical company, engaged in the development and commercializing genetically- |
2011 | 250,00$ |
Smruthi Organics Limited (590046) - Financial and Strategic SWOT Analysis ReviewSmruthi Organics Limited (Smruthi) is an API manufacturing company. It offers contract research, manufacturing and custom synthesi |
2011 | 250,00$ |
MolMed S.p.A. (MLM) - Financial and Strategic SWOT Analysis ReviewMolMed S.p.A. (Molmed) is a publicly traded medical biotechnology company engaged in research, development and the clinical valida |
2011 | 250,00$ |
Sinovac Biotech Ltd. (SVA) - Financial and Strategic SWOT Analysis ReviewSinovac Biotech Ltd (Sinovac Biotech) is engaged in the research, development, manufacture and commercialization of vaccines that |
2011 | 250,00$ |
Myrexis, Inc. (MYRX) - Financial and Strategic SWOT Analysis ReviewMyrexis, Inc. (Myrexis) is a pharmaceutical company, engaged in the discovery, development, and commercialization of small molecul |
2011 | 250,00$ |
Genexine Co., Ltd. (095700) - Financial and Strategic SWOT Analysis ReviewGenexine Co., Ltd. (Genexine) is involved in the research and development of therapeutic vaccines for incurable diseases and next- |
2011 | 250,00$ |
Giaconda Limited (GIA) - Financial and Strategic SWOT Analysis ReviewGiaconda Limited (Giaconda) is a research focused biotechnology company, engaged in research, development and commercialization of |
2011 | 250,00$ |
CytoDyn, Inc. (CYDY) - Financial and Strategic SWOT Analysis ReviewCytoDyn, Inc. (CytoDyn ) is a biotechnology research company that is engaged in the development of drugs to treat HIV/AIDS. The co |
2011 | 250,00$ |
Intellect Neurosciences, Inc. (ILNS) - Financial and Strategic SWOT Analysis ReviewIntellect Neurosciences, Inc. (Intellect Neuro) is a publicly held biopharmaceutical company. Intellect Neuro is in development st |
2011 | 250,00$ |
QRxPharma Limited (QRX) - Financial and Strategic SWOT Analysis ReviewQRxPharma Limited (QRxPharma) is clinical-stage specialty pharmaceutical company. The company is engaged in the development, manuf |
2011 | 250,00$ |
Omeros Corporation (OMER) - Financial and Strategic SWOT Analysis ReviewOmeros Corporation (Omeros) is the US based clinical-stage bio-pharmaceutical company. It is engaged in the discovery, development |
2011 | 250,00$ |
Sosei Co. Ltd. (4565) - Financial and Strategic SWOT Analysis ReviewSosei Co. Ltd., (Sosei)is a privately held company that is engaged in the process of drug development. The product pipeline of the |
2011 | 250,00$ |
China Medical System Holdings Limited (867) - Financial and Strategic SWOT Analysis ReviewChina Medical System Holdings Limited (CMS) is an integrated pharmaceutical group that focuses on the research development, manufa |
2011 | 250,00$ |
Laboratorios Farmaceuticos ROVI, S.A. (ROVI) - Financial and Strategic SWOT Analysis ReviewLaboratorios Farmaceuticos ROVI, S.A. (Laboratorios Farmaceuticos) is a chemical and pharmaceutical company. The company is engage |
2011 | 125,00$ |
BioStar Pharmaceuticals, Inc. (BSPM) - Financial and Strategic SWOT Analysis ReviewBioStar Pharmaceuticals, Inc. (BioStar) is a pharmaceutical company engaged in development, manufacture, and marketing of pharmace |
2011 | 250,00$ |
China Medicine Corporation (CHME) - Financial and Strategic SWOT Analysis ReviewChina Medicine Corporation (CMC) is involved in the discovery, development, distribution and manufacturing of pharmaceutical produ |
2011 | 250,00$ |
Lijun International Pharmaceutical (Holding) Co., Ltd. (2005) - Financial and Strategic SWOT Analysis ReviewLijun International Pharmaceutical (Holding) Co., Ltd. (Lijun) is engaged in the research, development, manufacture and marketing |
2011 | 125,00$ |
China Shineway Pharmaceutical Group Limited (2877) - Financial and Strategic SWOT Analysis ReviewChina Shineway Pharmaceutical Group Limited (China Shineway) is a pharmaceutical company that is focused in the research, developm |
2011 | 125,00$ |
Cornerstone Therapeutics Inc. (CRTX) - Financial and Strategic SWOT Analysis ReviewCornerstone Therapeutics Inc. (Cornerstone Therapeutics) is a specialty pharmaceutical company. It is engaged in acquiring, develo |
2011 | 250,00$ |
Zhejiang CONBA Pharmaceutical Co.,Ltd. (600572) - Financial and Strategic SWOT Analysis ReviewZhejiang CONBA Pharmaceutical Co., Ltd. (Zhejiang) is principally engaged in providing medicine raw materials. The company offers |
2011 | 125,00$ |
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (600196) - Financial and Strategic SWOT Analysis ReviewShanghai Fosun Pharmaceutical (Group) Co., Ltd. (SFP) is a pharmaceutical company primarily engaged in research, development, prod |
2011 | 125,00$ |
Tongjitang Chinese Medicines Company (TCM) - Financial and Strategic SWOT Analysis ReviewTongjitang Chinese Medicines Company (Tongjitang) is a specialty pharmaceutical company that is engaged in the development, manufa |
2011 | 250,00$ |
Guilin Sanjin Pharmaceutical Co., Ltd. (002275) - Financial and Strategic SWOT Analysis ReviewGuilin Sanjin Pharmaceutical Co., Ltd. (Sanjin, formerly known as Guilin Traditional Chinese Medicine Factory) is a pharmaceutical |
2011 | 125,00$ |
Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. (600436) - Financial and Strategic SWOT Analysis ReviewZhangzhou Pientzehuang Pharmaceutical Co., Ltd. (ZPP) is engaged in development and marketing of Chinese herbs mainly in the marke |
2011 | 250,00$ |
Sanofi-aventis Pakistan limited (SAPL) - Financial and Strategic SWOT Analysis ReviewSanofi-aventis Pakistan limited (Sanofi-aventis Pakistan) is a pharmaceutical company engaged in the manufacture and sale of pharm |
2011 | 250,00$ |
Vetoquinol S A (VETO) - Financial and Strategic SWOT Analysis ReviewVetoquinol S A (Vetoquinol) is a publicly traded company primarily engaged in the animal healthcare. The company is mainly involve |
2011 | 125,00$ |
Shandong Lukang International Trading Co., Ltd (600789) - Financial and Strategic SWOT Analysis ReviewShandong Lukang International Trading Co., Ltd (Shandong Lukang), formerly Jining Antibiotic Factory is a publicly traded biotechn |
2011 | 125,00$ |
Vital Pharmaceutical Holdings Limited (1164) - Financial and Strategic SWOT Analysis ReviewVital Pharmaceutical Holdings Limited (Vital Pharmaceutical) is a publicly traded investment holding company. The company engages |
2011 | 250,00$ |
Shandong Luoxin Pharmacy Stock Co., Ltd. (8058) - Financial and Strategic SWOT Analysis ReviewShandong Luoxin Pharmacy Stock Co., Ltd. (Shandong Luoxin, formerly Shandong Luoxin Factory) is a pharmaceutical company engaged i |
2011 | 250,00$ |
Shin Nippon Biomedical Laboratories, Ltd. (2395) - Financial and Strategic SWOT Analysis ReviewShin Nippon Biomedical Laboratories, Ltd. (SNBL) is a Japan based company engaged in providing various drug development services t |
2011 | 125,00$ |
Wai Yuen Tong Medicine Holdings Limited (897) - Financial and Strategic SWOT Analysis ReviewWai Yuen Tong Medicine Holdings Limited (Wai Yuen Tong) is a pharmaceutical company that is engaged in the production and sale of |
2011 | 250,00$ |
Shanghai Jiao Da Onlly Co., Ltd. (600530) - Financial and Strategic SWOT Analysis ReviewShanghai Jiao Da Onlly Co., Ltd. is a publicly held healthcare food company. It is involved in the production and sales of biologi |
2011 | 250,00$ |
Jiangsu Sihuan Bioengineering Co., Ltd (000518) - Financial and Strategic SWOT Analysis ReviewJiangsu Sihuan Bioengineering Co., Ltd (Jiangsu Sihuan) is a biological medicine manufacturer and provider engaged in the biologic |
2011 | 250,00$ |
Beijing Tiantan Biological Products Co., Ltd. (600161) - Financial and Strategic SWOT Analysis ReviewBeijing Tiantan Biological Products Co., Ltd. (Tiantan Biological) is a publicly held biotechnology company that is principally en |
2011 | 250,00$ |
Caplin Point Laboratories Ltd (524742) - Financial and Strategic SWOT Analysis ReviewCaplin Point Laboratories Ltd (Caplin Point) is a pharmaceutical company engaged in contract manufacturing of several pharmaceutic |
2011 | 250,00$ |
ImmunoVaccine Technologies Inc. (IMV) - Financial and Strategic SWOT Analysis ReviewImmunoVaccine Technologies Inc. (IMV, formerly Rhino Resources Inc.) is a biotechnology company engaged in the development of high |
2011 | 250,00$ |
Mediscience Planning Inc. (2182) - Financial and Strategic SWOT Analysis ReviewMediscience Planning Inc. (Mediscience Planning) is engaged in providing contract research services to medical and pharmaceutical |
2011 | 250,00$ |
Winteam Pharmaceutical Group Limited (570) - Financial and Strategic SWOT Analysis ReviewWinteam Pharmaceutical Group Limited (Winteam) is a public traded company engaged in the manufacture and sale of Chinese medicine |
2011 | 250,00$ |
Southwest Synthetic Pharmaceutical Corporation Ltd. (000788) - Financial and Strategic SWOT Analysis ReviewSouthwest Synthetic Pharmaceutical Corporation Ltd. (SSPCL) is a publicly held pharmaceutical company that is engaged in the manuf |
2011 | 250,00$ |
Zhejiang Hangzhou Xinfu Pharma Co., Ltd. (002019) - Financial and Strategic SWOT Analysis ReviewZhejiang Hangzhou Xinfu Pharma Co., Ltd. (Xinfu), a public share holding company engaged in production and sale of fine chemical a |
2011 | 250,00$ |
Zhejiang Hisoar Pharmaceutical Co.,LTD. (002099) - Financial and Strategic SWOT Analysis ReviewZhejiang Hisoar Pharmaceutical Co.,LTD. (Hisoar), a public share holding company engaged in the production and sale of drug substa |
2011 | 250,00$ |
Zhejiang Jingxin Pharmaceutical Co., Ltd (002020) - Financial and Strategic SWOT Analysis ReviewZhejiang Jingxin Pharmaceutical Co., Ltd (Jingxin Pharma), formerly known as Zhejiang Jingxin Pharmaceutical Factory is a public s |
2011 | 250,00$ |
Tianjin Tasly Pharmaceutical Co., Ltd. (600535) - Financial and Strategic SWOT Analysis ReviewTianjin Tasly Pharmaceutical Co. Ltd. (Tasly) is a public traded pharmaceutical company engaged in the development, manufacturing |
2011 | 125,00$ |
Welichem Biotech Inc. (WBI) - Financial and Strategic SWOT Analysis ReviewWelichem Biotech Inc. (Welichem, formerly known as Welichem Technology Corporation) is a public share holding company. It is princ |
2011 | 250,00$ |
Adeona Pharmaceuticals, Inc. (AEN) - Financial and Strategic SWOT Analysis ReviewAdeona Pharmaceuticals, Inc. (Adeona), a public share holding company, is a development-stage specialty pharmaceutical company. Th |
2011 | 250,00$ |
Tianjin Zhongxin Pharmaceutical Group Corporation Limited (600329) - Financial and Strategic SWOT Analysis ReviewTianjin Zhongxin Pharmaceutical Group Corporation Limited (TZPG) is a publicly traded pharmaceutical company, engaged in the produ |
2011 | 125,00$ |
Pharmstandard (PHST) - Financial and Strategic SWOT Analysis ReviewPharmstandard is engaged in the manufacture and marketing of pharmaceuticals and medical products. It operates in two segments nam |
2011 | 250,00$ |
The United Laboratories International Holdings Limited (3933) - Financial and Strategic SWOT Analysis ReviewThe United Laboratories International Holdings Limited (TUL) is a public traded pharmaceutical company engaged in the production a |
2011 | 125,00$ |
Wuhan Humanwell Hi-Tech Industry Co., LTD. (600079) - Financial and Strategic SWOT Analysis ReviewWuhan Humanwell Hi-Tech Industry Co., LTD. (Wuhan Humanwell) is a pharmaceutical company, based in China. The company is specializ |
2011 | 125,00$ |
Wuyi International Pharmaceutical Company Limited (1889) - Financial and Strategic SWOT Analysis ReviewWuyi International Pharmaceutical Company Limited (Wuyi International) is a public traded company involved in the research and dev |
2011 | 250,00$ |
GeneLink BioSciences, Inc. (GNLK) - Financial and Strategic SWOT Analysis ReviewGeneLink BioSciences, Inc. (Genelink) is a public traded biosciences company. The company provides genetically guided health, beau |
2011 | 250,00$ |
GENova Biotherapeutics, Inc. (GVBP) - Financial and Strategic SWOT Analysis ReviewGENova Biotherapeutics, Inc. (GENova) is a publicly traded biotechnological drug development company, engaged in the identifying, |
2011 | 250,00$ |
Shandong Jintai Group Co.,Ltd. (600385) - Financial and Strategic SWOT Analysis ReviewShandong Jintai Group Co., Ltd. (Shandong Jintai) is a pharmaceutical company principally engaged in the production and distributi |
2011 | 250,00$ |
iBio, Inc. (IBIO) - Financial and Strategic SWOT Analysis ReviewiBio, Inc. (iBio, formerly iBioPharma, Inc.) is a biotechnology company, engaged in the development of vaccines and therapeutic pr |
2011 | 250,00$ |
Cellceutix Corporation (CTIX) - Financial and Strategic SWOT Analysis ReviewCellceutix Corporation (Cellceutix) is a publicly traded development stage bio-pharmaceutical company and is engaged in the develo |
2011 | 250,00$ |
VIA Pharmaceuticals, Inc. (VIAP) - Financial and Strategic SWOT Analysis ReviewVIA Pharmaceuticals, Inc. (VIA) is a public traded biotechnology company, based in the US. The company is engaged in discovery, de |
2011 | 250,00$ |
Vanda Pharmaceuticals Inc. (VNDA) - Financial and Strategic SWOT Analysis ReviewVanda Pharmaceuticals Inc. (Vanda) is a biopharmaceutical company, engaged in developing and commercializing clinical-stage drug c |
2011 | 250,00$ |
Virax Holdings Limited (VHL) - Financial and Strategic SWOT Analysis ReviewVirax Holdings Limited (Virax) is a biopharmaceutical company, principally engaged in the discovery and development of novel immun |
2011 | 250,00$ |
Intellipharmaceutics International Inc. (IPCI) - Financial and Strategic SWOT Analysis ReviewIntellipharmaceutics International Inc. (formerly known as IntelliPharmaCeutics Corp.) is engaged in the design and development of |
2011 | 250,00$ |
AB Science (AB) - Financial and Strategic SWOT Analysis ReviewAB Science (ABS) is a privtely held biopharmaceutical company. It is principally engaged in the research, development and commerci |
2011 | 250,00$ |
Tetragenex Pharmaceuticals, Inc. (TTRXQ) - Financial and Strategic SWOT Analysis ReviewTetragenex Pharmaceuticals, Inc. (Tetragenex) is a publicly held bio pharmaceutical company. It is principally engaged in developm |
2011 | 250,00$ |
Anthera Pharmaceuticals‚ Inc. (ANTH) - Financial and Strategic SWOT Analysis ReviewAnthera Pharmaceuticals, Inc. (Anthera) is a research based biopharmaceutical company targeting on development and commercializati |
2011 | 250,00$ |
GNI, LTD. (2160) - Financial and Strategic SWOT Analysis ReviewGNI, LTD. (GNI) is a publicly traded bio-pharmaceutical company, focused on the discovery and development and manufacturing of the |
2011 | 250,00$ |
Adamis Pharmaceuticals Corporation (ADMP) - Financial and Strategic SWOT Analysis ReviewAdamis Pharmaceuticals Corporation (Adamis), formerly known as Cellegy Pharmaceuticals, Inc., is a publicly traded specialty pharm |
2011 | 250,00$ |
Tianyin Pharmaceutical Co., Inc. (TPI) - Financial and Strategic SWOT Analysis ReviewTianyin Pharmaceutical Co., Inc. (Tianyin) formerly known as Viscorp, Inc. is a publicly held pharmaceutical company, engaged in d |
2011 | 250,00$ |
Cannabis Science, Inc. (CBISE) - Financial and Strategic SWOT Analysis ReviewCannabis Science, Inc. (formerly, Gulf Onshore, Inc.) is a public traded, pharmaceutical company that is engaged in the developmen |
2011 | 125,00$ |
Synergy Pharmaceuticals, Inc. (SGYP) - Financial and Strategic SWOT Analysis ReviewSynergy Pharmaceuticals, Inc. (Synergy) is a development-stage biopharmaceutical company, based in the US. The company is engaged |
2011 | 250,00$ |
AVEO Pharmaceuticals, Inc. (AVEO) - Financial and Strategic SWOT Analysis ReviewAVEO Pharmaceuticals, Inc. (Aveo Pharmaceuticals) is a pharmaceutical company engaged in the discovery and development of therapeu |
2011 | 250,00$ |
Winston Pharmaceuticals, Inc. (WPHM) - Financial and Strategic SWOT Analysis ReviewWinston Pharmaceuticals, Inc. (Winston Pharmaceuticals, formerly known as Getting Ready Corporation) is a development stage, resea |
2011 | 250,00$ |
Vitro Diagnostics, Inc. (VODG) - Financial and Strategic SWOT Analysis ReviewVitro Diagnostics, Inc. (Vitro Biopharma) is a bio-pharmaceutical company. The company is principally engaged in the research, dev |
2011 | 250,00$ |
BioNeutral Group, Inc. (BONU) - Financial and Strategic SWOT Analysis ReviewBioNeutral Group, Inc. (BioNeutral) is a public traded, specialty life science company. The company is principally engaged in the |
2011 | 250,00$ |
ViroMed Co., Ltd. (084990) - Financial and Strategic SWOT Analysis ReviewViromed Co. Ltd. (Viromed) is a Korea based biotechnology company. The company is principally engaged in the research and developm |
2011 | 250,00$ |
NasVax Ltd. (NSVX) - Financial and Strategic SWOT Analysis ReviewNasVax Ltd. (NasVax) is bio-pharmaceutical company, principally engaged in developing advanced vaccines and immunotherapeutics. It |
2011 | 250,00$ |
Afexa Life Sciences Inc. (FXA) - Financial and Strategic SWOT Analysis ReviewAfexa Life Sciences Inc. (ALSI, formerly known as CV Technologies Inc.) is a health sciences and technology company. The company i |
2011 | 250,00$ |
Ind-Swift Limited. (524652) - Financial and Strategic SWOT Analysis ReviewInd-Swift Limited. (Ind-Swift) is a public traded pharmaceutical company, engaged in the manufacturing and marketing of finished d |
2011 | 250,00$ |
Anu's Laboratories Limited (532981) - Financial and Strategic SWOT Analysis ReviewAnu's Laboratories Limited (Anu's Laboratories) is involved in the production of drug intermediates, based in India. The company i |
2011 | 250,00$ |
Kawamura Cycle Co., Ltd. (7311) - Financial and Strategic SWOT Analysis ReviewKawamura Cycle Co., Ltd. (Kawamura Cycle) is a Japan based manufacturing company. The company is engaged in the manufacture and sa |
2011 | 250,00$ |
IADELPA SAECA (IAD) - Financial and Strategic SWOT Analysis ReviewIADELPA SAECA (IADELPA) also known as Andromaco Institute of Paraguay, is a publicly held company that is engaged in the manufactu |
2011 | 250,00$ |
Hangzhou Tian-Mu-Shan Pharm. Enterp. Co (600671) - Financial and Strategic SWOT Analysis ReviewHangzhou Tian-Mu-Shan Pharm. Enterp. Co (Hangzhou) is a pharmaceutical company engaged in the production, distribution and trading |
2011 | 250,00$ |
B.O.S. Better OnLine Solutions Ltd. (BOSC) - Financial and Strategic SWOT Analysis ReviewB.O.S. Better OnLine Solutions Ltd. (B.O.S) is publicly held company focused on providing RFID, Mobile and Supply Chain Solutions |
2011 | 125,00$ |
Bal Pharma Limited (524824) - Financial and Strategic SWOT Analysis ReviewBal Pharma Limited (Bal Pharma) is a pharmaceutical company, engaged in the manufacturing and marketing of pharmaceutical formulat |
2011 | 250,00$ |
Fabryka Kosmetykow POLLENA-EWA SA (PLE) - Financial and Strategic SWOT Analysis ReviewFabryka Kosmetykow POLLENA-EWA SA (F.K. POLLENA-EWA) is a healthcare company, principally engaged in manufacturing of cosmetics. T |
2011 | 250,00$ |
Harbin Pharm Group Sanjing Pharm Co Ltd (600829) - Financial and Strategic SWOT Analysis ReviewHarbin Pharm Group Sanjing Pharm Co Ltd (Sanjing Pharmaceutical) is china based pharmaceutical company. The company is engaged in |
2011 | 125,00$ |
Al Borg Laboratory (ALAB) - Financial and Strategic SWOT Analysis ReviewAl Borg Laboratory (Al Borg) formerly known as Cairo Medical Tower Laboratory, is a publicly held pharmaceutical company engaged i |
2011 | 250,00$ |
Ahlcon Parenterals (India) Limited (524448) - Financial and Strategic SWOT Analysis ReviewAhlcon Parenterals (India) Ltd (APIL) is publicly held pharmaceutical company, based in India. The company is engaged in the manuf |
2011 | 250,00$ |
Hatay Pharmaceutical JSC (DHT) - Financial and Strategic SWOT Analysis ReviewHatay Pharmaceutical JSC (Hatay Pharmaceutical) is a publicly held pharmaceutical company engaged in manufacturing, marketing and |
2011 | 250,00$ |
Health Grades, Inc. (HGRD) - Financial and Strategic SWOT Analysis ReviewHealth Grades, Inc. (HGRD) is a healthcare ratings organization engaged in providing ratings and profiles of hospitals, nursing ho |
2011 | 250,00$ |
HealthSport, Inc. (HSPO) - Financial and Strategic SWOT Analysis ReviewHealthSport, Inc. (HealthSport) is a drug delivery company focused on the development, manufacture, distribution and sale of brand |
2011 | 250,00$ |
Surya Pharmaceutical Limited (SURYAPHARM) - Financial and Strategic SWOT Analysis ReviewSurya Pharmaceutical Limited (Surya Pharmaceutical) is a publicly traded company engaged in the production of range of Active Phar |
2011 | 250,00$ |
ImmunoBiotics, Inc. (IMBI) - Financial and Strategic SWOT Analysis ReviewImmunoBiotics, Inc. (ImmunoBiotics) is a bio-pharmaceutical company engaged in developing, testing, manufacturing, licensing of he |
2011 | 250,00$ |
OdontoPrev S.A. (ODPV3) - Financial and Strategic SWOT Analysis ReviewOdontoprev SA (Odontoprev) is a publicly held health services providing company. The company is engaged in providing dental health |
2011 | 125,00$ |
Procognia Limited (PRCG) - Financial and Strategic SWOT Analysis ReviewProcognia Limited (Procognia) is a public listed biotechnology company that is engaged in providing fast and accurate glycoanalysi |
2011 | 250,00$ |
Alpa Laboratories Limited (ALPA) - Financial and Strategic SWOT Analysis ReviewAlpa Laboratories Limited (Alpa) is publicly held company engaged in research, development and production of ethical drugs, over t |
2011 | 250,00$ |
Merriman Curhan Ford Group, Inc. (MERR) - Financial and Strategic SWOT Analysis ReviewMerriman Curhan Ford Group, Inc. (Merriman Curhan) is an US based financial services provider to various industries including Heal |
2011 | 250,00$ |
Access Plans, Inc. (APNC) - Financial and Strategic SWOT Analysis ReviewAccess Plans, Inc. (Access Plans) formerly known as Alliance HealthCard, Inc., is a leading provider of health discount and lifest |
2011 | 250,00$ |
Pacific Healthcare Holdings Ltd. (P47) - Financial and Strategic SWOT Analysis ReviewPacific Healthcare Holdings Ltd. (Pacific Healthcare) is a health care provider that is engaged in offering a range of health care |
2011 | 250,00$ |
CardioGenics Holdings Inc. (CGNH) - Financial and Strategic SWOT Analysis ReviewCardioGenics Holdings Inc. (CardioGenics) is a publicly held company engaged in the development of technology and products, which |
2011 | 250,00$ |
Transax International Limited (TNSX) - Financial and Strategic SWOT Analysis ReviewTransax International Limited (Transax) offers information network solutions to health care providers and health insurance compani |
2011 | 125,00$ |
Bliss GVS Pharma Limited (BLISSGVS) - Financial and Strategic SWOT Analysis ReviewBliss GVS Pharma Limited (Bliss) is a publicly held pharmaceutical company that is engaged in manufacturing prescription drugs and |
2011 | 250,00$ |
World Health Energy Holdings, Inc. (WHEN) - Financial and Strategic SWOT Analysis ReviewWorld Health Energy Holdings, Inc (WHEN) engages in providing new innovative clean green energy and pioneering new food crops. The |
2011 | 125,00$ |
The Advisory Board Company (ABCO) - Financial and Strategic SWOT Analysis ReviewThe Advisory Board Company (The Advisory Board) is engaged in providing best practices research and analysis services to the healt |
2011 | 125,00$ |
Spectral Diagnostics Inc. (SDI) - Financial and Strategic SWOT Analysis ReviewSpectral Diagnostics Inc. (Spectral) is a health care company, engaged in the development and commercialization of innovative diag |
2011 | 250,00$ |
Shenzhen Neptunus Interlong Bio-Technique Co. Ltd. (8329) - Financial and Strategic SWOT Analysis ReviewShenzhen Neptunus Interlong Bio-Technique Co., Ltd. (Interlong) is a biological pharmaceutical manufacturer in China and a leading |
2011 | 250,00$ |
Venturepharm Laboratories Limited (8225) - Financial and Strategic SWOT Analysis ReviewVenturepharm Laboratories Limited (Venturepharm) is engaged in providing a range of pharmaceutical development services by bringin |
2011 | 250,00$ |
Medika d.d. (MDKA-R-A) - Financial and Strategic SWOT Analysis ReviewMedika d.d. (Medika) is a publicly held wholesale drug company that is engaged in supply and distribution of pharmaceutical and me |
2011 | 125,00$ |
WuXi PharmaTech (Cayman), Inc. (WX) - Financial and Strategic SWOT Analysis ReviewWuXi PharmaTech (Cayman), Inc. (WuXi PharmaTech) is a healthcare service company engaged in the providing various services for pha |
2011 | 125,00$ |
Nano Dimensions, Inc. (NDSI) - Financial and Strategic SWOT Analysis ReviewThis comprehensive SWOT profile of Nano Dimensions, Inc. provides you an in-depth strategic analysis of the company’s businesses |
2011 | 250,00$ |
Lee's Pharmaceutical Holdings Limited (950) - Financial and Strategic SWOT Analysis ReviewLee's Pharmaceutical Holdings Limited (Lee's Pharma) is a publicly held company that is engaged in research, development, manufact |
2011 | 250,00$ |
Shrink Nanotechnologies, Inc. (INKN) - Financial and Strategic SWOT Analysis ReviewShrink Nanotechnologies, Inc. (Shrink) is engaged in developing technologies primarily for solar energy, medical and diagnostic se |
2011 | 250,00$ |
China Biologic Products, Inc. (CBPO) - Financial and Strategic SWOT Analysis ReviewChina Biologic Products, Inc. (China Biologic) is a biopharmaceutical company. It is engaged in the research, development, product |
2011 | 250,00$ |
Burcon NutraScience Corporation (BU) - Financial and Strategic SWOT Analysis ReviewBurcon NutraScience Corporation (Burcon) is a research and development company. The company is engaged in the development of novel |
2011 | 250,00$ |
Total Nutraceutical Solutions, Inc. (TNUS) - Financial and Strategic SWOT Analysis ReviewTotal Nutraceutical Solutions, Inc. (TNS) is a nutraceutical company. The company is engaged in the discovery, formulation and mar |
2011 | 250,00$ |
EPS Co., Ltd. (4282) - Financial and Strategic SWOT Analysis ReviewEPS Co., Ltd. (EPS) is a contract research organization, engaged in providing services in clinical trials for drug development pri |
2011 | 125,00$ |
Yomeishu Seizo Co. Ltd. (2540) - Financial and Strategic SWOT Analysis ReviewYomeishu Seizo Co. Ltd. (Yomeishu Seizo) is engaged in the development, manufacturing, production and sale of a therapeutic drug n |
2011 | 250,00$ |
Addus HomeCare Corporation (ADUS) - Financial and Strategic SWOT Analysis ReviewAddus HomeCare Corporation (Addus HomeCare) is a specialty service provider that operates through its subsidiary Addus HealthCare, |
2011 | 125,00$ |
NuRx Pharmaceuticals, Inc. (NUXP) - Financial and Strategic SWOT Analysis ReviewNuRx Pharmaceuticals, Inc. (NuRx Pharmaceuticals) is a development stage research and development biopharmaceutical company. The c |
2011 | 250,00$ |
First Physicians Capital Group, Inc. (FPCG) - Financial and Strategic SWOT Analysis ReviewFirst Physicians Capital Group, Inc. (formerly known as Tri-Isthmus Group, Inc.) provides financial and managerial services to phy |
2011 | 250,00$ |
Dil Ltd. (506414) - Financial and Strategic SWOT Analysis ReviewDil Ltd. (DIL, formerly known as Duphar Interfran Ltd.) is specializes in contract research, custom synthesis and process research |
2011 | 250,00$ |
Entest BioMedical Inc. (ENTB) - Financial and Strategic SWOT Analysis ReviewEntest BioMedical Inc. (Entest), a majority owned subsidiary of Bio-Matrix Scientific Group Inc. The company is engaged in the dev |
2011 | 250,00$ |
Sihuan Pharmaceutical Holdings Group Ltd. (460) - Financial and Strategic SWOT Analysis ReviewSihuan Pharmaceutical Holdings Group Ltd. (Sihuan) is a publicly held pharmaceutical company that is engaged in the research and d |
2011 | 250,00$ |
Freedom Eye Resources Limited (FYI) - Financial and Strategic SWOT Analysis ReviewFreedom Eye Limited (Freedom Eye) is a publicly held company that is engaged in research and development of novel pharmaceutical p |
2011 | 250,00$ |
China Baoan Group Co., Ltd. (000009) - Financial and Strategic SWOT Analysis ReviewChina Baoan Group Co., Ltd. (CBGC) is a bio-pharmaceutical industry. The company is principally engaged in the businesses of real |
2011 | 125,00$ |
Vivakor, Inc. (VIVK) - Financial and Strategic SWOT Analysis ReviewVivakor, Inc. (Vivakor) is engaged in the research, development and acquisition of products in the area of biological handling, el |
2011 | 250,00$ |
Reliv International, Inc. (RELV) - Financial and Strategic SWOT Analysis ReviewReliv International Inc. (Reliv) is engaged in the development, manufacturing and marketing of an array of innovative nutritional |
2011 | 125,00$ |
Adventa Berhad (ADVENTA) - Financial and Strategic SWOT Analysis ReviewAdventa Berhad (Adventa) is an investment holding company, based in Malaysia. The company is principally engaged in manufacture, d |
2011 | 250,00$ |
Acuvax Ltd (ACU) - Financial and Strategic SWOT Analysis ReviewAcuvax Ltd (Acuvax) is a publicly held holding company that is principally engaged in the development of cancer therapies and vacc |
2011 | 250,00$ |
J-COM Holdings Co., Ltd. (2462) - Financial and Strategic SWOT Analysis ReviewJ-COM Holdings Co., Ltd. (J-COM Holdings) is Japan based company. It is formerly known as J-Com Co., Ltd. J-COM Holdings is princi |
2011 | 250,00$ |
Ohr Pharmaceutical Inc. (OHRP) - Financial and Strategic SWOT Analysis ReviewOhr Pharmaceutical Inc. (Ohr) is a public listed biotechnology company. It is engaged in the research and development of first in |
2011 | 250,00$ |
Shanghai Dingli Technology Development (Group) Co., Ltd. (900907) - Financial and Strategic SWOT Analysis ReviewShanghai Dingli Technology Development (Group) Co., Ltd. (Shanghai Dingli) is a publicly held company that operates its businesses |
2011 | 250,00$ |
Centric Health Corporation (CHH) - Financial and Strategic SWOT Analysis ReviewCentric Health Corporation (Centric Health) is a publicly held diversified healthcare investment company. It offers surgical proce |
2011 | 250,00$ |
Synmosa Biopharma Corporation (4114) - Financial and Strategic SWOT Analysis ReviewSynmosa Biopharma Corporation (Synmosa) is engaged in the development, manufacture, marketing and distribution of pharmaceutical a |
2011 | 250,00$ |
Sunshine Biopharma, Inc. (SBFM) - Financial and Strategic SWOT Analysis ReviewSunshine BioPharma, Inc., (formerly known as Mountain West Business Solutions, Inc.) is a pharmaceutical company. It focuses on |
2011 | 250,00$ |
ECI, Inc. (4567) - Financial and Strategic SWOT Analysis ReviewECI, Inc. (ECI) is a publicly traded bio-pharmaceutical company, engaged in the research and development of cell function analysis |
2011 | 250,00$ |
The Westaim Corporation (WED) - Financial and Strategic SWOT Analysis ReviewThe Westaim Corporation (Westaim) is a publicly held investment company. The company invests, directly and indirectly, through acq |
2011 | 250,00$ |
ISU ABXIS Co.,Ltd. (086890) - Financial and Strategic SWOT Analysis ReviewISU ABXIS Co., Ltd. (ISU ABXIS), a subsidiary company of ISU Chemical Co. Ltd., is a Korean biotechnology company. It involves i |
2011 | 250,00$ |
Fem Care Pharma Ltd. (524608) - Financial and Strategic SWOT Analysis ReviewFem Care Pharma Ltd. (Fem Care Pharma) is engaged in manufacturing of consumer products and dermatological products. The company o |
2011 | 250,00$ |
Baolingbao Biology Co., Ltd. (002286) - Financial and Strategic SWOT Analysis ReviewBaolingbao Biology Co., Ltd. (Baolingbao) is a biotechnology company. It is principally engaged in the processing, manufacture and |
2011 | 250,00$ |
Cardia Bioplastics Limited (CNN) - Financial and Strategic SWOT Analysis ReviewCardia Bioplastics Limited (Cardia Bioplastics) is a biotechnology company, engaged in the development, manufacture and supply of |
2011 | 250,00$ |
Care Advantage, Inc. (CADV) - Financial and Strategic SWOT Analysis ReviewCare Advantage, Inc. (CAI) is a public company that is engaged in providing healthcare consulting services, senior living services |
2011 | 250,00$ |
La Positiva Seguros y Reaseguros S.A. (POSITIC1) - Financial and Strategic SWOT Analysis ReviewLa Positiva Seguros y Reaseguros S.A. (La Positiva) is an insurance company engaged in providing insurance for people, business in |
2011 | 250,00$ |
Kangmei Pharmaceutical Co., Ltd. (600518) - Financial and Strategic SWOT Analysis ReviewKangmei Pharmaceutical Co., Ltd. (Kangmei) is a publicly held pharmaceutical company. It is principally engaged in the manufacture |
2011 | 125,00$ |
BDH Industries Ltd. (524828) - Financial and Strategic SWOT Analysis ReviewBDH Industries Ltd. (BDH) is a pharmaceutical company engaged in the manufacturing and marketing of therapeutic formulations cover |
2011 | 250,00$ |
JCL Bioassay Corporation (2190) - Financial and Strategic SWOT Analysis ReviewJCL Bioassay Corporation (JCL Bioassay) is a publically held company that is engaged in testing and contract research services for |
2011 | 250,00$ |
EQUISnZAROO CO.,LTD (058530) - Financial and Strategic SWOT Analysis ReviewEQUISnZAROO CO.,LTD (formerly known as EquisPharm Co., Ltd.) is a publicly held manufacturing company which was formed by merging |
2011 | 250,00$ |
Modern Medical Modalities Corporation (MODM) - Financial and Strategic SWOT Analysis ReviewModern Medical Modalities, Inc., (MMMI) is a public listed specialty pharmaceutical company that is principally engaged in providi |
2011 | 250,00$ |
General Biologicals Corporation (4117) - Financial and Strategic SWOT Analysis ReviewGeneral Biologicals Corporation (GBC) is a public traded in vitro diagnostic device manufacturer, engaged in research, development |
2011 | 250,00$ |
General Medical Clinics PLC (GMCP) - Financial and Strategic SWOT Analysis ReviewGeneral Medical Clinics PLC (General Medical) is a medical and healthcare services providing company. It is engaged in providing g |
2011 | 250,00$ |
Concord Medical Services Holdings Limited (CCM) - Financial and Strategic SWOT Analysis ReviewConcord Medical Services Holdings Limited (CMS) is engaged in the provision of services such as cancer detection and therapy cente |
2011 | 250,00$ |
Cell Biotech Co., Ltd. (049960) - Financial and Strategic SWOT Analysis ReviewCell Biotech Co., Ltd. (Cell Biotech) is a publicly traded biochemical company. It is principally engaged in the manufacturing of |
2011 | 250,00$ |
Jiangbo Pharmaceuticals, Inc. (JGBO) - Financial and Strategic SWOT Analysis ReviewJiangbo Pharmaceuticals, Inc. (Jiangbo) is a pharmaceutical company, engaged in the research, development, production, marketing a |
2011 | 250,00$ |
KDL Biotech Ltd (KOPDRUGS) - Financial and Strategic SWOT Analysis ReviewKDL Biotech Ltd (KDL) is a publicly held healthcare company, based in India. The company is engaged in the development of various |
2011 | 250,00$ |
Jiangsu Kanion Pharmaceutical Co., Ltd. (600557) - Financial and Strategic SWOT Analysis ReviewJiangsu Kanion Pharmaceutical Co., Ltd. (Jiangsu-Kanion) is a publicly held pharmaceutical company that is principally engaged in |
2011 | 250,00$ |
Jiangsu Lianhuan Pharmaceutical Co. Ltd (600513) - Financial and Strategic SWOT Analysis ReviewJiangsu Lianhuan Pharmaceutical Co., Ltd. (Jiangsu Lianhuan) is an operational division of Jiangsu Lianhuan Pharmaceutical Group, |
2011 | 250,00$ |
Genmed Holding Corp. (GENM) - Financial and Strategic SWOT Analysis ReviewGenmed Holding Corp. (GHC) is a public traded an integrated generic pharmaceuticals company. The company operates through its whol |
2011 | 250,00$ |
Kerala Ayurveda Limited (530163) - Financial and Strategic SWOT Analysis ReviewKerala Ayurveda Limited (KAL) is a health care company, focused on the development of new products for the treatment of various di |
2011 | 250,00$ |
GFR Pharmaceuticals, Inc. (GFRP) - Financial and Strategic SWOT Analysis ReviewGFR Pharmaceuticals, Inc.(GFR Pharmaceuticals) is a research focused pharmaceuticals and medical device company. The company opera |
2011 | 250,00$ |
Beijing Tong Ren Tang Group Co., Ltd. (600085) - Financial and Strategic SWOT Analysis ReviewBeijing Tong Ren Tang Group Co., Ltd. (Tongrentang) is a publicly held company engaged in supplying medicines for the royal pharma |
2011 | 125,00$ |
Center for Wound Healing, Inc. (CFWH) - Financial and Strategic SWOT Analysis ReviewCenter for Wound Healing, Inc. (CFWH) is a publicly held company develops and manages hospital-based wound care centers that provi |
2011 | 250,00$ |
Central Securities Corporation (CET) - Financial and Strategic SWOT Analysis ReviewCentral Securities Corporation (Central Securities) is a publicly held investment company that invests in various sectors namely h |
2011 | 250,00$ |
Ayrton Drugs Manufacturing Company Ltd. (AYRTN) - Financial and Strategic SWOT Analysis ReviewAyrton Drug Manufacturing Limited (Ayrton) is a publicly held pharmaceutical company engaged in the manufacture, development, sale |
2011 | 250,00$ |
C-Pharma, Inc. (COBI) - Financial and Strategic SWOT Analysis ReviewC-Pharma, Inc. (C-Pharma), is a publicly held biotechnology company that is engaged in the development and commercialization of th |
2011 | 250,00$ |
Ceylon Hospitals PLC (CHL) - Financial and Strategic SWOT Analysis ReviewCeylon Hospitals PLC (Ceylon Hospitals), a subsidiary of Durdans Management Services Ltd. is a healthcare institution, engaged in |
2011 | 250,00$ |
CHA Bio & Diostech Co., Ltd. (085660) - Financial and Strategic SWOT Analysis ReviewCHA Bio & Diostech Co., Ltd. (CHA Bio & Diostech), formerly known as CHA Biotech, Co., Ltd., is a a publicly traded Korean company |
2011 | 125,00$ |
Changchun High & New Tech Industry Inc (000661) - Financial and Strategic SWOT Analysis ReviewChangchun High & New Tech Industry Inc (Changchun High) is a biotechnology company. It is primarily engaged in the development, ma |
2011 | 250,00$ |
ChemoMetec A/S (CHEMM) - Financial and Strategic SWOT Analysis ReviewChemoMetec A/S (ChemoMetec) is engaged in working with hospitals, research institutes and universities to focus on the development |
2011 | 250,00$ |
Chennai Meenakshi Multispeciality Hospital Limited (523489) - Financial and Strategic SWOT Analysis ReviewChennai Meenakshi Multispeciality Hospital Limited (Chennai Meenakshi) is an Indian based company. The hospital is engaged in oper |
2011 | 250,00$ |
Cherwell Capital PLC (CHEP) - Financial and Strategic SWOT Analysis ReviewCherwell Capital Plc (Cherwell Capital) is a publicly traded UK based investment company. It is a private equity and venture capit |
2011 | 250,00$ |
Lotus Pharmaceutical Co., Ltd. (1795) - Financial and Strategic SWOT Analysis ReviewLotus Pharmaceutical Co., Ltd. (Lotus) is a public listed, specialty pharmaceutical company that is engaged in the development and |
2011 | 250,00$ |
China Animal Husbandry Industry Co., Ltd (600195) - Financial and Strategic SWOT Analysis ReviewChina Animal Husbandry Industry Co., Ltd (CAHIC) is principally engaged in the manufacturing and distribution of animal feeds, vet |
2011 | 125,00$ |
Life Nutrition Products, Inc. (LIPN) - Financial and Strategic SWOT Analysis ReviewLife Nutrition Products, Inc., is a dietary supplement manufacturing company. The company has been into operation since 2005 and p |
2011 | 250,00$ |
Hong Kong Health Check and Medical Diagnostic Centre (397) - Financial and Strategic SWOT Analysis ReviewHong Kong Health Check and Laboratory (HK Health Check) is a pharmaceutical holding company engaged in providing health checks and |
2011 | 250,00$ |
Linical Co., Ltd. (2183) - Financial and Strategic SWOT Analysis ReviewLinical Co., Ltd., (Lincal) is a contract research organization (CRO) based in Japan. The company along with its subsidiary engage |
2011 | 250,00$ |
China Longyi Group International Holdings Limited (CGYG) - Financial and Strategic SWOT Analysis ReviewChina Longyi Group International Holdings Limited (China Longyi) is a pharmaceutical holding company operating through its subsidi |
2011 | 250,00$ |
Syncom Formulations (India) Ltd (524470) - Financial and Strategic SWOT Analysis ReviewSyncom Formulations (India) Ltd (Syncom) is a public company that is engaged in the manufacture of pharmaceutical formulations. It |
2011 | 250,00$ |
China Shenghuo Pharmaceutical Holdings, Inc. (KUN) - Financial and Strategic SWOT Analysis ReviewChina Shenghuo Pharmaceutical Holdings, Inc. (China Shenghuo) is a specialty pharmaceutical company engaged in the research, devel |
2011 | 250,00$ |
Hubei Biocause Pharmaceutical Co. , Ltd. (000627) - Financial and Strategic SWOT Analysis ReviewHubei Biocause Pharmaceutical Co. , Ltd. (Hubei Biocause) engages in manufacturing and exporting of metric tons of bulk Ibuprofen |
2011 | 250,00$ |
Bharat Immunologicals and Biologicals Corporation Limited (524663) - Financial and Strategic SWOT Analysis ReviewBharat Immunologicals and Biologicals Corporation Limited (BIBCOL) is a pharmaceutical company. It is engaged in the development a |
2011 | 250,00$ |
Longrun Tea Group Company Limited (2898) - Financial and Strategic SWOT Analysis ReviewLongrun Tea Group Company Limited (LTG), formerly known as Long Far Pharmaceutical Holdings Ltd. is engaged in manufacturing, sell |
2011 | 250,00$ |
China Organic Fertilizer Inc (CHOR) - Financial and Strategic SWOT Analysis ReviewChina Organic Fertilizer Inc (formerly known as China SXAN Biotech, Inc) is a holding company, engaged in the manufacturing and di |
2011 | 250,00$ |
Wakefield Health Limited (WFD) - Financial and Strategic SWOT Analysis ReviewWakefield Health Limited (Wakefield Health) is a publicaly held health care company. The company is engaged in the provision of pr |
2011 | 250,00$ |
Verisante Technology, Inc. (VRS) - Financial and Strategic SWOT Analysis ReviewVerisante Technology, Inc. (Verisante), formerly known as (T-Ray Science, Inc.) is a public traded company that provides portable |
2011 | 250,00$ |
Scientific Industries, Inc. (SCND) - Financial and Strategic SWOT Analysis ReviewScientific Industries, Inc. (Scientific Industries) is engaged in the design, manufacture and marketing of standard benchtop labor |
2011 | 125,00$ |
Choong Ang Biotech Co., Ltd. (015170) - Financial and Strategic SWOT Analysis ReviewChoong Ang Biotech Co., Ltd. (Choong Ang) is a publicly held pharmaceutical company. It is principally engaged in the manufacture |
2011 | 250,00$ |
Cybrdi, Inc. (CYDI) - Financial and Strategic SWOT Analysis ReviewCybrdi, Inc., (Cybrdi) is a public traded tissue micro-array products manufacturing company that are used for drug discovery and d |
2011 | 250,00$ |
China YCT International Group, Inc. (CYIG) - Financial and Strategic SWOT Analysis ReviewChina YCT International Group Inc. (China YCT) is a publicly held pharmaceutical manufacturing enterprise. The company through its |
2011 | 250,00$ |
CNS Response, Inc. (CNSO) - Financial and Strategic SWOT Analysis ReviewCNS Response, Inc. (CNS) is a life sciences company. It provides services through its subsidiaries, CNS California and CNS Colorad |
2011 | 250,00$ |
Inergetics Inc (NRTI) - Financial and Strategic SWOT Analysis ReviewInergetics Inc (Formerly known as Millennium Biotechnologies Group, Inc) is a research-based bio-nutraceutical company, principall |
2011 | 250,00$ |
Yung Shin Pharma Ind. Co. Ltd (1716) - Financial and Strategic SWOT Analysis ReviewYung Shin Pharma Ind. Co. Ltd (Yung Shin Pharma) is a pharmaceutical company engaged in principal activities like manufacturing an |
2011 | 125,00$ |
Shandong Xinhua Pharmaceutical Company Limited (000756) - Financial and Strategic SWOT Analysis ReviewShandong Xinhua Pharmaceutical Company Limited (Xinhua Pharm) is engaged in the manufacturing and exporting of chemical products, |
2011 | 125,00$ |
Vita Life Sciences Limited (VSC) - Financial and Strategic SWOT Analysis ReviewVita Life Sciences Limited (Vita Life Sciences) is a publicly traded life-science company. The company is engaged in formulation, |
2011 | 250,00$ |
May & Baker Nigeria PLC (MAYBAKER) - Financial and Strategic SWOT Analysis ReviewMay & Baker Nigeria PLC. (May & Baker) is a specialty pharmaceutical company that provides quality and affordable medicines, food |
2011 | 250,00$ |
Paradise Entertainment Limited (1180) - Financial and Strategic SWOT Analysis ReviewParadise Entertainment Limited (Paradise Entertainment) is an investment holding company and is formerly known as LifeTec Group Li |
2011 | 250,00$ |
RNL BIO Co., Ltd. (003190) - Financial and Strategic SWOT Analysis ReviewRNL BIO Co., Ltd. (RNL BIO) is a publically held biotechnology company. The company is principally engaged in the development and |
2011 | 250,00$ |
Savoy Equities Limited (SVY) - Financial and Strategic SWOT Analysis ReviewSavoy Equities Limited (Savoy Equities) operates as oil and resins extraction business. The company is also engaged in manufacturi |
2011 | 250,00$ |
Enerland Corporation Co., Ltd. (045260) - Financial and Strategic SWOT Analysis ReviewEnerland Corporation Co., Ltd. (Enerland) is a diversified company, involved in pharmaceutical, defense, energy and real estate se |
2011 | 250,00$ |
North China Pharmaceutical Co., Ltd. (600812) - Financial and Strategic SWOT Analysis ReviewNorth China Pharmaceutical Co., Ltd. (NCPC) is a publicaly held drug manufacturing company. The company is principally engaged in |
2011 | 125,00$ |
J Communications Co., Ltd. (060750) - Financial and Strategic SWOT Analysis ReviewJ Communications Co., Ltd. (J Communications) is a Korea-based company that is engaged in the pharmaceutical and communication dev |
2011 | 250,00$ |
Chongqing Taiji Industry(Group)Co., Ltd. (600129) - Financial and Strategic SWOT Analysis ReviewChongqing Taiji Industry(Group)Co., Ltd. (Chongqing Taiji), formerly Sichuan Taiji Industry (Group) Co., Ltd. is a pharmaceutical |
2011 | 125,00$ |
Shanghai Wingsung Investment Management Co., Ltd. (900904) - Financial and Strategic SWOT Analysis ReviewShanghai Wingsung Investment Management Co., Ltd. (Shanghai Wingsung) is a publicly held company that is principally engaged in th |
2011 | 250,00$ |
Shenzhen Neptunus Bioengineering Co. Ltd (000078) - Financial and Strategic SWOT Analysis ReviewShenzhen Neptunus Bioengineering Co. Ltd (Neptunus) is a publicly held company that is chiefly involved in the production and dist |
2011 | 125,00$ |
Ams Life Science Co., Ltd. (2927) - Financial and Strategic SWOT Analysis ReviewAMS Life Science Co.,Ltd. (AMS Life ) is an OEM manufacturer that delivers quality products which can correspond the lines of plan |
2011 | 250,00$ |
Dottikon ES Holding AG (DESN) - Financial and Strategic SWOT Analysis ReviewDottikon ES Holding AG (Dottikon ES) is a puclically held company engaged in producing hazardous chemistry and focuses on the excl |
2011 | 250,00$ |
Phylaxia 1912 Holding Nyrt (PHYLAXIA) - Financial and Strategic SWOT Analysis ReviewPhylaxia 1912 Holding Nyrt (Phylaxia) is engaged in the manufacture of pharmaceutical preparations. Also, the company manufactures |
2011 | 250,00$ |
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. (8231) - Financial and Strategic SWOT Analysis ReviewShanghai Fudan-zhangjiang Bio-Pharmaceutical Co., Ltd. (FDZJ) is a publically held company engaged in the research, development, m |
2011 | 250,00$ |
Shanghai Modern Pharmaceutical Co., Ltd. (600420) - Financial and Strategic SWOT Analysis ReviewShanghai Modern Pharmaceutical Co., Ltd. (SM Pharma) is publicly held pharmaceutical company. The company is principally engaged i |
2011 | 125,00$ |
Shandong Shanda Wit Science & Tech Co (000915) - Financial and Strategic SWOT Analysis ReviewShandong Shanda Wit Science & Technology Co., Ltd., (Shandong Shanda ) is a publically held pharmaceutical company based in China. |
2011 | 250,00$ |
Southwest Pharmaceutical Co., Ltd. (600666) - Financial and Strategic SWOT Analysis ReviewSouthwest Pharmaceutical Co., Ltd. (Southwest Pharmaceutical) is a publically held manufacturer of chemical preparations. The comp |
2011 | 250,00$ |
Shanghai Furen Industrial (Group) Co., Ltd. (600781) - Financial and Strategic SWOT Analysis ReviewShanghai Furen Industrial (Group) Co., Ltd. (Shanghai Furen) is publicly held pharmaceutical company. The company is engaged in th |
2011 | 250,00$ |
Yabao Pharmaceutical Group Co., Ltd (600351) - Financial and Strategic SWOT Analysis ReviewYabao Pharmaceutical Group Co.,Ltd, (Yabao Pharmaceutical) formerly known as Shanxi Yabao Pharmaceutical Group Co., Ltd. is a pub |
2011 | 250,00$ |
Shenzhen Cau Technology Co., Ltd. (000004) - Financial and Strategic SWOT Analysis ReviewShenzhen Cau Technology Co., Ltd. (Cau Technology) is a China-based diversified company. The company is principally engaged in res |
2011 | 250,00$ |
Institute of Applied Medicine, Inc. (2123) - Financial and Strategic SWOT Analysis ReviewInstitute of Applied Medicine,Inc. (IAM) is a publicaly held contract research organization engaged in the provision of outsourcin |
2011 | 250,00$ |
Middle East Pharmaceutical and Chemical Industries & Medical Appliances Co. (MPHA) - Financial and Strategic SWOT Analysis ReviewMiddle East Pharmaceutical and Chemical Industries & Medical Appliances Co. (Midpharma) is a publicaly held drug development and m |
2011 | 250,00$ |
Omega Diagnostics Group PLC (ODX) - Financial and Strategic SWOT Analysis ReviewOmega Diagnostics Group PLC (ODG) is a publicaly held biotechnology company, engaged in manufacture, development and distribution |
2011 | 250,00$ |
Wyeth Pakistan Limited (WYETH) - Financial and Strategic SWOT Analysis ReviewWyeth Pakistan Limited (Wyeth Pakistan) is a pubicaly held pharmaceutical company. The company is engaged in the manufacturing and |
2011 | 250,00$ |
Shandong Wohua Pharmaceutical Co., Ltd. (002107) - Financial and Strategic SWOT Analysis ReviewShandong Wohua Pharmaceutical Co., Ltd., (Wohua Pharma) is a traditional chinese pharmaceutical company that is principally engage |
2011 | 250,00$ |
Nuvilex, Inc. (NVLX) - Financial and Strategic SWOT Analysis ReviewNuvilex, Inc. (Nuvilex) is a US based holding company operates through its wholly-owned subsidiaries. The company is principally i |
2011 | 250,00$ |
Worldwide Biotech & Pharmaceutical Co. (WWBP) - Financial and Strategic SWOT Analysis ReviewWorldwide Biotech & Pharmaceutical Company (WWBP) is a pharmaceutical company engaged in developing and marketing of viruses and v |
2011 | 250,00$ |
Woogene B&G Co, Ltd. (018620) - Financial and Strategic SWOT Analysis ReviewWoogene B&G Co, Ltd. (Woogene B&G) is a Korea-based pharmaceutical company engaged in developing, manufacturing and marketing a wi |
2011 | 250,00$ |
Ivy Medical Chemicals PLC (IVMP) - Financial and Strategic SWOT Analysis ReviewIvy Medical Chemicals PLC (Ivy Medical) is engaged in the development and marketing of medical products to oncology markets. The c |
2011 | 250,00$ |
AquaSource Algae Group PLC (AAGP) - Financial and Strategic SWOT Analysis ReviewAquaSource Algae Group PLC (AquaSource) is a pharmaceutical company. The company is principally engaged in providing a wide variet |
2011 | 250,00$ |
Medical Developments International Limited (MVP) - Financial and Strategic SWOT Analysis ReviewMedical Developments International Limited (MDI) is a healthcare company, engaged in manufacturing of pain relief and respiratory |
2011 | 250,00$ |
AlumiFuel Power Corporation (AFPW) - Financial and Strategic SWOT Analysis ReviewAlumiFuel Power Corporation (AlumiFuel Power)is a publicly held holding company. The company operates through its subsidiary Alumi |
2011 | 250,00$ |
Newtime Infrastructure Ltd. (531959) - Financial and Strategic SWOT Analysis ReviewThis comprehensive SWOT profile of Newtime Infrastructure Ltd. provides you an in-depth strategic analysis of the company’s busin |
2011 | 250,00$ |
Beijing Century Health Medical, Inc. (BCHM) - Financial and Strategic SWOT Analysis ReviewBeijing Century Health Medical, Inc. (Formerly known as Super Luck, Inc. ) is a development stage pharmaceuticals company, engaged |
2011 | 250,00$ |
Omnimmune Holdings, Inc. (OMMH) - Financial and Strategic SWOT Analysis ReviewOmnimmune Holdings, Inc. (Omnimmune) is a development-stage biotechnology company, engaged in providing diagnostic, prognostic and |
2011 | 250,00$ |
Kun Run Biotechnology, Inc. (KURU) - Financial and Strategic SWOT Analysis ReviewKun Run Biotechnology, Inc. (Kun Run) is a pharmaceutical drug manufacturing company. The company is involved in drug development |
2011 | 250,00$ |
Metabolic Research, Inc. (MTBR) - Financial and Strategic SWOT Analysis ReviewMetabolic Research, Inc. (Metabolic Research) is a public traded biotechnology company. It is engaged in the development, manufact |
2011 | 250,00$ |
Procyon Corporation (PCYN) - Financial and Strategic SWOT Analysis ReviewProcyon Corporation (Procyon) is a publicly held pharmaceutical company engaged in manufacturing and marketing of wound and skin c |
2011 | 250,00$ |
AmStem Corporation (AMST) - Financial and Strategic SWOT Analysis ReviewAmStem Corporation is formerly known as Stem Cell Therapy International, Inc. (SCTI) is a biotechnology company, engaged in the fi |
2011 | 250,00$ |
Tensall Bio-Tech Co., LTD. (4135) - Financial and Strategic SWOT Analysis ReviewTensall Bio-Tech Co.,Ltd (Tensall) is a biotechnology company, engaged in providing probiotics and cosmetics. It is principally en |
2011 | 250,00$ |
The Sagemark Companies Ltd. (SKCO) - Financial and Strategic SWOT Analysis ReviewThe Sagemark Companies Ltd. (Sagemark) is a diagnostic imaging company. The company is engaged in the owning, operating and managi |
2011 | 250,00$ |
China Healthcare Limited (592) - Financial and Strategic SWOT Analysis ReviewChina Healthcare Limited (CHL) is healthcare service providers . The company, along with its subsidiaries provides planning, desig |
2011 | 250,00$ |
Supporta Plc (SOR) - Financial and Strategic SWOT Analysis ReviewSupporta Plc (Supporta) is a publicly held holding company engaged in providing domiciliary care services. Supporta operates throu |
2011 | 250,00$ |
Asiri Hospital PLC (ASIR.N0000) - Financial and Strategic SWOT Analysis ReviewAsiri Hospital PLC (Asiri) is principally engaged in providing a wide range of healthcare and hospital services. It is an operatin |
2011 | 250,00$ |
Corporacion Dermoestetica SA (DERM) - Financial and Strategic SWOT Analysis ReviewCorporacion Dermoestetica SA (Corporacion) is specialized in aesthetic medicine, aesthetic surgery, dietetics, nutrition and odont |
2011 | 250,00$ |
Nafais Holding Company (K.S.C.C.) (NAFAIS) - Financial and Strategic SWOT Analysis ReviewNafais Holding Company KSCC (Nafais Holding) is a Kuwait-based company, engaged in the provision of health care services, the esta |
2011 | 250,00$ |
Topchoice Medical Invesment Co., Inc (600763) - Financial and Strategic SWOT Analysis ReviewTopchoice Medical Investment Co., Inc (Topchoice Medical) is a provider of dental and oral health care services. Major services of |
2011 | 250,00$ |
Thai Nakarin Hospital Public Company Limited (TNH) - Financial and Strategic SWOT Analysis ReviewThai Nakarin Hospital Public Company Limited (Thai Nakarin Hospital) operates as a general hospital. The company has state-of-the- |
2011 | 250,00$ |
Sirona Biochem Corp (SBM) - Financial and Strategic SWOT Analysis ReviewSirona Biochem Corp (Sirona Biochem), is a biotech company which is engaged in discovery and development of drug compounds. It is |
2011 | 250,00$ |
Biomm S.A. (BIOM4) - Financial and Strategic SWOT Analysis ReviewBiomm S.A. (Biomm) is a publicly held Brazil-based biotechnology company that is principally engaged in the development of technol |
2011 | 250,00$ |
Spine Pain Management, Inc. (SPIN) - Financial and Strategic SWOT Analysis ReviewSpine Pain Management, Inc. (SPMI) focuses on the delivery of solutions to spine surgeons and orthopedic surgeons for necessary tr |
2011 | 250,00$ |
Patient Portal Technologies, Inc. (PPRG) - Financial and Strategic SWOT Analysis ReviewPatient Portal Technologies, Inc. (PPRG), formerly known as Gambino Apparel Group, Inc., is provider of innovative health care and |
2011 | 250,00$ |
ONE Bio, Corp. (ONBI) - Financial and Strategic SWOT Analysis ReviewONE Bio, Corp. (ONE Bio), formerly known as One Holdings Corporation, is engaged in utilizing green processes to manufacture raw c |
2011 | 250,00$ |
Jordanian Pharmaceutical Manufacturing Co. PLC (JPHM) - Financial and Strategic SWOT Analysis ReviewJordanian Pharmaceutical Manufacturing Co. PLC (JPM) is a pharmaceutical drug manufacturing company. The company develops, manufac |
2011 | 250,00$ |
Twilight Litaka Pharma Ltd. (TWILITAKA) - Financial and Strategic SWOT Analysis ReviewTwilight Litaka Pharma Ltd. (TL Pharma) is an Indian based pharmaceutical company principally engaged in the manufacture of drugs |
2011 | 250,00$ |
PHARMENA SA (PHR) - Financial and Strategic SWOT Analysis ReviewPHARMENA SA (PHARMENA) is a pharmaceutical company engaged in the production and commercialization of innovative pharmaceuticals a |
2011 | 250,00$ |
Agennix AG (AGX) - Financial and Strategic SWOT Analysis ReviewAgennix AG (Agennix) is a biopharmaceutical company resulting from the combination of GPC Biotech AG and Agennix. The company is e |
2011 | 250,00$ |
Traphaco Joint Stock Company (TRA) - Financial and Strategic SWOT Analysis ReviewTraphaco Joint Stock Company (Traphaco JSC) is a pharmaceutical manufacturing company. It is principally engaged in manufacturing, |
2011 | 250,00$ |
Molecular Pharmacology (USA) Limited (MLPH) - Financial and Strategic SWOT Analysis ReviewMolecular Pharmacology (the US.) Ltd. (MPL) is a biotechnology company. It is principally engaged in the discovery, development an |
2011 | 250,00$ |
Rekah Pharmaceutical Industry Ltd. (REKA) - Financial and Strategic SWOT Analysis ReviewRekah Pharmaceutical Industry Ltd. (Rekah) is a pharmaceutical company that is focuses on the development, manufacture, marketing, |
2011 | 250,00$ |
Wintac Limited (524758) - Financial and Strategic SWOT Analysis ReviewWintac Limited (Wintac), formerly known as Recon Ltd., is engaged in the research, development, production and commercialization o |
2011 | 250,00$ |
Luye Pharma Group Co., Ltd. (A61) - Financial and Strategic SWOT Analysis ReviewLuye Pharma Group Ltd. (Luye Pharma), formerly known as AsiaPharm Group Ltd., is one of the leading biopharmaceutical company. It |
2011 | 250,00$ |
Shenzhen Salubris Pharmaceuticals Co., Ltd. (002294) - Financial and Strategic SWOT Analysis ReviewShenzhen Salubris Pharmaceuticals Co., Ltd. (Salubris) is a global integrated pharmaceutical company. It focuses on the research, |
2011 | 250,00$ |
Kunming Pharmaceutical Group Co., Ltd. (600422) - Financial and Strategic SWOT Analysis ReviewKunming Pharmaceutical Group Co., Ltd. (KPC) is a pharmaceutical company engaged in drug manufacturing and marketing. The company |
2011 | 250,00$ |
Sierra Health Services - Strategic SWOT Analysis ReviewSierra Health Services, Inc. is a diversified healthcare services company that operates health maintenance organizations, indemnit |
2011 | 250,00$ |
Targanta Therapeutics Corporation - Strategic SWOT Analysis ReviewTarganta Therapeutics Corporation (Targanta) is a privately held bio-pharmaceutical company. The company principally focused on de |
2011 | 250,00$ |
Regent Assisted Living Inc. (RGNT) - Strategic SWOT Analysis ReviewThis comprehensive SWOT profile of Regent Assisted Living Inc. provides you with an in-depth strategic analysis of the company's b |
2011 | 250,00$ |
BND Co., Ltd. (047940) - Strategic SWOT Analysis ReviewThis comprehensive SWOT profile of BND Co., Ltd. provides you with an in-depth strategic analysis of the company's businesses and |
2011 | 250,00$ |
Polymer Research Corp. of America (PROAQ) - Strategic SWOT Analysis ReviewThis comprehensive SWOT profile of Polymer Research Corp. of America provides you with an in-depth strategic analysis of the compa |
2011 | 250,00$ |
Golden Pond Healthcare, Inc. (GPH) - Strategic SWOT Analysis ReviewThis comprehensive SWOT profile of Golden Pond Healthcare, Inc. provides you with an in-depth strategic analysis of the company's |
2011 | 250,00$ |
Integrated Health Services - Strategic SWOT Analysis ReviewIntegrated Health Services (Integrated Health) is engaged in providing post-acute healthcare services. Post-acute care is the prov |
2011 | 250,00$ |
Alert B&C Corporation (ACB) - Strategic SWOT Analysis ReviewThis comprehensive SWOT profile of Alert B&C Corporation provides you with an in-depth strategic analysis of the company's busines |
2011 | 250,00$ |
IRI SEPARATION TECHNOLOGIES INC. (IRI) - Strategic SWOT Analysis ReviewIRI Separation Technologies Inc is a biotechnology company specialized in the extraction, development and commercialization antibo |
2011 | 125,00$ |
Astralis, Ltd. - Strategic SWOT Analysis ReviewAstralis Ltd. (Astralis) is a development-stage pharmaceutical company that is principally enggaed in the development of treatment |
2011 | 250,00$ |
Memory Pharmaceuticals Corp. - Strategic SWOT Analysis ReviewMemory Pharmaceuticals Corp. (Memory Pharmaceutical) is a biopharmaceutical company, engaged in the discovery and development of d |
2011 | 250,00$ |
China Healthcare Acquisition Corporation - Strategic SWOT Analysis ReviewChina Healthcare Acquisition Corporation (CHAC) is engaged in acquiring one or more operating businesses in the healthcare sector. |
2011 | 250,00$ |
South Egypt Drug Industries Company - Strategic SWOT Analysis ReviewThis comprehensive SWOT profile of South Egypt Drug Industries Company provides you with an in-depth strategic analysis of the com |
2011 | 250,00$ |
Global Napi Pharmaceuticals - Strategic SWOT Analysis ReviewGlobal Napi Pharmaceuticals (Global Napi) is an Egypt based pharmaceutical company. Global Napi is engaged in developing and manuf |
2011 | 250,00$ |
Egyptian International Medical Center - Strategic SWOT Analysis ReviewEgyptian International Medical Center (EIMC) is a private pharma company, The company supplies cytotoxics, plasma derivatives and |
2011 | 250,00$ |
APEX Pharma S.A.E. - Strategic SWOT Analysis ReviewAPEX Pharma S.A.E. (APEX) is an Egyptian based Joint Stock company, engaged in the production, marketing and sale and importation |
2011 | 250,00$ |
Immune Network, Ltd. - Strategic SWOT Analysis ReviewImmune Network, Ltd. (formerly Immune Network Research Ltd.) is a biotechnology company. It is involved in the development of immu |
2011 | 250,00$ |
Keunwha Pharmaceutical Co.,Ltd. - Strategic SWOT Analysis ReviewThis comprehensive SWOT profile of Keunwha Pharmaceutical Co.,Ltd. provides you with an in-depth strategic analysis of the company |
2011 | 250,00$ |
Caribbean American Health Resorts, Inc. (CAHR) - Strategic SWOT Analysis ReviewCarribbean American Health Resorts, Inc, (CAHR) is a publicly held development-stage company that principally focuses on owning, d |
2011 | 250,00$ |
Lexington Healthcare Group, Inc. - Strategic SWOT Analysis ReviewLexington Healthcare Group, Inc. (Lexington Healthcare) in engaged in providing a wide range of healthcare services, including nur |
2011 | 250,00$ |
Sinovac Biotech Co., Ltd. - Strategic SWOT Analysis ReviewSinovac Biotech Co., Ltd.( Beijing Kexing Bioproducts.) engages in selling of human vaccines. It also engages in research and deve |
2011 | 250,00$ |
D I L Limited - Strategic SWOT Analysis ReviewThis comprehensive SWOT profile of D I L Limited provides you with an in-depth strategic analysis of the company's businesses and |
2011 | 250,00$ |
Harvard Scientific Corp. - Strategic SWOT Analysis ReviewHarvard Scientific Corp. (Harvard Scientific) is a bio pharmaceutical company engaged in the development, manufacturing and distri |
2011 | 250,00$ |
Health Sciences Group, Inc. (HESG) - Strategic SWOT Analysis ReviewHealth Sciences Group, Inc. (Health Sciences Group) is focused on the development and commercialization of products and functional |
2011 | 250,00$ |
CANCOG Technologies Inc. - Strategic SWOT Analysis ReviewCanCog Technologies, Inc. (CanCog Technologies) is a privately held contract research organization engaged in providing predictive |
2011 | 250,00$ |
Flagship Global Health, Inc. (FGHH) - Strategic SWOT Analysis ReviewFlagship Global Health, Inc. (formerly Patients & Physicians, Inc., ) is a health assurance organization providing prority access |
2011 | 250,00$ |
Comvita New Zealand Limited - Strategic SWOT Analysis ReviewComvita is a natural health and wellness company with a strong heritage in innovating and manufacturing therapeutic apicultural pr |
2011 | 125,00$ |
Terveystalo Healthcare Oyj - Strategic SWOT Analysis ReviewTerveystalo Healthcare Oyj (Terveystalo) is a privately held health care service company and is principally engaged in providing h |
2011 | 250,00$ |
Shanghai Fosun Medical Technology Development Co., Ltd. ( 600196) - Strategic SWOT Analysis ReviewShanghai Fosun Med-Tech Development Co., Ltd. (Shanghai Fosun) is a China based private company engaged in producuing in vitro dia |
2011 | 250,00$ |
The University of Texas M. D. Anderson Cancer Center - Strategic SWOT Analysis ReviewThe University of Texas M. D. Anderson Cancer Center (M. D. Anderson Cancer Center) conducts research on cancer. Its programs inte |
2011 | 250,00$ |
Millennium Pharmaceuticals, Inc. - Strategic SWOT Analysis ReviewMillennium Pharmaceuticals, Inc. (Millennium) is a biopharmaceutical company which is engaged in the research, development, and co |
2011 | 125,00$ |
Arkopharma SA - Strategic SWOT Analysis ReviewArkopharma SA (Arkopharma) is phytotherapy and nutritional supplements provider in Europe, engaged in the manufacture and distribu |
2011 | 125,00$ |
Austin Health - Strategic SWOT Analysis ReviewAustin Health (Austin) is the provider of tertiary health services, health professional education and research in the northeast of |
2011 | 125,00$ |
Bay of Plenty District Health Board - Strategic SWOT Analysis ReviewBay of Plenty District Health Board (BOPDHB) operates as one of the 21 district health boards in New Zealand. It provides a range |
2011 | 125,00$ |
Crucell Switzerland AG - Strategic SWOT Analysis ReviewCrucell Switzerland AG (Crucell) is a private biopharmaceutical company engaged in producing vaccines and antibodies. The company |
2011 | 125,00$ |
Capital & Coast District Health Board - Strategic SWOT Analysis ReviewCapital & Coast District Health Board (C&C DHB) is a one of the specialist health services providers in the central region of New |
2011 | 125,00$ |
Danbury Hospital - Strategic SWOT Analysis ReviewDanbury Hospital is a US based health care centre, principally engaged in providing various treatments relating to cancer and card |
2011 | 125,00$ |
DCH Health System - Strategic SWOT Analysis ReviewDCH Health System (DCH Health) is a medical and healthcare services provider. DCH Health is a US government subdivision, operating |
2011 | 125,00$ |
Ferrosan A/S - Strategic SWOT Analysis ReviewFerrosan A/S (Ferrosan) is an international consumer and healthcare company. The company offers various supplements and healthcare |
2011 | 125,00$ |
Fisher Scientific International Inc. (FSH) - Strategic SWOT Analysis ReviewFisher Scientific International, Inc. (Fisher) is an US based public company that provides analytical instruments and services to |
2011 | 250,00$ |
Health Protection Agency - Strategic SWOT Analysis ReviewThe Health Protection Agency (HPA) is a government organization that focuses on defending the public against health dangers in the |
2011 | 125,00$ |
Jose de Mello, SGPS - Strategic SWOT Analysis ReviewJose de Mello, SGPS (Jose de Mello) is one of the Portugal’s biggest corporate groups. It is an economic group which concentrates |
2011 | 125,00$ |
LEO Pharma A/S - Strategic SWOT Analysis ReviewLEO Pharma A/S (LEO Pharma) is one of the leading pharmaceutical companies within Dermatology and Critical Care. The company maint |
2011 | 125,00$ |
MDS Analytical Technologies - Strategic SWOT Analysis ReviewMDS Analytical Technologies (MDS Analytical) is one of the leading global suppliers of analytical instruments and technology solut |
2011 | 125,00$ |
Melbourne Health - Strategic SWOT Analysis ReviewMelbourne Health is an Australia based health service provider. The company is principally engaged in providing acute, sub-acute a |
2011 | 125,00$ |
Merz GmbH & Co. KGaA - Strategic SWOT Analysis ReviewMerz GmbH & Co. KGaA is a Germany based healthcare company. The company is principally engaged in providing pharmaceuticals, consu |
2011 | 125,00$ |
MidCentral District Health Board - Strategic SWOT Analysis ReviewMidCentral District Health Board (MDHB) is a New Zealand based health and disability support service provider. The company princip |
2011 | 250,00$ |
Norgine Limited - Strategic SWOT Analysis ReviewNorgine Limited (Norgine) is engaged in the development, manufacturing and marketing of pharmaceutical products. The company also |
2011 | 125,00$ |
Sandoz International GmbH - Strategic SWOT Analysis ReviewSandoz International GmbH (Sandoz) is one of the leading global generics companies. The company develops and markets off-patent me |
2011 | 125,00$ |
Taiho Pharmaceutical Co., Ltd. - Strategic SWOT Analysis ReviewTaiho Pharmaceutical Co., Ltd. (Taiho Pharmaceutical) is a Japan-based pharmaceutical company engaged in the development, producti |
2011 | 125,00$ |
Tamro Corporation - Strategic SWOT Analysis ReviewTamro Corporation is involved in the wholesale supply and distribution of pharmaceuticals principally in Northern Europe. It princ |
2011 | 125,00$ |
Toyama Chemical Co. Ltd - Strategic SWOT Analysis ReviewToyama Chemical Co. Ltd. was acquired by Fujifilm Holdings Corporation and became a consolidated subsidiary during 2008. Toyama Ch |
2011 | 125,00$ |
United Surgical Partners International - Strategic SWOT Analysis ReviewUnited Surgical Partners International (United Surgical Partners) is one of the leaders in the ambulatory surgery center and short |
2011 | 125,00$ |
Western Health - Strategic SWOT Analysis ReviewWestern Health (WH) is an Australian based health related service provider. The company is principally engaged in the field of off |
2011 | 125,00$ |
Zambon Group S.p.A. - Strategic SWOT Analysis ReviewZambon Group S.p.A. is a major multinational pharmaceutical and chemical company. Zambon Company SpA is the holding company of the |
2011 | 125,00$ |
Carl-Zeiss-Stiftung - Strategic SWOT Analysis ReviewCarl-Zeiss-Stiftung, is a German based company. The company operates through its subsidiaries namely Carl Zeiss AG and SCHOTT AG a |
2011 | 125,00$ |
Nelson Marlborough District Health Board - Strategic SWOT Analysis ReviewNelson Marlborough District Health Board (Nelson Marlborough) is a New Zealand based health board chiefly engaged in the planning |
2011 | 250,00$ |
APS Healthcare Inc - Strategic SWOT Analysis ReviewAPS Healthcare Inc. (APS) is a privately held health care company. The company works in collaboration with Medicaid Agencies , sta |
2011 | 125,00$ |
Groupe ORPEA (ORP) - Strategic SWOT Analysis ReviewGroupe ORPEA (Orpea) is France based company engaged in offering long-term care and post-acute care. The company is primarily enga |
2011 | 125,00$ |
PHOENIX Group - Strategic SWOT Analysis ReviewPHOENIX Group is a leading pharmaceutical distribution company in Europe. It provides a range of pharmaceutical and healthcare pro |
2011 | 125,00$ |
Universal Hospital Services Inc (UHS) - Strategic SWOT Analysis ReviewUniversal Hospital Services, Inc. (UHS) provides medical equipment management and service solutions to the health care industry in |
2011 | 125,00$ |
Nova BioGenetics, Inc. (NVBG) - Strategic SWOT Analysis ReviewNova BioGenetics, Inc. (Nova) is a publicly held research focused biotechnology company, engaged in discovery, development, commer |
2011 | 250,00$ |
ALIGN Pharmaceuticals, LLC. - Strategic SWOT Analysis ReviewALIGN Pharmaceuticals is a specialty pharmaceutical company principally engaged in providing supportive care solutions for symptom |
2011 | 125,00$ |
Scandinavian Clinical Nutrition i Sverige AB (SCN) - Strategic SWOT Analysis ReviewScandinavian Clinical Nutrition i Sverige AB (SCN) is a Sweden based company is nutritional products developer and supplier. The |
2011 | 250,00$ |
ReGenX Biosciences, LLC - Strategic SWOT Analysis ReviewReGenX Biosciences, LLC (ReGenX) is a bio pharmaceutical company that is engaged in research and development of therapeutics based |
2011 | 125,00$ |
NeuroGenesis, Inc. (NEUN) - Strategic SWOT Analysis ReviewNeuroGenesis, Inc. (Neurogenesis) is publicly held US based company. It is principally engaged in development of nutritional suppl |
2011 | 250,00$ |
Medical & Biological Laboratories Co., Ltd. (4557) - Strategic SWOT Analysis ReviewMedical & Biological Laboratories Co., Ltd.(MBL) is engaged in the research, development and manufacture of clinical reagents and |
2011 | 250,00$ |
PCI Biotech AS - Strategic SWOT Analysis ReviewPCI Biotech AS (PCI Biotech) is a drug delivery company, engaged in commercialization of photochemical drug delivery technology fo |
2011 | 250,00$ |
InterSystems Corporation - Strategic SWOT Analysis ReviewInterSystems Corporation (InterSystems) is a privately-held software company engaged in providing premier platform for connected h |
2011 | 125,00$ |
Carolinas Hospital System - Strategic SWOT Analysis ReviewCarolinas Hospital System (CHS) is a hospital providing acute health care services in Florence, South Carolina. CHS offers various |
2011 | 125,00$ |
TMC HealthCare - Strategic SWOT Analysis ReviewTMC HealthCare (TMC) is a nonprofit hospital. TMC is focused on supporting the communities’ health needs by supporting education a |
2011 | 125,00$ |
University Medical Center Corporation - Strategic SWOT Analysis ReviewUniversity Medical Center Corporation (UMC) is a privately held, nonprofit hospital located in Tucson, Arizona. The organization o |
2011 | 125,00$ |
D-Pharm Ltd. (DPRM) - Strategic SWOT Analysis ReviewD-Pharm LTD.(D-Pharm) is a specialty bio-pharmaceutical company. It is engaged in the design and development of innovative drugs f |
2011 | 250,00$ |
CepTor Corporation (CEPO) - Strategic SWOT Analysis ReviewCepTor Corporation (CepTor) is a development-stage biopharmaceutical company that is engaged in the discovery, development and com |
2011 | 250,00$ |
Axiogenesis AG (AI8) - Strategic SWOT Analysis ReviewAxiogenesis AG (Axiogenesis) is an innovative biotechnology company that specializes in applied stem cell technology and molecular |
2011 | 250,00$ |
The State University of New York - Strategic SWOT Analysis ReviewThe State University of New York (SUNY) is one of the largest and most comprehensive state university system in the US. The State |
2011 | 125,00$ |
Artec, Inc. (ATKJ) - Strategic SWOT Analysis ReviewArtec, Inc. (Artec) is a publicly held pharmaceutical company. It is principally engaged in the manufacture and distribution of a |
2011 | 250,00$ |
Italfarmaco S.p.A. - Strategic SWOT Analysis ReviewItalfarmaco S.p.A. (Italfarmaco) is an independently held private company based in Italy. The company along with its subsidiaries |
2011 | 125,00$ |
LONGPORT, INC (LPTI) - Strategic SWOT Analysis ReviewLONGPORT, INC (Longport) is a publicly-held Delaware corporation, which develops, manufactures, markets, and sells high resolution |
2011 | 250,00$ |
Advik Laboratories Ltd. (ADVIKLA) - Strategic SWOT Analysis ReviewAdvik Laboratories Ltd. (Advik) is an India based company engaged in the manufacture and sale of ethical and generic pharmaceutica |
2011 | 250,00$ |
Julphar (JULPHUR) - Strategic SWOT Analysis ReviewJulphar (Julphar) is a publicly held company that is engaged in the manufacture of medicines, drugs and various other types of pha |
2011 | 250,00$ |
Migami, Inc. (MIGA) - Strategic SWOT Analysis ReviewMigami, Inc. (Migami) is a publicly held development stage pharmaceutical company. It is principally engaged in the distribution o |
2011 | 250,00$ |
Cavit Sciences, Inc. (CVIT) - Strategic SWOT Analysis ReviewCavit Sciences, Inc. (Cavit Sciences) is a biotechnology company, based in the US. The company is engaged in the development of th |
2011 | 250,00$ |
Renato Corporation (4OZ) - Strategic SWOT Analysis ReviewRenato Corporation (Renato) is the publicly held US based biotechnology company which is principally engaged in providing health d |
2011 | 250,00$ |
GenoMed, Inc. (GMED) - Strategic SWOT Analysis ReviewGenoMed, Inc. (GenoMed) is a publicly held biotechnology company. It is principally engaged in medical genomics and disease manage |
2011 | 250,00$ |
Laboratorios Liomont S.A. de C.V. - Strategic SWOT Analysis ReviewLaboratorios Liomont S.A. de C.V. (Liomont) is a Mexico-based pharmaceutical company, engaged in offering a wide range of pharmace |
2011 | 125,00$ |
Armstrong Laboratorios de Mexico S.A. de C.V. - Strategic SWOT Analysis ReviewArmstrong Laboratorios de Mexico SA de C.V. (Armstrong Laboratorios) is a Mexican based company. It supplies quality medicines to |
2011 | 125,00$ |
TranXenoGen, Inc. - Strategic SWOT Analysis ReviewTranXenoGen, Inc. (TranXenoGen) is the US based privately held biotechnology company which is engaged in the development of new th |
2011 | 250,00$ |
Canopus BioPharma Incorporated (CBIA) - Strategic SWOT Analysis ReviewCanopus BioPharma Incorporated (Canopus BioPharma) is a publicly traded pharmaceutical company, engaged in the research and develo |
2011 | 250,00$ |
BIOQUAL, Inc. (BIOQ) - Strategic SWOT Analysis ReviewBIOQUAL, Inc. (Bioqual) is a public traded, research, development and consulting company and is engaged in providing quality resea |
2011 | 250,00$ |
Caleco Pharma Corp. (CAEH) - Strategic SWOT Analysis ReviewCaleco Pharma Corp. (Caleco) is a public company engaged in the development of products to treat moderate to severe liver maladies |
2011 | 250,00$ |
Sinobiopharma Inc. (SNBP) - Strategic SWOT Analysis ReviewSinobiopharma Inc. (Sinobiopharma) is an integrated and innovative biotechnology company. The company is focused on the research a |
2011 | 250,00$ |
Multiple Myeloma Research Foundation - Strategic SWOT Analysis ReviewMultiple Myeloma Research Foundation (MMRF) is a bio-pharmaceutical company, based in the US. It is principally engaged in the dev |
2011 | 250,00$ |
Amazon BioTech (AMZB) - Strategic SWOT Analysis ReviewAmazon BioTech (Amazon) is a privately held pharmaceutical company. It is principally engaged in research and development of natur |
2011 | 250,00$ |
China Health Management Corp. (CNHC) - Strategic SWOT Analysis ReviewChina Health Management Corp. (CHMC) engages in providing operations and management of hospitals in China. Its services include, h |
2011 | 250,00$ |
Immune-tree International, Inc. (IMUT) - Strategic SWOT Analysis ReviewImmune-tree International, Inc. (Immune tree)specializes in the development and manufacture of colostrum-based health food product |
2011 | 250,00$ |
Cannasat Therapeutics, Inc. (CTH) - Strategic SWOT Analysis ReviewCannasat Therapeutics, Inc. (Cannasat) publicly held clinicla stage pharmaceutical company, that is engaged in the discovery and d |
2011 | 250,00$ |
DelSite Biotechnologies, Inc. (DSII) - Strategic SWOT Analysis ReviewDelSite Biotechnologies, Inc. is an early stage drug-delivery and biotechnology company established to provide the pharmaceutical |
2011 | 250,00$ |
Milestone Biosciences, LLC (ACCP) - Strategic SWOT Analysis ReviewMilestone Biosciences, LLC (Milestone) is a development-stage biotechnology company. It is principally focuses on in-licensing and |
2011 | 250,00$ |
iDiS Limited - Strategic SWOT Analysis ReviewiDiS Limited (IDIS), has created a tool of Mobile Asset Management which helps to take giant strides within the space. Mobile Asse |
2011 | 250,00$ |
Shin Poong Pharm Co., Ltd. (019170) - Strategic SWOT Analysis ReviewShin Poong Pharm Co., Ltd.(Shin Poong) is a pharmaceutical company engaged in the development, marketing, and distribution of phar |
2011 | 250,00$ |
Tularik, Inc. - Strategic SWOT Analysis ReviewTularik, Inc. (Tularik) is a pharmaceutical company, based in the US. The company is engaged in the discovery and development of o |
2011 | 250,00$ |
SOHM Inc. (SOHM) - Strategic SWOT Analysis ReviewSOHM Inc. (SOHM) is a pharmaceutical company engaged in the manufacturing and marketing of generic pharmaceuticals. The company ma |
2011 | 250,00$ |
Vanguard Pharmaceutical Corporation (VGPH) - Strategic SWOT Analysis ReviewVanguard Pharmaceutical Corporation (Vanguard) is engaged in research, development, manufacture, and sale of generic and oncology |
2011 | 250,00$ |
Islet Holdings, Inc. (ISHI) - Strategic SWOT Analysis ReviewIslet Holdings, Inc. (formerly known as Biozhem Cosmeceuticals, Inc.) is a marketer of personal care products through a worldwide |
2011 | 250,00$ |
Perrigo Israel Pharmaceuticals Ltd. (PRGO) - Strategic SWOT Analysis ReviewPerrigo Israel Pharmaceuticals Ltd. (Perrigo Israel) is a privately held pharmaceutical company that is engaged in developing, man |
2011 | 250,00$ |
Ventana Biotech Inc. (VNTA) - Strategic SWOT Analysis ReviewVentana Biotech Inc. (Ventana Biotech) is a bioscience company that is engaged in the development and marketing of products for th |
2011 | 250,00$ |
Chemizon, Inc. (010170) - Strategic SWOT Analysis ReviewChemizon, Inc. (Chemizon) is a biotechnology company, engaged in the discovery and development of innovative therapeutics. The com |
2011 | 250,00$ |
Cellceutix Pharmaceuticals, Inc. (CTIX) - Strategic SWOT Analysis ReviewCellceutix Pharmaceuticals, Inc. (Cellceutix) is a publicly traded start-up bio pharmaceutical company. It is principally engaged |
2011 | 250,00$ |
Sinil Pharma Ltd. (012790) - Strategic SWOT Analysis ReviewSinil Pharma Co Ltd. (Sinil Pharma) is a pharmaceutical company. Sinil Pharma is engaged in the manufacture and distribution of ph |
2011 | 250,00$ |
Ranaz Corporation (RNZ) - Strategic SWOT Analysis ReviewRanaz Corporation (Ranaz) is engaged in designing, producing, and marketing of nutritional, protein, and dietary supplements all a |
2011 | 250,00$ |
Help at Home, Inc. (HAHI) - Strategic SWOT Analysis ReviewHelp at Home, Inc. (Help at Home) is a healthcare service provider that offers homemaker, custodial, and personal home care servic |
2011 | 250,00$ |
NGL Fine-chem Ltd. (524774) - Strategic SWOT Analysis ReviewNGL Fine-chem Ltd. (NGL) is a publicly held pharmaceutical company. It is principally engaged in the manufacture of pharmaceutical |
2011 | 250,00$ |
Piedmont Behavioral Healthcare - Strategic SWOT Analysis ReviewPiedmont Behavioral Healthcare (PBH) is engaged in managing a system of care for children and adults with mental health, developme |
2011 | 125,00$ |
Auro Laboratories Limited (530233) - Strategic SWOT Analysis ReviewAuro Laboratories Limited (Auro Laboratories) is pharmaceutical company that is engaged in the manufacturing of active pharmaceuti |
2011 | 250,00$ |
U.S NeuroSurgical, Inc. (USN) - Strategic SWOT Analysis ReviewU.S NeuroSurgical, Inc. (U.S. Neurosurgical) is a publicly traded specialty service company that offers expertise in the field of |
2011 | 250,00$ |
Ortin Laboratories Limited (590074) - Strategic SWOT Analysis ReviewOrtin Laboratories Limited (Ortin Labs) is a privately held company focused on the manufacture and supply of drugs and medicines i |
2011 | 250,00$ |
BioLife Remedies, Inc. (BLRS) - Strategic SWOT Analysis ReviewBioLife Remedies, Inc. (BioLife) is a pharmaceutical company that combines traditional chinese medicine and western academic resea |
2011 | 250,00$ |
DocPlanet.com Inc. (DOCP) - Strategic SWOT Analysis ReviewDocPlanet.com Inc. (DPI) is a business-to-business e-commerce company that provides pharmaceuticals to office-based physicians. Th |
2011 | 250,00$ |
Trinity Medical Group USA, Inc. (TMGU) - Strategic SWOT Analysis ReviewTrinity Medical Group the US., Inc. (TMG the US.), is a development stage company operating in the healthcare sector. The group is |
2011 | 250,00$ |
PharmChem, Inc. (PCHM) - Strategic SWOT Analysis ReviewPharmChem, Inc. (PharmChem) is a laboratory that offers integrated drug testing services to government and corporate customers. Th |
2011 | 250,00$ |
Physicians Adult Daycare Inc. - Strategic SWOT Analysis ReviewPhysicians Adult Daycare Inc. (Adult Daycare) is a managed healthcare organization engaged in providing senior living services. Th |
2011 | 250,00$ |
Venkat Pharma Limited (VKTP) - Strategic SWOT Analysis ReviewVenkat Pharma Limited (Venkat Pharma) is a publicly held Indian based pharmaceutic company. The company is principally engaged in |
2011 | 250,00$ |
Promethean Corporation (PRMN) - Strategic SWOT Analysis ReviewPromethean Corp. (Promethean) is a New York based Health Care company. The company develops, manufactures and distributes its own |
2011 | 250,00$ |
Searle Pakistan Limited (SEARL) - Strategic SWOT Analysis ReviewSearle Pakistan Limited (SPL) is a Pakistan-based pharmaceutical company engaged in the manufacture, sale, and distribution of pha |
2011 | 250,00$ |
Nigerian-German Chemicals Plc (NIG-GERMAN) - Strategic SWOT Analysis ReviewNigerian-German Chemicals Plc (NGC) is a biotechnology company engaged in manufacturing and distributing pharmaceutical, consumer |
2011 | 250,00$ |
Brawn Pharmaceuticals Limited (530207) - Strategic SWOT Analysis ReviewBrawn Pharmaceuticals Limited (BRAWN) is a public traded company engages in the marketing, trading and distribution of pharmaceuti |
2011 | 250,00$ |
Renata Limited (RENATA) - Strategic SWOT Analysis ReviewRenata Limited (Renata) is a public traded company specialized in the manufacture and marketing of pharmaceutical and nutritional |
2011 | 250,00$ |
Scandimed International A.S - Strategic SWOT Analysis ReviewScandimed International A.S (Scandimed) is a Denmark-based company. It specializes in the production of surgical, endo-urological |
2011 | 125,00$ |
Pine Rest Christian Mental Health Services - Strategic SWOT Analysis ReviewPine Rest Christian Mental Health Services (Pine Rest) is a non-profit health center engaged in providing comprehensive behavioral |
2011 | 125,00$ |
Health Dialog Services Corporation - Strategic SWOT Analysis ReviewHealth Dialog Services Corporation (Health Dialog) is a health based support services provider. The company is engages in providin |
2011 | 125,00$ |
Harvard Vanguard Medical Associates - Strategic SWOT Analysis ReviewHarvard Vanguard Medical Associates (Harvard Vanguard) is a non-profit organization that provides healthcare services. It offers a |
2011 | 125,00$ |
National Medical Development, Inc. - Strategic SWOT Analysis ReviewNational Medical Development, Inc. (NMDI) is a healthcare organization, engaged in developing, managing owning and operating outpa |
2011 | 125,00$ |
Summit plc (SUMM) - Strategic SWOT Analysis ReviewSummit plc (Summit) is engaged in the discovery and development of novel drugs. It develops new medicines using its proprietary im |
2011 | 250,00$ |
PD-Rx Pharmaceuticals, Inc (PDRX) - Strategic SWOT Analysis ReviewPD-Rx Pharmaceuticals, Inc (PD-Rx) is a provider of pharmaceutical services. It is engaged in distribution of pharmaceutical produ |
2011 | 250,00$ |
TCP Reliable - Strategic SWOT Analysis ReviewTCP Reliable is engaged in providing packaging solution in the field of temperature controlled packaging right from needs assessme |
2011 | 250,00$ |
Cardio Incorporated - Strategic SWOT Analysis ReviewCardio Incorporated (Cardio) is engaged in health care company. The company is involved in maintaining and improving the life of p |
2011 | 250,00$ |
Nventa Biopharmaceuticals Corp. (NVN) - Strategic SWOT Analysis ReviewThis comprehensive SWOT profile of Nventa Biopharmaceuticals Corp. provides you with an in-depth strategic analysis of the company |
2011 | 250,00$ |
Miracor Diagnostics, Inc. (MRDG) - Strategic SWOT Analysis ReviewThis comprehensive SWOT profile of Miracor Diagnostics, Inc. provides you with an in-depth strategic analysis of the company's bus |
2011 | 250,00$ |
MascoMid Co. - Strategic SWOT Analysis ReviewMascoMid Co. (MascoMid) is a medical device company, principally engaged in manufacturing of high quality medical disposable healt |
2011 | 125,00$ |
Nanjing Medical Co., Ltd. - Strategic SWOT Analysis ReviewThis comprehensive SWOT profile of Nanjing Medical Co., Ltd. provides you with an in-depth strategic analysis of the company's bus |
2011 | 250,00$ |
Incomex Paraguay SAECA (ICO) - Strategic SWOT Analysis ReviewThis comprehensive SWOT profile of Incomex Paraguay SAECA provides you with an in-depth strategic analysis of the company's busine |
2011 | 250,00$ |
Carematrix Corporation (CMDCQ) - Strategic SWOT Analysis ReviewThis comprehensive SWOT profile of Carematrix Corporation provides you with an in-depth strategic analysis of the company's busine |
2011 | 250,00$ |
Karver International, Inc. (KRVR) - Strategic SWOT Analysis ReviewKarver International, Inc. (Karver), formerly Medeorex, Inc. is a development stage pharmaceutical companyengaged in rendering hea |
2011 | 250,00$ |
Dental Patient Care America Inc (DPAT) - Strategic SWOT Analysis ReviewThis comprehensive SWOT profile of Dental Patient Care America Inc provides you with an in-depth strategic analysis of the company |
2011 | 250,00$ |
Chemeq Technologies Pty Ltd - Strategic SWOT Analysis ReviewChemeq Technologies Pty Ltd (Chemeq Technologies) is a privately held research company that is engaged in developing anti-microbia |
2011 | 250,00$ |
Let''s Talk Recovery Inc. (LKRV) - Strategic SWOT Analysis ReviewLet's Talk Recovery, Inc. is a publicly traded company offering dynamic, socially responsible solutions to the rapidly growing rec |
2011 | 125,00$ |
China Dasheng Biotechnology Co (CDBT) - Strategic SWOT Analysis ReviewThis comprehensive SWOT profile of China Dasheng Biotechnology Co provides you with an in-depth strategic analysis of the company' |
2011 | 250,00$ |
Livewave Media Plc (LIVP) - Strategic SWOT Analysis ReviewThis comprehensive SWOT profile of Livewave Media Plc provides you with an in-depth strategic analysis of the company's businesses |
2011 | 125,00$ |
Miravant Medical Technologies - Strategic SWOT Analysis ReviewMiravant Medical Technologies (Miravant Medical) is a US based pharmaceutical company. Miravant Medical is engaged in research and |
2011 | 250,00$ |
Combe Incorporated - Strategic SWOT Analysis ReviewCombe Incorporated (Combe) is engaged in providing over-the-counter healthcare products, which are used in dermatology, male healt |
2011 | 250,00$ |
Gliatech Inc. (GLIAQ) - Strategic SWOT Analysis ReviewGliatech Inc. (Gliatech) is principally engaged in the discovery and development of biosurgery and pharmaceutical products. The co |
2011 | 250,00$ |
Compare Generiks, Inc. - Strategic SWOT Analysis ReviewCompare Generiks, Inc. (CGI) is a pharmaceutical company engaged in marketing and distribution of dietary supplements and Over-the |
2011 | 250,00$ |
BioTransplant Inc. - Strategic SWOT Analysis ReviewBioTransplant Inc. (BioTransplant) is a specialty pharmaceutical company engaged in providing intellectual property rights that it |
2011 | 250,00$ |
Entropin, Inc. (ETOP) - Strategic SWOT Analysis ReviewEntropin, Inc. is engaged in the research and development of pharmaceutical products. The company is headquatered in Florida, the |
2011 | 250,00$ |
MitoPharm Corporation - Strategic SWOT Analysis ReviewMitopharm Corporation (MTPM) is a pharmaceutical company. The company engages in the research, development, marketing and sales of |
2011 | 250,00$ |
Select Therapeutics Inc. - Strategic SWOT Analysis ReviewSelect Therapeutics Inc. (Select Therapeutics) is a pharmaceutical company principally engaged in the research and development of |
2011 | 250,00$ |
Pilot Therapeutics Holdings, Inc. - Strategic SWOT Analysis ReviewPilot Therapeutics Holdings, Inc. (Pilot Therapeutics), formerly Interallied Group, Inc. is a pharmaceutical company principally e |
2011 | 250,00$ |
BHK Inc. - Strategic SWOT Analysis ReviewBHK Inc. (BHK) is engaged in selling electric parts, including MP3 and related business activities. In addition, it is also engage |
2011 | 250,00$ |
Avantogen Oncology, Inc. (AVTO) - Strategic SWOT Analysis ReviewAvantogen Oncology, Inc. (Avantogen) is principally engaged in the development and commercialization of oncology drugs. It is form |
2011 | 250,00$ |
Stem Cell Sciences Plc (STEM) - Strategic SWOT Analysis ReviewStem Cell Sciences plc is a provider of stem cells and associated technologies for drug discovery. The company is specialized in d |
2011 | 250,00$ |
GlaxoSmithkline Consumer Nig PLC (GLAXOSMITH) - Strategic SWOT Analysis ReviewGlaxoSmithKline Consumer Nigeria Plc company is engaged in manufacturing, distribution and marketing a range of consumer healthcar |
2011 | 250,00$ |
Synova Healthcare Group, Inc. (SNVHQ) - Strategic SWOT Analysis ReviewThis comprehensive SWOT profile of Synova Healthcare Group, Inc. provides you with an in-depth strategic analysis of the company's |
2011 | 250,00$ |
Span Diagnostics SARL - Strategic SWOT Analysis ReviewSpan Diagnostics SARL (Span Diagnostics) is a healthcare company, engaged in the development and manufacturing of novel products f |
2011 | 250,00$ |
Transderm Laboratories Corporation (TLCC) - Strategic SWOT Analysis ReviewThis comprehensive SWOT profile of Transderm Laboratories Corporation provides you with an in-depth strategic analysis of the comp |
2011 | 250,00$ |
CuraTech Industries, Inc. (CUTC) - Strategic SWOT Analysis ReviewCuraTech Industries, Inc., (CII), is a pharmaceutical company. CII is engaged in development and marketing of a health supplements |
2011 | 250,00$ |
Response Oncology, Inc. (ROIX) - Strategic SWOT Analysis ReviewThis comprehensive SWOT profile of Response Oncology, Inc. provides you with an in-depth strategic analysis of the company's busin |
2011 | 250,00$ |
U.S. Homecare Corporation (USHO) - Strategic SWOT Analysis ReviewThis comprehensive SWOT profile of U.S. Homecare Corporation provides you with an in-depth strategic analysis of the company's bus |
2011 | 250,00$ |
Integra, Inc. (INGA) - Strategic SWOT Analysis ReviewThis comprehensive SWOT profile of Integra, Inc. provides you with an in-depth strategic analysis of the company's businesses and |
2011 | 250,00$ |
Innovative Clinical Solutions, Ltd. - Strategic SWOT Analysis ReviewInnovative Clinical Solutions, Ltd. (ICSL) is a contract research organization engaged in the management of investigative clinical |
2011 | 250,00$ |
ProMedCo Management Co. - Strategic SWOT Analysis ReviewProMedCo Management Co. (ProMedCo) is a pharmaceutical company engaged in providing medical and healthcare services in the non-urb |
2011 | 250,00$ |
RainTree Healthcare Corp. - Strategic SWOT Analysis ReviewRainTree Healthcare Corp. (RainTree Healthcare), formerly known as Unison HealthCare Corp. is a privately held health care service |
2011 | 250,00$ |
Diversified Senior Services, Inc. - Strategic SWOT Analysis ReviewDiversified Senior Services, Inc. (DISS) is engaged in the development, acquisition and management of apartments, independent livi |
2011 | 250,00$ |
Molecular Imaging Corporation - Strategic SWOT Analysis ReviewMolecular Imaging Corporation (Molecular Imaging) is a diagnostic imaging company engaged in the provision of molecular imaging se |
2011 | 250,00$ |
Catasys Health, Inc - Strategic SWOT Analysis ReviewThis comprehensive SWOT profile of Catasys Health, Inc provides you with an in-depth strategic analysis of the company's businesse |
2011 | 250,00$ |
NewBiotics, Inc. - Strategic SWOT Analysis ReviewNewBiotics Inc. (NewBiotics) is a privately held pharmaceutical company engaged in the development of breakthrough drugs for the t |
2011 | 250,00$ |
Aperture Health, Inc. (APRE) - Strategic SWOT Analysis ReviewThis comprehensive SWOT profile of Aperture Health, Inc. provides you with an in-depth strategic analysis of the company's busines |
2011 | 250,00$ |
LifeWatch AG (LIFE) - Financial and Strategic SWOT Analysis ReviewLifeWatch AG (LIFE) - Financial and Strategic SWOT Analysis Review / / Summary / / LifeWatch AG (LifeWatch), formerly known as C |
2011 | 125,00$ |
Kensey Nash Corporation (KNSY) - Financial and Strategic SWOT Analysis ReviewKensey Nash Corporation (KNSY) - Financial and Strategic SWOT Analysis Review / / Summary / / Kensey Nash Corp (Kensey Nash) is |
2011 | 125,00$ |
Given Imaging Ltd. (GIVN) - Financial and Strategic SWOT Analysis ReviewGiven Imaging Ltd. (GIVN) - Financial and Strategic SWOT Analysis Review / / Summary / / Given Imaging Ltd. (Given Imaging) is e |
2011 | 125,00$ |
Nakanishi Inc. (7716) - Financial and Strategic SWOT Analysis ReviewNakanishi Inc. (7716) - Financial and Strategic SWOT Analysis Review / / Summary / / Nakanishi Inc. (Nakanishi) is engaged in th |
2011 | 125,00$ |
TranS1 Inc. (TSON) - Financial and Strategic SWOT Analysis ReviewTranS1 Inc. (TSON) - Financial and Strategic SWOT Analysis Review / / Summary / / TranS1 Inc. (TranS1) is a US-based medical dev |
2011 | 125,00$ |
Positron Corporation (POSC) - Financial and Strategic SWOT Analysis ReviewPositron Corporation (POSC) - Financial and Strategic SWOT Analysis Review / / Summary / / Positron Corporation (Positron) is a |
2011 | 250,00$ |
Oridion Systems Ltd. (ORIDN) - Financial and Strategic SWOT Analysis ReviewOridion Systems Ltd. (ORIDN) - Financial and Strategic SWOT Analysis Review / / Summary / / Oridion Systems Ltd. (Oridion) is a |
2011 | 125,00$ |
American Medical Alert Corp. (AMAC) - Financial and Strategic SWOT Analysis ReviewAmerican Medical Alert Corp. (AMAC) - Financial and Strategic SWOT Analysis Review / / Summary / / American Medical Alert Corp. |
2011 | 125,00$ |
Lincare Holdings Inc. (LNCR) - Financial and Strategic SWOT Analysis ReviewLincare Holdings Inc. (LNCR) - Financial and Strategic SWOT Analysis Review / / Summary / / Lincare Holdings Inc. (Lincare) is e |
2011 | 125,00$ |
Cambridge Heart, Inc. (CAMH) - Financial and Strategic SWOT Analysis ReviewCambridge Heart, Inc. (CAMH) - Financial and Strategic SWOT Analysis Review / / Summary / / Cambridge Heart, Inc. (Cambridge Hea |
2011 | 250,00$ |
MELA Sciences, Inc. (MELA) - Financial and Strategic SWOT Analysis ReviewMELA Sciences, Inc. (MELA) - Financial and Strategic SWOT Analysis Review / / Summary / / MELA Sciences, Inc. (MELA Sciences), f |
2011 | 250,00$ |
Mediwatch Plc (MDW) - Financial and Strategic SWOT Analysis ReviewMediwatch Plc (MDW) - Financial and Strategic SWOT Analysis Review / / Summary / / Mediwatch Plc (Mediwatch) is a medical device |
2011 | 125,00$ |
Bioheart, Inc. (BHRT) - Financial and Strategic SWOT Analysis ReviewBioheart, Inc. (BHRT) - Financial and Strategic SWOT Analysis Review / / Summary / / Bioheart, Inc. (Bioheart) is a biotechnolog |
2011 | 125,00$ |
Bioneer Corporation (064550) - Financial and Strategic SWOT Analysis ReviewBioneer Corporation (064550) - Financial and Strategic SWOT Analysis Review / / Summary / / Bioneer Corporation (Bioneer) is a b |
2011 | 250,00$ |
Insulet Corporation (PODD) - Financial and Strategic SWOT Analysis ReviewInsulet Corporation (PODD) - Financial and Strategic SWOT Analysis Review / / Summary / / Insulet Corporation (Insulet) is engag |
2011 | 125,00$ |
MedQuist Holdings Inc. (MEDH) - Financial and Strategic SWOT Analysis ReviewMedQuist Holdings Inc. (MEDH) - Financial and Strategic SWOT Analysis Review / / Summary / / MedQuist Holdings Inc. (MedQuist), |
2011 | 125,00$ |
Emdeon Inc. (EM) - Financial and Strategic SWOT Analysis ReviewEmdeon Inc. (EM) - Financial and Strategic SWOT Analysis Review / / Summary / / Emdeon Inc. (Emdeon) is a provider of healthcare |
2011 | 125,00$ |
curasan AG (CUR) - Financial and Strategic SWOT Analysis Reviewcurasan AG (CUR) - Financial and Strategic SWOT Analysis Review / / Summary / / curasan AG (curasan) is a medical device company |
2011 | 125,00$ |
Pacific Edge Limited (PEB) - Financial and Strategic SWOT Analysis ReviewPacific Edge Limited (PEB) - Financial and Strategic SWOT Analysis Review / / Summary / / Pacific Edge Limited (PEB), formerly P |
2011 | 125,00$ |
ImpediMed Limited (IPD) - Financial and Strategic SWOT Analysis ReviewImpediMed Limited (IPD) - Financial and Strategic SWOT Analysis Review / / Summary / / ImpediMed Limited (ImpediMed) is an Austr |
2011 | 125,00$ |
ClearStream Technologies Group plc (CTN) - Financial and Strategic SWOT Analysis ReviewClearStream Technologies Group plc (CTN) - Financial and Strategic SWOT Analysis Review / / Summary / / ClearStream Technologies |
2011 | 125,00$ |
Exalenz Bioscience Ltd. (EXEN) - Financial and Strategic SWOT Analysis ReviewExalenz Bioscience Ltd. (EXEN) - Financial and Strategic SWOT Analysis Review / / Summary / / Exalenz Bioscience Ltd (Exalenz), |
2011 | 125,00$ |
WaferGen Biosystems, Inc. (WGBS) - Financial and Strategic SWOT Analysis ReviewWaferGen Biosystems, Inc. (WGBS) - Financial and Strategic SWOT Analysis Review / / Summary / / WaferGen Biosystems, Inc. (Wafer |
2011 | 250,00$ |
Apex Biotechnology Corp. (1733) - Financial and Strategic SWOT Analysis ReviewApex Biotechnology Corp. (1733) - Financial and Strategic SWOT Analysis Review / / Summary / / Apex Biotechnology Corp. (ApexBio |
2011 | 125,00$ |
TaiDoc Technology Corporation (4736) - Financial and Strategic SWOT Analysis ReviewTaiDoc Technology Corporation (4736) - Financial and Strategic SWOT Analysis Review / / Summary / / TaiDoc Technology Corporatio |
2011 | 125,00$ |
Shanghai Kehua Bio-engineering Co., Ltd. (002022) - Financial and Strategic SWOT Analysis ReviewShanghai Kehua Bio-engineering Co., Ltd. (002022) - Financial and Strategic SWOT Analysis Review / / Summary / / Shanghai Kehua |
2011 | 125,00$ |
Versus Technology, Inc. (VSTI) - Financial and Strategic SWOT Analysis ReviewVersus Technology, Inc. (VSTI) - Financial and Strategic SWOT Analysis Review / / Summary / / Versus Technology, Inc. (Versus Te |
2011 | 250,00$ |
Comvita Limited (CVT) - Financial and Strategic SWOT Analysis ReviewComvita Limited (CVT) - Financial and Strategic SWOT Analysis Review / / Summary / / Comvita Limited (Comvita) is a healthcare c |
2011 | 125,00$ |
Angelica Corporation - Strategic SWOT Analysis ReviewAngelica Corporation - Strategic SWOT Analysis Review / / Summary / / Angelica Corporation (Angelica) is a provider of outsource |
2011 | 125,00$ |
FUJIFILM Medical Systems USA, Inc. - Strategic SWOT Analysis ReviewFUJIFILM Medical Systems USA, Inc. - Strategic SWOT Analysis Review / / Summary / / FUJIFILM Medical Systems USA, Inc. (Fujifilm |
2011 | 125,00$ |
3DM Inc. - Strategic SWOT Analysis Review3DM Inc. - Strategic SWOT Analysis Review / / Summary / / 3DM Inc. (3DM) is a privately held specialty biomaterials and medical |
2011 | 125,00$ |
US Endoscopy - Strategic SWOT Analysis ReviewUS Endoscopy - Strategic SWOT Analysis Review / / Summary / / US Endoscopy is a medical devices company engaged in the design an |
2011 | 125,00$ |
Ivoclar Vivadent AG - Strategic SWOT Analysis ReviewIvoclar Vivadent AG - Strategic SWOT Analysis Review / / Summary / / Ivoclar Vivadent AG (Ivoclar) is a medical device company e |
2011 | 125,00$ |
Biotronik SE & Co. KG - Strategic SWOT Analysis ReviewBiotronik SE & Co. KG - Strategic SWOT Analysis Review / / Summary / / Biotronik SE & Co. KG (Biotronik) is a leading biomedical |
2011 | 125,00$ |
Schiller AG - Strategic SWOT Analysis ReviewSchiller AG - Strategic SWOT Analysis Review / / Summary / / Schiller AG (Schiller) is a Switzerland-based global medical device |
2011 | 125,00$ |
MAQUET GmbH & Co. KG - Strategic SWOT Analysis ReviewMAQUET GmbH & Co. KG - Strategic SWOT Analysis Review / / Summary / / MAQUET GmbH & Co. KG (MAQUET) is engaged in the design, ma |
2011 | 125,00$ |
TRACOE medical GmbH - Strategic SWOT Analysis ReviewTRACOE medical GmbH - Strategic SWOT Analysis Review / / Summary / / TRACOE medical GmbH (TRACOE medical) is a medical device co |
2011 | 125,00$ |
Molnlycke Health Care AB - Strategic SWOT Analysis ReviewMolnlycke Health Care AB - Strategic SWOT Analysis Review / / Summary / / Molnlycke Health Care AB (Molnlycke) is engaged in the |
2011 | 125,00$ |
MedSolutions - Strategic SWOT Analysis ReviewMedSolutions - Strategic SWOT Analysis Review / / Summary / / MedSolutions (MedSolutions) is principally engaged in providing me |
2011 | 125,00$ |
AlloSource - Strategic SWOT Analysis ReviewAlloSource - Strategic SWOT Analysis Review / / Summary / / AlloSource is a non-profit medical device company engaged in the dev |
2011 | 125,00$ |
Creganna-Tactx Medical - Strategic SWOT Analysis ReviewCreganna-Tactx Medical - Strategic SWOT Analysis Review / / Summary / / Creganna-Tactx Medical (Creganna-Tactx) is a contract ma |
2011 | 125,00$ |
Teleflex Medical - Strategic SWOT Analysis ReviewTeleflex Medical - Strategic SWOT Analysis Review / / Summary / / Teleflex Medical, a business segment of Teleflex Incorporated, |
2011 | 125,00$ |
BARRX Medical, Inc. - Strategic SWOT Analysis ReviewBARRX Medical, Inc. - Strategic SWOT Analysis Review / / Summary / / BARRX Medical, Inc. (BARRX) is a medical device company eng |
2011 | 125,00$ |
Cook Medical Incorporated - Strategic SWOT Analysis ReviewCook Medical Incorporated - Strategic SWOT Analysis Review / / Summary / / Cook Medical Incorporated (Cook Medical) is engaged i |
2011 | 125,00$ |
Vygon SA - Strategic SWOT Analysis ReviewVygon SA - Strategic SWOT Analysis Review / / Summary / / Vygon SA (Vygon) is a medical device company engaged in the design, ma |
2011 | 125,00$ |
Cardiva Medical, Inc. - Strategic SWOT Analysis ReviewCardiva Medical, Inc. - Strategic SWOT Analysis Review / / Summary / / Cardiva Medical, Inc. (Cardiva) is a medical device compa |
2011 | 125,00$ |
SHPS, Inc. - Strategic SWOT Analysis ReviewSHPS, Inc. - Strategic SWOT Analysis Review / / Summary / / SHPS, Inc. (SHPS) provides a broad range of health management progra |
2011 | 125,00$ |
Medtronic CoreValve, LLC - Strategic SWOT Analysis ReviewMedtronic CoreValve, LLC - Strategic SWOT Analysis Review / / Summary / / Medtronic CoreValve, LLC (CoreValve) is a medical tech |
2011 | 125,00$ |
Lumenis Ltd. - Strategic SWOT Analysis ReviewLumenis Ltd. - Strategic SWOT Analysis Review / / Summary / / Lumenis Ltd. (Lumenis) is one of the leading medical and aesthetic |
2011 | 125,00$ |
Abbott Diagnostics - Strategic SWOT Analysis ReviewAbbott Diagnostics - Strategic SWOT Analysis Review / / Summary / / Abbott Diagnostics is one of the world’s leading in vitro di |
2011 | 125,00$ |
OrthoHelix Surgical Designs, Inc. - Strategic SWOT Analysis ReviewOrthoHelix Surgical Designs, Inc. - Strategic SWOT Analysis Review / / Summary / / OrthoHelix Surgical Designs, Inc. (OrthoHelix |
2011 | 125,00$ |
Kreatech Holding B.V. - Strategic SWOT Analysis ReviewKreatech Holding B.V. - Strategic SWOT Analysis Review / / Summary / / Kreatech Holding B.V. (Kreatech Diagnostics) is a private |
2011 | 125,00$ |
Samsung Medison Co.,Ltd. - Strategic SWOT Analysis ReviewSamsung Medison Co.,Ltd. - Strategic SWOT Analysis Review / / Summary / / Samsung Medison Co., Ltd. (Samsung Medison) is a medic |
2011 | 125,00$ |
HeartSine Technologies, Inc. - Strategic SWOT Analysis ReviewHeartSine Technologies, Inc. - Strategic SWOT Analysis Review / / Summary / / HeartSine Technologies, Inc. (HeartSine) is a medi |
2011 | 250,00$ |
Japan Medical Materials Corporation - Strategic SWOT Analysis ReviewJapan Medical Materials Corporation - Strategic SWOT Analysis Review / / Summary / / Japan Medical Materials Corporation (JMM) i |
2011 | 125,00$ |
Ferno-Washington, Inc. - Strategic SWOT Analysis ReviewFerno-Washington, Inc. - Strategic SWOT Analysis Review / / Summary / / Ferno-Washington, Inc. (Ferno) is engaged in the manufac |
2011 | 125,00$ |
Oxford Nanopore Technologies Ltd. - Strategic SWOT Analysis ReviewOxford Nanopore Technologies Ltd. - Strategic SWOT Analysis Review / / Summary / / Oxford Nanopore Technologies Ltd. (Oxford Nan |
2011 | 125,00$ |
iMDsoft Inc. - Strategic SWOT Analysis ReviewiMDsoft Inc. - Strategic SWOT Analysis Review / / Summary / / iMDsoft Inc. (iMDsoft) is a privately-held medical software compan |
2011 | 125,00$ |
Medicalis Corporation - Strategic SWOT Analysis ReviewMedicalis Corporation - Strategic SWOT Analysis Review / / Summary / / Medicalis Corporation (Medicalis) is a health care IT com |
2011 | 250,00$ |
ONTEX International N.V. - Strategic SWOT Analysis ReviewONTEX International N.V. - Strategic SWOT Analysis Review / / Summary / / ONTEX International N.V. (ONTEX) is a healthcare compa |
2011 | 250,00$ |
Nypro, Inc. - Strategic SWOT Analysis ReviewNypro, Inc. - Strategic SWOT Analysis Review / / Summary / / Nypro, Incorporated (Nypro) is a leading plastics technology compan |
2011 | 125,00$ |
Bracco S.p.A. - Strategic SWOT Analysis ReviewBracco S.p.A. - Strategic SWOT Analysis Review / / Summary / / Bracco S.p.A. (Bracco) is a holding company of Bracco Group, with |
2011 | 125,00$ |
Advanced BioHealing, Inc. - Strategic SWOT Analysis ReviewAdvanced BioHealing, Inc. - Strategic SWOT Analysis Review / / Summary / / Advanced BioHealing, Inc. (ABH) is a privately held, |
2011 | 125,00$ |
Medical Information Technology, Inc. - Strategic SWOT Analysis ReviewMedical Information Technology, Inc. - Strategic SWOT Analysis Review / / Summary / / Medical Information Technology, Inc. (Medi |
2011 | 125,00$ |
DMG America LLC - Strategic SWOT Analysis ReviewDMG America LLC - Strategic SWOT Analysis Review / / Summary / / DMG America LLC (DMG America), formerly known as Zenith Dental, |
2011 | 125,00$ |
Symphogen AS - Strategic SWOT Analysis ReviewSymphogen AS - Strategic SWOT Analysis Review / / Summary / / Symphogen A/S (Symphogen) is a privately-held biopharmaceutical co |
2011 | 125,00$ |
PEAK Surgical, Inc. - Strategic SWOT Analysis ReviewPEAK Surgical, Inc. - Strategic SWOT Analysis Review / / Summary / / PEAK Surgical, Inc. (PEAK Surgical) is a medical device com |
2011 | 125,00$ |
EOS imaging SA - Strategic SWOT Analysis ReviewEOS imaging SA - Strategic SWOT Analysis Review / / Summary / / EOS imaging SA (EOS Imaging), formerly Biospace Med, is an ortho |
2011 | 125,00$ |
KARL STORZ Endoscopy-America, Inc. - Strategic SWOT Analysis ReviewKARL STORZ Endoscopy-America, Inc. - Strategic SWOT Analysis Review / / Summary / / KARL STORZ Endoscopy-America, Inc. (KSEA) is |
2011 | 125,00$ |
Medtronic ENT - Strategic SWOT Analysis ReviewMedtronic ENT - Strategic SWOT Analysis Review / / Summary / / Medtronic ENT, a division of Medtronic, Inc., is engaged in the d |
2011 | 125,00$ |
Systagenix Wound Management - Strategic SWOT Analysis ReviewSystagenix Wound Management - Strategic SWOT Analysis Review / / Summary / / Systagenix Wound Management (Systagenix) is a medic |
2011 | 125,00$ |
Cardiocom, LLC - Strategic SWOT Analysis ReviewCardiocom, LLC - Strategic SWOT Analysis Review / / Summary / / Cardiocom, LLC (Cardiocom) is a leader in providing daily remote |
2011 | 125,00$ |
In Veritas Medical Diagnostics Inc. (IVME) - Strategic SWOT Analysis ReviewIn Veritas Medical Diagnostics Inc. (IVME) - Strategic SWOT Analysis Review / / Summary / / In Veritas Medical Diagnostics Inc. |
2011 | 125,00$ |
DSM Dyneema B.V. - Strategic SWOT Analysis ReviewDSM Dyneema B.V. - Strategic SWOT Analysis Review / / Summary / / DSM Dyneema B.V. (DSM Dyneema) is engaged in the manufacture a |
2011 | 125,00$ |
Illumina, Inc. (ILMN) - Financial and Strategic SWOT Analysis ReviewIllumina, Inc. (ILMN) - Financial and Strategic SWOT Analysis Review / / Summary / / Illumina, Inc. (Illumina) is a molecular di |
2011 | 125,00$ |
AlphaRx, Inc. (ALRX) - Financial and Strategic SWOT Analysis ReviewAlphaRx, Inc. (ALRX) - Financial and Strategic SWOT Analysis Review / / Summary / / AlphaRX, Inc. (AlphaRX), formerly known as L |
2011 | 125,00$ |
Valeant Pharmaceuticals International, Inc. (VRX) - Financial and Strategic SWOT Analysis ReviewValeant Pharmaceuticals International, Inc. (VRX) - Financial and Strategic SWOT Analysis Review / / Summary / / Valeant Pharmac |
2011 | 125,00$ |
Neoprobe Corporation (NEOP) - Financial and Strategic SWOT Analysis ReviewNeoprobe Corporation (NEOP) - Financial and Strategic SWOT Analysis Review / / Summary / / Neoprobe Corporation (Neoprobe) is a |
2011 | 125,00$ |
Sanofi (SAN) - Financial and Strategic SWOT Analysis ReviewSanofi (SAN) - Financial and Strategic SWOT Analysis Review / / Summary / / Sanofi is a global pharmaceutical company engaged in |
2011 | 125,00$ |
Agilent Technologies, Inc. (A) - Financial and Strategic SWOT Analysis ReviewAgilent Technologies, Inc. (A) - Financial and Strategic SWOT Analysis Review / / Summary / / Agilent Technologies, Inc. (Agilen |
2011 | 125,00$ |
Bioniche Life Sciences, Inc. (BNC) - Financial and Strategic SWOT Analysis ReviewBioniche Life Sciences, Inc. (BNC) - Financial and Strategic SWOT Analysis Review / / Summary / / Bioniche Life Sciences Inc. (B |
2011 | 125,00$ |
Alkermes, Inc. (ALKS) - Financial and Strategic SWOT Analysis ReviewAlkermes, Inc. (ALKS) - Financial and Strategic SWOT Analysis Review / / Summary / / Alkermes, Inc., (Alkermes) is a publicly tr |
2011 | 125,00$ |
Myriad Genetics, Inc. (MYGN) - Financial and Strategic SWOT Analysis ReviewMyriad Genetics, Inc. (MYGN) - Financial and Strategic SWOT Analysis Review / / Summary / / Myriad Genetics, Inc. (Myriad) is a |
2011 | 125,00$ |
CK Life Sciences International (Holdings) Inc. (0775) - Financial and Strategic SWOT Analysis ReviewCK Life Sciences International (Holdings) Inc. (0775) - Financial and Strategic SWOT Analysis Review / / Summary / / CK Life Sci |
2011 | 125,00$ |
Healthscope Limited (HSP) - Financial and Strategic SWOT Analysis ReviewHealthscope Limited (HSP) - Financial and Strategic SWOT Analysis Review / / Summary / / Healthscope Limited (Healthscope) is an |
2011 | 125,00$ |
IMS Health Incorporated (RX) - Financial and Strategic SWOT Analysis ReviewIMS Health Incorporated (RX) - Financial and Strategic SWOT Analysis Review / / Summary / / IMS Health (IMS) is engaged in provi |
2011 | 125,00$ |
InterMune, Inc. (ITMN) - Financial and Strategic SWOT Analysis ReviewInterMune, Inc. (ITMN) - Financial and Strategic SWOT Analysis Review / / Summary / / InterMune, Inc. (InterMune) is a biopharma |
2011 | 125,00$ |
Kindred Healthcare, Inc. (KND) - Financial and Strategic SWOT Analysis ReviewKindred Healthcare, Inc. (KND) - Financial and Strategic SWOT Analysis Review / / Summary / / Kindred Healthcare Inc. (Kindred H |
2011 | 125,00$ |
King Pharmaceuticals, Inc. (KG) - Financial and Strategic SWOT Analysis ReviewKing Pharmaceuticals, Inc. (KG) - Financial and Strategic SWOT Analysis Review / / Summary / / King Pharmaceuticals, Inc. (King) |
2011 | 125,00$ |
KV Pharmaceutical Company (KV.A) - Financial and Strategic SWOT Analysis ReviewKV Pharmaceutical Company (KV.A) - Financial and Strategic SWOT Analysis Review / / Summary / / KV Pharmaceutical Company (KV Ph |
2011 | 125,00$ |
Magellan Health Services, Inc. (MGLN) - Financial and Strategic SWOT Analysis ReviewMagellan Health Services, Inc. (MGLN) - Financial and Strategic SWOT Analysis Review / / Summary / / Magellan Health Services, I |
2011 | 125,00$ |
Novavax, Inc. (NVAX) - Financial and Strategic SWOT Analysis ReviewNovavax, Inc. (NVAX) - Financial and Strategic SWOT Analysis Review / / Summary / / Novavax, Inc. (Novavax) is a clinical-stage |
2011 | 125,00$ |
Acura Pharmaceuticals, Inc. (ACUR) - Financial and Strategic SWOT Analysis ReviewAcura Pharmaceuticals, Inc. (ACUR) - Financial and Strategic SWOT Analysis Review / / Summary / / Acura Pharmaceuticals, Inc. (A |
2011 | 125,00$ |
Hikma Pharmaceuticals PLC (HIK) - Financial and Strategic SWOT Analysis ReviewHikma Pharmaceuticals PLC (HIK) - Financial and Strategic SWOT Analysis Review / / Summary / / Hikma Pharmaceuticals PLC (Hikma |
2011 | 125,00$ |
Enzo Biochem, Inc. (ENZ) - Financial and Strategic SWOT Analysis ReviewEnzo Biochem, Inc. (ENZ) - Financial and Strategic SWOT Analysis Review / / Summary / / Enzo Biochem, Inc. (Enzo Biochem) is a l |
2011 | 125,00$ |
Imugene Limited (IMU) - Financial and Strategic SWOT Analysis ReviewImugene Limited (IMU) - Financial and Strategic SWOT Analysis Review / / Summary / / Imugene Limited (Imugene) is a biotechnolog |
2011 | 125,00$ |
AEterna Zentaris Inc. (AEZ) - Financial and Strategic SWOT Analysis ReviewAEterna Zentaris Inc. (AEZ) - Financial and Strategic SWOT Analysis Review / / Summary / / AEterna Zentaris Inc. (AEterna Zentar |
2011 | 125,00$ |
Immtech Pharmaceuticals, Inc. (IMMP) - Financial and Strategic SWOT Analysis ReviewImmtech Pharmaceuticals, Inc. (IMMP) - Financial and Strategic SWOT Analysis Review / / Summary / / Immtech Pharmaceuticals, Inc |
2011 | 125,00$ |
Amicus Therapeutics, Inc. (FOLD) - Financial and Strategic SWOT Analysis ReviewAmicus Therapeutics, Inc. (FOLD) - Financial and Strategic SWOT Analysis Review / / Summary / / Amicus Therapeutics, Inc. (Amicu |
2011 | 125,00$ |
IMMUNOMEDICS, INC (IMMU) - Financial and Strategic SWOT Analysis ReviewIMMUNOMEDICS, INC (IMMU) - Financial and Strategic SWOT Analysis Review / / Summary / / Immunomedics, Inc. (Immunomedics) is a N |
2011 | 125,00$ |
Ardea Biosciences, Inc. (RDEA) - Financial and Strategic SWOT Analysis ReviewArdea Biosciences, Inc. (RDEA) - Financial and Strategic SWOT Analysis Review / / Summary / / Ardea Biosciences, Inc. (Ardea Bio |
2011 | 125,00$ |
Insmed Incorporated (INSM) - Financial and Strategic SWOT Analysis ReviewInsmed Incorporated (INSM) - Financial and Strategic SWOT Analysis Review / / Summary / / Insmed Incorporated (Insmed) is a biop |
2011 | 125,00$ |
Takeda Pharmaceutical Company Limited (4502) - Financial and Strategic SWOT Analysis ReviewTakeda Pharmaceutical Company Limited (4502) - Financial and Strategic SWOT Analysis Review / / Summary / / Takeda Pharmaceutica |
2011 | 125,00$ |
Tsumura & co. (4540) - Financial and Strategic SWOT Analysis ReviewTsumura & co. (4540) - Financial and Strategic SWOT Analysis Review / / Summary / / Tsumura & Co (Tsumura) is a Japan based phar |
2011 | 125,00$ |
EBOS Group Limited (EBO) - Financial and Strategic SWOT Analysis ReviewEBOS Group Limited (EBO) - Financial and Strategic SWOT Analysis Review / / Summary / / EBOS Group Limited (EBOS) is New Zealand |
2011 | 125,00$ |
Delcath Systems, Inc. (DCTH) - Financial and Strategic SWOT Analysis ReviewDelcath Systems, Inc. (DCTH) - Financial and Strategic SWOT Analysis Review / / Summary / / Delcath Systems, Inc. (Delcath Syste |
2011 | 125,00$ |
Celltrion, Inc. (068270) - Financial and Strategic SWOT Analysis ReviewCelltrion, Inc. (068270) - Financial and Strategic SWOT Analysis Review / / Summary / / Celltrion Inc., (Celltrion) is a Korea-b |
2011 | 250,00$ |
Lutronic Corporation (085370) - Financial and Strategic SWOT Analysis ReviewLutronic Corporation (085370) - Financial and Strategic SWOT Analysis Review / / Summary / / Lutronic Corporation (Lutronic) is |
2011 | 250,00$ |
Air Methods Corporation (AIRM) - Financial and Strategic SWOT Analysis ReviewAir Methods Corporation (AIRM) - Financial and Strategic SWOT Analysis Review / / Summary / / Air Methods Corporation (Air Metho |
2011 | 125,00$ |
AMN Healthcare Services, Inc. (AHS) - Financial and Strategic SWOT Analysis ReviewAMN Healthcare Services, Inc. (AHS) - Financial and Strategic SWOT Analysis Review / / Summary / / AMN Healthcare Services, Inc. |
2011 | 125,00$ |
Biocon Limited (BIOCON) - Financial and Strategic SWOT Analysis ReviewBiocon Limited (BIOCON) - Financial and Strategic SWOT Analysis Review / / Summary / / Biocon Limited (Biocon) is a fully integr |
2011 | 125,00$ |
Brookdale Senior Living Inc. (BKD) - Financial and Strategic SWOT Analysis ReviewBrookdale Senior Living Inc. (BKD) - Financial and Strategic SWOT Analysis Review / / Summary / / Brookdale Senior Living Inc (B |
2011 | 125,00$ |
Centene Corporation (CNC) - Financial and Strategic SWOT Analysis ReviewCentene Corporation (CNC) - Financial and Strategic SWOT Analysis Review / / Summary / / Centene Corporation (Centene) is one of |
2011 | 125,00$ |
Charles River Laboratories International, Inc. (CRL) - Financial and Strategic SWOT Analysis ReviewCharles River Laboratories International, Inc. (CRL) - Financial and Strategic SWOT Analysis Review / / Summary / / Charles Rive |
2011 | 125,00$ |
Cross Country Healthcare, Inc. (CCRN) - Financial and Strategic SWOT Analysis ReviewCross Country Healthcare, Inc. (CCRN) - Financial and Strategic SWOT Analysis Review / / Summary / / Cross Country Healthcare, I |
2011 | 125,00$ |
FALCO SD Holdings Co., Ltd. (4671) - Financial and Strategic SWOT Analysis ReviewFALCO SD Holdings Co., Ltd. (4671) - Financial and Strategic SWOT Analysis Review / / Summary / / FALCO SD Holdings Co., Ltd. (F |
2011 | 125,00$ |
Guerbet Group (GBT) - Financial and Strategic SWOT Analysis ReviewGuerbet Group (GBT) - Financial and Strategic SWOT Analysis Review / / Summary / / Guerbet Group (Guerbet) is a pharmaceutical c |
2011 | 125,00$ |
The Medicines Company (MDCO) - Financial and Strategic SWOT Analysis ReviewThe Medicines Company (MDCO) - Financial and Strategic SWOT Analysis Review / / Summary / / The Medicines company a global pharm |
2011 | 125,00$ |
Molina Healthcare, Inc. (MOH) - Financial and Strategic SWOT Analysis ReviewMolina Healthcare, Inc. (MOH) - Financial and Strategic SWOT Analysis Review / / Summary / / Molina Healthcare, Inc (Molina) is |
2011 | 125,00$ |
Parkway Holdings Limited (P27) - Financial and Strategic SWOT Analysis ReviewParkway Holdings Limited (P27) - Financial and Strategic SWOT Analysis Review / / Summary / / Parkway Holdings Limited (Parkway) |
2011 | 125,00$ |
Phibro Animal Health Corporation (PAHC) - Financial and Strategic SWOT Analysis ReviewPhibro Animal Health Corporation (PAHC) - Financial and Strategic SWOT Analysis Review / / Summary / / Phibro Animal Health Corp |
2011 | 125,00$ |
Prestige Brands Holdings, Inc. (PBH) - Financial and Strategic SWOT Analysis ReviewPrestige Brands Holdings, Inc. (PBH) - Financial and Strategic SWOT Analysis Review / / Summary / / Prestige Brands Holdings, In |
2011 | 125,00$ |
Ranbaxy Laboratories Limited (500359) - Financial and Strategic SWOT Analysis ReviewRanbaxy Laboratories Limited (500359) - Financial and Strategic SWOT Analysis Review / / Summary / / Ranbaxy Laboratories Limite |
2011 | 125,00$ |
RuralMetro Corporation (RURL) - Financial and Strategic SWOT Analysis ReviewRuralMetro Corporation (RURL) - Financial and Strategic SWOT Analysis Review / / Summary / / Rural/Metro Corporation (Rural/Metr |
2011 | 250,00$ |
Shasun Pharmaceuticals Limited (SHASUNPHAR) - Financial and Strategic SWOT Analysis ReviewShasun Pharmaceuticals Limited (SHASUNPHAR) - Financial and Strategic SWOT Analysis Review / / Summary / / Shasun Pharmaceutical |
2011 | 125,00$ |
Siegfried Holding AG (SFZN) - Financial and Strategic SWOT Analysis ReviewSiegfried Holding AG (SFZN) - Financial and Strategic SWOT Analysis Review / / Summary / / Siegfried Holding AG (Siegfried) is a |
2011 | 250,00$ |
WebMD Health Corp. (WBMD) - Financial and Strategic SWOT Analysis ReviewWebMD Health Corp. (WBMD) - Financial and Strategic SWOT Analysis Review / / Summary / / WebMD Health Corp. (WebMD) is a US base |
2011 | 125,00$ |
PT Kalbe Farma Tbk (KLBF) - Financial and Strategic SWOT Analysis ReviewPT Kalbe Farma Tbk (KLBF) - Financial and Strategic SWOT Analysis Review / / Summary / / PT Kalbe Farma Tbk (Kalbe) is pharmaceu |
2011 | 250,00$ |
Shilpa Medicare Limited (SHILPAMED) - Financial and Strategic SWOT Analysis ReviewShilpa Medicare Limited (SHILPAMED) - Financial and Strategic SWOT Analysis Review / / Summary / / Shilpa Medicare Limited (Shil |
2011 | 250,00$ |
Blackmores Limited (BKL) - Financial and Strategic SWOT Analysis ReviewBlackmores Limited (BKL) - Financial and Strategic SWOT Analysis Review / / Summary / / Blackmores Limited (Blackmores) is an Au |
2011 | 125,00$ |
PAREXEL International Corporation (PRXL) - Financial and Strategic SWOT Analysis ReviewPAREXEL International Corporation (PRXL) - Financial and Strategic SWOT Analysis Review / / Summary / / PAREXEL International Co |
2011 | 125,00$ |
Suheung Capsule Co., Ltd. (008490) - Financial and Strategic SWOT Analysis ReviewSuheung Capsule Co., Ltd. (008490) - Financial and Strategic SWOT Analysis Review / / Summary / / Suheung Capsule Co., Ltd. (Suh |
2011 | 125,00$ |
Shanghai Pharmaceutical Co., Ltd. (601607) - Financial and Strategic SWOT Analysis ReviewShanghai Pharmaceutical Co., Ltd. (601607) - Financial and Strategic SWOT Analysis Review / / Summary / / Shanghai Pharmaceutica |
2011 | 250,00$ |
Kolon Life Science, Inc. (102940) - Financial and Strategic SWOT Analysis ReviewKolon Life Science, Inc. (102940) - Financial and Strategic SWOT Analysis Review / / Summary / / Kolon Life Science Inc. (KLS) i |
2011 | 125,00$ |
Zhejiang Medicine Co., Ltd. (600216) - Financial and Strategic SWOT Analysis ReviewZhejiang Medicine Co., Ltd. (600216) - Financial and Strategic SWOT Analysis Review / / Summary / / Zhejiang Medicine Co., Ltd. |
2011 | 125,00$ |
Health Fitness Corporation - Financial and Strategic SWOT Analysis ReviewHealth Fitness Corporation - Financial and Strategic SWOT Analysis Review / / Summary / / Health Fitness Corporation (HealthFitn |
2011 | 125,00$ |
Asterand plc (ATD) - Financial and Strategic SWOT Analysis ReviewAsterand plc (ATD) - Financial and Strategic SWOT Analysis Review / / Summary / / Asterand plc (Asterand) is a biotechnology com |
2011 | 125,00$ |
Starpharma Holdings Limited (SPL) - Financial and Strategic SWOT Analysis ReviewStarpharma Holdings Limited (SPL) - Financial and Strategic SWOT Analysis Review / / Summary / / Starpharma Holdings Limited (St |
2011 | 125,00$ |
Raffles Medical Group (R01) - Financial and Strategic SWOT Analysis ReviewRaffles Medical Group (R01) - Financial and Strategic SWOT Analysis Review / / Summary / / Raffles Medical Group Ltd. (RMG) is a |
2011 | 250,00$ |
Probiomics Ltd. (PCC) - Financial and Strategic SWOT Analysis ReviewProbiomics Ltd. (PCC) - Financial and Strategic SWOT Analysis Review / / Summary / / Probiomics Ltd. (Probiomics), formerly know |
2011 | 250,00$ |
Amrutanjan Health Care Ltd. (AMRUTANJAN) - Financial and Strategic SWOT Analysis ReviewAmrutanjan Health Care Ltd. (AMRUTANJAN) - Financial and Strategic SWOT Analysis Review / / Summary / / Amrutanjan Health Care L |
2011 | 125,00$ |
Dar Al Dawa Development & Investment Co. Ltd. (DADI) - Financial and Strategic SWOT Analysis ReviewDar Al Dawa Development & Investment Co. Ltd. (DADI) - Financial and Strategic SWOT Analysis Review / / Summary / / Dar Al Dawa |
2011 | 125,00$ |
JCR Pharmaceuticals Co., Ltd. (4552) - Financial and Strategic SWOT Analysis ReviewJCR Pharmaceuticals Co., Ltd. (4552) - Financial and Strategic SWOT Analysis Review / / Summary / / JCR Pharmaceuticals Co., Ltd |
2011 | 250,00$ |
Acibadem Saglik Hizmetleri ve Ticaret AS (ACIBD) - Financial and Strategic SWOT Analysis ReviewAcibadem Saglik Hizmetleri ve Ticaret AS (ACIBD) - Financial and Strategic SWOT Analysis Review / / Summary / / Acibadem Saglik |
2011 | 125,00$ |
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (000999) - Financial and Strategic SWOT Analysis ReviewChina Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (000999) - Financial and Strategic SWOT Analysis Review / / Summary / |
2011 | 125,00$ |
Jack Chia Industries (Thailand) Public Company Limited (JCT) - Financial and Strategic SWOT Analysis ReviewJack Chia Industries (Thailand) Public Company Limited (JCT) - Financial and Strategic SWOT Analysis Review / / Summary / / Jack |
2011 | 125,00$ |
Adcock Ingram Holdings Limited (AIPJ) - Financial and Strategic SWOT Analysis ReviewAdcock Ingram Holdings Limited (AIPJ) - Financial and Strategic SWOT Analysis Review / / Summary / / Adcock Ingram Holdings Limi |
2011 | 125,00$ |
Bangkok Chain Hospital Public Co. Ltd. (KH) - Financial and Strategic SWOT Analysis ReviewBangkok Chain Hospital Public Co. Ltd. (KH) - Financial and Strategic SWOT Analysis Review / / Summary / / Bangkok Chain Hospita |
2011 | 250,00$ |
Kotra Industries Berhad (KOTRA) - Financial and Strategic SWOT Analysis ReviewKotra Industries Berhad (KOTRA) - Financial and Strategic SWOT Analysis Review / / Summary / / Kotra Industries Berhad (Kotra) i |
2011 | 250,00$ |
Renovo Group Plc (RNVO) - Financial and Strategic SWOT Analysis ReviewRenovo Group Plc (RNVO) - Financial and Strategic SWOT Analysis Review / / Summary / / Renovo Group Plc (Renovo) is a biopharmac |
2011 | 125,00$ |
Pierrel S.p.A. (PRL) - Financial and Strategic SWOT Analysis ReviewPierrel S.p.A. (PRL) - Financial and Strategic SWOT Analysis Review / / Summary / / Pierrel S.P.A. (Pierrel) is a publicly held |
2011 | 125,00$ |
Clavis Pharma ASA (CLAVIS) - Financial and Strategic SWOT Analysis ReviewClavis Pharma ASA (CLAVIS) - Financial and Strategic SWOT Analysis Review / / Summary / / Clavis Pharma ASA (Clavis Pharma) is o |
2011 | 250,00$ |
OraSolv AB (OS) - Financial and Strategic SWOT Analysis ReviewOraSolv AB (OS) - Financial and Strategic SWOT Analysis Review / / Summary / / OraSolv AB (OraSolv) engages in the acquisition, |
2011 | 250,00$ |
ThromboGenics NV (THR) - Financial and Strategic SWOT Analysis ReviewThromboGenics NV (THR) - Financial and Strategic SWOT Analysis Review / / Summary / / ThromboGenics NV (ThromboGenics) is a biop |
2011 | 125,00$ |
Fortis Healthcare (India) Ltd. (FORTIS) - Financial and Strategic SWOT Analysis ReviewFortis Healthcare (India) Ltd. (FORTIS) - Financial and Strategic SWOT Analysis Review / / Summary / / Fortis Healthcare (India) |
2011 | 125,00$ |
China Pharma Holdings, Inc. (CPHI) - Financial and Strategic SWOT Analysis ReviewChina Pharma Holdings, Inc. (CPHI) - Financial and Strategic SWOT Analysis Review / / Summary / / China Pharma Holdings, Inc. (C |
2011 | 250,00$ |
Huons Co., Ltd. (084110) - Financial and Strategic SWOT Analysis ReviewHuons Co., Ltd. (084110) - Financial and Strategic SWOT Analysis Review / / Summary / / Huons Co., Ltd. (Huons) is a specialty p |
2011 | 250,00$ |
Orexigen Therapeutics, Inc. (OREX) - Financial and Strategic SWOT Analysis ReviewOrexigen Therapeutics, Inc. (OREX) - Financial and Strategic SWOT Analysis Review / / Summary / / Orexigen Therapeutics, Inc. (O |
2011 | 125,00$ |
Hybrigenics S.A. (ALHYG) - Financial and Strategic SWOT Analysis ReviewHybrigenics S.A. (ALHYG) - Financial and Strategic SWOT Analysis Review / / Summary / / Hybrigenics S.A. (Hybrigenics) is a Fran |
2011 | 125,00$ |
Genomma Lab Internacional SAB de CV (LABB) - Financial and Strategic SWOT Analysis ReviewGenomma Lab Internacional SAB de CV (LABB) - Financial and Strategic SWOT Analysis Review / / Summary / / Genomma Lab Internacio |
2011 | 125,00$ |
Healthway Medical Corporation Limited (5NG) - Financial and Strategic SWOT Analysis ReviewHealthway Medical Corporation Limited (5NG) - Financial and Strategic SWOT Analysis Review / / Summary / / Healthway Medical Cor |
2011 | 250,00$ |
Medicamen Biotech Limited (531146) - Financial and Strategic SWOT Analysis ReviewMedicamen Biotech Limited (531146) - Financial and Strategic SWOT Analysis Review / / Summary / / Medicamen Biotech Limited (Med |
2011 | 125,00$ |
Hester Biosciences Limited (524669) - Financial and Strategic SWOT Analysis ReviewHester Biosciences Limited (524669) - Financial and Strategic SWOT Analysis Review / / Summary / / Hester Biosciences Limited fo |
2011 | 125,00$ |
Verona Pharma Plc (VRP) - Financial and Strategic SWOT Analysis ReviewVerona Pharma Plc (VRP) - Financial and Strategic SWOT Analysis Review / / Summary / / Verona Pharma Plc (Verona Pharma), former |
2011 | 125,00$ |
Hypermarcas SA (HYPE3) - Financial and Strategic SWOT Analysis ReviewHypermarcas SA (HYPE3) - Financial and Strategic SWOT Analysis Review / / Summary / / Hypermarcas SA (Hypermarcas) is engaged in |
2011 | 125,00$ |
Solagran Ltd. (SLA) - Financial and Strategic SWOT Analysis ReviewSolagran Ltd. (SLA) - Financial and Strategic SWOT Analysis Review / / Summary / / Solagran Ltd. (Solagran) is a biotechnology c |
2011 | 250,00$ |
Ironwood Pharmaceuticals, Inc. (IRWD) - Financial and Strategic SWOT Analysis ReviewIronwood Pharmaceuticals, Inc. (IRWD) - Financial and Strategic SWOT Analysis Review / / Summary / / Ironwood Pharmaceuticals, I |
2011 | 125,00$ |
Orchid Cellmark Inc. (ORCH) - Financial and Strategic SWOT Analysis ReviewOrchid Cellmark Inc. (ORCH) - Financial and Strategic SWOT Analysis Review / / Summary / / Orchid Cellmark Inc. (Orchid Cellmark |
2011 | 125,00$ |
Mondobiotech Holding AG (RARE) - Financial and Strategic SWOT Analysis ReviewMondobiotech Holding AG (RARE) - Financial and Strategic SWOT Analysis Review / / Summary / / Mondobiotech Holding AG (Mondobiot |
2011 | 125,00$ |
Zhejiang Hisun Pharmaceutical Co. Ltd. (600267) - Financial and Strategic SWOT Analysis ReviewZhejiang Hisun Pharmaceutical Co. Ltd. (600267) - Financial and Strategic SWOT Analysis Review / / Summary / / Zhejiang Hisun Ph |
2011 | 125,00$ |
BPH Energy Limited (BPH) - Financial and Strategic SWOT Analysis ReviewBPH Energy Limited (BPH) - Financial and Strategic SWOT Analysis Review / / Summary / / BPH Energy Limited (BPH), formerly BPH C |
2011 | 250,00$ |
SMS Pharmaceuticals Ltd. (SMSPHARMA) - Financial and Strategic SWOT Analysis ReviewSMS Pharmaceuticals Ltd. (SMSPHARMA) - Financial and Strategic SWOT Analysis Review / / Summary / / SMS Pharmaceuticals Ltd. (SM |
2011 | 250,00$ |
Sinopharm Group Co. Ltd. (1099) - Financial and Strategic SWOT Analysis ReviewSinopharm Group Co. Ltd. (1099) - Financial and Strategic SWOT Analysis Review / / Summary / / Sinopharm Group Co. Ltd. (Sinopha |
2011 | 125,00$ |
Amil Participacoes S.A. (AMIL3) - Financial and Strategic SWOT Analysis ReviewAmil Participacoes S.A. (AMIL3) - Financial and Strategic SWOT Analysis Review / / Summary / / Amil Participacoes S.A. (Amil Par |
2011 | 125,00$ |
RegenoCELL Therapeutics, Inc. (RCLL) - Financial and Strategic SWOT Analysis ReviewRegenoCELL Therapeutics, Inc. (RCLL) - Financial and Strategic SWOT Analysis Review / / Summary / / RegenoCELL Therapeutics, Inc |
2011 | 125,00$ |
Mycenax Biotech Inc. (4726) - Financial and Strategic SWOT Analysis ReviewMycenax Biotech Inc. (4726) - Financial and Strategic SWOT Analysis Review / / Summary / / Mycenax Biotech Inc. (Mycenax) is a b |
2011 | 125,00$ |
Fibrocell Sciences, Inc. (ILEIQ) - Financial and Strategic SWOT Analysis ReviewFibrocell Sciences, Inc. (ILEIQ) - Financial and Strategic SWOT Analysis Review / / Summary / / Fibrocell Sciences, Inc. (Fibroc |
2011 | 125,00$ |
EUGENE SCIENCE, INC. (EUSI) - Strategic SWOT Analysis ReviewEUGENE SCIENCE, INC. (EUSI) - Strategic SWOT Analysis Review / / Summary / / Eugene Science, Inc. (Eugene) is a biotechnology co |
2011 | 125,00$ |
Hexima Limited - Strategic SWOT Analysis ReviewHexima Limited - Strategic SWOT Analysis Review / / Summary / / Hexima Limited (Hexima) is an Australia-based ag-biotech company |
2011 | 125,00$ |
Blue Cross and Blue Shield Association - Strategic SWOT Analysis ReviewBlue Cross and Blue Shield Association - Strategic SWOT Analysis Review / / Summary / / Blue Cross and Blue Shield Association ( |
2011 | 125,00$ |
Stiefel Laboratories, Inc. - Strategic SWOT Analysis ReviewStiefel Laboratories, Inc. - Strategic SWOT Analysis Review / / Summary / / Stiefel Laboratories, Inc. (Stiefel Laboratories) is |
2011 | 125,00$ |
Henry Ford Health System - Strategic SWOT Analysis ReviewHenry Ford Health System - Strategic SWOT Analysis Review / / Summary / / Henry Ford Health System (HFHS) is one of the leading |
2011 | 125,00$ |
Epic Systems Corporation - Strategic SWOT Analysis ReviewEpic Systems Corporation - Strategic SWOT Analysis Review / / Summary / / Epic Systems Corporation (Epic) is a privately held he |
2011 | 125,00$ |
Chiesi Farmaceutici SpA - Strategic SWOT Analysis ReviewChiesi Farmaceutici SpA - Strategic SWOT Analysis Review / / Summary / / Chiesi Farmaceutici SpA (Chiesi) is a European pharmace |
2011 | 250,00$ |
ESTEVE - Strategic SWOT Analysis ReviewESTEVE - Strategic SWOT Analysis Review / / Summary / / ESTEVE engages in the manufacture of pharmaceutical products. The compan |
2011 | 125,00$ |
Galderma S.A. - Strategic SWOT Analysis ReviewGalderma S.A. - Strategic SWOT Analysis Review / / Summary / / Galderma S.A. (Galderma) is one of the leading dermatology compan |
2011 | 125,00$ |
General Nutrition Centers, Inc. - Strategic SWOT Analysis ReviewGeneral Nutrition Centers, Inc. - Strategic SWOT Analysis Review / / Summary / / General Nutrition Centers, Inc. (GNC) is a spec |
2011 | 125,00$ |
Health Care Service Corporation - Strategic SWOT Analysis ReviewHealth Care Service Corporation - Strategic SWOT Analysis Review / / Summary / / Health Care Service Corporation (HCSC) is a cus |
2011 | 125,00$ |
Laboratoires Urgo - Strategic SWOT Analysis ReviewLaboratoires Urgo - Strategic SWOT Analysis Review / / Summary / / Laboratoires Urgo (Urgo Laboratoires) specializes in wound dr |
2011 | 125,00$ |
Nuffield Health - Strategic SWOT Analysis ReviewNuffield Health - Strategic SWOT Analysis Review / / Summary / / Nuffield Health (Nuffield) is a non-profit organization engaged |
2011 | 125,00$ |
Ingenix - Strategic SWOT Analysis ReviewIngenix - Strategic SWOT Analysis Review / / Summary / / Ingenix, Inc.(Ingenix), also known by OptumInsight is a health care da |
2011 | 125,00$ |
SCIOinspire Corp. - Strategic SWOT Analysis ReviewSCIOinspire Corp. - Strategic SWOT Analysis Review / / Summary / / SCIOinspire Corp. (SCIOinspire) is a healthcare technology se |
2011 | 125,00$ |
Ecron Acunova - Strategic SWOT Analysis ReviewEcron Acunova - Strategic SWOT Analysis Review / / Summary / / Ecron Acunova (EA) is a full-service expert contract service orga |
2011 | 125,00$ |
AccentCare, Inc. - Strategic SWOT Analysis ReviewAccentCare, Inc. - Strategic SWOT Analysis Review / / Summary / / AccentCare, Inc. (AccentCare) is a healthcare service company |
2011 | 125,00$ |
Stemgent, Inc. - Strategic SWOT Analysis ReviewStemgent, Inc. - Strategic SWOT Analysis Review / / Summary / / Stemgent, Inc. (Stemgent) is a stem cell research company which |
2011 | 125,00$ |
Aurora Health Care, Inc. - Strategic SWOT Analysis ReviewAurora Health Care, Inc. - Strategic SWOT Analysis Review / / Summary / / Aurora Health Care, Inc. (AHC) is a not-for-profit hea |
2011 | 250,00$ |
AIM Health Group Inc. (AHG) - Strategic SWOT Analysis ReviewAIM Health Group Inc. (AHG) - Strategic SWOT Analysis Review / / Summary / / AIM Health Group Inc. (AIM), formerly Orior Technol |
2011 | 125,00$ |
NaviNet, Inc. - Strategic SWOT Analysis ReviewNaviNet, Inc. - Strategic SWOT Analysis Review / / Summary / / NaviNet, Inc. (NaviNet) is a real-time healthcare communications |
2011 | 125,00$ |
OptumHealth, Inc. - Strategic SWOT Analysis ReviewOptumHealth, Inc. - Strategic SWOT Analysis Review / / Summary / / OptumHealth, Inc. (OptumHealth) is a health, wealth and finan |
2011 | 125,00$ |
American Academy of Ophthalmology (AAO) 2011 Annual Meeting - Review and AnalysisIntroduction / / GlobalData’s report, “American Academy of Ophthalmology (AAO) 2011 Annual Meeting - Review and Analysis” provide |
2011 | 1.000,00$ |
Transcatheter Cardiovascular Therapeutics (TCT) Conference 2011 - Review and AnalysisIntroduction / / GlobalData’s report, “Transcatheter Cardiovascular Therapeutics (TCT) Conference 2011 - Review and Analysis” pro |
2011 | 1.000,00$ |
Zimmer Acquires ExtraOrtho - To Increase Focus on the Non-Elective Trauma Business - Deal Analysis from GlobalDataIntroduction / / GlobalData’s report, “Zimmer Acquires ExtraOrtho - To Increase Focus on the Non-Elective Trauma Business” provid |
2011 | 500,00$ |
Samsung Electronics Acquires Nexus Division of ITC - A Move to Strengthen its Presence in the Medical Device Industry - Deal Analysis from GlobalDataIntroduction / / GlobalData’s report “Samsung Electronics Acquires Nexus Division of ITC - A Move to Strengthen its Presence in t |
2011 | 500,00$ |
Mammography Equipment Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017Introduction / / GlobalData’s new report, “Mammography Equipment Market Outlook in BRICS (Brazil, Russia, India, China, South Afr |
2011 | 2.500,00$ |
Nuclear Imaging Equipment Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017Introduction / / GlobalData’s new report, “Nuclear Imaging Equipment Market Outlook in BRICS (Brazil, Russia, India, China, South |
2011 | 2.500,00$ |
X-Ray Systems Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017Introduction / / GlobalData’s new report, “X-Ray Systems Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to |
2011 | 2.500,00$ |
Renal Dialysis Services - Global Opportunity Assessment, Competitive Landscape and Market Forecasts to 2017Introduction / / GlobalData’s new report, “Renal Dialysis Services - Global Opportunity Assessment, Competitive Landscape and Mar |
2011 | 3.500,00$ |
Middle East and Africa Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and OthersIntroduction / / GlobalData’s new report, “Middle East and Africa Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, |
2011 | 3.500,00$ |
South and Central America Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and OthersIntroduction / / GlobalData’s new report, “South and Central America Diagnostic Imaging Market Outlook to 2017 - Ultrasound Syste |
2011 | 3.500,00$ |
North America Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparameter Patient Monitoring, Neonatal Monitors, Non-Invasive Blood Pressure Monitors, Remote Patient Monitoring and OthersIntroduction / / GlobalData’s new report, “North America Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparamet |
2011 | 3.500,00$ |
Europe Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparameter Patient Monitoring, Neonatal Monitors, Non-Invasive Blood Pressure Monitors, Remote Patient Monitoring and OthersIntroduction / / GlobalData’s new report, “Europe Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparameter Pati |
2011 | 3.500,00$ |
Asia-Pacific Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparameter Patient Monitoring, Neonatal Monitors, Non-Invasive Blood Pressure Monitors, Remote Patient Monitoring and OthersIntroduction / / GlobalData’s new report, “Asia-Pacific Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparamete |
2011 | 3.500,00$ |
Craniomaxillofacial (CMF) Fixators - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017Introduction / / GlobalData’s new report, “Craniomaxillofacial (CMF) Fixators - Global Pipeline Analysis, Competitive Landscape a |
2011 | 3.500,00$ |
Middle East and Africa Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparameter Patient Monitoring, Neonatal Monitors, Non-Invasive Blood Pressure Monitors, Remote Patient Monitoring and OthersIntroduction / / GlobalData’s new report, “Middle East and Africa Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Mul |
2011 | 3.500,00$ |
South and Central America Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparameter Patient Monitoring, Neonatal Monitors, Non-Invasive Blood Pressure Monitors, Remote Patient Monitoring and OthersIntroduction / / GlobalData’s new report, “South and Central America Patient Monitoring Market Outlook to 2017 - Fetal Monitors, |
2011 | 3.500,00$ |
External Defibrillators - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017Introduction / / GlobalData’s new report, “External Defibrillators - Global Pipeline Analysis, Competitive Landscape and Market F |
2011 | 3.500,00$ |
Drug Eluting Balloons (DEB) - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017Introduction / / GlobalData’s new report, “Drug Eluting Balloons (DEB) - Global Pipeline Analysis, Competitive Landscape and Mark |
2011 | 3.500,00$ |
Computed Tomography (CT) Systems - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017Introduction / / GlobalData’s new report, “Computed Tomography (CT) Systems - Global Pipeline Analysis, Competitive Landscape and |
2011 | 3.500,00$ |
Insulin Pumps - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017Introduction / / GlobalData’s new report, “Insulin Pumps - Global Pipeline Analysis, Competitive Landscape and Market Forecasts t |
2011 | 3.500,00$ |
Canada Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparameter Patient Monitoring, Neonatal Monitors, Non-Invasive Blood Pressure Monitors, Remote Patient Monitoring and OthersIntroduction / / GlobalData’s new report, “Canada Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparameter Pati |
2011 | 2.500,00$ |
Netherlands Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparameter Patient Monitoring, Neonatal Monitors, Non-Invasive Blood Pressure Monitors, Remote Patient Monitoring and OthersIntroduction / / GlobalData’s new report, “Netherlands Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparameter |
2011 | 2.500,00$ |
Mexico Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparameter Patient Monitoring, Neonatal Monitors, Non-Invasive Blood Pressure Monitors, Remote Patient Monitoring and OthersIntroduction / / GlobalData’s new report, “Mexico Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparameter Pati |
2011 | 2.500,00$ |
Israel Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparameter Patient Monitoring, Neonatal Monitors, Non-Invasive Blood Pressure Monitors, Remote Patient Monitoring and OthersIntroduction / / GlobalData’s new report, “Israel Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparameter Pati |
2011 | 2.500,00$ |
United Kingdom Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparameter Patient Monitoring, Neonatal Monitors, Non-Invasive Blood Pressure Monitors, Remote Patient Monitoring and OthersIntroduction / / GlobalData’s new report, “United Kingdom Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparame |
2011 | 2.500,00$ |
United States Anesthesia and Respiratory Devices Market Outlook to 2017 - Respiratory Devices, Respiratory Measurement Devices, Airway and Anesthesia Devices, Anesthesia Machines, Sleep Apnea Diagnostic Systems, Pain Management Devices and OthersIntroduction / / GlobalData’s new report, “United States Anesthesia and Respiratory Devices Market Outlook to 2017 - Respiratory |
2011 | 2.500,00$ |
United Kingdom Anesthesia and Respiratory Devices Market Outlook to 2017- Respiratory Devices, Respiratory Measurement Devices, Airway and Anesthesia Devices, Anesthesia Machines, Sleep Apnea Diagnostic Systems, Pain Management Devices and OthersIntroduction / / GlobalData’s new report, “United Kingdom Anesthesia and Respiratory Devices Market Outlook to 2017- Respiratory |
2011 | 2.500,00$ |
Japan Anesthesia and Respiratory Devices Market Outlook to 2017- Respiratory Devices, Respiratory Measurement Devices, Airway and Anesthesia Devices, Anesthesia Machines, Sleep Apnea Diagnostic Systems, Pain Management Devices and OthersIntroduction / / GlobalData’s new report, “Japan Anesthesia and Respiratory Devices Market Outlook to 2017- Respiratory Devices, |
2011 | 2.500,00$ |
China Anesthesia and Respiratory Devices Market Outlook to 2017 - Respiratory Devices, Respiratory Measurement Devices, Airway and Anesthesia Devices, Anesthesia Machines, Sleep Apnea Diagnostic Systems, Pain Management Devices and OthersIntroduction / / GlobalData’s new report, “China Anesthesia and Respiratory Devices Market Outlook to 2017 - Respiratory Devices, |
2011 | 2.500,00$ |
Canada Anesthesia and Respiratory Devices Market Outlook to 2017 - Respiratory Devices, Respiratory Measurement Devices, Airway and Anesthesia Devices, Anesthesia Machines, Sleep Apnea Diagnostic Systems, Pain Management Devices and OthersIntroduction / / GlobalData’s new report, “Canada Anesthesia and Respiratory Devices Market Outlook to 2017 - Respiratory Devices |
2011 | 2.500,00$ |
Germany Anesthesia and Respiratory Devices Market Outlook to 2017- Respiratory Devices, Respiratory Measurement Devices, Airway and Anesthesia Devices, Anesthesia Machines, Sleep Apnea Diagnostic Systems, Pain Management Devices and OthersIntroduction / / GlobalData’s new report, “Germany Anesthesia and Respiratory Devices Market Outlook to 2017- Respiratory Devices |
2011 | 2.500,00$ |
Spain Anesthesia and Respiratory Devices Market Outlook to 2017 - Respiratory Devices, Respiratory Measurement Devices, Airway and Anesthesia Devices, Anesthesia Machines, Sleep Apnea Diagnostic Systems, Pain Management Devices and OthersIntroduction / / GlobalData’s new report, “Spain Anesthesia and Respiratory Devices Market Outlook to 2017 - Respiratory Devices, |
2011 | 2.500,00$ |
Australia Anesthesia and Respiratory Devices Market Outlook to 2017 - Respiratory Devices, Respiratory Measurement Devices, Airway and Anesthesia Devices, Anesthesia Machines, Sleep Apnea Diagnostic Systems, Pain Management Devices and OthersIntroduction / / GlobalData’s new report, “Australia Anesthesia and Respiratory Devices Market Outlook to 2017 - Respiratory Devi |
2011 | 2.500,00$ |
Netherlands Anesthesia and Respiratory Devices Market Outlook to 2017- Respiratory Devices, Respiratory Measurement Devices, Airway and Anesthesia Devices, Anesthesia Machines, Sleep Apnea Diagnostic Systems, Pain Management Devices and OthersIntroduction / / GlobalData’s new report, “Netherlands Anesthesia and Respiratory Devices Market Outlook to 2017- Respiratory Dev |
2011 | 2.500,00$ |
Belgium Anesthesia and Respiratory Devices Market Outlook to 2017 - Respiratory Devices, Respiratory Measurement Devices, Airway and Anesthesia Devices, Anesthesia Machines, Sleep Apnea Diagnostic Systems, Pain Management Devices and OthersIntroduction / / GlobalData’s new report, “Belgium Anesthesia and Respiratory Devices Market Outlook to 2017 - Respiratory Device |
2011 | 2.500,00$ |
Austria Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparameter Patient Monitoring, Neonatal Monitors, Non-Invasive Blood Pressure Monitors, Remote Patient Monitoring and OthersIntroduction / / GlobalData’s new report, “Austria Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparameter Pat |
2011 | 2.500,00$ |
Russian Federation Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparameter Patient Monitoring, Neonatal Monitors, Non-Invasive Blood Pressure Monitors, Remote Patient Monitoring and OthersIntroduction / / GlobalData’s new report, “Russian Federation Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multipa |
2011 | 2.500,00$ |
New Zealand Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparameter Patient Monitoring, Neonatal Monitors, Non-Invasive Blood Pressure Monitors, Remote Patient Monitoring and OthersIntroduction / / GlobalData’s new report, “New Zealand Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparameter |
2011 | 2.500,00$ |
Denmark Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparameter Patient Monitoring, Neonatal Monitors, Non-Invasive Blood Pressure Monitors, Remote Patient Monitoring and OthersIntroduction / / GlobalData’s new report, “Denmark Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparameter Pat |
2011 | 2.500,00$ |
Saudi Arabia Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparameter Patient Monitoring, Neonatal Monitors, Non-Invasive Blood Pressure Monitors, Remote Patient Monitoring and OthersIntroduction / / GlobalData’s new report, “Saudi Arabia Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparamete |
2011 | 2.500,00$ |
Portable/Disposable Negative Pressure Wound Therapy (NPWT) Systems - A Market SnapshotIntroduction / / GlobalData’s report, “Portable/Disposable Negative Pressure Wound Therapy (NPWT) Systems - A Market Snapshot” pr |
2011 | 500,00$ |
Russian Federation Anesthesia and Respiratory Devices Market Outlook to 2017 - Respiratory Devices, Respiratory Measurement Devices, Airway and Anesthesia Devices, Anesthesia Machines, Sleep Apnea Diagnostic Systems, Pain Management Devices and OthersIntroduction / / GlobalData’s new report, “Russian Federation Anesthesia and Respiratory Devices Market Outlook to 2017 - Respira |
2011 | 2.500,00$ |
Denmark Anesthesia and Respiratory Devices Market Outlook to 2017 - Respiratory Devices, Respiratory Measurement Devices, Airway and Anesthesia Devices, Anesthesia Machines, Sleep Apnea Diagnostic Systems, Pain Management Devices and OthersIntroduction / / GlobalData’s new report, “Denmark Anesthesia and Respiratory Devices Market Outlook to 2017 - Respiratory Device |
2011 | 2.500,00$ |
Tuberculosis Infection - Pipeline Assessment and Market Forecasts to 2018Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Tuberculosis Infection - Pipeline As |
2011 | 3.500,00$ |
Muscular Dystrophy (MD) Therapeutics - Pipeline Assessment and Market Forecasts to 2018Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Muscular Dystrophy (MD) Therapeutics |
2011 | 3.500,00$ |
Insomnia Therapeutics - Pipeline Assessment and Market Forecasts to 2018Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Insomnia Therapeutics - Pipeline Ass |
2011 | 3.500,00$ |
Brain Hemorrhage Therapeutics - Pipeline Assessment and Market Forecasts to 2018Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Brain Hemorrhage Therapeutics - Pipe |
2011 | 3.500,00$ |
Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics - Pipeline Assessment and Market Forecasts to 2018Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Attention Deficit Hyperactivity Diso |
2011 | 3.500,00$ |
Cross-Border M&A Activity In Pharmaceutical & Healthcare Industry - Q3 2011Introduction / / GlobalData's “Cross-Border M&A Activity In Pharmaceutical & Healthcare Industry - Q3 2011” report is an essentia |
2011 | 500,00$ |
Licensing Activity In Pharmaceutical & Healthcare Industry - Q3 2011Introduction / / GlobalData's “Licensing Activity In Pharmaceutical & Healthcare Industry - Q3 2011” report is an essential sourc |
2011 | 500,00$ |
Gilead to Acquire Pharmasset for $11 Billion - Deal Analysis from GlobalDataIntroduction / / GlobalData, the industry analysis specialist, has released its new report, “Gilead to Acquire Pharmasset for $11 |
2011 | 500,00$ |
Abbott Laboratories Likely to Reap Benefits from Strategic Split - Deal Analysis from GlobalDataIntroduction / / GlobalData, the industry analysis specialist, has released its new report, “Abbott Laboratories Likely to Reap B |
2011 | 500,00$ |
Novartis’s Zelnorm Suspension - Impact On The Irritable Bowel Syndrome (IBS) Treatment LandscapeIntroduction / / GlobalData, the industry analysis specialist, has released its new report, “Novartis’s Zelnorm Suspension - Impa |
2011 | 500,00$ |
Irritable Bowel Syndrome Epidemiology by Sub-Type in G7 CountriesIntroduction / / GlobalData, the industry analysis specialist, has released its new report, “Irritable Bowel Syndrome Epidemiolog |
2011 | 500,00$ |
Personalized Medicine for CancerIntroduction / / GlobalData, the industry analysis specialist, has released its new view point, “Personalized Medicine for Cancer |
2011 | 500,00$ |
Biologics Price Competition and Innovation (BPCI) Act - Industry Trends Creating Demand for BiosimilarsIntroduction / / GlobalData, the industry analysis specialist, has released its new report, “Biologics Price Competition and Inno |
2011 | 500,00$ |
FDA Reforms Fuel the Biotech Industry GrowthIntroduction / / GlobalData, the industry analysis specialist, has released its new report, “FDA Reforms Fuel the Biotech Industr |
2011 | 500,00$ |
Sarcomas and their SubtypesIntroduction / / GlobalData, the industry analysis specialist, has released its new view point, “Sarcomas and their Subtypes”. Th |
2011 | 500,00$ |
Provenge fails to Live up to Dendreon’s ExpectationsIntroduction / / GlobalData, the industry analysis specialist, has released its new report, “Provenge fails to Live up to Dendreo |
2011 | 500,00$ |
MDV3100 Raises Hopes for MedivationIntroduction / / GlobalData, the industry analysis specialist, has released its new report, “MDV3100 Raises Hopes for Medivation” |
2011 | 500,00$ |
Jakafi (ruxolitinib) Gains US FDA Approval to Become the First Drug Ever to be Approved for MyelofibrosisIntroduction / / GlobalData, the industry analysis specialist, has released its new report, “Jakafi (ruxolitinib) Gains US FDA Ap |
2011 | 500,00$ |
Future Technology Trends and Upcoming Players in Hemophilia Therapeutics MarketIntroduction / / GlobalData, the industry analysis specialist, has released its new report, “Future Technology Trends and Upcomin |
2011 | 500,00$ |
Celiac Disease - Pipeline Assessment and Market Forecasts to 2019Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Celiac Disease - Pipeline Assessment |
2011 | 3.500,00$ |
Lennox-Gastaut Syndrome (LGS) Therapeutics - Pipeline Assessment and Market Forecasts to 2018Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Lennox-Gastaut Syndrome (LGS) Therap |
2011 | 3.500,00$ |
Erectile Dysfunction Therapeutics - Pipeline Assessment and Market Forecasts to 2018Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Erectile Dysfunction Therapeutics - |
2011 | 3.500,00$ |
Chemotherapy-Induced Neutropenia (CIN) Therapeutics -Pipeline Assessment and Market Forecasts to 2018Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Chemotherapy-Induced Neutropenia (CI |
2011 | 3.500,00$ |
Peripheral Artery Disease (PAD) Therapeutics - Pipeline Assessment and Market Forecasts to 2018Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Peripheral Artery Disease (PAD) Ther |
2011 | 3.500,00$ |
Gastrointestinal Bleeding Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Gastrointestinal Bleeding Global Clinical Trials Review, H2, 2011" provides |
2011 | 1.000,00$ |
Aortic Valve Stenosis Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Aortic Valve Stenosis Global Clinical Trials Review, H2, 2011" provides dat |
2011 | 1.000,00$ |
Asperger Syndrome Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Asperger Syndrome Global Clinical Trials Review, H2, 2011" provides data on |
2011 | 1.000,00$ |
Burkitt Lymphoma Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Burkitt Lymphoma Global Clinical Trials Review, H2, 2011" provides data on |
2011 | 1.000,00$ |
Chronic Kidney Disease (Chronic Renal Failure) Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Chronic Kidney Disease (Chronic Renal Failure) Global Clinical Trials Revie |
2011 | 1.000,00$ |
Diastolic Heart Failure Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Diastolic Heart Failure Global Clinical Trials Review, H2, 2011" provides d |
2011 | 1.000,00$ |
Duodenal Ulcer Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Duodenal Ulcer Global Clinical Trials Review, H2, 2011" provides data on th |
2011 | 1.000,00$ |
Enterovirus Infections Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Enterovirus Infections Global Clinical Trials Review, H2, 2011" provides da |
2011 | 1.000,00$ |
Epidermolysis Bullosa Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Epidermolysis Bullosa Global Clinical Trials Review, H2, 2011" provides dat |
2011 | 1.000,00$ |
Filariasis Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Filariasis Global Clinical Trials Review, H2, 2011" provides data on the Fi |
2011 | 1.000,00$ |
Fungemia Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Fungemia Global Clinical Trials Review, H2, 2011" provides data on the Fung |
2011 | 1.000,00$ |
Glioblastoma Multiforme (GBM) Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Glioblastoma Multiforme (GBM) Global Clinical Trials Review, H2, 2011" prov |
2011 | 1.000,00$ |
Hyponatremia Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Nutritional Disorders Global Clinical Trials Review, H2, 2011" provides dat |
2011 | 1.000,00$ |
Idiopathic Pulmonary Fibrosis Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Idiopathic Pulmonary Fibrosis Global Clinical Trials Review, H2, 2011" prov |
2011 | 1.000,00$ |
Joint Pain Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Joint Pain Global Clinical Trials Review, H2, 2011" provides data on the Jo |
2011 | 1.000,00$ |
Keratitis Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Keratitis Global Clinical Trials Review, H2, 2011" provides data on the Ker |
2011 | 1.000,00$ |
Circadian Rhythm Sleep Disorders Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Circadian Rhythm Global Clinical Trials Review, H2, 2011" provides data on |
2011 | 1.000,00$ |
Lymphedema Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Lymphedema Global Clinical Trials Review, H2, 2011" provides data on the Ly |
2011 | 1.000,00$ |
Pompe Disease Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Pompe Disease Global Clinical Trials Review, H2, 2011" provides data on the |
2011 | 1.000,00$ |
Renal Pain Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Renal Pain Global Clinical Trials Review, H2, 2011" provides data on the Re |
2011 | 1.000,00$ |
Respiratory Insufficiency Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Respiratory Insufficiency Global Clinical Trials Review, H2, 2011" provides |
2011 | 1.000,00$ |
Type 1 Diabetes (Juvenile Diabetes) Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Type 1 Diabetes (Juvenile Diabetes) Global Clinical Trials Review, H2, 2011 |
2011 | 1.000,00$ |
Uterine Cancer Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Uterine Cancer Global Clinical Trials Review, H2, 2011" provides data on th |
2011 | 1.000,00$ |
Vaginal Cancer Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Vaginal Cancer Global Clinical Trials Review, H2, 2011" provides data on th |
2011 | 1.000,00$ |
Von Willebrand Disease Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Von Willebrand Disease Global Clinical Trials Review, H2, 2011" provides da |
2011 | 1.000,00$ |
West Nile Virus Infections Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “West Nile Virus Infections Global Clinical Trials Review, H2, 2011" provide |
2011 | 1.000,00$ |
Xerostomia Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Xerostomia Global Clinical Trials Review, H2, 2011" provides data on the Xe |
2011 | 1.000,00$ |
Anal Fissure Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Anal Fissure Global Clinical Trials Review, H2, 2011" provides data on the |
2011 | 1.000,00$ |
Blepharitis Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Blepharitis Global Clinical Trials Review, H2, 2011" provides data on the B |
2011 | 1.000,00$ |
Coronary Arteriosclerosis Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Coronary Arteriosclerosis Global Clinical Trials Review, H2, 2011" provides |
2011 | 1.000,00$ |
Cytomegalovirus (CMV) Retinitis Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Cytomegalovirus (CMV) Retinitis Global Clinical Trials Review, H2, 2011" pr |
2011 | 1.000,00$ |
Focal Segmental Glomerulosclerosis (FSGS) Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Focal Segmental Glomerulosclerosis (FSGS) Global Clinical Trials Review, H2 |
2011 | 1.000,00$ |
Gastric Cancer Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Gastric Cancer Global Clinical Trials Review, H2, 2011" provides data on th |
2011 | 1.000,00$ |
Hyperthyroidism Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Hyperthyroidism Global Clinical Trials Review, H2, 2011" provides data on t |
2011 | 1.000,00$ |
Thalassemia Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Thalassemia Global Clinical Trials Review, H2, 2011" provides data on the T |
2011 | 1.000,00$ |
Chlamydia Infections Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Chlamydia Infections Global Clinical Trials Review, H2, 2011" provides data |
2011 | 1.000,00$ |
Hemiplegia Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Hemiplegia Global Clinical Trials Review, H2, 2011" provides data on the He |
2011 | 1.000,00$ |
Pulmonary Edema Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Pulmonary Edema Global Clinical Trials Review, H2, 2011" provides data on t |
2011 | 1.000,00$ |
Streptococcal Infections Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Streptococcal Infections Global Clinical Trials Review, H2, 2011" provides |
2011 | 1.000,00$ |
Hyperuricemia Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Hyperuricemia Global Clinical Trials Review, H2, 2011" provides data on the |
2011 | 1.000,00$ |
Tuberous Sclerosis Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Tuberous Sclerosis Global Clinical Trials Review, H2, 2011" provides data o |
2011 | 1.000,00$ |
Biliary Cirrhosis Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Biliary Cirrhosis Global Clinical Trials Review, H2, 2011" provides data on |
2011 | 1.000,00$ |
Mucositis Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Mucositis Global Clinical Trials Review, H2, 2011" provides data on the Muc |
2011 | 1.000,00$ |
Osteomyelitis Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Osteomyelitis Global Clinical Trials Review, H2, 2011" provides data on the |
2011 | 1.000,00$ |
Nasal Polyps Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Nasal Polyps Global Clinical Trials Review, H2, 2011" provides data on the |
2011 | 1.000,00$ |
Paralysis Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Paralysis Global Clinical Trials Review, H2, 2011" provides data on the Par |
2011 | 1.000,00$ |
Schistosomiasis Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Schistosomiasis Global Clinical Trials Review, H2, 2011" provides data on t |
2011 | 1.000,00$ |
Seborrhea Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Seborrhea Global Clinical Trials Review, H2, 2011" provides data on the Seb |
2011 | 1.000,00$ |
Syphilis Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Syphilis Global Clinical Trials Review, H2, 2011" provides data on the Syph |
2011 | 1.000,00$ |
Thymus Cancer Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Thymus Cancer Global Clinical Trials Review, H2, 2011" provides data on the |
2011 | 1.000,00$ |
Bacteriuria Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Bacteriuria Global Clinical Trials Review, H2, 2011" provides data on the B |
2011 | 1.000,00$ |
Typhoid Fever Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Typhoid Fever Global Clinical Trials Review, H2, 2011" provides data on the |
2011 | 1.000,00$ |
Rabies Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Rabies Global Clinical Trials Review, H2, 2011" provides data on the Rabies |
2011 | 1.000,00$ |
Cerebral Hypoxia Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Cerebral Hypoxia Global Clinical Trials Review, H2, 2011" provides data on |
2011 | 1.000,00$ |
Angioedema Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Angioedema Global Clinical Trials Review, H2, 2011" provides data on the An |
2011 | 1.000,00$ |
Sleep Disorders Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Sleep Disorders Global Clinical Trials Review, H2, 2011" provides data on t |
2011 | 1.000,00$ |
Sleep Apnea Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Sleep Apnea Global Clinical Trials Review, H2, 2011" provides data on the S |
2011 | 1.000,00$ |
Apnea Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Apnea Global Clinical Trials Review, H2, 2011" provides data on the Apnea c |
2011 | 1.000,00$ |
Multiple Myeloma Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Multiple Myeloma Global Clinical Trials Review, H2, 2011" provides data on |
2011 | 1.000,00$ |
Liver Cancer Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Liver Cancer Global Clinical Trials Review, H2, 2011" provides data on the |
2011 | 1.000,00$ |
Venous Thromboembolism Therapeutics - Pipeline Assessment and Market Forecasts to 2018Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Venous Thromboembolism Therapeutics |
2011 | 3.500,00$ |
Myocardial Infarction Therapeutics - Pipeline Assessment and Market Forecasts to 2018Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Myocardial Infarction Therapeutics - |
2011 | 3.500,00$ |
Gaucher's Disease Therapeutics - Pipeline Assessment and Market Forecasts to 2018Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Gaucher's Disease Therapeutics - Pip |
2011 | 3.500,00$ |
Peptic Ulcer Therapeutics - Pipeline Assessment and Market Forecasts to 2018Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Peptic Ulcer Therapeutics - Pipeline |
2011 | 3.500,00$ |
Fabry's Disease Therapeutics - Pipeline Assessment and Market Forecasts to 2018Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Fabry's Disease Therapeutics - Pipel |
2011 | 3.500,00$ |
Unstable Angina Therapeutics - Pipeline Assessment and Market Forecasts to 2018Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Unstable Angina Therapeutics - Pipel |
2011 | 3.500,00$ |
Germany Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparameter Patient Monitoring, Neonatal Monitors, Non-Invasive Blood Pressure Monitors, Remote Patient Monitoring and OthersIntroduction / / GlobalData’s new report, “Germany Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparameter Pat |
2011 | 2.500,00$ |
France Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparameter Patient Monitoring, Neonatal Monitors, Non-Invasive Blood Pressure Monitors, Remote Patient Monitoring and OthersIntroduction / / GlobalData’s new report, “France Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparameter Pati |
2011 | 2.500,00$ |
Italy Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparameter Patient Monitoring, Neonatal Monitors, Non-Invasive Blood Pressure Monitors, Remote Patient Monitoring and OthersIntroduction / / GlobalData’s new report, “Italy Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparameter Patie |
2011 | 2.500,00$ |
Spain Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparameter Patient Monitoring, Neonatal Monitors, Non-Invasive Blood Pressure Monitors, Remote Patient Monitoring and OthersIntroduction / / GlobalData’s new report, “Spain Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparameter Patie |
2011 | 2.500,00$ |
Australia Patient Monitoring Market Outlook to 2017 – Fetal Monitors, Multiparameter Patient Monitoring, Neonatal Monitors, Non-Invasive Blood Pressure Monitors, Remote Patient Monitoring and OthersIntroduction / / GlobalData’s new report, “Australia Patient Monitoring Market Outlook to 2017 – Fetal Monitors, Multiparameter P |
2011 | 2.500,00$ |
Brazil Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparameter Patient Monitoring, Neonatal Monitors, Non-Invasive Blood Pressure Monitors, Remote Patient Monitoring and OthersIntroduction / / GlobalData’s new report, “Brazil Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparameter Pati |
2011 | 2.500,00$ |
Belgium Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparameter Patient Monitoring, Neonatal Monitors, Non-Invasive Blood Pressure Monitors, Remote Patient Monitoring and OthersIntroduction / / GlobalData’s new report, “Belgium Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparameter Pat |
2011 | 2.500,00$ |
Argentina Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparameter Patient Monitoring, Neonatal Monitors, Non-Invasive Blood Pressure Monitors, Remote Patient Monitoring and OthersIntroduction / / GlobalData’s new report, “Argentina Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparameter P |
2011 | 2.500,00$ |
Republic of Korea Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparameter Patient Monitoring, Neonatal Monitors, Non-Invasive Blood Pressure Monitors, Remote Patient Monitoring and OthersIntroduction / / GlobalData’s new report, “Republic of Korea Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multipar |
2011 | 2.500,00$ |
Taiwan Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparameter Patient Monitoring, Neonatal Monitors, Non-Invasive Blood Pressure Monitors, Remote Patient Monitoring and OthersIntroduction / / GlobalData’s new report, “Taiwan Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparameter Pati |
2011 | 2.500,00$ |
South Africa Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparameter Patient Monitoring, Neonatal Monitors, Non-Invasive Blood Pressure Monitors, Remote Patient Monitoring and OthersIntroduction / / GlobalData’s new report, “South Africa Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparamete |
2011 | 2.500,00$ |
Japan Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparameter Patient Monitoring, Neonatal Monitors, Non-Invasive Blood Pressure Monitors, Remote Patient Monitoring and OthersIntroduction / / GlobalData’s new report, “Japan Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparameter Patie |
2011 | 2.500,00$ |
India Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparameter Patient Monitoring, Neonatal Monitors, Non-Invasive Blood Pressure Monitors, Remote Patient Monitoring and OthersIntroduction / / GlobalData’s new report, “India Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparameter Patie |
2011 | 2.500,00$ |
China Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparameter Patient Monitoring, Neonatal Monitors, Non-Invasive Blood Pressure Monitors, Remote Patient Monitoring and OthersIntroduction / / GlobalData’s new report, “China Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparameter Patie |
2011 | 2.500,00$ |
Czech Republic Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparameter Patient Monitoring, Neonatal Monitors, Non-Invasive Blood Pressure Monitors, Remote Patient Monitoring and OthersIntroduction / / GlobalData’s new report, “Czech Republic Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparame |
2011 | 2.500,00$ |
Sweden Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparameter Patient Monitoring, Neonatal Monitors, Non-Invasive Blood Pressure Monitors, Remote Patient Monitoring and OthersIntroduction / / GlobalData’s new report, “Sweden Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparameter Pati |
2011 | 2.500,00$ |
SWOT Review of the Key Orthopedic Device CompaniesIntroduction / / GlobalData’s report, “SWOT Review of the Key Orthopedic Device Companies” provides information and analysis on t |
2011 | 500,00$ |
United States Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparameter Patient Monitoring, Neonatal Monitors, Non-Invasive Blood Pressure Monitors, Remote Patient Monitoring and OthersIntroduction / / GlobalData’s new report, “United States Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparamet |
2011 | 2.500,00$ |
Afinitor (Breast Cancer) – Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “Afinitor (Breast Cancer) – Analysis and Forecasts to 2020” provides Afinit |
2011 | 2.000,00$ |
Cardiovascular Inflammation Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Cardiovascular Inflammation Global Clinical Trials Review, H2, 2011" provid |
2011 | 1.000,00$ |
Abscess Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Abscess Global Clinical Trials Review, H2, 2011" provides data on the Absce |
2011 | 1.000,00$ |
Respiratory Depression Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Respiratory Depression Global Clinical Trials Review, H2, 2011" provides da |
2011 | 1.000,00$ |
Friedreich Ataxia Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Friedreich Ataxia Global Clinical Trials Review, H2, 2011" provides data on |
2011 | 1.000,00$ |
Acute Heart Failure Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Acute Heart Failure Global Clinical Trials Review, H2, 2011" provides data |
2011 | 1.000,00$ |
Vascular Dysfunction Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Vascular Dysfunction Global Clinical Trials Review, H2, 2011" provides data |
2011 | 1.000,00$ |
Sickle Cell Disease Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Sickle Cell Disease Global Clinical Trials Review, H2, 2011" provides data |
2011 | 1.000,00$ |
Hemoglobinuria Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Hemoglobinuria Global Clinical Trials Review, H2, 2011" provides data on th |
2011 | 1.000,00$ |
Osteonecrosis Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Osteonecrosis Global Clinical Trials Review, H2, 2011" provides data on the |
2011 | 1.000,00$ |
Myasthenia Gravis Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Myasthenia Gravis Global Clinical Trials Review, H2, 2011" provides data on |
2011 | 1.000,00$ |
Obstructive Sleep Apnea Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Obstructive Sleep Apnea Global Clinical Trials Review, H2, 2011" provides d |
2011 | 1.000,00$ |
Acute Respiratory Distress Syndrome Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Acute Respiratory Distress Syndrome Global Clinical Trials Review, H2, 2011 |
2011 | 1.000,00$ |
Pulmonary Embolism Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Pulmonary Embolism Global Clinical Trials Review, H2, 2011" provides data o |
2011 | 1.000,00$ |
Type 2 Diabetes Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Type 2 Diabetes Global Clinical Trials Review, H2, 2011" provides data on t |
2011 | 1.000,00$ |
Warts Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Warts Global Clinical Trials Review, H2, 2011" provides data on the Warts c |
2011 | 1.000,00$ |
Cervical Dysplasia Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Cervical Dysplasia Global Clinical Trials Review, H2, 2011" provides data o |
2011 | 1.000,00$ |
Endocarditis Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Endocarditis Global Clinical Trials Review, H2, 2011" provides data on the |
2011 | 1.000,00$ |
Hemophilia Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Hemophilia Global Clinical Trials Review, H2, 2011" provides data on the He |
2011 | 1.000,00$ |
Abdominal Aortic Aneurysms Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Abdominal Aortic Aneurysms Global Clinical Trials Review, H2, 2011" provide |
2011 | 1.000,00$ |
Dilated Cardiomyopathy Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Dilated Cardiomyopathy Global Clinical Trials Review, H2, 2011" provides da |
2011 | 1.000,00$ |
Left Ventricular Hypertrophy Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Left Ventricular Hypertrophy Global Clinical Trials Review, H2, 2011" provi |
2011 | 1.000,00$ |
Respiratory Tract Infections Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Respiratory Tract Infections Global Clinical Trials Review, H2, 2011" provi |
2011 | 1.000,00$ |
Urinary Retention Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Urinary Retention Global Clinical Trials Review, H2, 2011" provides data on |
2011 | 1.000,00$ |
Influenza Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Influenza Global Clinical Trials Review, H2, 2011" provides data on the Inf |
2011 | 1.000,00$ |
Narcolepsy Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Narcolepsy Global Clinical Trials Review, H2, 2011" provides data on the Na |
2011 | 1.000,00$ |
Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - November 2011Introduction / / GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - November 2011” |
2011 | 1.000,00$ |
CorAssist Cardiovascular Ltd. - Product Pipeline AnalysisCorAssist Cardiovascular Ltd. - Product Pipeline Analysis / / Summary / / CorAssist Cardiovascular Ltd. (CorAssist) is principal |
2011 | 750,00$ |
Pathfinder Cell Therapy, Inc. (SYMD) - Product Pipeline AnalysisPathfinder Cell Therapy, Inc. (SYMD) - Product Pipeline Analysis / / Summary / / Pathfinder Cell Therapy, Inc. (Pathfinder Cell |
2011 | 750,00$ |
Diazyme Laboratories - Product Pipeline AnalysisDiazyme Laboratories - Product Pipeline Analysis / / Summary / / Diazyme Laboratories (Diazyme) is a medical device company is p |
2011 | 750,00$ |
Optiscan Imaging Limited (OIL) - Product Pipeline AnalysisOptiscan Imaging Limited (OIL) - Product Pipeline Analysis / / Summary / / Optiscan Imaging Limited (Optiscan Imaging) is a medi |
2011 | 750,00$ |
Predictive Biosciences, Inc. - Product Pipeline AnalysisPredictive Biosciences, Inc. - Product Pipeline Analysis / / Summary / / Predictive Biosciences, Inc. (Predictive Biosciences) i |
2011 | 750,00$ |
A&G Pharmaceutical, Inc. - Product Pipeline AnalysisA&G Pharmaceutical, Inc. - Product Pipeline Analysis / / Summary / / A&G Pharmaceutical, Inc. (A&G) is a provider of personalize |
2011 | 750,00$ |
Exonhit S.A. (ALEHT) - Product Pipeline AnalysisExonhit S.A. (ALEHT) - Product Pipeline Analysis / / Summary / / Exonhit S.A. (Exonhit), formerly ExonHit Therapeutics SA, is a |
2011 | 750,00$ |
MRI Systems - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017Introduction / / GlobalData’s new report, “MRI Systems - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to |
2011 | 3.500,00$ |
Cardiovascular Devices - Emerging Countries (China, India, Brazil) Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017Introduction / / GlobalData’s new report, “Cardiovascular Devices - Emerging Countries (China, India, Brazil) Pipeline Analysis, |
2011 | 3.500,00$ |
Spinal Non-Fusion Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2017Introduction / / GlobalData’s new report, “Spinal Non-Fusion Devices - Global Pipeline Analysis, Opportunity Assessment and Marke |
2011 | 3.500,00$ |
Nuclear Imaging Equipment - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017Introduction / / GlobalData’s new report, “Nuclear Imaging Equipment - Global Pipeline Analysis, Competitive Landscape and Market |
2011 | 3.500,00$ |
Peripheral Vascular Stents - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017Introduction / / GlobalData’s new report, “Peripheral Vascular Stents - Global Pipeline Analysis, Competitive Landscape and Marke |
2011 | 3.500,00$ |
Electrophysiology Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017Introduction / / GlobalData’s new report, “Electrophysiology Devices - Global Pipeline Analysis, Competitive Landscape and Market |
2011 | 3.500,00$ |
Pacemakers and Cardiac Resynchronization Therapy Pacemakers (CRT-P) - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017Introduction / / GlobalData’s new report, “Pacemakers and Cardiac Resynchronization Therapy Pacemakers (CRT-P) - Global Pipeline |
2011 | 3.500,00$ |
Middle East and Africa and South and Central America Healthcare IT Market Outlook to 2017Introduction / / GlobalData’s new report, “Middle East and Africa Healthcare IT Market Outlook to 2017” provides key market data |
2011 | 3.500,00$ |
Extremities (Shoulder and Small Joint Implants) - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017Introduction / / GlobalData’s new report, “Extremities (Shoulder and Small Joint Implants) - Global Pipeline Analysis, Competitiv |
2011 | 3.500,00$ |
Asia-Pacific Healthcare IT Market Outlook to 2017Introduction / / GlobalData’s new report, “Asia-Pacific Healthcare IT Market Outlook to 2017” provides key market data on the Asi |
2011 | 3.500,00$ |
North America Healthcare IT Market Outlook to 2017Introduction / / GlobalData’s new report, “North America Healthcare IT Market Outlook to 2017” provides key market data on the No |
2011 | 3.500,00$ |
Medical Imaging Information Systems Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017Introduction / / GlobalData’s new report, “Medical Imaging Information Systems Market Outlook in BRICS (Brazil, Russia, India, Ch |
2011 | 2.500,00$ |
Ultrasound Systems Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017Introduction / / GlobalData’s new report, “Ultrasound Systems Market Outlook in BRICS (Brazil, Russia, India, China, South Africa |
2011 | 2.500,00$ |
Computed Tomography Systems Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017Introduction / / GlobalData’s new report, “Computed Tomography Systems Market Outlook in BRICS (Brazil, Russia, India, China, Sou |
2011 | 2.500,00$ |
New Zealand Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and OthersIntroduction / / GlobalData’s new report, “New Zealand Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI System |
2011 | 2.500,00$ |
Sweden Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and OthersIntroduction / / GlobalData’s new report, “Sweden Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, Co |
2011 | 2.500,00$ |
Russian Federation Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and OthersIntroduction / / GlobalData’s new report, “Russian Federation Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI |
2011 | 2.500,00$ |
Czech Republic Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and OthersIntroduction / / GlobalData’s new report, “Czech Republic Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Sys |
2011 | 2.500,00$ |
Austria Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and OthersIntroduction / / GlobalData’s new report, “Austria Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, C |
2011 | 2.500,00$ |
Israel Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and OthersIntroduction / / GlobalData’s new report, “Israel Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, Co |
2011 | 2.500,00$ |
Taiwan Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and OthersIntroduction / / GlobalData’s new report, “Taiwan Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, Co |
2011 | 2.500,00$ |
X-Ray Systems - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017Introduction / / GlobalData’s new report, “X-Ray Systems - Global Pipeline Analysis, Competitive Landscape and Market Forecasts t |
2011 | 3.500,00$ |
Belgium Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and OthersIntroduction / / GlobalData’s new report, “Belgium Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, C |
2011 | 2.500,00$ |
Argentina Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and OthersIntroduction / / GlobalData’s new report, “Argentina Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, |
2011 | 2.500,00$ |
Mexico Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and OthersIntroduction / / GlobalData’s new report, “Mexico Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, Co |
2011 | 2.500,00$ |
North America Diagnostic Imaging Market Outlook to 2017Introduction / / GlobalData’s new report, “North America Diagnostic Imaging Market Outlook to 2017” provides key market data on |
2011 | 3.500,00$ |
Europe Diagnostic Imaging Market Outlook to 2017Introduction / / GlobalData’s new report, “Europe Diagnostic Imaging Market Outlook to 2017” provides key market data on the Eu |
2011 | 3.500,00$ |
Asia-Pacific Diagnostic Imaging Market Outlook to 2017Introduction / / GlobalData’s new report, “Asia-Pacific Diagnostic Imaging Market Outlook to 2017” provides key market data on t |
2011 | 3.500,00$ |
Denmark Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and OthersIntroduction / / GlobalData’s new report, “Denmark Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, C |
2011 | 2.500,00$ |
Saudi Arabia Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and OthersIntroduction / / GlobalData’s new report, “Saudi Arabia Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Syste |
2011 | 2.500,00$ |
Healthcare IT Market Outlook in Germany to 2017 - Hospital Information Systems and Medical Imaging Information SystemsIntroduction / / GlobalData’s new report, “Healthcare IT Market Outlook in Germany to 2017 - Hospital Information Systems and Med |
2011 | 2.500,00$ |
Healthcare IT Market Outlook in Japan to 2017 - Hospital Information Systems and Medical Imaging Information SystemsIntroduction / / GlobalData’s new report, “Healthcare IT Market Outlook in Japan to 2017 - Hospital Information Systems and Medic |
2011 | 2.500,00$ |
Healthcare IT Market Outlook in Spain to 2017 - Hospital Information Systems and Medical Imaging Information SystemsIntroduction / / GlobalData’s new report, “Healthcare IT Market Outlook in Spain to 2017 - Hospital Information Systems and Medic |
2011 | 2.500,00$ |
Healthcare IT Market Outlook in Denmark to 2017 - Hospital Information Systems and Medical Imaging Information SystemsIntroduction / / GlobalData’s new report, “Healthcare IT Market Outlook in Denmark to 2017 - Hospital Information Systems and Med |
2011 | 2.500,00$ |
Healthcare IT Market Outlook in Sweden to 2017 - Hospital Information Systems and Medical Imaging Information SystemsIntroduction / / GlobalData’s new report, “Healthcare IT Market Outlook in Sweden to 2017 - Hospital Information Systems and Medi |
2011 | 2.500,00$ |
Healthcare IT Market Outlook in New Zealand to 2017 - Hospital Information Systems and Medical Imaging Information SystemsIntroduction / / GlobalData’s new report, “Healthcare IT Market Outlook in New Zealand to 2017 - Hospital Information Systems and |
2011 | 2.500,00$ |
Interstitial Cystitis Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Interstitial Cystitis Global Clinical Trials Review, H2, 2011" provides dat |
2011 | 1.000,00$ |
Retinitis Pigmentosa (Retinitis) Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Retinitis Pigmentosa (Retinitis) Global Clinical Trials Review, H2, 2011" p |
2011 | 1.000,00$ |
Acne Vulgaris Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Acne Vulgaris Global Clinical Trials Review, H2, 2011" provides data on the |
2011 | 1.000,00$ |
Otitis Media Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Otitis Media Global Clinical Trials Review, H2, 2011" provides data on the |
2011 | 1.000,00$ |
Cystoid Macular Edema Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Cystoid Macular Edema Global Clinical Trials Review, H2, 2011" provides dat |
2011 | 1.000,00$ |
Encephalitis Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Encephalitis Global Clinical Trials Review, H2, 2011" provides data on the |
2011 | 1.000,00$ |
Gastroenteritis Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Gastroenteritis Global Clinical Trials Review, H2, 2011" provides data on t |
2011 | 1.000,00$ |
Cerebral Aneurysms Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Cerebral Aneurysms Global Clinical Trials Review, H2, 2011" provides data o |
2011 | 1.000,00$ |
Hypercholesterolemia Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Hypercholesterolemia Global Clinical Trials Review, H2, 2011" provides data |
2011 | 1.000,00$ |
Gaucher’s Disease Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Gaucher’s Disease (Gout) Global Clinical Trials Review, H2, 2011" provides |
2011 | 1.000,00$ |
The Seventh International Congress on Vascular Dementia - Post Conference Review and AnalysisIntroduction / / GlobalData, the industry analysis specialist, has released its new conference alerts, “The Seventh International |
2011 | 1.000,00$ |
Urinary Incontinence (UI) Therapeutics - Pipeline Assessment and Market Forecasts to 2018Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Urinary Incontinence (UI) Therapeuti |
2011 | 3.500,00$ |
Sarcopenia Therapeutics - Pipeline Assessment and Market Forecasts to 2018Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Sarcopenia Therapeutics - Pipeline A |
2011 | 3.500,00$ |
Pneumonia Therapeutics - Pipeline Assessment and Market Forecasts to 2018Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Pneumonia Therapeutics - Pipeline As |
2011 | 3.500,00$ |
Polycystic Ovarian Syndrome (PCOS) Therapeutics - Pipeline Assessment and Market Forecasts to 2018Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Polycystic Ovarian Syndrome (PCOS) T |
2011 | 3.500,00$ |
Heart Failure (HF) Therapeutics - Pipeline Assessment and Market Forecasts to 2018Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Heart Failure (HF) Therapeutics - Pi |
2011 | 3.500,00$ |
Bipolar Disorder Therapeutics - Pipeline Assessment and Market Forecasts to 2018Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Bipolar Disorder Therapeutics - Pipe |
2011 | 3.500,00$ |
GV1001 (Pancreatic Cancer) - Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “GV1001 (Pancreatic Cancer) - Analysis and Forecasts to 2020” provides GV10 |
2011 | 2.000,00$ |
Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q3 2011Introduction / / GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q3 2011” report |
2011 | 1.500,00$ |
21st European Meeting on Hypertension and Cardiovascular Prevention 2011 - Post-Conference Review and AnalysisIntroduction / / GlobalData, the industry analysis specialist, has released its new conference alerts, “21st European Meeting on |
2011 | 1.000,00$ |
Periodontal Disease Therapeutics - Pipeline Assessment and Market Forecasts to 2018Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Periodontal Disease Therapeutics - P |
2011 | 3.500,00$ |
Healthcare IT Market Outlook in Italy to 2017 - Hospital Information Systems and Medical Imaging Information SystemsIntroduction / / GlobalData’s new report, “Healthcare IT Market Outlook in Italy to 2017 - Hospital Information Systems and Medic |
2011 | 2.500,00$ |
Artificial Disc Replacement Devices - A Market SnapshotIntroduction / / GlobalData’s report, “Artificial Disc Replacement Devices - A Market Snapshot” provides information and analysis |
2011 | 500,00$ |
South Africa Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and OthersIntroduction / / GlobalData’s new report, “South Africa Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Syste |
2011 | 2.500,00$ |
Australia Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and OthersIntroduction / / GlobalData’s new report, “Australia Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, |
2011 | 2.500,00$ |
Spain Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and OthersIntroduction / / GlobalData’s new report, “Spain Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, Com |
2011 | 2.500,00$ |
Germany Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and OthersIntroduction / / GlobalData’s new report, “Germany Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, C |
2011 | 2.500,00$ |
Canada Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and OthersIntroduction / / GlobalData’s new report, “Canada Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, Co |
2011 | 2.500,00$ |
China Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and OthersIntroduction / / GlobalData’s new report, “China Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, Com |
2011 | 2.500,00$ |
Medical Equipment Quarterly Deals Analysis - M&A and Investment Trends - Q3 2011Introduction / / GlobalData's “Medical Equipment Quarterly Deals Analysis - M&A and Investment Trends - Q3 2011” report is an ess |
2011 | 1.500,00$ |
Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy-Defibrillators - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017Introduction / / GlobalData’s new report, “Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy-Defibril |
2011 | 3.500,00$ |
Ophthalmic Diagnostic Equipments Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017Introduction / / GlobalData’s new report, “Ophthalmic Diagnostic Equipments Market Outlook in BRICS (Brazil, Russia, India, China |
2011 | 2.500,00$ |
Vision Care Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017Introduction / / GlobalData’s new report, “Vision Care Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 20 |
2011 | 2.500,00$ |
Refractive Surgery Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017Introduction / / GlobalData’s new report, “Refractive Surgery Devices Market Outlook in BRICS (Brazil, Russia, India, China, Sout |
2011 | 2.500,00$ |
Global Healthcare IT Monthly Deals Analysis - M&A and Investment Trends, September 2011Introduction / / GlobalData's “Global Healthcare IT Monthly Deals Analysis - M&A and Investment Trends, September 2011” report is |
2011 | 1.000,00$ |
Netherlands Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and OthersIntroduction / / GlobalData’s new report, “Netherlands Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI System |
2011 | 2.500,00$ |
Republic of Korea Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and OthersIntroduction / / GlobalData’s new report, “Republic of Korea Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI |
2011 | 2.500,00$ |
Taiwan Ophthalmic Devices Market Outlook to 2017 - Vision Care, Ophthalmic Diagnostic Equipment, Cataract, Refractive, Vitreo Retinal and Glaucoma Surgery DevicesIntroduction / / GlobalData’s new report, “Taiwan Ophthalmic Devices Market Outlook to 2017 - Vision Care, Ophthalmic Diagnostic |
2011 | 2.500,00$ |
Healthcare IT Market Outlook in Australia to 2017 - Hospital Information Systems and Medical Imaging Information SystemsIntroduction / / GlobalData’s new report, “Healthcare IT Market Outlook in Australia to 2017 - Hospital Information Systems and M |
2011 | 2.500,00$ |
Healthcare IT Market Outlook in United Kingdom to 2017 - Hospital Information Systems and Medical Imaging Information SystemsIntroduction / / GlobalData’s new report, “Healthcare IT Market Outlook in United Kingdom to 2017 - Hospital Information Systems |
2011 | 2.500,00$ |
Healthcare IT Market Outlook in United States to 2017 - Hospital Information Systems and Medical Imaging Information SystemsIntroduction / / GlobalData’s new report, “Healthcare IT Market Outlook in United States to 2017 - Hospital Information Systems a |
2011 | 2.500,00$ |
Healthcare IT Market Outlook in Brazil to 2017 - Hospital Information Systems and Medical Imaging Information SystemsIntroduction / / GlobalData’s new report, “Healthcare IT Market Outlook in Brazil to 2017 - Hospital Information Systems and Medi |
2011 | 2.500,00$ |
Healthcare IT Market Outlook in China to 2017 - Hospital Information Systems and Medical Imaging Information SystemsIntroduction / / GlobalData’s new report, “Healthcare IT Market Outlook in China to 2017 - Hospital Information Systems and Medic |
2011 | 2.500,00$ |
Healthcare IT Market Outlook in France to 2017 - Hospital Information Systems and Medical Imaging Information SystemsIntroduction / / GlobalData’s new report, “Healthcare IT Market Outlook in France to 2017 - Hospital Information Systems and Medi |
2011 | 2.500,00$ |
Healthcare IT Market Outlook in South Africa to 2017 - Hospital Information Systems and Medical Imaging Information SystemsIntroduction / / GlobalData’s new report, “Healthcare IT Market Outlook in South Africa to 2017 - Hospital Information Systems an |
2011 | 2.500,00$ |
Healthcare IT Market Outlook in Belgium to 2017 - Hospital Information Systems and Medical Imaging Information SystemsIntroduction / / GlobalData’s new report, “Healthcare IT Market Outlook in Belgium to 2017 - Hospital Information Systems and Med |
2011 | 2.500,00$ |
Healthcare IT Market Outlook in Russian Federation to 2017 - Hospital Information Systems and Medical Imaging Information SystemsIntroduction / / GlobalData’s new report, “Healthcare IT Market Outlook in Russian Federation to 2017 - Hospital Information Syst |
2011 | 2.500,00$ |
Healthcare IT Market Outlook in Israel to 2017 - Hospital Information Systems and Medical Imaging Information SystemsIntroduction / / GlobalData’s new report, “Healthcare IT Market Outlook in Israel to 2017 - Hospital Information Systems and Medi |
2011 | 2.500,00$ |
Dementia Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Dementia Global Clinical Trials Review, H2, 2011" provides data on the Deme |
2011 | 1.000,00$ |
Epilepsy Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Epilepsy Global Clinical Trials Review, H2, 2011" provides data on the Epil |
2011 | 1.000,00$ |
Migraine Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Migraine Global Clinical Trials Review, H2, 2011" provides data on the Migr |
2011 | 1.000,00$ |
Duchenne Muscular Dystrophy Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Duchenne Muscular Dystrophy Global Clinical Trials Review, H2, 2011" provid |
2011 | 1.000,00$ |
Schizophrenia Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Schizophrenia Global Clinical Trials Review, H2, 2011" provides data on the |
2011 | 1.000,00$ |
Diabetic Foot Infection (DFI) Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Diabetic Foot Infection (DFI) Global Clinical Trials Review, H2, 2011" prov |
2011 | 1.000,00$ |
Osteoporosis Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Osteoporosis Global Clinical Trials Review, H2, 2011" provides data on the |
2011 | 1.000,00$ |
Gouty Arthritis (Gout) Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Gouty Arthritis (Gout) Global Clinical Trials Review, H2, 2011" provides d |
2011 | 1.000,00$ |
Rhinosinusitis Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Rhinosinusitis Global Clinical Trials Review, H2, 2011" provides data on th |
2011 | 1.000,00$ |
Septic Shock Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Septic Shock Global Clinical Trials Review, H2, 2011" provides data on the |
2011 | 1.000,00$ |
Hepatitis C Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Hepatitis C Global Clinical Trials Review, H2, 2011" provides data on the H |
2011 | 1.000,00$ |
Hepatitis A Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Hepatitis A Global Clinical Trials Review, H2, 2011" provides data on the H |
2011 | 1.000,00$ |
Peptic Ulcers Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Peptic Ulcer Global Clinical Trials Review, H2, 2011" provides data on the |
2011 | 1.000,00$ |
Bronchitis Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Bronchitis Global Clinical Trials Review, H2, 2011" provides data on the Br |
2011 | 1.000,00$ |
Parkinson’s Disease Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Parkinson’s Disease Global Clinical Trials Review, H2, 2011" provides data |
2011 | 1.000,00$ |
Alzheimer’s Disease Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Alzheimer’s Disease Global Clinical Trials Review, H2, 2011" provides data |
2011 | 1.000,00$ |
Diphtheria Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Diphtheria Global Clinical Trials Review, H2, 2011" provides data on the Di |
2011 | 1.000,00$ |
Emphysema Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Emphysema Global Clinical Trials Review, H2, 2011" provides data on the Emp |
2011 | 1.000,00$ |
Pulmonary Arterial Hypertension Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Pulmonary Arterial Hypertension Global Clinical Trials Review, H2, 2011" pr |
2011 | 1.000,00$ |
Cerebral Palsy Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Cerebral Palsy Global Clinical Trials Review, H2, 2011" provides data on th |
2011 | 1.000,00$ |
Acute Lung Injury Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Acute Lung Injury Global Clinical Trials Review, H2, 2011" provides data on |
2011 | 1.000,00$ |
Non-Small Cell Lung Cancer (NSCLC) Therapeutics - Pipeline Assessment and Market Forecasts to 2018Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Non-Small Cell Lung Cancer (NSCLC) T |
2011 | 3.500,00$ |
Major Depressive Disorder (MDD) Therapeutics - Pipeline Assessment and Market Forecasts to 2018Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Major Depressive Disorder (MDD) Ther |
2011 | 3.500,00$ |
Benign Prostatic Hyperplasia (BPH) Therapeutics - Pipeline Assessment and Market Forecasts to 2018Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Benign Prostatic Hyperplasia (BPH) T |
2011 | 3.500,00$ |
Anti-Hypertension Therapeutics - Pipeline Assessment and Market Forecasts to 2018Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Anti-Hypertension Therapeutics - Pip |
2011 | 3.500,00$ |
Paclitaxel (Ovarian Cancer) - Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, "Paclitaxel (Ovarian Cancer) - Analysis and Forecasts to 2020” provides Pac |
2011 | 2.000,00$ |
Talactoferrin Alfa (NSCLC) – Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “Talactoferrin Alfa (NSCLC) – Analysis and Forecasts to 2020” provides Tala |
2011 | 2.000,00$ |
Victhom Human Bionics Inc. (VHB) - Product Pipeline AnalysisVicthom Human Bionics Inc. (VHB) - Product Pipeline Analysis / / Summary / / Victhom Human Bionics Inc. (Victhom) is a medical d |
2011 | 750,00$ |
Micronics, Inc. - Product Pipeline AnalysisMicronics, Inc. - Product Pipeline Analysis / / Summary / / Micronics, Inc. (Micronics), a privately-held medical device company |
2011 | 750,00$ |
Biomoda, Inc. (BMOD) - Product Pipeline AnalysisBiomoda, Inc. (BMOD) - Product Pipeline Analysis / / Summary / / Biomoda, Inc. (Biomoda) is a medical device manufacturing compa |
2011 | 750,00$ |
Medispec LTD - Product Pipeline AnalysisMedispec LTD - Product Pipeline Analysis / / Summary / / Medispec LTD, (Medispec) is a privately-held medical device company. It |
2011 | 750,00$ |
Ceragenix Pharmaceuticals, Inc. (CGXP) - Product Pipeline AnalysisCeragenix Pharmaceuticals, Inc. (CGXP) - Product Pipeline Analysis / / Summary / / Ceragenix Pharmaceuticals, Inc. (Ceragenix) i |
2011 | 750,00$ |
Fina Biotech - Product Pipeline AnalysisFina Biotech - Product Pipeline Analysis / / Summary / / Fina Biotech, formerly known as Indas Biotech is a biotechnology compan |
2011 | 750,00$ |
SANUWAVE Health, Inc. (SNWV) - Product Pipeline AnalysisSANUWAVE Health, Inc. (SNWV) - Product Pipeline Analysis / / Summary / / SANUWAVE, Inc. (SANUWAVE) is a medical technology compa |
2011 | 750,00$ |
TcLand Expression - Product Pipeline AnalysisTcLand Expression - Product Pipeline Analysis / / Summary / / TcLand Expression (TcLand) is an privately held integrated biotech |
2011 | 750,00$ |
AOI Medical, Inc. - Product Pipeline AnalysisAOI Medical, Inc. - Product Pipeline Analysis / / Summary / / AOI Medical, Inc. (AOI Medical) is a medical device company, engag |
2011 | 750,00$ |
TherOx, Inc. - Product Pipeline AnalysisTherOx, Inc. - Product Pipeline Analysis / / Summary / / TherOx, Inc. (TherOx) is a privately held medical device company. It is |
2011 | 750,00$ |
Spectros Corporation - Product Pipeline AnalysisSpectros Corporation - Product Pipeline Analysis / / Summary / / Spectros Corporation (Spectros) is a privately-held medical dev |
2011 | 750,00$ |
Ascension Orthopedics, Inc. - Product Pipeline AnalysisAscension Orthopedics, Inc. - Product Pipeline Analysis / / Summary / / Ascension Orthopedics Corporation (Ascension) is a priva |
2011 | 750,00$ |
InSightec Ltd. - Product Pipeline AnalysisInSightec Ltd. - Product Pipeline Analysis / / Summary / / InSightec Ltd. (InSightec) is a privately held medical device company |
2011 | 750,00$ |
Toscana Biomarkers Srl - Product Pipeline AnalysisToscana Biomarkers Srl - Product Pipeline Analysis / / Summary / / Toscana Biomarkers Srl (Toscana Biomarkers) is a start up com |
2011 | 750,00$ |
Xcorporeal, Inc. (XCRP) - Product Pipeline AnalysisXcorporeal, Inc. (XCRP) - Product Pipeline Analysis / / Summary / / Xcorporeal, Inc. (Xcorporeal) is a medical device company pr |
2011 | 750,00$ |
CorNova, Inc. - Product Pipeline AnalysisCorNova, Inc. - Product Pipeline Analysis / / Summary / / CorNova, Inc. (CorNova) is a medical device company engaged in the man |
2011 | 750,00$ |
Epinex Diagnostics Incorporated - Product Pipeline AnalysisEpinex Diagnostics Incorporated - Product Pipeline Analysis / / Summary / / Epinex Diagnostics Inc.,(Epinex) is a medical diagno |
2011 | 750,00$ |
Cytograft Tissue Engineering, Inc. - Product Pipeline AnalysisCytograft Tissue Engineering, Inc. - Product Pipeline Analysis / / Summary / / Cytograft Tissue Engineering, Inc. (Cytograft) is |
2011 | 750,00$ |
XEPTAGEN SpA - Product Pipeline AnalysisXEPTAGEN SpA - Product Pipeline Analysis / / Summary / / XEPTAGEN SpA. (XEPTAGEN) is engaged in the development, production and |
2011 | 750,00$ |
ValveXchange, Inc. - Product Pipeline AnalysisValveXchange, Inc. - Product Pipeline Analysis / / Summary / / ValveXchange, Inc. (ValveXchange) is a medical device company eng |
2011 | 750,00$ |
Orthox Ltd. - Product Pipeline AnalysisOrthox Ltd. - Product Pipeline Analysis / / Summary / / Orthox Ltd (Orthox) is a privately-held medical device company engaged i |
2011 | 750,00$ |
MEDICREA INTERNATIONAL (ALMED) - Product Pipeline AnalysisMEDICREA INTERNATIONAL (ALMED) - Product Pipeline Analysis / / Summary / / MEDICREA INTERNATIONAL (Medicrea) is a medical device |
2011 | 750,00$ |
Aeon Astron Corporation - Product Pipeline AnalysisAeon Astron Corporation - Product Pipeline Analysis / / Summary / / Aeon Astron Corporation (AAC) is a corporate holding company |
2011 | 750,00$ |
X-spine Systems, Inc. - Product Pipeline AnalysisX-spine Systems, Inc. - Product Pipeline Analysis / / Summary / / X-spine Systems, Inc. (X-spine) is a privately held medical de |
2011 | 750,00$ |
Jemo Spine, LLC. - Product Pipeline AnalysisJemo Spine, LLC. - Product Pipeline Analysis / / Summary / / Jemo Spine, LLC. (Jemo Spine) is a privately-held medical device co |
2011 | 750,00$ |
Palmaz Scientific, Inc. - Product Pipeline AnalysisPalmaz Scientific, Inc. - Product Pipeline Analysis / / Summary / / Palmaz Scientific, Inc. (Palmaz) is a privately held medical |
2011 | 750,00$ |
Abbott Vascular Inc. - Product Pipeline AnalysisAbbott Vascular Inc. - Product Pipeline Analysis / / Summary / / Abbott Vascular Inc. (Abbott Vascular) is engaged in the develo |
2011 | 750,00$ |
Akonni Biosystems Inc - Product Pipeline AnalysisAkonni Biosystems Inc - Product Pipeline Analysis / / Summary / / Akonni Biosystems Inc (Akonni Biosystems) is a US based life s |
2011 | 750,00$ |
BioQ Devices Pty Ltd - Product Pipeline AnalysisBioQ Devices Pty Ltd - Product Pipeline Analysis / / Summary / / BioQ Devices Pty Ltd (BioQ Devices) is a medical device company |
2011 | 750,00$ |
BioTech One Inc - Product Pipeline AnalysisBioTech One Inc - Product Pipeline Analysis / / Summary / / BioTech One Inc (BioTech One) is a privately held medical device com |
2011 | 750,00$ |
Bonovo Orthopedics, Inc. - Product Pipeline AnalysisBonovo Orthopedics, Inc. - Product Pipeline Analysis / / Summary / / Bonovo Orthopedics, Inc. (Bonovo) is a privately held compa |
2011 | 750,00$ |
MabCure Inc. (MBCI) - Product Pipeline AnalysisMabCure Inc. (MBCI) - Product Pipeline Analysis / / Summary / / MabCure Inc. (MabCure), formerly Smartec Holdings Inc. is a deve |
2011 | 750,00$ |
BioHelix Corporation - Product Pipeline AnalysisBioHelix Corporation - Product Pipeline Analysis / / Summary / / BioHelix Corporation (Biohelix) is a privately held molecular d |
2011 | 750,00$ |
TransMedics, Inc. - Product Pipeline AnalysisTransMedics, Inc. - Product Pipeline Analysis / / Summary / / TransMedics, Inc. (TransMedics) is a privately held medical device |
2011 | 750,00$ |
Aurelium BioPharma Inc. - Product Pipeline AnalysisAurelium BioPharma Inc. - Product Pipeline Analysis / / Summary / / Aurelium BioPharma Inc. (Aurelium) is a privately held medic |
2011 | 750,00$ |
Control Medical Technology - Product Pipeline AnalysisControl Medical Technology - Product Pipeline Analysis / / Summary / / Control Medical Technology is a medical equipments compan |
2011 | 750,00$ |
Sensile Medical AG - Product Pipeline AnalysisSensile Medical AG - Product Pipeline Analysis / / Summary / / Sensile Medical AG (Sensile) is a privately held medical device c |
2011 | 750,00$ |
Debiotech S.A. - Product Pipeline AnalysisDebiotech S.A. - Product Pipeline Analysis / / Summary / / Debiotech S.A. (Debiotech) is engaged in the development of innovativ |
2011 | 750,00$ |
AbaStar MDx - Product Pipeline AnalysisAbaStar MDx - Product Pipeline Analysis / / Summary / / AbaStar MDx, Inc. (AbaStar) is a healthcare medical device company princ |
2011 | 750,00$ |
AutoGenomics, Inc. - Product Pipeline AnalysisAutoGenomics, Inc. - Product Pipeline Analysis / / Summary / / AutoGenomics, Inc. (AutoGenomics) is engaged in the design, devel |
2011 | 750,00$ |
China Medical Technologies, Inc. (CMED) - Product Pipeline AnalysisChina Medical Technologies, Inc. (CMED) - Product Pipeline Analysis / / Summary / / China Medical Technologies, (China Medical) |
2011 | 750,00$ |
Cardima, Inc. (CADM) - Product Pipeline AnalysisCardima, Inc. (CADM) - Product Pipeline Analysis / / Summary / / Cardima, Inc. (Cardima) designs, develops, manufactures and mar |
2011 | 750,00$ |
Bone Solutions, Inc. - Product Pipeline AnalysisBone Solutions, Inc. - Product Pipeline Analysis / / Summary / / Bone Solutions, Inc. (Bone Solutions) is a bone adhesive techno |
2011 | 750,00$ |
LifeBond Ltd. - Product Pipeline AnalysisLifeBond Ltd. - Product Pipeline Analysis / / Summary / / LifeBond Ltd. (LifeBond) is a medical device company principally engag |
2011 | 750,00$ |
Axial Biotech, Inc. - Product Pipeline AnalysisAxial Biotech, Inc. - Product Pipeline Analysis / / Summary / / Axial Biotech, Inc. (Axial Biotech) is medical technology compan |
2011 | 750,00$ |
Pluromed, Inc. - Product Pipeline AnalysisPluromed, Inc. - Product Pipeline Analysis / / Summary / / Pluromed, Inc. (Pluromed) is an early-stage medical technology compan |
2011 | 750,00$ |
Bioretec Ltd. - Product Pipeline AnalysisBioretec Ltd. - Product Pipeline Analysis / / Summary / / Bioretec Ltd. (Bioretec) is a medical device company engaged in the de |
2011 | 750,00$ |
Xylos Corporation - Product Pipeline AnalysisXylos Corporation - Product Pipeline Analysis / / Summary / / Xylos Corporation (Xylos), a privately-held biotechnology company |
2011 | 750,00$ |
Xhale Diagnostics, Inc. - Product Pipeline AnalysisXhale Diagnostics, Inc. - Product Pipeline Analysis / / Summary / / Xhale Diagnostics, Inc. (Xhale) is a privately-held medical |
2011 | 750,00$ |
NewCardio, Inc. (NWCI) - Product Pipeline AnalysisNewCardio, Inc. (NWCI) - Product Pipeline Analysis / / Summary / / NewCardio, Inc. (NewCardio) is a medical technology company. |
2011 | 750,00$ |
GeneEx, Inc - Product Pipeline AnalysisGeneEx, Inc - Product Pipeline Analysis / / Summary / / GeneEx, Inc. (GenEx), a privately-held medical device service provider c |
2011 | 750,00$ |
DiagnoCure Inc. (CUR) - Product Pipeline AnalysisDiagnoCure Inc. (CUR) - Product Pipeline Analysis / / Summary / / DiagnoCure Inc. (DiagnoCure) is engaged in the development, pr |
2011 | 750,00$ |
Glycominds Ltd. - Product Pipeline AnalysisGlycominds Ltd. - Product Pipeline Analysis / / Summary / / Glycominds Ltd. (GML), a privately-held medical device provider, is |
2011 | 750,00$ |
Disc Motion Technologies - Product Pipeline AnalysisDisc Motion Technologies - Product Pipeline Analysis / / Summary / / Disc Motion Technologies (DMT) is a privately-held spine te |
2011 | 750,00$ |
Instrumentation Laboratory - Product Pipeline AnalysisInstrumentation Laboratory - Product Pipeline Analysis / / Summary / / Instrumentation Laboratory is a subsidiary of Werfen Grou |
2011 | 750,00$ |
Mystic Pharmaceuticals, Inc. - Product Pipeline AnalysisMystic Pharmaceuticals, Inc. - Product Pipeline Analysis / / Summary / / Mystic Pharmaceuticals, Inc. (Mystic) is a specialty ph |
2011 | 750,00$ |
Target Discovery, Inc. - Product Pipeline AnalysisTarget Discovery, Inc. - Product Pipeline Analysis / / Summary / / Target Discovery, Inc. (TDI) is a medical equipment company, |
2011 | 750,00$ |
Innocoll Technologies Ltd - Product Pipeline AnalysisInnocoll Technologies Ltd - Product Pipeline Analysis / / Summary / / Innocoll Technologies Ltd (Innocoll Technologies) is a med |
2011 | 750,00$ |
FMI Technologies, Inc. - Product Pipeline AnalysisFMI Technologies, Inc. - Product Pipeline Analysis / / Summary / / FMI Technologies, Inc. (FMI Technologies) is a medical device |
2011 | 750,00$ |
Tepha, Inc. - Product Pipeline AnalysisTepha, Inc. - Product Pipeline Analysis / / Summary / / Tepha, Inc. (Tepha) is a privately-held medical device company engaged i |
2011 | 750,00$ |
Marvel Medtech, LLC - Product Pipeline AnalysisMarvel Medtech, LLC - Product Pipeline Analysis / / Summary / / Marvel Medtech, LLC (Marvel Medtech) is principally engaged in t |
2011 | 750,00$ |
Apaxis Medical, Inc. - Product Pipeline AnalysisApaxis Medical, Inc. - Product Pipeline Analysis / / Summary / / Apaxis Medical, Inc. (formerly known as SEMMT, Inc.) is a priva |
2011 | 750,00$ |
Source MDx - Product Pipeline AnalysisSource MDx - Product Pipeline Analysis / / Summary / / Source MDx (Source) is a privately held medical device company. It is pri |
2011 | 750,00$ |
Tigran Technologies AB (TIGR) - Product Pipeline AnalysisTigran Technologies AB (TIGR) - Product Pipeline Analysis / / Summary / / Tigran Technologies AB (Tigran Technologies) is a medi |
2011 | 750,00$ |
B1 Medical Ltd - Product Pipeline AnalysisB1 Medical Ltd - Product Pipeline Analysis / / Summary / / B1 Medical Ltd (B1 Medical) is a medical device company, principally |
2011 | 750,00$ |
KISCO International - Product Pipeline AnalysisKISCO International - Product Pipeline Analysis / / Summary / / KISCO International is formerly known as Kiscomedica, it is prin |
2011 | 750,00$ |
HyperBranch Medical Technology, Inc. - Product Pipeline AnalysisHyperBranch Medical Technology, Inc. - Product Pipeline Analysis / / Summary / / Hyperbranch Medical Technology, Inc. (Hyperbran |
2011 | 750,00$ |
JetGuide Ltd. - Product Pipeline AnalysisJetGuide Ltd. - Product Pipeline Analysis / / Summary / / JetGuide Ltd. (JetGuide) is a medical device company, principally enga |
2011 | 750,00$ |
BioCure, Inc. - Product Pipeline AnalysisBioCure, Inc. - Product Pipeline Analysis / / Summary / / BioCure, Inc. (BioCure) is medical device company, engaged in the deve |
2011 | 750,00$ |
Minos Medical Inc. - Product Pipeline AnalysisMinos Medical Inc. - Product Pipeline Analysis / / Summary / / Minos Medical Inc. (Minos Medical) is a medical device company pr |
2011 | 750,00$ |
AGA Medical Holdings, Inc. - Product Pipeline AnalysisAGA Medical Holdings, Inc. - Product Pipeline Analysis / / Summary / / AGA Medical Holdings, Inc. (AGA Medical), a medical devic |
2011 | 750,00$ |
Integrated Diagnostics - Product Pipeline AnalysisIntegrated Diagnostics - Product Pipeline Analysis / / Summary / / Integrated Diagnostics is engaged in developing diagnostic pr |
2011 | 750,00$ |
Milagen, Inc. - Product Pipeline AnalysisMilagen, Inc. - Product Pipeline Analysis / / Summary / / Milagen, Inc. (Milagen) is a medical device company is principally eng |
2011 | 750,00$ |
CollPlant Ltd. - Product Pipeline AnalysisCollPlant Ltd. - Product Pipeline Analysis / / Summary / / CollPlant Ltd. (CollPlant) is a biotechnology company. It is engaged |
2011 | 750,00$ |
Prediction Sciences - Product Pipeline AnalysisPrediction Sciences - Product Pipeline Analysis / / Summary / / Prediction Sciences is a medical device company is principally e |
2011 | 750,00$ |
Cohera Medical, Inc. - Product Pipeline AnalysisCohera Medical, Inc. - Product Pipeline Analysis / / Summary / / Cohera Medical, Inc. (Cohera), a privately-held medical device |
2011 | 750,00$ |
Rosetta Genomics, Ltd. (ROSG) - Product Pipeline AnalysisRosetta Genomics, Ltd. (ROSG) - Product Pipeline Analysis / / Summary / / Rosetta Genomics, Ltd. (RGL) is a medical device compa |
2011 | 750,00$ |
Innova Biotechnology Co., Ltd. - Product Pipeline AnalysisInnova Biotechnology Co., Ltd. - Product Pipeline Analysis / / Summary / / Innova Biotechnology Co., Ltd. (Innova Biotechnology) |
2011 | 750,00$ |
Spring Health Solutions Ltd. - Product Pipeline AnalysisSpring Health Solutions Ltd. - Product Pipeline Analysis / / Summary / / Spring Health Solutions Ltd. (Spring Health) is a medic |
2011 | 750,00$ |
MND Diagnostic LTD - Product Pipeline AnalysisMND Diagnostic LTD - Product Pipeline Analysis / / Summary / / MND Diagnostic LTD (MND Diagnostic) is engaged in the development |
2011 | 750,00$ |
Biosign Technologies Inc. (BIO) - Product Pipeline AnalysisBiosign Technologies Inc. (BIO) - Product Pipeline Analysis / / Summary / / Biosign Technologies Inc. (Biosign) is a medical dev |
2011 | 750,00$ |
EndoChoice Inc. - Product Pipeline AnalysisEndoChoice Inc. - Product Pipeline Analysis / / Summary / / EndoChoice Inc. (EndoChoice) is one of the leading gastrointestinal |
2011 | 750,00$ |
Quanterix Corporation - Product Pipeline AnalysisQuanterix Corporation - Product Pipeline Analysis / / Summary / / Quanterix Corporation is engaged in developing a platform for |
2011 | 750,00$ |
GT Urological, LLC - Product Pipeline AnalysisGT Urological, LLC - Product Pipeline Analysis / / Summary / / GT Urological, LLC (GTU) is a medical device company principally |
2011 | 750,00$ |
CW Optics, Inc. - Product Pipeline AnalysisCW Optics, Inc. - Product Pipeline Analysis / / Summary / / CW Optics, Inc. (CW Optics) is a medical technology company principa |
2011 | 750,00$ |
AMPLITUDE SAS - Product Pipeline AnalysisAMPLITUDE SAS - Product Pipeline Analysis / / Summary / / AMPLITUDE SAS (Amplitude) is a medical device company, which is engage |
2011 | 750,00$ |
SQI Diagnostics Inc. (SQD) - Product Pipeline AnalysisSQI Diagnostics Inc. (SQD) - Product Pipeline Analysis / / Summary / / SQI Diagnostics Inc. (SQI) is a privately-held medical de |
2011 | 750,00$ |
Corgenix, Inc. - Product Pipeline AnalysisCorgenix, Inc. - Product Pipeline Analysis / / Summary / / Corgenix, Inc. (Corgenix) is a medical device company engaged in the |
2011 | 750,00$ |
Scil Technology Gmbh - Product Pipeline AnalysisScil Technology Gmbh - Product Pipeline Analysis / / Summary / / Scil Technology Gmbh (Scil) is a biopharmaceutical drug develop |
2011 | 750,00$ |
Bolton Medical, Inc. - Product Pipeline AnalysisBolton Medical, Inc. - Product Pipeline Analysis / / Summary / / Bolton Medical, Inc. (Bolton Medical) is a privately-held medic |
2011 | 750,00$ |
Mentor Worldwide LLC - Product Pipeline AnalysisMentor Worldwide LLC - Product Pipeline Analysis / / Summary / / Mentor Worldwide LLC (Mentor) is a medical device company engag |
2011 | 750,00$ |
Elixir Medical Corporation - Product Pipeline AnalysisElixir Medical Corporation - Product Pipeline Analysis / / Summary / / Elixir Medical Corporation (Elixir Medical) is a privatel |
2011 | 750,00$ |
BG Medicine, Inc. (BGMD) - Product Pipeline AnalysisBG Medicine, Inc. (BGMD) - Product Pipeline Analysis / / Summary / / BG Medicine, Inc. (BG Medicine) is life sciences company, p |
2011 | 750,00$ |
Kytogenics Pharmaceuticals, Inc. - Product Pipeline AnalysisKytogenics Pharmaceuticals, Inc. - Product Pipeline Analysis / / Summary / / Kytogenics Pharmaceuticals, Inc. (Kytogenics) is a |
2011 | 750,00$ |
MCS Medical Compression Systems (DBN) Ltd. (MDCL) - Product Pipeline AnalysisMCS Medical Compression Systems (DBN) Ltd. (MDCL) - Product Pipeline Analysis / / Summary / / MCS Medical Compression Systems (D |
2011 | 750,00$ |
Covalon Technologies Ltd. (COV) - Product Pipeline AnalysisCovalon Technologies Ltd. (COV) - Product Pipeline Analysis / / Summary / / Covalon Technologies, Ltd. (Covalon) is a publicly h |
2011 | 750,00$ |
Cytokine PharmaSciences, Inc. - Product Pipeline AnalysisCytokine PharmaSciences, Inc. - Product Pipeline Analysis / / Summary / / Cytokine PharmaSciences, Inc. (CPSI) is engaged in the |
2011 | 750,00$ |
Atlas Genetics Ltd. - Product Pipeline AnalysisAtlas Genetics Ltd. - Product Pipeline Analysis / / Summary / / Atlas Genetics Ltd. (Atlas Genetics) is a medical diagnostic com |
2011 | 750,00$ |
Medical Bionics Inc. - Product Pipeline AnalysisMedical Bionics Inc. - Product Pipeline Analysis / / Summary / / Medical Bionics Inc (Medical Bionics) is a privately-held compa |
2011 | 750,00$ |
EXINI Diagnostics AB - Product Pipeline AnalysisEXINI Diagnostics AB - Product Pipeline Analysis / / Summary / / EXINI Diagnostics AB (EXINI Diagnostics) is a privately-held me |
2011 | 750,00$ |
Eurocor GmbH - Product Pipeline AnalysisEurocor GmbH - Product Pipeline Analysis / / Summary / / Eurocor GmbH (Eurocor) is a medical device company which is principally |
2011 | 750,00$ |
Brazil Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and OthersIntroduction / / GlobalData’s new report, “Brazil Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, Co |
2011 | 2.500,00$ |
Italy Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and OthersIntroduction / / GlobalData’s new report, “Italy Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, Com |
2011 | 2.500,00$ |
France Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and OthersIntroduction / / GlobalData’s new report, “France Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, Co |
2011 | 2.500,00$ |
India Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and OthersIntroduction / / GlobalData’s new report, “India Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, Com |
2011 | 2.500,00$ |
Private Equity and Venture Capital Investments in Medical Equipment Industry - Q3 2011Introduction / / GlobalData's “Private Equity and Venture Capital Investments in Medical Equipment Industry - Q3 2011” report is |
2011 | 1.500,00$ |
Healthcare IT Market Outlook in Netherlands to 2017 - Hospital Information Systems and Medical Imaging Information SystemsIntroduction / / GlobalData’s new report, “Healthcare IT Market Outlook in Netherlands to 2017 - Hospital Information Systems and |
2011 | 2.500,00$ |
Healthcare IT Market Outlook in Canada to 2017 - Hospital Information Systems and Medical Imaging Information SystemsIntroduction / / GlobalData’s new report, “Healthcare IT Market Outlook in Canada to 2017 - Hospital Information Systems and Medi |
2011 | 2.500,00$ |
Saudi Arabia Ophthalmic Devices Market Outlook to 2017 - Vision Care, Ophthalmic Diagnostic Equipment, Cataract, Refractive, Vitreo Retinal and Glaucoma Surgery DevicesIntroduction / / GlobalData’s new report, “Saudi Arabia Ophthalmic Devices Market Outlook to 2017 - Vision Care, Ophthalmic Diagn |
2011 | 2.500,00$ |
Denmark Ophthalmic Devices Market Outlook to 2017 - Vision Care, Ophthalmic Diagnostic Equipment, Cataract, Refractive, Vitreo Retinal and Glaucoma Surgery DevicesIntroduction / / GlobalData’s new report, “Denmark Ophthalmic Devices Market Outlook to 2017 - Vision Care, Ophthalmic Diagnostic |
2011 | 2.500,00$ |
Israel Ophthalmic Devices Market Outlook to 2017 - Vision Care, Ophthalmic Diagnostic Equipment, Cataract, Refractive, Vitreo Retinal and Glaucoma Surgery DevicesIntroduction / / GlobalData’s new report, “Israel Ophthalmic Devices Market Outlook to 2017 - Vision Care, Ophthalmic Diagnostic |
2011 | 2.500,00$ |
Japan Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and OthersIntroduction / / GlobalData’s new report, “Japan Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, Com |
2011 | 2.500,00$ |
United Kingdom Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and OthersIntroduction / / GlobalData’s new report, “United Kingdom Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Sys |
2011 | 2.500,00$ |
Middle East and Africa Ophthalmic Devices Market Outlook to 2017Introduction / / GlobalData’s new report, “Middle East and Africa Ophthalmic Devices Market Outlook to 2017” provides key market |
2011 | 3.500,00$ |
Vitreo Retinal Surgery Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017Introduction / / GlobalData’s new report, “Vitreo Retinal Surgery Devices Market Outlook in BRICS (Brazil, Russia, India, China, |
2011 | 2.500,00$ |
Cataract Surgery Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017Introduction / / GlobalData’s new report, “Cataract Surgery Devices Market Outlook in BRICS (Brazil, Russia, India, China, South |
2011 | 2.500,00$ |
Heart Failure Society of America (HFSA) 15th Annual Scientific Meeting - Review and AnalysisIntroduction / / GlobalData’s report, “Heart Failure Society of America (HFSA) 15th Annual Scientific Meeting - Review and Analys |
2011 | 1.000,00$ |
Periodontal Disease - Pipeline Assessment and Market Forecasts to 2018Introduction / / GlobalData, the industry analysis specialist’s new report, “Periodontal Disease - Pipeline Assessment and Market |
2011 | 3.500,00$ |
Osteoarthritis Therapeutics - Pipeline Assessment and Market Forecasts to 2018Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Osteoarthritis Therapeutics - Pipeli |
2011 | 3.500,00$ |
Growth Hormone Deficiency (GHD) Therapeutics - Pipeline Assessment and Market Forecasts to 2018Introduction / / GlobalData, the Industry analysis specialist, has released its new report, “Growth Hormone Deficiency (GHD) Ther |
2011 | 3.500,00$ |
Atherosclerosis or Coronary Artery Disease Therapeutics (CAD) - Pipeline Assessment and Market Forecasts to 2018Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Atherosclerosis or Coronary Artery D |
2011 | 3.500,00$ |
Chemotherapy-Induced Neutropenia (CIN) Therapeutics –Pipeline Assessment and Market Forecasts to 2018Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Chemotherapy-Induced Neutropenia (CI |
2011 | 3.500,00$ |
Bronchitis Therapeutics- Pipeline Assessment and Market Forecasts to 2018Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Bronchitis Therapeutics- Pipeline As |
2011 | 3.500,00$ |
Angina Pectoris Therapeutics - Pipeline Assessment and Market Forecasts to 2018Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Angina Pectoris Therapeutics - Pipel |
2011 | 3.500,00$ |
Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - September 2011Introduction / / GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - September 2011” |
2011 | 1.000,00$ |
Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - October 2011Introduction / / GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - October 2011” r |
2011 | 1.000,00$ |
Waldenstrom Macroglobulinemia Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Waldenstrom Macroglobulinemia Global Clinical Trials Review, H2, 2011" prov |
2011 | 1.000,00$ |
Chronic Plaque Psoriasis Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Chronic Plaque Psoriasis Global Clinical Trials Review, H2, 2011" provides |
2011 | 1.000,00$ |
Uveitis Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Uveitis Global Clinical Trials Review, H2, 2011" provides data on the Uveit |
2011 | 1.000,00$ |
Glaucoma Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Glaucoma Global Clinical Trials Review, H2, 2011" provides data on the Glau |
2011 | 1.000,00$ |
Hernia Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Hernia Global Clinical Trials Review, H2, 2011" provides data on the Hernia |
2011 | 1.000,00$ |
Leprosy Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Leprosy Global Clinical Trials Review, H2, 2011" provides data on the Lepro |
2011 | 1.000,00$ |
Keratoconjunctivitis sicca (Dry Eye) Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Keratoconjunctivitis sicca (Dry Eye) Global Clinical Trials Review, H2, 201 |
2011 | 1.000,00$ |
Hemophilia A Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Hemophilia A Global Clinical Trials Review, H2, 2011" provides data on the |
2011 | 1.000,00$ |
Valstar (Bladder Cancer) - Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “Valstar (Bladder Cancer) - Analysis and Forecasts to 2020” provides Valsta |
2011 | 2.000,00$ |
Urocidin (Bladder Cancer) - Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “Urocidin (Bladder Cancer) - Analysis and Forecasts to 2020” provides Uroci |
2011 | 2.000,00$ |
Thiotepa (Bladder Cancer) - Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “Thiotepa (Bladder Cancer) - Analysis and Forecasts to 2020” provides Thiot |
2011 | 2.000,00$ |
Gemzar (Bladder Cancer) - Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “Gemzar (Bladder Cancer) - Analysis and Forecasts to 2020” provides Gemzar |
2011 | 2.000,00$ |
BCG (Bladder Cancer) - Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “BCG (Bladder Cancer) - Analysis and Forecasts to 2020” provides BCG global |
2011 | 2.000,00$ |
MVAC (Bladder Cancer) - Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “MVAC (Bladder Cancer) - Analysis and Forecasts to 2020” provides MVAC glob |
2011 | 2.000,00$ |
Mitomycin (Bladder Cancer) - Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “Mitomycin (Bladder Cancer) - Analysis and Forecasts to 2020” provides Javl |
2011 | 2.000,00$ |
Javlor (Bladder Cancer) - Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “Javlor (Bladder Cancer) - Analysis and Forecasts to 2020” provides Javlor |
2011 | 2.000,00$ |
Eoquin (Bladder Cancer) - Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “Eoquin (Bladder Cancer) - Analysis and Forecasts to 2020” provides Eoquin |
2011 | 2.000,00$ |
Tykerb (Bladder Cancer) - Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “Tykerb (Bladder Cancer) - Analysis and Forecasts to 2020” provides Tykerb |
2011 | 2.000,00$ |
Ellence (Bladder Cancer) - Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “Ellence (Bladder Cancer) - Analysis and Forecasts to 2020” provides Ellenc |
2011 | 2.000,00$ |
Iressa (Bladder Cancer) - Analysis and Forecast to 2020Introduction / / GlobalData’s pharmaceuticals report, “Iressa (Bladder Cancer) - Analysis and Forecast to 2020” provides Iressa g |
2011 | 2.000,00$ |
Vectibix (Gastric Cancer) - Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “Vectibix (Gastric Cancer) - Analysis and Forecasts to 2020 ” provides Vect |
2011 | 2.000,00$ |
Taxotere (Gastric Cancer) - Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “Taxotere (Gastric Cancer) - Analysis and Forecasts to 2020” provides Taxot |
2011 | 2.000,00$ |
Mitomycin (Gastric Cancer) - Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “Mitomycin (Gastric Cancer) - Analysis and Forecasts to 2020 ” provides Mit |
2011 | 2.000,00$ |
Erbitux (Gastric Cancer)- Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “Erbitux (Gastric Cancer)- Analysis and Forecasts to 2020” provides Erbitux |
2011 | 2.000,00$ |
Ellence (Gastric Cancer) - Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “Ellence (Gastric Cancer) - Analysis and Forecasts to 2020” provides Ellenc |
2011 | 2.000,00$ |
Actos (Type 2 Diabetes) – Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “Actos (Type 2 Diabetes) – Analysis and Forecasts to 2020” provides Actos s |
2011 | 2.000,00$ |
Aleglitazar (Type 2 Diabetes) – Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “Aleglitazar (Type 2 Diabetes) – Analysis and Forecasts to 2020” provides A |
2011 | 2.000,00$ |
Amaryl (Type 2 Diabetes) – Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “Amaryl (Type 2 Diabetes) – Analysis and Forecasts to 2020” provides Amaryl |
2011 | 2.000,00$ |
Apidra (Type 2 Diabetes) – Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “Apidra (Type 2 Diabetes) – Analysis and Forecasts to 2020” provides Apidra |
2011 | 2.000,00$ |
ASP1941 (Type 2 Diabetes) – Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “ASP1941 (Type 2 Diabetes) – Analysis and Forecasts to 2020” provides ASP19 |
2011 | 2.000,00$ |
Avandia (Type 2 Diabetes) – Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “Avandia (Type 2 Diabetes) – Analysis and Forecasts to 2020” provides Avand |
2011 | 2.000,00$ |
Basen (Type 2 Diabetes) – Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “Basen (Type 2 Diabetes) – Analysis and Forecasts to 2020” provides Basen s |
2011 | 2.000,00$ |
BI 10773 (Type 2 Diabetes) – Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “BI 10773 (Type 2 Diabetes) – Analysis and Forecasts to 2020” provides BI10 |
2011 | 2.000,00$ |
Bydureon (Type 2 Diabetes) – Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “Bydureon (Type 2 Diabetes) – Analysis and Forecasts to 2020” provides Bydu |
2011 | 2.000,00$ |
Byetta (Type 2 Diabetes) – Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “Byetta (Type 2 Diabetes) – Analysis and Forecasts to 2020” provides Byetta |
2011 | 2.000,00$ |
Canagliflozin (Type 2 Diabetes) – Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “Canagliflozin (Type 2 Diabetes) – Analysis and Forecasts to 2020” provides |
2011 | 2.000,00$ |
Cycloset (Type 2 Diabetes) – Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “Cycloset (Type 2 Diabetes) – Analysis and Forecasts to 2020” provides Cycl |
2011 | 2.000,00$ |
Dapagliflozin (Type 2 Diabetes) – Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “Dapagliflozin (Type 2 Diabetes) – Analysis and Forecasts to 2020” provides |
2011 | 2.000,00$ |
Galvus (Type 2 Diabetes) – Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “Galvus (Type 2 Diabetes) – Analysis and Forecasts to 2020” provides Galvus |
2011 | 2.000,00$ |
Glipizide (Type 2 Diabetes) – Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “Glipizide (Type 2 Diabetes) – Analysis and Forecasts to 2020” provides Gal |
2011 | 2.000,00$ |
Glyburide (Type 2 Diabetes) – Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “Glyburide (Type 2 Diabetes) – Analysis and Forecasts to 2020” provides Gly |
2011 | 2.000,00$ |
Glyset (Type 2 Diabetes) – Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “Glyset (Type 2 Diabetes) – Analysis and Forecasts to 2020” provides Glyset |
2011 | 2.000,00$ |
Humalog (Type 2 Diabetes) – Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “Humalog (Type 2 Diabetes) – Analysis and Forecasts to 2020” provides Humal |
2011 | 2.000,00$ |
Humulin (Type 2 Diabetes) – Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “Humulin (Type 2 Diabetes) – Analysis and Forecasts to 2020” provides Humul |
2011 | 2.000,00$ |
Insulin Degludec (Type 2 Diabetes) – Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “Insulin Degludec (Type 2 Diabetes) – Analysis and Forecasts to 2020” provi |
2011 | 2.000,00$ |
Janumet (Type 2 Diabetes) – Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “Janumet (Type 2 Diabetes) – Analysis and Forecasts to 2020” provides Janum |
2011 | 2.000,00$ |
Januvia (Type 2 Diabetes) – Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “Januvia (Type 2 Diabetes) – Analysis and Forecasts to 2020” provides Januv |
2011 | 2.000,00$ |
Kombiglyze XR (Type 2 Diabetes) – Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “Kombiglyze XR (Type 2 Diabetes) – Analysis and Forecasts to 2020” provides |
2011 | 2.000,00$ |
Lantus (Type 2 Diabetes) – Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “Lantus (Type 2 Diabetes) – Analysis and Forecasts to 2020” provides Lantus |
2011 | 2.000,00$ |
Levemir (Type 2 Diabetes) – Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “Levemir (Type 2 Diabetes) – Analysis and Forecasts to 2020” provides Levem |
2011 | 2.000,00$ |
LY2189265 (Type 2 Diabetes) – Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “LY2189265 (Type 2 Diabetes) – Analysis and Forecasts to 2020” provides LY2 |
2011 | 2.000,00$ |
Lyxumia (Type 2 Diabetes) – Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “Lyxumia (Type 2 Diabetes) – Analysis and Forecasts to 2020” provides Lyxum |
2011 | 2.000,00$ |
Naturlose (Type 2 Diabetes) – Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “Naturlose (Type 2 Diabetes) – Analysis and Forecasts to 2020” provides Nat |
2011 | 2.000,00$ |
Nesina (Type 2 Diabetes) – Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “Nesina (Type 2 Diabetes) – Analysis and Forecasts to 2020” provides Nesina |
2011 | 2.000,00$ |
Onglyza (Type 2 Diabetes) – Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “Onglyza (Type 2 Diabetes) – Analysis and Forecasts to 2020” provides Ongly |
2011 | 2.000,00$ |
Prandin (Type 2 Diabetes) – Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “Prandin (Type 2 Diabetes) – Analysis and Forecasts to 2020” provides Prand |
2011 | 2.000,00$ |
Precose (Type 2 Diabetes) – Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “Precose (Type 2 Diabetes) – Analysis and Forecasts to 2020” provides Preco |
2011 | 2.000,00$ |
Starlix (Type 2 Diabetes) – Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “Starlix (Type 2 Diabetes) – Analysis and Forecasts to 2020” provides Starl |
2011 | 2.000,00$ |
Symlin (Type 2 Diabetes) – Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “Symlin (Type 2 Diabetes) – Analysis and Forecasts to 2020” provides Nesina |
2011 | 2.000,00$ |
Syncria (Type 2 Diabetes) – Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “Syncria (Type 2 Diabetes) – Analysis and Forecasts to 2020” provides Syncr |
2011 | 2.000,00$ |
Tradjenta (Type 2 Diabetes) – Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “Tradjenta (Type 2 Diabetes) – Analysis and Forecasts to 2020” provides Tra |
2011 | 2.000,00$ |
Victoza (Type 2 Diabetes) – Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “Victoza (Type 2 Diabetes) – Analysis and Forecasts to 2020” provides Victo |
2011 | 2.000,00$ |
Welchol (Type 2 Diabetes) – Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “Welchol (Type 2 Diabetes) – Analysis and Forecasts to 2020” provides Welch |
2011 | 2.000,00$ |
Avastin (Ovarian Cancer) – Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “Avastin (Ovarian Cancer) - Analysis and Forecasts to 2020” provides Avasti |
2011 | 2.000,00$ |
Gemzar (Ovarian Cancer) – Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “Gemzar (Ovarian Cancer) - Analysis and Forecasts to 2020” provides Gemzar |
2011 | 2.000,00$ |
Farletuzumab (Ovarian Cancer) – Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “Farletuzumab (Ovarian Cancer) - Analysis and Forecasts to 2020” provides F |
2011 | 2.000,00$ |
Votrient (Ovarian Cancer) – Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “Votrient (Ovarian Cancer) - Analysis and Forecasts to 2020” provides Votri |
2011 | 2.000,00$ |
Hycamtin (Ovarian Cancer) – Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “Hycamtin (Ovarian Cancer) - Analysis and Forecasts to 2020” provides Hycam |
2011 | 2.000,00$ |
Opaxio (Ovarian Cancer) – Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “Opaxio (Ovarian Cancer) - Analysis and Forecasts to 2020” provides Opaxio |
2011 | 2.000,00$ |
Doxil/Caelyx (Ovarian Cancer) – Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “Doxil/Caelyx (Ovarian Cancer) - Analysis and Forecasts to 2020” provides D |
2011 | 2.000,00$ |
Vargatef (Ovarian Cancer) – Analysis and Forecats to 2020Introduction / / GlobalData’s pharmaceuticals report, “Vargatef (Ovarian Cancer) - Analysis and Forecats to 2020” provides Vargat |
2011 | 2.000,00$ |
Karenitecin (Ovarian Cancer) – Analysis and Forecast to 2020Introduction / / GlobalData’s pharmaceuticals report, "Karenitecin (Ovarian Cancer) - Analysis and Forecasts to 2020” provides Ka |
2011 | 2.000,00$ |
Paclical (Ovarian Cancer) – Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, "Paclical (Ovarian Cancer) - Analysis and Forecasts to 2020” provides Pacli |
2011 | 2.000,00$ |
Cisplatin (Ovarian Cancer) – Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, "Cisplatin (Ovarian Cancer) - Analysis and Forecasts to 2020” provides Cisp |
2011 | 2.000,00$ |
AMG 386 (Ovarian Cancer) – Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, "AMG 386 (Ovarian Cancer) - Analysis and Forecasts to 2020” provides AMG 38 |
2011 | 2.000,00$ |
Carboplatin (Ovarian Cancer) – Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, "Carboplatin (Ovarian Cancer) - Analysis and Forecasts to 2020” provides Ca |
2011 | 2.000,00$ |
Yondelis (Ovarian Cancer) - Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “Yondelis (Ovarian Cancer) - Analysis and Forecasts to 2020” provides Yonde |
2011 | 2.000,00$ |
Recentin (Ovarian Cancer) – Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “Recentin (Ovarian Cancer) – Analysis and Forecasts to 2020” provides Recen |
2011 | 2.000,00$ |
Olaparib (Ovarian Cancer) – Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “Olaparib (Ovarian Cancer) – Analysis and Forecasts to 2020” provides Olapa |
2011 | 2.000,00$ |
EC145 (Ovarian Cancer) – Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “EC145 (Ovarian Cancer) - Analysis and Forecasts to 2020” provides EC145 sa |
2011 | 2.000,00$ |
Taxol (Breast Cancer) – Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “Taxol (Breast Cancer) – Analysis and Forecasts to 2020” provides Taxol sal |
2011 | 2.000,00$ |
Avastin (Breast Cancer) – Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “Avastin (Breast Cancer) – Analysis and Forecasts to 2020” provides Avastin |
2011 | 2.000,00$ |
Taxotere (Breast Cancer) – Analysis and Forecats to 2017Introduction / / GlobalData’s pharmaceuticals report, “Taxotere (Breast Cancer) – Analysis and Forecasts to 2017” provides Taxote |
2011 | 2.000,00$ |
Afatinib (Breast Cancer) – Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “Afatinib (Breast Cancer) – Analysis and Forecasts to 2020” provides Afatin |
2011 | 2.000,00$ |
Femara (Breast Cancer) – Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “Femara (Breast Cancer) – Analysis and Forecasts to 2020” provides Femara s |
2011 | 2.000,00$ |
Herceptin (Breast Cancer) – Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “Herceptin (Breast Cancer) – Analysis and Forecasts to 2020” provides Herce |
2011 | 2.000,00$ |
Omnitarg (Breast Cancer) – Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “Omnitarg (Breast Cancer) – Analysis and Forecasts to 2020” provides Omnita |
2011 | 2.000,00$ |
Trastuzumab-DM1 (Breast Cancer) – Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “Trastuzumab-DM1 (Breast Cancer) – Analysis and Forecasts to 2020” provides |
2011 | 2.000,00$ |
Gemzar (Breast Cancer) – Analysis and Forecasts to 2015Introduction / / GlobalData’s pharmaceuticals report, “Gemzar (Breast Cancer) – Analysis and Forecasts to 2015” provides Gemzar s |
2011 | 2.000,00$ |
Ixempra (Breast Cancer) – Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “Ixempra (Breast Cancer) – Analysis and Forecasts to 2020” provides Ixempra |
2011 | 2.000,00$ |
Arimidex (Breast Cancer) – Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “Arimidex (Breast cancer) - Analysis and Forecasts to 2020” provides Arimid |
2011 | 2.000,00$ |
Aromasin (Breast Cancer) – Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “Aromasin (Breast cancer) - Analysis and Forecasts to 2020” provides Aromas |
2011 | 2.000,00$ |
Faslodex (Breast cancer) – Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “Faslodex (Breast cancer) - Analysis and Forecasts to 2020” provides Faslod |
2011 | 2.000,00$ |
Neratinib (Breast cancer) – Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “Neratinib (Breast cancer) - Analysis and Forecasts to 2020” provides Nerat |
2011 | 2.000,00$ |
Nolvadex (Breast cancer) – Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “Nolvadex (Breast cancer) - Analysis and Forecasts to 2020” provides Nolvad |
2011 | 2.000,00$ |
Tykerb (Breast cancer) – Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “Tykerb (Breast cancer) - Analysis and Forecasts to 2020” provides Tykerb s |
2011 | 2.000,00$ |
Xeloda (Breast cancer) – Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “Xeloda (Breast cancer) - Analysis and Forecasts to 2020” provides Xeloda s |
2011 | 2.000,00$ |
Zoladex (Breast cancer) – Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “Zoladex (Breast cancer) - Analysis and Forecasts to 2020” provides Zoladex |
2011 | 2.000,00$ |
Ellence (Breast cancer) – Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “Ellence (Breast cancer) - Analysis and Forecasts to 2020” provides Ellence |
2011 | 2.000,00$ |
Halaven (Breast cancer) – Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “Halaven (Breast cancer) - Analysis and Forecasts to 2020” provides Halaven |
2011 | 2.000,00$ |
Tarceva (Pancreatic cancer) – Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “Tarceva (Pancreatic cancer) - Analysis and Forecasts to 2020” provides Tar |
2011 | 2.000,00$ |
Afinitor (Pancreatic cancer) – Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “Afinitor (Pancreatic cancer) - Analysis and Forecasts to 2020” provides Af |
2011 | 2.000,00$ |
Gemzar (Pancreatic cancer) – Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “Gemzar (Pancreatic cancer) - Analysis and Forecasts to 2020” provides Gemz |
2011 | 2.000,00$ |
Abraxane (Pancreatic cancer) – Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “Abraxane (Pancreatic cancer) - Analysis and Forecasts to 2020” provides Ab |
2011 | 2.000,00$ |
Sutent (Pancreatic Cancer) - Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “Sutent (Pancreatic Cancer) - Analysis and Forecasts to 2020” provides Sute |
2011 | 2.000,00$ |
S-1 (Pancreatic Cancer) - Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “S-1 (Pancreatic Cancer) - Analysis and Forecasts to 2020” provides S-1 sal |
2011 | 2.000,00$ |
AMG479 (Pancreatic Cancer) - Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “AMG479 (Pancreatic Cancer) - Analysis and Forecasts to 2020” provides AMG4 |
2011 | 2.000,00$ |
Hyper Acute Pancreas (Pancreatic Cancer) - Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “Hyper Acute Pancreas (Pancreatic Cancer) - Analysis and Forecasts to 2020” |
2011 | 2.000,00$ |
Masitinib (Pancreatic Cancer) - Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “Masitinib (Pancreatic Cancer) - Analysis and Forecasts to 2020” provides M |
2011 | 2.000,00$ |
GVAX (Pancreatic Cancer) - Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “GVAX (Pancreatic Cancer) - Analysis and Forecasts to 2020” provides GVAX s |
2011 | 2.000,00$ |
Cisplatin (Cervical Cancer) - Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “Cisplatin (Cervical Cancer) - Analysis and Forecasts to 2020” provides Cis |
2011 | 2.000,00$ |
Cervarix (Cervical Cancer) - Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “Cervarix (Cervical Cancer) - Analysis and Forecasts to 2020” provides Cerv |
2011 | 2.000,00$ |
V503 (Cervical Cancer) - Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “V503 (Cervical Cancer) - Analysis and Forecasts to 2020” provides V503 sal |
2011 | 2.000,00$ |
Gardasil (Cervical Cancer) - Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “Gardasil (Cervical Cancer) - Analysis and Forecasts to 2020” provides Gard |
2011 | 2.000,00$ |
Hycamtin (Cervical Cancer) - Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “Hycamtin (Cervical Cancer) - Analysis and Forecasts to 2020” provides Hyca |
2011 | 2.000,00$ |
Avastin (Cervical Cancer) – Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “Avastin (Cervical Cancer) - Analysis and Forecasts to 2020 ” provides Avas |
2011 | 2.000,00$ |
Tirazone (Cervical Cancer) – Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “ Tirazone ( Cervical Cancer) - Analysis and Forecasts to 2020” provides Ti |
2011 | 2.000,00$ |
S-1 (Cervical Cancer) – Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “ S-1 ( Cervical Cancer) - Analysis and Forecasts to 2020” provides S-1 sal |
2011 | 2.000,00$ |
Gemzar (Non Small Cell Lung Cancer) – Analysis and Forecasts to 2015Introduction / / GlobalData’s pharmaceuticals report, “ Gemzar (Non Small Cell Lung Cancer) - Analysis and Forecasts to 2015” pro |
2011 | 2.000,00$ |
Tarceva (Non Small Cell Lung Cancer) – Analysis and Forecasts to 2015Introduction / / GlobalData’s pharmaceuticals report, “ Tarceva (Non Small Cell Lung Cancer) - Analysis and Forecasts to 2020” pr |
2011 | 2.000,00$ |
Vargatef (Non Small Cell Lung Cancer) – Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “ Vargatef (Non Small Cell Lung Cancer) - Analysis and Forecasts to 2020” p |
2011 | 2.000,00$ |
Cisplatin (Non Small Cell Lung Cancer) – Analysis and forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “ Cisplatin (Non Small Cell Lung Cancer) - Analysis and Estimates from 2002 |
2011 | 2.000,00$ |
Abraxane (Non Small Cell Lung Cancer) – Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “ Abraxane (Non Small Cell Lung Cancer) - Analysis and Forecasts to 2020 ” |
2011 | 2.000,00$ |
ARQ 197 (Non Small Cell Lung Cancer) – Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “ ARQ 197 (Non Small Cell Lung Cancer) - Analysis and Forecasts to 2020” pr |
2011 | 2.000,00$ |
Opaxio (Non Small Cell Lung Cancer) – Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “ Opaxio (Non Small Cell Lung Cancer) - Analysis and Forecasts to 2020” pro |
2011 | 2.000,00$ |
Etoposide (Non Small Cell Lung Cancer) – Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “ Etoposide (Non Small Cell Lung Cancer)- Analysis and Forecasts to 2020” p |
2011 | 2.000,00$ |
Alimta (Non Small Cell Lung Cancer) – Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “ Alimta (Non Small Cell Lung Cancer)- Analysis and Forecasts to 2020” prov |
2011 | 2.000,00$ |
Stimuvax (Non Small Cell Lung Cancer) – Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “ Stimuvax (Non Small Cell Lung Cancer)- Analysis and Forecasts to 2020” pr |
2011 | 2.000,00$ |
Taxol (Non Small Cell Lung Cancer) – Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “ Taxol (Non Small Cell Lung Cancer)- Analysis and Forecasts to 2020” provi |
2011 | 2.000,00$ |
Afatinib (Non Small Cell Lung Cancer)-Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “Afatinib (Non Small Cell Lung Cancer)-Analysis and Forecasts to 2020” pro |
2011 | 2.000,00$ |
Taxotere (Non Small Cell Lung Cancer)-Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “Taxotere (Non Small Cell Lung Cancer)-Analysis and Forecasts to 2020” pro |
2011 | 2.000,00$ |
Avastin (Non Small Cell Lung Cancer)-Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “Avastin (Non Small Cell Lung Cancer)-Analysis and Forecasts to 2020” prov |
2011 | 2.000,00$ |
Crizotinib (Non Small Cell Lung Cancer)-Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “Crizotinib (Non Small Cell Lung Cancer)-Analysis and Forecasts to 2020” p |
2011 | 2.000,00$ |
Iressa (Non Small Cell Lung Cancer)-Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “Iressa (Non Small Cell Lung Cancer)-Analysis and Forecasts to 2020” provi |
2011 | 2.000,00$ |
Erbitux (Non Small Cell Lung Cancer)-Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “Erbitux (Non Small Cell Lung Cancer)-Analysis and Forecasts to 2020” pro |
2011 | 2.000,00$ |
Navelbine (Non Small Cell Lung Cancer)-Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “Navelbine (Non Small Cell Lung Cancer)-Analysis and Forecasts to 2020” p |
2011 | 2.000,00$ |
Tykerb (Head and Neck Cancer) - Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “Tykerb(Head and Neck Cancer )-Analysis and Forecasts to 2020” provides Ze |
2011 | 2.000,00$ |
Reolysin (Head and Neck Cancer) - Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “Reolysin(Head and Neck Cancer )-Analysis and Forecasts to 2020” provides |
2011 | 2.000,00$ |
Methotrexate (Head and Neck Cancer) - Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “Methotrexate (Head and Neck Cancer )-Analysis and Forecasts to 2020” prov |
2011 | 2.000,00$ |
Bleomycin (Head and Neck Cancer) –Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “Bleomycin (Head and Neck Cancer) –Analysis and Forecasts to 2020” provides |
2011 | 2.000,00$ |
Iressa (Head and Neck Cancer) –Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “Iressa (Head and Neck Cancer) –Analysis and Forecasts to 2020” provides Ir |
2011 | 2.000,00$ |
Avastin (Head and Neck Cancer) –Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “Avastin (Head and Neck Cancer) –Analysis and Forecasts to 2020” provides |
2011 | 2.000,00$ |
Cisplatin (Head and Neck Cancer) –Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “Cisplatin (Head and Neck Cancer) –Analysis and Forecasts to 2020” provides |
2011 | 2.000,00$ |
Erbitux (Head and Neck Cancer) – Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “Erbitux (Head and Neck cancer)- Analysis and Forecasts to 2020” provides E |
2011 | 2.000,00$ |
Nimotuzumab (Head and Neck Cancer) - Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “Nimotuzumab (Head and Neck Cancer) - Analysis and Forecasts to 2020” provi |
2011 | 2.000,00$ |
Taxotere (Head and Neck Cancer) – Analysis and Forecasts to 2017Introduction / / GlobalData’s pharmaceuticals report, “Taxotere (Head and Neck cancer)- Analysis and Forecasts to 2017” provides |
2011 | 2.000,00$ |
Axitinib (Renal Cell Carcinoma) – Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “Axitinib (Renal Cell Carcinoma)- Analysis and Forecasts to 2020” provides |
2011 | 2.000,00$ |
Dovitinib (Renal Cell Carcinoma) – Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “Dovitinib (Renal Cell Carcinoma)- Analysis and Forecasts to 2020” provides |
2011 | 2.000,00$ |
Avastin (Renal Cell Carcinoma) – Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “Avastin (Renal Cell Carcinoma)- Analysis and Forecasts to 2020” provides A |
2011 | 2.000,00$ |
Rencarex (Renal Cell Carcinoma) – Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “Rencarex (Renal Cell Carcinoma)- Analysis and Forecasts to 2020” provides |
2011 | 2.000,00$ |
Anyara (Renal Cell Carcinoma) – Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “Anyara (Renal Cell Carcinoma)- Analysis and Forecasts to 2020” provides An |
2011 | 2.000,00$ |
Nexavar (Renal Cell Carcinoma) – Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “Nexavar (Renal Cell Carcinoma)- Analysis and Forecasts to 2020 ” provides |
2011 | 2.000,00$ |
Sutent (Renal Cell Carcinoma) – Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “Sutent (Renal Cell Carcinoma)- Analysis and Forecasts to 2020” provides Su |
2011 | 2.000,00$ |
Torisel (Renal Cell Carcinoma) – Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “Torisel (Renal Cell Carcinoma)- Analysis and Forecasts to 2020” provides T |
2011 | 2.000,00$ |
Afinitor (Renal Cell Carcinoma) – Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “Afinitor (Renal Cell Carcinoma) Analysis and Forecasts to 2020” provides A |
2011 | 2.000,00$ |
Tivozanib (Renal Cell Carcinoma) – Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “Tivozanib (Renal Cell Carcinoma) Analysis and Forecasts to 2020” provides |
2011 | 2.000,00$ |
Votrient (Renal Cell Carcinoma) – Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “Votrient (Renal Cell Carcinoma) Analysis and Forecasts to 2020 ” provides |
2011 | 2.000,00$ |
Tesetaxel (Gastric Cancer) – Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “Tesetaxel (Gastric Cancer) Analysis and Forecasts to 2020 ” provides Teset |
2011 | 2.000,00$ |
Herceptin (Gastric Cancer) -Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “Herceptin (Gastric Cancer)-Analysis and Forecasts to 2020” provides Hercep |
2011 | 2.000,00$ |
Tykerb (Gastric Cancer) - Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “Tykerb (Gastric Cancer) - Analysis and Forecasts from 2012 to 2020” provid |
2011 | 2.000,00$ |
S-1 (Gastric Cancer) - Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “S-1 (Gastric Cancer) - Analysis and Forecasts to 2020 ” provides S-1 sales |
2011 | 2.000,00$ |
Xeloda (Gastric Cancer)- Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “Xeloda (Gastric Cancer)- Analysis and Forecasts to 2020 ” provides Xeloda |
2011 | 2.000,00$ |
Etoposide (Gastric Cancer) - Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “Etoposide (Gastric Cancer) - Analysis and Forecasts to 2020” provides Etop |
2011 | 2.000,00$ |
Afinitor (Gastric Cancer) - Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “Afinitor (Gastric Cancer) - Analysis and Forecasts to 2020 ” provides Afin |
2011 | 2.000,00$ |
Ramucirumab (Gastric Cancer) - Analysis and Forecast to 2020Introduction / / GlobalData’s pharmaceuticals report, “Ramucirumab (Gastric Cancer) - Analysis and Forecast to 2020” provides Ram |
2011 | 2.000,00$ |
Cisplatin (Gastric Cancer) - Analysis and Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “Cisplatin (Gastric Cancer) – Analysis and Forecasts to 2020” provides Cis |
2011 | 2.000,00$ |
Doxorubicin (Gastric Cancer) - Analysis and Forecast to 2020Introduction / / GlobalData’s pharmaceuticals report, “Doxorubicin (Gastric Cancer) - Analysis and Forecast to 2020” provides Dox |
2011 | 2.000,00$ |
Medical Equipment Monthly Deals Analysis - M&A and Investment Trends, October 2011Introduction / / GlobalData's “Medical Equipment Monthly Deals Analysis - M&A and Investment Trends, October 2011” report is an e |
2011 | 1.000,00$ |
Ophthalmic Diagnostic Equipment - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017Introduction / / GlobalData’s new report, “Ophthalmic Diagnostic Equipment - Global Pipeline Analysis, Competitive Landscape and |
2011 | 3.500,00$ |
Bare Metal Stents (BMS) - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017Introduction / / GlobalData’s new report, “Bare Metal Stents (BMS) - Global Pipeline Analysis, Competitive Landscape and Market F |
2011 | 3.500,00$ |
Ventricular Assist Devices (VAD) - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017Introduction / / GlobalData’s new report, “Ventricular Assist Devices (VAD) - Global Pipeline Analysis, Competitive Landscape and |
2011 | 3.500,00$ |
Bioabsorbable Stents - A Future OutlookIntroduction / / GlobalData’s report, “Bioabsorbable Stents - A Future Outlook” provides key information on bioabsorbable stents |
2011 | 500,00$ |
Influenza Vaccines Therapeutics - Pipeline Assessment and Market Forecasts to 2018Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Influenza Vaccines Therapeutics - Pi |
2011 | 3.500,00$ |
Cancer Vaccines - Pipeline Assessment and Market Forecasts to 2018Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Cancer Vaccines - Pipeline Assessmen |
2011 | 3.500,00$ |
Systemic Lupus Erythematosus Therapeutics (SLE) - Pipeline Assessment and Market Forecasts to 2018Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Systemic Lupus Erythematosus Therape |
2011 | 3.500,00$ |
Depression Therapeutics - Pipeline Assessment and Market Forecasts to 2018Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Depression Therapeutics - Pipeline A |
2011 | 3.500,00$ |
Glioblastoma Multiforme (GBM) Therapeutics - Pipeline Assessment and Market Forecasts to 2018Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Glioblastoma Multiforme (GBM) Therap |
2011 | 3.500,00$ |
Uterine Fibroids Global Clinical Trials Review, H2 2011Introduction / / GlobalData's clinical trial report, “Uterine Fibroids Global Clinical Trials Review, H2, 2011" provides data on |
2011 | 1.000,00$ |
Systemic Sclerosis (Scleroderma) Global Clinical Trials Review, H2 2011Introduction / / GlobalData's clinical trial report, “Systemic Sclerosis (Scleroderma) Global Clinical Trials Review, H2, 2011" p |
2011 | 1.000,00$ |
Osteopenia Global Clinical Trials Review, H2 2011Introduction / / GlobalData's clinical trial report, “Osteopenia Global Clinical Trials Review, H2, 2011" provides data on the Os |
2011 | 1.000,00$ |
Growth Hormone Deficiency Global Clinical Trials Review, H2 2011Introduction / / GlobalData's clinical trial report, “Growth Hormone Deficiency Global Clinical Trials Review, H2, 2011" provides |
2011 | 1.000,00$ |
Hyperglycemia Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Hyperglycemia Global Clinical Trials Review, H2, 2011" provides data on the |
2011 | 1.000,00$ |
Hepatitis B Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Hepatitis B Global Clinical Trials Review, H2, 2011" provides data on the H |
2011 | 1.000,00$ |
Barrett’s Esophagus Global Clinical Trials Review, H2 2011Introduction / / GlobalData's clinical trial report, “Barrett’s Esophagus Global Clinical Trials Review, H2, 2011" provides data |
2011 | 1.000,00$ |
Gastroesophageal Reflux Disease (GERD) Therapeutics - Pipeline Assessment and Market Forecasts to 2018Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Gastroesophageal Reflux Disease (GER |
2011 | 3.500,00$ |
Polycystic Ovarian Syndrome Global Clinical Trials Review, H2 2011Introduction / / GlobalData's clinical trial report, “Polycystic Ovarian Syndrome Global Clinical Trials Review, H2, 2011" provid |
2011 | 1.000,00$ |
Choroidal Neovascularization Global Clinical Trials Review, H2 2011Introduction / / GlobalData's clinical trial report, “Choroidal Neovascularization Global Clinical Trials Review, H2, 2011" provi |
2011 | 1.000,00$ |
Cerus Corporation (CERS) - Product Pipeline AnalysisCerus Corporation (CERS) - Product Pipeline Analysis / / Summary / / Cerus Corporation (Cerus) is a biomedical products manufact |
2011 | 750,00$ |
IRIS International, Inc. (IRIS) - Product Pipeline AnalysisIRIS International, Inc. (IRIS) - Product Pipeline Analysis / / Summary / / IRIS International, Inc. (IRIS) designs, develops, m |
2011 | 750,00$ |
W. L. Gore & Associates, Inc. - Product Pipeline AnalysisW. L. Gore & Associates, Inc. - Product Pipeline Analysis / / Summary / / W. L. Gore & Associates, Inc. (Gore) is engaged in the |
2011 | 750,00$ |
China Sky One Medical, Inc. (CSKI) - Product Pipeline AnalysisChina Sky One Medical, Inc. (CSKI) - Product Pipeline Analysis / / Summary / / China Sky One Medical, Inc. formerly Comet Techno |
2011 | 750,00$ |
Visualase, Inc. - Product Pipeline AnalysisVisualase, Inc. - Product Pipeline Analysis / / Summary / / Visualase, Inc. (Visualase) is a US based privately-held company eng |
2011 | 750,00$ |
CathRx Ltd (CXD) - Product Pipeline AnalysisCathRx Ltd (CXD) - Product Pipeline Analysis / / Summary / / CathRx Ltd (CathRx) is a medical device company engaged in the rese |
2011 | 750,00$ |
SensiVida Medical Technologies, Inc (SVMT) - Product Pipeline AnalysisSensiVida Medical Technologies, Inc (SVMT) - Product Pipeline Analysis / / Summary / / SensiVida Medical Technologies Inc.(Sensi |
2011 | 750,00$ |
SynCardia Systems, Inc. - Product Pipeline AnalysisSynCardia Systems, Inc. - Product Pipeline Analysis / / Summary / / SynCardia Systems, Inc. (SynCardia Systems) is engaged in th |
2011 | 750,00$ |
Echo Therapeutics, Inc. (ECTE) - Product Pipeline AnalysisEcho Therapeutics, Inc. (ECTE) - Product Pipeline Analysis / / Summary / / Echo Therapeutics, Inc. (Echo Therapeutics) is a medi |
2011 | 750,00$ |
Hai Kang Life Corporation Limited - Product Pipeline AnalysisHai Kang Life Corporation Limited - Product Pipeline Analysis / / Summary / / Hai Kang Life Corporation Limited (Hai Kang Life) |
2011 | 750,00$ |
Terumo Corporation (4543) - Product Pipeline AnalysisTerumo Corporation (4543) - Product Pipeline Analysis / / Summary / / Terumo Corporation (Terumo) is a medical technology compan |
2011 | 750,00$ |
New Zealand Ophthalmic Devices Market Outlook to 2017 - Vision Care, Ophthalmic Diagnostic Equipment, Cataract, Refractive, Vitreo Retinal and Glaucoma Surgery DevicesIntroduction / / GlobalData’s new report, “New Zealand Ophthalmic Devices Market Outlook to 2017 - Vision Care, Ophthalmic Diagno |
2011 | 2.500,00$ |
Sweden Ophthalmic Devices Market Outlook to 2017 - Vision Care, Ophthalmic Diagnostic Equipment, Cataract, Refractive, Vitreo Retinal and Glaucoma Surgery DevicesIntroduction / / GlobalData’s new report, “Sweden Ophthalmic Devices Market Outlook to 2017 - Vision Care, Ophthalmic Diagnostic |
2011 | 2.500,00$ |
Russian Federation Ophthalmic Devices Market Outlook to 2017 - Vision Care, Ophthalmic Diagnostic Equipment, Cataract, Refractive, Vitreo Retinal and Glaucoma Surgery DevicesIntroduction / / GlobalData’s new report, “Russian Federation Ophthalmic Devices Market Outlook to 2017 - Vision Care, Ophthalmic |
2011 | 2.500,00$ |
Czech Republic Ophthalmic Devices Market Outlook to 2017 - Vision Care, Ophthalmic Diagnostic Equipment, Cataract, Refractive, Vitreo Retinal and Glaucoma Surgery DevicesIntroduction / / GlobalData’s new report, “Czech Republic Ophthalmic Devices Market Outlook to 2017 - Vision Care, Ophthalmic Dia |
2011 | 2.500,00$ |
Austria Ophthalmic Devices Market Outlook to 2017 - Vision Care, Ophthalmic Diagnostic Equipment, Cataract, Refractive, Vitreo Retinal and Glaucoma Surgery DevicesIntroduction / / GlobalData’s new report, “Austria Ophthalmic Devices Market Outlook to 2017 - Vision Care, Ophthalmic Diagnostic |
2011 | 2.500,00$ |
Disposable Insulin Pumps - A Market SnapshotIntroduction / / GlobalData’s report, “Disposable Insulin Pumps - A Market Snapshot” provides information and analysis on the glo |
2011 | 500,00$ |
Kyphoplasty and Vertebroplasty Market - Favourable Clinical Evidence and Penetration into New Markets to Drive GrowthIntroduction / / GlobalData’s report, “Kyphoplasty and Vertebroplasty Market - Favourable Clinical Evidence and Penetration into |
2011 | 500,00$ |
Automated Dispensing Machines - A Market SnapshotIntroduction / / GlobalData’s report, “Automated Dispensing Machines - A Market Snapshot” provides key information and analysis o |
2011 | 500,00$ |
South Africa Ophthalmic Devices Market Outlook to 2017 - Vision Care, Ophthalmic Diagnostic Equipment, Cataract, Refractive, Vitreo Retinal and Glaucoma Surgery DevicesIntroduction / / GlobalData’s new report, “South Africa Ophthalmic Devices Market Outlook to 2017 - Vision Care, Ophthalmic Diagn |
2011 | 2.500,00$ |
Republic of Korea Ophthalmic Devices Market Outlook to 2017 - Vision Care, Ophthalmic Diagnostic Equipment, Cataract, Refractive, Vitreo Retinal and Glaucoma Surgery DevicesIntroduction / / GlobalData’s new report, “Republic of Korea Ophthalmic Devices Market Outlook to 2017 - Vision Care, Ophthalmic |
2011 | 2.500,00$ |
Mexico Ophthalmic Devices Market Outlook to 2017 - Vision Care, Ophthalmic Diagnostic Equipment, Cataract, Refractive, Vitreo Retinal and Glaucoma Surgery DevicesIntroduction / / GlobalData’s new report, “Mexico Ophthalmic Devices Market Outlook to 2017 - Vision Care, Ophthalmic Diagnostic |
2011 | 2.500,00$ |
Argentina Ophthalmic Devices Market Outlook to 2017 - Vision Care, Ophthalmic Diagnostic Equipment, Cataract, Refractive, Vitreo Retinal and Glaucoma Surgery DevicesIntroduction / / GlobalData’s new report, “Argentina Ophthalmic Devices Market Outlook to 2017 - Vision Care, Ophthalmic Diagnost |
2011 | 2.500,00$ |
Belgium Ophthalmic Devices Market Outlook to 2017 - Vision Care, Ophthalmic Diagnostic Equipment, Cataract, Refractive, Vitreo Retinal and Glaucoma Surgery DevicesIntroduction / / GlobalData’s new report, “Belgium Ophthalmic Devices Market Outlook to 2017 - Vision Care, Ophthalmic Diagnostic |
2011 | 2.500,00$ |
Netherlands Ophthalmic Devices Market Outlook to 2017 - Vision Care, Ophthalmic Diagnostic Equipment, Cataract, Refractive, Vitreo Retinal and Glaucoma Surgery DevicesIntroduction / / GlobalData’s new report, “Netherlands Ophthalmic Devices Market Outlook to 2017 - Vision Care, Ophthalmic Diagno |
2011 | 2.500,00$ |
Brazil Ophthalmic Devices Market Outlook to 2017 - Vision Care, Ophthalmic Diagnostic Equipment, Cataract, Refractive, Vitreo Retinal and Glaucoma Surgery DevicesIntroduction / / GlobalData’s new report, “Brazil Ophthalmic Devices Market Outlook to 2017 - Vision Care, Ophthalmic Diagnostic |
2011 | 2.500,00$ |
Italy Ophthalmic Devices Market Outlook to 2017 - Vision Care, Ophthalmic Diagnostic Equipment, Cataract, Refractive, Vitreo Retinal and Glaucoma Surgery DevicesIntroduction / / GlobalData’s new report, “Italy Ophthalmic Devices Market Outlook to 2017 - Vision Care, Ophthalmic Diagnostic E |
2011 | 2.500,00$ |
France Ophthalmic Devices Market Outlook to 2017 - Vision Care, Ophthalmic Diagnostic Equipment, Cataract, Refractive, Vitreo Retinal and Glaucoma Surgery DevicesIntroduction / / GlobalData’s new report, “France Ophthalmic Devices Market Outlook to 2017 - Vision Care, Ophthalmic Diagnostic |
2011 | 2.500,00$ |
Germany Ophthalmic Devices Market Outlook to 2017 - Vision Care, Ophthalmic Diagnostic Equipment, Cataract, Refractive, Vitreo Retinal and Glaucoma Surgery DevicesIntroduction / / GlobalData’s new report, “Germany Ophthalmic Devices Market Outlook to 2017 - Vision Care, Ophthalmic Diagnostic |
2011 | 2.500,00$ |
China Ophthalmic Devices Market Outlook to 2017 - Vision Care, Ophthalmic Diagnostic Equipment, Cataract, Refractive, Vitreo Retinal and Glaucoma Surgery DevicesIntroduction / / GlobalData’s new report, “China Ophthalmic Devices Market Outlook to 2017 - Vision Care, Ophthalmic Diagnostic E |
2011 | 2.500,00$ |
Bayer HealthCare AG Market Share AnalysisIntroduction / / GlobalData’s new report, “Bayer HealthCare AG Market Share Analysis” provides in-depth information on Bayer Heal |
2011 | 1.000,00$ |
Fujitsu Limited Market Share AnalysisIntroduction / / GlobalData’s new report, “Fujitsu Limited Market Share Analysis” provides in-depth information on Fujitsu Limite |
2011 | 1.000,00$ |
McKesson Corporation Market Share AnalysisIntroduction / / GlobalData’s new report, “McKesson Corporation Market Share Analysis” provides in-depth information on McKesson |
2011 | 1.000,00$ |
Quantel Medical SA Market Share AnalysisIntroduction / / GlobalData’s new report, “Quantel Medical SA Market Share Analysis” provides in-depth information on Quantel Med |
2011 | 1.000,00$ |
STAAR Surgical Company Market Share AnalysisIntroduction / / GlobalData’s new report, “STAAR Surgical Company Market Share Analysis” provides in-depth information on STAAR S |
2011 | 1.000,00$ |
Vascular Concepts Limited Market Share AnalysisIntroduction / / GlobalData’s new report, “Vascular Concepts Limited Market Share Analysis” provides in-depth information on Vasc |
2011 | 1.000,00$ |
United States Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and OthersIntroduction / / GlobalData’s new report, “United States Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Syst |
2011 | 2.500,00$ |
Europe Healthcare IT Market Outlook to 2017Introduction / / GlobalData’s new report, “Europe Healthcare IT Market Outlook to 2017” provides key market data on the Europe |
2011 | 3.500,00$ |
South and Central America Ophthalmic Devices Market Outlook to 2017Introduction / / GlobalData’s new report, “South and Central America Ophthalmic Devices Market Outlook to 2017” provides key mar |
2011 | 3.500,00$ |
Asia-Pacific Ophthalmic Devices Market Outlook to 2017Introduction / / GlobalData’s new report, “Asia-Pacific Ophthalmic Devices Market Outlook to 2017” provides key market data on t |
2011 | 3.500,00$ |
Interventional Cardiology Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017Introduction / / GlobalData’s new report, “Interventional Cardiology Market Outlook in BRICS (Brazil, Russia, India, China, South |
2011 | 2.500,00$ |
Peripheral Vascular Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017Introduction / / GlobalData’s new report, “Peripheral Vascular Devices Market Outlook in BRICS (Brazil, Russia, India, China, Sou |
2011 | 2.500,00$ |
Europe Ophthalmic Devices Market Outlook to 2017Introduction / / GlobalData’s new report, “Europe Ophthalmic Devices Market Outlook to 2017” provides key market data on the Eu |
2011 | 3.500,00$ |
KW-6002– Analysis and Forecasts from 2013 to 2020Introduction / / GlobalData’s pharmaceuticals report, “KW-6002– Analysis and Forecasts from 2013 to 2020” provides KW-6002 sales |
2011 | 2.000,00$ |
Neupro - Analysis and Estimates from 2006 to 2020Introduction / / GlobalData’s pharmaceuticals report, “Neupro - Analysis and Estimates from 2006 to 2020” provides Neupro sales e |
2011 | 2.000,00$ |
Atrial Septal Defect Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Atrial Septal Defect Global Clinical Trials Review, H2, 2011" provides data |
2011 | 1.000,00$ |
Diabetic Nephropathy Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Diabetic Nephropathy Global Clinical Trials Review, H2, 2011" provides data |
2011 | 1.000,00$ |
Glucose Intolerance Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Glucose Intolerance Global Clinical Trials Review, H2, 2011" provides data |
2011 | 1.000,00$ |
Type 1 Diabetes Therapeutics - Pipeline Assessment and Market Forecasts to 2018Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Type 1 Diabetes Therapeutics - Pipel |
2011 | 3.500,00$ |
Psoriasis Therapeutics - Pipeline Assessment and Market Forecasts to 2018Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Psoriasis Therapeutics - Pipeline As |
2011 | 3.500,00$ |
Azilect – Analysis and Estimates from 2005 to 2020Introduction / / GlobalData’s pharmaceuticals report, “Azilect – Analysis and Estimates from 2005 to 2020” provides Azilect sales |
2011 | 2.000,00$ |
Requip (ropinirole) – Analysis and Estimates from 2002 to 2020Introduction / / GlobalData’s pharmaceuticals report, “Requip (ropinirole) – Analysis and Estimates from 2002 to 2020” provides R |
2011 | 2.000,00$ |
Apokyn – Analysis and Estimates from 2004 to 2020Introduction / / GlobalData’s pharmaceuticals report, “Apokyn – Analysis and Estimates from 2004 to 2020” provides Apokyn sales e |
2011 | 2.000,00$ |
Stalevo – Analysis and Estimates from 2003 to 2020Introduction / / GlobalData’s pharmaceuticals report, “Stalevo – Analysis and Estimates from 2003 to 2020” provides Stalevo sales |
2011 | 2.000,00$ |
Mirapex – Analysis and Estimates from 2002 to 2020Introduction / / GlobalData’s pharmaceuticals report, “Mirapex – Analysis and Estimates from 2002 to 2020” provides Mirapex sales |
2011 | 2.000,00$ |
Comtan - Analysis and Estimates from 2002 to 2020Introduction / / GlobalData’s pharmaceuticals report, “Comtan - Analysis and Estimates from 2002 to 2020” provides Comtan sales e |
2011 | 2.000,00$ |
Zelapar – Analysis and Estimates from 2002 to 2020Introduction / / GlobalData’s pharmaceuticals report, “Zelapar – Analysis and Estimates from 2002 to 2020” provides Zelapar sales |
2011 | 2.000,00$ |
Eldepryl – Analysis and Estimates from 2002 to 2012Introduction / / GlobalData’s pharmaceuticals report, “Eldepryl – Analysis and Estimates from 2002 to 2012” provides Eldepryl sal |
2011 | 2.000,00$ |
Tasmar – Analysis and Estimates from 2004 to 2020Introduction / / GlobalData’s pharmaceuticals report, “Tasmar – Analysis and Estimates from 2004 to 2020” provides Tasmarsales es |
2011 | 2.000,00$ |
Requip XL – Analysis and Estimates from 2007 to 2020Introduction / / GlobalData’s pharmaceuticals report, “Requip XL – Analysis and Estimates from 2007 to 2020” provides Requip XL |
2011 | 2.000,00$ |
Mirapex ER – Analysis and Estimates from 2009 to 2020Introduction / / GlobalData’s pharmaceuticals report, “Mirapex ER – Analysis and Estimates from 2009 to 2020” provides Mirapex ER |
2011 | 2.000,00$ |
Trerief – Analysis and Estimates from 2009 to 2020Introduction / / GlobalData’s pharmaceuticals report, “Trerief – Analysis and Estimates from 2009 to 2020” provides Trerief sales |
2011 | 2.000,00$ |
Safinamide – Analysis and Estimates from 2012 to 2020Introduction / / GlobalData’s pharmaceuticals report, “Safinamide – Analysis and Estimates from 2012 to 2020” provides Safinamide |
2011 | 2.000,00$ |
IPX066 – Analysis and Estimates from 2013 to 2020Introduction / / GlobalData’s pharmaceuticals report, “IPX066 – Analysis and Estimates from 2013 to 2020” provides IPX066 sales |
2011 | 2.000,00$ |
Preladenant– Analysis and Estimates from 2014 to 2020Introduction / / GlobalData’s pharmaceuticals report, “Preladenant– Analysis and Estimates from 2014 to 2020” provides Preladenan |
2011 | 2.000,00$ |
Pardoprunox – Analysis and Forecasts from 2013 to 2020Introduction / / GlobalData’s pharmaceuticals report, “Pardoprunox – Analysis and Forecasts from 2013 to 2020” provides Pardoprun |
2011 | 2.000,00$ |
Abilify – Analysis and Estimates from 2002 to 2020Introduction / / GlobalData’s pharmaceuticals report, “Abilify – Analysis and Estimates from 2002 to 2020” provides Abilify sale |
2011 | 2.000,00$ |
Clozapine – Analysis and Forecasts from 2002 to 2020Introduction / / GlobalData’s pharmaceuticals report, “Clozapine – Analysis and Forecasts from 2002 to 2020” provides Clozapines |
2011 | 2.000,00$ |
Geodon – Analysis and Forecasts from 2002 to 2017Introduction / / GlobalData’s pharmaceuticals report, “Geodon – Analysis and Forecasts from 2002 to 2017” provides Geodon sales |
2011 | 2.000,00$ |
Invega – Analysis and Forecasts from 2007 to 2020Introduction / / GlobalData’s pharmaceuticals report, “Invega – Analysis and Forecasts from 2007 to 2020” provides Invega sales |
2011 | 2.000,00$ |
Latuda – Analysis and Forecasts from 2011 to 2020Introduction / / GlobalData’s pharmaceuticals report, “Latuda – Analysis and Forecasts from 2011 to 2020” provides Latuda sales |
2011 | 2.000,00$ |
Risperdal Consta – Analysis and Forecasts from 2003 to 2020Introduction / / GlobalData’s pharmaceuticals report, “Risperdal Consta – Analysis and Forecasts from 2003 to 2020” provides Risp |
2011 | 2.000,00$ |
Saphris – Analysis and Estimates from 2009 to 2020Introduction / / GlobalData’s pharmaceuticals report, “Saphris – Analysis and Estimates from 2009 to 2020” provides Saphris sale |
2011 | 2.000,00$ |
Seroquel – Analysis and Estimates from 2002 to 2020Introduction / / GlobalData’s pharmaceuticals report, “Seroquel – Analysis and Estimates from 2002 to 2020” provides Seroquel sal |
2011 | 2.000,00$ |
Zyprexa – Analysis and Forecasts from 2002 to 2018Introduction / / GlobalData’s pharmaceuticals report, “Zyprexa – Analysis and Forecasts from 2002 to 2018” provides Zyprexa sal |
2011 | 2.000,00$ |
Seroquel XR – Analysis and Estimates from 2007 to 2020Introduction / / GlobalData’s pharmaceuticals report, “Seroquel XR – Analysis and Estimates from 2007 to 2020” provides Seroquel |
2011 | 2.000,00$ |
Invega Sustenna – Analysis and Forecasts from 2009 to 2020Introduction / / GlobalData’s pharmaceuticals report, “Invega Sustenna – Analysis and Forecasts from 2009 to 2020” provides Inv |
2011 | 2.000,00$ |
Cariprazine – Analysis and Forecasts from 2013 to 2020Introduction / / GlobalData’s pharmaceuticals report, “Cariprazine – Analysis and Forecasts from 2013 to 2020” provides Caripra |
2011 | 2.000,00$ |
Zicronapine – Analysis and Forecasts from 2014 to 2020Introduction / / GlobalData’s pharmaceuticals report, “Zicronapine – Analysis and Forecasts from 2014 to 2020” provides Zicrona |
2011 | 2.000,00$ |
RG1678 – Analysis and Forecasts from 2014 to 2020Introduction / / GlobalData’s pharmaceuticals report, “RG1678 – Analysis and Forecasts from 2014 to 2020” provides RG1678 sale |
2011 | 2.000,00$ |
Tracleer (bosentan) - Analysis and Forecasts from 2002 to 2020Introduction / / GlobalData’s pharmaceuticals report, “Tracleer (bosentan) - Analysis and Forecasts from 2002 to 2020” provides T |
2011 | 2.000,00$ |
Revatio (sildenafil)- Analysis and Estimates from 2005 to 2020Introduction / / GlobalData’s pharmaceuticals report, “Revatio (sildenafil)- Analysis and Estimates from 2005 to 2020” provides R |
2011 | 2.000,00$ |
Remodulin - Analysis and Forecasts from 2002 to 2020Introduction / / GlobalData’s pharmaceuticals report, “Remodulin - Analysis and Forecasts from 2002 to 2020” provides Remodulin s |
2011 | 2.000,00$ |
Letairis/Volibris (ambrisentan) - Analysis and Forecasts from 2007 to 2020Introduction / / GlobalData’s pharmaceuticals report, “Letairis/Volibris (ambrisentan) - Analysis and Forecasts from 2007 to 2020 |
2011 | 2.000,00$ |
Ventavis (iloprost) - Analysis and Estimates from 2003 to 2017Introduction / / GlobalData’s pharmaceuticals report, “Ventavis (iloprost) - Analysis and Estimates from 2003 to 2017” provides V |
2011 | 2.000,00$ |
Adcirca (tadalafil) - Analysis and Estimates from 2009 to 2020Introduction / / GlobalData’s pharmaceuticals report, “Adcirca (tadalafil) - Analysis and Estimates from 2009 to 2020” provides A |
2011 | 2.000,00$ |
Tyvaso (treprostinil)- Analysis and Estimates from 2009 to 2020Introduction / / GlobalData’s pharmaceuticals report, “Tyvaso (treprostinil)- Analysis and Estimates from 2009 to 2020” provides |
2011 | 2.000,00$ |
Veletri (epoprostenol) - Analysis and Forecasts from 2010 to 2020Introduction / / GlobalData’s pharmaceuticals report, “Veletri (epoprostenol) - Analysis and Forecasts from 2010 to 2020” provide |
2011 | 2.000,00$ |
Macitentan (ACT-064992) - Analysis and Forecasts from 2013 to 2020Introduction / / GlobalData’s pharmaceuticals report, “Macitentan (ACT-064992) - Analysis and Forecasts from 2013 to 2020” provid |
2011 | 2.000,00$ |
Riociguat - Analysis and Forecasts from 2013 to 2020Introduction / / GlobalData’s pharmaceuticals report, “Riociguat - Analysis and Forecasts from 2013 to 2020” provides Riociguat s |
2011 | 2.000,00$ |
Selexipag (ACT-293987, NS-304) - Analysis and Forecasts from 2015 to 2020Introduction / / GlobalData’s pharmaceuticals report, “Selexipag (ACT-293987, NS-304) - Analysis and Forecasts from 2015 to 2020” |
2011 | 2.000,00$ |
Gleevec - Analysis and Forecasts from 2013 to 2020Introduction / / GlobalData’s pharmaceuticals report, “Gleevec - Analysis and Forecasts from 2013 to 2020” provides Gleevec sales |
2011 | 2.000,00$ |
Doxorubicin – Analysis and Market Forecasts from 2011 to 2020Introduction / / GlobalData’s pharmaceuticals report, “Doxorubicin – Analysis and Market Forecasts from 2011 to 2020” provides Do |
2011 | 2.000,00$ |
Miripla – Analysis and Market Forecasts from 2010 to 2020Introduction / / GlobalData’s pharmaceuticals report, “Miripla – Analysis and Market Forecasts from 2010 to 2020” provides Miripl |
2011 | 2.000,00$ |
PrevOnco – Analysis and Market Forecasts from 2014 to 2020Introduction / / GlobalData’s pharmaceuticals report, “PrevOnco – Analysis and Market Forecasts from 2014 to 2020” provides PrevO |
2011 | 2.000,00$ |
Ramucirumab – Analysis and Market Forecasts from 2014 to 2020Introduction / / GlobalData’s pharmaceuticals report, “Ramucirumab – Analysis and Market Forecasts from 2014 to 2020” provides Ra |
2011 | 2.000,00$ |
Tarceva – Analysis and Market Forecasts from 2013 to 2020Introduction / / GlobalData’s pharmaceuticals report, “Tarceva – Analysis and Market Forecasts from 2013 to 2020” provides Tarcev |
2011 | 2.000,00$ |
Thalidomide – Analysis and Market Forecasts from 2015 to 2020Introduction / / GlobalData’s pharmaceuticals report, “Thalidomide – Analysis and Market Forecasts from 2015 to 2020” provides Th |
2011 | 2.000,00$ |
Muparfostat – Analysis and Market Forecasts from 2017 to 2020Introduction / / GlobalData’s pharmaceuticals report, “Muparfostat – Analysis and Market Forecasts from 2017 to 2020” provides Mu |
2011 | 2.000,00$ |
Nexavar – Analysis and Market Forecasts from 2007 to 2020Introduction / / GlobalData’s pharmaceuticals report, “Nexavar – Analysis and Market Forecasts from 2007 to 2020” provides Nexava |
2011 | 2.000,00$ |
ThermoDox – Analysis and Market Forecasts from 2012 to 2020Introduction / / GlobalData’s pharmaceuticals report, “ThermoDox – Analysis and Market Forecasts from 2012 to 2020” provides Ther |
2011 | 2.000,00$ |
Avastin (bevacizumab) – Analysis and Market Forecasts from 2016 to 2020Introduction / / GlobalData’s pharmaceuticals report, “Avastin (bevacizumab) – Analysis and Market Forecasts from 2016 to 2020” p |
2011 | 2.000,00$ |
Brivanib – Analysis and Market Forecasts from 2013 to 2020Introduction / / GlobalData’s pharmaceuticals report, “Brivanib – Analysis and Market Forecasts from 2013 to 2020” provides Briva |
2011 | 2.000,00$ |
Linifanib – Assessment and Market Forecasts from 2013 to 2020Introduction / / GlobalData’s pharmaceuticals report, “Linifanib – Analysis and Market Forecasts from 2013 to 2020” provides Lini |
2011 | 2.000,00$ |
European Society of Cardiology Congress 2011 - Post-Conference Review and AnalysisIntroduction / / GlobalData, the industry analysis specialist, has released its new conference alerts, “European Society of Cardi |
2011 | 1.000,00$ |
Development of New Antibiotics Hits a Road BlockIntroduction / / GlobalData, the industry analysis specialist, has released its new viewpoint, “Development of New Antibiotics Hi |
2011 | 500,00$ |
Autistic Disorder Therapeutics - Pipeline Assessment and Market Forecasts to 2018Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Autistic Disorder Therapeutics - Pip |
2011 | 3.500,00$ |
Multiple Myeloma Therapeutics - Pipeline Assessment and Market Forecasts to 2018Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Multiple Myeloma Therapeutics - Pipe |
2011 | 3.500,00$ |
Non-Hodgkin's Lymphoma (NHL) Therapeutics - Pipeline Assessment and Market Forecasts to 2018Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Non-Hodgkin's Lymphoma (NHL) Therape |
2011 | 3.500,00$ |
Aortic Valve Diseases Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Aortic Valve Diseases Global Clinical Trials Review, H2, 2011" provides dat |
2011 | 1.000,00$ |
Melanoma Global Clinical Trials Review, H2 2011Introduction / / GlobalData's clinical trial report, “Melanoma Global Clinical Trials Review, H2, 2011" provides data on the Mela |
2011 | 1.000,00$ |
Hemorrhagic Shock Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Hemorrhagic Shock Global Clinical Trials Review, H2, 2011" provides data on |
2011 | 1.000,00$ |
Sick Sinus Syndrome Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Sick Sinus Syndrome Global Clinical Trials Review, H2, 2011" provides data |
2011 | 1.000,00$ |
Hypoplastic Left Heart Syndrome Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Hypoplastic Left Heart Syndrome Global Clinical Trials Review, H2, 2011" pr |
2011 | 1.000,00$ |
Raynauds Disease Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Raynauds Disease Global Clinical Trials Review, H2, 2011" provides data on |
2011 | 1.000,00$ |
Coronary Thrombosis Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Coronary Thrombosis Global Clinical Trials Review, H2, 2011" provides data |
2011 | 1.000,00$ |
Bone Metastasis Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Bone Metastasis Global Clinical Trials Review, H2, 2011" provides data on t |
2011 | 1.000,00$ |
Shock Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Shock Global Clinical Trials Review, H2, 2011" provides data on the Shock c |
2011 | 1.000,00$ |
Hemorrhage Global Clinical Trials Review, H2 2011Introduction / / GlobalData's clinical trial report, “Hemorrhage Global Clinical Trials Review, H2, 2011" provides data on the He |
2011 | 1.000,00$ |
Tetralogy Of Fallot Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Tetralogy Of Fallot Global Clinical Trials Review, H2, 2011" provides data |
2011 | 1.000,00$ |
Malignant Mesothelioma Therapeutics - Pipeline Assessment and Market Forecasts to 2017Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Malignant Mesothelioma Therapeutics |
2011 | 2.000,00$ |
Hyperparathyroidism Therapeutics - Pipeline Assessment and Market Forecasts to 2017Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Hyperparathyroidism Therapeutics - P |
2011 | 2.000,00$ |
Hyperthyroidism Therapeutics - Pipeline Assessment and Market Forecasts to 2017Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Hyperthyroidism Therapeutics - Pipel |
2011 | 2.000,00$ |
Alopecia Therapeutics - Pipeline Assessment and Market Forecasts to 2017Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Alopecia Therapeutics - Pipeline Ass |
2011 | 2.000,00$ |
Restless Leg Syndrome (RLS) Therapeutics - Pipeline Assessment and Market Forecasts to 2017Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Restless Leg Syndrome (RLS) Therapeu |
2011 | 2.000,00$ |
Acute Ischemic Stroke (AIS) Therapeutics - Pipeline Assessment and Market Forecasts to 2018Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Acute Ischemic Stroke (AIS) Therapeu |
2011 | 3.500,00$ |
Amyotrophic Lateral Sclerosis (ALS) Therapeutics - Pipeline Assessment and Market Forecasts to 2018Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Amyotrophic Lateral Sclerosis (ALS) |
2011 | 3.500,00$ |
Endometriosis Therapeutics- Pipeline Assessment and Market Forecasts to 2018Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Endometriosis Therapeutics- Pipeline |
2011 | 3.500,00$ |
Rheumatoid Arthritis Therapeutics - Pipeline Assessment and Market Forecasts to 2018Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Rheumatoid Arthritis Therapeutics - |
2011 | 3.500,00$ |
Chronic Kidney Disease (CKD) Therapeutics - Pipeline Assessment and Market Forecasts to 2018Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Chronic Kidney Disease (CKD) Therape |
2011 | 3.500,00$ |
Atopic Dermatitis Therapeutics - Pipeline Assessment and Market Forecasts to 2018Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Atopic Dermatitis Therapeutics - Pip |
2011 | 3.500,00$ |
Dyslipidemia Therapeutics - Pipeline Assessment and Market Forecasts to 2018Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Dyslipidemia Therapeutics - Pipeline |
2011 | 3.500,00$ |
Cardiovascular Monitoring and Diagnostic Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017Introduction / / GlobalData’s new report, “Cardiovascular Monitoring and Diagnostic Devices Market Outlook in BRICS (Brazil, Russ |
2011 | 2.500,00$ |
North America Ophthalmic Devices Market Outlook to 2017Introduction / / GlobalData’s new report, “North America Ophthalmic Devices Market Outlook to 2017” provides key market data on t |
2011 | 3.500,00$ |
Netherlands Cardiovascular Devices Market Outlook to 2017 - Cardiac Rhythm Management, Interventional Cardiology, Peripheral Vascular Devices, Prosthetic Heart Valves, Electrophysiology and OthersIntroduction / / GlobalData’s new report, “Netherlands Cardiovascular Devices Market Outlook to 2017 - Cardiac Rhythm Management, |
2011 | 2.500,00$ |
Taiwan Cardiovascular Devices Market Outlook to 2017 - Cardiac Rhythm Management, Interventional Cardiology, Peripheral Vascular Devices, Prosthetic Heart Valves, Electrophysiology and OthersIntroduction / / GlobalData’s new report, “Taiwan Cardiovascular Devices Market Outlook to 2017 - Cardiac Rhythm Management, Inte |
2011 | 2.500,00$ |
United States Ophthalmic Devices Market Outlook to 2017 - Vision Care, Ophthalmic Diagnostic Equipment, Cataract, Refractive, Vitreo Retinal and Glaucoma Surgery DevicesIntroduction / / GlobalData’s new report, “United States Ophthalmic Devices Market Outlook to 2017 - Vision Care, Ophthalmic Diag |
2011 | 2.500,00$ |
United Kingdom Ophthalmic Devices Market Outlook to 2017 - Vision Care, Ophthalmic Diagnostic Equipment, Cataract, Refractive, Vitreo Retinal and Glaucoma Surgery DevicesIntroduction / / GlobalData’s new report, “United Kingdom Ophthalmic Devices Market Outlook to 2017 - Vision Care, Ophthalmic Dia |
2011 | 2.500,00$ |
Japan Ophthalmic Devices Market Outlook to 2017 - Vision Care, Ophthalmic Diagnostic Equipment, Cataract, Refractive, Vitreo Retinal and Glaucoma Surgery DevicesIntroduction / / GlobalData’s new report, “Japan Ophthalmic Devices Market Outlook to 2017 - Vision Care, Ophthalmic Diagnostic E |
2011 | 2.500,00$ |
India Ophthalmic Devices Market Outlook to 2017 - Vision Care, Ophthalmic Diagnostic Equipment, Cataract, Refractive, Vitreo Retinal and Glaucoma Surgery DevicesIntroduction / / GlobalData’s new report, “India Ophthalmic Devices Market Outlook to 2017 - Vision Care, Ophthalmic Diagnostic E |
2011 | 2.500,00$ |
Canada Ophthalmic Devices Market Outlook to 2017 - Vision Care, Ophthalmic Diagnostic Equipment, Cataract, Refractive, Vitreo Retinal and Glaucoma Surgery DevicesIntroduction / / GlobalData’s new report, “Canada Ophthalmic Devices Market Outlook to 2017 - Vision Care, Ophthalmic Diagnostic |
2011 | 2.500,00$ |
Spain Ophthalmic Devices Market Outlook to 2017 - Vision Care, Ophthalmic Diagnostic Equipment, Cataract, Refractive, Vitreo Retinal and Glaucoma Surgery DevicesIntroduction / / GlobalData’s new report, “Spain Ophthalmic Devices Market Outlook to 2017 - Vision Care, Ophthalmic Diagnostic E |
2011 | 2.500,00$ |
Australia Ophthalmic Devices Market Outlook to 2017 - Vision Care, Ophthalmic Diagnostic Equipment, Cataract, Refractive, Vitreo Retinal and Glaucoma Surgery DevicesIntroduction / / GlobalData’s new report, “Australia Ophthalmic Devices Market Outlook to 2017 - Vision Care, Ophthalmic Diagnost |
2011 | 2.500,00$ |
Abdominal Aortic Stent Grafts - A Market SnapshotIntroduction / / GlobalData’s report “Abdominal Aortic Stent Grafts - A Market Snapshot” provides key insights on the abdominal a |
2011 | 500,00$ |
Liver Cirrhosis Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Liver Cirrhosis Global Clinical Trials Review, H2, 2011" provides data on t |
2011 | 1.000,00$ |
Ventricular Arrhythmia Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Ventricular Arrhythmia Global Clinical Trials Review, H2, 2011" provides da |
2011 | 1.000,00$ |
Low Cardiac Output Syndrome Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Low Cardiac Output Syndrome Global Clinical Trials Review, H2, 2011" provid |
2011 | 1.000,00$ |
Bleeding and Clotting Disorders Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Bleeding and Clotting Disorders Global Clinical Trials Review, H2, 2011" pr |
2011 | 1.000,00$ |
Menopausal Disorders Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Menopausal Disorders Global Clinical Trials Review, H2, 2011" provides data |
2011 | 1.000,00$ |
Coronary Vasospasm Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Coronary Vasospasm Global Clinical Trials Review, H2, 2011" provides data o |
2011 | 1.000,00$ |
Pre-Eclampsia Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Pre-Eclampsia Global Clinical Trials Review, H2, 2011" provides data on the |
2011 | 1.000,00$ |
High Triglyceridemia Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “High Triglyceridemia Global Clinical Trials Review, H2, 2011" provides data |
2011 | 1.000,00$ |
Left Ventricular Dysfunction Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Left Ventricular Dysfunction Global Clinical Trials Review, H2, 2011" provi |
2011 | 1.000,00$ |
American Medical Technologies, Inc. (ADLI) - Financial and Strategic SWOT Analysis ReviewAmerican Medical Technologies, Inc (AMT) is a dental medical device company engaged in development, manufacture and marketing of h |
2011 | 125,00$ |
Biocompatibles International Ltd. - Financial and Strategic SWOT Analysis ReviewBiocompatibles International Ltd. (Biocompatibles) is a medical technology company, engaged in the development of products used fo |
2011 | 125,00$ |
Biophan Technologies, Inc. - Financial and Strategic SWOT Analysis ReviewBiophan Technologies, Inc. (Biophan Technologies) is a technology development and holding company, engaged in the development and |
2011 | 125,00$ |
Atrion Corporation (ATRI) - Financial and Strategic SWOT Analysis ReviewAtrion Corporation (Atrion), is engaged in the design, development, manufacture, sale and distribution of products and components |
2011 | 250,00$ |
NMT Medical, Inc. (NMTI) - Financial and Strategic SWOT Analysis ReviewNMT Medical, Inc. (NMT Medical) designs, develops and markets innovative medical devices for the non-surgical treatment of patient |
2011 | 250,00$ |
CMT Medical Technologies Ltd (CMD) - Financial and Strategic SWOT Analysis ReviewCMT Medical Technologies Ltd (CMT) is a medical device company engaged in the design, development, manufacture and marketing of hi |
2011 | 250,00$ |
Merz Aesthetics, Inc. - Financial and Strategic SWOT Analysis ReviewMerz Aesthetics, Inc. (Merz Aesthetics) formely known as BioForm Medical, Inc. is a medical aesthetics company specialized in the |
2011 | 125,00$ |
Zygo Corporation (ZIGO) - Financial and Strategic SWOT Analysis ReviewZYGO Corporation (ZYGO) is engaged in the design, manufacture and marketing of high-end optical systems and components for metrolo |
2011 | 250,00$ |
Samyang Corporation (000070) - Financial and Strategic SWOT Analysis ReviewSamyang Corporation (Samyang), through its subsidiaries, provides various products and services in the areas of food, chemicals, p |
2011 | 125,00$ |
BioMedical Enterprises, Inc. - Strategic SWOT Analysis ReviewBioMedical Enterprises, Inc. (BME) is a medical device company, engaged in the development, manufacture and marketing of orthopedi |
2011 | 125,00$ |
Maximus Medical Products, Inc. - Strategic SWOT Analysis ReviewMaximus Medical Products, Inc. (Maximus Medical) is engaged in the manufacture and distribution of specialty intravenous (I.V.) th |
2011 | 125,00$ |
LifeMasters Supported SelfCare, Inc. - Strategic SWOT Analysis ReviewLifeMasters Supported SelfCare, Inc. (LifeMasters) is a US based disease management company. The company is engaged in the provisi |
2011 | 125,00$ |
Goold Health Systems, Inc. - Strategic SWOT Analysis ReviewGoold Health Systems, Inc. (GHS) is a privately-held healthcare management company that focuses on providing pharmacy benefit serv |
2011 | 125,00$ |
Jubilant Life Sciences Limited (JUBILANT) - Financial and Strategic SWOT Analysis ReviewJubilant Life Sciences Limited (formerly Jubilant Organosys Limited) is engaged in the research and development of advanced and in |
2011 | 125,00$ |
Campbell Brothers Limited (CPB) - Financial and Strategic SWOT Analysis ReviewCampbell Brothers Limited (Campbell) is an Australia-based commercial services company. The company operates its business through |
2011 | 125,00$ |
Animal Health International, Inc. - Financial and Strategic SWOT Analysis ReviewAnimal Health International, Inc. (Animal Health) is one of the leading distributors of animal health products in the US and Canad |
2011 | 125,00$ |
Polydex Pharmaceuticals Limited (POLXF) - Financial and Strategic SWOT Analysis ReviewPolydex Pharmaceuticals Limited (PPL) is a biotechnology company, engaged in the development and manufacturing of products based o |
2011 | 250,00$ |
VaxGen, Inc. (VXGN) - Financial and Strategic SWOT Analysis ReviewVaxGen, Inc., (VaxGen) is a biopharmaceutical company, engaged in the development, manufacture and marketing of biologic products |
2011 | 250,00$ |
Microfluidics International Corporation (MFLU) - Financial and Strategic SWOT Analysis ReviewMicrofluidics International Corporation (Microfluidics) is engaged in manufacturing and marketing a range of materials processing |
2011 | 250,00$ |
Synthetech, Inc. (NZYM) - Financial and Strategic SWOT Analysis ReviewSynthetech, Inc. (Synthetech) is a publicly held pharmaceutical company specializing in organic synthesis, bio catalysis and chira |
2011 | 250,00$ |
LecTec Corporation (LECT) - Financial and Strategic SWOT Analysis ReviewLecTec Corporation (LecTec) is an intellectual property licensing and holding company. The company principally earns royalties by |
2011 | 250,00$ |
O.I. Corporation (OICO) - Financial and Strategic SWOT Analysis ReviewO.I. Corporation (OI) is a medical device company and it is engaged in providing and supplying the products for chemical analysi |
2011 | 250,00$ |
Minapharm Pharmaceuticals & Chemical Industries - Strategic SWOT Analysis ReviewMinapharm Pharmaceuticals & Chemical Industries (Minapharm) is a privately held specialty pharmaceutical company engaged in the ma |
2011 | 250,00$ |
RegeneRx Biopharmaceuticals, Inc. (RGN) - Strategic SWOT Analysis ReviewRegeneRx Biopharmaceuticals, Inc. (RegeneRx Biopharmaceuticals) is publicly held US based biopharmaceutical company. The company i |
2011 | 250,00$ |
Binex Co., Ltd. (053030) - Strategic SWOT Analysis ReviewBinex Co., Ltd. (Binex) is a pharmaceutical company engaged in manufacturing over-the-counter (OTC) drugs and bulk pharmaceuticals |
2011 | 250,00$ |
First Health Services Corporation - Strategic SWOT Analysis ReviewFirst Health Services Corporation (First Health Services) is a leading provider of integrated clinical management services for pub |
2011 | 125,00$ |
Chemaphor Inc. (CFR) - Strategic SWOT Analysis ReviewChemaphor Inc. (Chemaphor) is a publicly held biotechnology company that is engaged in the development and commercialization of sm |
2011 | 250,00$ |
China Pediatric Pharmaceuticals, Inc. (CPDU) - Strategic SWOT Analysis ReviewChina Pediatric Pharmaceuticals, Inc.(China Pediatric Pharmaceuticals) is a pharmaceutical company principally engaged in the deve |
2011 | 250,00$ |
Beluga Composites Corp. (BGCC) - Strategic SWOT Analysis ReviewBeluga Composites Corp. (Beluga) is engaged in the development of immunodiagnostic testing systems. The company performs immunodia |
2011 | 250,00$ |
Vivimed Labs Limited (532660 ) - Strategic SWOT Analysis ReviewVivimed Labs (Vivimed) is an publicly held India based pharma company. It is engaged in the manufacture of ingredients used in the |
2011 | 250,00$ |
Middle East and Africa Cardiovascular Devices Market Outlook to 2017Introduction / / GlobalData’s new report, “Middle East and Africa Cardiovascular Devices Market Outlook to 2017” provides key mar |
2011 | 3.500,00$ |
South and Central America Cardiovascular Devices Market Outlook to 2017Introduction / / GlobalData’s new report, “South and Central America Cardiovascular Devices Market Outlook to 2017” provides key |
2011 | 3.500,00$ |
Dental Implants - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017Introduction / / GlobalData’s new report, “Dental Implants - Global Pipeline Analysis, Competitive Landscape and Market Forecasts |
2011 | 3.500,00$ |
Spinal Fusion - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017Introduction / / GlobalData’s new report, “Spinal Fusion - Global Pipeline Analysis, Competitive Landscape and Market Forecasts t |
2011 | 3.500,00$ |
Prosthetic Heart Valves - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017Introduction / / GlobalData’s new report, “Prosthetic Heart Valves - Global Pipeline Analysis, Competitive Landscape and Market F |
2011 | 3.500,00$ |
Aortic Stent Grafts - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017Introduction / / GlobalData’s new report, “Aortic Stent Grafts - Global Pipeline Analysis, Competitive Landscape and Market Forec |
2011 | 3.500,00$ |
Medical Equipment Monthly Deals Analysis - M&A and Investment Trends, September 2011Introduction / / GlobalData's “Medical Equipment Monthly Deals Analysis - M&A and Investment Trends, September 2011” report is an |
2011 | 1.000,00$ |
Belgium Cardiovascular Devices Market Outlook to 2017 - Cardiac Rhythm Management, Interventional Cardiology, Peripheral Vascular Devices, Prosthetic Heart Valves, Electrophysiology and OthersIntroduction / / GlobalData’s new report, “Belgium Cardiovascular Devices Market Outlook to 2017 - Cardiac Rhythm Management, Int |
2011 | 2.500,00$ |
Mexico Cardiovascular Devices Market Outlook to 2017 - Cardiac Rhythm Management, Interventional Cardiology, Peripheral Vascular Devices, Prosthetic Heart Valves, Electrophysiology and OthersIntroduction / / GlobalData’s new report, “Mexico Cardiovascular Devices Market Outlook to 2017 - Cardiac Rhythm Management, Inte |
2011 | 2.500,00$ |
Republic of Korea Cardiovascular Devices Market Outlook to 2017 - Cardiac Rhythm Management, Interventional Cardiology, Peripheral Vascular Devices, Prosthetic Heart Valves, Electrophysiology and OthersIntroduction / / GlobalData’s new report, “Republic of Korea Cardiovascular Devices Market Outlook to 2017 - Cardiac Rhythm Manag |
2011 | 2.500,00$ |
South Africa Cardiovascular Devices Market Outlook to 2017 - Cardiac Rhythm Management, Interventional Cardiology, Peripheral Vascular Devices, Prosthetic Heart Valves, Electrophysiology and OthersIntroduction / / GlobalData’s new report, “South Africa Cardiovascular Devices Market Outlook to 2017 - Cardiac Rhythm Management |
2011 | 2.500,00$ |
Israel Cardiovascular Devices Market Outlook to 2017 - Cardiac Rhythm Management, Interventional Cardiology, Peripheral Vascular Devices, Prosthetic Heart Valves, Electrophysiology and OthersIntroduction / / GlobalData’s new report, “Israel Cardiovascular Devices Market Outlook to 2017 - Cardiac Rhythm Management, Inte |
2011 | 2.500,00$ |
US Cloud Computing Market for Medical Imaging - Exponential Growth in the Volume of Medical Imaging Data to Drive MarketIntroduction / / GlobalData’s report, “US Cloud Computing Market for Medical Imaging - Exponential Growth in the Volume of Medica |
2011 | 500,00$ |
Austria Cardiovascular Devices Market Outlook to 2017 - Cardiac Rhythm Management, Interventional Cardiology, Peripheral Vascular Devices, Prosthetic Heart Valves, Electrophysiology and OthersIntroduction / / GlobalData’s new report, “Austria Cardiovascular Devices Market Outlook to 2017 - Cardiac Rhythm Management, Int |
2011 | 2.500,00$ |
Czech Republic Cardiovascular Devices Market Outlook to 2017 - Cardiac Rhythm Management, Interventional Cardiology, Peripheral Vascular Devices, Prosthetic Heart Valves, Electrophysiology and OthersIntroduction / / GlobalData’s new report, “Czech Republic Cardiovascular Devices Market Outlook to 2017 - Cardiac Rhythm Manageme |
2011 | 2.500,00$ |
Russian Federation Cardiovascular Devices Market Outlook to 2017 - Cardiac Rhythm Management, Interventional Cardiology, Peripheral Vascular Devices, Prosthetic Heart Valves, Electrophysiology and OthersIntroduction / / GlobalData’s new report, “Russian Federation Cardiovascular Devices Market Outlook to 2017 - Cardiac Rhythm Mana |
2011 | 2.500,00$ |
Sweden Cardiovascular Devices Market Outlook to 2017 - Cardiac Rhythm Management, Interventional Cardiology, Peripheral Vascular Devices, Prosthetic Heart Valves, Electrophysiology and OthersIntroduction / / GlobalData’s new report, “Sweden Cardiovascular Devices Market Outlook to 2017 - Cardiac Rhythm Management, Inte |
2011 | 2.500,00$ |
New Zealand Cardiovascular Devices Market Outlook to 2017 - Cardiac Rhythm Management, Interventional Cardiology, Peripheral Vascular Devices, Prosthetic Heart Valves, Electrophysiology and OthersIntroduction / / GlobalData’s new report, “New Zealand Cardiovascular Devices Market Outlook to 2017 - Cardiac Rhythm Management, |
2011 | 2.500,00$ |
Denmark Cardiovascular Devices Market Outlook to 2017 - Cardiac Rhythm Management, Interventional Cardiology, Peripheral Vascular Devices, Prosthetic Heart Valves, Electrophysiology and OthersIntroduction / / GlobalData’s new report, “Denmark Cardiovascular Devices Market Outlook to 2017 - Cardiac Rhythm Management, Int |
2011 | 2.500,00$ |
Saudi Arabia Cardiovascular Devices Market Outlook to 2017 - Cardiac Rhythm Management, Interventional Cardiology, Peripheral Vascular Devices, Prosthetic Heart Valves, Electrophysiology and OthersIntroduction / / GlobalData’s new report, “Saudi Arabia Cardiovascular Devices Market Outlook to 2017 - Cardiac Rhythm Management |
2011 | 2.500,00$ |
Gilead’s newly approved drug Complera, the Second Triple Combination Once-a-Day Pill Intended for Untreated HIV Patients is unlikely to displace its own market-leading drug, AtriplaIntroduction / / GlobalData’s viewpoint, “Gilead’s newly approved drug Complera, the Second Triple Combination Once-a-Day Pill In |
2011 | 500,00$ |
Increasing Collaboration Between Big Pharma and Academia to Counter R&D, Patent and Approval Issues in the IndustryIntroduction / / GlobalData’s viewpoint, “Increasing Collaboration Between Big Pharma and Academia to Counter R&D, Patent and App |
2011 | 500,00$ |
Acute Lymphocytic Leukemia (ALL) Therapeutics - Pipeline Assessment and Market Forecasts to 2017Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Acute Lymphocytic Leukemia (ALL) The |
2011 | 2.000,00$ |
Nocturnal Enuresis Therapeutics - Pipeline Assessment and Market Forecasts to 2017Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Nocturnal Enuresis Therapeutics - Pi |
2011 | 2.000,00$ |
HIV-Associated Lipodystrophy Therapeutics - Pipeline Assessment and Market Forecasts to 2017Introduction / / Industry analysis specialist, GlobalData, has released its new report, “HIV-Associated Lipodystrophy Therapeutic |
2011 | 2.000,00$ |
Cytomegalovirus (CMV) Infections - Pipeline Assessment and Market Forecasts to 2018Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Cytomegalovirus (CMV) Infections - P |
2011 | 3.500,00$ |
Small Cell Lung Cancer (SCLC) Therapeutics - Pipeline Assessment and Market Forecasts to 2018Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Small Cell Lung Cancer (SCLC) Therap |
2011 | 3.500,00$ |
Asthma Therapeutics - Pipeline Assessment and Market Forecasts to 2018Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Asthma Therapeutics - Pipeline Asses |
2011 | 3.500,00$ |
Glaucoma Therapeutics - Pipeline Assessment and Market Forecasts to 2018Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Glaucoma Therapeutics - Pipeline Ass |
2011 | 3.500,00$ |
Post-Menopausal Hormone Replacement Therapy (HRT) - Pipeline Assessment and Market Forecasts to 2018Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Post-Menopausal Hormone Replacement |
2011 | 3.500,00$ |
Macular Edema Therapeutics - Pipeline Assessment and Market Forecasts to 2018Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Macular Edema Therapeutics - Pipelin |
2011 | 3.500,00$ |
Neuropathic Pain Therapeutics - Pipeline Assessment and Market Forecasts to 2018Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Neuropathic Pain Therapeutics - Pipe |
2011 | 3.500,00$ |
Macular Degeneration Therapeutics - Pipeline Assessment and Market Forecasts to 2018Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Macular Degeneration Therapeutics - |
2011 | 3.500,00$ |
Allergic Conjunctivitis Therapeutics - Pipeline Assessment and Market Forecasts to 2018Introduction / / GlobalData's report, “Allergic Conjunctivitis Therapeutics - Pipeline Assessment and Market Forecasts to 2018”, |
2011 | 3.500,00$ |
Irritable Bowel Syndrome (IBS) Therapeutics - Pipeline Assessment and Market Forecasts to 2018Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Irritable Bowel Syndrome (IBS) Thera |
2011 | 3.500,00$ |
Hemophilia Therapeutics - Pipeline Assessment and Market Forecasts to 2018Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Hemophilia Therapeutics - Pipeline A |
2011 | 3.500,00$ |
Ulcerative Colitis Therapeutics - Pipeline Assessment and Market Forecasts to 2018Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Ulcerative Colitis Therapeutics - Pi |
2011 | 3.500,00$ |
Herpes Simplex Therapeutics - Pipeline Assessment and Market Forecasts to 2018Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Herpes Simplex Therapeutics - Pipeli |
2011 | 3.500,00$ |
Meningitis - Pipeline Assessment and Market Forecasts to 2018Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Meningitis - Pipeline Assessment and |
2011 | 3.500,00$ |
Cataract Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Cataract Global Clinical Trials Review, H2, 2011" provides data on the Cata |
2011 | 1.000,00$ |
Liver Fibrosis Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Liver Fibrosis Global Clinical Trials Review, H2, 2011" provides data on th |
2011 | 1.000,00$ |
Fatty Liver Disease Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Fatty Liver Disease Global Clinical Trials Review, H2, 2011" provides data |
2011 | 1.000,00$ |
Malaria Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Malaria Global Clinical Trials Review, H2, 2011" provides data on the Malar |
2011 | 1.000,00$ |
CryoLife, Inc. (CRY) - Product Pipeline AnalysisCryoLife, Inc. (CRY) - Product Pipeline Analysis / / Summary / / CryoLife, Inc. (CryoLife) is a biological medical device compan |
2011 | 750,00$ |
Sequenom, Inc. (SQNM) - Product Pipeline AnalysisSequenom, Inc. (SQNM) - Product Pipeline Analysis / / Summary / / Sequenom, Inc. (Sequenom) is a molecular diagnostic testing an |
2011 | 750,00$ |
Qiagen N.V. (QIA) - Product Pipeline AnalysisQiagen N.V. (QIA) - Product Pipeline Analysis / / Summary / / Qiagen N.V. (Qiagen) is engaged in providing innovative technologi |
2011 | 750,00$ |
BioMimetic Therapeutics, Inc. (BMTI) - Product Pipeline AnalysisBioMimetic Therapeutics, Inc. (BMTI) - Product Pipeline Analysis / / Summary / / BioMimetic Therapeutics, Inc. (BioMimetic) is a |
2011 | 750,00$ |
CytoCore, Inc. (CYOE) - Product Pipeline AnalysisCytoCore, Inc. (CYOE) - Product Pipeline Analysis / / Summary / / CytoCore, Inc. (CCI), formerly known as Molecular Diagnostics, |
2011 | 750,00$ |
Toshiba America Medical Systems, Inc. - Product Pipeline AnalysisToshiba America Medical Systems, Inc. - Product Pipeline Analysis / / Summary / / Toshiba America Medical Systems, Inc. (TAMS) i |
2011 | 750,00$ |
Genomic Health, Inc. (GHDX) - Product Pipeline AnalysisGenomic Health, Inc. (GHDX) - Product Pipeline Analysis / / Summary / / Genomic Health, Inc. (Genomic Health) is a life science |
2011 | 750,00$ |
Exiqon AS (EXQ) - Product Pipeline AnalysisExiqon AS (EXQ) - Product Pipeline Analysis / / Summary / / Exiqon A/S (Exiqon) is a biotechnology company principally engaged i |
2011 | 750,00$ |
Interleukin Genetics, Inc. (ILIU) - Product Pipeline AnalysisInterleukin Genetics, Inc. (ILIU) - Product Pipeline Analysis / / Summary / / Interleukin Genetics, Inc. (Interleukin) is a gene |
2011 | 750,00$ |
Pacific Edge Limited (PEB) - Product Pipeline AnalysisPacific Edge Limited (PEB) - Product Pipeline Analysis / / Summary / / Pacific Edge Limited (PEB), formerly Pacific Edge Biotech |
2011 | 750,00$ |
Merit Medical Systems, Inc. (MMSI) - Product Pipeline AnalysisMerit Medical Systems, Inc. (MMSI) - Product Pipeline Analysis / / Summary / / Merit Medical Systems, Inc. (Merit Medical) is a |
2011 | 750,00$ |
Luminex Corporation (LMNX) - Product Pipeline AnalysisLuminex Corporation (LMNX) - Product Pipeline Analysis / / Summary / / Luminex Corporation (Luminex) engages in the development, |
2011 | 750,00$ |
Artimplant AB (ARTI B) - Product Pipeline AnalysisArtimplant AB (ARTI B) - Product Pipeline Analysis / / Summary / / Artimplant AB (Artimplant) is a biomaterials company providin |
2011 | 750,00$ |
Biomerica, Inc. (BMRA) - Product Pipeline AnalysisBiomerica, Inc. (BMRA) - Product Pipeline Analysis / / Summary / / Biomerica, Inc. (Biomerica) is engaged in the development, ma |
2011 | 750,00$ |
SpectraScience, Inc. (SCIE) - Product Pipeline AnalysisSpectraScience, Inc. (SCIE) - Product Pipeline Analysis / / Summary / / SpectraScience, Inc. (SpectraScience) is a medical devic |
2011 | 750,00$ |
Cyberonics, Inc. (CYBX) - Product Pipeline AnalysisCyberonics, Inc. (CYBX) - Product Pipeline Analysis / / Summary / / Cyberonics, Inc. (Cyberonics) is a neuromodulation company. |
2011 | 750,00$ |
Quidel Corporation (QDEL) - Product Pipeline AnalysisQuidel Corporation (QDEL) - Product Pipeline Analysis / / Summary / / Quidel Corporation (Quidel) is a medical device company en |
2011 | 750,00$ |
Thoratec Corporation (THOR) - Product Pipeline AnalysisThoratec Corporation (THOR) - Product Pipeline Analysis / / Summary / / Thoratec Corporation (Thoratec) is a medical device comp |
2011 | 750,00$ |
Spire Corporation (SPIR) - Product Pipeline AnalysisSpire Corporation (SPIR) - Product Pipeline Analysis / / Summary / / Spire Corporation (Spire) is engaged in the development, ma |
2011 | 750,00$ |
Akers Biosciences, Inc. (AKR) - Product Pipeline AnalysisAkers Biosciences, Inc. (AKR) - Product Pipeline Analysis / / Summary / / Akers Biosciences, Inc. (ABI) is engaged in the develo |
2011 | 750,00$ |
DiaGenic ASA (DIAG) - Product Pipeline AnalysisDiaGenic ASA (DIAG) - Product Pipeline Analysis / / Summary / / DiaGenic ASA (DiaGenic) is a life sciences company, primarily en |
2011 | 750,00$ |
Nephros, Inc. (NEPH) - Product Pipeline AnalysisNephros, Inc. (NEPH) - Product Pipeline Analysis / / Summary / / Nephros, Inc. (Nephros) is US-based medical device company that |
2011 | 750,00$ |
Calypte Biomedical Corporation (CBMC) - Product Pipeline AnalysisCalypte Biomedical Corporation (CBMC) - Product Pipeline Analysis / / Summary / / Calypte Biomedical Corporation (Calypte) is a |
2011 | 750,00$ |
Misonix, Inc. (MSON) - Product Pipeline AnalysisMisonix, Inc. (MSON) - Product Pipeline Analysis / / Summary / / Misonix, Inc. (Misonix) is engaged in the design, development, |
2011 | 750,00$ |
Antares Pharma, Inc. (AIS) - Product Pipeline AnalysisAntares Pharma, Inc. (AIS) - Product Pipeline Analysis / / Summary / / Antares Pharma, Inc. (Antares Pharma) is a specialty phar |
2011 | 750,00$ |
Clarient, Inc. - Product Pipeline AnalysisClarient, Inc. - Product Pipeline Analysis / / Summary / / Clarient, Inc. (Clarient) is an oncology diagnostics services company |
2011 | 750,00$ |
Cardium Therapeutics, Inc. (CXM) - Product Pipeline AnalysisCardium Therapeutics, Inc. (CXM) - Product Pipeline Analysis / / Summary / / Cardium Therapeutics, Inc. (Cardium) is a medical t |
2011 | 750,00$ |
LeMaitre Vascular, Inc. (LMAT) - Product Pipeline AnalysisLeMaitre Vascular, Inc. (LMAT) - Product Pipeline Analysis / / Summary / / LeMaitre Vascular, Inc. (LeMaitre Vascular) is a medi |
2011 | 750,00$ |
Cytori Therapeutics, Inc. (XMP) - Product Pipeline AnalysisCytori Therapeutics, Inc. (XMP) - Product Pipeline Analysis / / Summary / / Cytori Therapeutics, Inc. (Cytori) is a medical devi |
2011 | 750,00$ |
NuVasive, Inc. (NUVA) - Product Pipeline AnalysisNuVasive, Inc. (NUVA) - Product Pipeline Analysis / / Summary / / NuVasive, Inc. (NuVasive) is a medical device company engaged |
2011 | 750,00$ |
Ethicon Endo-Surgery, Inc. - Product Pipeline AnalysisEthicon Endo-Surgery, Inc. - Product Pipeline Analysis / / Summary / / Ethicon Endo-Surgery, Inc. (EES) is a US-based medical de |
2011 | 750,00$ |
Abbott Diagnostics - Product Pipeline AnalysisAbbott Diagnostics - Product Pipeline Analysis / / Summary / / Abbott Diagnostics, one of the world’s leading in vitro diagnosti |
2011 | 750,00$ |
Integra LifeSciences Holdings Corporation (IART) - Product Pipeline AnalysisIntegra LifeSciences Holdings Corporation (IART) - Product Pipeline Analysis / / Summary / / Integra LifeSciences Holdings Corpo |
2011 | 750,00$ |
Kinetic Concepts, Inc. (KCI) - Product Pipeline AnalysisKinetic Concepts, Inc. (KCI) - Product Pipeline Analysis / / Summary / / Kinetic Concepts, Inc. (KCI) is a global medical techno |
2011 | 750,00$ |
Cepheid (CPHD) - Product Pipeline AnalysisCepheid (CPHD) - Product Pipeline Analysis / / Summary / / Cepheid is a molecular diagnostic company, engaged in the development |
2011 | 750,00$ |
Alphatec Holdings, Inc. (ATEC) - Product Pipeline AnalysisAlphatec Holdings, Inc. (ATEC) - Product Pipeline Analysis / / Summary / / Alphatec Holdings, Inc. (Alphatec) is a medical techn |
2011 | 750,00$ |
Epigenomics AG (ECX) - Product Pipeline AnalysisEpigenomics AG (ECX) - Product Pipeline Analysis / / Summary / / Epigenomics AG (Epigenomics) is a molecular diagnostics company |
2011 | 750,00$ |
Anika Therapeutics, Inc. (ANIK) - Product Pipeline AnalysisAnika Therapeutics, Inc. (ANIK) - Product Pipeline Analysis / / Summary / / Anika Therapeutics, Inc. (Anika) is engaged in the d |
2011 | 750,00$ |
Nanosphere, Inc. (NSPH) - Product Pipeline AnalysisNanosphere, Inc. (NSPH) - Product Pipeline Analysis / / Summary / / Nanosphere, Inc. (Nanosphere) is a nanotechnology-based mole |
2011 | 750,00$ |
Endologix, Inc. (ELGX) - Product Pipeline AnalysisEndologix, Inc. (ELGX) - Product Pipeline Analysis / / Summary / / Endologix, Inc. (Endologix) is a medical device company engag |
2011 | 750,00$ |
Cardiac Assist Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017Introduction / / GlobalData’s new report, “Cardiac Assist Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Af |
2011 | 2.500,00$ |
Cardiac Rhythm Management Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017Introduction / / GlobalData’s new report, “Cardiac Rhythm Management Market Outlook in BRICS (Brazil, Russia, India, China, South |
2011 | 2.500,00$ |
Cardiovascular Prosthetic Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017Introduction / / GlobalData’s new report, “Cardiovascular Prosthetic Devices Market Outlook in BRICS (Brazil, Russia, India, Chin |
2011 | 2.500,00$ |
Cardiovascular Surgery Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017Introduction / / GlobalData’s new report, “Cardiovascular Surgery Market Outlook in BRICS (Brazil, Russia, India, China, South Af |
2011 | 2.500,00$ |
Prosthetic Heart Valves Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017Introduction / / GlobalData’s new report, “Prosthetic Heart Valves Market Outlook in BRICS (Brazil, Russia, India, China, South A |
2011 | 2.500,00$ |
Electrophysiology Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017Introduction / / GlobalData’s new report, “Electrophysiology Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) |
2011 | 2.500,00$ |
External Defibrillator Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017Introduction / / GlobalData’s new report, “External Defibrillator Market Outlook in BRICS (Brazil, Russia, India, China, South Af |
2011 | 2.500,00$ |
Orthobiologics Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017Introduction / / GlobalData’s new report, “Orthobiologics Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to |
2011 | 2.500,00$ |
Merge Healthcare Completes Acquisition of Ophthalmic Imaging Systems (OIS) - A Move to Expand into New Markets through Strategic Acquisition - Deal Analysis from GlobalDataIntroduction / / GlobalData’s “Merge Healthcare Completes Acquisition of Ophthalmic Imaging Systems (OIS): A Move to Expand Throu |
2011 | 500,00$ |
Orthopedic Joint Reconstruction Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017Introduction / / GlobalData’s new report, “Orthopedic Joint Reconstruction Market Outlook in BRICS (Brazil, Russia, India, China, |
2011 | 2.500,00$ |
Spinal Surgery Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017Introduction / / GlobalData’s new report, “Spinal Surgery Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to |
2011 | 2.500,00$ |
Trauma Fixation Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017Introduction / / GlobalData’s new report, “Trauma Fixation Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) t |
2011 | 2.500,00$ |
Arthroscopy Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017Introduction / / GlobalData’s new report, “Arthroscopy Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 20 |
2011 | 2.500,00$ |
Orthopedic Accessories Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017Introduction / / GlobalData’s new report, “Orthopedic Accessories Market Outlook in BRICS (Brazil, Russia, India, China, South Af |
2011 | 2.500,00$ |
Orthopedic Braces and Supports Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017Introduction / / GlobalData’s new report, “Orthopedic Braces and Supports Market Outlook in BRICS (Brazil, Russia, India, China, |
2011 | 2.500,00$ |
Cranio Maxillofacial Fixation (CMF) Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017Introduction / / GlobalData’s new report, “Cranio Maxillofacial Fixation (CMF) Market Outlook in BRICS (Brazil, Russia, India, Ch |
2011 | 2.500,00$ |
Orthopedic Prosthetics Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017Introduction / / GlobalData’s new report, “Orthopedic Prosthetics Market Outlook in BRICS (Brazil, Russia, India, China, South Af |
2011 | 2.500,00$ |
Operating Room Equipment - Global Opportunity Assessment, Competitive Landscape and Market Forecasts to 2017Introduction / / GlobalData’s new report, “Operating Room Equipment - Global Opportunity Assessment, Competitive Landscape and Ma |
2011 | 3.500,00$ |
North America Cardiovascular Devices Market Outlook to 2017Introduction / / GlobalData’s new report, “North America Cardiovascular Devices Market Outlook to 2017” provides key market data |
2011 | 3.500,00$ |
Europe Cardiovascular Devices Market Outlook to 2017Introduction / / GlobalData’s new report, “Europe Cardiovascular Devices Market Outlook to 2017” provides key market data on the |
2011 | 3.500,00$ |
Asia-Pacific Cardiovascular Devices Market Outlook to 2017Introduction / / GlobalData’s new report, “Asia-Pacific Cardiovascular Devices Market Outlook to 2017” provides key market data |
2011 | 3.500,00$ |
Orthobiologics - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017Introduction / / GlobalData’s new report, “Orthobiologics - Global Pipeline Analysis, Competitive Landscape and Market Forecasts |
2011 | 3.500,00$ |
Medical Equipment Monthly Deals Analysis - M&A and Investment Trends - August 2011Introduction / / GlobalData's “Medical Equipment Monthly Deals Analysis - M&A and Investment Trends - August 2011” report is an e |
2011 | 1.000,00$ |
United States Cardiovascular Devices Market Outlook to 2017 - Cardiac Rhythm Management, Interventional Cardiology, Peripheral Vascular Devices, Prosthetic Heart Valves, Electrophysiology and OthersIntroduction / / GlobalData’s new report, “United States Cardiovascular Devices Market Outlook to 2017 - Cardiac Rhythm Managemen |
2011 | 2.500,00$ |
United Kingdom Cardiovascular Devices Market Outlook to 2017 - Cardiac Rhythm Management, Interventional Cardiology, Peripheral Vascular Devices, Prosthetic Heart Valves, Electrophysiology and OthersIntroduction / / GlobalData’s new report, “United Kingdom Cardiovascular Devices Market Outlook to 2017 - Cardiac Rhythm Manageme |
2011 | 2.500,00$ |
Japan Cardiovascular Devices Market Outlook to 2017 - Cardiac Rhythm Management, Interventional Cardiology, Peripheral Vascular Devices, Prosthetic Heart Valves, Electrophysiology and OthersIntroduction / / GlobalData’s new report, “Japan Cardiovascular Devices Market Outlook to 2017 - Cardiac Rhythm Management, Inter |
2011 | 2.500,00$ |
India Cardiovascular Devices Market Outlook to 2017 - Cardiac Rhythm Management, Interventional Cardiology, Peripheral Vascular Devices, Prosthetic Heart Valves, Electrophysiology and OthersIntroduction / / GlobalData’s new report, “India Cardiovascular Devices Market Outlook to 2017 - Cardiac Rhythm Management, Inter |
2011 | 2.500,00$ |
China Cardiovascular Devices Market Outlook to 2017 - Cardiac Rhythm Management, Interventional Cardiology, Peripheral Vascular Devices, Prosthetic Heart Valves, Electrophysiology and OthersIntroduction / / GlobalData’s new report, “China Cardiovascular Devices Market Outlook to 2017 - Cardiac Rhythm Management, Inter |
2011 | 2.500,00$ |
Canada Cardiovascular Devices Market Outlook to 2017 - Cardiac Rhythm Management, Interventional Cardiology, Peripheral Vascular Devices, Prosthetic Heart Valves, Electrophysiology and OthersIntroduction / / GlobalData’s new report, “Canada Cardiovascular Devices Market Outlook to 2017 - Cardiac Rhythm Management, Inte |
2011 | 2.500,00$ |
Germany Cardiovascular Devices Market Outlook to 2017 - Cardiac Rhythm Management, Interventional Cardiology, Peripheral Vascular Devices, Prosthetic Heart Valves, Electrophysiology and OthersIntroduction / / GlobalData’s new report, “Germany Cardiovascular Devices Market Outlook to 2017 - Cardiac Rhythm Management, Int |
2011 | 2.500,00$ |
France Cardiovascular Devices Market Outlook to 2017 - Cardiac Rhythm Management, Interventional Cardiology, Peripheral Vascular Devices, Prosthetic Heart Valves, Electrophysiology and OthersIntroduction / / GlobalData’s new report, “France Cardiovascular Devices Market Outlook to 2017 - Cardiac Rhythm Management, Inte |
2011 | 2.500,00$ |
Italy Cardiovascular Devices Market Outlook to 2017 - Cardiac Rhythm Management, Interventional Cardiology, Peripheral Vascular Devices, Prosthetic Heart Valves, Electrophysiology and OthersIntroduction / / GlobalData’s new report, “Italy Cardiovascular Devices Market Outlook to 2017 - Cardiac Rhythm Management, Inter |
2011 | 2.500,00$ |
Spain Cardiovascular Devices Market Outlook to 2017 - Cardiac Rhythm Management, Interventional Cardiology, Peripheral Vascular Devices, Prosthetic Heart Valves, Electrophysiology and OthersIntroduction / / GlobalData’s new report, “Spain Cardiovascular Devices Market Outlook to 2017 - Cardiac Rhythm Management, Inter |
2011 | 2.500,00$ |
Australia Cardiovascular Devices Market Outlook to 2017 - Cardiac Rhythm Management, Interventional Cardiology, Peripheral Vascular Devices, Prosthetic Heart Valves, Electrophysiology and OthersIntroduction / / GlobalData’s new report, “Australia Cardiovascular Devices Market Outlook to 2017 - Cardiac Rhythm Management, I |
2011 | 2.500,00$ |
Brazil Cardiovascular Devices Market Outlook to 2017 - Cardiac Rhythm Management, Interventional Cardiology, Peripheral Vascular Devices, Prosthetic Heart Valves, Electrophysiology and OthersIntroduction / / GlobalData’s new report, “Brazil Cardiovascular Devices Market Outlook to 2017 - Cardiac Rhythm Management, Inte |
2011 | 2.500,00$ |
Argentina Cardiovascular Devices Market Outlook to 2017 - Cardiac Rhythm Management, Interventional Cardiology, Peripheral Vascular Devices, Prosthetic Heart Valves, Electrophysiology and OthersIntroduction / / GlobalData’s new report, “Argentina Cardiovascular Devices Market Outlook to 2017 - Cardiac Rhythm Management, I |
2011 | 2.500,00$ |
Postmenopausal Osteoporosis Therapeutics - Pipeline Assessment and Market Forecasts to 2017Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Postmenopausal Osteoporosis Therapeu |
2011 | 2.000,00$ |
Pneumococcal Infections - Pipeline Assessment and Market Forecasts to 2017Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Pneumococcal Infections - Pipeline A |
2011 | 2.000,00$ |
Uterine Fibroids Therapeutics - Pipeline Assessment and Market Forecasts to 2017Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Uterine Fibroids Therapeutics - Pipe |
2011 | 2.000,00$ |
Acromegaly and Gigantism Therapeutics - Pipeline Assessment and Market Forecasts to 2017Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Acromegaly and Gigantism Therapeutic |
2011 | 2.000,00$ |
Staphylococcal Infections Therapeutics - Pipeline Assessment and Market Forecasts to 2017Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Staphylococcal Infections Therapeuti |
2011 | 2.000,00$ |
Idiopathic Pulmonary Fibrosis (IPF) Therapeutics - Pipeline Assessment and Market Forecasts to 2018Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Idiopathic Pulmonary Fibrosis (IPF) |
2011 | 3.500,00$ |
Nonalcoholic Steatohepatitis (NASH) Therapeutics - Pipeline Assessment and Market Forecasts to 2018Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Nonalcoholic Steatohepatitis (NASH) |
2011 | 3.500,00$ |
Women’s Infertility Therapeutics - Pipeline Assessment and Market Forecasts to 2018Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Women’s Infertility Therapeutics - P |
2011 | 3.500,00$ |
Anemia Therapeutics - Pipeline Assessment and Market Forecasts to 2018Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Anemia Therapeutics - Pipeline Asses |
2011 | 3.500,00$ |
Chronic Obstructive Pulmonary Disease (COPD) Therapeutics - Pipeline Assessment and Market Forecasts to 2018Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Chronic Obstructive Pulmonary Diseas |
2011 | 3.500,00$ |
Acne Therapeutics - Pipeline Assessment and Market Forecasts to 2018Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Acne Therapeutics - Pipeline Assessm |
2011 | 3.500,00$ |
Cystic Fibrosis (CF) Therapeutics - Pipeline Assessment and Market Forecasts to 2018Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Cystic Fibrosis (CF) Therapeutics - |
2011 | 3.500,00$ |
Breast Cancer Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Breast Cancer Global Clinical Trials Review, H2, 2011" provides data on the |
2011 | 1.000,00$ |
Acute Lymphocytic Leukemia (ALL) Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Acute Lymphocytic Leukemia (ALL) Global Clinical Trials Review, H2, 2011" p |
2011 | 1.000,00$ |
Acute Myelocytic Leukemia (AML) Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Acute Myelocytic Leukemia (AML) Global Clinical Trials Review, H2, 2011" pr |
2011 | 1.000,00$ |
Bile Duct Cancer Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Bile Duct Cancer Global Clinical Trials Review, H2, 2011" provides data on |
2011 | 1.000,00$ |
Bladder Cancer Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Bladder Cancer Global Clinical Trials Review, H2, 2011" provides data on th |
2011 | 1.000,00$ |
Bone Cancer Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Bone Cancer Global Clinical Trials Review, H2, 2011" provides data on the B |
2011 | 1.000,00$ |
Brain Cancer Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Brain Cancer Global Clinical Trials Review, H2, 2011" provides data on the |
2011 | 1.000,00$ |
Cervical Cancer Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Cervical Cancer Global Clinical Trials Review, H2, 2011" provides data on t |
2011 | 1.000,00$ |
Chronic Lymphocytic Leukemia (CLL) Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Chronic Lymphocytic Leukemia (CLL) Global Clinical Trials Review, H2, 2011" |
2011 | 1.000,00$ |
Chronic Myelocytic Leukemia (CML) Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Chronic Myelocytic Leukemia (CML) Global Clinical Trials Review, H2, 2011" |
2011 | 1.000,00$ |
Hemophilia B Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Hemophilia B Global Clinical Trials Review, H2, 2011" provides data on the |
2011 | 1.000,00$ |
Liver Transplantation Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Liver Transplantation Global Clinical Trials Review, H2, 2011" provides dat |
2011 | 1.000,00$ |
Heart Transplantation Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Heart Transplantation Global Clinical Trials Review, H2, 2011" provides dat |
2011 | 1.000,00$ |
Endometriosis Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Endometriosis Global Clinical Trials Review, H2, 2011" provides data on the |
2011 | 1.000,00$ |
Shigella Infections Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Shigella Infections Global Clinical Trials Review, H2, 2011" provides data |
2011 | 1.000,00$ |
Cardiogenic Shock Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Cardiogenic Shock Global Clinical Trials Review, H2, 2011" provides data on |
2011 | 1.000,00$ |
Colon Cancers Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Colon Cancers Global Clinical Trials Review, H2, 2011" provides data on the |
2011 | 1.000,00$ |
Hyperlipidemia Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Hyperlipidemia Global Clinical Trials Review, H2, 2011" provides data on th |
2011 | 1.000,00$ |
Hyperparathyroidism Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Hyperparathyroidism Global Clinical Trials Review, H2, 2011" provides data |
2011 | 1.000,00$ |
Inflammation Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Inflammation Global Clinical Trials Review, H2, 2011" provides data on the |
2011 | 1.000,00$ |
Myopia Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Myopia Global Clinical Trials Review, H2, 2011" provides data on the Myopia |
2011 | 1.000,00$ |
Sepsis Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Sepsis Global Clinical Trials Review, H2, 2011" provides data on the Sepsis |
2011 | 1.000,00$ |
Ulcerative Colitis Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Ulcerative Colitis Global Clinical Trials Review, H2, 2011" provides data o |
2011 | 1.000,00$ |
Inflammatory Bowel Disease Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Inflammatory Bowel Disease Global Clinical Trials Review, H2, 2011" provide |
2011 | 1.000,00$ |
Hypothyroidism Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Hypothyroidism Global Clinical Trials Review, H2, 2011" provides data on th |
2011 | 1.000,00$ |
Benign Prostatic Hyperplasia Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Benign Prostatic Hyperplasia Global Clinical Trials Review, H2, 2011" provi |
2011 | 1.000,00$ |
Peritoneal Tumor Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Peritoneal Tumor Global Clinical Trials Review, H2, 2011" provides data on |
2011 | 1.000,00$ |
Malnutrition Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Malnutrition Global Clinical Trials Review, H2, 2011" provides data on the |
2011 | 1.000,00$ |
Vitamin D Deficiency Global Clinical Trials Review, H2, 2011Introduction / / GlobalData's clinical trial report, “Vitamin D Deficiency Global Clinical Trials Review, H2, 2011" provides data |
2011 | 1.000,00$ |
Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - August 2011Introduction / / GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals – August 2011” re |
2011 | 1.000,00$ |
Facial Aesthetics (Botox, Dermal Fillers, Collagen) - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017Introduction / / GlobalData’s new report, “Facial Aesthetics (Botox, Dermal Fillers, Collagen) - Global Pipeline Analysis, Compet |
2011 | 3.500,00$ |
Hospital Supplies Market Outlook in United States to 2017 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and OthersIntroduction / / GlobalData’s new report, “Hospital Supplies Market Outlook in United States to 2017 - Disposable Hospital Suppli |
2011 | 2.500,00$ |
Covidien Set to Become a Pure-play Medical Devices Company - Expected to sell its Pharmaceutical Business UnitIntroduction / / GlobalData’s medical equipment report “Covidien Set to Become a Pure-play Medical Devices Company - Expected to |
2011 | 500,00$ |
Orthobiologics - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016Introduction / / GlobalData’s new report, “Orthobiologics - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts |
2010 | 3.500,00$ |
Acute Pain Therapeutics - Pipeline Assessment and Market Forecasts to 2017Introduction / / GlobalData has released its new report, “Acute Pain Therapeutics - Pipeline Assessment and Market Forecasts to 2 |
2011 | 2.000,00$ |
Chronic Lymphocytic Leukemia (CLL) Therapeutics - Pipeline Assessment and Market Forecasts to 2017Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Chronic Lymphocytic Leukemia (CLL) T |
2011 | 2.000,00$ |
Liver Cirrhosis Therapeutics - Pipeline Assessment and Market Forecasts to 2017Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Liver Cirrhosis Therapeutics - Pipel |
2011 | 2.000,00$ |
Diabetic Retinopathy Therapeutics - Pipeline Assessment and Market Forecasts to 2017Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Diabetic Retinopathy Therapeutics - |
2011 | 2.000,00$ |
Diabetic Neuropathy Therapeutics - Pipeline Assessment and Market Forecasts to 2017Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Diabetic Neuropathy Therapeutics - P |
2011 | 2.000,00$ |
Lupus Nephritis Therapeutics - Pipeline Assessment and Market Forecast to 2017Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Lupus Nephritis Therapeutics - Pipel |
2011 | 2.000,00$ |
Glomerulonephritis Therapeutics - Pipeline Assessment and Market Forecasts to 2017Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Glomerulonephritis Therapeutics - Pi |
2011 | 2.000,00$ |
Methicillin-Resistant Staphylococcus aureus (MRSA) Therapeutics - Pipeline Assessment and Market Forecasts to 2017Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Methicillin-Resistant Staphylococcus |
2011 | 2.000,00$ |
Hepatitis A Preventive Vaccines - Pipeline Assessment and Market Forecasts to 2017Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Hepatitis A Preventive Vaccines - Pi |
2011 | 2.000,00$ |
Gout Therapeutics - Pipeline Assessment and Market Forecasts to 2017Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Gout Therapeutics - Pipeline Assessm |
2011 | 2.000,00$ |
Herpes Zoster - Pipeline Assessment and Market Forecasts to 2017Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Herpes Zoster - Pipeline Assessment |
2011 | 2.000,00$ |
Dry Eye Syndrome Therapeutics - Pipeline Assessment and Market Forecasts to 2017Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Dry Eye Syndrome Therapeutics - Pipe |
2011 | 2.000,00$ |
H1N1 (Swine Influenza) - Pipeline Assessment and Market Forecasts to 2017Introduction / / GlobalData, the industry analysis specialist, has released its new report, “H1N1 (Swine Influenza) - Pipeline As |
2011 | 2.000,00$ |
Ascites Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Ascites Global Clinical Trials Review, Q1, 2011" provides data on the Ascit |
2011 | 1.000,00$ |
Gastrointestinal Stromal Tumors (GIST) Therapeutics - Pipeline Assessment and Market Forecasts to 2017Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Gastrointestinal Stromal Tumors (GIS |
2011 | 2.000,00$ |
Thyroid Cancer Therapeutics - Pipeline Assessment and Market Forecast to 2017Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Thyroid Cancer Therapeutics - Pipeli |
2011 | 2.000,00$ |
Endometrial Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2017Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Endometrial Cancer Therapeutics - Pi |
2011 | 2.000,00$ |
Bone Metastases Therapeutics - Pipeline Assessment and Market Forecasts to 2017Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Bone Metastases Therapeutics - Pipel |
2011 | 2.000,00$ |
Chronic Pain Therapeutics - Pipeline Assessment and Market Forecasts to 2017Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Chronic Pain Therapeutics - Pipeline |
2011 | 2.000,00$ |
Juvenile Rheumatoid Arthritis (JRA) Therapeutics - Pipeline Assessment and Market Forecasts to 2017Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Juvenile Rheumatoid Arthritis (JRA) |
2011 | 2.000,00$ |
Diabetic Foot Ulcer (DFU) Therapeutics - Pipeline Assessment and Market Forecasts to 2017Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Diabetic Foot Ulcer (DFU) Therapeuti |
2011 | 2.000,00$ |
Uveitis Therapeutics - Pipeline Assessment and Market Forecasts to 2017Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Uveitis Therapeutics - Pipeline Asse |
2011 | 2.000,00$ |
Traumatic Brain Injury (TBI) Therapeutics - Pipeline Assessment and Market Forecasts to 2017Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Traumatic Brain Injury (TBI) Therape |
2011 | 2.000,00$ |
Mucopolysaccharidosis Therapeutics - Pipeline Assessment and Market Forecasts to 2017Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Mucopolysaccharidosis Therapeutics - |
2011 | 2.000,00$ |
Osteoarthritis Pain Therapeutics - Pipeline Assessment and Market Forecasts to 2017Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Osteoarthritis Pain Therapeutics - P |
2011 | 2.000,00$ |
Dermatophytic Onychomycosis Therapeutics - Pipeline Assessment and Market Forecasts to 2017Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Dermatophytic Onychomycosis Therapeu |
2011 | 2.000,00$ |
Hypercholesterolemia Therapeutics - Pipeline Assessment and Market Forecasts to 2017Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Hypercholesterolemia Therapeutics - |
2011 | 2.000,00$ |
Acute Upper Respiratory Infections (AURI) Therapeutics - Pipeline Assessment and Market Forecasts to 2017Introduction / / GlobalData has released its new report, “Acute Upper Respiratory Infections (AURI) Therapeutics - Pipeline Asses |
2011 | 2.000,00$ |
Dementia Therapeutics - Pipeline Assessment and Market Forecasts to 2017Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Dementia Therapeutics - Pipeline Ass |
2011 | 2.000,00$ |
Cytomegalovirus (CMV) Retinitis Therapeutics - Pipeline Assessment and Market Forecasts to 2017Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Cytomegalovirus (CMV) Retinitis Ther |
2011 | 2.000,00$ |
Guillain Barre Syndrome (GBS) Therapeutics - Pipeline Assessment and Market Forecasts to 2017Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Guillain Barre Syndrome (GBS) Therap |
2011 | 2.000,00$ |
Retinal Vein Occlusion (RVO) Therapeutics - Pipeline Assessment and Market Forecasts to 2017Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Retinal Vein Occlusion (RVO) Therape |
2011 | 2.000,00$ |
HIV/AIDS Therapeutics - Pipeline Assessment and Market Forecasts to 2017Introduction / / GlobalData has released its new report, “HIV/AIDS Therapeutics - Pipeline Assessment and Market Forecasts to 201 |
2011 | 2.000,00$ |
Myelodysplastic Syndrome Therapeutics - Pipeline Assessment and Market Forecasts to 2017Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Myelodysplastic Syndrome Therapeutic |
2011 | 2.000,00$ |
Cancer Pain Therapeutics - Pipeline Assessment and Market Forecasts to 2017Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Cancer Pain Therapeutics - Pipeline |
2011 | 2.000,00$ |
Human Papillomavirus (HPV) Therapeutics - Pipeline Assessment and Market Forecasts to 2017Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Human Papillomavirus (HPV) Therapeut |
2011 | 2.000,00$ |
Testicular Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2017Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Testicular Cancer Therapeutics - Pip |
2011 | 2.000,00$ |
Osteosarcoma Therapeutics - Pipeline Assessment and Market Forecasts to 2017Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Osteosarcoma Therapeutics - Pipeline |
2011 | 2.000,00$ |
Anxiety Disorders Therapeutics - Pipeline Assessment and Market Forecasts to 2017Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Anxiety Disorders Therapeutics - Pip |
2011 | 2.000,00$ |
Acute Spinal Cord Injury (ASCI) Therapeutics - Pipeline Assessment and Market Forecasts to 2017Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Acute Spinal Cord Injury (ASCI) Ther |
2011 | 2.000,00$ |
Obsessive Compulsive Disorder (OCD) Therapeutics - Pipeline Assessment and Market Forecasts to 2017Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Obsessive Compulsive Disorder (OCD) |
2011 | 2.000,00$ |
AIDS-Related Kaposi’s Sarcoma (ARKS) Therapeutics -Pipeline Assessment and Market Forecasts to 2017Introduction / / GlobalData, the industry analysis specialist, has released its new report, “AIDS-Related Kaposi’s Sarcoma (ARKS) |
2011 | 2.000,00$ |
Diabetic Nephropathy Therapeutics - Pipeline Assessment and Market Forecasts to 2017Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Diabetic Nephropathy Therapeutics - |
2011 | 2.000,00$ |
Genital Herpes Therapeutics - Pipeline Assessment and Market Forecasts to 2017Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Genital Herpes Therapeutics - Pipeli |
2011 | 2.000,00$ |
Chronic Myelogenous Leukemia (CML) Therapeutics - Pipeline Assessment and Market Forecasts to 2017Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Chronic Myelogenous Leukemia (CML) T |
2011 | 2.000,00$ |
Acute Respiratory Distress Syndrome (ARDS) Therapeutics - Pipeline Assessment and Market Forecasts to 2017Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Acute Respiratory Distress Syndrome |
2011 | 2.000,00$ |
Choroidal Neovascularization (CNV) Therapeutics - Pipeline Assessment and Market Forecasts to 2017Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Choroidal Neovascularization (CNV) T |
2011 | 2.000,00$ |
Premature Ejaculation (PE) Therapeutics - Pipeline Assessment and Market Forecasts to 2017Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Premature Ejaculation (PE) Therapeut |
2011 | 2.000,00$ |
Shigella Infections Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Shigella Infections Global Clinical Trials Review, Q2, 2011" provides data |
2011 | 1.000,00$ |
Primary Biliary Cirrhosis Therapeutics - Pipeline Assessment and Market Forecasts to 2017Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Primary Biliary Cirrhosis Therapeuti |
2011 | 2.000,00$ |
Trigeminal Neuralgia (TN) Therapeutics - Pipeline Assessment and Market Forecasts to 2017Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Trigeminal Neuralgia (TN) Therapeuti |
2011 | 2.000,00$ |
Peripheral Ulcerative Keratitis Therapeutics - Pipeline Assessment and Market Forecasts to 2017Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Peripheral Ulcerative Keratitis Ther |
2011 | 2.000,00$ |
Oropharyngeal Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2017Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Oropharyngeal Cancer Therapeutics - |
2011 | 2.000,00$ |
Postherpetic Neuralgia (PHN) Therapeutics - Pipeline Assessment and Market Forecasts to 2017Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Postherpetic Neuralgia (PHN) Therape |
2011 | 2.000,00$ |
Post-Traumatic Stress Disorder (PTSD) Therapeutics - Pipeline Assessment and Market Forecasts to 2017Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Post-Traumatic Stress Disorder (PTSD |
2011 | 2.000,00$ |
Sepsis Therapeutics - Pipeline Assessment and Market Forecasts to 2017Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Sepsis Therapeutics - Pipeline Asses |
2011 | 2.000,00$ |
Ewing’s Sarcoma Therapeutics - Pipeline Assessment and Market Forecasts to 2017Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Ewing’s Sarcoma Therapeutics - Pipel |
2011 | 2.000,00$ |
Neuroendocrine Carcinoma Therapeutics - Pipeline Assessment and Market Forecast to 2017Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Neuroendocrine Carcinoma Therapeutic |
2011 | 2.000,00$ |
Critical Limb Ischemia (CLI) Therapeutics - Pipeline Assessment and Market Forecasts to 2017Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Critical Limb Ischemia (CLI) Therape |
2011 | 2.000,00$ |
Oral Mucositis Therapeutics - Pipeline Assessment and Market Forecasts to 2017Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Oral Mucositis Therapeutics - Pipeli |
2011 | 2.000,00$ |
Healthcare IT Market Outlook in Brazil to 2016- Hospital Information Systems and Medical Imaging Information SystemsIntroduction / / GlobalData’s medical equipment report, “Healthcare IT Market Outlook in Brazil to 2016- Hospital Information Sys |
2010 | 2.500,00$ |
Dental Radiology Equipment - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017Introduction / / GlobalData’s new report, “Dental Radiology Equipment - Global Pipeline Analysis, Competitive Landscape and Marke |
2011 | 3.500,00$ |
Gentium S.p.A’s Defibrotide Set to Become the First Treatment Option for Veno-occlusive Disease (VOD)Introduction / / GlobalData’s report “Gentium S.p.A’s Defibrotide Set to Become the First Treatment Option for Veno-occlusive Dis |
2011 | 500,00$ |
FDA Approves Xarelto (Rivaroxaban) - The First New Oral Anticoagulant Approved to Prevent VTE in Joint Replacement Surgeries in the USIntroduction / / GlobalData’s report “FDA Approves Xarelto (Rivaroxaban) - The First New Oral Anticoagulant Approved to Prevent V |
2011 | 500,00$ |
Erythropoiesis-Stimulating Agents in the Treatment of Chemotherapy Induced Anemia and Anemia in Chronic Kidney Disease in the USIntroduction / / GlobalData’s report “Erythropoiesis-Stimulating Agents in the Treatment of Chemotherapy Induced Anemia and Anemi |
2011 | 500,00$ |
Esophageal Cancer Therapeutics - Pipeline Assessment and Market Forecast to 2017Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Esophageal Cancer Therapeutics - Pip |
2011 | 2.000,00$ |
Hodgkin Lymphoma (HL) Therapeutics - Pipeline Assessment and Market Forecasts to 2017Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Hodgkin Lymphoma (HL) Therapeutics - |
2011 | 2.000,00$ |
Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q2 2011Introduction / / GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q2 2011” report |
2011 | 1.500,00$ |
KW 6002 (Parkinson's Disease) - Analysis and Sales Forecasts to 2020Introduction / / GlobalData’s pharmaceuticals report, “KW-6002(Parkinson's Disease) - Analysis and Sales Forecasts to 2020” provi |
2011 | 2.000,00$ |
IS Pharma plc (ISPH) - Financial and Strategic SWOT Analysis ReviewIS Pharma plc (ISPH) - Financial and Strategic SWOT Analysis Review / / Summary / / IS Pharma plc (Previously known as Maelor pl |
2011 | 125,00$ |
bioMD Limited (BOD) - Financial and Strategic SWOT Analysis ReviewbioMD Limited (BOD) - Financial and Strategic SWOT Analysis Review / / Summary / / bioMD Limited (bioMD) is a Western Australia- |
2011 | 125,00$ |
Gaymar Industries, Inc. - Strategic SWOT Analysis ReviewGaymar Industries, Inc. - Strategic SWOT Analysis Review / / Summary / / Gaymar Industries, Inc. (Gaymar) is a provider of produ |
2011 | 125,00$ |
Oberg Industries, Inc. - Strategic SWOT Analysis ReviewOberg Industries, Inc. - Strategic SWOT Analysis Review / / Summary / / Oberg Industries, Inc. (Oberg) is engaged in providing p |
2011 | 125,00$ |
Drug Eluting Stents - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017Introduction / / GlobalData’s new report, “Drug Eluting Stents - Global Pipeline Analysis, Competitive Landscape and Market Forec |
2011 | 3.500,00$ |
North America Orthopedic Devices Market Outlook to 2017Introduction / / GlobalData’s new report, “North America Orthopedic Devices Market Outlook to 2017” provides key market data on |
2011 | 3.500,00$ |
Europe Orthopedic Devices Market Outlook to 2017Introduction / / GlobalData’s new report, “Europe Orthopedic Devices Market Outlook to 2017” provides key market data on the Eu |
2011 | 3.500,00$ |
Asia Pacific Orthopedic Devices Market Outlook to 2017Introduction / / GlobalData’s new report, “Asia-Pacific Orthopedic Devices Market Outlook to 2017” provides key market data on t |
2011 | 3.500,00$ |
Middle East and Africa Orthopedic Devices Market Outlook to 2017Introduction / / GlobalData’s new report, “Middle East and Africa Orthopedic Devices Market Outlook to 2017” provides key market |
2011 | 3.500,00$ |
South and Central America Orthopedic Devices Market Outlook to 2017Introduction / / GlobalData’s new report, “South and Central America Orthopedic Devices Market Outlook to 2017” provides key mar |
2011 | 3.500,00$ |
Disposable Hospital Supplies - Global Opportunity Assessment, Competitive Landscape and Market Forecasts to 2017Introduction / / GlobalData’s new report, “Disposable Hospital Supplies - Global Opportunity Assessment, Competitive Landscape an |
2011 | 3.500,00$ |
Respiratory Measurement Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017Introduction / / GlobalData’s new report, “Respiratory Measurement Devices - Global Pipeline Analysis, Competitive Landscape and |
2011 | 3.500,00$ |
Interventional Cardiology Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017Introduction / / GlobalData’s new report, “Interventional Cardiology Devices - Global Pipeline Analysis, Competitive Landscape an |
2011 | 3.500,00$ |
Medical Equipment Quarterly Deals Analysis: M&A and Investment Trends - Q2 2011Introduction / / GlobalData's “Medical Equipment Quarterly Deals Analysis: M&A and Investment Trends - Q2 2011” report is an esse |
2011 | 1.500,00$ |
United Kingdom Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and OthersIntroduction / / GlobalData’s new report, “United Kingdom Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spina |
2011 | 2.500,00$ |
Germany Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and OthersIntroduction / / GlobalData’s new report, “Germany Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surge |
2011 | 2.500,00$ |
France Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and OthersIntroduction / / GlobalData’s new report, “France Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surger |
2011 | 2.500,00$ |
Italy Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and OthersIntroduction / / GlobalData’s new report, “Italy Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surgery |
2011 | 2.500,00$ |
Spain Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and OthersIntroduction / / GlobalData’s new report, “Spain Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surgery |
2011 | 2.500,00$ |
Brazil Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and OthersIntroduction / / GlobalData’s new report, “Brazil Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surger |
2011 | 2.500,00$ |
Netherlands Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and OthersIntroduction / / GlobalData’s new report, “Netherlands Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal S |
2011 | 2.500,00$ |
Belgium Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and OthersIntroduction / / GlobalData’s new report, “Belgium Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surge |
2011 | 2.500,00$ |
Mexico Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and OthersIntroduction / / GlobalData’s new report, “Mexico Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surger |
2011 | 2.500,00$ |
Republic of Korea Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and OthersIntroduction / / GlobalData’s new report, “Republic of Korea Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Sp |
2011 | 2.500,00$ |
Taiwan Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and OthersIntroduction / / GlobalData’s new report, “Taiwan Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surger |
2011 | 2.500,00$ |
South Africa Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and OthersIntroduction / / GlobalData’s new report, “South Africa Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal |
2011 | 2.500,00$ |
Austria Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and OthersIntroduction / / GlobalData’s new report, “Austria Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surge |
2011 | 2.500,00$ |
New Zealand Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and OthersIntroduction / / GlobalData’s new report, “New Zealand Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal S |
2011 | 2.500,00$ |
Denmark Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and OthersIntroduction / / GlobalData’s new report, “Denmark Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surge |
2011 | 2.500,00$ |
Saudi Arabia Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and OthersIntroduction / / GlobalData’s new report, “Saudi Arabia Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal |
2011 | 2.500,00$ |
United States Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and OthersIntroduction / / GlobalData’s new report, “United States Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal |
2011 | 2.500,00$ |
Japan Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and OthersIntroduction / / GlobalData’s new report, “Japan Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surgery |
2011 | 2.500,00$ |
India Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and OthersIntroduction / / GlobalData’s new report, “India Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surgery |
2011 | 2.500,00$ |
China Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and OthersIntroduction / / GlobalData’s new report, “China Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surgery |
2011 | 2.500,00$ |
Canada Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and OthersIntroduction / / GlobalData’s new report, “Canada Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surger |
2011 | 2.500,00$ |
Australia Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and OthersIntroduction / / GlobalData’s new report, “Australia Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Sur |
2011 | 2.500,00$ |
Argentina Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and OthersIntroduction / / GlobalData’s new report, “Argentina Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Sur |
2011 | 2.500,00$ |
Israel Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and OthersIntroduction / / GlobalData’s new report, “Israel Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surger |
2011 | 2.500,00$ |
Czech Republic Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and OthersIntroduction / / GlobalData’s new report, “Czech Republic Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spina |
2011 | 2.500,00$ |
Russian Federation Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and OthersIntroduction / / GlobalData’s new report, “Russian Federation Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, S |
2011 | 2.500,00$ |
Sweden Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and OthersIntroduction / / GlobalData’s new report, “Sweden Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surger |
2011 | 2.500,00$ |
Neurostimulation Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017Introduction / / GlobalData’s new report, “Neurostimulation Devices Market Outlook in BRICS (Brazil, Russia, India, China, South |
2011 | 2.500,00$ |
Interventional Neurology Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017Introduction / / GlobalData’s new report, “Interventional Neurology Market Outlook in BRICS (Brazil, Russia, India, China, South |
2011 | 2.500,00$ |
Infusion Systems Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017Introduction / / GlobalData’s new report, “Infusion Systems Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) |
2011 | 2.500,00$ |
Peripheral Vascular Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017Introduction / / GlobalData’s new report, “Peripheral Vascular Devices - Global Pipeline Analysis, Competitive Landscape and Mark |
2011 | 3.500,00$ |
Aesthetic Lasers and Energy Devices - Global Market Briefing to 2017Introduction / / GlobalData’s new report, “Aesthetic Lasers and Energy Devices - Global Market Briefing to 2017” provides key dat |
2011 | 3.500,00$ |
Respiratory Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017Introduction / / GlobalData’s new report, “Respiratory Devices - Global Pipeline Analysis, Competitive Landscape and Market Forec |
2011 | 3.500,00$ |
Bone Graft Substitutes - Global Pipeline Analysis, Competitive Landscape and Market Forecast to 2017Introduction / / GlobalData’s new report, “Bone Graft Substitutes - Global Pipeline Analysis, Competitive Landscape and Market Fo |
2011 | 3.500,00$ |
Medical Equipment Monthly Deals Analysis - M&A and Investment Trends, July 2011Introduction / / GlobalData's “Medical Equipment Monthly Deals Analysis - M&A and Investment Trends, July 2011” report is an esse |
2011 | 1.000,00$ |
Lab-on-Chip Devices - Diagnostics to Witness Growing Adoption in the FutureIntroduction / / GlobalData’s viewpoint, “Lab-on-Chip Devices - Diagnostics to Witness Growing Adoption in the Future” provides k |
2011 | 500,00$ |
The 43rd Meeting 2011 of the European Pancreatic Club – Post Conference Review and AnalysisIntroduction / / GlobalData, the industry analysis specialist, has released its new conference alert, “The 43rd Meeting 2011 of t |
2011 | 1.000,00$ |
71st Scientific sessions of American Diabetes Association 2011 - Post-Conference Review and AnalysisIntroduction / / GlobalData, the industry analysis specialist, has released its new conference alerts, “71st Scientific sessions |
2011 | 1.000,00$ |
Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals, July 2011Introduction / / GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals, July 2011” repor |
2011 | 1.000,00$ |
Neurosurgical Products Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017Introduction / / GlobalData’s new report, “Neurosurgical Products Market Outlook in BRICS (Brazil, Russia, India, China, South A |
2011 | 2.500,00$ |
Dental Chairs and Equipment Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017Introduction / / GlobalData’s new report, “Dental Chairs and Equipment Market Outlook in BRICS (Brazil, Russia, India, China, Sou |
2011 | 2.500,00$ |
Dental Lasers Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017Introduction / / GlobalData’s new report, “Dental Lasers Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to |
2011 | 2.500,00$ |
Dental Radiology Equipment Market Outlook in BRICS (Brazil, Russian, India, China, South Africa) to 2017Introduction / / GlobalData’s new report, “Dental Radiology Equipment Market Outlook in BRICS (Brazil, Russia, India, China, Sou |
2011 | 2.500,00$ |
Diagnostic Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017Introduction / / GlobalData’s new report, “Diagnostic Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa |
2011 | 2.500,00$ |
Hearing Aid Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017Introduction / / GlobalData’s new report, “Hearing Aid Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Afric |
2011 | 2.500,00$ |
Hearing Implants Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017Introduction / / GlobalData’s new report, “Hearing Implants Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) |
2011 | 2.500,00$ |
Central Venous Catheters Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017Introduction / / GlobalData’s new report, “Central Venous Catheters Market Outlook in BRICS (Brazil, Russia, India, China, South |
2011 | 2.500,00$ |
Disposable Hospital Supplies Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017Introduction / / GlobalData’s new report, “Disposable Hospital Supplies Market Outlook in BRICS (Brazil, Russia, India, China, So |
2011 | 2.500,00$ |
Patient Examination Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017Introduction / / GlobalData’s new report, “Patient Examination Devices Market Outlook in BRICS (Brazil, Russia, India, China, Sou |
2011 | 2.500,00$ |
Sterilization and Disinfectant Equipment Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017Introduction / / GlobalData’s new report, “Sterilization and Disinfectant Equipment Market Outlook in BRICS (Brazil, Russia, Indi |
2011 | 2.500,00$ |
Medical Syringes and Needles Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017Introduction / / GlobalData’s new report, “Medical Syringes and Needles Market Outlook in BRICS (Brazil, Russia, India, China, So |
2011 | 2.500,00$ |
CAD/CAM Dental Systems - Global Pipeline Analysis, Competitive Landscape and Market Forecast to 2017Introduction / / GlobalData’s new report, “CAD/CAM Dental Systems – Global Pipeline Analysis, Competitive Landscape and Market Fo |
2011 | 3.500,00$ |
Flexible Endoscopes - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017Introduction / / GlobalData’s new report, “Flexible Endoscopes - Global Pipeline Analysis, Competitive Landscape and Market Forec |
2011 | 3.500,00$ |
Capsule Endoscope Systems - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017Introduction / / GlobalData’s new report, “Capsule Endoscope Systems – Global Pipeline Analysis, Competitive Landscape and Market |
2011 | 3.500,00$ |
Global Food Microbiology Diagnostics Market - Tighter Food Safety Regulations to Drive MarketIntroduction / / GlobalData’s report, “Global Food Microbiology Diagnostics Market - Tighter Food Safety Regulations to Drive Mar |
2011 | 500,00$ |
Renal Dialysis Equipment Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017Introduction / / GlobalData’s new report, “Renal Dialysis Equipment Market Outlook in BRICS (Brazil, Russia, India, China, South |
2011 | 2.500,00$ |
Neurological Diagnostic Equipment Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017Introduction / / GlobalData’s new report, “Neurological Diagnostic Equipment Market Outlook in BRICS (Brazil, Russia, India, Chin |
2011 | 2.500,00$ |
Crowns and Bridges Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017Introduction / / GlobalData’s new report, “Crowns and Bridges Market Outlook in BRICS (Brazil, Russia, India, China, South Africa |
2011 | 2.500,00$ |
CAD/CAM Dental Systems Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017Introduction / / GlobalData’s new report, “CAD/CAM Dental Systems Market Outlook in BRICS (Brazil, Russia, India, China, South Af |
2011 | 2.500,00$ |
Waldenstrom Macroglobulinemia Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Waldenstrom Macroglobulinemia Global Clinical Trials Review, Q2, 2011" prov |
2011 | 1.000,00$ |
Keratoconjunctivitis sicca (Dry Eye) Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Keratoconjunctivitis sicca (Dry Eye) Global Clinical Trials Review, Q2, 201 |
2011 | 1.000,00$ |
Gastrointestinal Endoscopes - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017Introduction / / GlobalData’s new report, “Gastrointestinal Endoscopes - Global Pipeline Analysis, Competitive Landscape and Mark |
2011 | 3.500,00$ |
Japanese Medical Device Industry - An OverviewIntroduction / / GlobalData’s medical equipment report, “Japanese Medical Device Industry - An Overview” provides the medical equ |
2011 | 500,00$ |
Dental Implants Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017Introduction / / GlobalData’s new report, “Dental Implants Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) t |
2011 | 2.500,00$ |
Dental Biomaterials Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017Introduction / / GlobalData’s new report, “Dental Biomaterials Market Outlook in BRICS (Brazil, Russia, India, China, South Afric |
2011 | 2.500,00$ |
Mobility Aids and Transportation Equipment Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017Introduction / / GlobalData’s new report, “Mobility Aids and Transportation Equipment Market Outlook in BRICS (Brazil, Russia, In |
2011 | 2.500,00$ |
Operating Room Equipment Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017Introduction / / GlobalData’s new report, “Operating Room Equipment Market Outlook in BRICS (Brazil, Russia, India, China, South |
2011 | 2.500,00$ |
Incontinence Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017Introduction / / GlobalData’s new report, “Incontinence Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Afri |
2011 | 2.500,00$ |
Hypothyroidism Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Hypothyroidism Global Clinical Trials Review, Q2, 2011" provides data on th |
2011 | 1.000,00$ |
Peritoneal Tumor Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Peritoneal Tumor Global Clinical Trials Review, Q2, 2011" provides data on |
2011 | 1.000,00$ |
Benign Prostatic Hyperplasia Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Benign Prostatic Hyperplasia Global Clinical Trials Review, Q2, 2011" provi |
2011 | 1.000,00$ |
Vitamin D Deficiency Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Vitamin D Deficiency Global Clinical Trials Review, Q2, 2011" provides data |
2011 | 1.000,00$ |
Polycystic Ovarian Syndrome Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Polycystic Ovarian Syndrome Global Clinical Trials Review, Q2, 2011" provid |
2011 | 1.000,00$ |
Growth Hormone Deficiency Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Growth Hormone Deficiency Global Clinical Trials Review, Q2, 2011" provides |
2011 | 1.000,00$ |
Systemic Sclerosis (Scleroderma) Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Systemic Sclerosis (Scleroderma) Global Clinical Trials Review, Q2, 2011" p |
2011 | 1.000,00$ |
Hyperparathyroidism Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Hyperparathyroidism Global Clinical Trials Review, Q2, 2011" provides data |
2011 | 1.000,00$ |
Bone Metastasis Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Bone Metastasis Global Clinical Trials Review, Q2, 2011" provides data on t |
2011 | 1.000,00$ |
Allergic Conjunctivitis Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Allergic Conjunctivitis Global Clinical Trials Review, Q2, 2011" provides d |
2011 | 1.000,00$ |
Chronic Plaque Psoriasis Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Chronic Plaque Psoriasis Global Clinical Trials Review, Q2, 2011" provides |
2011 | 1.000,00$ |
Heart Transplantation Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Heart Transplantation Global Clinical Trials Review, Q2, 2011" provides dat |
2011 | 1.000,00$ |
Osteopenia Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Osteopenia Global Clinical Trials Review, Q2, 2011" provides data on the Os |
2011 | 1.000,00$ |
Choroidal Neovascularization Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Choroidal Neovascularization Global Clinical Trials Review, Q2, 2011" provi |
2011 | 1.000,00$ |
Uterine Fibroids Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Uterine Fibroids Global Clinical Trials Review, Q2, 2011" provides data on |
2011 | 1.000,00$ |
Cachexia Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Cachexia Global Clinical Trials Review, Q2, 2011" provides data on the Cach |
2011 | 1.000,00$ |
Alcon, Inc. (ACL) - Product Pipeline AnalysisAlcon, Inc. (ACL) - Product Pipeline Analysis / / Summary / / Alcon, Inc. (Alcon) is one of the leading eye care providers in th |
2011 | 750,00$ |
Exactech, Inc. (EXAC) - Product Pipeline AnalysisExactech, Inc. (EXAC) - Product Pipeline Analysis / / Summary / / Exactech, Inc. (Exactech) is engaged in the development, manuf |
2011 | 750,00$ |
Vermillion, Inc. (VRML) - Product Pipeline AnalysisVermillion, Inc. (VRML) - Product Pipeline Analysis / / Summary / / Vermillion, Inc. (VRML) is a pharmaceutical company that dis |
2011 | 750,00$ |
Volcano Corporation (VOLC) - Product Pipeline AnalysisVolcano Corporation (VOLC) - Product Pipeline Analysis / / Summary / / Volcano Corporation (Volcano) is a medical device company |
2011 | 750,00$ |
Aachen Resonance GmbH - Product Pipeline AnalysisAachen Resonance GmbH - Product Pipeline Analysis / / Summary / / Aachen Resonance GmbH (Aachen Resonance) is engaged in the dev |
2011 | 750,00$ |
Nobel Biocare Holding AG (NOBN) - Product Pipeline AnalysisNobel Biocare Holding AG (NOBN) - Product Pipeline Analysis / / Summary / / Nobel Biocare Holding AG (Nobel Biocare) is a medica |
2011 | 750,00$ |
Globus Medical, Inc. - Product Pipeline AnalysisGlobus Medical, Inc. - Product Pipeline Analysis / / Summary / / Globus Medical, Inc. (Globus Medical) is a privately-held medic |
2011 | 750,00$ |
TrovaGene, Inc. (TROV) - Product Pipeline AnalysisTrovaGene, Inc. (TROV) - Product Pipeline Analysis / / Summary / / TrovaGene, Inc. (TrovaGene), formally, Xenomics, Inc. is a de |
2011 | 750,00$ |
aap Implantate AG (AAQ) - Product Pipeline Analysisaap Implantate AG (AAQ) - Product Pipeline Analysis / / Summary / / aap Implantate AG (aap) is a medical technology company prin |
2011 | 750,00$ |
DiaSorin S.p.A (DIA) - Product Pipeline AnalysisDiaSorin S.p.A (DIA) - Product Pipeline Analysis / / Summary / / DiaSorin S.p.A. (DiaSorin) is a medical device company, engaged |
2011 | 750,00$ |
Kuros Biosurgery AG - Product Pipeline AnalysisKuros Biosurgery AG - Product Pipeline Analysis / / Summary / / Kuros Biosurgery AG (Kuros) is a biomedical company engaged in t |
2011 | 750,00$ |
Smith & Nephew Plc (SN.) - Product Pipeline AnalysisSmith & Nephew Plc (SN.) - Product Pipeline Analysis / / Summary / / Smith & Nephew Plc (Smith & Nephew) is a global medical dev |
2011 | 750,00$ |
BIOLASE Technology, Inc. (BLTI) - Product Pipeline AnalysisBIOLASE Technology, Inc. (BLTI) - Product Pipeline Analysis / / Summary / / BIOLASE Technology, Inc. (BIOLASE) is a medical tech |
2011 | 750,00$ |
BioTex, Inc. - Product Pipeline AnalysisBioTex, Inc. - Product Pipeline Analysis / / Summary / / BioTex, Inc. (BioTex) is engaged in the research, development and marke |
2011 | 750,00$ |
The 2011 ASCO (American Society of Clinical Oncology) Annual Meeting - Post Conference Review and AnalysisIntroduction / / GlobalData, the industry analysis specialist, has released its new conference alerts, “The 2011 ASCO (American S |
2011 | 1.000,00$ |
Kidney Transplantation Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Kidney Transplantation Global Clinical Trials Review, Q2, 2011" provides da |
2011 | 1.000,00$ |
Pregnancy Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Pregnancy Global Clinical Trials Review, Q2, 2011" provides data on the Pre |
2011 | 1.000,00$ |
Smoking Addiction Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Smoking Addiction Global Clinical Trials Review, Q2, 2011" provides data on |
2011 | 1.000,00$ |
Inflammation Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Inflammation Global Clinical Trials Review, Q2, 2011" provides data on the |
2011 | 1.000,00$ |
Ocular Hypertension Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Ocular Hypertension Global Clinical Trials Review, Q2, 2011" provides data |
2011 | 1.000,00$ |
Post Menopausal Osteoporosis Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Post Menopausal Osteoporosis Global Clinical Trials Review, Q2, 2011" provi |
2011 | 1.000,00$ |
Infertility Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Infertility Global Clinical Trials Review, Q2, 2011" provides data on the I |
2011 | 1.000,00$ |
Nausea and Vomiting Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Nausea and Vomiting Global Clinical Trials Review, Q2, 2011" provides data |
2011 | 1.000,00$ |
Open-Angle Glaucoma Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Open-Angle Glaucoma Global Clinical Trials Review, Q2, 2011" provides data |
2011 | 1.000,00$ |
Urinary Incontinence Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Urinary Incontinence Global Clinical Trials Review, Q2, 2011" provides data |
2011 | 1.000,00$ |
Systemic Lupus Erythematosus Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Systemic Lupus Erythematosus Global Clinical Trials Review, Q2, 2011" provi |
2011 | 1.000,00$ |
Erectile Dysfunction Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Erectile Dysfunction Global Clinical Trials Review, Q2, 2011" provides data |
2011 | 1.000,00$ |
Overactive Bladder Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Overactive Bladder Global Clinical Trials Review, Q2, 2011" provides data o |
2011 | 1.000,00$ |
HIV-1 Infection Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “HIV-1 Infection Global Clinical Trials Review, Q2, 2011" provides data on t |
2011 | 1.000,00$ |
Acute Renal Failure (ARF) (Acute Kidney Injury) Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Acute Renal Failure (ARF) (Acute Kidney Injury) Global Clinical Trials Revi |
2011 | 1.000,00$ |
Transplantation Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Transplantation Global Clinical Trials Review, Q2, 2011" provides data on t |
2011 | 1.000,00$ |
Ankylosing Spondylitis (Bekhterev’s Disease) Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Ankylosing Spondylitis (Bekhterev’s Disease) Global Clinical Trials Review, |
2011 | 1.000,00$ |
Acne Vulgaris Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Acne Vulgaris Global Clinical Trials Review, Q2, 2011" provides data on the |
2011 | 1.000,00$ |
Liver Transplantation Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Liver Transplantation Global Clinical Trials Review, Q2, 2011" provides dat |
2011 | 1.000,00$ |
Cytomegalovirus (HHV-5) Infections Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Cytomegalovirus (HHV-5) Infections Global Clinical Trials Review, Q2, 2011" |
2011 | 1.000,00$ |
Pertussis Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Pertussis Global Clinical Trials Review, Q2, 2011" provides data on thePert |
2011 | 1.000,00$ |
Macular Degeneration Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Macular Degeneration Global Clinical Trials Review, Q2, 2011" provides data |
2011 | 1.000,00$ |
Myeloproliferative Disorders Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Myeloproliferative Disorders Global Clinical Trials Review, Q2, 2011" provi |
2011 | 1.000,00$ |
Hemorrhage Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Hemorrhage Global Clinical Trials Review, Q2, 2011" provides data on theHem |
2011 | 1.000,00$ |
Arrhythmias Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Arrhythmias Global Clinical Trials Review, Q2, 2011" provides data on theAr |
2011 | 1.000,00$ |
Lip and Oral Cavity Cancer Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Lip and Oral Cavity Cancer Global Clinical Trials Review, Q2, 2011" provide |
2011 | 1.000,00$ |
Sjogren’s Syndrome Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Sjogren’s Syndrome Global Clinical Trials Review, Q2, 2011" provides data o |
2011 | 1.000,00$ |
Varicose Veins Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Varicose Veins Global Clinical Trials Review, Q2, 2011" provides data on th |
2011 | 1.000,00$ |
Celiac Disease Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Celiac Disease Global Clinical Trials Review, Q2, 2011" provides data on th |
2011 | 1.000,00$ |
Presbyopia Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Presbyopia Global Clinical Trials Review, Q2, 2011" provides data on the Pr |
2011 | 1.000,00$ |
Stryker to Acquire Memometal Technologies - To Increase Presence in the Fast Growing Extremities Market - Deal Analysis from GlobalDataIntroduction / / GlobalData’s report, “Stryker to Acquire Memometal Technologies – To Increase Presence in the Fast Growing Extre |
2011 | 500,00$ |
Knee Replacement Implants - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017Introduction / / GlobalData’s new report, “Knee Replacement Implants – Global Pipeline Analysis, Competitive Landscape and Market |
2011 | 3.500,00$ |
Hypercholesterolemia Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Hypercholesterolemia Global Clinical Trials Review, Q2, 2011" provides data |
2011 | 1.000,00$ |
Hepatitis B Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Hepatitis B Global Clinical Trials Review, Q2, 2011" provides data on the H |
2011 | 1.000,00$ |
Hepatitis C Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Hepatitis C Global Clinical Trials Review, Q2, 2011" provides data on the H |
2011 | 1.000,00$ |
Ulcerative Colitis Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Ulcerative Colitis Global Clinical Trials Review, Q2, 2011" provides data o |
2011 | 1.000,00$ |
Sepsis Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Sepsis Global Clinical Trials Review, Q2, 2011" provides data on the Sepsis |
2011 | 1.000,00$ |
Hyperlipidemia Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Hyperlipidemia Global Clinical Trials Review, Q2, 2011" provides data on th |
2011 | 1.000,00$ |
Myopia Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Myopia Global Clinical Trials Review, Q2, 2011" provides data on the Myopia |
2011 | 1.000,00$ |
Immune Thombocytopenic Purpura (ITP) Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Immune Thombocytopenic Purpura (ITP) Global Clinical Trials Review, Q2, 201 |
2011 | 1.000,00$ |
Male Hypogonadism Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Male Hypogonadism Global Clinical Trials Review, Q2, 2011" provides data on |
2011 | 1.000,00$ |
Hyperphosphatemia Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Hyperphosphatemia Global Clinical Trials Review, Q2, 2011" provides data on |
2011 | 1.000,00$ |
Inguinal Hernia Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Inguinal Hernia Global Clinical Trials Review, Q2, 2011" provides data on t |
2011 | 1.000,00$ |
Hepatitis A Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Hepatitis A Global Clinical Trials Review, Q2, 2011" provides data on the H |
2011 | 1.000,00$ |
Rhinosinusitis Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Rhinosinusitis Global Clinical Trials Review, Q2, 2011" provides data on th |
2011 | 1.000,00$ |
Medical Equipment Monthly Deals Analysis - M&A and Investment Trends, June 2011Introduction
/
/ GlobalData's “Medical Equipment Monthly Deals Analysis - M&A and Investment Trends, June 2011” report is an es |
2011 | 1.000,00$ |
Germany Nephrology Biomarkers - A Market SnapshotIntroduction
/
/ GlobalData’s report, “Germany Nephrology Biomarkers - A Market Snapshot” provides key information and analysis |
2011 | 500,00$ |
Heart Failure Congress 2011 - Post - Conference Review and AnalysisIntroduction
/
/ GlobalData, the industry analysis specialist, has released its new conference alerts, “Heart Failure Congress |
2011 | 1.000,00$ |
20th European Stroke Conference - Post Conference Review and AnalysisIntroduction
/
/ GlobalData, the industry analysis specialist, has released its new conference alerts, “20th European Stroke Co |
2011 | 1.000,00$ |
Pharmaceuticals Monthly Deal Analysis - Partnerships, Licensing, Investments and M&A Trends, June 2011Introduction
/
/ GlobalData's “Pharmaceuticals Monthly Deal Analysis - Partnerships, Licensing, Investments and M&A Trends, Jun |
2011 | 1.000,00$ |
North America Drug Delivery Devices Market Outlook to 2017Introduction / / GlobalData’s new report, “North America Drug Delivery Devices Market Outlook to 2017” provides key market data |
2011 | 3.500,00$ |
Europe Drug Delivery Devices Market Outlook to 2017Introduction / / GlobalData’s new report, “Europe Drug Delivery Devices Market Outlook to 2017” provides key market data on the |
2011 | 3.500,00$ |
Asia-Pacific Drug Delivery Devices Market Outlook to 2017Introduction / / GlobalData’s new report, “Asia-Pacific Drug Delivery Devices Market Outlook to 2017” provides key market data on |
2011 | 3.500,00$ |
South and Central America Drug Delivery Devices Market Outlook to 2017Introduction / / GlobalData’s new report, “South and Central America Drug Delivery Devices Market Outlook to 2017” provides key |
2011 | 3.500,00$ |
Middle East and Africa Drug Delivery Devices Market Outlook to 2017Introduction / / GlobalData’s new report, “Middle East and Africa Drug Delivery Devices Market Outlook to 2017” provides key mark |
2011 | 3.500,00$ |
South and Central America Nephrology and Urology Devices Market Outlook to 2017Introduction / / GlobalData’s new report, “South and Central America Nephrology and Urology Devices Market Outlook to 2017” prov |
2011 | 3.500,00$ |
Middle East and Africa Nephrology & Urology Devices Market Outlook to 2017Introduction / / GlobalData’s new report, “Middle East and Africa Nephrology & Urology Devices Market Outlook to 2017” provides k |
2011 | 3.500,00$ |
South and Central America Neurology Devices Market Outlook to 2017Introduction / / GlobalData’s new report, “South and Central America Neurology Devices Market Outlook to 2017” provides key mark |
2011 | 3.500,00$ |
Middle East And Africa Neurology Devices Market Outlook to 2017Introduction / / GlobalData’s new report, “Middle East and Africa Neurology Devices Market Outlook to 2017” provides key market |
2011 | 3.500,00$ |
South and Central America Dental Devices Market Outlook to 2017Introduction / / GlobalData’s new report, “South and Central America Dental Devices Market Outlook to 2017” provides key market |
2011 | 3.500,00$ |
Middle East and Africa Dental Devices Market Outlook to 2017Introduction / / GlobalData’s new report, “Middle East and Africa Dental Devices Market Outlook to 2017” provides key market dat |
2011 | 3.500,00$ |
Hip Replacement Implants - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017Introduction / / GlobalData’s new report, “Hip Replacement Implants – Global Pipeline Analysis, Competitive Landscape and Market |
2011 | 3.500,00$ |
South and Central America ENT Devices Market Outlook to 2017Introduction / / GlobalData’s new report, “South and Central America ENT Devices Market Outlook to 2017” provides key market dat |
2011 | 3.500,00$ |
Middle East and Africa ENT Devices Market Outlook to 2017Introduction / / GlobalData’s new report, “Middle East and Africa ENT Devices Market Outlook to 2017” provides key market data o |
2011 | 3.500,00$ |
South and Central America Hospital Supplies Market Outlook to 2017Introduction / / GlobalData’s new report, “South and Central America Hospital Supplies Market Outlook to 2017” provides key mark |
2011 | 3.500,00$ |
Neurostimulation Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017Introduction / / GlobalData’s new report, “Neurostimulation Devices - Global Pipeline Analysis, Competitive Landscape and Market |
2011 | 3.500,00$ |
Middle East and Africa Hospital Supplies Market Outlook to 2017Introduction / / GlobalData’s new report, “Middle East and Africa Hospital Supplies Market Outlook to 2017” provides key market |
2011 | 3.500,00$ |
China Medical Devices Industry - A Market Snapshot and Key Company ProfilesIntroduction / / GlobalData’s new report, “China Medical Devices Industry - A Market Snapshot and Key Company Profiles” provides |
2011 | 3.500,00$ |
India Medical Device Industry - Key Company ProfilesIntroduction / / GlobalData’s report, “India Medical Device Industry - Key Company Profiles” provides detailed information and an |
2011 | 500,00$ |
Tradjenta (linagliptin) - First Member of DPP - 4 Inhibitor Class to Be Approved by US FDA at One Dosage StrengthIntroduction / / GlobalData’s report “Tradjenta (linagliptin) - First Member of DPP - 4 Inhibitor Class to Be Approved by US FDA |
2011 | 500,00$ |
Hypoalbuminemia Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Hypoalbuminemia Global Clinical Trials Review, Q2, 2011" provides data on t |
2011 | 1.000,00$ |
Thrombophilia Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Thrombophilia Global Clinical Trials Review, Q2, 2011" provides data on the |
2011 | 1.000,00$ |
Adenovirus Infection Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Adenovirus Infection Global Clinical Trials Review, Q2, 2011" provides data |
2011 | 1.000,00$ |
Acid Indigestion / Heartburn/ Pyrosis Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Acid Indigestion / Heartburn/ Pyrosis Global Clinical Trials Review, Q2, 20 |
2011 | 1.000,00$ |
Gastrointestinal Bleeding Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Gastrointestinal Bleeding Global Clinical Trials Review, Q2, 2011" provides |
2011 | 1.000,00$ |
Gastrointestinal Hemorrhage Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Gastrointestinal Hemorrhage Global Clinical Trials Review, Q2, 2011" provid |
2011 | 1.000,00$ |
Hepatic Encephalopathy Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Hepatic Encephalopathy Global Clinical Trials Review, Q2, 2011" provides da |
2011 | 1.000,00$ |
Hepatic Insufficiency Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Hepatic Insufficiency Global Clinical Trials Review, Q2, 2011" provides dat |
2011 | 1.000,00$ |
Hepatic Lesion Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Hepatic Lesion Global Clinical Trials Review, Q2, 2011" provides data on th |
2011 | 1.000,00$ |
Indigestion Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Indigestion Global Clinical Trials Review, Q2, 2011" provides data on the I |
2011 | 1.000,00$ |
Other Metabolic Disorders Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Other Metabolic Disorders Global Clinical Trials Review, Q2, 2011" provides |
2011 | 1.000,00$ |
Spondylitis Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Spondylitis Global Clinical Trials Review, Q2, 2011" provides data on the S |
2011 | 1.000,00$ |
Arterial Obstructive Disease Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Arterial Obstructive Disease Global Clinical Trials Review, Q2, 2011" provi |
2011 | 1.000,00$ |
Abdominal Aortic Aneurysms Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Abdominal Aortic Aneurysms Global Clinical Trials Review, Q2, 2011" provide |
2011 | 1.000,00$ |
Aorto-Iliac Aneurysms Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Aorto-Iliac Aneurysms Global Clinical Trials Review, Q2, 2011" provides dat |
2011 | 1.000,00$ |
Cerebral Aneurysms Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Cerebral Aneurysms Global Clinical Trials Review, Q2, 2011" provides data o |
2011 | 1.000,00$ |
Iliac Aneurysms Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Iliac Aneurysms Global Clinical Trials Review, Q2, 2011" provides data on t |
2011 | 1.000,00$ |
Chronic Stable Angina Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Chronic Stable Angina Global Clinical Trials Review, Q2, 2011" provides dat |
2011 | 1.000,00$ |
Ventricular Arrhythmia Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Ventricular Arrhythmia Global Clinical Trials Review, Q2, 2011" provides da |
2011 | 1.000,00$ |
Atrial Flutter Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Atrial Flutter Global Clinical Trials Review, Q2, 2011" provides data on th |
2011 | 1.000,00$ |
Chagas Cardiomyopathy Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Chagas Cardiomyopathy Global Clinical Trials Review, Q2, 2011" provides dat |
2011 | 1.000,00$ |
Dilated Cardiomyopathy Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Dilated Cardiomyopathy Global Clinical Trials Review, Q2, 2011" provides da |
2011 | 1.000,00$ |
Ischemic Cardiomyopathy Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Ischemic Cardiomyopathy Global Clinical Trials Review, Q2, 2011" provides d |
2011 | 1.000,00$ |
Aortic Aneurysm Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Aortic Aneurysm Global Clinical Trials Review, Q2, 2011" provides data on t |
2011 | 1.000,00$ |
Sick Sinus Syndrome Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Sick Sinus Syndromes Global Clinical Trials Review, Q2, 2011" provides data |
2011 | 1.000,00$ |
Congenital Heart Disease Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Congenital Heart Disease Global Clinical Trials Review, Q2, 2011" provides |
2011 | 1.000,00$ |
Hypoplastic Left Heart Syndrome Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Hypoplastic Left Heart Syndrome Global Clinical Trials Review, Q2, 2011" pr |
2011 | 1.000,00$ |
Atrial Septal Defect Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Atrial Septal Defect Global Clinical Trials Review, Q2, 2011" provides data |
2011 | 1.000,00$ |
Tetralogy Of Fallot Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Tetralogy Of Fallot Global Clinical Trials Review, Q2, 2011" provides data |
2011 | 1.000,00$ |
Congestive Heart Failure Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Congestive Heart Failure Global Clinical Trials Review, Q2, 2011" provides |
2011 | 1.000,00$ |
Diastolic Heart Failure Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Diastolic Heart Failure Global Clinical Trials Review, Q2, 2011" provides d |
2011 | 1.000,00$ |
Coronary Arteriosclerosis Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Coronary Arteriosclerosis Global Clinical Trials Review, Q2, 2011" provides |
2011 | 1.000,00$ |
Coronary Disease Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Coronary Disease Global Clinical Trials Review, Q2, 2011" provides data on |
2011 | 1.000,00$ |
Heart Failure Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Heart Failure Global Clinical Trials Review, Q2, 2011" provides data on the |
2011 | 1.000,00$ |
Acute Heart Failure Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Acute Heart Failure Global Clinical Trials Review, Q2, 2011" provides data |
2011 | 1.000,00$ |
Hypotension Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Hypotension Global Clinical Trials Review, Q2, 2011" provides data on the H |
2011 | 1.000,00$ |
Orthostatic Hypotension Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Orthostatic Hypotension Global Clinical Trials Review, Q2, 2011" provides d |
2011 | 1.000,00$ |
Ischemia Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Ischemia Global Clinical Trials Review, Q2, 2011" provides data on the Isch |
2011 | 1.000,00$ |
Critical Limb Ischemia Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Critical Limb Ischemia Global Clinical Trials Review, Q2, 2011" provides da |
2011 | 1.000,00$ |
Left Ventricular Dysfunction Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Left Ventricular Dysfunction Global Clinical Trials Review, Q2, 2011" provi |
2011 | 1.000,00$ |
Left Ventricular Hypertrophy Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Left Ventricular Hypertrophy Global Clinical Trials Review, Q2, 2011" provi |
2011 | 1.000,00$ |
Low Cardiac Output Syndrome Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Low Cardiac Output Syndrome Global Clinical Trials Review, Q2, 2011" provid |
2011 | 1.000,00$ |
Shock Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Shock Global Clinical Trials Review, Q2, 2011" provides data on the Shock c |
2011 | 1.000,00$ |
Cardiogenic Shock Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Cardiogenic Shock Global Clinical Trials Review, Q2, 2011" provides data on |
2011 | 1.000,00$ |
Hemorrhagic Shock Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Hemorrhagic Shock Global Clinical Trials Review, Q2, 2011" provides data on |
2011 | 1.000,00$ |
Coronary Thrombosis Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Coronary Thrombosis Global Clinical Trials Review, Q2, 2011" provides data |
2011 | 1.000,00$ |
Thromboembolism Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Thromboembolism Global Clinical Trials Review, Q2, 2011" provides data on t |
2011 | 1.000,00$ |
Deep Vein Thrombosis (DVT) Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Deep Vein Thrombosis (DVT) Global Clinical Trials Review, Q2, 2011" provide |
2011 | 1.000,00$ |
Vascular Dysfunction Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Vascular Dysfunction Global Clinical Trials Review, Q2, 2011" provides data |
2011 | 1.000,00$ |
Ventricular Fibrillation Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Ventricular Fibrillation Global Clinical Trials Review, Q2, 2011" provides |
2011 | 1.000,00$ |
Cardiovascular Inflammation Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Cardiovascular Inflammation Global Clinical Trials Review, Q2, 2011" provid |
2011 | 1.000,00$ |
Arteritis Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Arteritis Global Clinical Trials Review, Q2, 2011" provides data on the Art |
2011 | 1.000,00$ |
Coronary Vasospasm Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Coronary Vasospasm Global Clinical Trials Review, Q2, 2011" provides data o |
2011 | 1.000,00$ |
Bradycardia Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Bradycardia Global Clinical Trials Review, Q2, 2011" provides data on the B |
2011 | 1.000,00$ |
High Triglyceridemia Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “High Triglyceridemia Global Clinical Trials Review, Q2, 2011" provides data |
2011 | 1.000,00$ |
Portal Hypertension Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Portal Hypertension Global Clinical Trials Review, Q2, 2011" provides data |
2011 | 1.000,00$ |
Pre-Eclampsia Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Pre-Eclampsia Global Clinical Trials Review, Q2, 2011" provides data on the |
2011 | 1.000,00$ |
Restenosis Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Restenosis Global Clinical Trials Review, Q2, 2011" provides data on the Re |
2011 | 1.000,00$ |
Ventricular Tachycardia Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Ventricular Tachycardia Global Clinical Trials Review, Q2, 2011" provides d |
2011 | 1.000,00$ |
Aortic Valve Diseases Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Aortic Valve Diseases Global Clinical Trials Review, Q2, 2011" provides dat |
2011 | 1.000,00$ |
Hypoxemia Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Hypoxemia Global Clinical Trials Review, Q2, 2011" provides data on the Hyp |
2011 | 1.000,00$ |
Other Cardiovascular Disorders Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Other Cardiovascular Disorders Global Clinical Trials Review, Q2, 2011" pro |
2011 | 1.000,00$ |
Raynauds Disease Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Raynauds Disease Global Clinical Trials Review, Q2, 2011" provides data on |
2011 | 1.000,00$ |
Regurgitation Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Regurgitation Global Clinical Trials Review, Q2, 2011" provides data on the |
2011 | 1.000,00$ |
Mitral Regurgitation Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Mitral Regurgitation Global Clinical Trials Review, Q2, 2011" provides data |
2011 | 1.000,00$ |
Reperfusion Injury Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Reperfusion Injury Global Clinical Trials Review, Q2, 2011" provides data o |
2011 | 1.000,00$ |
Telangiectasis Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Telangiectasis Global Clinical Trials Review, Q2, 2011" provides data on th |
2011 | 1.000,00$ |
Ulcers Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Ulcers Global Clinical Trials Review, Q2, 2011" provides data on the Ulcers |
2011 | 1.000,00$ |
Varicosis Ulcer Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Varicosis Ulcer Global Clinical Trials Review, Q2, 2011" provides data on t |
2011 | 1.000,00$ |
Venous Ulcers Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Venous Ulcers Global Clinical Trials Review, Q2, 2011" provides data on the |
2011 | 1.000,00$ |
Louis-Bar Syndrome Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “ Louis-Bar Syndrome Global Clinical Trials Review, Q2, 2011"” provides data |
2011 | 1.000,00$ |
Attention Deficit Hyperactivity Disorder (ADHD) Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Attention Deficit Hyperactivity Disorder (ADHD) Global Clinical Trials Revi |
2011 | 1.000,00$ |
Cerebellar Ataxia Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Cerebellar Ataxia Global Clinical Trials Review, Q2, 2011" provides data on |
2011 | 1.000,00$ |
Cognitive Disorders Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Cognitive Disorders Global Clinical Trials Review, Q2, 2011" provides data |
2011 | 1.000,00$ |
Encephalitis Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Encephalitis Global Clinical Trials Review, Q2, 2011" provides data on the |
2011 | 1.000,00$ |
Hernia Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Hernia Global Clinical Trials Review, Q2, 2011" provides data on the Hernia |
2011 | 1.000,00$ |
Diabetic Retinopathy Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Diabetic Retinopathy Global Clinical Trials Review, Q1, 2011" provides data |
2011 | 1.000,00$ |
Paralysis Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Paralysis Global Clinical Trials Review, Q2, 2011" provides data on the Par |
2011 | 1.000,00$ |
Sedation Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Sedation Global Clinical Trials Review, Q2, 2011" provides data on the Seda |
2011 | 1.000,00$ |
Renal Pain Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Renal Pain Global Clinical Trials Review, Q2, 2011" provides data on the Re |
2011 | 1.000,00$ |
General Anxiety Disorder Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “General Anxiety Disorder Global Clinical Trials Review, Q2, 2011" provides |
2011 | 1.000,00$ |
Child Abuse Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Child Abuse Global Clinical Trials Review, Q2, 2011" provides data on the |
2011 | 1.000,00$ |
Diabetic Neuropathy Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Diabetic Neuropathy Global Clinical Trials Review, Q1, 2011" provides data |
2011 | 1.000,00$ |
Chronic Kidney Disease (Chronic Renal Failure) Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Chronic Kidney Disease (Chronic Renal Failure) Global Clinical Trials Revi |
2011 | 1.000,00$ |
Alcohol Addiction Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Alcohol Addiction Global Clinical Trials Review, Q1, 2011" provides data |
2011 | 1.000,00$ |
Cystic Fibrosis Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Cystic Fibrosis Global Clinical Trials Review, Q1, 2011" provides data on t |
2011 | 1.000,00$ |
Crohn’s Disease Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Crohn’s Disease Global Clinical Trials Review, Q1, 2011" provides data on t |
2011 | 1.000,00$ |
Atopic Dermatitis (Eczema) Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Atopic Dermatitis (Eczema) Global Clinical Trials Review, Q1, 2011" provide |
2011 | 1.000,00$ |
Dyslipidemia Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Dyslipidemia Global Clinical Trials Review, Q1, 2011" provides data on the |
2011 | 1.000,00$ |
Age Related Macular Degeneration Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Age Related Macular Degeneration Global Clinical Trials Review, Q1, 2011" p |
2011 | 1.000,00$ |
Arthritis Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Arthritis Global Clinical Trials Review, Q1, 2011" provides data on the Art |
2011 | 1.000,00$ |
Septic Shock Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Septic Shock Global Clinical Trials Review, Q1, 2011" provides data on the |
2011 | 1.000,00$ |
Endometriosis Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Endometriosis Global Clinical Trials Review, Q1, 2011" provides data on the |
2011 | 1.000,00$ |
Interstitial Cystitis Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Interstitial Cystitis Global Clinical Trials Review, Q1, 2011" provides dat |
2011 | 1.000,00$ |
Duchenne Muscular Dystrophy Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Duchenne Muscular Dystrophy Global Clinical Trials Review, Q1, 2011" provid |
2011 | 1.000,00$ |
Retinitis Pigmentosa Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Retinitis Pigmentosa Global Clinical Trials Review, Q1, 2011" provides data |
2011 | 1.000,00$ |
Gaucher's Disease Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Gaucher’s Disease Global Clinical Trials Review, Q1, 2011" provides data on |
2011 | 1.000,00$ |
LifeScan, Inc. - Product Pipeline AnalysisLifeScan, Inc. - Product Pipeline Analysis / / Summary / / LifeScan, Inc. (LifeScan) is a medical device company engaged in the |
2011 | 750,00$ |
Allergan, Inc. (AGN) - Product Pipeline AnalysisAllergan, Inc. (AGN) - Product Pipeline Analysis / / Summary / / Allergan, Inc. (Allergan) is a global healthcare company engage |
2011 | 750,00$ |
Varian Medical Systems, Inc. (VAR) - Product Pipeline AnalysisVarian Medical Systems, Inc. (VAR) - Product Pipeline Analysis / / Summary / / Varian Medical Systems, Inc. (Varian) is a leadin |
2011 | 750,00$ |
DePuy, Inc. - Product Pipeline AnalysisDePuy, Inc. - Product Pipeline Analysis / / Summary / / DePuy, Inc. (DePuy) is a subsidiary of Johnson & Johnson, which principa |
2011 | 750,00$ |
Berlin Heart GmbH - Product Pipeline AnalysisBerlin Heart GmbH - Product Pipeline Analysis / / Summary / / Berlin Heart GmbH (Berlin Heart) is engaged in development, manufa |
2011 | 750,00$ |
Ortho-Clinical Diagnostics Inc. - Product Pipeline AnalysisOrtho-Clinical Diagnostics Inc. - Product Pipeline Analysis / / Summary / / Ortho-Clinical Diagnostics, Inc., (Ortho-Clinical) i |
2011 | 750,00$ |
TORNIER, Inc. - Product Pipeline AnalysisTORNIER, Inc. - Product Pipeline Analysis / / Summary / / TORNIER, Inc. (Tornier) is a medical device company, principally engag |
2011 | 750,00$ |
Roche Diagnostics Limited - Product Pipeline AnalysisRoche Diagnostics Limited - Product Pipeline Analysis / / Summary / / Roche Diagnostics Limited (Roche Diagnostics), a division |
2011 | 750,00$ |
Pioneer Surgical Technology, Inc. - Product Pipeline AnalysisPioneer Surgical Technology, Inc. - Product Pipeline Analysis / / Summary / / Pioneer Surgical Technology, Inc. (Pioneer Surgica |
2011 | 750,00$ |
Stryker Corporation (SYK) - Product Pipeline AnalysisStryker Corporation (SYK) - Product Pipeline Analysis / / Summary / / Stryker Corporation (Stryker) is one of the leading manufa |
2011 | 750,00$ |
Alere Inc. (ALR) - Product Pipeline AnalysisAlere Inc. (ALR) - Product Pipeline Analysis / / Summary / / Alere Inc. (formerly Inverness Medical Innovations, Inc.) is a prov |
2011 | 750,00$ |
Beckman Coulter, Inc. (BEC) - Product Pipeline AnalysisBeckman Coulter, Inc. (BEC) - Product Pipeline Analysis / / Summary / / Beckman Coulter, Inc. (Beckman) is principally engaged i |
2011 | 750,00$ |
SurModics, Inc. (SRDX) - Product Pipeline AnalysisSurModics, Inc. (SRDX) - Product Pipeline Analysis / / Summary / / SurModics, Inc. (SurModics) is a healthcare company engaged i |
2011 | 750,00$ |
Biomet, Inc. - Product Pipeline AnalysisBiomet, Inc. - Product Pipeline Analysis / / Summary / / Biomet, Inc. (Biomet) is engaged in the design, manufacture and marketi |
2011 | 750,00$ |
Baxter International Inc. (BAX) - Product Pipeline AnalysisBaxter International Inc. (BAX) - Product Pipeline Analysis / / Summary / / Baxter International Inc. (Baxter) is a globally div |
2011 | 750,00$ |
Becton, Dickinson and Company (BDX) - Product Pipeline AnalysisBecton, Dickinson and Company (BDX) - Product Pipeline Analysis / / Summary / / Becton, Dickinson and Company (BD) is a medical |
2011 | 750,00$ |
Boston Scientific Corporation (BSX) - Product Pipeline AnalysisBoston Scientific Corporation (BSX) - Product Pipeline Analysis / / Summary / / Boston Scientific Corporation (Boston Scientific |
2011 | 750,00$ |
C. R. Bard, Inc. (BCR) - Product Pipeline AnalysisC. R. Bard, Inc. (BCR) - Product Pipeline Analysis / / Summary / / C. R. Bard, Inc. (Bard) is a multinational company engaged in |
2011 | 750,00$ |
Gen-Probe Incorporated (GPRO) - Product Pipeline AnalysisGen-Probe Incorporated (GPRO) - Product Pipeline Analysis / / Summary / / Gen-Probe Incorporated (Gen-Probe) is engaged in the d |
2011 | 750,00$ |
Philips Healthcare - Product Pipeline AnalysisPhilips Healthcare - Product Pipeline Analysis / / Summary / / Philips Healthcare (formerly known as Philips Medical Systems) is |
2011 | 750,00$ |
Synthes, Inc. (SYST) - Product Pipeline AnalysisSynthes, Inc. (SYST) - Product Pipeline Analysis / / Summary / / Synthes, Inc. (Synthes) is a medical device company specializin |
2011 | 750,00$ |
Edwards Lifesciences Corporation (EW) - Product Pipeline AnalysisEdwards Lifesciences Corporation (EW) - Product Pipeline Analysis / / Summary / / Edwards Lifesciences Corporation (Edwards) pro |
2011 | 750,00$ |
Ethicon, Inc. - Product Pipeline AnalysisEthicon, Inc. - Product Pipeline Analysis / / Summary / / Ethicon, Inc. (Ethicon) is a global surgical products company engaged |
2011 | 750,00$ |
Zimmer Holdings, Inc. (ZMH) - Product Pipeline AnalysisZimmer Holdings, Inc. (ZMH) - Product Pipeline Analysis / / Summary / / Zimmer Holdings, Inc. (Zimmer) engages in the design, de |
2011 | 750,00$ |
St. Jude Medical, Inc. (STJ) - Product Pipeline AnalysisSt. Jude Medical, Inc. (STJ) - Product Pipeline Analysis / / Summary / / St. Jude Medical, Inc. (SJM) is a medical device compan |
2011 | 750,00$ |
Covidien plc (COV) - Product Pipeline AnalysisCovidien plc (COV) - Product Pipeline Analysis / / Summary / / Covidien plc (Covidien) is a leading global healthcare company. I |
2011 | 750,00$ |
AtriCure, Inc. (ATRC) - Product Pipeline AnalysisAtriCure, Inc. (ATRC) - Product Pipeline Analysis / / Summary / / AtriCure, Inc. (AtriCure) is a medical device company principa |
2011 | 750,00$ |
Cordis Corporation - Product Pipeline AnalysisCordis Corporation - Product Pipeline Analysis / / Summary / / Cordis Corporation (Cordis) is a medical device corporation, whic |
2011 | 750,00$ |
Renal Dialysis Equipment - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017Introduction / / GlobalData’s new report, “Renal Dialysis Equipment - Global Pipeline Analysis, Competitive Landscape and Market |
2011 | 3.500,00$ |
Cardiovascular Monitoring and Diagnostic Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017Introduction / / GlobalData’s new report, “Cardiovascular Monitoring and Diagnostic Devices – Global Pipeline Analysis, Competiti |
2011 | 3.500,00$ |
Interventional Neurology - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017Introduction / / GlobalData’s new report, “Interventional Neurology - Global Pipeline Analysis, Competitive Landscape and Market |
2011 | 3.500,00$ |
Hearing Aid Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2017Introduction / / GlobalData’s new report, “Hearing Aid Devices - Global Pipeline Analysis, Opportunity Assessment and Market Fore |
2011 | 3.500,00$ |
Hearing Aid Devices - A Market SnapshotIntroduction / / GlobalData’s report, “Hearing Aid Devices – A Market Sanpshot” provides key data, information and analysis on th |
2011 | 500,00$ |
Endothelin A Receptor Antagonist (atrasentan) Fails to Demonstrate an Advantage in the Treatment of Advanced Prostate CancerIntroduction / / This year another endothelin A receptor antagonist failed to demonstrate an advantage for advanced prostate canc |
2011 | 500,00$ |
Healthcare Reform in the US - Impact on Pricing and ReimbursementIntroduction / / On 23 March, 2010, the Obama administration brought into effect the Patient Protection and Affordable Care Act ( |
2011 | 500,00$ |
Successes and Failures for Avastin (Bevacizumab) mean Mixed News for the Blockbuster Drug in the Oncology Therapeutics MarketIntroduction / / Avastin (bevacizumab) is a vascular endothelial growth factor (VEGF) receptor inhibitor. It was first approved i |
2011 | 500,00$ |
FDA Approves Zytiga (Abiraterone Acetate) for the Second-Line Treatment of Metastatic Castration-Resistant Prostate CancerIntroduction / / It has been an exciting year for prostate cancer therapeutics. On April 28, 2011, the US Food and Drug Administr |
2011 | 500,00$ |
US FDA Approval of Afinitor Ends a Three Decade Long Wait for Pancreatic Neuroendocrine Tumor (PNET) PatientsIntroduction / / On May 5, 2011, the US Food and Drug Association (FDA) approved Afinitor (everolimus) for the treatment of progr |
2011 | 500,00$ |
Brentuximab Vedotin – First Treatment Option for Relapsed Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma (Subset of Non-Hodgkin Lymphoma)Introduction / / The group of cancers that originate in the lymphatic system are known as lymphoma. Lymphoma is broadly classifie |
2011 | 500,00$ |
Victrelis (boceprevir) - First-in-Class Oral Hepatitis C Virus (HCV) Protease Inhibitor Approved in The US and Telaprevir to FollowIntroduction / / Hepatitis C is caused by a type of virus called hepatitis C virus (HCV). The virus infects the liver, causing se |
2011 | 500,00$ |
Sanofi - Aventis seals Licensing Deal with Glenmark for $613m - Deal Analysis from GlobalDataIntroduction / / May 16, 2011 witnessed the commencement of the licensing deal between Glenmark Pharmaceuticals S.A (GPSA), a who |
2011 | 500,00$ |
Osmetech plc (OMH) - Financial and Strategic SWOT Analysis ReviewOsmetech plc (Osmetech) is engaged in the manufacturing, development, design and distribution of molecular diagnostic technologies |
2011 | 125,00$ |
Orthomimetics Limited - Strategic SWOT Analysis ReviewOrthoMimetics Limited (OrthoMimetics) is a medical technology company engaged in the design, development and manufacturing of biol |
2011 | 125,00$ |
Mead Johnson Nutrition Company (MJN) - Financial and Strategic SWOT Analysis ReviewMead Johnson Nutrition Company (Mead Johnson) is a pediatric nutrition company engaged in the production, distribution and sale of |
2011 | 125,00$ |
NascaCell Technologies AG (N7C) - Financial and Strategic SWOT Analysis ReviewNascacell Technologies AG (Nascacell) is a publicly held company specialized in the development of products and drug development c |
2011 | 250,00$ |
Unigene Laboratories, Inc. (UGNE) - Strategic SWOT Analysis ReviewUnigene Laboratories, Inc. (Unigene) is publicly held US based biopharmaceutical company provides peptide related products. It is |
2011 | 250,00$ |
1st Dental Laboratories plc (FDT) - Financial and Strategic SWOT Analysis Review1st Dental Laboratories PLC (1st Dental) is one of the leading provider of dental laboratory products and services in the UK. The |
2011 | 125,00$ |
Black Ridge Mining Limited (BRD) - Financial and Strategic SWOT Analysis ReviewBlack Ridge Mining Limited (formerly Genesis Biomedical Ltd.) was formally a medical technology company and was engaged in the de |
2011 | 125,00$ |
Acri Tec Gmbh - Strategic SWOT Analysis ReviewThis comprehensive SWOT profile of Acri Tec Gmbh provides you with an in-depth strategic analysis of the company's businesses and |
2011 | 250,00$ |
Gen-Probe Prodesse, Inc. - Strategic SWOT Analysis ReviewGen-Probe Prodesse, Inc. (Prodesse), a biotechnology company engaged in the manufacture, development and distribution of molecular |
2011 | 125,00$ |
Fujinon Corporation - Strategic SWOT Analysis ReviewFujinon Corporation (Fujinon), formerly Fuji Photo Optical Co., Ltd. is a conglomerate principally engaged in the development, man |
2011 | 125,00$ |
Kane Biotech Inc. (KNE) - Strategic SWOT Analysis ReviewKane Biotech Inc. (Kane Biotech) is a developmental stage biotechnology company. It is engaged in the research and development o |
2011 | 125,00$ |
Alere LLC - Strategic SWOT Analysis ReviewAlere LLC (Alere) is a healthcare company. It provides the most comprehensive and patient-centric health management services, rang |
2011 | 125,00$ |
Gentex Corporation (GNTX) - Strategic SWOT Analysis ReviewGentex Corporation (Gentex) is principally engaged in designing, developing, manufacturing and marketing integrated military life |
2011 | 250,00$ |
Bradmer Pharmaceuticals Inc. (BMR) - Financial and Strategic SWOT Analysis ReviewBradmer Pharmaceuticals Inc. (Bradmer) is a publicly held life sciences company that is engaged in the development and marketing o |
2011 | 250,00$ |
Dhanuka Agritech Ltd (507717) - Financial and Strategic SWOT Analysis ReviewDhanuka Agritech Ltd (DAL) is engaged in the development of agro-chemicals, fertilizers, and seeds. The company provides numerous |
2011 | 250,00$ |
Bering Exploration, Inc. (OCOL) - Strategic SWOT Analysis ReviewBering Exploration, Inc (Bering Exploration) is a company engaged in the exploration, development, production, acquisition and mar |
2011 | 250,00$ |
Biolight AB (BIOL) - Strategic SWOT Analysis ReviewBiolight AB (Biolight) is a Sweden-based medical technology company. It is principally engaged in the development and sale of mach |
2011 | 250,00$ |
Saudi Arabia Medical Equipment Market Analysis and Forecasts to 2017Introduction / / GlobalData’s new report, “Saudi Arabia Medical Equipment Market Analysis and Forecasts to 2017” provides key dat |
2011 | 3.500,00$ |
Neurostimulation Devices - A Market SnapshotIntroduction / / GlobalData’s report, “Neurostimulation Devices - A Market Snapshot” provides information and analysis on the glo |
2011 | 500,00$ |
The 2011 Tsunami and Earthquake in Japan - A Medical Devices Industry PerspectiveIntroduction / / GlobalData’s medical equipment viewpoint, “The 2011 Tsunami and Earthquake in Japan - A Medical Devices Industry |
2011 | 500,00$ |
Drug Delivery Devices Market Outlook in United States to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free InjectionsIntroduction / / GlobalData’s new report, “Drug Delivery Devices Market Outlook in United States to 2017 - Metered Dose Inhaler D |
2011 | 2.500,00$ |
Drug Delivery Devices Market Outlook in United Kingdom to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free InjectionsIntroduction / / GlobalData’s new report, “Drug Delivery Devices Market Outlook in United Kingdom to 2017 - Metered Dose Inhaler |
2011 | 2.500,00$ |
Drug Delivery Devices Market Outlook in Japan to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free InjectionsIntroduction / / GlobalData’s new report, “Drug Delivery Devices Market Outlook in Japan to 2017 - Metered Dose Inhaler Devices, |
2011 | 2.500,00$ |
Drug Delivery Devices Market Outlook in India to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free InjectionsIntroduction / / GlobalData’s new report, “Drug Delivery Devices Market Outlook in India to 2017 - Metered Dose Inhaler Devices, |
2011 | 2.500,00$ |
Drug Delivery Devices Market Outlook in China to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free InjectionsIntroduction / / GlobalData’s new report, “Drug Delivery Devices Market Outlook in China to 2017 - Metered Dose Inhaler Devices, |
2011 | 2.500,00$ |
Drug Delivery Devices Market Outlook in Canada to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free InjectionsIntroduction / / GlobalData’s new report, “Drug Delivery Devices Market Outlook in Canada to 2017 - Metered Dose Inhaler Devices, |
2011 | 2.500,00$ |
Drug Delivery Devices Market Outlook in Germany to 2017- Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free InjectionsIntroduction / / GlobalData’s new report, “Drug Delivery Devices Market Outlook in Germany to 2017 - Metered Dose Inhaler Devices |
2011 | 2.500,00$ |
Drug Delivery Devices Market Outlook in France to 2017- Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free InjectionsIntroduction / / GlobalData’s new report, “Drug Delivery Devices Market Outlook in France to 2017 - Metered Dose Inhaler Devices, |
2011 | 2.500,00$ |
Drug Delivery Devices Market Outlook in Italy to 2017- Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free InjectionsIntroduction / / GlobalData’s new report, “Drug Delivery Devices Market Outlook in Italy to 2017 - Metered Dose Inhaler Devices, |
2011 | 2.500,00$ |
Drug Delivery Devices Market Outlook in Spain to 2017- Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free InjectionsIntroduction / / GlobalData’s new report, “Drug Delivery Devices Market Outlook in Spain to 2017 - Metered Dose Inhaler Devices, |
2011 | 2.500,00$ |
Drug Delivery Devices Market Outlook in Australia to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free InjectionsIntroduction / / GlobalData’s new report, “Drug Delivery Devices Market Outlook in Australia to 2017 - Metered Dose Inhaler Devic |
2011 | 2.500,00$ |
Drug Delivery Devices Market Outlook in Brazil to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free InjectionsIntroduction / / GlobalData’s new report, “Drug Delivery Devices Market Outlook in Brazil to 2017 - Metered Dose Inhaler Devices, |
2011 | 2.500,00$ |
Drug Delivery Devices Market Outlook in Netherlands to 2017- Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free InjectionsIntroduction / / GlobalData’s new report, “Drug Delivery Devices Market Outlook in Netherlands to 2017 - Metered Dose Inhaler Dev |
2011 | 2.500,00$ |
Drug Delivery Devices Market Outlook in Belgium to 2017- Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free InjectionsIntroduction / / GlobalData’s new report, “Drug Delivery Devices Market Outlook in Belgium to 2017 - Metered Dose Inhaler Devices |
2011 | 2.500,00$ |
Drug Delivery Devices Market Outlook in Argentina to 2017- Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free InjectionsIntroduction / / GlobalData’s new report, “Drug Delivery Devices Market Outlook in Argentina to 2017 - Metered Dose Inhaler Devic |
2011 | 2.500,00$ |
Drug Delivery Devices Market Outlook in Mexico to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free InjectionsIntroduction / / GlobalData’s new report, “Drug Delivery Devices Market Outlook in Mexico to 2017 - Metered Dose Inhaler Devices, |
2011 | 2.500,00$ |
Drug Delivery Devices Market Outlook in Republic of Korea to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free InjectionsIntroduction / / GlobalData’s new report, “Drug Delivery Devices Market Outlook in Republic of Korea to 2017 - Metered Dose Inhal |
2011 | 2.500,00$ |
Drug Delivery Devices Market Outlook in Taiwan to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free InjectionsIntroduction / / GlobalData’s new report, “Drug Delivery Devices Market Outlook in Taiwan to 2017 - Metered Dose Inhaler Devices, |
2011 | 2.500,00$ |
Drug Delivery Devices Market Outlook in South Africa to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free InjectionsIntroduction / / GlobalData’s new report, “Drug Delivery Devices Market Outlook in South Africa to 2017 - Metered Dose Inhaler De |
2011 | 2.500,00$ |
Drug Delivery Devices Market Outlook in Israel to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free InjectionsIntroduction / / GlobalData’s new report, “Drug Delivery Devices Market Outlook in Israel to 2017 - Metered Dose Inhaler Devices, |
2011 | 2.500,00$ |
Drug Delivery Devices Market Outlook in Austria to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free InjectionsIntroduction / / GlobalData’s new report, “Drug Delivery Devices Market Outlook in Austria to 2017 - Metered Dose Inhaler Devices |
2011 | 2.500,00$ |
Drug Delivery Devices Market Outlook in Czech Republic to 2017- Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free InjectionsIntroduction / / GlobalData’s new report, “Drug Delivery Devices Market Outlook in Czech Republic to 2017 - Metered Dose Inhaler |
2011 | 2.500,00$ |
Drug Delivery Devices Market Outlook in Russian Federation to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free InjectionsIntroduction / / GlobalData’s new report, “Drug Delivery Devices Market Outlook in Russian Federation to 2017 - Metered Dose Inha |
2011 | 2.500,00$ |
Drug Delivery Devices Market Outlook in Sweden to 2017- Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free InjectionsIntroduction / / GlobalData’s new report, “Drug Delivery Devices Market Outlook in Sweden to 2017 - Metered Dose Inhaler Devices, |
2011 | 2.500,00$ |
Drug Delivery Devices Market Outlook in New Zealand to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free InjectionsIntroduction / / GlobalData’s new report, “Drug Delivery Devices Market Outlook in New Zealand to 2017 - Metered Dose Inhaler Dev |
2011 | 2.500,00$ |
Drug Delivery Devices Market Outlook in Denmark to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free InjectionsIntroduction / / GlobalData’s new report, “Drug Delivery Devices Market Outlook in Denmark to 2017 - Metered Dose Inhaler Devices |
2011 | 2.500,00$ |
Drug Delivery Devices Market Outlook in Saudi Arabia to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free InjectionsIntroduction / / GlobalData’s new report, “Drug Delivery Devices Market Outlook in Saudi Arabia to 2017 - Metered Dose Inhaler De |
2011 | 2.500,00$ |
Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - May 2011Introduction / / GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - May 2011” repor |
2011 | 1.000,00$ |
Nordion Inc. - Strategic SWOT Analysis ReviewNordion Inc. - Strategic SWOT Analysis Review / / Summary / / Nordion Inc. (formerly known as MDS Inc.) is a global specialty he |
2011 | 125,00$ |
Novozymes AS (NZYM B) - Financial and Strategic SWOT Analysis ReviewNovozymes AS (NZYM B) - Financial and Strategic SWOT Analysis Review / / Summary / / Novozymes A/S (Novozymes) is a Denmark base |
2011 | 125,00$ |
Hospital Supplies Market Outlook in Australia to 2017 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and OthersIntroduction / / GlobalData’s new report, “Hospital Supplies Market Outlook in Australia to 2017 - Disposable Hospital Supplies, |
2011 | 2.500,00$ |
Hospital Supplies Market Outlook in Spain to 2017 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and OthersIntroduction / / GlobalData’s new report, “Hospital Supplies Market Outlook in Spain to 2017 - Disposable Hospital Supplies, Ster |
2011 | 2.500,00$ |
Hospital Supplies Market Outlook in Germany to 2017 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and OthersIntroduction / / GlobalData’s new report, “Hospital Supplies Market Outlook in Germany to 2017 - Disposable Hospital Supplies, St |
2011 | 2.500,00$ |
Hospital Supplies Market Outlook in South Africa to 2017 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and OthersIntroduction / / GlobalData’s new report, “Hospital Supplies Market Outlook in South Africa to 2017 - Disposable Hospital Supplie |
2011 | 2.500,00$ |
Hospital Supplies Market Outlook in Italy to 2017 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and OthersIntroduction / / GlobalData’s new report, “Hospital Supplies Market Outlook in Italy to 2017 - Disposable Hospital Supplies, Ster |
2011 | 2.500,00$ |
Hospital Supplies Market Outlook in Brazil to 2017 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and OthersIntroduction / / GlobalData’s new report, “Hospital Supplies Market Outlook in Brazil to 2017 - Disposable Hospital Supplies, Ste |
2011 | 2.500,00$ |
Hospital Supplies Market Outlook in Mexico to 2017 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and OthersIntroduction / / GlobalData’s new report, “Hospital Supplies Market Outlook in Mexico to 2017 - Disposable Hospital Supplies, Ste |
2011 | 2.500,00$ |
Hospital Supplies Market Outlook in Republic of Korea to 2017 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and OthersIntroduction / / GlobalData’s new report, “Hospital Supplies Market Outlook in Republic of Korea to 2017 - Disposable Hospital Su |
2011 | 2.500,00$ |
Hospital Supplies Market Outlook in Netherlands to 2017 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and OthersIntroduction / / GlobalData’s new report, “Hospital Supplies Market Outlook in Netherlands to 2017 - Disposable Hospital Supplies |
2011 | 2.500,00$ |
Hospital Supplies Market Outlook in Czech Republic to 2017 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and OthersIntroduction / / GlobalData’s new report, “Hospital Supplies Market Outlook in Czech Republic to 2017 - Disposable Hospital Suppl |
2011 | 2.500,00$ |
Hospital Supplies Market Outlook in Sweden to 2017 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and OthersIntroduction / / GlobalData’s new report, “Hospital Supplies Market Outlook in Sweden to 2017 - Disposable Hospital Supplies, Ste |
2011 | 2.500,00$ |
Hospital Supplies Market Outlook in Belgium to 2017 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and OthersIntroduction / / GlobalData’s new report, “Hospital Supplies Market Outlook in Belgium to 2017 - Disposable Hospital Supplies, St |
2011 | 2.500,00$ |
Hospital Supplies Market Outlook in Austria to 2017 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and OthersIntroduction / / GlobalData’s new report, “Hospital Supplies Market Outlook in Austria to 2017 - Disposable Hospital Supplies, St |
2011 | 2.500,00$ |
Hospital Supplies Market Outlook in Denmark to 2017 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and OthersIntroduction / / GlobalData’s new report, “Hospital Supplies Market Outlook in Denmark to 2017 - Disposable Hospital Supplies, St |
2011 | 2.500,00$ |
Hospital Supplies Market Outlook in Saudi Arabia to 2017 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and OthersIntroduction / / GlobalData’s new report, “Hospital Supplies Market Outlook in Saudi Arabia to 2017 - Disposable Hospital Supplie |
2011 | 2.500,00$ |
Hospital Supplies Market Outlook in New Zealand to 2017 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and OthersIntroduction / / GlobalData’s new report, “Hospital Supplies Market Outlook in New Zealand to 2017 - Disposable Hospital Supplies |
2011 | 2.500,00$ |
Hospital Supplies Market Outlook in Argentina to 2017 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and OthersIntroduction / / GlobalData’s new report, “Hospital Supplies Market Outlook in Argentina to 2017 - Disposable Hospital Supplies, |
2011 | 2.500,00$ |
Hospital Supplies Market Outlook in Israel to 2017 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and OthersIntroduction / / GlobalData’s new report, “Hospital Supplies Market Outlook in Israel to 2017 - Disposable Hospital Supplies, Ste |
2011 | 2.500,00$ |
Hospital Supplies Market Outlook in Taiwan to 2017 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and OthersIntroduction / / GlobalData’s new report, “Hospital Supplies Market Outlook in Taiwan to 2017 - Disposable Hospital Supplies, Ste |
2011 | 2.500,00$ |
Endo Pharmaceuticals to Buy American Medical Systems for $2.9 Billion - Deal Analysis from GlobalDataIntroduction / / GlobalData’s medical equipment report, “Endo Pharmaceuticals to Buy American Medical Systems for $2.9 Billion” p |
2011 | 500,00$ |
North America Hospital Supplies Market Outlook to 2017Introduction / / GlobalData’s new report, “North America Hospital Supplies Market Outlook to 2017” provides key market data on t |
2011 | 3.500,00$ |
Europe Hospital Supplies Market Outlook to 2017Introduction / / GlobalData’s new report, “Europe Hospital Supplies Market Outlook to 2017” provides key market data on the Eur |
2011 | 3.500,00$ |
Asia Pacific Hospital Supplies Market Outlook to 2017Introduction / / GlobalData’s new report, “Asia Pacific Hospital Supplies Market Outlook to 2017” provides key market data on the |
2011 | 3.500,00$ |
Medical Equipment Monthly Deals Analysis - M&A and Investment Trends, May 2011Introduction / / GlobalData's “Medical Equipment Monthly Deals Analysis - M&A and Investment Trends, May 2011” report is an essen |
2011 | 1.000,00$ |
Johnson & Johnson to Acquire Synthes – Betting Big on the Orthopedic Devices Market OpportunityIntroduction / / GlobalData’s medical equipment report, “Johnson & Johnson to Acquire Synthes - Betting Big on the Orthopedic Dev |
2011 | 500,00$ |
Clinical Chemistry Reagents, Analyzers and Test Kits - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017Introduction / / GlobalData’s new report, “Clinical Chemistry Reagents, Analyzers and Test Kits - Global Pipeline Analysis, Compe |
2011 | 3.500,00$ |
Radiation Therapy Devices - Global Opportunity Assessment, Competitive Landscape and Market Forecasts to 2017Introduction / / GlobalData’s medical equipment report, “Radiation Therapy Devices - Global Opportunity Assessment, Competitive L |
2011 | 3.500,00$ |
Hip Resurfacing Implants - Global Pipeline Analysis,Competitive Landscape and Market Forecasts to 2017Introduction / / GlobalData’s new report, “Hip Resurfacing Implants - Global Pipeline Analysis, Competitive Landscape and Market |
2011 | 3.500,00$ |
Tumor Markers - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017Introduction / / GlobalData’s new report, “Tumor Markers - Global Pipeline Analysis, Competitive Landscape and Market Forecasts t |
2011 | 3.500,00$ |
Medical Equipment Quarterly Deals Analysis - M&A and Investment Trends, Q1 2011Introduction / / GlobalData's “Medical Equipment Quarterly Deals Analysis - M&A and Investment Trends, Q1 2011” report is an esse |
2011 | 1.500,00$ |
Dental Devices Market Outlook in Argentina to 2017 – Dental Chairs and Equipment, Dental Implants, Biomaterials and Crowns and Bridges and OthersIntroduction / / GlobalData’s new report, “Dental Devices Market Outlook in Argentina to 2017 - Dental Chairs and Equipment, Dent |
2011 | 2.500,00$ |
Dental Devices Market Outlook in Taiwan to 2017 – Dental Chairs and Equipment, Dental Implants, Biomaterials and Crowns and Bridges and OthersIntroduction / / GlobalData’s new report, “Dental Devices Market Outlook in Taiwan to 2017 - Dental Chairs and Equipment, Dental |
2011 | 2.500,00$ |
Hospital Supplies Market Outlook in United Kingdom to 2017 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and OthersIntroduction / / GlobalData’s new report, “Hospital Supplies Market Outlook in United Kingdom to 2017 - Disposable Hospital Suppl |
2011 | 2.500,00$ |
Hospital Supplies Market Outlook in Japan to 2017 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and OthersIntroduction / / GlobalData’s new report, “Hospital Supplies Market Outlook in Japan to 2017 - Disposable Hospital Supplies, Ster |
2011 | 2.500,00$ |
Hospital Supplies Market Outlook in India to 2017 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and OthersIntroduction / / GlobalData’s new report, “Hospital Supplies Market Outlook in India to 2017 - Disposable Hospital Supplies, Ster |
2011 | 2.500,00$ |
Hospital Supplies Market Outlook in China to 2017 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and OthersIntroduction / / GlobalData’s new report, “Hospital Supplies Market Outlook in China to 2017 - Disposable Hospital Supplies, Ster |
2011 | 2.500,00$ |
Hospital Supplies Market Outlook in Canada to 2017 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and OthersIntroduction / / GlobalData’s new report, “Hospital Supplies Market Outlook in Canada to 2017 - Disposable Hospital Supplies, Ste |
2011 | 2.500,00$ |
Hospital Supplies Market Outlook in France to 2017 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and OthersIntroduction / / GlobalData’s new report, “Hospital Supplies Market Outlook in France to 2017 - Disposable Hospital Supplies, Ste |
2011 | 2.500,00$ |
Hospital Supplies Market Outlook in Russian Federation to 2017 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and OthersIntroduction / / GlobalData’s new report, “Hospital Supplies Market Outlook in Russian Federation to 2017 - Disposable Hospital S |
2011 | 2.500,00$ |
Lymphangioleiomyomatosis Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Lymphangioleiomyomatosis Global Clinical Trials Review, Q1, 2011" provides |
2011 | 1.000,00$ |
Cytomegalovirus (CMV) Retinitis Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Cytomegalovirus (CMV) Retinitis Global Clinical Trials Review, Q1, 2011" pr |
2011 | 1.000,00$ |
Hemostasis Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Hemostasis Global Clinical Trials Review, Q1, 2011" provides data on the He |
2011 | 1.000,00$ |
Pancytopenia Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Pancytopenia Global Clinical Trials Review, Q1, 2011" provides data on the |
2011 | 1.000,00$ |
Thrombocytopenia Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Thrombocytopenia Global Clinical Trials Review, Q1, 2011" provides data on |
2011 | 1.000,00$ |
Lymphedema Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Lymphedema Global Clinical Trials Review, Q1, 2011" provides data on the Ly |
2011 | 1.000,00$ |
Hyponatremia Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Hyponatremia Global Clinical Trials Review, Q1, 2011" provides data on the |
2011 | 1.000,00$ |
Hyperuricemia Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Hyperuricemia Global Clinical Trials Review, Q1, 2011" provides data on the |
2011 | 1.000,00$ |
Hemoglobinuria Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Hemoglobinuria Global Clinical Trials Review, Q1, 2011" provides data on th |
2011 | 1.000,00$ |
Von Willebrand Disease Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Von Willebrand Disease Global Clinical Trials Review, Q1, 2011" provides da |
2011 | 1.000,00$ |
Hemophilia Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Hemophilia Global Clinical Trials Review, Q1, 2011" provides data on the He |
2011 | 1.000,00$ |
Thalassemia Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Thalassemia Global Clinical Trials Review, Q1, 2011" provides data on the T |
2011 | 1.000,00$ |
Sickle Cell Disease Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Sickle Cell Disease Global Clinical Trials Review, Q1, 2011" provides data |
2011 | 1.000,00$ |
West Nile Virus Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “West Nile Virus Global Clinical Trials Review, Q1, 2011" provides data on t |
2011 | 1.000,00$ |
Warts Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Warts Global Clinical Trials Review, Q1, 2011" provides data on the Warts c |
2011 | 1.000,00$ |
Herpes Zoster Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Herpes Zoster Global Clinical Trials Review, Q1, 2011" provides data on the |
2011 | 1.000,00$ |
Herpes Simplex Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Herpes Simplex Global Clinical Trials Review, Q1, 2011" provides data on th |
2011 | 1.000,00$ |
Herpes Labialis Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Herpes Labialis Global Clinical Trials Review, Q1, 2011" provides data on t |
2011 | 1.000,00$ |
Genital Herpes Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Genital Herpes Global Clinical Trials Review, Q1, 2011" provides data on th |
2011 | 1.000,00$ |
Enterovirus Infections Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Enterovirus Infections Global Clinical Trials Review, Q1, 2011" provides da |
2011 | 1.000,00$ |
Cytomegalovirus Infection Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Cytomegalovirus Infection Global Clinical Trials Review, Q1, 2011" provides |
2011 | 1.000,00$ |
Condyloma Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Condyloma Global Clinical Trials Review, Q1, 2011" provides data on the Con |
2011 | 1.000,00$ |
Periodontal Disease Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Periodontal Disease Global Clinical Trials Review, Q1, 2011" provides data |
2011 | 1.000,00$ |
Gingivitis Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Gingivitis Global Clinical Trials Review, Q1, 2011" provides data on the Gi |
2011 | 1.000,00$ |
Dental Plaque Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Dental Plaque Global Clinical Trials Review, Q1, 2011" provides data on the |
2011 | 1.000,00$ |
Trypanosomiasis Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Trypanosomiasis Global Clinical Trials Review, Q1, 2011" provides data on t |
2011 | 1.000,00$ |
Glaucoma Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Glaucoma Global Clinical Trials Review, Q1, 2011" provides data on the Glau |
2011 | 1.000,00$ |
Osteoporosis Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Osteoporosis Global Clinical Trials Review, Q1, 2011" provides data on the |
2011 | 1.000,00$ |
Pancreatic Fistula Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Pancreatic Fistula Global Clinical Trials Review, Q1, 2011" provides data o |
2011 | 1.000,00$ |
Cellulitis Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Cellulitis Global Clinical Trials Review, Q1, 2011" provides data on the Ce |
2011 | 1.000,00$ |
Gonorrhea Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Gonorrhea Global Clinical Trials Review, Q1, 2011" provides data on the Gon |
2011 | 1.000,00$ |
Impetigo Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Impetigo Global Clinical Trials Review, Q1, 2011" provides data on the Impe |
2011 | 1.000,00$ |
Pelvic Infection Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Pelvic Infection Global Clinical Trials Review, Q1, 2011" provides data on |
2011 | 1.000,00$ |
Surgical Wound Infection Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Surgical Wound Infection Global Clinical Trials Review, Q1, 2011" provides |
2011 | 1.000,00$ |
Fungemia Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Fungemia Global Clinical Trials Review, Q1, 2011" provides data on the Fung |
2011 | 1.000,00$ |
Cryptococcosis Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Cryptococcosis Global Clinical Trials Review, Q1, 2011" provides data on th |
2011 | 1.000,00$ |
Onychomycosis Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Onychomycosis Global Clinical Trials Review, Q1, 2011" provides data on the |
2011 | 1.000,00$ |
Alopecia Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Alopecia Global Clinical Trials Review, Q1, 2011" provides data on the Alop |
2011 | 1.000,00$ |
Rosacea Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Rosacea Global Clinical Trials Review, Q1, 2011" provides data on the Rosac |
2011 | 1.000,00$ |
Vitiligo Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Vitiligo Global Clinical Trials Review, Q1, 2011" provides data on the Viti |
2011 | 1.000,00$ |
Epistaxis Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Epistaxis Global Clinical Trials Review, Q1, 2011" provides data on the Epi |
2011 | 1.000,00$ |
Nasal Obstruction Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Nasal Obstruction Global Clinical Trials Review, Q1, 2011" provides data on |
2011 | 1.000,00$ |
Vestibular Diseases Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Vestibular Diseases Global Clinical Trials Review, Q1, 2011" provides data |
2011 | 1.000,00$ |
Vocal Cord Paralysis Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Vocal Cord Paralysis Global Clinical Trials Review, Q1, 2011" provides data |
2011 | 1.000,00$ |
Voice Disorders Global Clinical Trials Review, Q2, 2011Introduction / / GlobalData's clinical trial report, “Voice Disorders Global Clinical Trials Review, Q1, 2011" provides data on t |
2011 | 1.000,00$ |
Strabismus Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Strabismus Global Clinical Trials Review, Q1, 2011" provides data on the St |
2011 | 1.000,00$ |
Blepharitis Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Blepharitis Global Clinical Trials Review, Q1, 2011" provides data on the B |
2011 | 1.000,00$ |
Presbyopia Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Presbyopia Global Clinical Trials Review, Q1, 2011" provides data on the Pr |
2011 | 1.000,00$ |
Retinal Vein Occlusion Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Retinal Vein Occlusion Global Clinical Trials Review, Q1, 2011" provides da |
2011 | 1.000,00$ |
Retinoblastoma Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Retinoblastoma Global Clinical Trials Review, Q1, 2011" provides data on th |
2011 | 1.000,00$ |
Cryptosporidiosis Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Cryptosporidiosis Global Clinical Trials Review, Q1, 2011" provides data on |
2011 | 1.000,00$ |
Cognition Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Cognition Global Clinical Trials Review, Q1, 2011" provides data on the Cog |
2011 | 1.000,00$ |
Skin and Soft Tissue Infections Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Skin and Soft Tissue Infections Global Clinical Trials Review, Q1, 2011" pr |
2011 | 1.000,00$ |
Hemorrhoids Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Hemorrhoids Global Clinical Trials Review, Q1, 2011" provides data on the H |
2011 | 1.000,00$ |
Hepatobiliary Disease Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Hepatobiliary Disease Global Clinical Trials Review, Q1, 2011" provides dat |
2011 | 1.000,00$ |
Hepatorenal Syndrome Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Hepatorenal Syndrome Global Clinical Trials Review, Q1, 2011" provides data |
2011 | 1.000,00$ |
Intussusception Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Intussusception Global Clinical Trials Review, Q1, 2011" provides data on t |
2011 | 1.000,00$ |
Inflammatory Bowel Disease Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Inflammatory Bowel Disease Global Clinical Trials Review, Q1, 2011" provide |
2011 | 1.000,00$ |
Biliary Atresia Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Biliary Atresia Global Clinical Trials Review, Q1, 2011" provides data on t |
2011 | 1.000,00$ |
Chronic Liver Disease Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Chronic Liver Disease Global Clinical Trials Review, Q1, 2011" provides dat |
2011 | 1.000,00$ |
Fatty Liver Disease Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Fatty Liver Disease Global Clinical Trials Review, Q1, 2011" provides data |
2011 | 1.000,00$ |
Hepatic Injury Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Hepatic Injury Global Clinical Trials Review, Q1, 2011" provides data on th |
2011 | 1.000,00$ |
Liver Cirrhosis Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Liver Cirrhosis Global Clinical Trials Review, Q1, 2011" provides data on t |
2011 | 1.000,00$ |
Liver Failure Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Liver Failure Global Clinical Trials Review, Q1, 2011" provides data on the |
2011 | 1.000,00$ |
Liver Fibrosis Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Liver Fibrosis Global Clinical Trials Review, Q1, 2011" provides data on th |
2011 | 1.000,00$ |
Malabsorption Syndrome Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Malabsorption Syndrome Global Clinical Trials Review, Q1, 2011" provides da |
2011 | 1.000,00$ |
Non-Alcoholic Steatohepatitis Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Non-Alcoholic Steatohepatitis Global Clinical Trials Review, Q1, 2011" prov |
2011 | 1.000,00$ |
Fabry Disease Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Fabry Disease Global Clinical Trials Review, Q1, 2011" provides data on the |
2011 | 1.000,00$ |
Bacterial Vaginosis Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Bacterial Vaginosis Global Clinical Trials Review, Q1, 2011" provides data |
2011 | 1.000,00$ |
Allergic Corneal Marginal Ulcers Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Allergic Corneal Marginal Ulcers Global Clinical Trials Review, Q1, 2011" p |
2011 | 1.000,00$ |
Enterobacteriaceae Infections Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Enterobacteriaceae Infections Global Clinical Trials Review, Q1, 2011" prov |
2011 | 1.000,00$ |
Mycobacterium Infections Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Mycobacterium Infections Global Clinical Trials Review, Q1, 2011" provides |
2011 | 1.000,00$ |
Alpha- Antitrypsin Deficiency Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Alpha- Antitrypsin Deficiency Global Clinical Trials Review, Q1, 2011" prov |
2011 | 1.000,00$ |
Q Fever Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Q Fever Global Clinical Trials Review, Q1, 2011" provides data on the Q Fev |
2011 | 1.000,00$ |
Deglutition Disorders Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Deglutition Disorders Global Clinical Trials Review, Q1, 2011" provides dat |
2011 | 1.000,00$ |
Hemophilia A Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Hemophilia A Global Clinical Trials Review, Q1, 2011" provides data on the |
2011 | 1.000,00$ |
Hemophilia B Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Hemophilia B Global Clinical Trials Review, Q1, 2011" provides data on the |
2011 | 1.000,00$ |
Cognitive Disorders Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Cognitive Disorders Global Clinical Trials Review, Q1, 2011" provides data |
2011 | 1.000,00$ |
Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q1 2011Introduction / / GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q1 2011” report |
2011 | 1.500,00$ |
Hit by the Infamous Patent Cliff, Big Pharma Strategize Counter Measures for the FutureIntroduction / / GlobalData’s report, “Hit by the Infamous Patent Cliff, Big Pharma Strategize Counter Measures for the Future” p |
2011 | 500,00$ |
AutoGenomics and PGXL Laboratories to Partner to Expand Molecular Testing in Pharmacogenetics - Deal Analysis from GlobalDataIntroduction / / GlobalData’s medical equipment report, “AutoGenomics and PGXL Laboratories to Partner to Expand Molecular Testin |
2011 | 500,00$ |
Medical Action Industries Acquires AVID Medical - To Gain a Stronghold in the Custom Procedure Tray Market - Deal Analysis from GlobalDataIntroduction / / GlobalData’s medical equipment report, “Medical Action Industries Acquires AVID Medical - To Gain a Stronghold i |
2011 | 500,00$ |
FDA Changes Suggested in 510(k) Process - Impact and OpportunitiesIntroduction / / GlobalData’s report, “FDA Changes Suggested in 510(k) Process- Impact and Opportunities” provides key informatio |
2011 | 500,00$ |
Europe Dental Devices Market Outlook to 2017Introduction / / GlobalData’s new report, “Europe Dental Devices Market Outlook to 2017” provides key market data on the Europe |
2011 | 3.500,00$ |
Asia-Pacific Dental Devices Market Outlook to 2017Introduction / / GlobalData’s new report, “Asia-Pacific Dental Devices Market Outlook to 2017” provides key market data on the |
2011 | 3.500,00$ |
Europe ENT Devices Market Outlook to 2017Introduction / / GlobalData’s new report, “Europe ENT Devices Market Outlook to 2017” provides key market data on the Europe EN |
2011 | 3.500,00$ |
Brachytherapy Devices - Global Opportunity Assessment, Competitive Landscape and Market Forecasts to 2017Introduction / / GlobalData’s medical equipment report, “Brachytherapy Devices - Global Opportunity Assessment, Competitive Lands |
2011 | 3.500,00$ |
Asia-Pacific ENT Devices Market Outlook to 2017Introduction / / GlobalData’s new report, “Asia-Pacific ENT Devices Market Outlook to 2017” provides key market data on the Asi |
2011 | 3.500,00$ |
Medical Equipment Annual Deals Analysis 2011Introduction / / GlobalData's “Medical Equipment Annual Deals Analysis 2011” report is an essential source of data and trend anal |
2011 | 3.500,00$ |
Medical Equipment Monthly Deals Analysis - M&A and Investment Trends, April 2011Introduction / / GlobalData's “Medical Equipment Monthly Deals Analysis - M&A and Investment Trends, April 2011” report is an ess |
2011 | 1.000,00$ |
ENT Devices Market Outlook in Republic of Korea to 2017 - Hearing Aid Devices and Implants and Diagnostic DevicesIntroduction / / GlobalData’s new report, “ENT Devices Market Outlook in Republic of Korea to 2017 - Hearing Aid Devices and Impl |
2011 | 2.500,00$ |
ENT Devices Market Outlook in Sweden to 2017 - Hearing Aid Devices and Implants and Diagnostic DevicesIntroduction / / GlobalData’s new report, “ENT Devices Market Outlook in Sweden to 2017 - Hearing Aid Devices and Implants and Di |
2011 | 2.500,00$ |
ENT Devices Market Outlook in New Zealand to 2017 - Hearing Aid Devices and Implants and Diagnostic DevicesIntroduction / / GlobalData’s new report, “ENT Devices Market Outlook in New Zealand to 2017 - Hearing Aid Devices and Implants a |
2011 | 2.500,00$ |
ENT Devices Market Outlook in Denmark to 2017 - Hearing Aid Devices and Implants and Diagnostic DevicesIntroduction / / GlobalData’s new report, “ENT Devices Market Outlook in Denmark to 2017 - Hearing Aid Devices and Implants and D |
2011 | 2.500,00$ |
ENT Devices Market Outlook in Saudi Arabia to 2017 - Hearing Aid Devices and Implants and Diagnostic DevicesIntroduction / / GlobalData’s new report, “ENT Devices Market Outlook in Saudi Arabia to 2017 - Hearing Aid Devices and Implants |
2011 | 2.500,00$ |
Brazil Medical Device Industry – Key Company ProfilesIntroduction / / GlobalData’s report, “Brazil Medical Device Industry - Key Company Profiles” provides information and analysis o |
2011 | 500,00$ |
Dental Devices Market Outlook in Austria to 2017 – Dental Chairs and Equipment, Dental Implants, Biomaterials and Crowns and Bridges and OthersIntroduction / / GlobalData’s new report, “Dental Devices Market Outlook in Austria to 2017 – Dental Chairs and Equipment, Dental |
2011 | 2.500,00$ |
Healthcare IT Market Outlook in India to 2017 - Hospital Information Systems and Medical Imaging Information SystemsIntroduction / / GlobalData’s new report, “Healthcare IT Market Outlook in India to 2017 - Hospital Information Systems and Medic |
2011 | 2.500,00$ |
Body Contouring Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017Introduction / / GlobalData’s new report, “Body Contouring Devices - Global Pipeline Analysis, Competitive Landscape and Market F |
2011 | 3.500,00$ |
Dental Devices Market Outlook in Israel to 2017 - Dental Chairs and Equipment, Dental Implants, Biomaterials and Crowns and Bridges and OthersIntroduction / / GlobalData’s new report, “Dental Devices Market Outlook in Israel to 2017 - Dental Chairs and Equipment, Dental |
2011 | 2.500,00$ |
ENT Devices Market Outlook in Taiwan to 2017 - Hearing Aid Devices and Implants and Diagnostic DevicesIntroduction / / GlobalData’s new report, “ENT Devices Market Outlook in Taiwan to 2017 - Hearing Aid Devices and Implants and Di |
2011 | 2.500,00$ |
ENT Devices Market Outlook in Austria to 2017 - Hearing Aid Devices and Implants and Diagnostic DevicesIntroduction / / GlobalData’s new report, “ENT Devices Market Outlook in Austria to 2017 - Hearing Aid Devices and Implants and D |
2011 | 2.500,00$ |
Dental Devices Market Outlook in Czech Republic to 2017 - Dental Chairs and Equipment, Dental Implants, Biomaterials and Crowns and Bridges and OthersIntroduction / / GlobalData’s new report, “Dental Devices Market Outlook in Czech Republic to 2017 - Dental Chairs and Equipment, |
2011 | 2.500,00$ |
Dental Devices Market Outlook in Sweden to 2017 - Dental Chairs and Equipment, Dental Implants, Biomaterials and Crowns and Bridges and OthersIntroduction / / GlobalData’s new report, “Dental Devices Market Outlook in Sweden to 2017 - Dental Chairs and Equipment, Dental |
2011 | 2.500,00$ |
Dental Devices Market Outlook in New Zealand to 2017 - Dental Chairs and Equipment, Dental Implants, Biomaterials and Crowns and Bridges and OthersIntroduction / / GlobalData’s new report, “Dental Devices Market Outlook in New Zealand to 2017 - Dental Chairs and Equipment, De |
2011 | 2.500,00$ |
Dental Devices Market Outlook in Denmark to 2017 - Dental Chairs and Equipment, Dental Implants, Biomaterials and Crowns and Bridges and OthersIntroduction / / GlobalData’s new report, “Dental Devices Market Outlook in Denmark to 2017 - Dental Chairs and Equipment, Dental |
2011 | 2.500,00$ |
Dental Devices Market Outlook in Saudi Arabia to 2017 - Dental Chairs and Equipment, Dental Implants, Biomaterials and Crowns and Bridges and OthersIntroduction / / GlobalData’s new report, “Dental Devices Market Outlook in Saudi Arabia to 2017 - Dental Chairs and Equipment, D |
2011 | 2.500,00$ |
BioDelivery Sciences International Prices Private Placement of $15m - Deal Analysis from GlobalDataIntroduction / / The drug discovery process has become more complex, time consuming and quite expensive leading to big rise in R& |
2011 | 500,00$ |
Cephalon To Acquire Gemin X Pharmaceuticals - Deal Analysis from GlobalDataIntroduction / / In March 2011, Cephalon announced that it had signed an agreement to acquire the outstanding stock of Gemin X Ph |
2011 | 500,00$ |
FDA Approves Yervoy (Ipilimumab), First Targeted Melanoma Therapy for Over a DecadeIntroduction / / GlobalData’s report, “FDA Approves Yervoy (Ipilimumab), First Targeted Melanoma Therapy for Over a Decade” provi |
2011 | 500,00$ |
Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals, April 2011Introduction / / GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals, April 2011” repo |
2011 | 1.000,00$ |
Schistosomiasis Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Schistosomiasis Global Clinical Trials Review, Q1, 2011" provides data on t |
2011 | 1.000,00$ |
United Kingdom Diagnostic Imaging Market Outlook to 2016Introduction / / GlobalData’s medical equipment report, “United Kingdom Diagnostic Imaging Market Outlook to 2016” provides key m |
2010 | 2.500,00$ |
Continuous Glucose Monitoring (CGM) Systems - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016Introduction / / GlobalData’s new report, “Continuous Glucose Monitoring (CGM) Systems - Global Pipeline Analysis, Opportunity As |
2011 | 3.500,00$ |
American Academy of Orthopaedic Surgeons Annual Meeting 2011 - Review and AnalysisIntroduction / / GlobalData’s report, “American Academy of Orthopaedic Surgeons Annual Meeting 2011: Review and Analysis” provide |
2011 | 1.000,00$ |
Healthcare Information and Management Systems Society (HIMSS) Conference 2011: Review and AnalysisIntroduction / / GlobalData’s report, “Healthcare Information and Management Systems Society (HIMSS) Conference 2011: Review and |
2011 | 1.000,00$ |
Accuray to Acquire Tomotherapy: To Become Third Largest Player in Global Radiation Therapy Market – Deal Analysis from GlobalDataIntroduction / / GlobalData’s medical equipment report, “Accuray to Acquire Tomotherapy: To Become Third Largest Player in Global |
2011 | 500,00$ |
Terumo to Buy Blood Transfusion Business from Gambro: To become the Largest Player in the Blood Transfusion Market - Deal Analysis From GlobalDataIntroduction / / GlobalData’s “Terumo to Buy Blood Transfusion Business from Gambro to become the Largest Player in Blood Transfu |
2011 | 500,00$ |
Aramark Healthcare Buys ReMedPar, MasterPlan and MESA to Become End-to-End Clinical Technology Service Provider - Deal Analysis From GlobalDataIntroduction / / GlobalData’s medical equipment report, “Aramark Healthcare Buys ReMedPar, MasterPlan and MESA to Become End-to-E |
2011 | 500,00$ |
North America Nephrology and Urology Devices Market Outlook to 2017Introduction / / GlobalData’s new report, “North America Nephrology and Urology Devices Market Outlook to 2017” provides key mar |
2011 | 3.500,00$ |
Europe Nephrology and Urology Devices Market Outlook to 2017Introduction / / GlobalData’s new report, “Europe Nephrology and Urology Devices Market Outlook to 2017” provides key market dat |
2011 | 3.500,00$ |
Asia-Pacific Nephrology and Urology Devices Market Outlook to 2017Introduction / / GlobalData’s new report, “Asia-Pacific Nephrology and Urology Devices Market Outlook to 2017” provides key mark |
2011 | 3.500,00$ |
North America Neurology Devices Market Outlook to 2017Introduction / / GlobalData’s new report, “North America Neurology Devices Market Outlook to 2017” provides key market data on th |
2011 | 3.500,00$ |
Infectious Immunology Reagents, Instruments and Test Kits - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017Introduction / / GlobalData’s new report, “Infectious Immunology Reagents, Instruments and Test Kits - Global Pipeline Analysis, |
2011 | 3.500,00$ |
Europe Neurology Devices Market Outlook to 2017Introduction / / GlobalData’s new report, “Europe Neurology Devices Market Outlook to 2017” provides key market data on the Eur |
2011 | 3.500,00$ |
Asia-Pacific Neurology Devices Market Outlook to 2017Introduction / / GlobalData’s new report, “Asia-Pacific Neurology Devices Market Outlook to 2017” provides key market data on th |
2011 | 3.500,00$ |
Genetic Testing Reagents - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017Introduction / / GlobalData’s new report, “Genetic Testing Reagents - Global Pipeline Analysis, Competitive Landscape and Market |
2011 | 3.500,00$ |
Immuno Chemistry Reagents, Analyzers and Test Kits - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017Introduction / / GlobalData’s new report, “Immuno Chemistry Reagents, Analyzers and Test Kits - Global Pipeline Analysis, Competi |
2011 | 3.500,00$ |
Hematology Reagents and Analyzers - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017Introduction / / GlobalData’s new report, “Hematology Reagents and Analyzers - Global Pipeline Analysis, Competitive Landscape an |
2011 | 3.500,00$ |
North America ENT Devices Market Outlook to 2017Introduction / / GlobalData’s new report, “North America ENT Devices Market Outlook to 2017” provides key market data on the Nort |
2011 | 3.500,00$ |
Orthotics and Prosthetics - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017Introduction / / GlobalData’s new report, “Orthotics and Prosthetics - Global Pipeline Analysis, Competitive Landscape and Market |
2011 | 3.500,00$ |
India X-Ray Systems and Mammography Equipment Market Briefing to 2017Introduction / / GlobalData’s new report, “India X-Ray Systems and Mammography Equipment Market Briefing to 2017” provides key da |
2011 | 2.000,00$ |
Cardiac Markers - Global Pipeline Analysis, Competitive Landscape and Market Forecast to 2017Introduction / / GlobalData’s new report, “Cardiac Markers - Global Pipeline Analysis, Competitive Landscape and Market Forecasts |
2011 | 3.500,00$ |
Nephrology and Urology Devices Market Outlook in South Africa to 2017 - Incontinence Devices, Renal Dialysis Equipment and OthersIntroduction / / GlobalData’s new report, “Nephrology and Urology Devices Market Outlook in South Africa to 2017 - Incontinence D |
2011 | 2.500,00$ |
Dental Devices Market Outlook in United States to 2017 - Dental Chairs and Equipment, Dental Implants, Biomaterials and Crowns and Bridges and OthersIntroduction / / GlobalData’s new report, “Dental Devices Market Outlook in United States to 2017 - Dental Chairs and Equipment, |
2011 | 2.500,00$ |
Dental Devices Market Outlook in United Kingdom to 2017 - Dental Chairs and Equipment, Dental Implants, Biomaterials and Crowns and Bridges and OthersIntroduction / / GlobalData’s new report, “Dental Devices Market Outlook in United Kingdom to 2017 - Dental Chairs and Equipment, |
2011 | 2.500,00$ |
Dental Devices Market Outlook in Japan to 2017 - Dental Chairs and Equipment, Dental Implants, Biomaterials and Crowns and Bridges and OthersIntroduction / / GlobalData’s new report, “Dental Devices Market Outlook in Japan to 2017 - Dental Chairs and Equipment, Dental I |
2011 | 2.500,00$ |
Dental Devices Market Outlook in India to 2017 - Dental Chairs and Equipment, Dental Implants, Biomaterials and Crowns and Bridges and OthersIntroduction / / GlobalData’s new report, “Dental Devices Market Outlook in India to 2017 - Dental Chairs and Equipment, Dental I |
2011 | 2.500,00$ |
Dental Devices Market Outlook in China to 2017 - Dental Chairs and Equipment, Dental Implants, Biomaterials and Crowns and Bridges and OthersIntroduction / / GlobalData’s new report, “Dental Devices Market Outlook in China to 2017 - Dental Chairs and Equipment, Dental I |
2011 | 2.500,00$ |
Dental Devices Market Outlook in Canada to 2017 - Dental Chairs and Equipment, Dental Implants, Biomaterials and Crowns and Bridges and OthersIntroduction / / GlobalData’s new report, “Dental Devices Market Outlook in Canada to 2017 - Dental Chairs and Equipment, Dental |
2011 | 2.500,00$ |
Dental Devices Market Outlook in Germany to 2017 - Dental Chairs and Equipment, Dental Implants, Biomaterials and Crowns and Bridges and OthersIntroduction / / GlobalData’s new report, “Dental Devices Market Outlook in Germany to 2017 - Dental Chairs and Equipment, Dental |
2011 | 2.500,00$ |
Dental Devices Market Outlook in France to 2017 - Dental Chairs and Equipment, Dental Implants, Biomaterials and Crowns and Bridges and OthersIntroduction / / GlobalData’s new report, “Dental Devices Market Outlook in France to 2017 - Dental Chairs and Equipment, Dental |
2011 | 2.500,00$ |
Dental Devices Market Outlook in Italy to 2017 - Dental Chairs and Equipment, Dental Implants, Biomaterials and Crowns and Bridges and OthersIntroduction / / GlobalData’s new report, “Dental Devices Market Outlook in Italy to 2017 - Dental Chairs and Equipment, Dental I |
2011 | 2.500,00$ |
Dental Devices Market Outlook in Spain to 2017 - Dental Chairs and Equipment, Dental Implants, Biomaterials and Crowns and Bridges and OthersIntroduction / / GlobalData’s new report, “Dental Devices Market Outlook in Spain to 2017 - Dental Chairs and Equipment, Dental I |
2011 | 2.500,00$ |
Dental Devices Market Outlook in Australia to 2017 - Dental Chairs and Equipment, Dental Implants, Biomaterials and Crowns and Bridges and OthersIntroduction / / GlobalData’s new report, “Dental Devices Market Outlook in Australia to 2017 - Dental Chairs and Equipment, Dent |
2011 | 2.500,00$ |
Dental Devices Market Outlook in Brazil to 2017 - Dental Chairs and Equipment, Dental Implants, Biomaterials and Crowns and Bridges and OthersIntroduction / / GlobalData’s new report, “Dental Devices Market Outlook in Brazil to 2017 - Dental Chairs and Equipment, Dental |
2011 | 2.500,00$ |
Dental Devices Market Outlook in Netherlands to 2017 - Dental Chairs and Equipment, Dental Implants, Biomaterials and Crowns and Bridges and OthersIntroduction / / GlobalData’s new report, “Dental Devices Market Outlook in Netherlands to 2017 - Dental Chairs and Equipment, De |
2011 | 2.500,00$ |
Dental Devices Market Outlook in Belgium to 2017 - Dental Chairs and Equipment, Dental Implants, Biomaterials and Crowns and Bridges and OthersIntroduction / / GlobalData’s new report, “Dental Devices Market Outlook in Belgium to 2017 - Dental Chairs and Equipment, Dental |
2011 | 2.500,00$ |
Dental Devices Market Outlook in Mexico to 2017 - Dental Chairs and Equipment, Dental Implants, Biomaterials and Crowns and Bridges and OthersIntroduction / / GlobalData’s new report, “Dental Devices Market Outlook in Mexico to 2017 - Dental Chairs and Equipment, Dental |
2011 | 2.500,00$ |
Dental Devices Market Outlook in Republic of Korea to 2017 - Dental Chairs and Equipment, Dental Implants, Biomaterials and Crowns and Bridges and OthersIntroduction / / GlobalData’s new report, “Dental Devices Market Outlook in Republic of Korea to 2017 - Dental Chairs and Equipme |
2011 | 2.500,00$ |
Dental Devices Market Outlook in South Africa to 2017 - Dental Chairs and Equipment, Dental Implants, Biomaterials and Crowns and Bridges and OthersIntroduction / / GlobalData’s new report, “Dental Devices Market Outlook in South Africa to 2017 - Dental Chairs and Equipment, D |
2011 | 2.500,00$ |
Neurology Devices Market Outlook in United States to 2017 – Neurostimulation Devices, Interventional Neurology and OthersIntroduction / / GlobalData’s new report, “Neurology Devices Market Outlook in United States to 2017 – Neurostimulation Devices, |
2011 | 2.500,00$ |
Neurology Devices Market Outlook in United Kingdom to 2017 – Neurostimulation Devices, Interventional Neurology and OtherIntroduction / / GlobalData’s new report, “Neurology Devices Market Outlook in United Kingdom to 2017 – Neurostimulation Devices, |
2011 | 2.500,00$ |
North America Dental Devices Market Outlook to 2017Introduction / / GlobalData’s new report, “North America Dental Devices Market Outlook to 2017” provides key market data on the |
2011 | 3.500,00$ |
Neurology Devices Market Outlook in Japan to 2017 – Neurostimulation Devices, Interventional Neurology and OtherIntroduction / / GlobalData’s new report, “Neurology Devices Market Outlook in Japan to 2017 – Neurostimulation Devices, Interven |
2011 | 2.500,00$ |
Neurology Devices Market Outlook in India to 2017 - Neurostimulation Devices, Interventional Neurology and OthersIntroduction / / GlobalData’s new report, “Neurology Devices Market Outlook in India to 2017 - Neurostimulation Devices, Interven |
2011 | 2.500,00$ |
Neurology Devices Market Outlook in China to 2017 – Neurostimulation Devices, Interventional Neurology and OtherIntroduction / / GlobalData’s new report, “Neurology Devices Market Outlook in China to 2017 – Neurostimulation Devices, Interven |
2011 | 2.500,00$ |
Neurology Devices Market Outlook in Canada to 2017 - Neurostimulation Devices, Interventional Neurology and OthersIntroduction / / GlobalData’s new report, “Neurology Devices Market Outlook in Canada to 2017 - Neurostimulation Devices, Interve |
2011 | 2.500,00$ |
Neurology Devices Market Outlook in Germany to 2017 – Neurostimulation Devices, Interventional Neurology and OthersIntroduction / / GlobalData’s new report, “Neurology Devices Market Outlook in Germany to 2017 – Neurostimulation Devices, Interv |
2011 | 2.500,00$ |
Neurology Devices Market Outlook in France to 2017 - Neurostimulation Devices, Interventional Neurology and OthersIntroduction / / GlobalData’s new report, “Neurology Devices Market Outlook in France to 2017 - Neurostimulation Devices, Interve |
2011 | 2.500,00$ |
Neurology Devices Market Outlook in Italy to 2017 - Neurostimulation Devices, Interventional Neurology and OthersIntroduction / / GlobalData’s new report, “Neurology Devices Market Outlook in Italy to 2017 - Neurostimulation Devices, Interven |
2011 | 2.500,00$ |
Neurology Devices Market Outlook in Spain to 2017 - Neurostimulation Devices, Interventional Neurology and OthersIntroduction / / GlobalData’s new report, “Neurology Devices Market Outlook in Spain to 2017 - Neurostimulation Devices, Interven |
2011 | 2.500,00$ |
Neurology Devices Market Outlook in Australia to 2017 - Neurostimulation Devices, Interventional Neurology and OthersIntroduction / / GlobalData’s new report, “Neurology Devices Market Outlook in Australia to 2017 - Neurostimulation Devices, Inte |
2011 | 2.500,00$ |
Neurology Devices Market Outlook in Brazil to 2017 – Neurostimulation Devices, Interventional Neurology and OtherIntroduction / / GlobalData’s new report, “Neurology Devices Market Outlook in Brazil to 2017 – Neurostimulation Devices, Interve |
2011 | 2.500,00$ |
Neurology Devices Market Outlook in Netherlands to 2017 - Neurostimulation Devices, Interventional Neurology and OthersIntroduction / / GlobalData’s new report, “Neurology Devices Market Outlook in Netherlands to 2017 - Neurostimulation Devices, In |
2011 | 2.500,00$ |
Neurology Devices Market Outlook in Belgium to 2017 - Neurostimulation Devices, Interventional Neurology and OthersIntroduction / / GlobalData’s new report, “Neurology Devices Market Outlook in Belgium to 2017 - Neurostimulation Devices, Interv |
2011 | 2.500,00$ |
Neurology Devices Market Outlook in Argentina to 2017 - Neurostimulation Devices, Interventional Neurology and OthersIntroduction / / GlobalData’s new report, “Neurology Devices Market Outlook in Argentina to 2017 - Neurostimulation Devices, Inte |
2011 | 2.500,00$ |
Neurology Devices Market Outlook in Mexico to 2017 – Neurostimulation Devices, Interventional Neurology and OtherIntroduction / / GlobalData’s new report, “Neurology Devices Market Outlook in Mexico to 2017 – Neurostimulation Devices, Interve |
2011 | 2.500,00$ |
Neurology Devices Market Outlook in Republic of Korea to 2017 - Neurostimulation Devices, Interventional Neurology and OthersIntroduction / / GlobalData’s new report, “Neurology Devices Market Outlook in Republic of Korea to 2017 - Neurostimulation Devic |
2011 | 2.500,00$ |
Neurology Devices Market Outlook in Taiwan to 2017 – Neurostimulation Devices, Interventional Neurology and OtherIntroduction / / GlobalData’s new report, “Neurology Devices Market Outlook in Taiwan to 2017 – Neurostimulation Devices, Interve |
2011 | 2.500,00$ |
Neurology Devices Market Outlook in South Africa to 2017 - Neurostimulation Devices, Interventional Neurology and OthersIntroduction / / GlobalData’s new report, “Neurology Devices Market Outlook in South Africa to 2017 - Neurostimulation Devices, I |
2011 | 2.500,00$ |
Neurology Devices Market Outlook in Israel to 2017 - Neurostimulation Devices, Interventional Neurology and OthersIntroduction / / GlobalData’s new report, “Neurology Devices Market Outlook in Israel to 2017 - Neurostimulation Devices, Interve |
2011 | 2.500,00$ |
Neurology Devices Market Outlook in Austria to 2017 - Neurostimulation Devices, Interventional Neurology and OthersIntroduction / / GlobalData’s new report, “Neurology Devices Market Outlook in Austria to 2017 - Neurostimulation Devices, Interv |
2011 | 2.500,00$ |
Neurology Devices Market Outlook in Czech Republic to 2017 - Neurostimulation Devices, Interventional Neurology and OthersIntroduction / / GlobalData’s new report, “Neurology Devices Market Outlook in Czech Republic to 2017 - Neurostimulation Devices, |
2011 | 2.500,00$ |
Neurology Devices Market Outlook in Russian Federation to 2017 – Neurostimulation Devices, Interventional Neurology and OthersIntroduction / / GlobalData’s new report, “Neurology Devices Market Outlook in Russian Federation to 2017 – Neurostimulation Devi |
2011 | 2.500,00$ |
Neurology Devices Market Outlook in Sweden to 2017 – Neurostimulation Devices, Interventional Neurology and OthersIntroduction / / GlobalData’s new report, “Neurology Devices Market Outlook in Sweden to 2017 – Neurostimulation Devices, Interve |
2011 | 2.500,00$ |
Neurology Devices Market Outlook in New Zealand to 2017 – Neurostimulation Devices, Interventional Neurology and OthersIntroduction / / GlobalData’s new report, “Neurology Devices Market Outlook in New Zealand to 2017 – Neurostimulation Devices, In |
2011 | 2.500,00$ |
Neurology Devices Market Outlook in Denmark, to 2017 – Neurostimulation Devices, Interventional Neurology and OthersIntroduction / / GlobalData’s new report, “Neurology Devices Market Outlook in Denmark, to 2017 – Neurostimulation Devices, Inter |
2011 | 2.500,00$ |
Neurology Devices Market Outlook in Saudi Arabia to 2017 – Neurostimulation Devices, Interventional Neurology and OtherIntroduction / / GlobalData’s new report, “Neurology Devices Market Outlook in Saudi Arabia to 2017 – Neurostimulation Devices, I |
2011 | 2.500,00$ |
Nephrology and Urology Devices Market Outlook in Czech Republic to 2017 - Incontinence Devices, Renal Dialysis Equipment and OthersIntroduction / / GlobalData’s new report, “Nephrology and Urology Devices Market Outlook in Czech Republic to 2017 - Incontinence |
2011 | 2.500,00$ |
Nephrology and Urology Devices Market Outlook in Russian Federation to 2017 - Incontinence Devices, Renal Dialysis Equipment and OthersIntroduction / / GlobalData’s new report, “Nephrology and Urology Devices Market Outlook in Russian Federation to 2017 - Incontin |
2011 | 2.500,00$ |
Nephrology and Urology Devices Market Outlook in Sweden to 2017 - Incontinence Devices, Renal Dialysis Equipment and OthersIntroduction / / GlobalData’s new report, “Nephrology and Urology Devices Market Outlook in Sweden to 2017 - Incontinence Devices |
2011 | 2.500,00$ |
Nephrology and Urology Devices Market Outlook in New Zealand to 2017 - Incontinence Devices, Renal Dialysis Equipment and OthersIntroduction / / GlobalData’s new report, “Nephrology and Urology Devices Market Outlook in New Zealand to 2017 - Incontinence De |
2011 | 2.500,00$ |
Nephrology and Urology Devices Market Outlook in Denmark to 2017 - Incontinence Devices, Renal Dialysis Equipment and OthersIntroduction / / GlobalData’s new report, “Nephrology and Urology Devices Market Outlook in Denmark to 2017 - Incontinence Device |
2011 | 2.500,00$ |
Nephrology and Urology Devices Market Outlook in Saudi Arabia to 2017 - Incontinence Devices, Renal Dialysis Equipment and OthersIntroduction / / GlobalData’s new report, “Nephrology and Urology Devices Market Outlook in Saudi Arabia to 2017 - Incontinence D |
2011 | 2.500,00$ |
ENT Devices Market Outlook in United States to 2017 - Hearing Aid Devices and Implants and Diagnostic DevicesIntroduction / / GlobalData’s new report, “ENT Devices Market Outlook in United States to 2017 - Hearing Aid Devices and Implants |
2011 | 2.500,00$ |
ENT Devices Market Outlook in United Kingdom to 2017 - Hearing Aid Devices and Implants and Diagnostic DevicesIntroduction / / GlobalData’s new report, “ENT Devices Market Outlook in United Kingdom to 2017 - Hearing Aid Devices and Implant |
2011 | 2.500,00$ |
ENT Devices Market Outlook in Japan to 2017 - Hearing Aid Devices and Implants and Diagnostic DevicesIntroduction / / GlobalData’s new report, “ENT Devices Market Outlook in Japan to 2017 - Hearing Aid Devices and Implants and Dia |
2011 | 2.500,00$ |
ENT Devices Market Outlook in India to 2017 - Hearing Aid Devices and Implants and Diagnostic DevicesIntroduction / / GlobalData’s new report, “ENT Devices Market Outlook in India to 2017 - Hearing Aid Devices and Implants and Dia |
2011 | 2.500,00$ |
ENT Devices Market Outlook in China to 2017 - Hearing Aid Devices and Implants and Diagnostic DevicesIntroduction / / GlobalData’s new report, “ENT Devices Market Outlook in China to 2017 - Hearing Aid Devices and Implants and Dia |
2011 | 2.500,00$ |
ENT Devices Market Outlook in Canada to 2017 - Hearing Aid Devices and Implants and Diagnostic DevicesIntroduction / / GlobalData’s new report, “ENT Devices Market Outlook in Canada to 2017 - Hearing Aid Devices and Implants and Di |
2011 | 2.500,00$ |
ENT Devices Market Outlook in Germany to 2017 - Hearing Aid Devices and Implants and Diagnostic DevicesIntroduction / / GlobalData’s new report, “ENT Devices Market Outlook in Germany to 2017 - Hearing Aid Devices and Implants and D |
2011 | 2.500,00$ |
ENT Devices Market Outlook in France to 2017 - Hearing Aid Devices and Implants and Diagnostic DevicesIntroduction / / GlobalData’s new report, “ENT Devices Market Outlook in France to 2017 - Hearing Aid Devices and Implants and Di |
2011 | 2.500,00$ |
ENT Devices Market Outlook in Italy to 2017 - Hearing Aid Devices and Implants and Diagnostic DevicesIntroduction / / GlobalData’s new report, “ENT Devices Market Outlook in Italy to 2017 - Hearing Aid Devices and Implants and Dia |
2011 | 2.500,00$ |
ENT Devices Market Outlook in Spain to 2017 - Hearing Aid Devices and Implants and Diagnostic DevicesIntroduction / / GlobalData’s new report, “ENT Devices Market Outlook in Spain to 2017 - Hearing Aid Devices and Implants and Dia |
2011 | 2.500,00$ |
ENT Devices Market Outlook in Australia to 2017 - Hearing Aid Devices and Implants and Diagnostic DevicesIntroduction / / GlobalData’s new report, “ENT Devices Market Outlook in Australia to 2017 - Hearing Aid Devices and Implants and |
2011 | 2.500,00$ |
ENT Devices Market Outlook in Brazil to 2017 - Hearing Aid Devices and Implants and Diagnostic DevicesIntroduction / / GlobalData’s new report, “ENT Devices Market Outlook in Brazil to 2017 - Hearing Aid Devices and Implants and Di |
2011 | 2.500,00$ |
ENT Devices Market Outlook in Netherlands to 2017 - Hearing Aid Devices and Implants and Diagnostic DevicesIntroduction / / GlobalData’s new report, “ENT Devices Market Outlook in Netherlands to 2017 - Hearing Aid Devices and Implants a |
2011 | 2.500,00$ |
ENT Devices Market Outlook in Belgium to 2017 - Hearing Aid Devices and Implants and Diagnostic DevicesIntroduction / / GlobalData’s new report, “ENT Devices Market Outlook in Belgium to 2017 - Hearing Aid Devices and Implants and D |
2011 | 2.500,00$ |
ENT Devices Market Outlook in Argentina to 2017 - Hearing Aid Devices and Implants and Diagnostic DevicesIntroduction / / GlobalData’s new report, “ENT Devices Market Outlook in Argentina to 2017 - Hearing Aid Devices and Implants and |
2011 | 2.500,00$ |
ENT Devices Market Outlook in Mexico to 2017 - Hearing Aid Devices and Implants and Diagnostic DevicesIntroduction / / GlobalData’s new report, “ENT Devices Market Outlook in Mexico to 2017 - Hearing Aid Devices and Implants and Di |
2011 | 2.500,00$ |
ENT Devices Market Outlook in South Africa to 2017 - Hearing Aid Devices and Implants and Diagnostic DevicesIntroduction / / GlobalData’s new report, “ENT Devices Market Outlook in South Africa to 2017 - Hearing Aid Devices and Implants |
2011 | 2.500,00$ |
ENT Devices Market Outlook in Israel to 2017 - Hearing Aid Devices and Implants and Diagnostic DevicesIntroduction / / GlobalData’s new report, “ENT Devices Market Outlook in Israel to 2017 - Hearing Aid Devices and Implants and Di |
2011 | 2.500,00$ |
ENT Devices Market Outlook in Czech Republic to 2017 - Hearing Aid Devices and Implants and Diagnostic DevicesIntroduction / / GlobalData’s new report, “ENT Devices Market Outlook in Czech Republic to 2017 - Hearing Aid Devices and Implant |
2011 | 2.500,00$ |
ENT Devices Market Outlook in Russian Federation to 2017 - Hearing Aid Devices and Implants and Diagnostic DevicesIntroduction / / GlobalData’s new report, “ENT Devices Market Outlook in Russian Federation to 2017 - Hearing Aid Devices and Imp |
2011 | 2.500,00$ |
Critical Care Settings: An Impact Analysis of Ongoing and Expected TrendsIntroduction / / GlobalData’s report, “Critical Care Settings -An Impact Analysis of Ongoing and Expected Trends” provides key in |
2011 | 500,00$ |
Biomaterials that Deliver Antimicrobials: An OverviewIntroduction / / GlobalData’s report, “Biomaterials that Deliver Antimicrobials: An Overview” provides key information, products |
2011 | 500,00$ |
Dental Devices Market Outlook in Russian Federation to 2017 - Dental Chairs and Equipment, Dental Implants, Biomaterials and Crowns and Bridges and OthersIntroduction / / GlobalData’s new report, “Dental Devices Market Outlook in Russian Federation to 2017 - Dental Chairs and Equipm |
2011 | 2.500,00$ |
Uveitis Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Uveitis Global Clinical Trials Review, Q1, 2011" provides data on the Uveit |
2011 | 1.000,00$ |
Urinary Tract Cancer Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Urinary Tract Cancer Global Clinical Trials Review, Q1, 2011" provides data |
2011 | 1.000,00$ |
Epidermolysis Bullosa Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Epidermolysis Bullosa Global Clinical Trials Review, Q1, 2011" provides dat |
2011 | 1.000,00$ |
Xerostomia Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Xerostomia Global Clinical Trials Review, Q1, 2011" provides data on the Xe |
2011 | 1.000,00$ |
Respiratory Insufficiency Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Respiratory Insufficiency Global Clinical Trials Review, Q1, 2011" provides |
2011 | 1.000,00$ |
Neuroendocrine Carcinoma Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Neuroendocrine Carcinoma Global Clinical Trials Review, Q1, 2011" provides |
2011 | 1.000,00$ |
Tinnitus Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Tinnitus Global Clinical Trials Review, Q1, 2011" provides data on the Tinn |
2011 | 1.000,00$ |
Pulmonary Hypertension Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Pulmonary Hypertension Global Clinical Trials Review, Q1, 2011" provides da |
2011 | 1.000,00$ |
Filariasis Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Filariasis Global Clinical Trials Review, Q1, 2011" provides data on the Fi |
2011 | 1.000,00$ |
Anemia Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Anemia Global Clinical Trials Review, Q1, 2011" provides data on the Anemia |
2011 | 1.000,00$ |
Leishmaniasis (Kala-Azar) Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Leishmaniasis (Kala-Azar) Global Clinical Trials Review, Q1, 2011" provides |
2011 | 1.000,00$ |
Schizophrenia Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Schizophrenia Global Clinical Trials Review, Q1, 2011" provides data on the |
2011 | 1.000,00$ |
Depression Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Depression Global Clinical Trials Review, Q1, 2011" provides data on the De |
2011 | 1.000,00$ |
Arrythmia Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Arrhythmia Global Clinical Trials Review, Q1, 2011" provides data on the Ar |
2011 | 1.000,00$ |
Coronary Artery Disease (CAD) Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Coronary Artery Disease Global Clinical Trials Review, Q1, 2011" provides d |
2011 | 1.000,00$ |
Heart Valve Disease Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Heart Valve Disease Global Clinical Trials Review, Q1, 2011" provides data |
2011 | 1.000,00$ |
Respiration Disorders Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Respiration Disorders Global Clinical Trials Review, Q1, 2011" provides dat |
2011 | 1.000,00$ |
Pain Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Pain Global Clinical Trials Review, Q1, 2011" provides data on the Pain cli |
2011 | 1.000,00$ |
Retinitis Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Retinitis Global Clinical Trials Review, Q1, 2011" provides data on the Ret |
2011 | 1.000,00$ |
Helminthiasis Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Helminthiasis Global Clinical Trials Review, Q1, 2011" provides data on the |
2011 | 1.000,00$ |
Hypertension Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Hypertension Global Clinical Trials Review, Q1, 2011" provides data on the |
2011 | 1.000,00$ |
Other Psychiatric Disorders Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Other Psychiatric Disorders Global Clinical Trials Review, Q1, 2011" provid |
2011 | 1.000,00$ |
Other Neurologic Disorders Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Other Neurologic Disorders Global Clinical Trials Review, Q1, 2011" provide |
2011 | 1.000,00$ |
Mental Illness Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Mental Illness Global Clinical Trials Review, Q1, 2011" provides data on th |
2011 | 1.000,00$ |
Spinal Cord Injury Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Spinal Cord Injury Global Clinical Trials Review, Q1, 2011" provides data o |
2011 | 1.000,00$ |
Neuroblastoma Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Neuroblastoma Global Clinical Trials Review, Q1, 2011" provides data on the |
2011 | 1.000,00$ |
Tropical Spastic Paraparesis Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Tropical Spastic Paraparesis Global Clinical Trials Review, Q1, 2011" provi |
2011 | 1.000,00$ |
Back Pain Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Back Pain Global Clinical Trials Review, Q1, 2011" provides data on the Bac |
2011 | 1.000,00$ |
Anorexia Nervosa Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Anorexia Nervosa Global Clinical Trials Review, Q1, 2011" provides data on |
2011 | 1.000,00$ |
Aphasia Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Aphasia Global Clinical Trials Review, Q1, 2011" provides data on the Aphas |
2011 | 1.000,00$ |
Delirium Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Delirium Global Clinical Trials Review, Q1, 2011" provides data on the Deli |
2011 | 1.000,00$ |
Brain Infarction Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Brain Infarction Global Clinical Trials Review, Q1, 2011" provides data on |
2011 | 1.000,00$ |
Ataxia-Telangiectasia [Louis-Bar syndrome] Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Ataxia-Telangiectasia [Louis-Bar Syndrome] Global Clinical Trials Review, Q |
2011 | 1.000,00$ |
Diabetes Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Diabetes Global Clinical Trials Review, Q1, 2011" provides data on the Diab |
2011 | 1.000,00$ |
Diabetic Foot Ulcers Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Diabetic Foot Ulcers Global Clinical Trials Review, Q1, 2011" provides data |
2011 | 1.000,00$ |
Diabetic Foot Infection (DFI) Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Diabetic Foot Infection (DFI) Global Clinical Trials Review, Q1, 2011" prov |
2011 | 1.000,00$ |
Diabetic Gastroparesis Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Diabetic Gastroparesis Global Clinical Trials Review, Q1, 2011" provides da |
2011 | 1.000,00$ |
Diabetic Ketoacidosis Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Diabetic Ketoacidosis Global Clinical Trials Review, Q1, 2011" provides dat |
2011 | 1.000,00$ |
Drug Abuse Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Drug Abuse Global Clinical Trials Review, Q1, 2011" provides data on the Dr |
2011 | 1.000,00$ |
Other Central Nervous System Disorders Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Other Central Nervous System Disorders Global Clinical Trials Review, Q1, 2 |
2011 | 1.000,00$ |
Neurotoxicity Syndromes Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Neurotoxicity Syndromes Global Clinical Trials Review, Q1, 2011" provides d |
2011 | 1.000,00$ |
Amyotrophic Lateral Sclerosis Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Amyotrophic Lateral Sclerosis Global Clinical Trials Review, Q1, 2011" prov |
2011 | 1.000,00$ |
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Global Clinical Tr |
2011 | 1.000,00$ |
Carotid Sinus Syncope Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Carotid Sinus Syncope Global Clinical Trials Review, Q1, 2011" provides dat |
2011 | 1.000,00$ |
Cerebellar Ataxia Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Cerebellar Ataxia Global Clinical Trials Review, Q1, 2011" provides data on |
2011 | 1.000,00$ |
Brain Injury Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Brain Injury Global Clinical Trials Review, Q1, 2011" provides data on the |
2011 | 1.000,00$ |
Other Pain Disorders Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Other Pain Disorders Global Clinical Trials Review, Q1, 2011" provides data |
2011 | 1.000,00$ |
Cancer Pain Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Cancer Pain Global Clinical Trials Review, Q1, 2011" provides data on the C |
2011 | 1.000,00$ |
Brain Hemorrhage Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Brain Hemorrhage Global Clinical Trials Review, Q1, 2011" provides data on |
2011 | 1.000,00$ |
Amblyopia Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Amblyopia Global Clinical Trials Review, Q1, 2011" provides data on the Amb |
2011 | 1.000,00$ |
Asperger Syndrome Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Asperger Syndrome Global Clinical Trials Review, Q1, 2011" provides data on |
2011 | 1.000,00$ |
Cerebral Hypoxia Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Cerebral Hypoxia Global Clinical Trials Review, Q1, 2011" provides data on |
2011 | 1.000,00$ |
Cerebrovascular Disease Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Cerebrovascular Disease Global Clinical Trials Review, Q1, 2011" provides d |
2011 | 1.000,00$ |
Brain Disease Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Brain Disease Global Clinical Trials Review, Q1, 2011" provides data on the |
2011 | 1.000,00$ |
Constipation Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Constipation Global Clinical Trials Review, Q1, 2011" provides data on the |
2011 | 1.000,00$ |
Cardiac Arrest Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Cardiac Arrest Global Clinical Trials Review, Q1, 2011" provides data on th |
2011 | 1.000,00$ |
Candidiasis Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Candidiasis Global Clinical Trials Review, Q1, 2011" provides data on the C |
2011 | 1.000,00$ |
Cluster Headache Syndrome Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Cluster Headache Syndrome Global Clinical Trials Review, Q1, 2011" provides |
2011 | 1.000,00$ |
Complex Regional Pain Syndrome Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Complex Regional Pain Syndrome Global Clinical Trials Review, Q1, 2011" pro |
2011 | 1.000,00$ |
Anesthetic Effect Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Anesthetic Effect Global Clinical Trials Review, Q1, 2011" provides data on |
2011 | 1.000,00$ |
Fragile X Syndrome Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Fragile X Syndrome Global Clinical Trials Review, Q1, 2011" provides data o |
2011 | 1.000,00$ |
Anthrax Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Anthrax Global Clinical Trials Review, Q1, 2011" provides data on the Anth |
2011 | 1.000,00$ |
Attention Deficit Disorder Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Attention Deficit Disorder Global Clinical Trials Review, Q1, 2011" provid |
2011 | 1.000,00$ |
Panic Disorders Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Panic Disorders Global Clinical Trials Review, Q1, 2011" provides data on t |
2011 | 1.000,00$ |
Subarachnoid Hemorrhage Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Subarachnoid Hemorrhage Global Clinical Trials Review, Q1, 2011" provides d |
2011 | 1.000,00$ |
Movement Disorders Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Movement Disorders Global Clinical Trials Review, Q1, 2011" provides data o |
2011 | 1.000,00$ |
Nevus Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Nevus Global Clinical Trials Review, Q1, 2011" provides data on the Nevus |
2011 | 1.000,00$ |
Skin Rash Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Skin Rash Global Clinical Trials Review, Q1, 2011" provides data on the Ski |
2011 | 1.000,00$ |
Hidradenitis Suppurativa Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Hidradenitis Suppurativa Global Clinical Trials Review, Q1, 2011" provides |
2011 | 1.000,00$ |
Tinea Pedis Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Tinea Pedis Global Clinical Trials Review, Q1, 2011" provides data on the T |
2011 | 1.000,00$ |
Ankylosing Spondylitis Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Ankylosing Spondylitis Global Clinical Trials Review, Q1, 2011" provides da |
2011 | 1.000,00$ |
Lupus Nephritis Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Lupus Nephritis Global Clinical Trials Review, Q1, 2011" provides data on t |
2011 | 1.000,00$ |
International Stroke Conference 2011: Review and AnalysisIntroduction / / GlobalData, the industry analysis specialist, has released its new conference alerts, “International Stroke Conf |
2011 | 1.000,00$ |
2nd World Congress on Controversies in Ophthalmology 2011: Post-Conference Review and AnalysisIntroduction / / GlobalData, the industry analysis specialist, has released its new conference alerts, “2nd World Congress on Con |
2011 | 1.000,00$ |
The 10th International Conference on Alzheimer’s and Parkinson’s Diseases: Post-Conference Review and AnalysisIntroduction / / GlobalData, the industry analysis specialist, has released its new conference alert, “The 10th International Con |
2011 | 1.000,00$ |
Bladder Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume 1 2011Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Bladder Cancer - Global Drug Forecas |
2011 | 5.000,00$ |
Gastric Cancer - Global Drug Forecasts and Treatment Analysis to 2020 – Volume I 2011Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Gastric Cancer - Global Drug Forecas |
2011 | 5.000,00$ |
Telaprevir and Boceprevir: The First Generation Protease Inhibitors Boosts Response Rates to Standard Chronic Hepatitis C TreatmentIntroduction / / Global Data“Telaprevir and Boceprevir: The First Generation Protease Inhibitors Boosts Response Rates to Standar |
2011 | 500,00$ |
Cypress Bioscience Announces the Discontinuation of Co-Promotion Agreement with Forest Laboratories for Savella (Milnacipran)Introduction / / GlobalData’s report, “Cypress Bioscience Announces the Discontinuation of Co-Promotion Agreement with Forest Lab |
2011 | 500,00$ |
Jevtana (Cabazitaxel) - Positive Recommendation in the EU for Metastatic Castration-Resistant Prostate CancerIntroduction / / GlobalData’s report, “Jevtana (Cabazitaxel) - Positive Recommendation in the EU for Metastatic Castration-Resist |
2011 | 500,00$ |
Gilenya (Fingolimod), Laquinimod and Cladribine - Impact on the Multiple Sclerosis (MS) Treatment LandscapeIntroduction / / GlobalData’s report, “Gilenya (Fingolimod), Laquinimod and Cladribine - Impact on the Multiple Sclerosis (MS) Tr |
2011 | 500,00$ |
Increasing Disease Burden of Alzheimer’s Disease - Is There a Solution in Sight?Introduction / / GlobalData’s report, “Increasing Disease Burden of Alzheimer’s Disease - Is There a Solution in Sight? ” provide |
2011 | 500,00$ |
Iniparib Failure: Highlights the Uncertainty in Late Stage Breast Cancer PipelineIntroduction / / GlobalData’s report, “Iniparib Failure - Highlights the Uncertainty in Late Stage Breast Cancer Pipeline” provid |
2011 | 500,00$ |
FDA ends the 50-year long wait for Lupus patients - Benlysta set to become the next blockbusterIntroduction / / GlobalData’s report, “FDA ends the 50-year long wait for Lupus patients - Benlysta set to become the next blockb |
2011 | 500,00$ |
Early Diagnosis of Alzheimer’s Disease - Benefits, Challenges and Recent DevelopmentsIntroduction / / GlobalData’s report, “Early Diagnosis of Alzheimer’s Disease - Benefits, Challenges and Recent Developments” pro |
2011 | 500,00$ |
Paradigm Shift in R&D from Small Molecules to Biologics and Need for More Efficient Logistics InfrastructureIntroduction / / GlobalData’s report, “Paradigm Shift in R&D from Small Molecules to Biologics and Need for More Efficient Logist |
2011 | 500,00$ |
Erosive Oral Lichen Planus Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Erosive Oral Lichen Planus Global Clinical Trials Review, Q1, 2011" provide |
2011 | 1.000,00$ |
Enamel Carious Lesions Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Enamel Carious Lesions Global Clinical Trials Review, Q1, 2011" provides da |
2011 | 1.000,00$ |
Cholera Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Cholera Global Clinical Trials Review, Q1, 2011" provides data on the Chole |
2011 | 1.000,00$ |
Hairy Cell Leukemia Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Hairy Cell Leukemia Global Clinical Trials Review, Q1, 2011" provides data |
2011 | 1.000,00$ |
Partial Seizure Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Partial Seizure Global Clinical Trials Review, Q1, 2011" provides data on t |
2011 | 1.000,00$ |
Addiction Control Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Addiction Control Global Clinical Trials Review, Q1, 2011" provides data on |
2011 | 1.000,00$ |
Acidity Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Acidity Global Clinical Trials Review, Q1, 2011" provides data on the Acidi |
2011 | 1.000,00$ |
Appetite Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Appetite Global Clinical Trials Review, Q1, 2011" provides data on the Appe |
2011 | 1.000,00$ |
Biliary Tract Disease Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Billary Tract Disease Global Clinical Trials Review, Q1, 2011" provides dat |
2011 | 1.000,00$ |
Duodenitis Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Duodenitis Global Clinical Trials Review, Q1, 2011" provides data on the Du |
2011 | 1.000,00$ |
Burns Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Burns Global Clinical Trials Review, Q1, 2011" provides data on the Burns c |
2011 | 1.000,00$ |
Cellulite Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Cellulite Global Clinical Trials Review, Q1, 2011" provides data on the Cel |
2011 | 1.000,00$ |
Chronic Urticaria or Hives Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Chronic Urticaria or Hives Global Clinical Trials Review, Q1, 2011" provide |
2011 | 1.000,00$ |
Cutaneous Mastocytosis Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Cutaneous Mastocytosis Global Clinical Trials Review, Q1, 2011" provides da |
2011 | 1.000,00$ |
Dental Caries Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Dental Caries Global Clinical Trials Review, Q1, 2011" provides data on the |
2011 | 1.000,00$ |
Dental Pain Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Dental Pain Global Clinical Trials Review, Q1, 2011" provides data on the D |
2011 | 1.000,00$ |
Dermatitis Herpetiformis Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Dermatitis Herpetiformis Global Clinical Trials Review, Q1, 2011" provides |
2011 | 1.000,00$ |
Inflammatory Skin Diseases Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Inflammatory Skin Diseases Global Clinical Trials Review, Q1, 2011" provide |
2011 | 1.000,00$ |
Leg Ulcer Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Leg Ulcer Global Clinical Trials Review, Q1, 2011" provides data on the Leg |
2011 | 1.000,00$ |
Mouth Ulcers Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Mouth Ulcers Global Clinical Trials Review, Q1, 2011" provides data on the |
2011 | 1.000,00$ |
Muckle-Wells Syndrome Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Muckle-Wells Syndrome Global Clinical Trials Review, Q1, 2011" provides dat |
2011 | 1.000,00$ |
Pressure Ulcer Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Pressure Ulcer Global Clinical Trials Review, Q1, 2011" provides data on th |
2011 | 1.000,00$ |
Psoriasis Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Psoriasis Global Clinical Trials Review, Q1, 2011" provides data on the Pso |
2011 | 1.000,00$ |
Psoriatic Arthritis Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Psoriatic Arthritis Global Clinical Trials Review, Q1, 2011" provides data |
2011 | 1.000,00$ |
Scar Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Scar Global Clinical Trials Review, Q1, 2011" provides data on the Scar cli |
2011 | 1.000,00$ |
Skin Ulcers Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Skin Ulcers Global Clinical Trials Review, Q1, 2011" provides data on the S |
2011 | 1.000,00$ |
Wounds Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Wounds Global Clinical Trials Review, Q1, 2011" provides data on the Wounds |
2011 | 1.000,00$ |
Wrinkles Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Wrinkles Global Clinical Trials Review, Q1, 2011" provides data on the Wrin |
2011 | 1.000,00$ |
Sarcopenia Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Sarcopenia Global Clinical Trials Review, Q1, 2011" provides data on the Sa |
2011 | 1.000,00$ |
Enteritis Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Enteritis Global Clinical Trials Review, Q1, 2011" provides data on the Ent |
2011 | 1.000,00$ |
Barrett’s Esophagus Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Barrett’s Esophagus Global Clinical Trials Review, Q1, 2011" provides data |
2011 | 1.000,00$ |
Eosinophilic Esophagitis Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Eosinophilic Esophagitis Global Clinical Trials Review, Q1, 2011" provides |
2011 | 1.000,00$ |
Fistula Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Fistula Global Clinical Trials Review, Q1, 2011" provides data on the Fistu |
2011 | 1.000,00$ |
Choledocholithiasis Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Choledocholithiasis Global Clinical Trials Review, Q1, 2011" provides data |
2011 | 1.000,00$ |
Cholelithiasis Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Cholelithiasis Global Clinical Trials Review, Q1, 2011" provides data on th |
2011 | 1.000,00$ |
Gastric Motility Disorder Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Gastric Motility Disorder Global Clinical Trials Review, Q1, 2011" provides |
2011 | 1.000,00$ |
Gastroesophageal Reflux Disease Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Gastroesophageal Reflux Disease Global Clinical Trials Review, Q1, 2011" pr |
2011 | 1.000,00$ |
Dyspepsia Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Dyspepsia Global Clinical Trials Review, Q1, 2011" provides data on the Dys |
2011 | 1.000,00$ |
Dry Eye Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Dry Eye Global Clinical Trials Review, Q1, 2011" provides data on the Dry E |
2011 | 1.000,00$ |
Varicella-Zoster Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Varicella-Zoster Global Clinical Trials Review, Q1, 2011" provides data on |
2011 | 1.000,00$ |
Orthomyxoviridae Infections Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Orthomyxoviridae Infections Global Clinical Trials Review, Q1, 2011" provid |
2011 | 1.000,00$ |
Croup Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Croup Global Clinical Trials Review, Q1, 2011" provides data on the Croup c |
2011 | 1.000,00$ |
Human Papillomavirus Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Human Papillomavirus Global Clinical Trials Review, Q1, 2011" provides data |
2011 | 1.000,00$ |
Genital Warts Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Genital Warts Global Clinical Trials Review, Q1, 2011" provides data on the |
2011 | 1.000,00$ |
Graft Versus Host Disease (GVHD) Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Graft Versus Host Disease (GVHD) Global Clinical Trials Review, Q1, 2011" p |
2011 | 1.000,00$ |
Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - March 2011Introduction / / GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals – March 2011” rep |
2011 | 1.000,00$ |
Gall Stone Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Gall Stone Global Clinical Trials Review, Q1, 2011" provides data on the Ga |
2011 | 1.000,00$ |
DURECT Corporation (DRRX) - Product Pipeline AnalysisDURECT Corporation (DRRX) - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable |
2011 | 750,00$ |
EKOS Corporation - Product Pipeline AnalysisEKOS Corporation - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intellige |
2011 | 750,00$ |
Medlogics Device Corporation - Product Pipeline AnalysisMedlogics Device Corporation - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionab |
2011 | 750,00$ |
Amorfix Life Sciences Ltd. (AMF) - Product Pipeline AnalysisAmorfix Life Sciences Ltd. (AMF) - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and acti |
2011 | 750,00$ |
NeuroMetrix, Inc. (NURO) - Product Pipeline AnalysisNeuroMetrix, Inc. (NURO) - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable i |
2011 | 750,00$ |
Arterial Remodeling Technologies - Product Pipeline AnalysisArterial Remodeling Technologies - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and acti |
2011 | 750,00$ |
LifeWave, Inc. - Product Pipeline AnalysisLifeWave, Inc. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intelligenc |
2011 | 750,00$ |
Gene Express, Inc. - Product Pipeline AnalysisGene Express, Inc. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intelli |
2011 | 750,00$ |
TYRX, Inc. - Product Pipeline AnalysisTYRX, Inc. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intelligence on |
2011 | 750,00$ |
Doxa AB - Product Pipeline AnalysisDoxa AB - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intelligence on th |
2011 | 750,00$ |
Scient'x USA - Product Pipeline AnalysisScient'x USA - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intelligence |
2011 | 750,00$ |
Korea Bone Bank Inc. - Product Pipeline AnalysisKorea Bone Bank Inc. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intel |
2011 | 750,00$ |
Japan Medical Materials Corporation - Product Pipeline AnalysisJapan Medical Materials Corporation - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and a |
2011 | 750,00$ |
SomaLogic, Inc. - Product Pipeline AnalysisSomaLogic, Inc. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intelligen |
2011 | 750,00$ |
Raymedica, LLC - Product Pipeline AnalysisRaymedica, LLC - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intelligenc |
2011 | 750,00$ |
Small Bone Innovations, Inc. - Product Pipeline AnalysisSmall Bone Innovations, Inc. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionab |
2011 | 750,00$ |
Onconome, Inc. - Product Pipeline AnalysisOnconome, Inc. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intelligenc |
2011 | 750,00$ |
Micrus Endovascular Corporation (MEND) - Product Pipeline AnalysisMicrus Endovascular Corporation (MEND) - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis an |
2011 | 750,00$ |
OrSense Ltd. - Product Pipeline AnalysisOrSense Ltd. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intelligence |
2011 | 750,00$ |
Lithotech Medical Ltd. - Product Pipeline AnalysisLithotech Medical Ltd. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable int |
2011 | 750,00$ |
LDR Holding Corporation - Product Pipeline AnalysisLDR Holding Corporation - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable in |
2011 | 750,00$ |
Heart Tronics, Inc. (HRTT) - Product Pipeline AnalysisHeart Tronics, Inc. (HRTT) - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable |
2011 | 750,00$ |
ITGI Medical Ltd. - Product Pipeline AnalysisITGI Medical Ltd. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intellig |
2011 | 750,00$ |
Medicsight PLC (MDST) - Product Pipeline AnalysisMedicsight PLC (MDST) - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable inte |
2011 | 750,00$ |
Nerites Corporation - Product Pipeline AnalysisNerites Corporation - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intell |
2011 | 750,00$ |
Nanomix, Inc. - Product Pipeline AnalysisNanomix, Inc. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intelligence |
2011 | 750,00$ |
Palomar Medical Technologies, Inc. (PMTI) - Product Pipeline AnalysisPalomar Medical Technologies, Inc. (PMTI) - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis |
2011 | 750,00$ |
Infopia Co., Ltd. (036220) - Product Pipeline AnalysisInfopia Co., Ltd. (036220) - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable |
2011 | 750,00$ |
HEXACATH - Product Pipeline AnalysisHEXACATH - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intelligence on t |
2011 | 750,00$ |
Wet Nose Technologies, LLC - Product Pipeline AnalysisWet Nose Technologies, LLC - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable |
2011 | 750,00$ |
Eden Spine, LLC - Product Pipeline AnalysisEden Spine, LLC - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intelligen |
2011 | 750,00$ |
Nesstent Ltd. - Product Pipeline AnalysisNesstent Ltd. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intelligence |
2011 | 750,00$ |
Amedica Corporation - Product Pipeline AnalysisAmedica Corporation - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intell |
2011 | 750,00$ |
Alfa Scientific Designs, Inc. - Product Pipeline AnalysisAlfa Scientific Designs, Inc. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actiona |
2011 | 750,00$ |
VentriPoint, Inc. - Product Pipeline AnalysisVentriPoint, Inc. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intellig |
2011 | 750,00$ |
Satoris, Inc. - Product Pipeline AnalysisSatoris, Inc. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intelligence |
2011 | 750,00$ |
Dynatomics Ltd. - Product Pipeline AnalysisDynatomics Ltd. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intelligen |
2011 | 750,00$ |
Sphere Medical Limited - Product Pipeline AnalysisSphere Medical Limited - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable int |
2011 | 750,00$ |
BioCardia, Inc. - Product Pipeline AnalysisBioCardia, Inc. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intelligen |
2011 | 750,00$ |
Angiotech Pharmaceuticals, Inc. (ANP) - Product Pipeline AnalysisAngiotech Pharmaceuticals, Inc. (ANP) - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and |
2011 | 750,00$ |
University of Tampere - Product Pipeline AnalysisUniversity of Tampere - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable inte |
2011 | 750,00$ |
Sahajanand Medical Technologies Pvt. Ltd. - Product Pipeline AnalysisSahajanand Medical Technologies Pvt. Ltd. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis |
2011 | 750,00$ |
Danaher Signs an Agreement to Acquire Beckman Coulter: A Move to Leverage its Position in the Life Sciences Market in View of the Increasing Demand - Deal Analysis From GlobalDataIntroduction / / GlobalData’s report, “Danaher Corp. Acquires Beckman Coulter Inc.: Move to Leverage its Position in the Life Sci |
2011 | 500,00$ |
Medical Equipment Monthly Deals Analysis: M&A and Investment Trends - March 2011Introduction / / GlobalData's “Medical Equipment Monthly Deals Analysis: M&A and Investment Trends – March 2011” report is an ess |
2011 | 1.000,00$ |
Nephrology and Urology Devices Market Outlook in United States to 2017 - Incontinence Devices, Renal Dialysis Equipment and OthersIntroduction / / GlobalData’s new report, “Nephrology and Urology Devices Market Outlook in United States to 2017 - Incontinence |
2011 | 2.500,00$ |
Nephrology and Urology Devices Market Outlook in United Kingdom to 2017 - Incontinence Devices, Renal Dialysis Equipment and OthersIntroduction / / GlobalData’s new report, “Nephrology and Urology Devices Market Outlook in United Kingdom to 2017 - Incontinence |
2011 | 2.500,00$ |
Nephrology and Urology Devices Market Outlook in Japan to 2017 - Incontinence Devices, Renal Dialysis Equipment and OthersIntroduction / / GlobalData’s new report, “Nephrology and Urology Devices Market Outlook in Japan to 2017 - Incontinence Devices, |
2011 | 2.500,00$ |
Nephrology and Urology Devices Market Outlook in India to 2017 - Incontinence Devices, Renal Dialysis Equipment and OthersIntroduction / / GlobalData’s new report, “Nephrology and Urology Devices Market Outlook in India to 2017 - Incontinence Devices, |
2011 | 2.500,00$ |
Nephrology and Urology Devices Market Outlook in China to 2017 - Incontinence Devices, Renal Dialysis Equipment and OthersIntroduction / / GlobalData’s new report, “Nephrology and Urology Devices Market Outlook in China to 2017 - Incontinence Devices, |
2011 | 2.500,00$ |
Nephrology and Urology Devices Market Outlook in Canada to 2017 - Incontinence Devices, Renal Dialysis Equipment and OthersIntroduction / / GlobalData’s new report, “Nephrology and Urology Devices Market Outlook in Canada to 2017 - Incontinence Devices |
2011 | 2.500,00$ |
Nephrology and Urology Devices Market Outlook in Germany to 2017 - Incontinence Devices, Renal Dialysis Equipment and OthersIntroduction / / GlobalData’s new report, “Nephrology and Urology Devices Market Outlook in Germany to 2017 - Incontinence Device |
2011 | 2.500,00$ |
Nephrology and Urology Devices Market Outlook in France to 2017 - Incontinence Devices, Renal Dialysis Equipment and OthersIntroduction / / GlobalData’s new report, “Nephrology and Urology Devices Market Outlook in France to 2017 - Incontinence Devices |
2011 | 2.500,00$ |
Nephrology and Urology Devices Market Outlook in Italy to 2017 - Incontinence Devices, Renal Dialysis Equipment and OthersIntroduction / / GlobalData’s new report, “Nephrology and Urology Devices Market Outlook in Italy to 2017 - Incontinence Devices, |
2011 | 2.500,00$ |
Nephrology and Urology Devices Market Outlook in Spain to 2017 - Incontinence Devices, Renal Dialysis Equipment and OthersIntroduction / / GlobalData’s new report, “Nephrology and Urology Devices Market Outlook in Spain to 2017 - Incontinence Devices, |
2011 | 2.500,00$ |
Nephrology and Urology Devices Market Outlook in Australia to 2017 - Incontinence Devices, Renal Dialysis Equipment and OthersIntroduction / / GlobalData’s new report, “Nephrology and Urology Devices Market Outlook in Australia to 2017 - Incontinence Devi |
2011 | 2.500,00$ |
Nephrology and Urology Devices Market Outlook in Brazil to 2017 - Incontinence Devices, Renal Dialysis Equipment and OthersIntroduction / / GlobalData’s new report, “Nephrology and Urology Devices Market Outlook in Brazil to 2017 - Incontinence Devices |
2011 | 2.500,00$ |
Nephrology and Urology Devices Market Outlook in Netherlands to 2017 - Incontinence Devices, Renal Dialysis Equipment and OthersIntroduction / / GlobalData’s new report, “Nephrology and Urology Devices Market Outlook in Netherlands to 2017 - Incontinence De |
2011 | 2.500,00$ |
Nephrology and Urology Devices Market Outlook in Belgium to 2017 - Incontinence Devices, Renal Dialysis Equipment and OthersIntroduction / / GlobalData’s new report, “Nephrology and Urology Devices Market Outlook in Belgium to 2017 - Incontinence Device |
2011 | 2.500,00$ |
Nephrology and Urology Devices Market Outlook in Argentina to 2017 - Incontinence Devices, Renal Dialysis Equipment and OthersIntroduction / / GlobalData’s new report, “Nephrology and Urology Devices Market Outlook in Argentina to 2017 - Incontinence Devi |
2011 | 2.500,00$ |
Nephrology and Urology Devices Market Outlook in Mexico to 2017 - Incontinence Devices, Renal Dialysis Equipment and OthersIntroduction / / GlobalData’s new report, “Nephrology and Urology Devices Market Outlook in Mexico to 2017 - Incontinence Devices |
2011 | 2.500,00$ |
Nephrology and Urology Devices Market Outlook in Republic of Korea to 2017 - Incontinence Devices, Renal Dialysis Equipment and OthersIntroduction / / GlobalData’s new report, “Nephrology and Urology Devices Market Outlook in Republic of Korea to 2017 - Incontine |
2011 | 2.500,00$ |
Nephrology and Urology Devices Market Outlook in Taiwan to 2017 - Incontinence Devices, Renal Dialysis Equipment and OthersIntroduction / / GlobalData’s new report, “Nephrology and Urology Devices Market Outlook in Taiwan to 2017 - Incontinence Devices |
2011 | 2.500,00$ |
Nephrology and Urology Devices Market Outlook in Israel to 2017 - Incontinence Devices, Renal Dialysis Equipment and OthersIntroduction / / GlobalData’s new report, “Nephrology and Urology Devices Market Outlook in Israel to 2017 - Incontinence Devices |
2011 | 2.500,00$ |
Nephrology and Urology Devices Market Outlook in Austria to 2017 - Incontinence Devices, Renal Dialysis Equipment and OthersIntroduction / / GlobalData’s new report, “Nephrology and Urology Devices Market Outlook in Austria to 2017 - Incontinence Device |
2011 | 2.500,00$ |
Strong Pipeline Characterized with Novel Therapies will Drive the Methicillin-Resistant Staphylococcus Aureus (MRSA) MarketIntroduction / / GlobalData’s report, “Strong Pipeline Characterized with Novel Therapies will drive the Methicillin-Resistant St |
2011 | 500,00$ |
Novel Targeted Therapies Hold the Promise of Cure for Parkinson’s Disease (PD)Introduction / / GlobalData’s report, “Novel Targeted Therapies Hold the Promise of Cure for Parkinson’s Disease (PD) ” provides |
2011 | 500,00$ |
Tivozanib: Newer VEGF Inhibitors Represent A Paradigm Shift In Renal Cell Carcinoma TherapyIntroduction / / GlobalData’s report, “Tivozanib: Newer VEGF Inhibitors Represent A Paradigm Shift In Renal Cell Carcinoma Therap |
2011 | 500,00$ |
Vertex’s VX770 Is Poised To Become The First Targeted Therapy To Be Approved In Cystic FibrosisIntroduction / / GlobalData’s report, “Vertex’s VX770 Is Poised To Become The First Targeted Therapy To Be Approved In Cystic Fib |
2011 | 500,00$ |
Will 2011 Spell a Brighter Year for the Pharmaceutical Companies?Introduction / / GlobalData’s report, “Will 2011 Spell a Brighter Year for the Pharmaceutical Companies?” provides information on |
2011 | 500,00$ |
Cerebral Infarction Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Cerebral Infarction Global Clinical Trials Review, Q1, 2011" provides data |
2011 | 1.000,00$ |
Aneurysmal Subarachnoid Hemorrhage (SAH) Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Aneurysmal Subarachnoid Hemorrhage (SAH) Global Clinical Trials Review, Q1, |
2011 | 1.000,00$ |
Motor Neurone Disease Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Motor Neurone Disease Global Clinical Trials Review, Q1, 2011" provides dat |
2011 | 1.000,00$ |
Hyperalgesia Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Hyperalgesia Global Clinical Trials Review, Q1, 2011" provides data on the |
2011 | 1.000,00$ |
Radiculopathy Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Radiculopathy Global Clinical Trials Review, Q1, 2011" provides data on the |
2011 | 1.000,00$ |
Musculoskeletal Pain Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Musculoskeletal Pain Global Clinical Trials Review, Q1, 2011" provides data |
2011 | 1.000,00$ |
Brain Ischemia Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Brain Ischemia Global Clinical Trials Review, Q1, 2011" provides data on th |
2011 | 1.000,00$ |
Craniocerebral Trauma Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Craniocerebral Trauma Global Clinical Trials Review, Q1, 2011" provides dat |
2011 | 1.000,00$ |
Circadian Rhythm Sleep Disorders Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Circadian Rhythm Sleep Disorders Global Clinical Trials Review, Q1, 2011" p |
2011 | 1.000,00$ |
Inflammatory Pain Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Inflammatory Pain Global Clinical Trials Review, Q1, 2011" provides data on |
2011 | 1.000,00$ |
Anal Fissure Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Anal Fissure Global Clinical Trials Review, Q1, 2011" provides data on the |
2011 | 1.000,00$ |
Biliary Cirrhosis Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Biliary Cirrhosis Global Clinical Trials Review, Q1, 2011" provides data on |
2011 | 1.000,00$ |
Colitis Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Colitis Global Clinical Trials Review, Q1, 2011" provides data on the Colit |
2011 | 1.000,00$ |
Diverticulitis Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Diverticulitis Global Clinical Trials Review, Q1, 2011" provides data on th |
2011 | 1.000,00$ |
Dysphagia Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Dysphagia Global Clinical Trials Review, Q1, 2011" provides data on the Dys |
2011 | 1.000,00$ |
Angioedema Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Angioedema Global Clinical Trials Review, Q1, 2011" provides data on the An |
2011 | 1.000,00$ |
Chlamydia Infections Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Chlamydia Infections Global Clinical Trials Review, Q1, 2011" provides data |
2011 | 1.000,00$ |
Clostridium Infections Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Clostridium Infections Global Clinical Trials Review, Q1, 2011" provides da |
2011 | 1.000,00$ |
Endophthalmitis Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Endophthalmitis Global Clinical Trials Review, Q1, 2011" provides data on t |
2011 | 1.000,00$ |
Escherichia coli Infections Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Escherichia coli Infections Global Clinical Trials Review, Q1, 2011" provid |
2011 | 1.000,00$ |
Histoplasmosis Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Histoplasmosis Global Clinical Trials Review, Q1, 2011" provides data on th |
2011 | 1.000,00$ |
Pneumococcal Infections Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Pneumococcal Infections Global Clinical Trials Review, Q1, 2011" provides d |
2011 | 1.000,00$ |
Trauma Fixation Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017Introduction / / GlobalData’s new report, “Trauma Fixation Devices - Global Pipeline Analysis, Competitive Landscape and Market F |
2011 | 3.500,00$ |
Wireless Medical Devices - A Market SnapshotIntroduction / / GlobalData’s report, “Wireless Medical Devices - A Market Snapshot” provides information and analysis on the glo |
2011 | 500,00$ |
Generalized Seizures Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Generalized Seizures Global Clinical Trials Review, Q1, 2011" provides data |
2011 | 1.000,00$ |
Memory Impairment Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Memory Impairment Global Clinical Trials Review, Q1, 2011" provides data on |
2011 | 1.000,00$ |
Tardive Dyskinesia Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Tardive Dyskinesia Global Clinical Trials Review, Q1, 2011" provides data o |
2011 | 1.000,00$ |
Seborrhea Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Seborrhea Global Clinical Trials Review, Q1, 2011" provides data on the Seb |
2011 | 1.000,00$ |
Syphilis Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Syphilis Global Clinical Trials Review, Q1, 2011" provides data on the Syph |
2011 | 1.000,00$ |
Pharmaceutical & Healthcare Annual Deals Analysis 2011Analysis of the market trends for the pharmaceutical industry in the global arena.
/ Review of deal trends in the cardiovascular |
2011 | 3.500,00$ |
Cancer Vaccines - Pipeline Assessment and Market Forecasts to 2017Introduction / / GlobalData, the industry analysis specialist’s new report, “Cancer Vaccines - Pipeline Assessment and Market For |
2010 | 2.000,00$ |
CHAD Therapeutics, Inc. (CHADQ) - Financial and Strategic SWOT Analysis ReviewCHAD Therapeutics (CHAD ) is engaged in the development, production and distribution of respiratory care products for hospital and |
2011 | 250,00$ |
VNUS Medical Technologies, Inc. (VNUS) - Financial and Strategic SWOT Analysis ReviewVNUS Medical Technologies, Inc. (VNUS Medical) develops, manufactures and licenses VNUS Closure system of products used in the min |
2011 | 250,00$ |
LMS Medical Systems Inc. (LMZ) - Financial and Strategic SWOT Analysis ReviewLMS Medical Systems Inc. (LMS), a healthcare technology service provider company. The company is principally engaged in the develo |
2011 | 250,00$ |
SSL International plc (Inactive) (SSL) - Financial and Strategic SWOT Analysis ReviewSSL International plc (SSL) is engaged in manufacturing and distributing healthcare products to the consumer markets worldwide. Th |
2011 | 125,00$ |
Tepnel Life Sciences PLC (TED) - Financial and Strategic SWOT Analysis ReviewTepnel Life Sciences PLC is engaged in offering products and services in healthcare market. The company operates through its subsi |
2011 | 250,00$ |
Xcorporeal, Inc. (XCRP) - Financial and Strategic SWOT Analysis ReviewXcorporeal, Inc. (Xcorporeal) is a medical device company principally engaged in the development of an extra-corporeal platform t |
2011 | 250,00$ |
KOKEN CO., LTD (7963) - Financial and Strategic SWOT Analysis ReviewKOKEN CO., LTD. (KOKEN) is engaged in the development, manufacture and marketing of medical devices and products for the healthcar |
2011 | 250,00$ |
US Spine, Inc. - Strategic SWOT Analysis ReviewUS Spine, Inc. (US Spine) is a privately-held medical technology company, engaged in the design, development, manufacture and mark |
2011 | 125,00$ |
Medical Equipment Monthly Deals Analysis: M&A and Investment Trends - February 2011Introduction / / GlobalData's “Medical Equipment Monthly Deals Analysis: M&A and Investment Trends – February 2011” report is an |
2011 | 1.000,00$ |
Changing Regulatory and Health Economics Scenarios in Europe - An Orthopedic Devices Industry PerspectiveIntroduction / / GlobalData’s report, “Changing Regulatory and Health Economics Scenarios in Europe - An Orthopedic Devices Indus |
2011 | 500,00$ |
Hospital Hygiene - How to ImproveIntroduction / / GlobalData’s report, “Hospital Hygiene – How to Improve” provides comprehensive information on hospital hygiene |
2011 | 500,00$ |
STEN Corporation (STEN) - Financial and Strategic SWOT Analysis ReviewSTEN Corporation (STEN) is a diversified company that is engaged in offering contract manufacturing and financial services to its |
2011 | 250,00$ |
TLC Vision Corporation (TLC) - Financial and Strategic SWOT Analysis ReviewTLC Vision Corporation (TLC Vision) is an eye care services company based in Canada. TLC Vision is principally engaged in providin |
2011 | 125,00$ |
Zentiva NV (BAAZEN) - Financial and Strategic SWOT Analysis ReviewZentiva NV is a leading pharmaceutical company in Czech Republic, Turkey, Romania, Poland, Slovakia and Russia. Its business opera |
2011 | 125,00$ |
Jerini AG (JI4) - Financial and Strategic SWOT Analysis ReviewJerini AG (Jerini) is a publicly held pharmaceutical company that is engaged in the discovery, development, and commercialization |
2011 | 250,00$ |
MedCom USA, Inc. (EMED) - Financial and Strategic SWOT Analysis ReviewMedCom USA, Inc. (MedCom USA) a publicly held company is engaged in providing technology solutions for the healthcare industry in |
2011 | 250,00$ |
Synovics Pharmaceuticals, Inc. (SYVC) - Financial and Strategic SWOT Analysis ReviewSynovics Pharmaceuticals, Inc. (Synovics) is a US based Pharmaceutical company. It is engaged in developing, manufacturing and dis |
2011 | 250,00$ |
MIV Therapeutics Inc (MIVI) - Financial and Strategic SWOT Analysis ReviewMIV Therapeutics Inc. (MIVT) is an advanced stage, research and development company, that is engaged in the development of biocomp |
2011 | 250,00$ |
China Biopharma, Inc. (CHBO) - Financial and Strategic SWOT Analysis ReviewChina Biopharma Inc. (CBI) is a biopharmaceutical company, that is engaged in introduction and marketing of human vaccines and oth |
2011 | 250,00$ |
Clearant, Inc. (CLRA) - Financial and Strategic SWOT Analysis ReviewClearant, Inc. (Clearant) is a publicly trading pharmaceutical company engaged in developing and marketing of pathogen inactivatio |
2011 | 250,00$ |
MedCap AB (MCAP) - Financial and Strategic SWOT Analysis ReviewMedCap AB (MedCap), formerly New Science Svenska AB, is a investment company that invests in research companies within the life sc |
2011 | 250,00$ |
Upstream Biosciences Inc. (UPBS) - Financial and Strategic SWOT Analysis ReviewUpstream Biosciences Inc. (Upstream Biosciences) is a biotechnology company, engaged in the discovery, design, development and mar |
2011 | 250,00$ |
Zorka Pharma A.D. Sabac (ZOPH) - Financial and Strategic SWOT Analysis ReviewZorka Pharma A.D. Sabac (Zorka Pharma), a Hemofarm Group company is a serbia-based public shareholding company. It is engaged in m |
2011 | 250,00$ |
Toxin Alert Inc. (TOX) - Financial and Strategic SWOT Analysis ReviewToxin Alert Inc. (Toxin Alert) is a development stage company operating in the food safety business. The company is primarily enga |
2011 | 250,00$ |
Cordex Pharma, Inc. (CDXP) - Financial and Strategic SWOT Analysis ReviewCordex Pharma, Inc. (Cordex Pharma) is a pharmaceutical company that develops therapeutic and diagnostic products. It also develop |
2011 | 250,00$ |
Shanghai Industrial Pharmaceutical Investment Co. Ltd. (600607) - Financial and Strategic SWOT Analysis ReviewShanghai Industrial Pharmaceutical Investment Co. Ltd. (Shanghai Industrial Pharmaceutical) is a China based company which is invo |
2011 | 125,00$ |
Zdravlje A.D. Leskovac (ZDRV) - Financial and Strategic SWOT Analysis ReviewZdravlje A.D. Leskovac (Actavis Serbia) is a research based pharmaceutical company, engaged in the development and commercializati |
2011 | 250,00$ |
Daewoong Bio, Inc. (016890) - Financial and Strategic SWOT Analysis ReviewDaewoong Bio, Inc. (DBI), is a leading pharmaceutical raw materials manufacturer. DBI is engaged in research and development; manu |
2011 | 125,00$ |
Chuounyu Co., Ltd. (9053) - Financial and Strategic SWOT Analysis ReviewChuounyu Co., Ltd. (Chuounyu) is a Japan-based company engaged in the transportation of pharmaceuticals and warehousing. The compa |
2011 | 250,00$ |
LensWista AG (LZVB) - Financial and Strategic SWOT Analysis ReviewLensWista AG (LensWista) is a privately held pharmaceutical company that is engaged in the production and distribution of contact |
2011 | 250,00$ |
Shanghai Zhongxi Pharmaceutical Co., Ltd. (600842) - Financial and Strategic SWOT Analysis ReviewShanghai Zhongxi Pharmaceutical Co., Ltd. (Zhongxi Pharmaceutical) is a publicly held China-based drug manufacturing company. The |
2011 | 250,00$ |
Tissera, Inc. (TSSR) - Financial and Strategic SWOT Analysis ReviewTissera, Inc. (Tissera) is a developmental stage company engaged in the development, testing and commercializing solid organ trans |
2011 | 250,00$ |
VYTA Corp. (VYTC) - Financial and Strategic SWOT Analysis ReviewVyta Corp. (Vyta), formerly known as NanoPierce Technologies, Inc., is a pharmaceutical company. The company is principally engage |
2011 | 250,00$ |
Thomas Pharmaceuticals, Ltd. (TPHM) - Financial and Strategic SWOT Analysis ReviewThomas Pharmaceuticals, Ltd. is a public traded company focuses on relaunching products with proven effectiveness and usefulness s |
2011 | 250,00$ |
UCB S.A. (UCB) - Strategic SWOT Analysis ReviewUCB S.A (UCB) is a publicly held bio-pharmaceutical company. UCB is engaged in developing treatments for severe diseases. It focus |
2011 | 250,00$ |
Therapeutic Cancer Vaccines - A New Paradigm in Cancer TherapyIntroduction / / GlobalData’s report, “Therapeutic Cancer Vaccines - A New Paradigm in Cancer Therapy” provides key information o |
2011 | 500,00$ |
Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - February 2011Introduction / / GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals – February 2011” |
2011 | 1.000,00$ |
Attention Deficit Hyperactivity Disorder (ADHD) Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Attention Deficit Hyperactivity Disorder (ADHD) Global Clinical Trials Revi |
2011 | 1.000,00$ |
Post-Operative Pain Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Post-Operative Pain Global Clinical Trials Review, Q1, 2011" provides data |
2011 | 1.000,00$ |
Exocrine Pancreatic Insufficiency Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Exocrine Pancreatic Insufficiency Global Clinical Trials Review, Q1, 2011" |
2011 | 1.000,00$ |
Peripheral Neuropathy Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Peripheral Neuropathy Global Clinical Trials Review, Q1, 2011" provides dat |
2011 | 1.000,00$ |
Mania Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Mania Global Clinical Trials Review, Q1, 2011" provides data on the Mania c |
2011 | 1.000,00$ |
Neuralgia Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Neuralgia Global Clinical Trials Review, Q1, 2011" provides data on the Neu |
2011 | 1.000,00$ |
Postherpetic Neuralgia Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Postherpetic Neuralgia Global Clinical Trials Review, Q1, 2011" provides da |
2011 | 1.000,00$ |
Spasticity Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Spasticity Global Clinical Trials Review, Q1, 2011" provides data on the Sp |
2011 | 1.000,00$ |
Hemiplegia Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Hemiplegia Global Clinical Trials Review, Q1, 2011" provides data on the He |
2011 | 1.000,00$ |
Narcolepsy Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Narcolepsy Global Clinical Trials Review, Q1, 2011" provides data on the Na |
2011 | 1.000,00$ |
Osteoarthritis Pain Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Osteoarthritis Pain Global Clinical Trials Review, Q1, 2011" provides data |
2011 | 1.000,00$ |
Joint Pains Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Joint Pains Global Clinical Trials Review, Q1, 2011" provides data on the J |
2011 | 1.000,00$ |
Polyneuropathies Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Polyneuropathies Global Clinical Trials Review, Q1, 2011" provides data on |
2011 | 1.000,00$ |
Tension–Type Headache Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Tension–Type Headache Global Clinical Trials Review, Q1, 2011" provides dat |
2011 | 1.000,00$ |
Status Epilepticus Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Status Epilepticus Global Clinical Trials Review, Q1, 2011" provides data o |
2011 | 1.000,00$ |
Dyslexia Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Dyslexia Global Clinical Trials Review, Q1, 2011" provides data on the Dysl |
2011 | 1.000,00$ |
Diarrhea Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Diarrhea Global Clinical Trials Review, Q1, 2011" provides data on the Diar |
2011 | 1.000,00$ |
Metabolic Syndrome Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Metabolic Syndrome Global Clinical Trials Review, Q1, 2011" provides data o |
2011 | 1.000,00$ |
Insulin Resistance Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Diabetes Global Clinical Trials Review, Q1, 2011" provides data on the Diab |
2011 | 1.000,00$ |
Pre-Diabetes/Impaired Glucose Tolerance Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Pre-Diabetes/Impaired Glucose Tolerance Global Clinical Trials Review, Q1, |
2011 | 1.000,00$ |
Keratoconjunctivitis Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Keratoconjunctivitis Global Clinical Trials Review, Q1, 2011" provides data |
2011 | 1.000,00$ |
Endotoxemia Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Endotoxemia Global Clinical Trials Review, Q1, 2011" provides data on the E |
2011 | 1.000,00$ |
Helicobacter Pylori Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Helicobacter Pylori Global Clinical Trials Review, Q1, 2011" provides data |
2011 | 1.000,00$ |
Leprosy Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Leprosy Global Clinical Trials Review, Q1, 2011" provides data on the Lepro |
2011 | 1.000,00$ |
Lyme Disease Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Lyme Disease Global Clinical Trials Review, Q1, 2011" provides data on the |
2011 | 1.000,00$ |
Typhoid Fever Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Typhoid Fever Global Clinical Trials Review, Q1, 2011" provides data on the |
2011 | 1.000,00$ |
Dysentery Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Dysentery Global Clinical Trials Review, Q1, 2011" provides data on the Dys |
2011 | 1.000,00$ |
ImageWorks (AFPC) - Financial and Strategic SWOT Analysis ReviewImageWorks (formerly known as AFP Imaging Corporation) is a privately held medical device company. The company is engaged in the d |
2011 | 250,00$ |
Elron Electronic Industries, Ltd. (ELRN) - Financial and Strategic SWOT Analysis ReviewElron Electronic Industries, Ltd. (Elron) is a medical devices company. It is operating through its group of companies in the fiel |
2011 | 250,00$ |
I-Flow Corporation (IFLO) - Financial and Strategic SWOT Analysis ReviewI-Flow Corporation (I-Flow) is a medical device company engaged in the design, development, manufacture and marketing of technical |
2011 | 250,00$ |
Inion Oy (IIN) - Financial and Strategic SWOT Analysis ReviewInion Oy, (Inion) is engaged in the development of biodegradable medical implants for the orthopedics market. The company manufact |
2011 | 125,00$ |
Genetix Group plc (GTX) - Financial and Strategic SWOT Analysis ReviewGenetix Group plc (Genetix) is a Medical Diagnostic company engaged in designing, development, manufacturing and marketing of auto |
2011 | 125,00$ |
Northstar Neuroscience, Inc. (NSTR) - Financial and Strategic SWOT Analysis ReviewNorthstar Neuroscience, Inc. (Northstar) is principally engaged in the manufacture and development of novel neurostimulation thera |
2011 | 125,00$ |
Power Medical Interventions, Inc. (PMII) - Financial and Strategic SWOT Analysis ReviewPower Medical Interventions, Inc. (PMII) is engaged in the development and commercialization of medical equipments for surgical ma |
2011 | 250,00$ |
Intercytex Group plc (ICX) - Financial and Strategic SWOT Analysis ReviewIntercytex Group plc (Intercytex) is engaged in the development of cell therapy products for the wound care markets. It develops w |
2011 | 250,00$ |
Protein Polymer Technologies, Inc. (PPTI) - Financial and Strategic SWOT Analysis ReviewProtein Polymer Technologies, Inc., (PPTI) is a biotechnology company engaged in the research, development and production of bio-a |
2011 | 125,00$ |
Genexel-Sein Inc. (034660) - Financial and Strategic SWOT Analysis ReviewGenexel-Sein Inc. (Genexel-Sein) is one of the world’s largest manufacturers of blood pressure measuring equipment and nerve stimu |
2011 | 250,00$ |
Point Blank Solutions, Inc. (PBSO) - Financial and Strategic SWOT Analysis ReviewPoint Blank Solutions, Inc. (Point Blank Solutions) is engaged in designing, manufacturing and distribution of stab, bullet and fr |
2011 | 125,00$ |
IOMED, Inc. (Inactive) - Strategic SWOT Analysis ReviewIOMED, Inc. (IOMED) is a medical devices company. It is engaged in the development, manufacturing and marketing of active drug del |
2011 | 125,00$ |
Everest Biomedical Instruments Company - Strategic SWOT Analysis ReviewEverest Biomedical Instruments Company (Everest Biomedical) is principally engaged in the design and development of advanced, stat |
2011 | 125,00$ |
ProRhythm Inc. (Inactive) - Strategic SWOT Analysis ReviewProRhythm, Inc. (ProRhythm) is a medical device company, engaged in the development, manufacture and marketing of high intensity f |
2011 | 125,00$ |
PLC Medical Systems, Inc. (PLCSF) - Financial and Strategic SWOT Analysis ReviewPLC Medical Systems, Inc., is engaged in providing process control programming and control tasks. The company's Diagnostics Syste |
2011 | 250,00$ |
Nordion Inc. (NDN) - Financial and Strategic SWOT Analysis ReviewNordion Inc. (formerly MDS Inc.) is a health science company. It is engaged in developing, manufacturing and commercializing of sp |
2011 | 125,00$ |
HLTH Corporation (HLTH) - Financial and Strategic SWOT Analysis ReviewHLTH Corporation, through its principal subsidiary, WebMD Health Corp., provides health information services to consumers, healthc |
2011 | 125,00$ |
Global Clean Energy Holdings, LLC (GCEH) - Financial and Strategic SWOT Analysis ReviewGlobal Clean Energy Holdings, LLC (GCEH) is a publicly held company engaged in the research and development of biofuel feedstock d |
2011 | 250,00$ |
NORTHFIELD LABORATORIES INC (NFLD) - Financial and Strategic SWOT Analysis ReviewNorthfield Laboratories Inc. is principally engaged in research, development, testing, manufacturing, marketing, and distributing |
2011 | 250,00$ |
Orbus Pharma Inc. (ORB) - Financial and Strategic SWOT Analysis ReviewOrbus Pharma Inc. (Orbus Pharma), formerly known as BOVAR Inc, is a publicly held pharmaceutical company. It is engaged in the dev |
2011 | 250,00$ |
GeneThera, Inc. (GTHR) - Financial and Strategic SWOT Analysis ReviewGeneThera, Inc. (GeneThera) is a biotechnology company. It is engaged in the development molecular diagnostic testing and vaccines |
2011 | 250,00$ |
MWG-Biotech AG (NWU) - Financial and Strategic SWOT Analysis ReviewMWG-Biotech AG (MWG) is a biotechnology company engaged in the manufacture and marketing of biomolecules and apparatuses for use i |
2011 | 250,00$ |
GeneScan Europe AG (GEP1) - Financial and Strategic SWOT Analysis ReviewGeneScan Europe AG (GeneScan) is a German company, engaged in the molecular biology sector. The company offers complete solutions |
2011 | 250,00$ |
NitroMed, Inc. (NTMD) - Financial and Strategic SWOT Analysis ReviewNitroMed, Inc. (NitroMed) is a pharmaceutical company that is engaged in discovery, development and commercialization of proprieta |
2011 | 250,00$ |
Praxitelio Hospital S.A. (PRAXC) - Financial and Strategic SWOT Analysis ReviewPraxitelio Hospital S.A. (Praxitelio) is engaged in providing healthcare services. Praxitelio operates two clinics namely, Gallin |
2011 | 250,00$ |
Pharco Pharmaceuticals (PHPC) - Financial and Strategic SWOT Analysis ReviewPharco Pharmaceuticals (Pharco Pharma) is a subsidiary of Pharco Corporation, the biggest pharmaceutical organization in North Afr |
2011 | 125,00$ |
Phynova Group Ltd (PYN) - Financial and Strategic SWOT Analysis ReviewPhynova Group Ltd (Phynova) is a publicly held pharmaceutical company engaged in the development of drugs to satisfy unmet therape |
2011 | 250,00$ |
RayClinic AB (RCLN B) - Financial and Strategic SWOT Analysis ReviewRayClinic AB (RayClinic) is a pharmaceutical company that provides treatment for cancer related diseases. It focuses on treating c |
2011 | 250,00$ |
Hebi Health Care AB (HEBI B) - Financial and Strategic SWOT Analysis ReviewHebi Health Care AB (Hebi Health Care), through its subsidiaries is focused on offering products for the life science and healthca |
2011 | 250,00$ |
Norwood Immunology Limited (AIM) - Financial and Strategic SWOT Analysis ReviewNorwood Immunology Ltd. (Norwood) is a publicly held research focused biotechnology company. The company is principally engaged in |
2011 | 250,00$ |
ReSearch Pharmaceutical Services, Inc. (RPSE) - Financial and Strategic SWOT Analysis ReviewReSearch Pharmaceutical Services, Inc. (RPS) is a contract research organization, providing phase I-IV clinical development servic |
2011 | 125,00$ |
HC Innovations, Inc. (HCNV) - Financial and Strategic SWOT Analysis ReviewHC Innovations, Inc. (HC Innovations) is a specialty disease and care management company. It is engaged in providing specialty car |
2011 | 250,00$ |
Fountain Healthy Aging Inc. (FHAIE) - Financial and Strategic SWOT Analysis ReviewFountain Healthy Aging, Inc. (FHAI) is a health care product distributor that is principally engaged in licensing and distributing |
2011 | 250,00$ |
QSound Labs, Inc. (QSND) - Financial and Strategic SWOT Analysis ReviewQSound Labs, Inc. (QSound Labs) is an audio technology company. It is engaged in the development of proprietary audio solutions fo |
2011 | 250,00$ |
Sepracor Inc. (SEPR) - Financial and Strategic SWOT Analysis ReviewSepracor Inc. (SEPR) - Financial and Strategic SWOT Analysis Review / / Sepracor Inc. (Sepracor) is a research oriented pharmaceu |
2011 | 125,00$ |
BSML, Inc. (BSML) - Financial and Strategic SWOT Analysis ReviewBSML, Inc. ( BSML ) is a medical devices company. It is engaged in development, distribution, marketing and selling of advanced t |
2011 | 250,00$ |
ALUS Liquidation Corp. (ALUS) - Financial and Strategic SWOT Analysis ReviewALUS Liquidation Corp. (previously known as Alsius Corporation) is a medical device company engaged in the development, manufactur |
2011 | 250,00$ |
BodyTel Scientific Inc. (BDYT) - Financial and Strategic SWOT Analysis ReviewBodyTel Scientific Inc. (BodyTel) is a medical equipment company engaged in the development and marketing of monitoring and manage |
2011 | 125,00$ |
AOI Medical, Inc. (AOI) - Financial and Strategic SWOT Analysis ReviewAOI Medical, Inc. (AOI Medical) is a medical device company, engaged in the development and marketing of innovative medical device |
2011 | 250,00$ |
Ascribe plc (ASP) - Financial and Strategic SWOT Analysis ReviewAscribe plc (Ascribe) is a healthcare company that is engaged in the development and marketing of software solutions. The company |
2011 | 125,00$ |
American CryoStem Corporation (AMCY) - Strategic SWOT Analysis ReviewThis comprehensive SWOT profile of American CryoStem Corporation provides you with an in-depth strategic analysis of the company's |
2011 | 250,00$ |
Allion Healthcare, Inc. (ALLI) - Financial and Strategic SWOT Analysis ReviewAllion Healthcare, Inc. (Allion) is one of US’s leading providers of specialty pharmacy and disease management services. The compa |
2011 | 125,00$ |
AIDA Pharmaceuticals, Inc. (AIDA) - Financial and Strategic SWOT Analysis ReviewAida Pharmaceuticals (AIDA) is a pharmaceuticals company focused on formulation, development, clinical testing, registration, manu |
2011 | 125,00$ |
Avastra Sleep Centres Limited (AVS) - Financial and Strategic SWOT Analysis ReviewAvastra Sleep Centres Limited (Avastra ) is a publicly held Australia based company that operates diagnostic sleep centers. It is |
2011 | 250,00$ |
Amoun Pharmaceutical Co. SAE (BOARD (ORDERS MARKET)) - Financial and Strategic SWOT Analysis ReviewAmoun Pharmaceutical Co. SAE (BOARD (ORDERS MARKET)) - Financial and Strategic SWOT Analysis Review / / Amoun Pharmaceutical Co. |
2011 | 125,00$ |
Amreyah Pharmaceuticals Company (ARPP) - Financial and Strategic SWOT Analysis ReviewAmreyah Pharmaceuticals Company (Amreyah) is engaged in the manufacturing and distribution of pharmaceutical and veterinary produc |
2011 | 250,00$ |
AngioGenex, Inc. (AGGX) - Financial and Strategic SWOT Analysis ReviewAngioGenex, Inc. (AngioGenex) is a development stage, publicly held bio-pharmaceutical company engaged in the discovery and develo |
2011 | 250,00$ |
Cairo Radiology Center Co. (RADI) - Financial and Strategic SWOT Analysis ReviewCairo Radiology Center Co. (Cairo Scan) is a pharmaceutical company offering diagnostic imaging services. The company’s services c |
2011 | 250,00$ |
Cell Kinetics Ltd. (CKNTF) - Financial and Strategic SWOT Analysis ReviewCell Kinetics Ltd. (Cell Kinetics) is engaged in the design, development, manufacture and marketing of life science and medical de |
2011 | 250,00$ |
Austria Medical Equipment Market ProfileIntroduction / / GlobalData’s medical equipment report, “Austria Medical Equipment Market Profile” provides the medical equipment |
2011 | 500,00$ |
Myocardial Ischemia Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Myocardial Ischemia Global Clinical Trials Review, Q1, 2011" provides data |
2011 | 1.000,00$ |
Migraine Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Migraine Global Clinical Trials Review, Q1, 2011" provides data on the Migr |
2011 | 1.000,00$ |
Sleep Disorders Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Sleep Disorders Global Clinical Trials Review, Q1, 2011" provides data on t |
2011 | 1.000,00$ |
Fatigue Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Fatigue Global Clinical Trials Review, Q1, 2011" provides data on the Fatig |
2011 | 1.000,00$ |
Mild Cognitive Impairment Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Mild Cognitive Impairment Global Clinical Trials Review, Q1, 2011" provides |
2011 | 1.000,00$ |
Restless Legs Syndrome Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Restless Legs Syndrome Global Clinical Trials Review, Q1, 2011" provides da |
2011 | 1.000,00$ |
Friedreich Ataxia Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Friedreich Ataxia Global Clinical Trials Review, Q1, 2011" provides data on |
2011 | 1.000,00$ |
Psychogenic Movement Disorders Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Psychogenic Movement Disorders Clinical Trials Review, Q1, 2011" provides d |
2011 | 1.000,00$ |
Non Erosive Reflux Disease (NERD) Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Non Erosive Reflux Disease (NERD)Global Clinical Trials Review, Q1, 2011" p |
2011 | 1.000,00$ |
Obesity Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Obesity Global Clinical Trials Review, Q1, 2011" provides data on the obesi |
2011 | 1.000,00$ |
Gestational Diabetes Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Gestational Diabetes Global Clinical Trials Review, Q1, 2011" provides data |
2011 | 1.000,00$ |
Hyperglycemia Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Hyperglycemia Global Clinical Trials Review, Q1, 2011" provides data on the |
2011 | 1.000,00$ |
Glucose Intolerance Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Glucose Intolerance Global Clinical Trials Review, Q1, 2011" provides data |
2011 | 1.000,00$ |
Hypoglycemia Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Hypoglycemia Global Clinical Trials Review, Q1, 2011" provides data on the |
2011 | 1.000,00$ |
Texas Instruments Incorporated (TXN) - Financial and Strategic SWOT Analysis ReviewTexas Instruments Incorporated (TXN) - Financial and Strategic SWOT Analysis Review / / Summary / / Texas Instruments Incorporat |
2011 | 125,00$ |
Electronic Medical Records (EMR) - Global Opportunity Assessment, Competitive Landscape and Market Forecasts to 2016Introduction / / GlobalData’s new report, “Electronic Medical Records (EMR) - Global Opportunity Assessment, Competitive Landscap |
2011 | 3.500,00$ |
Wound Care Management - Emerging Countries (China, India, Brazil) Opportunity Assessment, Competitive Landscape and Market Forecasts to 2016Introduction / / GlobalData’s medical equipment report, “Wound Care Management - Emerging Countries (China, India, Brazil) Opport |
2011 | 3.500,00$ |
European Medical Devices Industry: An Impact Analysis of the Changing Regulatory and Health Economics ScenariosIntroduction / / GlobalData’s report, “European Medical Devices Industry: An Impact Analysis of the Changing Regulatory and Healt |
2011 | 500,00$ |
Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals – Q4 2010Introduction / / GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals – Q4 2010” report |
2011 | 1.500,00$ |
FDA Withdraws Approval of Avastin in Breast CancerIntroduction / / GlobalData’s report, “FFDA Withdraws Approval of Avastin in Breast Cancer” provides key data, information on Bre |
2011 | 500,00$ |
Withdrawal of Rimonabant and Sibutramine Create High Unmet Need in Obesity MarketIntroduction / / GlobalData’s report, “Withdrawal of Rimonabant and Sibutramine Create High Unmet Need in Obesity Market” provide |
2010 | 500,00$ |
Novel Targeted Therapies Hold Promise of Reversing the Progress of Alzheimer’s Disease (AD)Introduction / / GlobalData’s report, “Novel Targeted Therapies Hold Promise of Reversing the Progress of Alzheimer’s Disease (AD |
2011 | 500,00$ |
Pharmacy Benefit Managers (PBMs) are Critical for Ensuring Quality of Pharmaceutical Care and Controlling Drug ExpendituresIntroduction / / GlobalData’s report, “Pharmacy Benefit Managers (PBMs) are Critical for Ensuring Quality of Pharmaceutical Care |
2011 | 500,00$ |
Withdrawal of Sitaxentan (Thelin) Creates Huge Unmet Need in the Pulmonary Arterial Hypertension (PAH) MarketIntroduction / / GlobalData’s report, “Withdrawal of Sitaxentan (Thelin) Creates Huge Unmet Need in the Pulmonary Arterial Hype |
2011 | 500,00$ |
Pituitary Neoplasms Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Pituitary Neoplasms Global Clinical Trials Review, Q1, 2011" provides data |
2011 | 1.000,00$ |
Achlorhydria Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Achlorhydria Global Clinical Trials Review, Q1, 2011" provides data on the |
2011 | 1.000,00$ |
Acute Ischemic Stroke Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Acute Ischemic Stroke Global Clinical Trials Review, Q1, 2011" provides dat |
2011 | 1.000,00$ |
Chronic Pain Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Chronic Pain Global Clinical Trials Review, Q1, 2011" provides data on the |
2011 | 1.000,00$ |
Nicotine Addiction Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Nicotine Addiction Global Clinical Trials Review, Q1, 2011" provides data o |
2011 | 1.000,00$ |
Sleep Apnea Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Sleep Apnea Global Clinical Trials Review, Q1, 2011" provides data on the S |
2011 | 1.000,00$ |
Dystonia Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Dystonia Global Clinical Trials Review, Q1, 2011" provides data on the Dyst |
2011 | 1.000,00$ |
Huntington’s Disease Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Huntington’s Disease Global Clinical Trials Review, Q1, 2011" provides data |
2011 | 1.000,00$ |
Tourette Syndrome Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Tourette Syndrome Global Clinical Trials Review, Q1, 2011" provides data on |
2011 | 1.000,00$ |
Acute Pain Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Acute Pain Global Clinical Trials Review, Q1, 2011" provides data on the |
2011 | 1.000,00$ |
Down syndrome Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Down Syndrome Global Clinical Trials Review, Q1, 2011" provides data on the |
2011 | 1.000,00$ |
Dyskinesia Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Dyskinesia Global Clinical Trials Review, Q1, 2011" provides data on the |
2011 | 1.000,00$ |
Radiological Society of North America Conference 2010: Review and AnalysisIntroduction / / GlobalData’s report, “Radiological Society of North America Conference 2010: Review and Analysis” provides key d |
2011 | 1.000,00$ |
Medline Industries Acquires O'Mara Scientific: A Strategy to Expand Inorganically - Deal Analysis From GlobalDataIntroduction / / GlobalData’s report, “Medline Industries Acquires O'Mara Scientific: A Strategy to Expand Inorganically” provide |
2011 | 500,00$ |
Ultrasound Systems - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016Introduction / / GlobalData’s new report, “Ultrasound Systems - Global Pipeline Analysis, Opportunity Assessment and Market Forec |
2011 | 3.500,00$ |
Wound Closure Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016Introduction / / GlobalData’s new report, “Wound Closure Devices - Global Pipeline Analysis, Opportunity Assessment and Market Fo |
2011 | 3.500,00$ |
Advanced Wound Management - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016Introduction / / GlobalData’s new report, “Advanced Wound Management - Global Pipeline Analysis, Opportunity Assessment and Marke |
2011 | 3.500,00$ |
Cranio Maxillofacial Fixation (CMF) Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016Introduction / / GlobalData’s new report, “Cranio Maxillofacial Fixation (CMF) Devices - Global Pipeline Analysis, Opportunity As |
2011 | 3.500,00$ |
Patient Monitoring - Emerging Countries (China, India, Brazil) Opportunity Assessment, Competitive Landscape and Market Forecasts to 2016Introduction / / GlobalData’s new report, “Patient Monitoring - Emerging Countries (China, India, Brazil) Opportunity Assessment, |
2011 | 3.500,00$ |
Remote Patient Monitoring - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016Introduction / / GlobalData’s new report, “Remote Patient Monitoring - Global Pipeline Analysis, Opportunity Assessment and Marke |
2011 | 3.500,00$ |
Medical Equipment Monthly Deals Analysis: M&A and Investment Trends - January 2011Introduction / / GlobalData's “Medical Equipment Monthly Deals Analysis: M&A and Investment Trends – January 2011” report is an e |
2011 | 1.000,00$ |
Medical Equipment Quarterly Deals Analysis: M&A and Investments Trends - Q4 2010Introduction / / GlobalData's “Medical Equipment Quarterly Deals Analysis: M&A and Investments Trends - Q4 2010” report is an ess |
2011 | 1.500,00$ |
Global In-Vitro Diagnostics Market TrendsIntroduction / / GlobalData’s medical equipment report, “Global In-Vitro Diagnostics Market Trends” provides key market data on t |
2011 | 500,00$ |
Peripheral Intravenous Catheters: A Market SnapshotIntroduction / / GlobalData’s report, “Peripheral Intravenous Catheters: A Market Snapshot” provides key data, information and an |
2011 | 500,00$ |
Canada Medical Equipment Market Analysis and Forecasts to 2016Introduction / / This report is an essential source for in-depth information and data relating to the Canada medical equipment ma |
2010 | 3.500,00$ |
The Proton-Deuterium Swap – Will the Heavy Strategy Work?Introduction / / GlobalData’s report, “The Proton-Deuterium Swap – Will the Heavy Strategy Work?” provides key information on the |
2011 | 500,00$ |
Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - January 2011Introduction / / GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals – January 2011” r |
2011 | 1.000,00$ |
Schistosomiasis Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Schistosomiasis Global Clinical Trials Review, Q1, 2011" provides data on t |
2011 | 1.000,00$ |
Gastritis Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Gastritis Global Global Clinical Trials Review, Q4, 2010" provides data on |
2010 | 1.000,00$ |
Carcinoma of the Bile Duct Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Carcinoma Of The Bile Duct Global Clinical Trials Review, Q4, 2010" provide |
2010 | 1.000,00$ |
Stroke Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Stroke Global Clinical Trials Review, Q1, 2011" provides data on the Stroke |
2011 | 1.000,00$ |
Aortic Valve Stenosis Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Aortic Valve Stenosis Global Clinical Trials Review, Q1, 2011" provides dat |
2011 | 1.000,00$ |
Atrial Fibrillation Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Atrial Fibrillation Global Clinical Trials Review, Q1, 2011" provides data |
2011 | 1.000,00$ |
Coronary Stenosis Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Coronary Stenosis Global Clinical Trials Review, Q1, 2011" provides data on |
2011 | 1.000,00$ |
Cardiomyopathy Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Cardiomyopathy Global Clinical Trials Review, Q1, 2011" provides data on th |
2011 | 1.000,00$ |
Appendicitis Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Appendicitis Global Clinical Trials Review, Q1, 2011" provides data on the |
2011 | 1.000,00$ |
Cholangitis Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Cholangitis Global Clinical Trials Review, Q1, 2011" provides data on the C |
2011 | 1.000,00$ |
Cholecystitis Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Cholecystitis Global Clinical Trials Review, Q1, 2011" provides data on the |
2011 | 1.000,00$ |
Gall Stone Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Gall Stone Global Clinical Trials Review, Q1, 2011" provides data on the Ga |
2011 | 1.000,00$ |
Gastroparesis Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Gastroparesis Global Clinical Trials Review, Q1, 2011" provides data on the |
2011 | 1.000,00$ |
Peritonitis Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Peritonitis Global Clinical Trials Review, Q1, 2011" provides data on the P |
2011 | 1.000,00$ |
Pancreatitis Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Pancreatitis Global Clinical Trials Review, Q1, 2011" provides data on the |
2011 | 1.000,00$ |
Duodenal Ulcer Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Duodenal Ulcer Global Clinical Trials Review, Q1, 2011" provides data on th |
2011 | 1.000,00$ |
Zollinger-Ellison Syndrome Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Zollinger-Ellison Syndrome Global Clinical Trials Review, Q1, 2011" provide |
2011 | 1.000,00$ |
Abscess Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Abscess Global Clinical Trials Review, Q1, 2011" provides data on the Absce |
2011 | 1.000,00$ |
Bacteremia Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Bacteremia Global Clinical Trials Review, Q1, 2011" provides data on the Ba |
2011 | 1.000,00$ |
Bacteriuria Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Bacteriuria Global Clinical Trials Review, Q1, 2011" provides data on the B |
2011 | 1.000,00$ |
Brucellosis Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Brucellosis Global Clinical Trials Review, Q1, 2011" provides data on the B |
2011 | 1.000,00$ |
Osteomyelitis Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Osteomyelitis Global Clinical Trials Review, Q1, 2011" provides data on the |
2011 | 1.000,00$ |
Nasal Polyps Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Nasal Polyps Global Clinical Trials Review, Q1, 2011" provides data on the |
2011 | 1.000,00$ |
Left Ventricular Dysfunction Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Left Ventricular Dysfunction Global Clinical Trials Review, Q1, 2011" provi |
2011 | 1.000,00$ |
Tachycardia Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Tachycardia Global Clinical Trials Review, Q1, 2011" provides data on the T |
2011 | 1.000,00$ |
Other Respiratory Disorders Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Other Respiratory Disorders Global Clinical Trials Review, Q1, 2011" provid |
2011 | 1.000,00$ |
Congenital Lung Disease Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Congenital Lung Disease Global Clinical Trials Review, Q1, 2011" provides d |
2011 | 1.000,00$ |
Bronchiectasis Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Bronchiectasis Global Clinical Trials Review, Q1, 2011" provides data on th |
2011 | 1.000,00$ |
Obstructive Pulmonary Disease Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Obstructive Pulmonary Disease Global Clinical Trials Review, Q1, 2011" prov |
2011 | 1.000,00$ |
Haemophilus Influenzae Infection Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Haemophilus Influenzae Infection Global Clinical Trials Review, Q1, 2011" p |
2011 | 1.000,00$ |
Interstitial Lung Diseases Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Interstitial Lung Diseases Global Clinical Trials Review, Q1, 2011" provide |
2011 | 1.000,00$ |
Lung Injury Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Lung Injury Global Clinical Trials Review, Q1, 2011" provides data on the L |
2011 | 1.000,00$ |
Neonatal Respiratory Distress Syndrome Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Neonatal Respiratory Distress Syndrome Global Clinical Trials Review, Q1, 2 |
2011 | 1.000,00$ |
Bronchopulmonary Dysplasia Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Bronchopulmonary Dysplasia Global Clinical Trials Review, Q1, 2011" provide |
2011 | 1.000,00$ |
Bronchospasm Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Bronchospasm Global Clinical Trials Review, Q1, 2011" provides data on the |
2011 | 1.000,00$ |
Respiratory Depression Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Respiratory Depression Global Clinical Trials Review, Q1, 2011" provides da |
2011 | 1.000,00$ |
Nasal Congestion Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Nasal Congestion Global Clinical Trials Review, Q1, 2011" provides data on |
2011 | 1.000,00$ |
Viral Respiratory Tract Infection Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Viral Respiratory Tract Infection Global Clinical Trials Review, Q1, 2011" |
2011 | 1.000,00$ |
Anxiety Disorders Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Anxiety Disorders Global Clinical Trials Review, Q1, 2011" provides data on |
2011 | 1.000,00$ |
Nonhematologic Malignancy Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Nonhematologic Malignancy Global Clinical Trials Review, Q1, 2011" provides |
2011 | 1.000,00$ |
Stomatitis Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Stomatitis Global Clinical Trials Review, Q1, 2011" provides data on the St |
2011 | 1.000,00$ |
Hypopharyngeal Cancer Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Hypopharyngeal Cancer Global Clinical Trials Review, Q1, 2011" provides dat |
2011 | 1.000,00$ |
Indolent Lymphoma Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Indolent Lymphoma Global Clinical Trials Review, Q1, 2011" provides data on |
2011 | 1.000,00$ |
Salivary Gland Cancer Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Salivary Gland Cancer Global Clinical Trials Review, Q1, 2011" provides dat |
2011 | 1.000,00$ |
Medullary Thyroid Cancer Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Medullary Thyroid Cancer Global Clinical Trials Review, Q1, 2011" provides |
2011 | 1.000,00$ |
Angioimmunoblastic T-cell Lymphoma (AILT)/Immunoblastic Lymphadenopathy Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Angioimmunoblastic T-Cell Lymphoma (AILT)/Immunoblastic Lymphadenopathy Glo |
2011 | 1.000,00$ |
Lymphoma Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Lymphoma Global Clinical Trials Review, Q1, 2011" provides data on the Lymp |
2011 | 1.000,00$ |
Skin Neoplasms Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Skin Neoplasms Global Clinical Trials Review, Q1, 2011" provides data on th |
2011 | 1.000,00$ |
Neuropathic Pain Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Neuropathic Pain Global Clinical Trials Review, Q1, 2011" provides data on |
2011 | 1.000,00$ |
Major Depressive Disorder Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Major Depressive Disorder Global Clinical Trials Review, Q1, 2011" provides |
2011 | 1.000,00$ |
Substance Abuse Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Substance Abuse Global Clinical Trials Review, Q1, 2011" provides data on t |
2011 | 1.000,00$ |
Dementia Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Dementia Global Clinical Trials Review, Q1, 2011" provides data on the Deme |
2011 | 1.000,00$ |
Obsessive-Compulsive Disorder Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Obsessive-Compulsive Disorder Global Clinical Trials Review, Q1, 2011" prov |
2011 | 1.000,00$ |
Psychosis Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Psychosis Global Clinical Trials Review, Q1, 2011" provides data on the Psy |
2011 | 1.000,00$ |
Alcoholism Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Alcoholism Global Clinical Trials Review, Q1, 2011" provides data on the Al |
2011 | 1.000,00$ |
Pharyngeal Neoplasms Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Pharyngeal Neoplasms Global Clinical Trials Review, Q1, 2011" provides data |
2011 | 1.000,00$ |
Traumatic Brain Injury Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Traumatic Brain Injury Global Clinical Trials Review, Q1, 2011" provides da |
2011 | 1.000,00$ |
Vasculitis Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Vasculitis Global Clinical Trials Review, Q1, 2011" provides data on the Va |
2011 | 1.000,00$ |
Lennox-Gastaut Syndrome Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Lennox-Gastaut Syndrome Global Clinical Trials Review, Q1, 2011" provides d |
2011 | 1.000,00$ |
Autism Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Autism Global Clinical Trials Review, Q1, 2011" provides data on the Autism |
2011 | 1.000,00$ |
Dysmorphophobia Trichotillomania Eating Disorder Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Dysmorphophobia Trichotillomania Eating Disorder Global Clinical Trials Rev |
2011 | 1.000,00$ |
Fibromyalgia Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Fibromyalgia Global Clinical Trials Review, Q1, 2011" provides data on the |
2011 | 1.000,00$ |
Cerebral Palsy Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Cerebral Palsy Global Clinical Trials Review, Q1, 2011" provides data on th |
2011 | 1.000,00$ |
Opium Addiction Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Opium Addiction Global Clinical Trials Review, Q1, 2011" provides data on t |
2011 | 1.000,00$ |
Smoking Cessation Global Clinical Trials Review, Q1, 2011Introduction / / GlobalData's clinical trial report, “Smoking Cessation Global Clinical Trials Review, Q1, 2011" provides data on |
2011 | 1.000,00$ |
India Diagnostic Imaging Market Outlook to 2016Introduction / / GlobalData’s medical equipment report, “India Diagnostic Imaging Market Outlook to 2016” provides key market dat |
2010 | 2.500,00$ |
Picture Archiving and Communication Systems (PACS) - Global Opportunity Assessment, Competitive Landscape and Market Forecasts to 2016Introduction / / GlobalData’s new report, “Picture Archiving and Communication Systems (PACS) - Global Opportunity Assessment, Co |
2010 | 3.500,00$ |
Cardiac Rhythm Management (CRM) Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016Introduction / / GlobalData’s new report, “Cardiac Rhythm Management (CRM) Devices - Global Pipeline Analysis, Opportunity Assess |
2011 | 3.500,00$ |
Vision Care (Contact Lenses and Spectacle Lenses) - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016Introduction / / GlobalData’s new report, “Vision Care (Contact Lenses and Spectacle Lenses) - Global Pipeline Analysis, Opportun |
2011 | 3.500,00$ |
Mammography Equipment - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016Introduction / / GlobalData’s new report, “Mammography Equipment - Global Pipeline Analysis, Opportunity Assessment and Market Fo |
2011 | 3.500,00$ |
Magnetic Resonance Imaging (MRI) Systems - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016Introduction / / GlobalData’s new report, “Magnetic Resonance Imaging (MRI) Systems - Global Pipeline Analysis, Opportunity Asses |
2011 | 3.500,00$ |
Insulin Delivery Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016Introduction / / GlobalData’s new report, “Insulin Delivery Devices - Global Pipeline Analysis, Opportunity Assessment and Market |
2011 | 3.500,00$ |
Dental Implants and Biomaterials - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016Introduction / / GlobalData’s new report, “Dental Implants and Biomaterials - Global Pipeline Analysis, Opportunity Assessment an |
2011 | 3.500,00$ |
Glucose Monitoring Systems - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016Introduction / / GlobalData’s new report, “Glucose Monitoring Systems - Global Pipeline Analysis, Opportunity Assessment and Mark |
2011 | 3.500,00$ |
Clinical Chemistry Global Market Briefing to 2016Introduction / / GlobalData’s new report, “Clinical Chemistry Global Market Briefing to 2016” provides key data, information and |
2011 | 2.000,00$ |
Negative Pressure Wound Therapy (NPWT) - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016Introduction / / GlobalData’s new report, “Negative Pressure Wound Therapy (NPWT) - Global Pipeline Analysis, Opportunity Assessm |
2011 | 3.500,00$ |
Nuclear Imaging Equipment - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016Introduction / / GlobalData’s new report, “Nuclear Imaging Equipment - Global Pipeline Analysis, Opportunity Assessment and Marke |
2011 | 3.500,00$ |
Dental Lasers - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016Introduction / / GlobalData’s new report, “Dental Lasers - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts |
2011 | 3.500,00$ |
Diagnostic Imaging Equipment - Emerging Countries (China, India, Brazil) Opportunity Assessment, Competitive Landscape and Market Forecasts to 2016Introduction / / GlobalData’s new report, “Diagnostic Imaging Equipment - Emerging Countries (China, India, Brazil) Opportunity |
2011 | 3.500,00$ |
Haematology Global Market Briefing to 2016Introduction / / GlobalData’s new report, “Haematology Global Market Briefing to 2016” provides key data, information and analysi |
2011 | 2.000,00$ |
Cardiac Assist Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016Introduction / / GlobalData’s new report, “Cardiac Assist Devices - Global Pipeline Analysis, Opportunity Assessment and Market F |
2010 | 3.500,00$ |
Breast Cancer Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Breast Cancer Clinical Trials Review, Q4, 2010"” provides data on the Breas |
2010 | 1.000,00$ |
Acute Lymphocytic Leukemia (ALL) Clinical Trials Review Q4, 2010Introduction / / GlobalData's clinical trial report, “Acute Lymphocytic Leukemia (ALL) Global Clinical Trials Review, Q4, 2010"” |
2010 | 1.000,00$ |
Acute Myelogenous Leukemia Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “ Acute Myelocytic Leukemia (AML)Global Clinical Trials Review, Q4, 2010"” p |
2010 | 1.000,00$ |
Bile Duct Cancer Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Bile Duct Cancer Global Clinical Trials Review, Q4, 2010" provides data on |
2010 | 1.000,00$ |
Bladder Cancer Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Bladder Cancer Global Clinical Trials Review, Q4, 2010" provides data on th |
2010 | 1.000,00$ |
Bone Cancer Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Bone Cancer Global Clinical Trials Review, Q4, 2010" provides data on the B |
2010 | 1.000,00$ |
Brain Cancer Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Brain Cancer Global Clinical Trials Review, Q4, 2010" provides data on the |
2010 | 1.000,00$ |
Cervical Cancer Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Cervical Cancer Global Clinical Trials Review, Q4, 2010" provides data on t |
2010 | 1.000,00$ |
Chronic Lymphocytic Leukemia (CLL) Global Clinical Trial Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Chronic Lymphocytic Leukemia (CLL) Global Clinical Trials Review, Q4, 2010" |
2010 | 1.000,00$ |
Chronic Myelocytic Leukemia(CML) Global Clinical Trial Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Chronic Myelocytic Leukemia (CML) Global Clinical Trials Review, Q4, 2010" |
2010 | 1.000,00$ |
Central Nervous System Tumors Global Clinical Trial Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Central Nervous System Tumors Global Clinical Trials Review, Q4, 2010" prov |
2010 | 1.000,00$ |
Colon Cancer Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Colon Cancer Global Clinical Trials Review, Q4, 2010" provides data on the |
2010 | 1.000,00$ |
Colorectal Cancer Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Colorectal Cancer Global Clinical Trials Review, Q4, 2010" provides data on |
2010 | 1.000,00$ |
Endometrial Cancer Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Endometrial Cancer Global Clinical Trials Review, Q4, 2010" provides data o |
2010 | 1.000,00$ |
Esophageal Cancer Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Eosophageal Cancer Global Clinical Trials Review, Q4, 2010" provides data o |
2010 | 1.000,00$ |
Fallopian Tube Cancer Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Fallopian Tube Cancer Global Clinical Trials Review, Q4, 2010" provides dat |
2010 | 1.000,00$ |
Gastric Cancer Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Gastric Cancer Global Clinical Trials Review, Q4, 2010" provides data on th |
2010 | 1.000,00$ |
Gastrointestinal Stromal Tumors (GIST) Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “ Gastrointestinal Stromal Tumors (GIST) Global Clinical Trials Review, Q4, |
2010 | 1.000,00$ |
Germ Cell Tumors Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Germ Cell Tumors Global Clinical Trials Review, Q4, 2010" provides data on |
2010 | 1.000,00$ |
Glioblastoma (GBM) Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “ Glioblastoma (GBM) Global Clinical Trials Review, Q4, 2010" provides data |
2010 | 1.000,00$ |
Glioma Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “ Glioma Global Clinical Trials Review, Q4, 2010" provides data on the Gliom |
2010 | 1.000,00$ |
Head and Neck Cancer Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Head and Neck Cancer Global Clinical Trials Review, Q4, 2010" provides data |
2010 | 1.000,00$ |
Hematological Cancers Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “ Hematological Cancers Global Clinical Trials Review, Q4, 2010" provides da |
2010 | 1.000,00$ |
Hepatic Tumor Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Hepatic Tumor Clinical Trials Review, Q4, 2010""” provides data on the Hepa |
2010 | 1.000,00$ |
Hodgkin Lymphoma Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “ Hodgkin Lymphoma Global Clinical Trials Review, Q4, 2010" provides data on |
2010 | 1.000,00$ |
Kidney Cancer Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Kidney Cancer Global Clinical Trials Review, Q4, 2010" provides data on the |
2010 | 1.000,00$ |
Larynx Cancer Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “ Larynx Cancer Global Clinical Trials Review, Q4, 2010" provides data on th |
2010 | 1.000,00$ |
Leukemia Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Leukemia Global Clinical Trials Review, Q4, 2010" provides data on the Leuk |
2010 | 1.000,00$ |
Liver Cancer Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “ Liver Cancer Global Clinical Trials Review, Q4, 2010" provides data on the |
2010 | 1.000,00$ |
Lung Cancer Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Lung Cancer Global Clinical Trials Review, Q4, 2010"” provides data on the |
2010 | 1.000,00$ |
Melanoma Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Melanoma Global Clinical Trials Review, Q4, 2010"” provides data on the Mel |
2010 | 1.000,00$ |
Multiple Myeloma Therapeutics Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Multiple Myeloma Global Clinical Trials Review, Q4, 2010"” provides data on |
2010 | 1.000,00$ |
Myelodysplastic Syndrome Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Myelodsplastic Syndrome Global Clinical Trials Review, Q4, 2010"” provides |
2010 | 1.000,00$ |
Post-Traumatic Stress Disorder (PTSD) Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Post-Traumatic Stress Disorder Global Clinical Trials Review, Q4, 2010"” pr |
2010 | 1.000,00$ |
Non-Hodgkin Lymphoma Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Non-Hodgkin Lymphoma Global Clinical Trials Review, Q4, 2010"” provides dat |
2010 | 1.000,00$ |
Non-Small Cell Lung Cancer Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Non-Small Cell Lung Cancer Global Clinical Trials Review, Q4, 2010"” provid |
2010 | 1.000,00$ |
Oral Cancer Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Oral Cancer Global Clinical Trials Review, Q4, 2010"” provides data on the |
2010 | 1.000,00$ |
Ovarian Cancer Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Ovarian Cancer Global Clinical Trials Review, Q4, 2010"” provides data on t |
2010 | 1.000,00$ |
Pancreatic cancer Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Pancreatic Cancer Global Clinical Trials Review, Q4, 2010"” provides data o |
2010 | 1.000,00$ |
Peritoneal Cancer Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Pancreatic Cancer Global Clinical Trials Review, Q4, 2010"” provides data o |
2010 | 1.000,00$ |
Precancerous Condition Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Precancerous Condition Global Clinical Trials Review, Q4, 2010"” provides d |
2010 | 1.000,00$ |
Prostate Cancer Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Prostate Cancer Global Clinical Trials Review, Q4, 2010"” provides data on |
2010 | 1.000,00$ |
Rectal Cancer Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Rectal Cancer Global Clinical Trials Review, Q4, 2010"” provides data on th |
2010 | 1.000,00$ |
Small-Cell Lung Cancer Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Small Cell Lung Cancer Global Clinical Trials Review, Q4, 2010"” provides d |
2010 | 1.000,00$ |
Soft Tissue Sarcoma Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Soft Tissue Sarcoma Global Clinical Trials Review, Q4, 2010"” provides data |
2010 | 1.000,00$ |
Solid Tumors Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Solid Tumors Global Clinical Trials Review, Q4, 2010"” provides data on the |
2010 | 1.000,00$ |
Testicular Cancer Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Testicular Cancer Global Clinical Trials Review, Q4, 2010"” provides data o |
2010 | 1.000,00$ |
Thymus Cancer Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Thymus Cancer Global Clinical Trials Review, Q4, 2010"” provides data on th |
2010 | 1.000,00$ |
Thyroid Cancer Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Thyroid Cancer Global Clinical Trials Review, Q4, 2010"” provides data on t |
2010 | 1.000,00$ |
Uterine Cancer Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Uterine Cancer Global Clinical Trials Review, Q4, 2010"” provides data on t |
2010 | 1.000,00$ |
Vaginal Cancer Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Vaginal Cancer Global Clinical Trials Review, Q4, 2010"” provides data on t |
2010 | 1.000,00$ |
Burkitt Lymphoma Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Burkitt Lymphoma Global Clinical Trials Review, Q4, 2010"” provides data on |
2010 | 1.000,00$ |
Osteosarcoma Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Osteosarcoma Global Clinical Trials Review, Q4, 2010"” provides data on the |
2010 | 1.000,00$ |
Hepatocellular Carcinoma Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Hepatocellular Carcinoma Global Clinical Trials Review, Q4, 2010"” provides |
2010 | 1.000,00$ |
Gallbladder Cancer Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Gallbladder Cancer Global Clinical Trials Review, Q4, 2010"” provides data |
2010 | 1.000,00$ |
Brain Metastasis Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Brain Metastasis Global Clinical Trials Review, Q4, 2010"” provides data on |
2010 | 1.000,00$ |
Basal Cell Carcinoma Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Basal Cell Carcinoma Global Clinical Trials Review, Q4, 2010"” provides dat |
2010 | 1.000,00$ |
Astrocytoma Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Astrocytoma Global Clinical Trials Review, Q4, 2010"” provides data on the |
2010 | 1.000,00$ |
Anal Cancer Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Anal Cancer Global Clinical Trials Review, Q4, 2010"” provides data on the |
2010 | 1.000,00$ |
Adenomas Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Adenomas Global Clinical Trials Review, Q4, 2010"” provides data on the Ade |
2010 | 1.000,00$ |
Insomnia Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Insomnia Global Clinical Trials Review, Q4, 2010"” provides data on the Ins |
2010 | 1.000,00$ |
Parkinson’s Disease Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Parkinson’s Disease Global Clinical Trials Review, Q4, 2010"” provides data |
2010 | 1.000,00$ |
Alzheimer's Disease Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Alzheimer’s Disease Global Clinical Trials Review, Q4, 2010"” provides data |
2010 | 1.000,00$ |
Aneurysm Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Aneurysm Global Clinical Trials Review, Q4, 2010"” provides data on the Ane |
2010 | 1.000,00$ |
Angina Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Angina Global Clinical Trials Review, Q4, 2010"” provides data on the Angin |
2010 | 1.000,00$ |
Phlebitis Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Phlebitis Global Clinical Trials Review, Q4, 2010"” provides data on the Ph |
2010 | 1.000,00$ |
Chronic Obstructive Pulmonary Disease (COPD) Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “COPD Global Clinical Trials Review, Q4, 2010"” provides data on the COPD cl |
2010 | 1.000,00$ |
Apnea Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Apnea Global Clinical Trials Review, Q4, 2010"” provides data on the Apnea |
2010 | 1.000,00$ |
Bronchitis Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Bronchitis Global Clinical Trials Review, Q4, 2010"” provides data on the B |
2010 | 1.000,00$ |
Allergic Rhinitis Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Allergic Rhinitis Global Clinical Trials Review, Q4, 2010"” provides data o |
2010 | 1.000,00$ |
Asthma Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Asthma Global Clinical Trials Review, Q4, 2010"” provides data on the Asthm |
2010 | 1.000,00$ |
Polio Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Polio Global Clinical Trials Review, Q4, 2010"” provides data on the Polio |
2010 | 1.000,00$ |
Dengue Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Dengue Global Clinical Trials Review, Q4, 2010"” provides data on the Dengu |
2010 | 1.000,00$ |
Pompe Disease Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Pompe Disease Global Clinical Trials Review, Q4, 2010" provides data on the |
2010 | 1.000,00$ |
Smallpox Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Small Pox Global Global Clinical Trials Review, Q4, 2010"” provides data on |
2010 | 1.000,00$ |
Meningitis Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Meningitis Global Global Clinical Trials Review, Q4, 2010"” provides data o |
2010 | 1.000,00$ |
Chicken Pox Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Chicken Pox Global Global Clinical Trials Review, Q4, 2010"” provides data |
2010 | 1.000,00$ |
Irritable Bowel Syndrome Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Irritable bowel syndrome Global Global Clinical Trials Review, Q4, 2010"” p |
2010 | 1.000,00$ |
Tetanus Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Tetanus Global Global Clinical Trials Review, Q4, 2010"” provides data on t |
2010 | 1.000,00$ |
Equine Encephalitis Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Equine Encephalitis Global Global Clinical Trials Review, Q4, 2010"” provid |
2010 | 1.000,00$ |
Tuberculosis Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Tuberculosis Global Global Clinical Trials Review, Q4, 2010"” provides data |
2010 | 1.000,00$ |
Enterocolitis Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Enterocolitis Global Global Clinical Trials Review, Q4, 2010"” provides dat |
2010 | 1.000,00$ |
Esophagitis Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Esophagitis Global Global Clinical Trials Review, Q4, 2010"” provides data |
2010 | 1.000,00$ |
Arteriosclerosis Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Arteriosclerosis Global Global Clinical Trials Review, Q4, 2010"” provides |
2010 | 1.000,00$ |
Venous Thromboembolism Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Venous Thromboembolism Global Global Clinical Trials Review, Q4, 2010"” pro |
2010 | 1.000,00$ |
Peripheral Arterial Disease Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Peripheral Arterial Disease Global Global Clinical Trials Review, Q4, 2010" |
2010 | 1.000,00$ |
Myocardial Infarction Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Myocardial Infarction Global Global Clinical Trials Review, Q4, 2010"” prov |
2010 | 1.000,00$ |
Upper Respiratory Tract Infections Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Upper Respiratory Tract Infections Global Global Clinical Trials Review, Q4 |
2010 | 1.000,00$ |
Pneumonia Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Pneumonia Global Global Clinical Trials Review, Q4, 2010"” provides data on |
2010 | 1.000,00$ |
Aspergillosis Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Aspergillosis Global Clinical Trials Review, Q4, 2010" provides data on the |
2010 | 1.000,00$ |
Plasma Cell Neoplasm Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Plasma Cell Neoplasm Global Global Clinical Trials Review, Q4, 2010"” provi |
2010 | 1.000,00$ |
Rhabdomyosarcoma Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Rhabdomyosarcoma Global Global Clinical Trials Review, Q4, 2010"” provides |
2010 | 1.000,00$ |
Squamous Cell Carcinoma Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Squamous Cell Carcinoma Global Global Clinical Trials Review, Q4, 2010"” pr |
2010 | 1.000,00$ |
Vulvar Cancer Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Vulvar Cancer Global Global Clinical Trials Review, Q4, 2010"” provides dat |
2010 | 1.000,00$ |
Epilepsy Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Epilepsy Global Global Clinical Trials Review, Q4, 2010"” provides data on |
2010 | 1.000,00$ |
Attention Deficit Hyperactivity Disorder (ADHD) Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Attention-Deficit Hyperactivity Disorder (ADHD) Global Global Clinical Tria |
2010 | 1.000,00$ |
Bipolar Depression Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Bipolar Depression Global Global Clinical Trials Review, Q4, 2010"” provide |
2010 | 1.000,00$ |
Ophthalmic Devices Market Outlook in Belgium to 2016 - Vision Care, Cataract and Refractive Surgery Devices and OthersIntroduction / / GlobalData’s medical device report, “Ophthalmic Devices Market Outlook in Belgium to 2016 - Vision Care, Catarac |
2010 | 2.500,00$ |
Ophthalmic Devices Market Outlook in Brazil to 2016 - Vision Care, Cataract and Refractive Surgery Devices and OthersIntroduction / / GlobalData’s medical device report, "Ophthalmic Devices Market Outlook in Brazil to 2016 - Vision Care, Cataract |
2010 | 2.500,00$ |
Ophthalmic Devices Market Outlook in India to 2016 - Vision Care, Cataract and Refractive Surgery Devices and OthersIntroduction / / GlobalData’s medical device report, “Ophthalmic Devices Market Outlook in India to 2016 - Vision Care, Cataract |
2010 | 2.500,00$ |
Ophthalmic Devices Market Outlook in Japan to 2016 - Vision Care, Cataract and Refractive Surgery Devices and OthersIntroduction / / GlobalData’s medical device report, “Ophthalmic Devices Market Outlook in Japan to 2016 - Vision Care, Cataract |
2010 | 2.500,00$ |
Ophthalmic Devices Market Outlook in Republic of Korea to 2016 - Vision Care, Cataract and Refractive Surgery Devices and OthersIntroduction / / GlobalData’s medical device report, “Ophthalmic Devices Market Outlook in Republic of Korea to 2016 - Vision Car |
2010 | 2.500,00$ |
Ophthalmic Devices Market Outlook in the UK to 2016 - Vision Care, Cataract and Refractive Surgery Devices and OthersIntroduction / / GlobalData’s medical device report, “Ophthalmic Devices Market Outlook in the UK to 2016 - Vision Care, Cataract |
2010 | 2.500,00$ |
Ophthalmic Devices Market Outlook in the United States (US) to 2016 - Vision Care, Cataract and Refractive Surgery Devices and OthersIntroduction / / GlobalData’s medical device report, “Ophthalmic Devices Market Outlook in the United States (US) to 2016 - Visio |
2010 | 2.500,00$ |
Surgical Equipment Market Outlook in Republic of Korea to 2016 - Surgical Sutures, Hand Instruments and Radiofrequency (RF) Generator and AccessoriesIntroduction / / GlobalData’s medical device report, “Surgical Equipment Market Outlook in Republic of Korea to 2016 - Surgical S |
2010 | 2.500,00$ |
Surgical Equipment Market Outlook in the US to 2016 - Surgical Sutures, Hand Instruments and Radiofrequency (RF) Generator and AccessoriesIntroduction / / GlobalData’s medical device report, “Surgical Equipment Market Outlook in the US to 2016 - Surgical Sutures, Han |
2010 | 2.500,00$ |
Refractive Surgery Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016Introduction / / GlobalData’s new report, “Refractive Surgery Devices - Global Pipeline Analysis, Opportunity Assessment and Mark |
2010 | 3.500,00$ |
Remote Patient Monitoring: A Global Industry OverviewIntroduction / / GlobalData’s new report, “Remote Patient Monitoring: A Global Industry Overview” provides an overview of the mar |
2010 | 500,00$ |
Medical Device Industry Regains PE/VC Investor AttentionIntroduction / / GlobalData’s new report, “Medical Device Industry Regains PEVC Investor Attention” provides key information and |
2010 | 500,00$ |
Malaria Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Malaria Global Clinical Trials Review, Q4, 2010" provides data on the Malar |
2010 | 1.000,00$ |
Tonsillitis Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Brain Cancer Global Clinical Trials Review, Q4, 2010" provides data on the |
2010 | 1.000,00$ |
Sarcomas Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Sarcomas Global Clinical Trials Review, Q4, 2010" provides data on the Sarc |
2010 | 1.000,00$ |
Carcinomas Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Carcinomas Global Clinical Trials Review, Q4, 2010" provides data on the Ca |
2010 | 1.000,00$ |
Metastatic Breast Cancer Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Metastatic Breast Cancer Global Clinical Trials Review, Q4, 2010" provides |
2010 | 1.000,00$ |
Metastatic Cancer Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Metastatic Cancer Global Clinical Trials Review, Q4, 2010" provides data on |
2010 | 1.000,00$ |
Metastatic Melanoma Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Metastatic Melanoma Global Clinical Trials Review, Q4, 2010" provides data |
2010 | 1.000,00$ |
Glioblastoma Multiforme Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Glioblastoma Multiforme Global Clinical Trials Review, Q4, 2010" provides d |
2010 | 1.000,00$ |
Pediatric Cancer Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Pediatric Cancer Global Clinical Trials Review, Q4, 2010" provides data on |
2010 | 1.000,00$ |
Renal Cell Carcinoma Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Renal Cell Carcinoma Global Clinical Trials Review, Q4, 2010" provides data |
2010 | 1.000,00$ |
Diffuse Large B-cell Lymphoma Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Diffuse Large B-Cell Lymphoma Global Clinical Trials Review, Q4, 2010" prov |
2010 | 1.000,00$ |
Gynecological Cancers Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Gynecological Cancers Global Clinical Trials Review, Q4, 2010" provides dat |
2010 | 1.000,00$ |
Malignant Mesothelioma Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Malignant Mesothelioma Global Clinical Trials Review, Q4, 2010" provides da |
2010 | 1.000,00$ |
Hepatocellular Cancer Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Hepatocellualar Cancer Global Clinical Trials Review, Q4, 2010" provides da |
2010 | 1.000,00$ |
Metastatic Liver Cancer Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Metastatic Liver Cancer Global Clinical Trials Review, Q4, 2010" provides d |
2010 | 1.000,00$ |
Hormone Refractory Prostate Cancer Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Hormone Refractory Prostate Cancer Global Clinical Trials Review, Q4, 2010" |
2010 | 1.000,00$ |
Neutropenia Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Neutropenia Global Clinical Trials Review, Q4, 2010" provides data on the N |
2010 | 1.000,00$ |
Bone Metastasis Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Bone Metastasis Global Clinical Trials Review, Q4, 2010" provides data on t |
2010 | 1.000,00$ |
Metastatic Pancreatic Cancer Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Metastatic Pancreatic Cancer Global Clinical Trials Review, Q4, 2010" provi |
2010 | 1.000,00$ |
Neuroendocrine Carcinoma Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Neuroendocrine Carcinoma Global Clinical Trials Review, Q4, 2010" provides |
2010 | 1.000,00$ |
B-cell Lymphomas Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “B-Cell Lymphomas Global Clinical Trials Review, Q4, 2010" provides data on |
2010 | 1.000,00$ |
T-cell Lymphomas Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “T-Cell Lymphomas Global Clinical Trials Review, Q4, 2010" provides data on |
2010 | 1.000,00$ |
Mantle Cell Lymphoma Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Mantle Cell Lymphoma Global Clinical Trials Review, Q4, 2010" provides data |
2010 | 1.000,00$ |
Follicular Lymphoma Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Follicular Lymphoma Global Clinical Trials Review, Q4, 2010" provides data |
2010 | 1.000,00$ |
Cutaneous T-cell Lymphoma Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Cutaneous T-Cell Lymphoma Global Clinical Trials Review, Q4, 2010" provides |
2010 | 1.000,00$ |
Oropharynx Cancer Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Oropharynx Cancer Global Clinical Trials Review, Q4, 2010" provides data on |
2010 | 1.000,00$ |
Anaplastic Astrocytoma Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Anaplastic Astrocytoma Global Clinical Trials Review, Q4, 2010" provides da |
2010 | 1.000,00$ |
Metastatic Brain Tumors Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “ Metastatic Brain Tumors Global Clinical Trials Review, Q4, 2010" provides |
2010 | 1.000,00$ |
Nonmelanomatous Skin Cancer Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Nonmelanomatous Skin Cancer Global Clinical Trials Review, Q4, 2010" provid |
2010 | 1.000,00$ |
Medulloblastoma Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Medulloblastoma Global Clinical Trials Review, Q4, 2010" provides data on t |
2010 | 1.000,00$ |
T-Cell Leukemia Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “T-Cell Leukemia Global Clinical Trials Review, Q4, 2010" provides data on t |
2010 | 1.000,00$ |
Carcinoid Cancer Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Carcinoid Cancer Global Clinical Trials Review, Q4, 2010" provides data on |
2010 | 1.000,00$ |
Adrenocortical Carcinoma Adrenal Tumor Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Adrenocortical Carcinoma Adrenal Tumor Global Clinical Trials Review, Q4, 2 |
2010 | 1.000,00$ |
Metastatic Lung Cancer Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Metastatic Lung Cancer Global Clinical Trials Review, Q4, 2010" provides da |
2010 | 1.000,00$ |
Ewing Sarcoma Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Ewing Sarcoma Global Clinical Trials Review, Q4, 2010" provides data on the |
2010 | 1.000,00$ |
Oligodendroglioma Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Oligodendroglioma Global Clinical Trials Review, Q4, 2010" provides data on |
2010 | 1.000,00$ |
AIDS - Related Cancers Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Aids - Related Cancers Global Clinical Trials Review, Q4, 2010" provides da |
2010 | 1.000,00$ |
Nasopharyngeal Cancer Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Nasopharyngeal Cancer Global Clinical Trials Review, Q4, 2010" provides dat |
2010 | 1.000,00$ |
Meningioma Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Meningioma Global Clinical Trials Review, Q4, 2010" provides data on the Me |
2010 | 1.000,00$ |
Ependymoma Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Ependymoma Global Clinical Trials Review, Q4, 2010" provides data on the Ep |
2010 | 1.000,00$ |
Hypopharynx Cancer Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Hypopharynx Cancer Global Clinical Trials Review, Q4, 2010" provides data o |
2010 | 1.000,00$ |
Other Brain-Related Conditions Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Other Brain-Related Conditions Global Clinical Trials Review, Q4, 2010" pro |
2010 | 1.000,00$ |
Gliosarcoma Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Gliosarcoma Global Clinical Trials Review, Q4, 2010" provides data on the G |
2010 | 1.000,00$ |
Transitional Cell Cancer Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Transitional Cell Cancer Global Clinical Trials Review, Q4, 2010" provides |
2010 | 1.000,00$ |
Leukocyte Disorders (White Blood Cell Disorders) Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Leukocyte Disorders (White Blood Cell Disorders) Global Clinical Trials Rev |
2010 | 1.000,00$ |
Laryngeal Cancer Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Laryngeal Cancer Global Clinical Trials Review, Q4, 2010" provides data on |
2010 | 1.000,00$ |
Adrenocortical Carcinoma Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Adrenocortical Carcinoma Global Clinical Trials Review, Q4, 2010" provides |
2010 | 1.000,00$ |
Wilms’ Tumor Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Wilms’ Tumor Global Clinical Trials Review, Q4, 2010" provides data on the |
2010 | 1.000,00$ |
Oropharyngeal Cancer Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Oropharyngeal Cancer Global Clinical Trials Review, Q4, 2010" provides data |
2010 | 1.000,00$ |
Gastrointestinal Tract Cancer Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Gastrointestinal Tract Cancer Global Clinical Trials Review, Q4, 2010" prov |
2010 | 1.000,00$ |
Chordoma Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Chordoma Global Clinical Trials Review, Q4, 2010" provides data on the Chor |
2010 | 1.000,00$ |
Penile Cancer Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Penile Cancer Global Clinical Trials Review, Q4, 2010" provides data on the |
2010 | 1.000,00$ |
Sezary Syndrome Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Sezary Syndrome Global Clinical Trials Review, Q4, 2010" provides data on t |
2010 | 1.000,00$ |
Pituitary Tumors Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Pituitary Tumors Global Clinical Trials Review, Q4, 2010" provides data on |
2010 | 1.000,00$ |
Cervical Dysplasia Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Cervical Dysplasia Global Clinical Trials Review, Q4, 2010" provides data o |
2010 | 1.000,00$ |
Cancer Cachexia Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Cancer Cachexia Global Clinical Trials Review, Q4, 2010" provides data on t |
2010 | 1.000,00$ |
Throat Cancer Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Throat Cancer Global Clinical Trials Review, Q4, 2010" provides data on the |
2010 | 1.000,00$ |
Lymphoblastic Lymphoma Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Lymphoblastic Lymphoma Global Clinical Trials Review, Q4, 2010" provides da |
2010 | 1.000,00$ |
Malignant Pleural Effusion Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Malignant Pleural Effusion Global Clinical Trials Review, Q4, 2010" provide |
2010 | 1.000,00$ |
Thrombosis Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Thrombosis Global Clinical Trials Review, Q4, 2010" provides data on the Th |
2010 | 1.000,00$ |
Obstructive Sleep Apnea Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Obstructive Sleep Apnea Global Clinical Trials Review, Q4, 2010" provides d |
2010 | 1.000,00$ |
Sinusitis Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Sinusitis Global Clinical Trials Review, Q4, 2010" provides data on the Sin |
2010 | 1.000,00$ |
Rabies Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Rabies Global Clinical Trials Review, Q4, 2010" provides data on the Rabies |
2010 | 1.000,00$ |
HIV / AIDS Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “HIV Global Clinical Trials Review, Q4, 2010" provides data on the HIV clini |
2010 | 1.000,00$ |
Pulmonary Edema Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Pulmonary Edema Global Clinical Trials Review, Q4, 2010" provides data on t |
2010 | 1.000,00$ |
Adult Respiratory Distress Syndrome Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Adult Respiratory Distress Syndrome Global Clinical Trials Review, Q4, 2010 |
2010 | 1.000,00$ |
Pharyngitis Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Pharyngitis Global Clinical Trials Review, Q4, 2010" provides data on the P |
2010 | 1.000,00$ |
Common Cold Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Common Cold Global Clinical Trials Review, Q4, 2010" provides data on the C |
2010 | 1.000,00$ |
Respiratory Syncytial Virus (RSV) Infection Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Respiratory Syncytial Virus (Rsv) Global Clinical Trials Review, Q4, 2010" |
2010 | 1.000,00$ |
Dyspnea Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Dyspnea Global Clinical Trials Review, Q4, 2010" provides data on the Dyspn |
2010 | 1.000,00$ |
Respiratory Distress Syndrome Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Respiratory Distress Syndrome Global Clinical Trials Review, Q4, 2010" prov |
2010 | 1.000,00$ |
Pulmonary Fibrosis Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Pulmonary Fibrosis Global Clinical Trials Review, Q4, 2010" provides data o |
2010 | 1.000,00$ |
Cough Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Cough Global Clinical Trials Review, Q4, 2010" provides data on the Cough c |
2010 | 1.000,00$ |
Acute Lung Injury Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Acute Lung Injury Global Clinical Trials Review, Q4, 2010" provides data on |
2010 | 1.000,00$ |
Idiopathic Pulmonary Fibrosis Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Idiopathic Pulmonary Fibrosis Global Clinical Trials Review, Q4, 2010" prov |
2010 | 1.000,00$ |
Emphysema Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Emphysema Global Clinical Trials Review, Q4, 2010" provides data on the Emp |
2010 | 1.000,00$ |
Pulmonary Arterial Hypertension Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Pulmonary Arterial Hypertension Global Clinical Trials Review, Q4, 2010" pr |
2010 | 1.000,00$ |
Acute Respiratory Distress Syndrome Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Acute Respiratory Distress Syndrome Global Clinical Trials Review, Q4, 2010 |
2010 | 1.000,00$ |
Respiratory Tract Infections Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Respiratory Tract Infections Global Clinical Trials Review, Q4, 2010" provi |
2010 | 1.000,00$ |
Pulmonary Embolism Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Pulmonary Embolism Global Clinical Trials Review, Q4, 2010" provides data o |
2010 | 1.000,00$ |
Diphtheria Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Diphtheria Global Clinical Trials Review, Q4, 2010" provides data on the Di |
2010 | 1.000,00$ |
Diabetic Macular Edema Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Diabetic Macular Edema Global Clinical Trials Review, Q4, 2010" provides da |
2010 | 1.000,00$ |
Bronchiolitis Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Bronchiolitis Global Clinical Trials Review, Q4, 2010" provides data on the |
2010 | 1.000,00$ |
Cystic Fibrosis Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Cystic fibrosis Global Clinical Trials Review, Q4, 2010" provides data on t |
2010 | 1.000,00$ |
Staphylococcal Infections Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Staphylococcal Infection Global Clinical Trials Review, Q4, 2010" provides |
2010 | 1.000,00$ |
Streptococcal Infections Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Streptococcal Infections Global Clinical Trials Review, Q4, 2010" provides |
2010 | 1.000,00$ |
Otitis Media Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Otitis Media Global Clinical Trials Review, Q4, 2010" provides data on the |
2010 | 1.000,00$ |
Cataract Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Cataract Global Clinical Trials Review, Q4, 2010" provides data on the Cata |
2010 | 1.000,00$ |
Cystoid Macular Edema Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Cystoid Macular Edema Global Clinical Trials Review, Q4, 2010" provides dat |
2010 | 1.000,00$ |
Gastroenteritis Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Gastroenteritis Global Clinical Trials Review, Q4, 2010" provides data on t |
2010 | 1.000,00$ |
Peptic Ulcer Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Peptic ulcer Global Clinical Trials Review, Q4, 2010" provides data on the |
2010 | 1.000,00$ |
Encephalitis Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Encephalitis Global Clinical Trials Review, Q4, 2010" provides data on the |
2010 | 1.000,00$ |
Influenza Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Influenza Global Clinical Trials Review, Q4, 2010" provides data on the Inf |
2010 | 1.000,00$ |
Acne Vulgaris Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Acne Vulgari Global Clinical Trials Review, Q4, 2010" provides data on the |
2010 | 1.000,00$ |
Dermatitis Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Dermatitis Global Clinical Trials Review, Q4, 2010" provides data on the De |
2010 | 1.000,00$ |
Mucositis Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Mucositis Global Clinical Trials Review, Q4, 2010" provides data on the Muc |
2010 | 1.000,00$ |
Gout Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Gout Global Clinical Trials Review, Q4, 2010" provides data on the Gout cli |
2010 | 1.000,00$ |
Type 1 Diabetes Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Type I Diabetes Global Clinical Trials Review, Q4, 2010" provides data on t |
2010 | 1.000,00$ |
Type 2 Diabetes Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Type II Diabetes Global Clinical Trials Review, Q4, 2010" provides data on |
2010 | 1.000,00$ |
Diabetic Nephropathy Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Diabetic Nephropathy Global Clinical Trials Review, Q4, 2010" provides data |
2010 | 1.000,00$ |
Neuroma Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Neuroma Global Clinical Trials Review, Q4, 2010" provides data on the Neuro |
2010 | 1.000,00$ |
Pruritus Global Clinical Trials Review, Q4, 2010Introduction / / GlobalData's clinical trial report, “Pruritus Global Clinical Trials Review, Q4, 2010" provides data on the Prur |
2010 | 1.000,00$ |
Failure of TAK442 to Meet the Primary End-point in a Phase II Study Underlines the Challenging Clinical Development Environment for Anticoagulants in Acute Coronary SyndromesIntroduction / / GlobalData’s report, “Failure of TAK442 to Meet the Primary End-point in a Phase II Study Underlines the Challen |
2010 | 500,00$ |
Stem Cell Therapy Holds Promise for Ischemic Heart Disease PatientsIntroduction / / GlobalData’s report, “Stem Cell Therapy Holds Promise for Ischemic Heart Disease Patients” provides key data, in |
2010 | 500,00$ |
FDA Approval for Xgeva (denosumab): Novel Therapies to Drive the Bone Metastases Therapy MarketIntroduction / / GlobalData’s report, “FDA Approval for Xgeva (denosumab): Novel Therapies to Drive the Bone Metastases Therapy M |
2010 | 500,00$ |
Bronchitis Therapeutics - Pipeline Assessment and Market Forecasts to 2017Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Bronchitis Therapeutics - Pipeline A |
2010 | 2.000,00$ |
Glaucoma Therapeutics - Pipeline Assessment and Market Forecasts to 2017Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Glaucoma Therapeutics - Pipeline Ass |
2010 | 2.000,00$ |
Cervical Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2017Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Cervical Cancer - Pipeline Assessmen |
2010 | 2.000,00$ |
Tuberculosis Therapeutics - Pipeline Assessment and Market Forecasts to 2017Annualized global tuberculosis therapeutics market revenues data from 2001 to 2009, forecast for eight years to 2017.
/ The pipe |
2010 | 2.000,00$ |
Anti-Obesity Therapeutics - Pipeline Assessment and Market Forecasts to 2017Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Anti-Obesity - Pipeline Assessment a |
2010 | 2.000,00$ |
Melanoma Therapeutics - Pipeline Assessment and Market Forecasts to 2017Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Melanoma Therapeutics - Pipeline Ass |
2010 | 2.000,00$ |
Multiple Myeloma Therapeutics - Pipeline Assessment and Market Forecasts to 2017Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Multiple Myeloma Therapeutics - Pipe |
2010 | 2.000,00$ |
Atrial Fibrillation Therapeutics – Pipeline Assessment and Market Forecasts to 2017Introduction / / GlobalData, the industry analysis specialist, has released a new report, “Atrial Fibrillation Therapeutics - Pip |
2010 | 2.000,00$ |
Multiple Sclerosis Therapeutics - Pipeline Assessment and Market Forecasts to 2017Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Multiple Sclerosis Therapeutics - Pi |
2010 | 2.000,00$ |
Bladder Cancer - Pipeline Assessment and Market Forecasts to 2017Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Bladder Cancer - Pipeline Assessment |
2010 | 2.000,00$ |
Ovarian Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2017Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Ovarian Cancer Therapeutics - Pipeli |
2010 | 2.000,00$ |
Non-Small Cell Lung Cancer (NSCLC) - Pipeline Assessment and Market Forecasts to 2017Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Non-Small Cell Lung Cancer (NSCLC) - |
2010 | 2.000,00$ |
Macular Degeneration - Pipeline Assessment and Market Forecasts to 2017Introduction
/
/ GlobalData, the industry analysis specialist, has released its new report, “Macular Degeneration - Pipeline As |
2010 | 2.000,00$ |
Atherosclerosis or Coronary Artery Disease (CAD) - Pipeline Assessment and Market Forecasts to 2017Introduction / / GlobalData, the industry analysis specialist’s new report, “Atherosclerosis or Coronary Artery Disease (CAD) - P |
2010 | 2.000,00$ |
Renal Cell Carcinoma (RCC) Therapeutics - Pipeline Assessment and Market Forecasts to 2017Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Renal Cell Carcinoma (RCC) Therapeut |
2010 | 2.000,00$ |
North America Wound Care Management Market Outlook to 2016Introduction / / GlobalData’s new report, “North America Wound Care Management Market Outlook to 2016” provides key market data o |
2010 | 3.500,00$ |
Europe Wound Care Management Market Outlook to 2016Introduction / / GlobalData’s new report, “Europe Wound Care Management Market Outlook to 2016” provides key market data on the E |
2010 | 3.500,00$ |
Asia-Pacific Wound Care Management Market Outlook to 2016Introduction / / GlobalData’s new report, “Asia-Pacific Wound Care Management Market Outlook to 2016” provides key market data on |
2010 | 3.500,00$ |
Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - December 2010Introduction / / GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals – December 2010” |
2010 | 1.000,00$ |
Crohn’s Disease - Pipeline Assessment and Market Forecasts to 2017Introduction / / GlobalData, the industry analysis specialist’s new report, “Crohn’s Disease –Pipeline Assessment and Market Fore |
2010 | 2.000,00$ |
Liver Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2017Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Liver Cancer Therapeutics - Pipeline |
2010 | 2.000,00$ |
Brain Tumor - Pipeline Assessment and Market Forecasts to 2017Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Brain tumor- Pipeline Assessment and |
2010 | 2.000,00$ |
Addiction Control Therapeutics - Pipeline Assessment and Market Forecasts to 2017Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Addiction Control Therapeutics - Pip |
2010 | 2.000,00$ |
Breast Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2017Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Breast Cancer Therapeutics - Pipelin |
2010 | 2.000,00$ |
Healthcare IT Services - Global Opportunity Assessment, Competitive Landscape and Market Forecasts to 2016Introduction / / GlobalData’s new report, “Healthcare IT Services - Global Opportunity Assessment, Competitive Landscape and Mark |
2010 | 3.500,00$ |
Vehicle-to-Grid (V2G) - Global Market Analysis and Forecasts to 2020Introduction / / GlobalData’s “Vehicle-to-Grid (V2G) - Global Market Analysis and Forecasts to 2020” provides information on mark |
2010 | 3.500,00$ |
Hemophilia - Pipeline Assessment and Market Forecasts to 2017Introduction
/
/ GlobalData, the industry analysis specialist, has released its new report, “Hemophilia - Pipeline Assessment a |
2010 | 2.000,00$ |
Schizophrenia - Pipeline Assessment and Market Forecast to 2017Introduction
/
/ GlobalData, the industry analysis specialist, has released its new report, “Schizophrenia - Pipeline Assessmen |
2010 | 2.000,00$ |
Macular Edema Therapeutics - Pipeline Assessment and Market Forecasts to 2017Introduction
/
/ GlobalData, the industry analysis specialist’s new report, “Macular Edema Therapeutics - Pipeline Assessment a |
2010 | 2.000,00$ |
Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Assessment and Market Forecasts to 2017Introduction
/
/ GlobalData, the industry analysis specialist, has released its new report, “Chronic Obstructive Pulmonary Dise |
2010 | 2.000,00$ |
Endometriosis - Pipeline Assessment and Market Forecasts to 2017Introduction
/
/ GlobalData, the industry analysis specialist, has released its new report, “Endometriosis - Pipeline Assessmen |
2010 | 2.000,00$ |
Dystonia - Pipeline Assessment and Market Forecasts to 2017Introduction
/
/ GlobalData, the industry analysis specialist, has released its new report, “Dystonia - Pipeline Assessment and |
2010 | 2.000,00$ |
Venous Thromboembolism – Pipeline Assessment and Market Forecasts to 2017Introduction
/
/ GlobalData, the industry analysis specialist, has released its new report, “Venous Thromboembolism - Pipeline |
2010 | 2.000,00$ |
Lyme Disease Therapeutics - Pipeline Assessment and Market Forecasts to 2017Introduction
/
/ GlobalData, the industry analysis specialist, has released a new report, “Lyme Disease Therapeutics - Pipelin |
2010 | 2.000,00$ |
Nonalcoholic Steatohepatitis Therapeutics - Pipeline Assessment and Market Forecasts to 2017Introduction
/
/ GlobalData, the industry analysis specialist, has released its new report, “Non-alcoholic Steatohepatitis (NAS |
2010 | 2.000,00$ |
Acute Coronary Syndrome Therapeutics - Pipeline Assessment and Market Forecasts to 2017Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Acute Coronary Syndrome - Pipeline A |
2010 | 2.000,00$ |
Prostate Cancer - Pipeline Assessment and Market Forecasts to 2020Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Prostate Cancer - Pipeline Assessmen |
2010 | 3.500,00$ |
Irritable Bowel Syndrome - Pipeline Assessment and Market Forecasts to 2017Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Irritaable Bowel Syndrome (IBS) - Pi |
2010 | 2.000,00$ |
Gastroesophageal Reflux Disease (GERD) Therapeutics - Pipeline Assessment and Market Forecasts to 2017Introduction / / GlobalData, the industry analysis specialist, has released a new report, “Gastroesophageal Reflux Disease (GERD) |
2010 | 2.000,00$ |
Celsis International Ltd. - Financial and Strategic SWOT Analysis ReviewCelsis International Ltd. (Celsis) provides innovative life science products and laboratory services to pharmaceutical, biopharmac |
2010 | 125,00$ |
Concateno plc - Financial and Strategic SWOT Analysis ReviewConcateno plc (Concateno) is a provider of drug and alcohol testing services. The company operates as a subsidiary of Inverness Me |
2010 | 125,00$ |
Asthma - Pipeline Assessment and Market Forecasts to 2017Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Asthma - Pipeline Assessment and Mar |
2010 | 2.000,00$ |
Prostate Cancer - Japan Drug Forecasts and Treatment Analysis to 2020Introduction / / GlobalData's pharmaceutical report, “Prostate Cancer - Japan Drug Forecasts and Treatment Analysis to 2020” is a |
2010 | 3.000,00$ |
Prostate Cancer - Italy Drug Forecasts and Treatment Analysis to 2020Introduction / / GlobalData's pharmaceutical report, “Prostate Cancer - Italy Drug Forecasts and Treatment Analysis to 2020”. The |
2010 | 3.000,00$ |
Prostate Cancer - Spain Drug Forecasts and Treatment Analysis to 2020Introduction / / GlobalData's pharmaceutical report, “Prostate Cancer - Spain Drug Forecasts and Treatment Analysis to 2020”. The |
2010 | 3.000,00$ |
Prostate Cancer - France Drug Forecasts and Treatment Analysis to 2020Introduction / / GlobalData's pharmaceutical report, “Prostate Cancer - France Drug Forecasts and Treatment Analysis to 2020” is |
2010 | 3.000,00$ |
Prostate Cancer - US Drug Forecasts and Treatment Analysis to 2020Introduction / / GlobalData's pharmaceutical report, “Prostate Cancer - US Drug Forecasts and Treatment Analysis to 2020” is an e |
2010 | 3.000,00$ |
Anti-Hypertension Therapeutics - Pipeline Assessment and Market Forecasts to 2017Introduction
/
/ GlobalData, the industry analysis specialist’s new report, “Anti-Hypertension Therapeutics - Pipeline Assessme |
2010 | 2.000,00$ |
Candidiasis Therapeutics Market - Pipeline Assessment and Market Forecasts to 2017Introduction
/
/ GlobalData, the industry analysis specialist, has released a new report, “Candidiasis Therapeutics Market - Pi |
2010 | 2.000,00$ |
Acute Ischemic Stroke Therapeutics - Pipeline Assessment and Market Forecasts to 2017Introduction
/
/ GlobalData, the industry analysis specialist’s new report, “Acute Ischemic Stroke (AIS) Therapeutics Market - |
2010 | 2.000,00$ |
Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics - Pipeline Assessment and Market Forecasts to 2017Introduction
/
/ GlobalData, the industry analysis specialist, has released its new report, “Attention Deficit Hyperactivity Di |
2010 | 2.000,00$ |
Ulcerative Colitis Therapeutics - Pipeline Assessment and Market Forecasts to 2017Introduction
/
/ GlobalData, the industry analysis specialist, has released a new report, “Ulcerative Colitis Therapeutics - Pi |
2010 | 2.000,00$ |
Angina Pectoris - Pipeline Assessment and Market Forecasts to 2017Introduction
/
/ GlobalData, the industry analysis specialist’s new report, “Angina pectoris - Pipeline Assessment and Market F |
2010 | 2.000,00$ |
Europe Patient Monitoring Market Outlook to 2016Introduction / / GlobalData’s new report, “Europe Patient Monitoring Market Outlook to 2016” provides key market data on the Euro |
2010 | 3.500,00$ |
Asia-Pacific Orthopedic Devices Market Outlook to 2016Introduction / / GlobalData’s new report, “Asia-Pacific Orthopedic Devices” Market Outlook to 2016” provides key market data on t |
2010 | 3.500,00$ |
North America Anesthesia and Respiratory Devices Market Outlook to 2016Introduction / / GlobalData’s new report, “North America Anesthesia and Respiratory Devices Market Outlook to 2016” provides key |
2010 | 3.500,00$ |
External Defibrillators - Global Opportunity Assessment, Competitive Landscape and Market Forecasts to 2016Introduction / / GlobalData’s new report, “External Defibrillators - Global Opportunity Assessment, Competitive Landscape and Mar |
2010 | 3.500,00$ |
North America Endoscopy Devices Market Outlook to 2016Introduction / / GlobalData’s new report, “North America Endoscopy Devices Market Outlook to 2016” provides key market data on th |
2010 | 3.500,00$ |
Europe Endoscopy Devices Market Outlook to 2016Introduction / / GlobalData’s new report, “Europe Endoscopy Devices Market Outlook to 2016” provides key market data on the Europ |
2010 | 3.500,00$ |
Asia-Pacific Endoscopy Devices Market Outlook to 2016Introduction / / GlobalData’s new report, “Asia-Pacific Endoscopy Devices Market Outlook to 2016” provides key market data on the |
2010 | 3.500,00$ |
North America Neurology Devices Market Outlook to 2016Introduction / / GlobalData’s new report, “North America Neurology Devices Market Outlook to 2016” provides key market data on th |
2010 | 3.500,00$ |
Asia-Pacific Hospital Supplies Market Outlook to 2016Introduction / / GlobalData’s new report, “Asia-Pacific Hospital Supplies Market Outlook to 2016” provides key market data on the |
2010 | 3.500,00$ |
Medical Equipment Monthly Deals Analysis: M&A and Investment Trends - November 2010Introduction / / GlobalData's “Medical Equipment Monthly Deals Analysis: M&A and Investment Trends – November 2010” report is an |
2010 | 1.000,00$ |
Europe Orthopedic Devices Market Outlook to 2016Introduction / / GlobalData’s new report, “Europe Orthopedic Devices Market Outlook to 2016” provides key market data on the Euro |
2010 | 3.500,00$ |
Europe Cardiovascular Devices Market Outlook to 2016Introduction / / GlobalData’s new report, “Europe Cardiovascular Devices Market Outlook to 2016” provides key market data on the |
2010 | 3.500,00$ |
Asia Pacific Cardiovascular Devices Market Outlook to 2016Introduction / / GlobalData’s new report, “Asia Pacific Cardiovascular Devices Market Outlook to 2016” provides key market data o |
2010 | 3.500,00$ |
Asia-Pacific Anesthesia and Respiratory Devices Market Outlook to 2016Introduction / / GlobalData’s new report, “Asia-Pacific Anesthesia and Respiratory Devices” Market Outlook to 2016” provides key |
2010 | 3.500,00$ |
Asia-Pacific Dental Devices Market Outlook to 2016Introduction / / GlobalData’s new report, “Asia-Pacific Dental Devices Market Outlook to 2016” provides key market data on the As |
2010 | 3.500,00$ |
Europe Neurology Devices Market Outlook to 2016Introduction / / GlobalData’s new report, “Europe Neurology Devices Market Outlook to 2016” provides key market data on the Europ |
2010 | 3.500,00$ |
Asia-Pacific Neurology Devices Market Outlook to 2016Introduction / / GlobalData’s new report, “Asia-Pacific Neurology Devices Market Outlook to 2016” provides key market data on the |
2010 | 3.500,00$ |
Europe Hospital Supplies Market Outlook to 2016Introduction / / GlobalData’s new report, “Europe Hospital Supplies” Market Outlook to 2016” provides key market data on the Euro |
2010 | 3.500,00$ |
North America Diagnostic Imaging Market Outlook to 2016Introduction / / GlobalData’s new report, “North America Diagnostic Imaging Market Outlook to 2016” provides key market data on t |
2010 | 3.500,00$ |
Europe Diagnostic Imaging Market Outlook to 2016Introduction / / GlobalData’s new report, “Europe Diagnostic Imaging Market Outlook to 2016” provides key market data on the Euro |
2010 | 3.500,00$ |
Asia-Pacific Diagnostic Imaging Market Outlook to 2016Introduction / / GlobalData’s new report, “Asia-Pacific Diagnostic Imaging Market Outlook to 2016” provides key market data on th |
2010 | 3.500,00$ |
Anticoagulants in Stroke Prevention in Atrial Fibrillation (SPAF): Novel Oral Anticoagulants with Superior Safety Profile will Drive the MarketIntroduction / / GlobalData’s report, “Anticoagulants in Stroke Prevention in Atrial Fibrillation (SPAF): Novel Oral Anticoagulan |
2010 | 500,00$ |
Benign Prostatic Hyperplasia (BPH) Therapeutics - Pipeline Assessment and Market Forecasts to 2017Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Benign Prostatic Hyperplasia (BPH) T |
2010 | 2.000,00$ |
Fibromyalgia Therapeutics - Pipeline Assessment and Market Forecasts to 2017Introduction / / GlobalData, the industry analysis specialist’s new report, “Fibromyalgia Therapeutics - Pipeline Assessment and |
2010 | 2.000,00$ |
Allergic Conjunctivitis - Pipeline Assessment and Market Forecasts to 2017Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Allergic Conjunctivitis - Pipeline A |
2010 | 2.000,00$ |
Asia-Pacific Patient Monitoring Market Outlook to 2016Introduction / / GlobalData’s new report, “Asia-Pacific Patient Monitoring Market Outlook to 2016” provides key market data on th |
2010 | 3.500,00$ |
North America Cardiovascular Devices Market Outlook to 2016Introduction / / GlobalData’s new report, “North America Cardiovascular Devices Market Outlook to 2016” provides key market data |
2010 | 3.500,00$ |
American Academy of Ophthalmology Joint Meeting 2010: Review and AnalysisIntroduction / / GlobalData’s report, “American Academy of Ophthalmology (AAO) Joint Meeting 2010 - Conference Review and Analysi |
2010 | 1.000,00$ |
Europe Diabetes Care Devices Market Outlook to 2016Introduction / / GlobalData’s new report, “Europe Diabetes Care Devices” Market Outlook to 2016” provides key market data on the |
2010 | 3.500,00$ |
North America In Vitro Diagnostics Market Outlook to 2016Introduction / / GlobalData’s new report, “North America In Vitro Diagnostics Market Outlook to 2016” provides key market data on |
2010 | 3.500,00$ |
North America Ophthalmic Devices Market Outlook to 2016Introduction / / GlobalData’s new report, “North America Ophthalmic Devices Market Outlook to 2016” provides key market data on t |
2010 | 3.500,00$ |
Europe Ophthalmic Devices Market Outlook to 2016Introduction / / GlobalData’s new report, “Europe Ophthalmic Devices” Market Outlook to 2016” provides key market data on the Eur |
2010 | 3.500,00$ |
Asia-Pacific Opthalmic Devices Market Outlook to 2016Introduction / / GlobalData’s new report, “Asia-Pacific Opthalmic Devices” Market Outlook to 2016” provides key market data on th |
2010 | 3.500,00$ |
Cataract Surgery - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016Introduction / / GlobalData’s new report, “Cataract Surgery Devices - Global Pipeline Analysis, Opportunity Assessment and Market |
2010 | 3.500,00$ |
North America Drug Delivery Devices Market Outlook to 2016Introduction / / GlobalData’s new report, “North America Drug Delivery Devices Market Outlook to 2016” provides key market data o |
2010 | 3.500,00$ |
Europe Drug Delivery Devices Market Outlook to 2016Introduction / / GlobalData’s new report, “Europe Drug Delivery Devices Market Outlook to 2016” provides key market data on the E |
2010 | 3.500,00$ |
Asia-Pacific Drug Delivery Devices Market Outlook to 2016Introduction / / GlobalData’s new report, “Asia-Pacific Drug Delivery Devices Market Outlook to 2016” provides key market data on |
2010 | 3.500,00$ |
Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals – November 2010Introduction / / GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals – November 2010” |
2010 | 1.000,00$ |
Prostate Cancer - BRIC Drug Forecasts and Treatment Analysis to 2020Introduction / / GlobalData's pharmaceutical report, “Prostate Cancer - Brazil, Russia, India and China (BRIC) Drug Forecasts and |
2010 | 3.000,00$ |
North America ENT Devices Market Outlook to 2016Introduction / / GlobalData’s new report, “North America ENT Devices Market Outlook to 2016” provides key market data on the Nort |
2010 | 3.500,00$ |
North America Dental Devices Market Outlook to 2016Introduction / / GlobalData’s new report, “North America Dental Devices Market Outlook to 2016” provides key market data on the N |
2010 | 3.500,00$ |
Asia-Pacific HealthCare IT Market Outlook to 2016Introduction / / GlobalData’s new report, “Asia-Pacific HealthCare IT Market Outlook to 2016” provides key market data on the Asi |
2010 | 3.500,00$ |
Europe HealthCare IT Market Outlook to 2016Introduction / / GlobalData’s new report, “Europe HealthCare IT Market Outlook to 2016” provides key market data on the Europe He |
2010 | 3.500,00$ |
North America HealthCare IT Market Outlook to 2016Introduction / / GlobalData’s new report, “North America HealthCare IT Market Outlook to 2016” provides key market data on the No |
2010 | 3.500,00$ |
North America Diabetes Care Devices Market Outlook to 2016Introduction / / GlobalData’s new report, “North America Diabetes Care Devices Market Outlook to 2016” provides key market data o |
2010 | 3.500,00$ |
Europe ENT Devices Market Outlook to 2016`Introduction / / GlobalData’s new report, “Europe ENT Devices Market Outlook to 2016” provides key market data on the Europe ENT |
2010 | 3.500,00$ |
North America Hospital Supplies Market Outlook to 2016Introduction / / GlobalData’s new report, “North America Hospital Supplies Market Outlook to 2016” provides key market data on th |
2010 | 3.500,00$ |
Europe Surgical Equipment Market Outlook to 2016Introduction / / GlobalData’s new report, “Europe Surgical Equipment Market Outlook to 2016” provides key market data on the Euro |
2010 | 3.500,00$ |
Asia-Pacific ENT Devices Market Outlook to 2016Introduction / / GlobalData’s new report, “Asia-Pacific ENT Devices Market Outlook to 2016” provides key market data on the Asia- |
2010 | 3.500,00$ |
North America Patient Monitoring Market Outlook to 2016Introduction / / GlobalData’s new report, “North America Patient Monitoring Market Outlook to 2016” provides key market data on t |
2010 | 3.500,00$ |
North America Orthopedic Devices Market Outlook to 2016Introduction / / GlobalData’s new report, “North America Orthopedic Devices Market Outlook to 2016” provides key market data on t |
2010 | 3.500,00$ |
Asia Pacific Diabetes Care Devices Market Outlook to 2016Introduction / / GlobalData’s new report, “Asia Pacific Diabetes Care Devices” Market Outlook to 2016” provides key market data o |
2010 | 3.500,00$ |
North America Nephrology and Urology Devices Market Outlook to 2016Introduction / / GlobalData’s new report, “North America Nephrology and Urology Devices Market Outlook to 2016” provides key mark |
2010 | 3.500,00$ |
Europe Nephrology and Urology Devices Market Outlook to 2016Introduction / / GlobalData’s new report, “Europe Nephrology and Urology Devices Market Outlook to 2016” provides key market data |
2010 | 3.500,00$ |
Asia Pacific Nephrology and Urology Devices Market Outlook to 2016Introduction / / GlobalData’s new report, “Asia-Pacific Nephrology and Urology Devices Market Outlook to 2016” provides key marke |
2010 | 3.500,00$ |
Europe Anesthesia and Respiratory Devices Market Outlook to 2016Introduction / / GlobalData’s new report, “Europe Anesthesia and Respiratory Devices Market Outlook to 2016” provides key market |
2010 | 3.500,00$ |
Europe Dental Devices Market Outlook to 2016Introduction / / GlobalData’s new report, “Europe Dental Devices Market Outlook to 2016” provides key market data on the Europe D |
2010 | 3.500,00$ |
Asia-Pacific Surgical Equipment Market Outlook to 2016Introduction / / GlobalData’s new report, “Asia Pacific Surgical Equipment Market Outlook to 2016” provides key market data on th |
2010 | 3.500,00$ |
North America Surgical Equipment Market Outlook to 2016Introduction / / GlobalData’s new report, “North America Surgical Equipment Market Outlook to 2016” provides key market data on t |
2010 | 3.500,00$ |
Asia-Pacific In Vitro Diagnostics Market Outlook to 2016Introduction / / GlobalData’s new report, “Asia Pacific In Vitro Diagnostics Market Outlook to 2016” provides key market data on |
2010 | 3.500,00$ |
Europe In Vitro Diagnostics Market Outlook to 2016Introduction / / GlobalData’s new report, “Europe In Vitro Diagnostics Market Outlook to 2016” provides key market data on the Eu |
2010 | 3.500,00$ |
Huntington’s Disease - Pipeline Assessment and Market Forecasts to 2017Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Huntington’s Disease - Pipeline Asse |
2010 | 2.000,00$ |
Brain Hemorrhage Therapeutics – Pipeline Assessment and Market Forecasts to 2017Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Brain Hemorrhage Therapeutics - Pipe |
2010 | 2.000,00$ |
Paget’s disease of Bone - Pipeline Assessment and Market Forecasts to 2017Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Paget’s disease of Bone – Pipeline A |
2010 | 2.000,00$ |
Osteoarthritis - Pipeline Assessment and Market Forecasts to 2017Introduction / / GlobalData, the industry analysis specialist’s new report, “Osteoarthritis - Pipeline Assessment and Market Fore |
2010 | 2.000,00$ |
Prostate Cancer - UK Drug Forecasts and Treatment Analysis to 2020Introduction
/
/ GlobalData's pharmaceutical report, “Prostate Cancer - UK Drug Forecasts and Treatment Analysis to 2020” is an |
2010 | 3.000,00$ |
Prostate Cancer - Germany Drug Forecasts and Treatment Analysis to 2020Introduction
/
/ GlobalData's pharmaceutical report, “Prostate Cancer - Germany Drug Forecasts and Treatment Analysis to 2020”. |
2010 | 3.000,00$ |
Acute Heart Failure - Pipeline Assessment and Market Forecasts to 2017Introduction
/
/ GlobalData, the industry analysis specialist, has released its new report, “Acute Heart Failure - Pipeline Ass |
2010 | 2.000,00$ |
Psoriasis - Pipeline Assessment and Market Forecasts to 2017Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Psoriasis - Pipeline Assessment and |
2010 | 2.000,00$ |
Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - October 2010Introduction / / GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals – October 2010” r |
2010 | 1.000,00$ |
Pneumonia - Pipeline Assessment and Market Forecasts to 2017Introduction
/
/ GlobalData, the industry analysis specialist, has released its new report, “Pneumonia - Pipeline Assessment an |
2010 | 2.000,00$ |
Dysmenorrhea - Pipeline Assessment and Market Forecasts to 2017Introduction
/
/ GlobalData, the industry analysis specialist’s new report, “Dysmenorrhea –Pipeline Assessment and Market Forec |
2010 | 2.000,00$ |
Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q3 2010Introduction / / GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q3 2010” report |
2010 | 1.500,00$ |
Orthopedic Joint Reconstruction - A Global Market SnapshotIntroduction / / GlobalData’s new report, “Orthopedic Joint Reconstruction – A Global Market Snapshot” provides key data, informa |
2010 | 500,00$ |
Epilepsy Therapeutics - Pipeline Assessment and Market Forecasts to 2017Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Epilepsy - Pipeline Assessment and M |
2010 | 2.000,00$ |
Urinary Tract Infections (UTI) - Pipeline Assessment and Market Forecasts to 2017Introduction / / GlobalData’s report, “Urinary Tract Infections - Pipeline Assessment and Market Forecasts to 2017”, is an essent |
2010 | 2.000,00$ |
Rheumatoid Arthritis - Pipeline Assessment and Market Forecasts to 2017Introduction
/
/ GlobalData, the industry analysis specialist, has released a new report, “Rheumatoid Arthritis - Pipeline Asse |
2010 | 2.000,00$ |
Systemic Lupus Erythematosus - Pipeline Assessment and Market Forecasts to 2017Introduction
/
/ GlobalData, the industry analysis specialist’s new report, “Systemic Lupus Erythematosus - Pipeline Assessment |
2010 | 2.000,00$ |
Head and Neck Cancer - Pipeline Assessment and Market Forecast to 2017Introduction
/
/ GlobalData, the industry analysis specialist’s new report, “Head and Neck Cancer – Pipeline Assessment and Mar |
2010 | 2.000,00$ |
Influenza Vaccines - Pipeline Assessment and Market Forecasts to 2017Introduction
/
/ GlobalData, the industry analysis specialist, has released its new report, “Influenza Vaccines - Pipeline Asse |
2010 | 2.000,00$ |
Anemia - Pipeline Assessment and Market Forecasts to 2017GlobalData, the industry analysis specialist, has released its new report, “Anemia - Pipeline Assessment and Market Forecasts to 2 |
2010 | 2.000,00$ |
Acute Myeloid Leukemia (AML) - Pipeline Assessment and Market Forecasts to 2017Introduction / / GlobalData has released its pharmaceutical report, “Acute Myeloid Leukemia (AML) - Pipeline Assessment and Marke |
2010 | 2.000,00$ |
Alzheimer’s Disease - Pipeline Assessment and Market Forecasts to 2017Introduction
/
/ GlobalData, the industry analysis specialist, has released its new report, “Alzheimer’s Disease - Pipeline As |
2010 | 2.000,00$ |
Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) - Pipeline Assessment and Market Forecasts to 2017Introduction
/
/ GlobalData, the industry analysis specialist, has released its new report, “Amyotrophic Lateral Sclerosis (ALS |
2010 | 2.000,00$ |
Major Depressive Disorder (MDD) - Pipeline Assessment and Market Forecasts to 2017Introduction
/
/ GlobalData, the industry analysis specialist, has released its new report, “Major Depressive Disorder - Pipeli |
2010 | 2.000,00$ |
Non-Hodgkin’s Lymphoma (NHL) - Pipeline Assessment and Market Forecasts to 2017Introduction / / GlobalData, the industry analysis specialist has released a new report, “Non-Hodgkin’s Lymphoma (NHL) - Pipeline |
2010 | 2.000,00$ |
Medical Devices: A Global Industry OverviewIntroduction / / GlobalData’s report, “Medical Devices: A Global Industry Overview” provides key data, information and analysis o |
2010 | 500,00$ |
Global Diagnostic Imaging Market - Emerging Economies Hold the Key to Growth and ProfitabilityIntroduction / / GlobalData’s new report, “Global Diagnostic Imaging Market – Emerging Economies Hold the Key to Growth and Profi |
2010 | 500,00$ |
Vitreoretinal Surgery: A Market SnapshotIntroduction / / GlobalData’s report, “Vitreoretinal Surgery: A Market Snapshot” provides key data, information and analysis on t |
2010 | 500,00$ |
Femtosecond Lasers: A Market SnapshotIntroduction / / GlobalData’s report, “Femtosecond Lasers: A Market Snapshot” provides key data, information and analysis on the |
2010 | 500,00$ |
Prostate Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Q4 2010Introduction / / GlobalData's pharmaceutical report, “Prostate Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Q4 |
2010 | 5.000,00$ |
Pancreatic Cancer - Pipeline Assessment and Market Forecasts to 2017Introduction / / GlobalData, the industry analysis specialist’s new report, “Pancreatic Cancer - Pipeline Assessment and Market F |
2010 | 2.000,00$ |
Hepatitis B Vaccines - Pipeline Assessment and Market Forecasts to 2017Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Hepatitis B - Pipeline Assessment an |
2010 | 2.000,00$ |
Bipolar Disorder - Drug Pipeline Assessment and Market Forecasts to 2017Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Bipolar Disorder - Drug Pipeline Ass |
2010 | 2.000,00$ |
Muscular Dystrophy - Pipeline Assessment and Market Forecasts to 2017Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Muscular Dystrophy – Pipeline Assess |
2010 | 2.000,00$ |
Insomnia - Pipeline Assessment and Market Forecasts to 2017Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Insomnia - Pipeline Assessment and M |
2010 | 2.000,00$ |
Neutropenia - Pipeline Assessment and Market Forecasts to 2017Introduction / / GlobalData, the industry analysis specialist, has released a new report, “Neutropenia - Pipeline Assessment and |
2010 | 2.000,00$ |
Advanced Malignancy Clinical Trials Review, Q4 2010Introduction / / GlobalData's clinical trial report, “Advancer Malignancy Clinical Trials Review, Q4, 2010" provides data on the |
2010 | 1.000,00$ |
Gastritis Clinical Trials Review, Q4 2010Introduction / / GlobalData's clinical trial report, “Gastritis Clinical Trials Review, Q4, 2010" provides data on the Gastritis |
2010 | 1.000,00$ |
Waldenstrom Macroglobulinemia (WM) Clinical Trials Review, Q4 2010Introduction / / GlobalData's clinical trial report, “Waldenstrom Macroglobulinemia Clinical Trials Review, Q4, 2010” provides da |
2010 | 1.000,00$ |
Chronic Kidney Disease - Pipeline Assessment and Market Forecasts to 2016Annualized global chronic kidney disease market revenues data from 2001 to 2009, forecast forward for 7 years to 2016.
/ Pipeline |
2010 | 2.000,00$ |
Med BioGene Inc. (MBI) - Product Pipeline AnalysisMed BioGene Inc. (MBI) - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable in |
2010 | 750,00$ |
ATS Medical, Inc. (ATSI) - Product Pipeline AnalysisATS Medical, Inc. (ATSI) - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable |
2010 | 750,00$ |
DNAPrint Genomics, Inc. (DNAG) - Product Pipeline AnalysisDNAPrint Genomics, Inc. (DNAG) - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actio |
2010 | 750,00$ |
The Magstim Company Limited - Product Pipeline AnalysisThe Magstim Company Limited - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionab |
2010 | 750,00$ |
Candela Corporation - Product Pipeline AnalysisCandela Corporation - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intel |
2010 | 750,00$ |
Phosphagenics Limited (POH) - Product Pipeline AnalysisPhosphagenics Limited (POH) - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionab |
2010 | 750,00$ |
Neovasc Inc. (NVC) - Product Pipeline AnalysisNeovasc Inc. (NVC) - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intell |
2010 | 750,00$ |
InDevR Inc. - Product Pipeline AnalysisInDevR Inc. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intelligence |
2010 | 750,00$ |
Serica Technologies, Inc. - Product Pipeline AnalysisSerica Technologies, Inc. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable |
2010 | 750,00$ |
Osteotech, Inc. (OSTE) - Product Pipeline AnalysisOsteotech, Inc. (OSTE) - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable in |
2010 | 750,00$ |
Orthofix International N.V. (OFIX) - Product Pipeline AnalysisOrthofix International N.V. (OFIX) - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and a |
2010 | 750,00$ |
Foster-Miller, Inc. - Product Pipeline AnalysisFoster-Miller, Inc. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intel |
2010 | 750,00$ |
Kensey Nash Corporation (KNSY) - Product Pipeline AnalysisKensey Nash Corporation (KNSY) - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actio |
2010 | 750,00$ |
Sutura, Inc. - Product Pipeline AnalysisSutura, Inc. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intelligence |
2010 | 750,00$ |
Spine Smith, LP - Product Pipeline AnalysisSpine Smith, LP - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intellige |
2010 | 750,00$ |
Divya Laboratories - Product Pipeline AnalysisDivya Laboratories - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intell |
2010 | 750,00$ |
TheraGenetics Inc. - Product Pipeline AnalysisTheraGenetics Inc. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intell |
2010 | 750,00$ |
Corin Group PLC (CRG) - Product Pipeline AnalysisCorin Group PLC (CRG) - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable int |
2010 | 750,00$ |
Nicast Ltd. - Product Pipeline AnalysisNicast Ltd. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intelligence |
2010 | 750,00$ |
ABIOMED, Inc. (ABMD) - Product Pipeline AnalysisABIOMED, Inc. (ABMD) - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable inte |
2010 | 750,00$ |
Siemens Healthcare Diagnostics, Inc. - Product Pipeline AnalysisSiemens Healthcare Diagnostics, Inc. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and |
2010 | 750,00$ |
Levitronix LLC - Product Pipeline AnalysisLevitronix LLC - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intelligen |
2010 | 750,00$ |
FIT Biotech Oyj Plc. - Product Pipeline AnalysisFIT Biotech Oyj Plc. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable inte |
2010 | 750,00$ |
BIOTRONIK SE & Co. KG - Product Pipeline AnalysisBIOTRONIK SE & Co. KG - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable int |
2010 | 750,00$ |
InspireMD Ltd. - Product Pipeline AnalysisInspireMD Ltd. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intelligen |
2010 | 750,00$ |
FemSuite LLC. - Product Pipeline AnalysisFemSuite LLC. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intelligenc |
2010 | 750,00$ |
Teikoku Seiyaku Co., Ltd. - Product Pipeline AnalysisTeikoku Seiyaku Co., Ltd. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable |
2010 | 750,00$ |
Corium International, Inc. Product Pipeline AnalysisCorium International, Inc. Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable |
2010 | 750,00$ |
Minvasys - Product Pipeline AnalysisMinvasys - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intelligence on |
2010 | 750,00$ |
InterGenetics Incorporated - Product Pipeline AnalysisInterGenetics Incorporated - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionabl |
2010 | 750,00$ |
Innovent Medical Solutions, Ltd. - Product Pipeline AnalysisInnovent Medical Solutions, Ltd. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and act |
2010 | 750,00$ |
Impliant Ltd. - Product Pipeline AnalysisImpliant Ltd. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intelligenc |
2010 | 750,00$ |
VeinAid, LLC - Product Pipeline AnalysisVeinAid, LLC - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intelligence |
2010 | 750,00$ |
ECI Biotech Inc. - Product Pipeline AnalysisECI Biotech Inc. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intellig |
2010 | 750,00$ |
Remon Medical Technologies, Inc. - Product Pipeline AnalysisRemon Medical Technologies, Inc. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and act |
2010 | 750,00$ |
Bioheart, Inc. (BHRT) - Product Pipeline AnalysisBioheart, Inc. (BHRT) - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable int |
2010 | 750,00$ |
Visual Pathways, Inc. - Product Pipeline AnalysisVisual Pathways, Inc. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable int |
2010 | 750,00$ |
Medtronic, Inc. (MDT) - Product Pipeline AnalysisMedtronic, Inc. (MDT) - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable int |
2010 | 750,00$ |
Proteus Biomedical, Inc. - Product Pipeline AnalysisProteus Biomedical, Inc. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable |
2010 | 750,00$ |
Power Medical Interventions, Inc. (PMII) - Product Pipeline AnalysisPower Medical Interventions, Inc. (PMII) - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis |
2010 | 750,00$ |
Osmetech plc (OMH) - Product Pipeline AnalysisOsmetech plc (OMH) - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intell |
2010 | 750,00$ |
Universal Biosensors, Inc. (UBI) - Product Pipeline AnalysisUniversal Biosensors, Inc. (UBI) - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and act |
2010 | 750,00$ |
VertiFlex - Product Pipeline AnalysisVertiFlex - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intelligence on |
2010 | 750,00$ |
Gray Surgical - Product Pipeline AnalysisGray Surgical - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intelligenc |
2010 | 750,00$ |
Advanced Brain Monitoring, Inc. - Product Pipeline AnalysisAdvanced Brain Monitoring, Inc. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and acti |
2010 | 750,00$ |
NuOrtho Surgical, Inc. - Product Pipeline AnalysisNuOrtho Surgical, Inc. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable in |
2010 | 750,00$ |
KeraCure, Inc. - Product Pipeline AnalysisKeraCure, Inc. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intelligen |
2010 | 750,00$ |
GE Healthcare - Product Pipeline AnalysisGE Healthcare - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intelligenc |
2010 | 750,00$ |
Malaysian Bio-Diagnostics Research Sdn Bhd - Product Pipeline AnalysisMalaysian Bio-Diagnostics Research Sdn Bhd - Product Pipeline Analysis / / Summary / / This report is a source for data, analys |
2010 | 750,00$ |
Ayanda Biosystems S.A. - Product Pipeline AnalysisAyanda Biosystems S.A. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable in |
2010 | 750,00$ |
Planmed Oy - Product Pipeline AnalysisPlanmed Oy - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intelligence o |
2010 | 750,00$ |
Sybaritic, Inc. - Product Pipeline AnalysisSybaritic, Inc. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intellige |
2010 | 750,00$ |
Tristan Technologies, Inc. - Product Pipeline AnalysisTristan Technologies, Inc. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionabl |
2010 | 750,00$ |
Simbex - Product Pipeline AnalysisSimbex - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intelligence on th |
2010 | 750,00$ |
NIPRO CORPORATION (8086) - Product Pipeline AnalysisNIPRO CORPORATION (8086) - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable |
2010 | 750,00$ |
Bioring SA - Product Pipeline AnalysisBioring SA - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intelligence o |
2010 | 750,00$ |
Protagen AG - Product Pipeline AnalysisProtagen AG - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intelligence |
2010 | 750,00$ |
STAAR Surgical Company (STAA) - Product Pipeline AnalysisSTAAR Surgical Company (STAA) - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and action |
2010 | 750,00$ |
SenoRx, Inc. (SENO) - Product Pipeline AnalysisSenoRx, Inc. (SENO) - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intel |
2010 | 750,00$ |
Q-Med AB (QMED) - Product Pipeline AnalysisQ-Med AB (QMED) - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intellige |
2010 | 750,00$ |
NMT Medical, Inc. (NMTI) - Product Pipeline AnalysisNMT Medical, Inc. (NMTI) - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable |
2010 | 750,00$ |
Miraculins Inc. (MOM) - Product Pipeline AnalysisMiraculins Inc. (MOM) - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable int |
2010 | 750,00$ |
Anaxsys Technology - Product Pipeline AnalysisAnaxsys Technology - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intell |
2010 | 750,00$ |
Acoustic MedSystems, Inc. - Product Pipeline AnalysisAcoustic MedSystems, Inc. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable |
2010 | 750,00$ |
Nano Interface Technology, Inc. - Product Pipeline AnalysisNano Interface Technology, Inc. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and acti |
2010 | 750,00$ |
EP Limited - Product Pipeline AnalysisEP Limited - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intelligence o |
2010 | 750,00$ |
Axis-Shield plc (ASD) - Product Pipeline AnalysisAxis-Shield plc (ASD) - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable int |
2010 | 750,00$ |
BioSciCon, Inc. - Product Pipeline AnalysisBioSciCon, Inc. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intellig |
2010 | 750,00$ |
Bayer HealthCare AG - Product Pipeline AnalysisBayer HealthCare AG - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intel |
2010 | 750,00$ |
Lifeline Biotechnologies, Inc. - Product Pipeline AnalysisLifeline Biotechnologies, Inc. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actio |
2010 | 750,00$ |
CeMines, Inc. - Product Pipeline AnalysisCeMines, Inc. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intelligenc |
2010 | 750,00$ |
XCounter AB (XCT) - Product Pipeline AnalysisXCounter AB (XCT) - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intelli |
2010 | 750,00$ |
Access Bio, Inc. - Product Pipeline AnalysisAccess Bio, Inc. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intellig |
2010 | 750,00$ |
Inion Oy (IIN) - Product Pipeline AnalysisInion Oy (IIN) - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intelligen |
2010 | 750,00$ |
pSivida Corp. (PSDV) - Product Pipeline AnalysispSivida Corp. (PSDV) - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable inte |
2010 | 750,00$ |
Dako Denmark AS - Product Pipeline AnalysisDako Denmark AS - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intellige |
2010 | 750,00$ |
Bioscan Technologies Inc. - Product Pipeline AnalysisBioscan Technologies Inc. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable |
2010 | 750,00$ |
XTENT, Inc. (XTNT) - Product Pipeline AnalysisXTENT, Inc. (XTNT) - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intell |
2010 | 750,00$ |
Clear Catheter Systems - Product Pipeline AnalysisClear Catheter Systems - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable in |
2010 | 750,00$ |
Core Essence Orthopaedics, LLC - Product Pipeline AnalysisCore Essence Orthopaedics, LLC - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actio |
2010 | 750,00$ |
Biomagnetics Diagnostics Corporation (BMGP) - Product Pipeline AnalysisBiomagnetics Diagnostics Corporation (BMGP) - Product Pipeline Analysis / / Summary / / This report is a source for data, analy |
2010 | 750,00$ |
Ani Biotech Oy - Product Pipeline AnalysisAni Biotech Oy - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intelligen |
2010 | 750,00$ |
Infinite Biomedical Technologies, LLC - Product Pipeline AnalysisInfinite Biomedical Technologies, LLC - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis an |
2010 | 750,00$ |
LightLab Imaging, Inc. - Product Pipeline AnalysisLightLab Imaging, Inc. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable in |
2010 | 750,00$ |
CarpoNovum AB - Product Pipeline AnalysisCarpoNovum AB - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intelligenc |
2010 | 750,00$ |
The Acrobot Company Limited - Product Pipeline AnalysisThe Acrobot Company Limited - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionab |
2010 | 750,00$ |
AsiaGen Corporation - Product Pipeline AnalysisAsiaGen Corporation - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intel |
2010 | 750,00$ |
Biocompatibles International plc (BII) - Product Pipeline AnalysisBiocompatibles International plc (BII) - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis a |
2010 | 750,00$ |
Arthro Kinetics plc (AKI) - Product Pipeline AnalysisArthro Kinetics plc (AKI) - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable |
2010 | 750,00$ |
A-Spine Holding Group Corp. - Product Pipeline AnalysisA-Spine Holding Group Corp. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionab |
2010 | 750,00$ |
Ikonisys, Inc. - Product Pipeline AnalysisIkonisys, Inc. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intelligen |
2010 | 750,00$ |
Hansen Medical, Inc. (HNSN) - Product Pipeline AnalysisHansen Medical, Inc. (HNSN) - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionab |
2010 | 750,00$ |
HandyLab, Inc. - Product Pipeline AnalysisHandyLab, Inc. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intelligen |
2010 | 750,00$ |
DISA Vascular (Pty) Ltd. - Product Pipeline AnalysisDISA Vascular (Pty) Ltd. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable |
2010 | 750,00$ |
Correlogic Systems, Inc. - Product Pipeline AnalysisCorrelogic Systems, Inc. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable |
2010 | 750,00$ |
Ash Access Technology, Inc. - Product Pipeline AnalysisAsh Access Technology, Inc. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionab |
2010 | 750,00$ |
AdnaGen AG - Product Pipeline AnalysisAdnaGen AG - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intelligence o |
2010 | 750,00$ |
Randox Laboratories Ltd. - Product Pipeline AnalysisRandox Laboratories Ltd. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable |
2010 | 750,00$ |
Vascular Concepts Limited - Product Pipeline AnalysisVascular Concepts Limited - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable |
2010 | 750,00$ |
TriReme Medical Inc. - Product Pipeline AnalysisTriReme Medical Inc. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable inte |
2010 | 750,00$ |
Exagen Diagnostics, Inc. - Product Pipeline AnalysisExagen Diagnostics, Inc. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable |
2010 | 750,00$ |
Foundation for Innovative New Diagnostics - Product Pipeline AnalysisFoundation for Innovative New Diagnostics - Product Pipeline Analysis / / Summary / / This report is a source for data, analysi |
2010 | 750,00$ |
Protein Polymer Technologies, Inc. (PPTI) - Product Pipeline AnalysisProtein Polymer Technologies, Inc. (PPTI) - Product Pipeline Analysis / / Summary / / This report is a source for data, analysi |
2010 | 750,00$ |
GRANT Life Sciences, Inc. (GLIF) - Product Pipeline AnalysisGRANT Life Sciences, Inc. (GLIF) - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and act |
2010 | 750,00$ |
Tomophase Corporation - Product Pipeline AnalysisTomophase Corporation - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable int |
2010 | 750,00$ |
CleveX, Inc. - Product Pipeline AnalysisCleveX, Inc. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intelligence |
2010 | 750,00$ |
Intelect Medical Inc. - Product Pipeline AnalysisIntelect Medical Inc. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable int |
2010 | 750,00$ |
Carestream Health, Inc. - Product Pipeline AnalysisCarestream Health, Inc. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable i |
2010 | 750,00$ |
Oryzon Genomics - Product Pipeline AnalysisOryzon Genomics - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intellige |
2010 | 750,00$ |
SONOWAND AS - Product Pipeline AnalysisSONOWAND AS - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intelligence |
2010 | 750,00$ |
IMEXCO General Ltd. - Product Pipeline AnalysisIMEXCO General Ltd. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intel |
2010 | 750,00$ |
BSD Medical Corporation (BSDM) - Product Pipeline AnalysisBSD Medical Corporation (BSDM) - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actio |
2010 | 750,00$ |
Biosensors International Group, Ltd. (B20) - Product Pipeline AnalysisBiosensors International Group, Ltd. (B20) - Product Pipeline Analysis / / Summary / / This report is a source for data, analys |
2010 | 750,00$ |
diaDexus, Inc. - Product Pipeline AnalysisdiaDexus, Inc. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intelligen |
2010 | 750,00$ |
Advanced Diagnostics, Inc. - Product Pipeline AnalysisAdvanced Diagnostics, Inc. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionabl |
2010 | 750,00$ |
Lux Biosciences, Inc. - Product Pipeline AnalysisLux Biosciences, Inc. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable int |
2010 | 750,00$ |
8sens.biognostic GmbH - Product Pipeline Analysis8sens.biognostic GmbH - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable int |
2010 | 750,00$ |
Orion Genomics LLC - Product Pipeline AnalysisOrion Genomics LLC - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intell |
2010 | 750,00$ |
World Heart Corporation (WHRT) - Product Pipeline AnalysisWorld Heart Corporation (WHRT) - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actio |
2010 | 750,00$ |
Zetiq Technologies Ltd. - Product Pipeline AnalysisZetiq Technologies Ltd. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable i |
2010 | 750,00$ |
Cook Medical Incorporated - Product Pipeline AnalysisCook Medical Incorporated - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable |
2010 | 750,00$ |
Perceptronix Medical Inc. - Product Pipeline AnalysisPerceptronix Medical Inc. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable |
2010 | 750,00$ |
BIOCRATES Life Sciences AG - Product Pipeline AnalysisBIOCRATES Life Sciences AG - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionabl |
2010 | 750,00$ |
ev3 Inc. - Product Pipeline Analysisev3 Inc. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intelligence on |
2010 | 750,00$ |
HeartWare International, Inc. (HTWR) - Product Pipeline AnalysisHeartWare International, Inc. (HTWR) - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and |
2010 | 750,00$ |
B. Braun Melsungen AG - Product Pipeline AnalysisB. Braun Melsungen AG - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable int |
2010 | 750,00$ |
PhotoMedex, Inc. (PHMD) - Product Pipeline AnalysisPhotoMedex, Inc. (PHMD) - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable i |
2010 | 750,00$ |
Nektar Therapeutics (NKTR) - Product Pipeline AnalysisNektar Therapeutics (NKTR) - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionabl |
2010 | 750,00$ |
Translumina GmbH - Product Pipeline AnalysisTranslumina GmbH - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable intellig |
2010 | 750,00$ |
Biosite Incorporated - Product Pipeline AnalysisBiosite Incorporated - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable inte |
2010 | 750,00$ |
BioForm Medical, Inc. (BFRM) - Product Pipeline AnalysisBioForm Medical, Inc. (BFRM) - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actiona |
2010 | 750,00$ |
ZOLL Medical Corporation (ZOLL) - Product Pipeline AnalysisZOLL Medical Corporation (ZOLL) - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and acti |
2010 | 750,00$ |
BioSyntech, Inc. (BSY) - Product Pipeline AnalysisBioSyntech, Inc. (BSY) - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable in |
2010 | 750,00$ |
Micro Medical Technologies - Product Pipeline AnalysisMicro Medical Technologies - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionabl |
2010 | 750,00$ |
Biosense Webster, Inc. - Product Pipeline AnalysisBiosense Webster, Inc. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and actionable in |
2010 | 750,00$ |
ProCure Treatment Centers, Inc. - Product Pipeline AnalysisProCure Treatment Centers, Inc. - Product Pipeline Analysis / / Summary / / This report is a source for data, analysis and acti |
2010 | 750,00$ |
Transcatheter Cardiovascular Therapeutics (TCT) Conference 2010: Review and AnalysisIntroduction / / GlobalData’s “Transcatheter Cardiovascular Therapeutics (TCT) 2010: Conference Review and Analysis” report is an |
2010 | 1.000,00$ |
Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - July 2010Introduction / / GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals – July 2010” repo |
2010 | 1.000,00$ |
Endoscopy Devices Market Outlook in Germany to 2016 - Endoscopy Visualization Systems, Flexible and Rigid Endoscopes, Capsule Endoscope Systems and OthersIntroduction / / GlobalData’s medical device report, “Endoscopy Devices Market Outlook in Germany to 2016 - Endoscopy Visualizati |
2010 | 2.500,00$ |
Endoscopy Devices Market Outlook in Israel to 2016 - Endoscopy Visualization Systems, Flexible and Rigid Endoscopes, Capsule Endoscope Systems and OthersIntroduction / / GlobalData’s medical device report, “Endoscopy Devices Market Outlook in Israel to 2016 - Endoscopy Visualizatio |
2010 | 2.500,00$ |
Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals – August 2010Introduction / / GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals – August 2010” re |
2010 | 1.000,00$ |
Arthroscopy Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecast to 2016Introduction / / GlobalData’s new report, “Arthroscopy Devices - Global Pipeline Analysis, Opportunity Assessment and Market Fore |
2010 | 3.500,00$ |
Spinal Implants - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016Introduction / / GlobalData’s new report, “Spinal Surgery Devices - Global Pipeline Analysis, Opportunity Assessment and Market F |
2010 | 3.500,00$ |
Ophthalmic Devices: Current Trends and DevelopmentsIntroduction / / GlobalData’s report, “Ophthalmic Devices: Current Trends and Developments” provides key data, information and an |
2010 | 500,00$ |
Premium Intraocular Lenses (IOLs) Market: Trends and Future OutlookIntroduction / / GlobalData’s report, “Premium Intraocular Lenses (IOLs) Market: Trends and Future Outlook” provides key data, in |
2010 | 500,00$ |
Meningitis Preventive Vaccines - Pipeline Analysis and Market Forecasts to 2017Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Meningitis Preventive Vaccines – Pip |
2010 | 2.000,00$ |
Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - June 2010Introduction / / GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals – June 2010” repo |
2010 | 1.000,00$ |
Peripheral Arterial Disease (PAD) - Pipeline Assessment and Market Forecasts to 2017Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Peripheral Arterial Disease (PAD) - |
2010 | 2.000,00$ |
Growth Hormone Deficiency (GHD) - Pipeline Assessment and Market Forecasts to 2017Introduction / / GlobalData’s report, “Growth Hormone Deficiency - Pipeline Assessment and Market Forecasts to 2017”, is an essen |
2010 | 2.000,00$ |
Hitachi Medical Corporation Market Share AnalysisIntroduction / / GlobalData’s new report, “Hitachi Medical Corporation Market Share Analysis” provides in-depth information on Hi |
2010 | 1.000,00$ |
China Cardiovascular Devices Market Outlook to 2016Introduction / / GlobalData’s medical device report offering, “China Cardiovascular Devices Market Outlook to 2016” provides key |
2010 | 2.500,00$ |
Endoscopy Devices Market Outlook in Argentina to 2016 - Endoscopy Visualization Systems, Flexible and Rigid Endoscopes, Capsule Endoscope Systems and OthersIntroduction / / GlobalData’s medical device report, “Endoscopy Devices Market Outlook in Argentina to 2016 - Endoscopy Visualiza |
2010 | 2.500,00$ |
Endoscopy Devices Market Outlook in Australia to 2016 - Endoscopy Visualization Systems, Flexible and Rigid Endoscopes, Capsule Endoscope Systems and OthersIntroduction / / GlobalData’s medical device report, “Endoscopy Devices Market Outlook in Australia to 2016 - Endoscopy Visualiza |
2010 | 2.500,00$ |
Endoscopy Devices Market Outlook in Belgium to 2016 - Endoscopy Visualization Systems, Flexible and Rigid Endoscopes, Capsule Endoscope Systems and OthersIntroduction / / GlobalData’s medical device report, “Endoscopy Devices Market Outlook in Belgium to 2016 - Endoscopy Visualizati |
2010 | 2.500,00$ |
Endoscopy Devices Market Outlook in Brazil to 2016 - Endoscopy Visualization Systems, Flexible and Rigid Endoscopes, Capsule Endoscope Systems and OthersIntroduction / / GlobalData’s medical device report, “Endoscopy Devices Market Outlook in Brazil to 2016 - Endoscopy Visualizatio |
2010 | 2.500,00$ |
Endoscopy Devices Market Outlook in Canada to 2016 - Endoscopy Visualization Systems, Flexible and Rigid Endoscopes, Capsule Endoscope Systems and OthersIntroduction / / GlobalData’s medical device report, “Endoscopy Devices Market Outlook in Canada to 2016 - Endoscopy Visualizatio |
2010 | 2.500,00$ |
Endoscopy Devices Market Outlook in France to 2016 - Endoscopy Visualization Systems, Flexible and Rigid Endoscopes, Capsule Endoscope Systems and OthersIntroduction / / GlobalData’s medical device report, “Endoscopy Devices Market Outlook in France to 2016 - Endoscopy Visualizatio |
2010 | 2.500,00$ |
Endoscopy Devices Market Outlook in India to 2016 - Endoscopy Visualization Systems, Flexible and Rigid Endoscopes, Capsule Endoscope Systems and OthersIntroduction / / GlobalData’s medical device report, “Endoscopy Devices Market Outlook in India to 2016 - Endoscopy Visualization |
2010 | 2.500,00$ |
Endoscopy Devices Market Outlook in Italy to 2016 - Endoscopy Visualization Systems, Flexible and Rigid Endoscopes, Capsule Endoscope Systems and OthersIntroduction / / GlobalData’s medical device report, “Endoscopy Devices Market Outlook in Italy to 2016 - Endoscopy Visualization |
2010 | 2.500,00$ |
Endoscopy Devices Market Outlook in Mexico to 2016 - Endoscopy Visualization Systems, Flexible and Rigid Endoscopes, Capsule Endoscope Systems and OthersIntroduction / / GlobalData’s medical device report, “Endoscopy Devices Market Outlook in Mexico to 2016 - Endoscopy Visualizatio |
2010 | 2.500,00$ |
Endoscopy Devices Market Outlook in Netherlands to 2016 - Endoscopy Visualization Systems, Flexible and Rigid Endoscopes, Capsule Endoscope Systems and OthersIntroduction / / GlobalData’s medical device report, “Endoscopy Devices Market Outlook in Netherlands to 2016 - Endoscopy Visuali |
2010 | 2.500,00$ |
Endoscopy Devices Market Outlook in South Africa to 2016 - Endoscopy Visualization Systems, Flexible and Rigid Endoscopes, Capsule Endoscope Systems and OthersIntroduction / / GlobalData’s medical device report, “Endoscopy Devices Market Outlook in South Africa to 2016 - Endoscopy Visual |
2010 | 2.500,00$ |
Endoscopy Devices Market Outlook in Spain to 2016 - Endoscopy Visualization Systems, Flexible and Rigid Endoscopes, Capsule Endoscope Systems and OthersIntroduction / / GlobalData’s medical device report, “Endoscopy Devices Market Outlook in Spain to 2016 - Endoscopy Visualization |
2010 | 2.500,00$ |
Endoscopy Devices Market Outlook in Taiwan to 2016 - Endoscopy Visualization Systems, Flexible and Rigid Endoscopes, Capsule Endoscope Systems and OthersIntroduction / / GlobalData’s medical device report, “Endoscopy Devices Market Outlook in Taiwan to 2016 - Endoscopy Visualizatio |
2010 | 2.500,00$ |
Endoscopy Devices Market Outlook in United Kingdom to 2016 - Endoscopy Visualization Systems, Flexible and Rigid Endoscopes, Capsule Endoscope Systems and OthersIntroduction / / GlobalData’s medical device report, “Endoscopy Devices Market Outlook in the UK to 2016 - Endoscopy Visualizatio |
2010 | 2.500,00$ |
Endoscopy Devices Market Outlook in United States to 2016 - Endoscopy Visualization Systems, Flexible and Rigid Endoscopes, Capsule Endoscope Systems and OthersIntroduction / / GlobalData’s medical device report, “Endoscopy Devices Market Outlook in the US to 2016 - Endoscopy Visualizatio |
2010 | 2.500,00$ |
Koninklijke Philips Electronics N.V. (PHIA) - Financial and Strategic Analysis ReviewKoninklijke Philips Electronics N.V. (Philips Electronics) is a diversified company. The company principally engages in manufactur |
2010 | 125,00$ |
Dental Devices Market Outlook in Argentina to 2016 – Dental Chairs and Equipment, Dental Implants, Biomaterials and Crowns and Bridges and OthersIntroduction / / GlobalData’s medical device report, “Dental Devices Market Outlook in Argentina to 2016 - Dental Chairs and Equi |
2010 | 2.500,00$ |
Dental Devices Market Outlook in Belgium to 2016 – Dental Chairs and Equipment, Dental Implants, Biomaterials and Crowns and Bridges and OthersIntroduction / / GlobalData’s medical device report, “Dental Devices Market Outlook in Belgium to 2016 - Dental Chairs and Equipm |
2010 | 2.500,00$ |
Dental Devices Market Outlook in Brazil to 2016 – Dental Chairs and Equipment, Dental Implants, Biomaterials and Crowns and Bridges and OthersIntroduction / / GlobalData’s medical device report, “Dental Devices Market Outlook in Brazil to 2016 - Dental Chairs and Equipme |
2010 | 2.500,00$ |
Dental Devices Market Outlook in China to 2016 – Dental Chairs and Equipment, Dental Implants, Biomaterials and Crowns and Bridges and OthersIntroduction / / GlobalData’s medical device report, “Dental Devices Market Outlook in China to 2016 - Dental Chairs and Equipmen |
2010 | 2.500,00$ |
Dental Devices Market Outlook in France to 2016 – Dental Chairs and Equipment, Dental Implants, Biomaterials and Crowns and Bridges and OthersIntroduction / / GlobalData’s medical device report, “Dental Devices Market Outlook in France to 2016 - Dental Chairs and Equipme |
2010 | 2.500,00$ |
Dental Devices Market Outlook in Germany to 2016 – Dental Chairs and Equipment, Dental Implants, Biomaterials and Crowns and Bridges and OthersIntroduction / / GlobalData’s medical device report, “Dental Devices Market Outlook in Germany to 2016 - Dental Chairs and Equipm |
2010 | 2.500,00$ |
Dental Devices Market Outlook in India to 2016 – Dental Chairs and Equipment, Dental Implants, Biomaterials and Crowns and Bridges and OthersIntroduction / / GlobalData’s medical device report, “Dental Devices Market Outlook in India to 2016 - Dental Chairs and Equipmen |
2010 | 2.500,00$ |
Dental Devices Market Outlook in Israel to 2016 – Dental Chairs and Equipment, Dental Implants, Biomaterials and Crowns and Bridges and OthersIntroduction / / GlobalData’s medical device report, “Dental Devices Market Outlook in Israel to 2016 - Dental Chairs and Equipme |
2010 | 2.500,00$ |
Dental Devices Market Outlook in Japan to 2016 – Dental Chairs and Equipment, Dental Implants, Biomaterials and Crowns and Bridges and OthersIntroduction / / GlobalData’s medical device report, “Dental Devices Market Outlook in Japan to 2016 - Dental Chairs and Equipmen |
2010 | 2.500,00$ |
Dental Devices Market Outlook in Mexico to 2016 – Dental Chairs and Equipment, Dental Implants, Biomaterials and Crowns and Bridges and OthersIntroduction / / GlobalData’s medical device report, “Dental Devices Market Outlook in Mexico to 2016 - Dental Chairs and Equipme |
2010 | 2.500,00$ |
Dental Devices Market Outlook in Netherlands to 2016 – Dental Chairs and Equipment, Dental Implants, Biomaterials and Crowns and Bridges and OthersIntroduction / / GlobalData’s medical device report, “Dental Devices Market Outlook in Netherlands to 2016 - Dental Chairs and Eq |
2010 | 2.500,00$ |
Dental Devices Market Outlook in Republic of Korea to 2016 – Dental Chairs and Equipment, Dental Implants, Biomaterials and Crowns and Bridges and OthersIntroduction / / GlobalData’s medical device report, “Dental Devices Market Outlook in Republic of Korea to 2016 - Dental Chairs |
2010 | 2.500,00$ |
Dental Devices Market Outlook in South Africa to 2016 – Dental Chairs and Equipment, Dental Implants, Biomaterials and Crowns and Bridges and OthersIntroduction / / GlobalData’s medical device report, “Dental Devices Market Outlook in South Africa to 2016 - Dental Chairs and E |
2010 | 2.500,00$ |
Dental Devices Market Outlook in Taiwan to 2016 – Dental Chairs and Equipment, Dental Implants, Biomaterials and Crowns and Bridges and OthersIntroduction / / GlobalData’s medical device report, “Dental Devices Market Outlook in Taiwan to 2016 - Dental Chairs and Equipme |
2010 | 2.500,00$ |
Dental Devices Market Outlook in United Kingdom to 2016 – Dental Chairs and Equipment, Dental Implants, Biomaterials and Crowns and Bridges and OthersIntroduction / / GlobalData’s medical device report, “Dental Devices Market Outlook in the UK to 2016 - Dental Chairs and Equipme |
2010 | 2.500,00$ |
Dental Devices Market Outlook in United States to 2016 – Dental Chairs and Equipment, Dental Implants, Biomaterials and Crowns and Bridges and OthersIntroduction / / GlobalData’s medical device report, “Dental Devices Market Outlook in the US to 2016 - Dental Chairs and Equipme |
2010 | 2.500,00$ |
Endoscopy Devices Market Outlook in Japan to 2016 - Endoscopy Visualization Systems, Flexible and Rigid Endoscopes, Capsule Endoscope Systems and OthersIntroduction / / GlobalData’s medical device report, “Endoscopy Devices Market Outlook in Japan to 2016 - Endoscopy Visualization |
2010 | 2.500,00$ |
ENT Devices Market Outlook in United Kingdom to 2016 - Hearing Aid Devices and Implants and Diagnostic DevicesIntroduction / / GlobalData’s medical device report, “ENT Devices Market Outlook in the UK to 2016 - Hearing Aid Devices and Impl |
2010 | 2.500,00$ |
Hospital Supplies Market Outlook in India to 2016 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and OthersIntroduction / / GlobalData’s medical device report, “Hospital Supplies Market Outlook in India to 2016 - Disposable Hospital Sup |
2010 | 2.500,00$ |
Hospital Supplies Market Outlook in Israel to 2016 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and OthersIntroduction / / GlobalData’s medical device report, “Hospital Supplies Market Outlook in Israel to 2016 - Disposable Hospital Su |
2010 | 2.500,00$ |
Hospital Supplies Market Outlook in South Africa to 2016 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and OthersIntroduction / / GlobalData’s medical device report, “Hospital Supplies Market Outlook in South Africa to 2016 - Disposable Hospi |
2010 | 2.500,00$ |
Hospital Supplies Market Outlook in Taiwan to 2016 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and OthersIntroduction / / GlobalData’s medical device report, “Hospital Supplies Market Outlook in Taiwan to 2016 - Disposable Hospital Su |
2010 | 2.500,00$ |
Neurology Devices Market Outlook in Argentina to 2016 - Neurostimulation Devices, Interventional Neurology and OthersIntroduction / / GlobalData’s medical device report, “Neurology Devices Market Outlook in Argentina to 2016 - Neurostimulation De |
2010 | 2.500,00$ |
Neurology Devices Market Outlook in Australia to 2016 - Neurostimulation Devices, Interventional Neurology and OthersIntroduction / / GlobalData’s medical device report, “Neurology Devices Market Outlook in Australia to 2016 - Neurostimulation De |
2010 | 2.500,00$ |
Neurology Devices Market Outlook in Belgium to 2016 - Neurostimulation Devices, Interventional Neurology and OthersIntroduction / / GlobalData’s medical device report, “Neurology Devices Market Outlook in Belgium to 2016 - Neurostimulation Devi |
2010 | 2.500,00$ |
Neurology Devices Market Outlook in Brazil to 2016 - Neurostimulation Devices, Interventional Neurology and OthersIntroduction / / GlobalData’s medical device report, “Neurology Devices Market Outlook in Brazil to 2016 - Neurostimulation Devic |
2010 | 2.500,00$ |
Neurology Devices Market Outlook in Canada to 2016 - Neurostimulation Devices, Interventional Neurology and OthersIntroduction / / GlobalData’s medical device report, “Neurology Devices Market Outlook in Canada to 2016 - Neurostimulation Devic |
2010 | 2.500,00$ |
Neurology Devices Market Outlook in China to 2016 - Neurostimulation Devices, Interventional Neurology and OthersIntroduction / / GlobalData’s medical device report, “Neurology Devices Market Outlook in China to 2016 - Neurostimulation Device |
2010 | 2.500,00$ |
Neurology Devices Market Outlook in France to 2016 - Neurostimulation Devices, Interventional Neurology and OthersIntroduction / / GlobalData’s medical device report, “Neurology Devices Market Outlook in France to 2016 - Neurostimulation Devic |
2010 | 2.500,00$ |
Neurology Devices Market Outlook in Germany to 2016 - Neurostimulation Devices, Interventional Neurology and OthersIntroduction / / GlobalData’s medical device report, “Neurology Devices Market Outlook in Germany to 2016 - Neurostimulation Devi |
2010 | 2.500,00$ |
Neurology Devices Market Outlook in India to 2016 - Neurostimulation Devices, Interventional Neurology and OthersIntroduction / / GlobalData’s medical device report, “Neurology Devices Market Outlook in India to 2016 - Neurostimulation Device |
2010 | 2.500,00$ |
Neurology Devices Market Outlook in Israel to 2016 - Neurostimulation Devices, Interventional Neurology and OthersIntroduction / / GlobalData’s medical device report, “Neurology Devices Market Outlook in Israel to 2016 - Neurostimulation Devic |
2010 | 2.500,00$ |
Neurology Devices Market Outlook in Italy to 2016 - Neurostimulation Devices, Interventional Neurology and OthersIntroduction / / GlobalData’s medical device report, “Neurology Devices Market Outlook in Italy to 2016 - Neurostimulation Device |
2010 | 2.500,00$ |
Neurology Devices Market Outlook in Japan to 2016 - Neurostimulation Devices, Interventional Neurology and OthersIntroduction / / GlobalData’s medical device report, “Neurology Devices Market Outlook in Japan to 2016 - Neurostimulation Device |
2010 | 2.500,00$ |
Neurology Devices Market Outlook in Mexico to 2016 - Neurostimulation Devices, Interventional Neurology and OthersIntroduction / / GlobalData’s medical device report, “Neurology Devices Market Outlook in Mexico to 2016 - Neurostimulation Devic |
2010 | 2.500,00$ |
Neurology Devices Market Outlook in Netherlands to 2016 - Neurostimulation Devices, Interventional Neurology and OthersIntroduction / / GlobalData’s medical device report, “Neurology Devices Market Outlook in Netherlands to 2016 - Neurostimulation |
2010 | 2.500,00$ |
Neurology Devices Market Outlook in Republic of Korea to 2016 - Neurostimulation Devices, Interventional Neurology and OthersIntroduction / / GlobalData’s medical device report, “Neurology Devices Market Outlook in Republic of Korea to 2016 - Neurostimul |
2010 | 2.500,00$ |
Neurology Devices Market Outlook in South Africa to 2016 - Neurostimulation Devices, Interventional Neurology and OthersIntroduction / / GlobalData’s medical device report, “Neurology Devices Market Outlook in South Africa to 2016 - Neurostimulation |
2010 | 2.500,00$ |
Neurology Devices Market Outlook in Spain to 2016 - Neurostimulation Devices, Interventional Neurology and OthersIntroduction / / GlobalData’s medical device report, “Neurology Devices Market Outlook in Spain to 2016 - Neurostimulation Device |
2010 | 2.500,00$ |
Neurology Devices Market Outlook in Taiwan to 2016 - Neurostimulation Devices, Interventional Neurology and OthersIntroduction / / GlobalData’s medical device report, “Neurology Devices Market Outlook in Taiwan to 2016 - Neurostimulation Devic |
2010 | 2.500,00$ |
Neurology Devices Market Outlook in United Kingdom to 2016 – Neurostimulation Devices, Interventional Neurology and OthersIntroduction / / GlobalData’s medical device report, “Neurology Devices Market Outlook in the UK to 2016 - Neurostimulation Devic |
2010 | 2.500,00$ |
Neurology Devices Market Outlook in United States to 2016 - Neurostimulation Devices, Interventional Neurology and OthersIntroduction / / GlobalData’s medical device report, “Neurology Devices Market Outlook in the US to 2016 - Neurostimulation Devic |
2010 | 2.500,00$ |
Colorectal Cancer - Japan Drug Forecasts and Treatment Analysis to 2020Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Colorectal Cancer - Japan Drug Forec |
2010 | 3.000,00$ |
Colorectal Cancer - Italy Drug Forecasts and Treatment Analysis to 2020Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Colorectal Cancer - Italy Drug Forec |
2010 | 3.000,00$ |
Colorectal Cancer - Germany Drug Forecasts and Treatment Analysis to 2020Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Colorectal Cancer - Germany Drug For |
2010 | 3.000,00$ |
Colorectal Cancer - US Drug Forecasts and Treatment Analysis to 2020Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Colorectal Cancer - US Drug Forecast |
2010 | 3.000,00$ |
Colorectal Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Q4 2010Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Colorectal Cancer - Global Drug Fore |
2010 | 5.000,00$ |
Colorectal Cancer - France Drug Forecasts and Treatment Analysis to 2020Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Colorectal Cancer - France Drug Fore |
2010 | 3.000,00$ |
Colorectal Cancer - Brazil, China, India and Russia (BRIC) Drug Drug Forecasts and Treatment Analysis to 2020Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Colorectal Cancer - Brazil, China, I |
2010 | 3.000,00$ |
Colorectal Cancer - Spain Drug Forecasts and Treatment Analysis to 2020Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Colorectal Cancer - Spain Drug Forec |
2010 | 3.000,00$ |
Colorectal Cancer - UK Drug Forecasts and Treatment Analysis to 2020Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Colorectal Cancer - UK Drug Forecast |
2010 | 3.000,00$ |
Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - May 2010Introduction / / GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals – May 2010” repor |
2010 | 1.000,00$ |
Healthcare IT Global Market Briefing to 2016Introduction / / GlobalData’s new report, “Healthcare IT Global Market Briefing to 2016” provides key data, information and analy |
2010 | 2.000,00$ |
Diabetes Care Devices Global Market Briefing to 2016Introduction / / GlobalData’s new report, “Diabetes Care Devices Global Market Briefing to 2016” provides key data, information a |
2010 | 2.000,00$ |
Respiratory Devices Global Market Briefing to 2016Introduction / / GlobalData’s new report, “Respiratory Devices Global Market Briefing to 2016” provides key data, information and |
2010 | 2.000,00$ |
Interventional Cardiology Devices Global Market Briefing to 2016Introduction / / GlobalData’s new report, “Interventional Cardiology Devices Global Market Briefing to 2016” provides key data, i |
2010 | 2.000,00$ |
Genetic Testing Global Market Briefing to 2016Introduction / / GlobalData’s new report, “Genetic Testing Global Market Briefing to 2016” provides key data, information and ana |
2010 | 2.000,00$ |
In Vitro Diagnostics (Immunochemistry and Infectious Immunology) Global Market Briefing to 2016Introduction / / GlobalData’s new report, “In Vitro Diagnostics (Immuno Chemistry, Infectious Immunology) Global Market Briefing |
2010 | 2.000,00$ |
Spinal Surgery Devices Global Market Briefing to 2016Introduction / / GlobalData’s new report, “Spinal Surgery Devices Global Market Briefing to 2016” provides key data, information |
2010 | 2.000,00$ |
Trauma Fixation - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016Introduction / / GlobalData’s new report, “Trauma Fixation - Global Pipeline Analysis, Opportunity Assessment and Market Forecast |
2010 | 3.500,00$ |
Extremities (Shoulder and Small Joint Implants) – Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016Introduction / / GlobalData’s new report, “Extremities (Shoulder and Small Joint Implants) - Global Pipeline Analysis, Opportunit |
2010 | 3.500,00$ |
Colorectal Cancer - Pipeline Assessment and Market Forecasts to 2020Introduction
/
/ GlobalData, the industry analysis specialist, has released its new report, “Colorectal Cancer - Pipeline Asses |
2010 | 3.500,00$ |
Stomach Cancer - Pipeline Assessment and Market Forecasts to 2017Introduction / / GlobalData’s report, “Stomach Cancer - Pipeline Assessment and Market Forecasts to 2017”, is an essential source |
2010 | 2.000,00$ |
Osteoporosis - Pipeline Assessment and Market Forecasts to 2017Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Osteoporosis - Pipeline Assessment a |
2010 | 2.000,00$ |
Medtronic Acquires Glucose Monitoring Assets from PreciSense: A Move to Develop New Platform for Closed Loop System – Deal Analysis from GlobalDataIntroduction / / GlobalData’s report, “Medtronic Acquires Glucose Monitoring Assets from PreciSense: A Move to Develop New Platfo |
2010 | 500,00$ |
Medical Equipment Monthly Deals Analysis: M&A and Investments Trends - September 2010Introduction / / GlobalData's “Medical Equipment Monthly Deals Analysis: M&A and Investments Trends – September 2010” report is a |
2010 | 1.000,00$ |
Computer Assisted Radiology and Surgery (CARS) 2010: Conference Review and AnalysisIntroduction / / GlobalData’s “Computer Assisted Radiology and Surgery (CARS) 2010 – Conference Review and Analysis” report is an |
2010 | 1.000,00$ |
Atopic Dermatitis - Pipeline Assessment and Market Forecasts to 2017Annualized global Atopic Dermatitis therapeutics market revenue data from 2001 to 2009, forecast for eight years to 2017.
/ Geog |
2010 | 2.000,00$ |
Wound Care Management Market Outlook in Republic of Korea to 2016 - Advanced Wound Management, Negative Pressure Wound Therapy (NPWT), Wound Closure Devices, Pressure Relief Devices and OthersIntroduction / / GlobalData’s medical device report, “Wound Care Management Market Outlook in Republic of Korea to 2016 - Advance |
2010 | 2.500,00$ |
Ophthalmic Devices Market Outlook in Canada to 2016 - Vision Care, Cataract and Refractive Surgery Devices and OthersIntroduction / / GlobalData's medical device report, “Ophthalmic Devices Market Outlook in Canada to 2016 - Vision Care, Cataract |
2010 | 2.500,00$ |
Healthcare IT Market Outlook in United States to 2016 - Hospital Information Systems and Medical Imaging Information SystemsIntroduction / / GlobalData’s medical equipment report, “Healthcare IT Market Outlook in the US to 2016 - Hospital Information Sy |
2010 | 2.500,00$ |
Healthcare IT Market Outlook in United Kingdom to 2016 - Hospital Information Systems and Medical Imaging Information SystemsIntroduction / / GlobalData’s medical equipment report, “Healthcare IT Market Outlook in the UK to 2016 - Hospital Information Sy |
2010 | 2.500,00$ |
Healthcare IT Market Outlook in Japan to 2016 - Hospital Information Systems and Medical Imaging Information SystemsIntroduction / / GlobalData’s medical equipment report, “Healthcare IT Market Outlook in Japan to 2016 - Hospital Information Sys |
2010 | 2.500,00$ |
Healthcare IT Market Outlook in China to 2016 - Hospital Information Systems and Medical Imaging Information SystemsIntroduction / / GlobalData’s medical equipment report, “Healthcare IT Market Outlook in China to 2016 - Hospital Information Sys |
2010 | 2.500,00$ |
Healthcare IT Market Outlook in Germany to 2016 - Hospital Information Systems and Medical Imaging Information SystemsIntroduction / / GlobalData’s medical equipment report, “Healthcare IT Market Outlook in Germany to 2016 - Hospital Information S |
2010 | 2.500,00$ |
Healthcare IT Market Outlook in Australia to 2016 - Hospital Information Systems and Medical Imaging Information SystemsIntroduction / / GlobalData’s medical equipment report, “Healthcare IT Market Outlook in Australia to 2016 - Hospital Information |
2010 | 2.500,00$ |
Healthcare IT Market Outlook in Sweden to 2016 - Hospital Information Systems and Medical Imaging Information SystemsIntroduction / / GlobalData’s medical equipment report, “Healthcare IT Market Outlook in Sweden to 2016 - Hospital Information Sy |
2010 | 2.500,00$ |
Ophthalmic Devices Market Outlook in Israel to 2016 - Vision Care, Cataract and Refractive Surgery Devices and OthersIntroduction / / GlobalData’s medical device report, “Ophthalmic Devices Market Outlook in Israel to 2016 - Vision Care, Cataract |
2010 | 2.500,00$ |
Healthcare IT Market Outlook in Israel to 2016 - Hospital Information Systems and Medical Imaging Information SystemsIntroduction / / GlobalData’s medical equipment report, “Healthcare IT Market Outlook in Israel to 2016 - Hospital Information Sy |
2010 | 2.500,00$ |
Nephrology and Urology Devices Market Outlook in United States to 2016 - Incontinence Devices, Renal Dialysis Equipment and OthersIntroduction / / GlobalData’s medical device report, “Nephrology and Urology Devices Market Outlook in the US to 2016 - Incontine |
2010 | 2.500,00$ |
Nephrology and Urology Devices Market Outlook in United Kingdom to 2016 - Incontinence Devices, Renal Dialysis Equipment and OthersIntroduction / / GlobalData’s medical device report, “Nephrology and Urology Devices Market Outlook in the UK to 2016 - Incontine |
2010 | 2.500,00$ |
Nephrology and Urology Devices Market Outlook in Japan to 2016 - Incontinence Devices, Renal Dialysis Equipment and OthersIntroduction / / GlobalData’s medical device report, “Nephrology and Urology Devices Market Outlook in Japan to 2016 - Incontinen |
2010 | 2.500,00$ |
Nephrology and Urology Devices Market Outlook in India to 2016 - Incontinence Devices, Renal Dialysis Equipment and OthersIntroduction / / GlobalData’s medical device report, “Nephrology and Urology Devices Market Outlook in India to 2016 - Incontinen |
2010 | 2.500,00$ |
Nephrology and Urology Devices Market Outlook in China to 2016 - Incontinence Devices, Renal Dialysis Equipment and OthersIntroduction / / GlobalData’s medical device report, “Nephrology and Urology Devices Market Outlook in China to 2016 - Incontinen |
2010 | 2.500,00$ |
Nephrology and Urology Devices Market Outlook in Canada to 2016 - Incontinence Devices, Renal Dialysis Equipment and OthersIntroduction / / GlobalData’s medical device report, “Nephrology and Urology Devices Market Outlook in Canada to 2016 - Incontine |
2010 | 2.500,00$ |
Nephrology and Urology Devices Market Outlook in France to 2016 - Incontinence Devices, Renal Dialysis Equipment and OthersIntroduction / / GlobalData’s medical device report, “Nephrology and Urology Devices Market Outlook in France to 2016 - Incontine |
2010 | 2.500,00$ |
Nephrology and Urology Devices Market Outlook in Italy to 2016 - Incontinence Devices, Renal Dialysis Equipment and OthersIntroduction / / GlobalData’s medical device report, “Nephrology and Urology Devices Market Outlook in Italy to 2016 - Incontinen |
2010 | 2.500,00$ |
Nephrology and Urology Devices Market Outlook in Spain to 2016 - Incontinence Devices, Renal Dialysis Equipment and OthersIntroduction / / GlobalData’s medical device report, “Nephrology and Urology Devices Market Outlook in Spain to 2016 - Incontinen |
2010 | 2.500,00$ |
Nephrology and Urology Devices Market Outlook in Republic of Korea to 2016 - Incontinence Devices, Renal Dialysis Equipment and OthersIntroduction / / GlobalData’s medical device report, “Nephrology and Urology Devices Market Outlook in Republic of Korea to 2016 |
2010 | 2.500,00$ |
Nephrology and Urology Devices Market Outlook in Taiwan to 2016 - Incontinence Devices, Renal Dialysis Equipmentand OthersIntroduction / / GlobalData’s medical device report, “Nephrology and Urology Devices Market Outlook in Taiwan to 2016 - Incontine |
2010 | 2.500,00$ |
Nephrology and Urology Devices Market Outlook in South Africa to 2016 - Incontinence Devices, Renal Dialysis Equipment and OthersIntroduction / / GlobalData’s medical device report, “Nephrology and Urology Devices Market Outlook in South Africa to 2016 - Inc |
2010 | 2.500,00$ |
Drug Delivery Devices Market Outlook in the United States to 2016 - Inhalation Systems, Infusion Systems and OthersIntroduction / / GlobalData’s medical device report, “Drug Delivery Devices Market Outlook in the US to 2016 - Inhalation Systems |
2010 | 2.500,00$ |
Drug Delivery Devices Market Outlook in the United Kingdom to 2016 - Inhalation Systems, Infusion Systems and OthersIntroduction / / GlobalData’s medical device report, “Drug Delivery Devices Market Outlook in the UK to 2016 - Inhalation Systems |
2010 | 2.500,00$ |
Drug Delivery Devices Market Outlook in Japan to 2016 - Inhalation Systems, Infusion Systems and OthersIntroduction / / GlobalData’s medical device report, “Drug Delivery Devices Market Outlook in Japan to 2016 - Inhalation Systems, |
2010 | 2.500,00$ |
Drug Delivery Devices Market Outlook in India to 2016 - Inhalation Systems, Infusion Systems and OthersIntroduction / / GlobalData’s medical device report, “Drug Delivery Devices Market Outlook in India to 2016 - Inhalation Systems, |
2010 | 2.500,00$ |
Drug Delivery Devices Market Outlook in China to 2016 - Inhalation Systems, Infusion Systems and OthersIntroduction / / GlobalData’s medical device report, “Drug Delivery Devices Market Outlook in China to 2016 - Inhalation Systems, |
2010 | 2.500,00$ |
Drug Delivery Devices Market Outlook in Canada to 2016 - Inhalation Systems, Infusion Systems and OthersIntroduction / / GlobalData’s medical device report, “Drug Delivery Devices Market Outlook in Canada to 2016 - Inhalation Systems |
2010 | 2.500,00$ |
Drug Delivery Devices Market Outlook in Germany to 2016 - Inhalation Systems, Infusion Systems and OthersIntroduction / / GlobalData’s medical device report, “Drug Delivery Devices Market Outlook in Germany to 2016 - Inhalation System |
2010 | 2.500,00$ |
Drug Delivery Devices Market Outlook in France to 2016 - Inhalation Systems, Infusion Systems and OthersIntroduction / / GlobalData’s medical device report, “Drug Delivery Devices Market Outlook in France to 2016 - Inhalation Systems |
2010 | 2.500,00$ |
Drug Delivery Devices Market Outlook in Italy to 2016 - Inhalation Systems, Infusion Systems and OthersIntroduction / / GlobalData’s medical device report, “Drug Delivery Devices Market Outlook in Italy to 2016 - Inhalation Systems, |
2010 | 2.500,00$ |
Drug Delivery Devices Market Outlook in Spain to 2016 - Inhalation Systems, Infusion Systems and OthersIntroduction / / GlobalData’s medical device report, “Drug Delivery Devices Market Outlook in Spain to 2016 - Inhalation Systems, |
2010 | 2.500,00$ |
Drug Delivery Devices Market Outlook in Australia to 2016 - Inhalation Systems, Infusion Systems and OthersIntroduction / / GlobalData’s medical device report, “Drug Delivery Devices Market Outlook in Australia to 2016 - Inhalation Syst |
2010 | 2.500,00$ |
Drug Delivery Devices Market Outlook in Brazil to 2016 - Inhalation Systems, Infusion Systems and OthersIntroduction / / GlobalData’s medical device report, “Drug Delivery Devices Market Outlook in Brazil to 2016 - Inhalation Systems |
2010 | 2.500,00$ |
Drug Delivery Devices Market Outlook in Netherlands to 2016 - Inhalation Systems, Infusion Systems and OthersIntroduction / / GlobalData’s medical device report, “Drug Delivery Devices Market Outlook in Netherlands to 2016 - Inhalation Sy |
2010 | 2.500,00$ |
Drug Delivery Devices Market Outlook in Belgium to 2016 - Inhalation Systems, Infusion Systems and OthersIntroduction / / GlobalData’s medical device report, “Drug Delivery Devices Market Outlook in Belgium to 2016 - Inhalation System |
2010 | 2.500,00$ |
Drug Delivery Devices Market Outlook in Argentina to 2016 - Inhalation Systems, Infusion Systems and OthersIntroduction / / GlobalData’s medical device report, “Drug Delivery Devices Market Outlook in Argentina to 2016 - Inhalation Syst |
2010 | 2.500,00$ |
Drug Delivery Devices Market Outlook in Mexico to 2016 - Inhalation Systems, Infusion Systems and OthersIntroduction / / GlobalData’s medical device report, “Drug Delivery Devices Market Outlook in Mexico to 2016 - Inhalation Systems |
2010 | 2.500,00$ |
Drug Delivery Devices Market Outlook in Republic of Korea to 2016 - Inhalation Systems, Infusion Systems and OthersIntroduction / / GlobalData’s medical device report, “Drug Delivery Devices Market Outlook in Republic of Korea to 2016 - Inhalat |
2010 | 2.500,00$ |
Drug Delivery Devices Market Outlook in Taiwan to 2016 - Inhalation systems, Infusion Systems and OthersIntroduction / / GlobalData’s medical device report, “Drug Delivery Devices Market Outlook in Taiwan to 2016 - Inhalation Systems |
2010 | 2.500,00$ |
Drug Delivery Devices Market Outlook in South Africa to 2016 - Inhalation Systems, Infusion Systems and OthersIntroduction / / GlobalData’s medical device report, “Drug Delivery Devices Market Outlook in South Africa to 2016 - Inhalation S |
2010 | 2.500,00$ |
Drug Delivery Devices Market Outlook in Israel to 2016 - Inhalation Systems, Infusion Systems and OthersIntroduction / / GlobalData’s medical device report, “Drug Delivery Devices Market Outlook in Israel to 2016 - Inhalation Systems |
2010 | 2.500,00$ |
Hospital Supplies Market Outlook in China to 2016 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and OthersIntroduction / / GlobalData’s medical device report, “Hospital Supplies Market Outlook in China to 2016 - Disposable Hospital Sup |
2010 | 2.500,00$ |
Hospital Supplies Market Outlook in Canada to 2016 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and OthersIntroduction / / GlobalData’s medical device report, “Hospital Supplies Market Outlook in Canada to 2016 - Disposable Hospital Su |
2010 | 2.500,00$ |
Hospital Supplies Market Outlook in France to 2016 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and OthersIntroduction / / GlobalData’s medical device report, “Hospital Supplies Market Outlook in France to 2016 - Disposable Hospital Su |
2010 | 2.500,00$ |
Hospital Supplies Market Outlook in Italy to 2016 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and OthersIntroduction / / GlobalData’s medical device report, “Hospital Supplies Market Outlook in Italy to 2016 - Disposable Hospital Sup |
2010 | 2.500,00$ |
Hospital Supplies Market Outlook in Spain to 2016 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and OthersIntroduction / / GlobalData’s medical device report, “Hospital Supplies Market Outlook in Spain to 2016 - Disposable Hospital Sup |
2010 | 2.500,00$ |
Hospital Supplies Market Outlook in Australia to 2016 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and OthersIntroduction / / GlobalData’s medical device report, “Hospital Supplies Market Outlook in Australia to 2016 - Disposable Hospital |
2010 | 2.500,00$ |
Hospital Supplies Market Outlook in Netherlands to 2016 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and OthersIntroduction / / GlobalData’s medical device report, “Hospital Supplies Market Outlook in Netherlands to 2016 - Disposable Hospit |
2010 | 2.500,00$ |
Hospital Supplies Market Outlook in Argentina to 2016 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and OthersIntroduction / / GlobalData’s medical device report, “Hospital Supplies Market Outlook in Argentina to 2016 - Disposable Hospital |
2010 | 2.500,00$ |
Ophthalmic Devices Market Outlook in China to 2016 - Vision Care, Cataract and Refractive Surgery Devices and OthersIntroduction / / GlobalData’s medical device report, “Ophthalmic Devices Market Outlook in China to 2016 - Vision Care, Cataract |
2010 | 2.500,00$ |
Ophthalmic Devices Market Outlook in Australia to 2016 - Vision Care, Cataract and Refractive Surgery Devices and OthersIntroduction / / GlobalData’s medical device report, “Ophthalmic Devices Market Outlook in Australia to 2016 - Vision Care, Catar |
2010 | 2.500,00$ |
Ophthalmic Devices Market Outlook in Argentina to 2016 - Vision Care, Cataract and Refractive Surgery Devices and OthersIntroduction / / GlobalData’s medical device report, “Ophthalmic Devices Market Outlook in Argentina to 2016 - Vision Care, Catar |
2010 | 2.500,00$ |
Ophthalmic Devices Market Outlook in Mexico to 2016 - Vision Care, Cataract and Refractive Surgery Devices and OthersIntroduction / / GlobalData’s medical device report, “Ophthalmic Devices Market Outlook in Mexico to 2016 - Vision Care, Cataract |
2010 | 2.500,00$ |
Ophthalmic Devices Market Outlook in Taiwan to 2016 - Vision Care, Cataract and Refractive Surgery Devices and OthersIntroduction / / GlobalData’s medical device report, “Ophthalmic Devices Market Outlook in Taiwan to 2016 - Vision Care, Cataract |
2010 | 2.500,00$ |
Ophthalmic Devices Market Outlook in South Africa to 2016 - Vision Care, Cataract and Refractive Surgery Devices and OthersIntroduction / / GlobalData’s medical device report, “Ophthalmic Devices Market Outlook in South Africa to 2016 - Vision Care, Ca |
2010 | 2.500,00$ |
Healthcare IT Market Outlook in India to 2016 - Hospital Information Systems and Medical Imaging Information SystemsIntroduction / / GlobalData’s medical equipment report, “Healthcare IT Market Outlook in India to 2016 - Hospital Information Sys |
2010 | 2.500,00$ |
Healthcare IT Market Outlook in Canada to 2016 - Hospital Information Systems and Medical Imaging Information SystemsIntroduction / / GlobalData’s medical equipment report, “Healthcare IT Market Outlook in Canada to 2016 - Hospital Information Sy |
2010 | 2.500,00$ |
Healthcare IT Market Outlook in France to 2016 - Hospital Information Systems and Medical Imaging Information SystemsIntroduction / / GlobalData’s medical equipment report, “Healthcare IT Market Outlook in France to 2016 - Hospital Information Sy |
2010 | 2.500,00$ |
Healthcare IT Market Outlook in Italy to 2016 - Hospital Information Systems and Medical Imaging Information SystemsIntroduction / / GlobalData’s medical equipment report, “Healthcare IT Market Outlook in Italy to 2016 - Hospital Information Sys |
2010 | 2.500,00$ |
Healthcare IT Market Outlook in Spain to 2016 - Hospital Information Systems and Medical Imaging Information SystemsIntroduction / / GlobalData’s medical equipment report, “Healthcare IT Market Outlook in Spain to 2016 - Hospital Information Sys |
2010 | 2.500,00$ |
Healthcare IT Market Outlook in Brazil to 2016 - Hospital Information Systems and Medical Imaging Information SystemsIntroduction / / GlobalData’s medical equipment report, “Healthcare IT Market Outlook in Brazil to 2016 - Hospital Information S |
2010 | 2.500,00$ |
Healthcare IT Market Outlook in New Zealand to 2016 - Hospital Information Systems and Medical Imaging Information SystemsIntroduction / / GlobalData’s medical equipment report, “Healthcare IT Market Outlook in New Zealand to 2016 - Hospital Informati |
2010 | 2.500,00$ |
Endoscopy Devices Market Outlook in China to 2016 - Endoscopy Visualization Systems, Flexible and Rigid Endoscopes, Capsule Endoscope Systems and OthersIntroduction / / GlobalData’s medical device report, “Endoscopy Devices Market Outlook in China to 2016 - Endoscopy Visualization |
2010 | 2.500,00$ |
Endoscopy Devices Market Outlook in Republic of Korea to 2016 - Endoscopy Visualization Systems, Flexible and Rigid Endoscopes, Capsule Endoscope Systems and OthersIntroduction / / GlobalData’s medical device report, “Endoscopy Devices Market Outlook in Republic of Korea to 2016 - Endoscopy V |
2010 | 2.500,00$ |
Nephrology and Urology Devices Market Outlook in Germany to 2016 - Incontinence Devices, Renal Dialysis Equipment and OthersIntroduction / / GlobalData’s medical device report, “Nephrology and Urology Devices Market Outlook in Germany to 2016 - Incontin |
2010 | 2.500,00$ |
Nephrology and Urology Devices Market Outlook in Australia to 2016 - Incontinence Devices, Renal Dialysis Equipment and OthersIntroduction / / GlobalData’s medical device report, “Nephrology and Urology Devices Market Outlook in Australia to 2016 - Incont |
2010 | 2.500,00$ |
Nephrology and Urology Devices Market Outlook in Brazil to 2016 - Incontinence Devices, Renal Dialysis Equipment and OthersIntroduction / / GlobalData’s medical device report, “Nephrology and Urology Devices Market Outlook in Brazil to 2016 - Incontine |
2010 | 2.500,00$ |
Nephrology and Urology Devices Market Outlook in Netherlands to 2016 - Incontinence Devices, Renal Dialysis Equipment and OthersIntroduction / / GlobalData’s medical device report, “Nephrology and Urology Devices Market Outlook in Netherlands to 2016 - Inco |
2010 | 2.500,00$ |
Nephrology and Urology Devices Market Outlook in Belgium to 2016 - Incontinence Devices, Renal Dialysis Equipment and OthersIntroduction / / GlobalData’s medical device report, “Nephrology and Urology Devices Market Outlook in Belgium to 2016 - Incontin |
2010 | 2.500,00$ |
Nephrology and Urology Devices Market Outlook in Argentina to 2016 - Incontinence Devices, Renal Dialysis Equipment and OthersIntroduction / / GlobalData’s medical device report, “Nephrology and Urology Devices Market Outlook in Argentina to 2016 - Incont |
2010 | 2.500,00$ |
Nephrology and Urology Devices Market Outlook in Mexico to 2016 - Incontinence Devices, Renal Dialysis Equipment and OthersIntroduction / / GlobalData’s medical device report, “Nephrology and Urology Devices Market Outlook in Mexico to 2016 - Incontine |
2010 | 2.500,00$ |
Nephrology and Urology Devices Market Outlook in Israel to 2016 - Incontinence Devices, Renal Dialysis Equipment and OthersIntroduction / / GlobalData’s medical device report, “Nephrology and Urology Devices Market Outlook in Israel to 2016 - Incontine |
2010 | 2.500,00$ |
Dental Devices Market Outlook in Canada to 2016 – Dental Chairs and Equipment, Dental Implants, Biomaterials and Crowns and Bridges and OthersIntroduction / / GlobalData’s medical device report, “Dental Devices Market Outlook in Canada to 2016 - Dental Chairs and Equipme |
2010 | 2.500,00$ |
Dental Devices Market Outlook in Italy to 2016 – Dental Chairs and Equipment, Dental Implants, Biomaterials and Crowns and Bridges and OthersIntroduction / / GlobalData’s medical device report, “Dental Devices Market Outlook in Italy to 2016 - Dental Chairs and Equipmen |
2010 | 2.500,00$ |
Dental Devices Market Outlook in Spain to 2016 - Dental Chairs and Equipment, Dental Implants, Biomaterials and Crowns and Bridges and OthersIntroduction / / GlobalData’s medical devices report, “Dental Devices Market Outlook in Spain to 2016 - Dental Chairs and Equipme |
2010 | 2.500,00$ |
Dental Devices Market Outlook in Australia to 2016 – Dental Chairs and Equipment, Dental Implants, Biomaterials and Crowns and Bridges and OthersIntroduction / / GlobalData’s medical device report, “Dental Devices Market Outlook in Australia to 2016 - Dental Chairs and Equi |
2010 | 2.500,00$ |
ENT Devices Market Outlook in United States to 2016 - Hearing Aid Devices and Implants and Diagnostic DevicesIntroduction / / GlobalData’s medical device report, “ENT Devices Market Outlook in the US to 2016 - Hearing Aid Devices and Impl |
2010 | 2.500,00$ |
ENT Devices Market Outlook in Japan to 2016 - Hearing Aid Devices and Implants and Diagnostic DevicesIntroduction / / GlobalData’s medical device report, “ENT Devices Market Outlook in Japan to 2016 - Hearing Aid Devices and Impla |
2010 | 2.500,00$ |
ENT Devices Market Outlook in India to 2016 - Hearing Aid Devices and Implants and Diagnostic DevicesIntroduction / / GlobalData’s medical device report, “ENT Devices Market Outlook in India to 2016 - Hearing Aid Devices and Impla |
2010 | 2.500,00$ |
ENT Devices Market Outlook in China to 2016 - Hearing Aid Devices and Implants and Diagnostic DevicesIntroduction / / GlobalData’s medical device report, “ENT Devices Market Outlook in China to 2016 - Hearing Aid Devices and Impla |
2010 | 2.500,00$ |
ENT Devices Market Outlook in Canada to 2016 - Hearing Aid Devices and Implants and Diagnostic DevicesIntroduction / / GlobalData’s medical device report, “ENT Devices Market Outlook in Canada to 2016 - Hearing Aid Devices and Impl |
2010 | 2.500,00$ |
ENT Devices Market Outlook in Germany to 2016 - Hearing Aid Devices and Implants and Diagnostic DevicesIntroduction / / GlobalData’s medical device report, “ENT Devices Market Outlook in Germany to 2016 - Hearing Aid Devices and Imp |
2010 | 2.500,00$ |
ENT Devices Market Outlook in France to 2016 - Hearing Aid Devices and Implants and Diagnostic DevicesIntroduction / / GlobalData’s medical device report, “ENT Devices Market Outlook in France to 2016 - Hearing Aid Devices and Impl |
2010 | 2.500,00$ |
ENT Devices Market Outlook in Italy to 2016 - Hearing Aid Devices and Implants and Diagnostic DevicesIntroduction / / GlobalData’s medical device report, “ENT Devices Market Outlook in Italy to 2016 - Hearing Aid Devices and Impla |
2010 | 2.500,00$ |
ENT Devices Market Outlook in Spain to 2016 - Hearing Aid Devices and Implants and Diagnostic DevicesIntroduction / / GlobalData’s medical device report, “ENT Devices Market Outlook in Spain to 2016 - Hearing Aid Devices and Impla |
2010 | 2.500,00$ |
ENT Devices Market Outlook in Australia to 2016 - Hearing Aid Devices and Implants and Diagnostic DevicesIntroduction / / GlobalData’s medical device report, “ENT Devices Market Outlook in Australia to 2016 - Hearing Aid Devices and I |
2010 | 2.500,00$ |
ENT Devices Market Outlook in Brazil to 2016 - Hearing Aid Devices and Implants and Diagnostic DevicesIntroduction / / GlobalData’s medical device report, “ENT Devices Market Outlook in Brazil to 2016 - Hearing Aid Devices and Impl |
2010 | 2.500,00$ |
ENT Devices Market Outlook in Netherlands to 2016 - Hearing Aid Devices and Implants and Diagnostic DevicesIntroduction / / GlobalData’s medical device report, “ENT Devices Market Outlook in Brazil to 2016 - Hearing Aid Devices and Impl |
2010 | 2.500,00$ |
ENT Devices Market Outlook in Belgium to 2016 - Hearing Aid Devices and Implants and Diagnostic DevicesIntroduction / / GlobalData’s medical device report, “ENT Devices Market Outlook in Belgium to 2016 - Hearing Aid Devices and Imp |
2010 | 2.500,00$ |
ENT Devices Market Outlook in Argentina to 2016 - Hearing Aid Devices and Implants and Diagnostic DevicesIntroduction / / GlobalData’s medical device report, “ENT Devices Market Outlook in Argentina to 2016 - Hearing Aid Devices and I |
2010 | 2.500,00$ |
ENT Devices Market Outlook in Mexico to 2016 - Hearing Aid Devices and Implants and Diagnostic DevicesIntroduction / / GlobalData’s medical device report, “ENT Devices Market Outlook in Mexico to 2016 - Hearing Aid Devices and Impl |
2010 | 2.500,00$ |
ENT Devices Market Outlook in Republic of Korea to 2016 - Hearing Aid Devices and Implants and Diagnostic DevicesIntroduction / / GlobalData’s medical device report, “ENT Devices Market Outlook in Republic of Korea to 2016 - Hearing Aid Devic |
2010 | 2.500,00$ |
ENT Devices Market Outlook in Taiwan to 2016 - Hearing Aid Devices and Implants and Diagnostic DevicesIntroduction / / GlobalData’s medical device report, “ENT Devices Market Outlook in Taiwan to 2016 - Hearing Aid Devices and Impl |
2010 | 2.500,00$ |
ENT Devices Market Outlook in South Africa to 2016 - Hearing Aid Devices and Implants and Diagnostic DevicesIntroduction / / GlobalData’s medical device report, “ENT Devices Market Outlook in South Africa to 2016 - Hearing Aid Devices an |
2010 | 2.500,00$ |
ENT Devices Market Outlook in Israel to 2016 - Hearing Aid Devices and Implants and Diagnostic DevicesIntroduction / / GlobalData’s medical device report, “ENT Devices Market Outlook in Israel to 2016 - Hearing Aid Devices and Impl |
2010 | 2.500,00$ |
Hospital Supplies Market Outlook in United States to 2016 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and OthersIntroduction / / GlobalData’s medical device report, “Hospital Supplies Market Outlook in the US to 2016 - Disposable Hospital Su |
2010 | 2.500,00$ |
Hospital Supplies Market Outlook in United Kingdom to 2016 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and OthersIntroduction / / GlobalData’s medical device report, “Hospital Supplies Market Outlook in the UK to 2016 - Disposable Hospital Su |
2010 | 2.500,00$ |
Hospital Supplies Market Outlook in Japan to 2016 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and OthersIntroduction / / GlobalData’s medical device report, “Hospital Supplies Market Outlook in Japan to 2016 - Disposable Hospital Sup |
2010 | 2.500,00$ |
Hospital Supplies Market Outlook in Germany to 2016 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and OthersIntroduction / / GlobalData’s medical device report, “Hospital Supplies Market Outlook in Germany to 2016 - Disposable Hospital S |
2010 | 2.500,00$ |
Hospital Supplies Market Outlook in Brazil to 2016 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and OthersIntroduction / / GlobalData’s medical device report, “Hospital Supplies Market Outlook in Brazil to 2016 - Disposable Hospital Su |
2010 | 2.500,00$ |
Hospital Supplies Market Outlook in Belgium to 2016 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and OthersIntroduction / / GlobalData’s medical device report, “Hospital Supplies Market Outlook in Belgium to 2016 - Disposable Hospital S |
2010 | 2.500,00$ |
Hospital Supplies Market Outlook in Mexico to 2016 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and OthersIntroduction / / GlobalData’s medical device report, “Hospital Supplies Market Outlook in Mexico to 2016 - Disposable Hospital Su |
2010 | 2.500,00$ |
Hospital Supplies Market Outlook in Republic of Korea to 2016 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and OthersIntroduction / / GlobalData’s medical device report, “Hospital Supplies Market Outlook in Republic of Korea to 2016 - Disposable |
2010 | 2.500,00$ |
Global Renal Dialysis Equipment Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016Introduction / / GlobalData’s medical device report offering, “Global Renal Dialysis Equipment Pipeline Analysis, Opportunity Ass |
2010 | 3.500,00$ |
Global Coronary Stents Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016Introduction / / GlobalData’s medical equipment report, “Global Coronary Stents Equipment Pipeline Analysis, Opportunity Assessme |
2010 | 3.500,00$ |
Respiratory Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016Introduction / / GlobalData’s medical equipment report, “Respiratory Devices – Global Pipeline Analysis, Opportunity Assessment a |
2010 | 3.500,00$ |
Insulin Pumps - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016Introduction / / GlobalData’s medical equipment report, “Insulin Pumps – Global Pipeline Analysis, Opportunity Assessment and Mar |
2010 | 3.500,00$ |
Interventional Cardiology Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016Introduction / / GlobalData’s new report, “Interventional Cardiology Devices - Global Pipeline Analysis, Opportunity Assessment a |
2010 | 3.500,00$ |
Periodontal Disease - Pipeline Assessment and Market Forecasts to 2017Introduction / / GlobalData, the industry analysis specialist’s new report, “Periodontal Disease - Pipeline Assessment and Market |
2010 | 2.000,00$ |
Cardiovascular Devices – Emerging Countries (China, India, Brazil) Opportunity Assessment, Competitive Landscape and Market Forecasts to 2016Introduction / / GlobalData’s medical equipment report, “Cardiovascular Devices - Emerging Countries (China, India, Brazil) Oppor |
2010 | 3.500,00$ |
Electrophysiology Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016Introduction / / GlobalData’s new report, “Electrophysiology Devices - Global Pipeline Analysis, Opportunity Assessment and Marke |
2010 | 3.500,00$ |
Cardiovascular Surgery Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016Introduction / / GlobalData’s new report, “Cardiovascular Surgery Devices - Global Pipeline Analysis, Opportunity Assessment and |
2010 | 3.500,00$ |
Peripheral Vascular Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016Introduction / / GlobalData’s medical equipment report, “Peripheral Vascular Devices - Global Pipeline Analysis, Opportunity Asse |
2010 | 3.500,00$ |
Prosthetic Heart Valves - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016Introduction / / GlobalData’s new report, “Prosthetic Heart Valves - Global Pipeline Analysis, Opportunity Assessment and Market |
2010 | 3.500,00$ |
Netherlands Surgical Equipment Market Outlook to 2016Introduction / / GlobalData’s medical device report, “Surgical Equipment Market Outlook in Netherlands to 2016 - Surgical Sutures |
2010 | 2.500,00$ |
Mexico Surgical Equipment Market Outlook to 2016Introduction / / GlobalData’s medical device report, “Surgical Equipment Market Outlook in Mexico to 2016 - Surgical Sutures, Han |
2010 | 2.500,00$ |
Acteon, Inc. Market Share AnalysisIntroduction / / GlobalData’s new report, “Acteon, Inc. Market Share Analysis” provides in-depth information on Acteon’s market p |
2010 | 1.000,00$ |
Advanced Bionics Corporation Market Share AnalysisIntroduction / / GlobalData’s new report, “Advanced Bionics Corporation Market Share Analysis” provides in-depth information on A |
2010 | 1.000,00$ |
ALCARE Co., Ltd. Market Share AnalysisIntroduction / / GlobalData’s new report, “ALCARE Co., Ltd. Market Share Analysis” provides in-depth information on ALCARE’s mark |
2010 | 1.000,00$ |
AlloSource Market Share AnalysisIntroduction / / GlobalData’s new report, “AlloSource Market Share Analysis” provides in-depth information on Allosource’s market |
2010 | 1.000,00$ |
Central Venous Catheters: Market Growth to be Driven by Increasing Demand for Catheters with Antimicrobial CoatingsIntroduction / / GlobalData’s report, “Central Venous Catheters Market Growth to be Driven by Increasing Demand for Catheters wit |
2010 | 500,00$ |
Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q2 2010Introduction / / GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q2 2010” report |
2010 | 1.500,00$ |
Polycystic Ovarian Syndrome - Pipeline Assessment and Market Forecasts to 2017Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Polycystic Ovarian Syndrome - Pipeli |
2010 | 2.000,00$ |
Hepatitis B - Pipeline Assessment and Market Forecasts to 2017Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Hepatitis B - Pipeline Assessment an |
2010 | 2.000,00$ |
Autistic Disorder - Pipeline Assessment and Market Forecasts to 2017Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Autistic Disorder – Pipeline Assessm |
2010 | 2.000,00$ |
India Orthopedic Devices Market Outlook to 2016Market size and company share data for seven orthopedic devices market categories – Orthobiologics, Joint Reconstruction, Spinal S |
2010 | 2.500,00$ |
Type 2 Diabetes - Pipeline Assessment and Market Forecasts to 2017Annualized global type 2 diabetes therapeutics market revenue data from 2001 to 2009, forecast for eight years to 2017.
/ Geogra |
2010 | 2.000,00$ |
Women’s Infertility - Pipeline Assessment and Market Forecasts to 2017Annualized global women’s infertility therapeutics market revenue data from 2001 to 2009, forecast for eight years to 2017.
/ Ge |
2010 | 2.000,00$ |
Urinary Incontinence - Pipeline Assessment and Market Forecasts to 2017Annualized global UI therapeutics market revenues data from 2001 to 2009, forecast for eight years to 2017.
/ Geographies covered |
2010 | 2.000,00$ |
Hologic Acquires Sentinelle Medical: A Move to Increase Presence in Breast Cancer MarketIntroduction / / GlobalData’s report, “Hologic to Acquire Sentinelle Medical: A Move to Increase Presence in Breast Cancer Market |
2010 | 500,00$ |
Peripheral Vascular Devices Market in JapanIntroduction / / GlobalData’s report, “Peripheral Vascular Devices Market in Japan” provides key data, information and analysis o |
2010 | 500,00$ |
Dental Lasers: A Market SnapshotIntroduction / / GlobalData’s report, “Dental Lasers: A Market Snapshot” provides key data, information and analysis on the globa |
2010 | 500,00$ |
Neurostimulation Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016Introduction / / GlobalData’s new report, “Neurostimulation Devices – Global Pipeline Analysis, Opportunity Assessment and Market |
2010 | 3.500,00$ |
Hansen Medical Enters into an Agreement with Siemens Healthcare: A Move to Increase Market PenetrationIntroduction / / GlobalData’s report, “Hansen Medical Enters into an Agreement with Siemens Healthcare: A Move to Increase Market |
2010 | 500,00$ |
Boston Scientific Invests in Cameron Health: A Move to Gain from New TechnologyIntroduction / / GlobalData’s report, “Boston Scientific Invests in Cameron Health: A Move to Gain from New Technology”” provides |
2010 | 500,00$ |
Medtronic Enters into Licensing Agreement with AGA Medical Holdings: A Move to Benefit from Huge Market Opportunity in Structural Heart Defects and Vascular AbnormalitiesIntroduction / / GlobalData’s report, “Medtronic Enters into Licensing Agreement with AGA Medical Holdings: A Move to Benefit fro |
2010 | 500,00$ |
Brazil Orthopedic Devices Market Outlook to 2016Introduction / / GlobalData’s medical devices report, “Brazil Orthopedic Devices Market Outlook to 2016” provides key market data |
2010 | 2.500,00$ |
Medical Equipment Monthly Deals Analysis: M&A and Investments Trends - August 2010Introduction / / GlobalData's “Medical Equipment Monthly Deals Analysis: M&A and Investments Trends – August 2010” report is an e |
2010 | 1.000,00$ |
Germany Opthalmic Devices Market Outlook to 2016Introduction / / GlobalData's medical devices report, “Germany Opthalmic Devices Market Outlook to 2016” provides key market data |
2010 | 2.500,00$ |
France Opthalmic Devices Market Outlook to 2016Introduction / / GlobalData's medical devices report, “France Opthalmic Devices Market Outlook to 2016” provides key market data |
2010 | 2.500,00$ |
Italy Opthalmic Devices Market Outlook to 2016Introduction / / GlobalData’s medical devices report, “Italy Opthalmic Devices Market Outlook to 2016” provides key market data o |
2010 | 2.500,00$ |
Spain Opthalmic Devices Market Outlook to 2016Introduction / / GlobalData’s medical devices report, “Spain Opthalmic Devices Market Outlook to 2016” provides key market data o |
2010 | 2.500,00$ |
Netherlands Opthalmic Devices Market Outlook to 2016Introduction / / GlobalData’s medical devices report, “Netherlands Opthalmic Devices Market Outlook to 2016” provides key market |
2010 | 2.500,00$ |
United Kingdom Surgical Equipment Market Outlook to 2016Introduction / / GlobalData’s medical devices report, “United Kingdom Surgical Equipment Market Outlook to 2016” provides key mar |
2010 | 2.500,00$ |
Japan Surgical Equipment Market Outlook to 2016Introduction / / GlobalData’s medical devices report, “Japan Surgical Equipment Market Outlook to 2016” provides key market data |
2010 | 2.500,00$ |
India Surgical Equipment Market Outlook to 2016Introduction / / GlobalData’s medical devices report, “India Surgical Equipment Market Outlook to 2016” provides key market data |
2010 | 2.500,00$ |
Spain Surgical Equipment Market Outlook to 2016Introduction / / GlobalData’s medical devices report, “Spain Surgical Equipment Market Outlook to 2016” provides key market data |
2010 | 2.500,00$ |
Belgium Surgical Equipment Market Outlook to 2016Introduction / / GlobalData’s medical devices report, “Belgium Surgical Equipment Market Outlook to 2016” provides key market dat |
2010 | 2.500,00$ |
Argentina Surgical Equipment Market Outlook to 2016Introduction / / GlobalData’s medical devices report, “Argentina Surgical Equipment Market Outlook to 2016” provides key market d |
2010 | 2.500,00$ |
Taiwan Surgical Equipment Market Outlook to 2016Introduction / / GlobalData’s medical devices report, “Taiwan Surgical Equipment Market Outlook to 2016” provides key market data |
2010 | 2.500,00$ |
South Africa Surgical Equipment Market Outlook to 2016Introduction / / GlobalData’s medical devices report, “South Africa Surgical Equipment Market Outlook to 2016” provides key marke |
2010 | 2.500,00$ |
Israel Surgical Equipment Market Outlook to 2016Introduction / / GlobalData’s medical devices report, “Israel Surgical Equipment Market Outlook to 2016” provides key market data |
2010 | 2.500,00$ |
Wound Care Management: Innovations and TrendsIntroduction / / GlobalData’s report, “Wound Care Management: Innovations and Trends” provides key data, information and analysis |
2010 | 500,00$ |
Erectile Dysfunction - Pipeline Assessment and Market Forecasts to 2017Introduction / / GlobalData’s pharmaceutical and healthcare report, “Erectile Dysfunction - Pipeline Assessment and Market Foreca |
2010 | 2.000,00$ |
Cystic Fibrosis – Pipeline Assessment and Market Forecasts to 2017Annualized global cystic fibrosis market revenues data from 2001 to 2009, forecast forward for eight years to 2017.
/ Pipeline a |
2010 | 2.000,00$ |
Dental Devices Market Outlook in Australia to 2016 - Dental Chairs and Equipment, Dental Implants, Biomaterials, and Crowns and Bridges and OthersIntroduction / / GlobalData’s medical device report, “Dental Devices Market Outlook in Australia to 2016 - Dental Chairs and Equi |
2010 | 2.500,00$ |
Dental Devices Market Outlook in Canada to 2016 - Dental Chairs and Equipment, Dental Implants, Biomaterials, and Crowns and Bridges and OthersIntroduction / / GlobalData’s medical device report, “Dental Devices Market Outlook in Canada to 2016 - Dental Chairs and Equipme |
2010 | 2.500,00$ |
Dental Devices Market Outlook in Italy to 2016 - Dental Chairs and Equipment, Dental Implants, Biomaterials, and Crowns and Bridges and OthersIntroduction / / GlobalData’s medical device report, “Dental Devices Market Outlook in Italy to 2016 - Dental Chairs and Equipmen |
2010 | 2.500,00$ |
Dental Devices Market Outlook in Spain to 2016 - Dental Chairs and Equipment, Dental Implants, Biomaterials, and Crowns and Bridges and OthersIntroduction / / GlobalData’s medical devices report, “Dental Devices Market Outlook in Spain to 2016 - Dental Chairs and Equipme |
2010 | 2.500,00$ |
Drug Delivery Devices Market Outlook in the UK to 2016 - Inhalation Systems, Infusion Systems and OthersIntroduction / / GlobalData’s medical device report, “Drug Delivery Devices Market Outlook in the UK to 2016 - Inhalation Systems |
2010 | 2.500,00$ |
Drug Delivery Devices Market Outlook in the US to 2016 - Inhalation Systems, Infusion Systems and OthersIntroduction / / GlobalData’s medical device report, “Drug Delivery Devices Market Outlook in the US to 2016 - Inhalation Systems |
2010 | 2.500,00$ |
ENT Devices Market Outlook in Franceto 2016 - Hearing Aid Devices and Implants and Diagnostic DevicesIntroduction / / GlobalData’s medical device report, “ENT Devices Market Outlook in Franceto 2016 - Hearing Aid Devices and Impla |
2010 | 2.500,00$ |
ENT Devices Market Outlook in Netherlands to 2016 - Hearing Aid Devices and Implants and Diagnostic DevicesIntroduction / / GlobalData’s medical device report, “ENT Devices Market Outlook in Netherlands to 2016 - Hearing Aid Devices and |
2010 | 2.500,00$ |
ENT Devices Market Outlook in the US to 2016 - Hearing Aid Devices and Implants and Diagnostic DevicesIntroduction / / GlobalData’s medical device report, “ENT Devices Market Outlook in the US to 2016 - Hearing Aid Devices and Impl |
2010 | 2.500,00$ |
Hospital Supplies Market Outlook in the UK to 2016 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and OthersIntroduction / / GlobalData’s medical device report, “Hospital Supplies Market Outlook in the UK to 2016 - Disposable Hospital Su |
2010 | 2.500,00$ |
Hospital Supplies Market Outlook in the US to 2016 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and OthersIntroduction / / GlobalData’s medical device report, “Hospital Supplies Market Outlook in the US to 2016 - Disposable Hospital Su |
2010 | 2.500,00$ |
Nephrology and Urology Devices Market Outlook in Taiwan to 2016 - Incontinence Devices, Renal Dialysis Equipment and OthersIntroduction / / GlobalData’s medical device report, “Nephrology and Urology Devices Market Outlook in Taiwan to 2016 - Incontine |
2010 | 2.500,00$ |
Nephrology and Urology Devices Market Outlook in the UK to 2016 - Incontinence Devices, Renal Dialysis Equipment and OthersIntroduction / / GlobalData’s medical device report, “Nephrology and Urology Devices Market Outlook in the UK to 2016 - Incontine |
2010 | 2.500,00$ |
Nephrology and Urology Devices Market Outlook in the US to 2016 - Incontinence Devices, Renal Dialysis Equipment and OthersIntroduction / / GlobalData’s medical device report, “Nephrology and Urology Devices Market Outlook in the US to 2016 - Incontine |
2010 | 2.500,00$ |
Healthcare IT Market Outlook in the UK to 2016 - Hospital Information Systems and Medical Imaging Information SystemsIntroduction / / GlobalData’s medical equipment report, “Healthcare IT Market Outlook in the UK to 2016 - Hospital Information Sy |
2010 | 2.500,00$ |
Healthcare IT Market Outlook in the US to 2016 - Hospital Information Systems and Medical Imaging Information SystemsIntroduction / / GlobalData’s medical equipment report, “Healthcare IT Market Outlook in the US to 2016 - Hospital Information Sy |
2010 | 2.500,00$ |
Ambu A/S Market Share AnalysisIntroduction
/
/ GlobalData’s new report, “Ambu A/S Market Share Analysis” provides in-depth information on Ambu’s market posit |
2010 | 1.000,00$ |
Boston Scientific Corporation Market Share AnalysisIntroduction
/
/ GlobalData’s new report, “Boston Scientific Corporation Market Share Analysis” provides in-depth information o |
2010 | 1.000,00$ |
Baxter International Inc. Market Share AnalysisIntroduction
/
/ GlobalData’s new report, “Baxter International Inc. Market Share Analysis” provides in-depth information on Ba |
2010 | 1.000,00$ |
Rossmax International Ltd. Market Share AnalysisIntroduction / / GlobalData’s new report, “Rossmax International Ltd. Market Share Analysis” provides in-depth information on Ros |
2010 | 1.000,00$ |
BPL Healthcare Business Group Market Share AnalysisIntroduction
/
/ GlobalData’s new report, “BPL Healthcare Business Group Market Share Analysis” provides in-depth information o |
2010 | 1.000,00$ |
TOSHIBA Medical Systems Corporation Market Share AnalysisIntroduction / / GlobalData’s new report, “TOSHIBA Medical Systems Corporation Market Share Analysis” provides in-depth informati |
2010 | 1.000,00$ |
SonoSite, Inc. Market Share AnalysisIntroduction / / GlobalData’s new report, “SonoSite, Inc. Market Share Analysis” provides in-depth information on SonoSite’s mark |
2010 | 1.000,00$ |
Nihon Kohden Corporation Market Share AnalysisIntroduction / / GlobalData’s new report, “Nihon Kohden Corporation Market Share Analysis” provides in-depth information on Nihon |
2010 | 1.000,00$ |
Fukuda Denshi Co., Ltd. Market Share AnalysisIntroduction / / GlobalData’s new report, “Fukuda Denshi Co., Ltd. Market Share Analysis” provides in-depth information on Fukuda |
2010 | 1.000,00$ |
Beijing Wandong Medical Equipment Co., Ltd. Market Share AnalysisIntroduction
/
/ GlobalData’s new report, “Beijing Wandong Medical Equipment Co., Ltd. Market Share Analysis” provides in-depth |
2010 | 1.000,00$ |
Philips Respironics, Inc. Market Share AnalysisIntroduction / / GlobalData’s new report, “Philips Respironics, Inc. Market Share Analysis” provides in-depth information on Phil |
2010 | 1.000,00$ |
Canada Orthopedic Devices Market Outlook to 2016Introduction
/
/ GlobalData’s medical equipment report, “Canada Orthopedic Devices Market Outlook to 2016” provides key market |
2010 | 2.500,00$ |
Hip and Knee Implants - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016Introduction / / GlobalData’s Orthopedic Devices report, “Hip and Knee Implants - Global Pipeline Analysis, Opportunity Assessmen |
2010 | 3.500,00$ |
Germany Orthopedic Devices Market Outlook to 2016Introduction / / GlobalData’s medical equipment report, “Germany Orthopedic Devices Market Outlook to 2016” provides key market d |
2010 | 2.500,00$ |
France Orthopedic Devices Market Outlook to 2016Introduction / / GlobalData’s medical equipment report, “France Orthopedic Devices Market Outlook to 2016” provides key market da |
2010 | 2.500,00$ |
Italy Orthopedic Devices Market Outlook to 2016Introduction / / GlobalData’s medical equipment report, “Italy Orthopedic Devices Market Outlook to 2016” provides key market dat |
2010 | 2.500,00$ |
Spain Orthopedic Devices Market Outlook to 2016Introduction / / GlobalData’s medical equipment report, “Spain Orthopedic Devices Market Outlook to 2016” provides key market dat |
2010 | 2.500,00$ |
Australia Orthopedic Devices Market Outlook to 2016Introduction
/
/ GlobalData’s medical equipment report, “Australia Orthopedic Devices Market Outlook to 2016” provides key mark |
2010 | 2.500,00$ |
Netherlands Orthopedic Devices Market Outlook to 2016Introduction / / GlobalData’s medical equipment report, “Netherlands Orthopedic Devices Market Outlook to 2016” provides key mark |
2010 | 2.500,00$ |
Belgium Orthopedic Devices Market Outlook to 2016Introduction
/
/ GlobalData’s medical equipment report, “Belgium Orthopedic Devices Market Outlook to 2016” provides key market |
2010 | 2.500,00$ |
Argentina Orthopedic Devices Market Outlook to 2016Introduction
/
/ GlobalData’s medical equipment report, “Argentina Orthopedic Devices Market Outlook to 2016” provides key mark |
2010 | 2.500,00$ |
Mexico Orthopedic Devices Market Outlook to 2016Introduction / / GlobalData’s medical equipment report, “Mexico Orthopedic Devices Market Outlook to 2016” provides key market da |
2010 | 2.500,00$ |
Republic of Korea Orthopedic Devices Market Outlook to 2016Introduction / / GlobalData’s medical equipment report, “Republic of Korea Orthopedic Devices Market Outlook to 2016” provides ke |
2010 | 2.500,00$ |
Taiwan Orthopedic Devices Market Outlook to 2016Introduction / / GlobalData’s medical equipment report, “Taiwan Orthopedic Devices Market Outlook to 2016” provides key market da |
2010 | 2.500,00$ |
South Africa Orthopedic Devices Market Outlook to 2016Introduction / / GlobalData’s medical equipment report, “South Africa Orthopedic Devices Market Outlook to 2016” provides key mar |
2010 | 2.500,00$ |
Israel Orthopedic Devices Market Outlook to 2016Introduction / / GlobalData’s medical equipment report, “Israel Orthopedic Devices Market Outlook to 2016” provides key market da |
2010 | 2.500,00$ |
United Kingdom Orthopedic Devices Market Outlook to 2016Introduction / / GlobalData’s medical equipment report, “The UK Orthopedic Devices Market Outlook to 2016” provides key market da |
2010 | 2.500,00$ |
Japan Orthopedic Devices Market Outlook to 2016Introduction / / GlobalData’s medical equipment report, “Japan Orthopedic Devices Market Outlook to 2016” provides key market dat |
2010 | 2.500,00$ |
China Orthopedic Devices Market Outlook to 2016Introduction / / GlobalData’s medical equipment report, “China Orthopedic Devices Market Outlook to 2016” provides key market dat |
2010 | 2.500,00$ |
United States Orthopedic Devices Market Outlook to 2016Introduction / / GlobalData’s medical equipment report, “US Orthopedic Devices Market Outlook to 2016” provides key market data o |
2010 | 2.500,00$ |
Argentina Wound Care Management Market Outlook to 2016Introduction
/
/ GlobalData’s new report, “Argentina Wound Care Management Market Outlook to 2016” provides key market data on |
2010 | 2.500,00$ |
Medical Equipment Monthly Deals Analysis: M&A and Investments Trends - July 2010Introduction / / GlobalData's “Medical Equipment Monthly Deals Analysis: M&A and Investments Trends – July 2010” report is an ess |
2010 | 1.000,00$ |
Medical Equipment Quarterly Deals Analysis: M&A and Investments Trends - Q2 2010Introduction / / GlobalData's “Medical Equipment Quarterly Deals Analysis: M&A and Investments Trends - Q2 2010” report is an ess |
2010 | 1.500,00$ |
United States In Vitro Diagnostics Market Outlook to 2016Introduction / / GlobalData’s new report, “US In Vitro Diagnostics Market Outlook to 2016” provides key market data on the US In |
2010 | 2.500,00$ |
United Kingdom In Vitro Diagnostics Market Outlook to 2016Introduction / / GlobalData’s new report, “UK In Vitro Diagnostics Market Outlook to 2016” provides key market data on the UK In |
2010 | 2.500,00$ |
Canada In Vitro Diagnostics Market Outlook to 2016Introduction
/
/ GlobalData’s new report, “Canada In Vitro Diagnostics Market Outlook to 2016” provides key market data on the |
2010 | 2.500,00$ |
Italy In Vitro Diagnostics Market Outlook to 2016Introduction / / GlobalData’s new report, “Italy In Vitro Diagnostics Market Outlook to 2016” provides key market data on the Ita |
2010 | 2.500,00$ |
Spain In Vitro Diagnostics Market Outlook to 2016Introduction / / GlobalData’s new report, "Spain In Vitro Diagnostics Market Outlook to 2016” provides key market data on the Spa |
2010 | 2.500,00$ |
Brazil In Vitro Diagnostics Market Outlook to 2016Introduction
/
/ GlobalData’s new report, “Brazil In Vitro Diagnostics Market Outlook to 2016” provides key market data on the |
2010 | 2.500,00$ |
Netherlands In Vitro Diagnostics Market Outlook to 2016Introduction / / GlobalData’s new report, “Netherlands In Vitro Diagnostics Market Outlook to 2016” provides key market data on t |
2010 | 2.500,00$ |
Belgium In Vitro Diagnostics Market Outlook to 2016Introduction
/
/ GlobalData’s new report, “Belgium In Vitro Diagnostics Market Outlook to 2016” provides key market data on the |
2010 | 2.500,00$ |
Republic of Korea In Vitro Diagnostics Market Outlook to 2016Introduction / / GlobalData’s new report, “Republic of Korea In Vitro Diagnostics Market Outlook to 2016” provides key market dat |
2010 | 2.500,00$ |
Israel Anesthesia and Respiratory Devices Market Outlook to 2016Introduction / / GlobalData’s medical equipment report, “Israel Anesthesia and Respiratory Devices Market Outlook to 2016” provid |
2010 | 2.500,00$ |
Israel Wound Care Management Market Outlook to 2016Introduction / / GlobalData’s new report, “Israel Wound Care Management Market Outlook to 2016” provides key market data on the I |
2010 | 2.500,00$ |
Israel In Vitro Diagnostics Market Outlook to 2016Introduction / / GlobalData’s new report, “Israel In Vitro Diagnostics Market Outlook to 2016” provides key market data on the Is |
2010 | 2.500,00$ |
China Surgical Equipment Market Outlook to 2016Introduction / / GlobalData’s new report, “China Surgical Equipment Market Outlook to 2016” provides key market data on the China |
2010 | 2.500,00$ |
Canada Surgical Equipment Market Outlook to 2016Introduction / / GlobalData’s new report, “Canada Surgical Equipment Market Outlook to 2016” provides key market data on the Cana |
2010 | 2.500,00$ |
Germany Surgical Equipment Market Outlook to 2016Introduction / / GlobalData’s new report, “Germany Surgical Equipment Market Outlook to 2016” provides key market data on the Ger |
2010 | 2.500,00$ |
France Surgical Equipment Market Outlook to 2016Introduction / / GlobalData’s new report, “France Surgical Equipment Market Outlook to 2016” provides key market data on the Fran |
2010 | 2.500,00$ |
Italy Surgical Equipment Market Outlook to 2016Introduction / / GlobalData’s new report, “Italy Surgical Equipment Market Outlook to 2016” provides key market data on the Italy |
2010 | 2.500,00$ |
Australia Surgical Equipment Market Outlook to 2016Introduction
/
/ GlobalData’s new report, “Australia Surgical Equipment Market Outlook to 2016” provides key market data on the |
2010 | 2.500,00$ |
Brazil Surgical Equipment Market Outlook to 2016Introduction
/
/ GlobalData’s new report, “Brazil Surgical Equipment Market Outlook to 2016” provides key market data on the Br |
2010 | 2.500,00$ |
Hormone Replacement Therapy in Menopause - Pipeline Assessment and Market Forecasts to 2017Introduction / / GlobalData's has released its pharmaceutical and healthcare report, “Hormone Replacement Therapy in Menopause - |
2010 | 2.000,00$ |
3M Health Care Market Share AnalysisIntroduction / / GlobalData’s medical devices report, “3M Healthcare Market Share Analysis” provides in-depth information on 3M H |
2010 | 1.000,00$ |
Draegerwerk AG & Co. KGaA Market Share AnalysisIntroduction / / GlobalData’s medical devices report, “Draegerwerk AG & Co. KGaA Market Share Analysis” provides in-depth informa |
2010 | 1.000,00$ |
Coloplast A/S Market Share AnalysisIntroduction / / GlobalData’s medical devices report, “Coloplast A/S Market Share Analysis” provides in-depth information on Colo |
2010 | 1.000,00$ |
Cordis Corporation Market Share AnalysisIntroduction / / GlobalData’s medical devices report, “Cordis Corporation Market Share Analysis” provides in-depth information on |
2010 | 1.000,00$ |
Larsen & Toubro Medical Equipment & Systems Market Share AnalysisIntroduction / / GlobalData’s medical devices report, “Larsen & Toubro Medical Equipment & Systems (L&T Medical) Market Share Ana |
2010 | 1.000,00$ |
Spain Patient Monitoring Market Outlook to 2016Introduction / / GlobalData’s new report, “Spain Patient Monitoring Market Outlook to 2016” provides key market data on the Spain |
2010 | 2.500,00$ |
Abbott Laboratories Market Share AnalysisIntroduction / / GlobalData’s medical devices report, “Abbott Laboratories Market Share Analysis” provides in-depth information o |
2010 | 1.000,00$ |
Molnlycke Health Care AB Market Share AnalysisIntroduction / / GlobalData’s medical devices report, “Molnlycke Health Care AB Market Share Analysis” provides in-depth informat |
2010 | 1.000,00$ |
BSN medical GmbH Market Share AnalysisIntroduction / / GlobalData’s medical devices report, “BSN medical GmbH Market Share Analysis” provides in-depth information on B |
2010 | 1.000,00$ |
Sectra AB Market Share AnalysisIntroduction / / GlobalData’s medical devices report, “Spectra AB. Market Share Analysis” provides in-depth information on Spectr |
2010 | 1.000,00$ |
Animas Corporation Market Share AnalysisIntroduction / / GlobalData’s medical devices report, “Animas Corporation Market Share Analysis” provides in-depth information on |
2010 | 1.000,00$ |
OSI Systems, Inc. Market Share AnalysisIntroduction / / GlobalData’s medical devices report, “OSI Systems, Inc. Market Share Analysis” provides in-depth information on |
2010 | 1.000,00$ |
Medison Co., Ltd. Market Share AnalysisIntroduction / / GlobalData’s medical devices report, “Medison Co., Ltd. Market Share Analysis” provides in-depth information on |
2010 | 1.000,00$ |
CooperVision, Inc. Market Share AnalysisIntroduction / / GlobalData’s medical devices report, “CooperVision, Inc. Market Share Analysis” provides in-depth information on |
2010 | 1.000,00$ |
Anthogyr S.A. Market Share AnalysisIntroduction / / GlobalData’s medical devices report, “Anthogyr S.A. Market Share Analysis” provides in-depth information on Anth |
2010 | 1.000,00$ |
Covidien plc Market Share AnalysisIntroduction / / GlobalData’s medical devices report, “Covidien plc Market Share Analysis” provides in-depth information on Covid |
2010 | 1.000,00$ |
Mindray Medical International Limited Market Share AnalysisIntroduction / / GlobalData’s medical devices report, “Mindray Medical International Market Share Analysis” provides in-depth inf |
2010 | 1.000,00$ |
Dameca a/s Market Share AnalysisIntroduction / / GlobalData’s medical devices report, “Dameca a/s Market Share Analysis” provides in-depth information on Dameca’ |
2010 | 1.000,00$ |
United States Wound Care Management Market Outlook to 2016Introduction / / GlobalData’s new report, “US Wound Care Management Market Outlook to 2016” provides key market data on the US wo |
2010 | 2.500,00$ |
United Kingdom Wound Care Management Market Outlook to 2016Introduction / / GlobalData’s new report, “UK Wound Care Management Market Outlook to 2016” provides key market data on the UK wo |
2010 | 2.500,00$ |
Japan Wound Care Management Market Outlook to 2016Introduction / / GlobalData’s new report, “Japan Wound Care Management Market Outlook to 2016” provides key market data on the Ja |
2010 | 2.500,00$ |
India Wound Care Management Market Outlook to 2016Introduction / / GlobalData’s new report, “India Wound Care Management Market Outlook to 2016” provides key market data on the In |
2010 | 2.500,00$ |
France Wound Care Management Market Outlook to 2016Introduction / / GlobalData’s new report, “France Wound Care Management Market Outlook to 2016” provides key market data on the F |
2010 | 2.500,00$ |
Australia Wound Care Management Market Outlook to 2016Introduction / / GlobalData’s new report, “Australia Wound Care Management Market Outlook to 2016” provides key market data on th |
2010 | 2.500,00$ |
South Africa Wound Care Management Market Outlook to 2016Introduction / / GlobalData’s new report, “South Africa Wound Care Management Market Outlook to 2016” provides key market data on |
2010 | 2.500,00$ |
Japan In Vitro Diagnostics Market Outlook to 2016Introduction / / GlobalData’s new report, “Japan In Vitro Diagnostics Market Outlook to 2016” provides key market data on the Jap |
2010 | 3.500,00$ |
India In Vitro Diagnostics Market Outlook to 2016Introduction / / GlobalData’s new report, “India In Vitro Diagnostics Market Outlook to 2016” provides key market data on the Ind |
2010 | 3.500,00$ |
China In Vitro Diagnostics Market Outlook to 2016Introduction / / GlobalData’s new report, “China In Vitro Diagnostics Market Outlook to 2016” provides key market data on the Chi |
2010 | 3.500,00$ |
Germany In Vitro Diagnostics Market Outlook to 2016Introduction / / GlobalData’s new report, “Germany In Vitro Diagnostics Market Outlook to 2016” provides key market data on the G |
2010 | 3.500,00$ |
France In Vitro Diagnostics Market Outlook to 2016Introduction / / GlobalData’s new report, “France In Vitro Diagnostics Market Outlook to 2016” provides key market data on the Fr |
2010 | 3.500,00$ |
Australia In Vitro Diagnostics Market Outlook to 2016Introduction / / GlobalData’s new report, “Australia In Vitro Diagnostics Market Outlook to 2016” provides key market data on the |
2010 | 3.500,00$ |
Argentina In Vitro Diagnostics Market Outlook to 2016Introduction / / GlobalData’s new report, “Argentina In Vitro Diagnostics Market Outlook to 2016” provides key market data on the |
2010 | 3.500,00$ |
Mexico In Vitro Diagnostics Market Outlook to 2016Introduction / / GlobalData’s new report, “Mexico In Vitro Diagnostics Market Outlook to 2016” provides key market data on the Me |
2010 | 3.500,00$ |
Taiwan In Vitro Diagnostics Market Outlook to 2016Introduction / / GlobalData’s new report, “Taiwan In Vitro Diagnostics Market Outlook to 2016” provides key market data on the Ta |
2010 | 3.500,00$ |
South Africa In Vitro Diagnostics Market Outlook to 2016Introduction / / GlobalData’s new report, “South Africa In Vitro Diagnostics Market Outlook to 2016” provides key market data on |
2010 | 3.500,00$ |
Diabetes Care Devices: Emerging Countries (China, India, Brazil) Opportunity Assessment, Competitive Landscape and Market Forecasts to 2016Introduction / / GlobalData’s new report, “Diabetes Care Devices - Emerging Countries Opportunity Assessment, Competitive Landsca |
2010 | 3.500,00$ |
Allergic Rhinitis - Pipeline Assessment and Market Forecasts to 2017Introduction
/
/ GlobalData, the industry analysis specialist, has released a new report, “Allergic Rhinitis - Pipeline Assessm |
2010 | 2.000,00$ |
Migraine - Pipeline Assessment and Market Forecasts to 2016Introduction
/
/ GlobalData, the industry analysis specialist’s new report, “Migraine - Pipeline Assessment and Market Forecast |
2010 | 2.000,00$ |
Idiopathic Pulmonary Fibrosis - Pipeline Assessment and Market Forecasts to 2017Introduction
/
/ GlobalData’s pharmaceutical and healthcare report, “Idiopathic Pulmonary Fibrosis - Pipeline Assessment and Ma |
2010 | 2.000,00$ |
Acne - Pipeline Assessment and Market Forecasts to 2017Introduction
/
/ GlobalData, the industry analysis specialist, has released a new report, “Acne - Pipeline Assessment and Marke |
2010 | 2.000,00$ |
US Patient Monitoring Devices Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016Introduction
/
/ GlobalData’s medical equipment report, “US Patient Monitoring Pipeline Analysis, Opportunity Assessment and Ma |
2010 | 3.500,00$ |
Mergers, Acquisitions and Partnerships in the Medical Devices Industry - Inorganic Growth Driven by the Strategic Need to Hold a Diversified PortfolioIntroduction
/
/ Investments in the global medical devices industry exceeded $73 billion in 2009. In the same year, $18.7 billi |
2010 | 3.500,00$ |
United States Anesthesia and Respiratory Devices Market Outlook to 2016Introduction
/
/ GlobalData’s medical equipment report, “US Anesthesia and Respiratory Devices Market Outlook to 2016” provides |
2010 | 2.500,00$ |
Japan Anesthesia and Respiratory Devices Market Outlook to 2016Introduction
/
/ GlobalData’s medical equipment report, “Japan Anesthesia and Respiratory Devices Market Outlook to 2016” provi |
2010 | 2.500,00$ |
China Anesthesia and Respiratory Devices Market Outlook to 2016Introduction
/
/ GlobalData’s medical equipment report, “China Anesthesia and Respiratory Devices Market Outlook to 2016” provi |
2010 | 2.500,00$ |
Australia Anesthesia and Respiratory Devices Market Outlook to 2016Introduction
/
/ GlobalData’s medical equipment report, “Australia Anesthesia and Respiratory Devices Market Outlook to 2016” p |
2010 | 2.500,00$ |
Netherlands Anesthesia and Respiratory Devices Market Outlook to 2016Introduction
/
/ GlobalData’s medical equipment report, “Netherlands Anesthesia and Respiratory Devices Market Outlook to 2016” |
2010 | 2.500,00$ |
Belgium Anesthesia and Respiratory Devices Market Outlook to 2016Introduction
/
/ GlobalData’s medical equipment report, “Belgium Anesthesia and Respiratory Devices Market Outlook to 2016” pro |
2010 | 2.500,00$ |
Mexico Anesthesia and Respiratory Devices Market Outlook to 2016Introduction
/
/ GlobalData’s medical equipment report, “Mexico Anesthesia and Respiratory Devices Market Outlook to 2016” prov |
2010 | 2.500,00$ |
South Africa Anesthesia and Respiratory Devices Market Outlook to 2016Introduction
/
/ GlobalData’s medical equipment report, “South Africa Anesthesia and Respiratory Devices Market Outlook to 2016 |
2010 | 2.500,00$ |
China Wound Care Management Market Outlook to 2016Introduction
/
/ GlobalData’s medical equipment report, “China Wound Care Management Market Outlook to 2016” provides key marke |
2010 | 2.500,00$ |
Canada Wound Care Management Market Outlook to 2016Introduction
/
/ GlobalData’s medical equipment report, “Canada Wound Care Management Market Outlook to 2016” provides key mark |
2010 | 2.500,00$ |
Germany Wound Care Management Market Outlook to 2016Introduction
/
/ GlobalData’s medical equipment report, “Germany Wound Care Management Market Outlook to 2016” provides key mar |
2010 | 2.500,00$ |
Italy Wound Care Management Market Outlook to 2016Introduction
/
/ GlobalData’s medical equipment report, “Italy Wound Care Management Market Outlook to 2016” provides key marke |
2010 | 2.500,00$ |
Spain Wound Care Management Market Outlook to 2016Introduction
/
/ GlobalData’s medical equipment report, “Spain Wound Care Management Market Outlook to 2016” provides key marke |
2010 | 2.500,00$ |
Brazil Wound Care Management Market Outlook to 2016Introduction
/
/ GlobalData’s medical equipment report, “Brazil Wound Care Management Market Outlook to 2016” provides key mark |
2010 | 2.500,00$ |
Netherlands Wound Care Management Market Outlook to 2016Introduction
/
/ GlobalData’s medical equipment report, “Netherlands Wound Care Management Market Outlook to 2016” provides key |
2010 | 2.500,00$ |
Belgium Wound Care Management Market Outlook to 2016Introduction
/
/ GlobalData’s medical equipment report, “Belgium Wound Care Management Market Outlook to 2016” provides key mar |
2010 | 2.500,00$ |
Mexico Wound Care Management Market Outlook to 2016Introduction
/
/ GlobalData’s medical equipment report, “Mexico Wound Care Management Market Outlook to 2016” provides key mark |
2010 | 2.500,00$ |
Taiwan Wound Care Management Market Outlook to 2016Introduction
/
/ GlobalData’s medical equipment report, “Taiwan Wound Care Management Market Outlook to 2016” provides key mark |
2010 | 2.500,00$ |
Viscosupplementation - A European Market SnapshotIntroduction
/
/ GlobalData’s report, “Viscosupplementation: A European Market Snapshot” provides key data, information and ana |
2010 | 500,00$ |
Antimicrobial Coatings for Medical Devices: An OverviewIntroduction
/
/ GlobalData’s report, “Antimicrobial Coatings for Medical Devices” provides key data, information and analysis |
2010 | 500,00$ |
Neuropathic Pain - Pipeline Assessment and Market Forecasts to 2016Introduction
/
/ GlobalData, the industry analysis specialist’s new report, “Neuropathic Pain - Pipeline Assessment and Market |
2010 | 2.000,00$ |
Herpes Simplex - Pipeline Assessment and Market Forecasts to 2017Introduction
/
/ GlobalData, the industry analysis specialist’s new report, “Herpes Simplex - Pipeline Assessment and Market Fo |
2010 | 2.000,00$ |
HIV-AIDS – Pipeline Assessment and Market Forecasts to 2016Annualized global HIV/AIDS market revenues data from 2001 to 2009, forecast for seven years to 2016.
/ Pipeline analysis data pr |
2010 | 2.000,00$ |
Hepatitis C (HCV) – Pipeline Assessment and Market Forecasts to 2016Annualized global hepatitis C market revenues data from 2000 to 2009, forecast for seven years to 2016.
/ Pipeline analysis data |
2010 | 2.000,00$ |
Dyslipidemia – Pipeline Assessment and Market Forecasts to 2016Annualized global dyslipidemia market revenues data from 2001 to 2009, forecast forward for 7 years to 2016.
/ Pipeline analysis |
2010 | 2.000,00$ |
Pulmonary Arterial Hypertension (PAH) - Pipeline Assessment and Market Forecasts to 2016Annualized global PAH market revenues data from 2005 to 2009, forecast forward for seven years to 2016.
/ Geographic markets cov |
2010 | 2.000,00$ |
Parkinson's Disease – Pipeline Assessment and Market Forecasts to 2016Annualized global Parkinson’s disease market revenues data from 2001 to 2009, forecast forward for 7 years to 2016.
/ Pipeline a |
2010 | 2.000,00$ |
Type 1 Diabetes - Drug Pipeline Assessment and Market Forecasts to 2017Annualized global type 1 diabetes market revenues data from data from 2001 to 2009, forecast for eight years to 2017.
/ Pipeline |
2010 | 2.000,00$ |
Dehaier Medical Systems Signs Distribution Agreement with HEYER Medical: A Move to Expand Product OfferingsIntroduction / / GlobalData’s report, “Dehaier Medical Systems Signs Distribution Agreement with HEYER Medical: A Move to Expand |
2010 | 500,00$ |
Japan Diagnostic Imaging Market Outlook to 2016Introduction / / GlobalData’s medical equipment report, “Japan Diagnostic Imaging Market Outlook to 2016” provides key market dat |
2010 | 2.500,00$ |
Germany Diagnostic Imaging Market Outlook to 2016Introduction / / GlobalData’s medical equipment report, “Germany Diagnostic Imaging Market Outlook to 2016” provides key market d |
2010 | 2.500,00$ |
France Diagnostic Imaging Market Outlook to 2016Introduction / / GlobalData’s medical equipment report, “France Diagnostic Imaging Market Outlook to 2016” provides key market da |
2010 | 2.500,00$ |
Spain Diagnostic Imaging Market Outlook to 2016Introduction / / GlobalData’s medical equipment report, “Spain Diagnostic Imaging Market Outlook to 2016” provides key market dat |
2010 | 2.500,00$ |
Australia Diagnostic Imaging Market Outlook to 2016Introduction / / GlobalData’s medical equipment report, “Australia Diagnostic Imaging Market Outlook to 2016” provides key market |
2010 | 2.500,00$ |
Belgium Diagnostic Imaging Market Outlook to 2016Introduction / / GlobalData’s medical equipment report, “Brazil Diagnostic Imaging Market Outlook to 2016” provides key market da |
2010 | 2.500,00$ |
Argentina Diagnostic Imaging Market Outlook to 2016Introduction / / GlobalData’s medical equipment report, “Argentina Diagnostic Imaging Market Outlook to 2016” provides key market |
2010 | 2.500,00$ |
Republic of Korea Diagnostic Imaging Market Outlook to 2016Introduction / / GlobalData’s medical equipment report, “Republic of Korea Diagnostic Imaging Market Outlook to 2016” provides ke |
2010 | 2.500,00$ |
South Africa Diagnostic Imaging Market Outlook to 2016Introduction / / GlobalData’s medical equipment report, “South Africa Diagnostic Imaging Market Outlook to 2016” provides key mar |
2010 | 2.500,00$ |
Israel Diagnostic Imaging Market Outlook to 2016Introduction / / GlobalData’s medical equipment report, “Israel Diagnostic Imaging Market Outlook to 2016” provides key market da |
2010 | 2.500,00$ |
United Kingdom Anesthesia and Respiratory Devices Market Outlook to 2016Introduction / / GlobalData’s medical equipment report, “UK Anesthesia and Respiratory Devices Market Outlook to 2016” provides k |
2010 | 2.500,00$ |
India Anesthesia and Respiratory Devices Market Outlook to 2016Introduction / / GlobalData’s medical equipment report, “India Anesthesia and Respiratory Devices Market Outlook to 2016” provide |
2010 | 2.500,00$ |
Canada Anesthesia and Respiratory Devices Market Outlook to 2016Introduction / / GlobalData’s medical equipment report, “Canada Anesthesia and Respiratory Devices Market Outlook to 2016” provid |
2010 | 2.500,00$ |
Germany Anesthesia and Respiratory Devices Market Outlook to 2016Introduction / / GlobalData’s medical equipment report, “Germany Anesthesia and Respiratory Devices Market Outlook to 2016” provi |
2010 | 2.500,00$ |
France Anesthesia and Respiratory Devices Market Outlook to 2016Introduction / / GlobalData’s medical equipment report, “France Anesthesia and Respiratory Devices Market Outlook to 2016” provid |
2010 | 2.500,00$ |
Italy Anesthesia and Respiratory Devices Market Outlook to 2016Introduction / / GlobalData’s medical equipment report, “Italy Anesthesia and Respiratory Devices Market Outlook to 2016” provide |
2010 | 2.500,00$ |
Spain Anesthesia and Respiratory Devices Market Outlook to 2016Introduction / / GlobalData’s medical equipment report, “Spain Anesthesia and Respiratory Devices Market Outlook to 2016” provide |
2010 | 2.500,00$ |
Brazil Anesthesia and Respiratory Devices Market Outlook to 2016Introduction / / GlobalData’s medical equipment report, “Brazil Anesthesia and Respiratory Devices Market Outlook to 2016” provid |
2010 | 2.500,00$ |
Argentina Anesthesia and Respiratory Devices Market Outlook to 2016Introduction / / GlobalData’s medical equipment report, “Argentina Anesthesia and Respiratory Devices Market Outlook to 2016” pro |
2010 | 2.500,00$ |
Republic of Korea Anesthesia and Respiratory Devices Market Outlook to 2016Introduction / / GlobalData’s medical equipment report, “Republic of Korea Anesthesia and Respiratory Devices Market Outlook to 2 |
2010 | 2.500,00$ |
Taiwan Anesthesia and Respiratory Devices Market Outlook to 2016Introduction / / GlobalData’s medical equipment report, “Taiwan Anesthesia and Respiratory Devices Market Outlook to 2016” provid |
2010 | 2.500,00$ |
Medical Equipment Monthly Deals Analysis: M&A and Investments Trends - June 2010Introduction / / GlobalData's “Medical Equipment Monthly Deals Analysis: M&A and Investments Trends – June 2010” report is an ess |
2010 | 1.000,00$ |
Economic Benefits and the Drive for Going Green Bolstering Medical Device ReprocessingIntroduction / / GlobalData’s report, “Economic Benefits and the Drive for Going Green Bolstering Medical Device Reprocessing” pr |
2010 | 500,00$ |
Arigene Co., Ltd. (67850) - Strategic Analysis ReviewThis comprehensive SWOT profile of Arigene Co., Ltd. provides you an in-depth strategic analysis of the company’s businesses and o |
2010 | 250,00$ |
DALTON CORPORATION - Strategic Analysis ReviewThis comprehensive SWOT profile of DALTON CORPORATION provides you an in-depth strategic analysis of the company’s businesses and |
2010 | 125,00$ |
Attwell Capital Inc. (AT.H) - Strategic Analysis ReviewThis comprehensive SWOT profile of Attwell Capital Inc. provides you an in-depth strategic analysis of the company’s businesses an |
2010 | 250,00$ |
Chemipal Ltd. (CMPL) - Strategic Analysis ReviewThis comprehensive SWOT profile of Chemipal Ltd. provides you an in-depth strategic analysis of the company’s businesses and opera |
2010 | 250,00$ |
DIO Corporation (39840) - Strategic Analysis ReviewThis comprehensive SWOT profile of DIO Corporation provides you an in-depth strategic analysis of the company’s businesses and ope |
2010 | 250,00$ |
Lilama 69-1 JSC (L61) - Strategic Analysis ReviewThis comprehensive SWOT profile of Lilama 69-1 JSC provides you an in-depth strategic analysis of the company’s businesses and ope |
2010 | 250,00$ |
HOSHI IRYO-SANKI CO., LTD (7634) - Strategic Analysis ReviewThis comprehensive SWOT profile of HOSHI IRYO-SANKI CO., LTD provides you an in-depth strategic analysis of the company’s business |
2010 | 250,00$ |
PositiveID Corporation (PSID) - Strategic Analysis ReviewPositiveID Corporation is a company which operates in two main divisions: HealthID and ID Security. The company's HealthID busines |
2010 | 250,00$ |
New Mexico Software Inc. - Strategic Analysis ReviewThis comprehensive SWOT profile of New Mexico Software Inc. provides you an in-depth strategic analysis of the company’s businesse |
2010 | 125,00$ |
PT. Millennium Pharmacon International TBK (SDPC) - Strategic Analysis ReviewThis comprehensive SWOT profile of PT. Millennium Pharmacon International TBK provides you an in-depth strategic analysis of the c |
2010 | 125,00$ |
J.L.Morison, Sons & Jones (Ceylon) PLC (MORI) - Strategic Analysis ReviewThis comprehensive SWOT profile of J.L.Morison, Sons & Jones (Ceylon) PLC provides you an in-depth strategic analysis of the compa |
2010 | 250,00$ |
In House Productions Limited (526610) - Strategic Analysis ReviewThis comprehensive SWOT profile of In House Productions Limited provides you an in-depth strategic analysis of the company’s busin |
2010 | 250,00$ |
Jacques Bogart SA (JBOG) - Strategic Analysis ReviewThis comprehensive SWOT profile of Jacques Bogart SA provides you an in-depth strategic analysis of the company’s businesses and o |
2010 | 250,00$ |
Indbank Merchant Banking Services Ltd (511473) - Strategic Analysis ReviewThis comprehensive SWOT profile of Indbank Merchant Banking Services Ltd provides you an in-depth strategic analysis of the compan |
2010 | 250,00$ |
Audiotech Healthcare Corporation (AUD) - Strategic Analysis ReviewThis comprehensive SWOT profile of Audiotech Healthcare Corporation provides you an in-depth strategic analysis of the company’s b |
2010 | 250,00$ |
Cassius Ventures Ltd. (CZ.P) - Strategic Analysis ReviewThis comprehensive SWOT profile of Cassius Ventures Ltd. provides you an in-depth strategic analysis of the company’s businesses a |
2010 | 250,00$ |
Bellmore Corp (BLMR) - Strategic Analysis ReviewThis comprehensive SWOT profile of Bellmore Corp provides you an in-depth strategic analysis of the company’s businesses and opera |
2010 | 250,00$ |
Latvijas Zoovetapgade AS (ZOV1R) - Strategic Analysis ReviewLatvijas Zoovetapgade AS (Latvijas Zoovetapgade JSC) is a veterinary preparations provider based in Latvia. The company is princip |
2010 | 250,00$ |
Chengdu Huasun Group Inc.,Ltd. (790) - Strategic Analysis ReviewThis comprehensive SWOT profile of Chengdu Huasun Group Inc.,Ltd. provides you an in-depth strategic analysis of the company’s bus |
2010 | 250,00$ |
Mangalam Drugs and Organics Limited (532637) - Strategic Analysis ReviewThis comprehensive SWOT profile of Mangalam Drugs and Organics Limited provides you an in-depth strategic analysis of the company’ |
2010 | 250,00$ |
Manitex Capital Inc. (MNX) - Strategic Analysis ReviewManitex Capital Inc. (Manitex) is a diversified technology investment company which invest in the life science industry. The compa |
2010 | 250,00$ |
China Health Industries Holdings Inc (CHHE) - Strategic Analysis ReviewThis comprehensive SWOT profile of China Health Industries Holdings Inc provides you an in-depth strategic analysis of the company |
2010 | 250,00$ |
Schiff Nutrition International Inc. (WNI) - Strategic Analysis ReviewThis comprehensive SWOT profile of Schiff Nutrition International Inc. provides you an in-depth strategic analysis of the company’ |
2010 | 250,00$ |
CHUO BUSSAN CORPORATION (9852) - Strategic Analysis ReviewThis comprehensive SWOT profile of CHUO BUSSAN CORPORATION provides you an in-depth strategic analysis of the company’s businesses |
2010 | 250,00$ |
CTD Holdings Inc. - Strategic Analysis ReviewCTD Holdings, Inc., (CHI) is a Florida based manufacturing and distribution company. CHI is principally engages in the distributio |
2010 | 250,00$ |
Inner Mongolia Jinyu Group Co Ltd (600201) - Strategic Analysis ReviewThis comprehensive SWOT profile of Inner Mongolia Jinyu Group Co Ltd provides you an in-depth strategic analysis of the company’s |
2010 | 250,00$ |
Procognia Israel Ltd - Strategic Analysis ReviewThis comprehensive SWOT profile of Procognia Israel Ltd provides you an in-depth strategic analysis of the company’s businesses an |
2010 | 125,00$ |
BITComputer (32850) - Strategic Analysis ReviewThis comprehensive SWOT profile of BITComputer provides you an in-depth strategic analysis of the company’s businesses and operati |
2010 | 125,00$ |
Instituto de Diagnostico S.A. (INDISA) - Strategic Analysis ReviewThis comprehensive SWOT profile of Instituto de Diagnostico S.A. provides you an in-depth strategic analysis of the company’s busi |
2010 | 250,00$ |
Northstar Healthcare, Inc. - Strategic Analysis ReviewThis comprehensive SWOT profile of Northstar Healthcare, Inc. provides you an in-depth strategic analysis of the company’s busines |
2010 | 125,00$ |
Siemens Medical Solutions Diagnostics (506559) - Strategic Analysis ReviewThis comprehensive SWOT profile of Siemens Medical Solutions Diagnostics provides you an in-depth strategic analysis of the compan |
2010 | 125,00$ |
MedTech Global Ltd. - Strategic Analysis ReviewThis comprehensive SWOT profile of MedTech Global Ltd. provides you an in-depth strategic analysis of the company’s businesses and |
2010 | 125,00$ |
PT Multi Indocitra Tbk (MICE) - Strategic Analysis ReviewThis comprehensive SWOT profile of PT Multi Indocitra Tbk provides you an in-depth strategic analysis of the company’s businesses |
2010 | 250,00$ |
Advanced Technology Company (ATC) - Strategic Analysis ReviewThis comprehensive SWOT profile of Advanced Technology Company provides you an in-depth strategic analysis of the company’s busine |
2010 | 250,00$ |
Alta Natural Herbs & Supplements Ltd. (AHS) - Strategic Analysis ReviewThis comprehensive SWOT profile of Alta Natural Herbs & Supplements Ltd. provides you an in-depth strategic analysis of the compan |
2010 | 250,00$ |
American Surgical Holdings Inc (ASRG) - Strategic Analysis ReviewThis comprehensive SWOT profile of American Surgical Holdings Inc provides you an in-depth strategic analysis of the company’s bus |
2010 | 250,00$ |
American Vietnamese Biotech Inc (AMV) - Strategic Analysis ReviewThis comprehensive SWOT profile of American Vietnamese Biotech Inc provides you an in-depth strategic analysis of the company’s bu |
2010 | 250,00$ |
Animalcare Group Plc (ANCR) - Strategic Analysis ReviewThis comprehensive SWOT profile of Animalcare Group Plc provides you an in-depth strategic analysis of the company’s businesses an |
2010 | 250,00$ |
Aquamer Medical Corp (AQUM) - Strategic Analysis ReviewThis comprehensive SWOT profile of Aquamer Medical Corp provides you an in-depth strategic analysis of the company’s businesses an |
2010 | 250,00$ |
AXS-One Inc. (AXSO) - Financial and Strategic Analysis ReviewAXS-One Inc. (AXSO) - Financial and Strategic Analysis Review / / Summary / / AXS-One Inc. (AXA-One) is engaged in providing con |
2010 | 125,00$ |
TZ Limited (TZL) - Financial and Strategic Analysis ReviewTZ Limited (TZL) - Financial and Strategic Analysis Review / / Summary / / TZ Limited is engaged in providing fuse environmental |
2010 | 125,00$ |
Global Med Technologies, Inc. (GLOB) - Financial and Strategic Analysis ReviewGlobal Med Technologies, Inc. (GLOB) - Financial and Strategic Analysis Review / / Summary / / Global Med Technologies, Inc., (G |
2010 | 125,00$ |
Pro Medicus Limited (PME) - Financial and Strategic Analysis ReviewPro Medicus Limited (PME) - Financial and Strategic Analysis Review / / Summary / / Pro Medicus Limited (Pro Medicus) is an Aust |
2010 | 125,00$ |
System C Healthcare plc (SYS) - Financial and Strategic Analysis ReviewSystem C Healthcare plc (SYS) - Financial and Strategic Analysis Review / / Summary / / System C Healthcare plc (SCH) is a UK ba |
2010 | 125,00$ |
SensiVida Medical Technologies, Inc - Strategic Analysis ReviewSensiVida Medical Systems, Inc. is a minimally-invasive diagnostic device company. The company's technology addresses a number of |
2010 | 250,00$ |
ZEVEX International, Inc. - Strategic Analysis ReviewZEVEX International, Inc. (ZEVEX) is a medical device company engaged in the design, manufacture, development and distribution of |
2010 | 250,00$ |
Heraeus Holding GmbH - Strategic Analysis ReviewHeraeus Holding GmbH (Heraeus) is a precious metals and technology group. It is engaged in the production and trading of high-qual |
2010 | 125,00$ |
1-800 Contacts, Inc. - Strategic Analysis Review1-800 Contacts, Inc (1-800 Contacts) is one of the worlds largest contact lens store. The company is involved in manufacturing, de |
2010 | 250,00$ |
Burkhart Dental, Inc. - Strategic Analysis ReviewBurkhart Dental, Inc. (Burkhart), is a dental supplier company principally engaged in the supply, distribution and marketing of de |
2010 | 250,00$ |
IDS plc - Strategic Analysis ReviewIDS plc formally known as IDS Nordic a/s is a biotechnology company, which is principally engaged in the manufacture, development |
2010 | 125,00$ |
Spectrum Surgical Instruments Corporation - Strategic Analysis ReviewSpectrum Surgical Instruments Corporation (Spectrum Surgical) is a medical device supplier, principally involved in providing a br |
2010 | 250,00$ |
Jebsen & Jessen (SEA) Pte Ltd - Strategic Analysis ReviewThe Jebsen & Jessen (SEA) Pte Ltd (Jebsen & Jessen) is a group company and principally operates in seven core businesses namely Ch |
2010 | 250,00$ |
National Distribution & Contracting, Inc. - Strategic Analysis ReviewNational Distribution & Contracting, Inc. (NDC) is a distributor company of medical, surgical, dental and laboratory equipments. T |
2010 | 250,00$ |
QHR Technologies Inc. (QHR) - Strategic Analysis ReviewQHR Technologies Inc. (QHR) is a healthcare IT company, which is specialized in the design of software to improve the efficiency o |
2010 | 125,00$ |
PLC Medical Systems, Inc. (PLCSF) - Strategic Analysis ReviewPLC Medical Systems, Inc. (PLC) is engaged in the development and marketing of innovative cardiac and vascular medical device-base |
2010 | 250,00$ |
Biomoda, Inc. (BMOD) - Strategic Analysis ReviewBiomoda, Inc. (Biomoda) is a medical device manufacturing company principally engaged in the development of disease specific test |
2010 | 250,00$ |
Theken - Strategic Analysis ReviewTheken family of companies are medical device companies, that are principally engaged in the research, development, manufacture an |
2010 | 125,00$ |
Pan Probe Biotech, Inc. - Strategic Analysis ReviewPan Probe Biotech, Inc. is a medical device manufacturing company in the rapid diagnostic kit industry. It is very useful to detec |
2010 | 250,00$ |
Span Diagnostics Ltd. (524727) - Strategic Analysis ReviewSpan Diagnostics Ltd. (Span Diagnostics) is an Indian based company. It is principally engaged in the manufacture and marketing of |
2010 | 125,00$ |
Sanrad International Pvt Ltd - Strategic Analysis ReviewSanrad International Pvt Ltd (Sanrad) is a medical equipment supplier. Sanrad is engaged in the business of import, export, and sa |
2010 | 250,00$ |
Ascent Healthcare Solutions, Inc. - Strategic Analysis ReviewAscent Healthcare Solutions, Inc. (Ascent) is a privately held medical device company engaged in medical device reprocessing and r |
2010 | 250,00$ |
CBaySystems Holdings Ltd. (CBAY) - Strategic Analysis ReviewCBaySystems Holdings Ltd. (CBaySystems) is a privately-held healthcare IT company engaged in providing software solutions for hea |
2010 | 250,00$ |
Marshall Products Limited - Strategic Analysis ReviewMarshall Products Limited (Marshall) is a medical equipment supplier company engaged in the importing, marketing and distribution |
2010 | 250,00$ |
Asyah Haavot Ltd. - Strategic Analysis ReviewAsyah Haavot Ltd. (Asyah) is a privately-held wholesale medical supplier company. The company focuses on marketing and distributio |
2010 | 250,00$ |
Eldan Electronic Instruments Co. Ltd - Strategic Analysis ReviewEldan Electronic Instruments Co. Ltd (Eldan) is a privately-held supplier of equipment and consumables in the areas of Healthcare, |
2010 | 250,00$ |
Futuremed Healthcare Income Fund (FMD.UN) - Strategic Analysis ReviewFuturemed Healthcare Income Fund (Futuremed) is engaged in the manufacture and distribution of innovative healthcare products. The |
2010 | 250,00$ |
A&T Corporation (6722) - Strategic Analysis ReviewThis comprehensive SWOT profile of A&T Corporation provides you an in-depth strategic analysis of the company’s businesses and ope |
2010 | 250,00$ |
American Shared Hospital Services - Strategic Analysis ReviewThis comprehensive SWOT profile of American Shared Hospital Services provides you an in-depth strategic analysis of the company’s |
2010 | 250,00$ |
Topcon Corporation - Strategic Analysis ReviewThis comprehensive SWOT profile of Topcon Corporation provides you an in-depth strategic analysis of the company’s businesses and |
2010 | 250,00$ |
Rockeby Biomed Limiteds - Strategic Analysis ReviewRockeby biomed Limited (Rockeby), is bio-technology service provider company. The company is principally engaged in the research a |
2010 | 125,00$ |
Baumer S.A.s - Strategic Analysis ReviewBaumer S.A. (Baumer) is a medical device manufacturing company principally engaged in the development, manufacturing and marketing |
2010 | 250,00$ |
Safety Medical Products Limited (SFP) - Strategic Analysis ReviewThis comprehensive SWOT profile of Safety Medical Products Limited provides you an in-depth strategic analysis of the company’s bu |
2010 | 250,00$ |
Integrated Surgical Systems, Inc. (ISSM) - Strategic Analysis ReviewThis comprehensive SWOT profile of Integrated Surgical Systems, Inc. provides you an in-depth strategic analysis of the company’s |
2010 | 250,00$ |
SMC Ventures Inc. - Strategic Analysis ReviewThis comprehensive SWOT profile of SMC Ventures Inc. provides you an in-depth strategic analysis of the company’s businesses and o |
2010 | 250,00$ |
Glycorex Transplantation AB - Strategic Analysis ReviewThis comprehensive SWOT profile of Glycorex Transplantation AB provides you an in-depth strategic analysis of the company’s busine |
2010 | 250,00$ |
Morishita Jintan Co., Ltd. - Strategic Analysis ReviewMorishita Jintan Co., Ltd. is a Japan based company that engages in offering product and services in the OTC market. The company o |
2010 | 250,00$ |
Nadex Co., Ltd. - Strategic Analysis ReviewNadex Co., Ltd. is a Japan-based company that engages in offering product and services in the Opthalmic device market. The company |
2010 | 250,00$ |
OKAMOTO INDUSTRIES, INC. - Strategic Analysis ReviewThis comprehensive SWOT profile of OKAMOTO INDUSTRIES, INC. provides you an in-depth strategic analysis of the company’s businesse |
2010 | 250,00$ |
Hartest Holdings plc (HTH) - Strategic Analysis ReviewHartest Holdings plc is a medical device company engaged in the manufacture and sale of specialist scientific instrumentation toge |
2010 | 250,00$ |
Cardio Vascular Medical Device Corp. - Strategic Analysis ReviewThis comprehensive SWOT profile of Cardio Vascular Medical Device Corp. provides you an in-depth strategic analysis of the company |
2010 | 250,00$ |
Sagentia Group AG (SAG) - Strategic Analysis ReviewThis comprehensive SWOT profile of Sagentia Group AG provides you an in-depth strategic analysis of the company’s businesses and o |
2010 | 250,00$ |
Medigus Ltd. (MDGS) - Strategic Analysis ReviewThis comprehensive SWOT profile of Medigus Ltd. provides you an in-depth strategic analysis of the company’s businesses and operat |
2010 | 250,00$ |
Ingen Technologies, Inc. - Strategic Analysis ReviewThis comprehensive SWOT profile of Ingen Technologies, Inc. provides you an in-depth strategic analysis of the company’s businesse |
2010 | 250,00$ |
Acceleware Corp. (AXE) - Strategic Analysis ReviewThis comprehensive SWOT profile of Acceleware Corp. provides you an in-depth strategic analysis of the company’s businesses and op |
2010 | 250,00$ |
A&D Company, Limited. - Strategic Analysis ReviewThis comprehensive SWOT profile of A&D Company, Limited. provides you an in-depth strategic analysis of the company’s businesses a |
2010 | 250,00$ |
American Science & Engineering Inc (ASEI) - Strategic Analysis ReviewAmerican Science & Engineering Inc is engaged in manufacturing of X-ray inspection products that can be used to inspect parcels, b |
2010 | 250,00$ |
Atos Wellness Ltd - Strategic Analysis ReviewThis comprehensive SWOT profile of Atos Wellness Ltd provides you an in-depth strategic analysis of the company’s businesses and o |
2010 | 250,00$ |
Bio-Gate Ag (BIG) - Strategic Analysis ReviewThis comprehensive SWOT profile of Bio-Gate Ag provides you an in-depth strategic analysis of the company’s businesses and operati |
2010 | 250,00$ |
Capitol Health Limited - Strategic Analysis ReviewThis comprehensive SWOT profile of Capitol Health Limited provides you an in-depth strategic analysis of the company’s businesses |
2010 | 125,00$ |
China Asean Resources Limited - Strategic Analysis ReviewThis comprehensive SWOT profile of China Asean Resources Limited provides you an in-depth strategic analysis of the company’s busi |
2010 | 250,00$ |
Corem Property Group Ab - Strategic Analysis ReviewCorem Property Group AB (publ) is a real estate company that owns and manages properties in central and southern Sweden and Denmar |
2010 | 250,00$ |
Ellen Ab - Strategic Analysis ReviewThis comprehensive SWOT profile of Ellen Ab provides you an in-depth strategic analysis of the company’s businesses and operations |
2010 | 250,00$ |
Euromedis Groupe Sa (EMG) - Strategic Analysis ReviewEuromedis Groupe Sa is a medical device company which provides products in five different categories. They are parenteral access, |
2010 | 250,00$ |
Fenwal Controls Of Japan Ltd - Strategic Analysis ReviewThis comprehensive SWOT profile of Fenwal Controls Of Japan Ltd provides you an in-depth strategic analysis of the company’s busin |
2010 | 250,00$ |
Kel Corporation - Strategic Analysis ReviewThis comprehensive SWOT profile of Kel Corporation provides you an in-depth strategic analysis of the company’s businesses and ope |
2010 | 250,00$ |
Mani, Inc. (7730) - Strategic Analysis ReviewThis comprehensive SWOT profile of Mani, Inc. provides you an in-depth strategic analysis of the company’s businesses and operatio |
2010 | 250,00$ |
Medic Vision Limited - Strategic Analysis ReviewMedic Vision Limited is an Australia based provider of healthcare training solutions. The company engages in providing training se |
2010 | 250,00$ |
Photon Control Inc - Strategic Analysis ReviewThis comprehensive SWOT profile of Photon Control Inc provides you an in-depth strategic analysis of the company’s businesses and |
2010 | 250,00$ |
Poly Medicure Ltd. - Strategic Analysis ReviewThis comprehensive SWOT profile of Poly Medicure Ltd. provides you an in-depth strategic analysis of the company’s businesses and |
2010 | 250,00$ |
Simtronics Asa - Strategic Analysis ReviewThis comprehensive SWOT profile of Simtronics Asa provides you an in-depth strategic analysis of the company’s businesses and oper |
2010 | 250,00$ |
Somnomed Limited - Strategic Analysis ReviewThis comprehensive SWOT profile of Somnomed Limited provides you an in-depth strategic analysis of the company’s businesses and op |
2010 | 125,00$ |
Sunray Holdings Limited - Strategic Analysis ReviewThis comprehensive SWOT profile of Sunray Holdings Limited provides you an in-depth strategic analysis of the company’s businesses |
2010 | 250,00$ |
Trestle Holdings, Inc. - Strategic Analysis ReviewTrestle Holdings, Inc. is engaged in the development and selling of digital tissue imaging products and solutions for improved wor |
2010 | 250,00$ |
Tso3 Inc (TOS) - Strategic Analysis ReviewThis comprehensive SWOT profile of Tso3 Inc provides you an in-depth strategic analysis of the company’s businesses and operations |
2010 | 125,00$ |
Viscom Ag - Strategic Analysis ReviewThis comprehensive SWOT profile of Viscom Ag provides you an in-depth strategic analysis of the company’s businesses and operation |
2010 | 250,00$ |
Yagami Inc. - Strategic Analysis ReviewThis comprehensive SWOT profile of Yagami Inc. provides you an in-depth strategic analysis of the company’s businesses and operati |
2010 | 250,00$ |
Immersion Corporation - Strategic Analysis ReviewImmersion Corporation is engaged in developing touch technology for automotive, consumer electronics, gaming, industrial, commerci |
2010 | 250,00$ |
Emerging Vision, Inc. - Strategic Analysis ReviewThis comprehensive SWOT profile of Emerging Vision, Inc. provides you an in-depth strategic analysis of the company’s businesses a |
2010 | 250,00$ |
Oncologix Tech, Inc. (OCLG) - Strategic Analysis ReviewOncologix Tech, Inc. (OCLG) is engaged in the research and development of medical devices for the treatment of soft tissue cancers |
2010 | 250,00$ |
co.don AG - Strategic Analysis ReviewThis comprehensive SWOT profile of co.don AG provides you an in-depth strategic analysis of the company’s businesses and operation |
2010 | 250,00$ |
HepaLife Technologies Inc. (HPLF) - Strategic Analysis ReviewHepaLife Technologies, Inc. (HepaLife) is Bioartificial Liver System Developer in United States. The company was principally engag |
2010 | 250,00$ |
INDUS Holding AG - Strategic Analysis ReviewThis comprehensive SWOT profile of INDUS Holding AG provides you an in-depth strategic analysis of the company’s businesses and op |
2010 | 250,00$ |
Acrongenomics Inc. (AGNM) - Strategic Analysis ReviewAcrongenomics, Inc. is engaged in developing and commercializing novel technology platforms concerning the life sciences sector. A |
2010 | 250,00$ |
addVise inredning skyddsventilation AB (ADDV) - Strategic Analysis ReviewThis comprehensive SWOT profile of addVise inredning skyddsventilation AB provides you an in-depth strategic analysis of the compa |
2010 | 250,00$ |
Applisonix Ltd. (APLS) - Strategic Analysis ReviewThis comprehensive SWOT profile of Applisonix Ltd. provides you an in-depth strategic analysis of the company’s businesses and ope |
2010 | 250,00$ |
Austofix Group Limited (AYX) - Strategic Analysis ReviewThis comprehensive SWOT profile of Austofix Group Limited provides you an in-depth strategic analysis of the company’s businesses |
2010 | 125,00$ |
Bilcare Limited (526853) - Strategic Analysis ReviewBilcare Limited is engaged in pharma packaging research solutions. It is a solutions provider that partners with the global pharma |
2010 | 250,00$ |
MeVis Medical Solutions AG - Strategic Analysis ReviewThis comprehensive SWOT profile of MeVis Medical Solutions AG provides you an in-depth strategic analysis of the company’s busines |
2010 | 125,00$ |
GENESIS BIOMEDICAL LTD - Strategic Analysis ReviewThis comprehensive SWOT profile of GENESIS BIOMEDICAL LTD provides you an in-depth strategic analysis of the company’s businesses |
2010 | 125,00$ |
Allied Motion Technologies, Inc. - Strategic Analysis ReviewThis comprehensive SWOT profile of Allied Motion Technologies, Inc. provides you an in-depth strategic analysis of the company’s b |
2010 | 250,00$ |
Bio-Cell Ltd. - Strategic Analysis ReviewBio-Cell Ltd. focuses on the development and manufacturing of protein-based medicines, using genetically engineered vegetal cultur |
2010 | 250,00$ |
Allan International Holdings Ltd. (684) - Strategic Analysis ReviewThis comprehensive SWOT profile of Allan International Holdings Ltd. provides you an in-depth strategic analysis of the company’s |
2010 | 250,00$ |
Bio-Matrix Scientific Group, Inc. - Strategic Analysis ReviewBio-Matrix Scientific Group, Inc. is a biotechnology research and development company engaged in inventing, developing, acquiring |
2010 | 250,00$ |
Lifeline Scientific, Inc. (LSI) - Strategic Analysis ReviewThis comprehensive SWOT profile of Lifeline Scientific, Inc. provides you an in-depth strategic analysis of the company’s business |
2010 | 250,00$ |
Raysearch Laboratories AB - Strategic Analysis ReviewRaysearch Laboratories AB is a medical technology company that develops software for radiation therapy of cancer. The company's pr |
2010 | 250,00$ |
Polylite Taiwan Co., Ltd. (1813) - Strategic Analysis ReviewThis comprehensive SWOT profile of Polylite Taiwan Co., Ltd. provides you an in-depth strategic analysis of the company’s business |
2010 | 250,00$ |
Guidant Corp. - Strategic Analysis ReviewThis comprehensive SWOT profile of Guidant Corp. provides you an in-depth strategic analysis of the company’s businesses and opera |
2010 | 250,00$ |
Caprius, Inc. (CAPI) - Strategic Analysis ReviewThis comprehensive SWOT profile of Caprius, Inc. provides you an in-depth strategic analysis of the company’s businesses and opera |
2010 | 250,00$ |
PJ Electronics Co., Ltd. (6140) - Strategic Analysis ReviewThis comprehensive SWOT profile of PJ Electronics Co., Ltd. provides you an in-depth strategic analysis of the company’s businesse |
2010 | 250,00$ |
CUREXO INC. - Strategic Analysis ReviewThis comprehensive SWOT profile of CUREXO INC. provides you an in-depth strategic analysis of the company’s businesses and operati |
2010 | 250,00$ |
Theralase Technologies Inc. - Strategic Analysis ReviewThis comprehensive SWOT profile of Theralase Technologies Inc. provides you an in-depth strategic analysis of the company’s busine |
2010 | 125,00$ |
C-Rad AB (CRAD B) - Strategic Analysis ReviewThis comprehensive SWOT profile of C-Rad AB provides you an in-depth strategic analysis of the company’s businesses and operations |
2010 | 250,00$ |
Universal Detection Technology - Strategic Analysis ReviewUniversal Detection Technology is a developer of monitoring technologies, including bio-terrorism detection devices.presently the |
2010 | 250,00$ |
ANGLE plc (AGL) - Strategic Analysis ReviewThis comprehensive SWOT profile of ANGLE plc provides you an in-depth strategic analysis of the company’s businesses and operation |
2010 | 250,00$ |
3M India Limited (523395) - Strategic Analysis ReviewThis comprehensive SWOT profile of 3M India Limited provides you an in-depth strategic analysis of the company’s businesses and op |
2010 | 250,00$ |
IntriCon Corporation (IIN) - Strategic Analysis ReviewThis comprehensive SWOT profile of IntriCon Corporation provides you an in-depth strategic analysis of the company’s businesses an |
2010 | 250,00$ |
Oclaro, Inc. (OCLR) - Strategic Analysis ReviewOclaro, Inc. is a engaged in providing optical and laser components and solutions for a broad range of diverse markets, including |
2010 | 250,00$ |
1300 Smiles Limited (ONT) - Strategic Analysis ReviewThis comprehensive SWOT profile of 1300 Smiles Limited provides you an in-depth strategic analysis of the company’s businesses and |
2010 | 250,00$ |
athenahealth, Inc. (ATHN) - Strategic Analysis Reviewathenahealth, Inc. offers the revenue cycle management solution to the healthcare industry. The company provides services related |
2010 | 250,00$ |
HealthStream, Inc. (HSTM) - Strategic Analysis ReviewThis comprehensive SWOT profile of HealthStream, Inc. provides you an in-depth strategic analysis of the company’s businesses and |
2010 | 250,00$ |
Chemel AB - Strategic Analysis ReviewThis comprehensive SWOT profile of Chemel AB provides you an in-depth strategic analysis of the company’s businesses and operation |
2010 | 250,00$ |
ZMAY Holdings Limited (8085) - Strategic Analysis ReviewThis comprehensive SWOT profile of ZMAY Holdings Limited provides you an in-depth strategic analysis of the company’s businesses a |
2010 | 250,00$ |
Techtran Polylenses Limited (523455) - Strategic Analysis ReviewThis comprehensive SWOT profile of Techtran Polylenses Limited provides you an in-depth strategic analysis of the company’s busine |
2010 | 250,00$ |
Omnisystem Co., Ltd (57540) - Strategic Analysis ReviewThis comprehensive SWOT profile of Omnisystem Co., Ltd provides you an in-depth strategic analysis of the company’s businesses and |
2010 | 250,00$ |
Memory & Testing Inc. (65150) - Strategic Analysis ReviewThis comprehensive SWOT profile of Memory & Testing Inc. provides you an in-depth strategic analysis of the company’s businesses a |
2010 | 250,00$ |
3S Korea Co., Ltd. (60310) - Strategic Analysis ReviewThis comprehensive SWOT profile of 3S Korea Co., Ltd. provides you an in-depth strategic analysis of the company’s businesses and |
2010 | 250,00$ |
Universal Vision Biotechnology Co., Ltd (3218) - Strategic Analysis ReviewThis comprehensive SWOT profile of Universal Vision Biotechnology Co., Ltd provides you an in-depth strategic analysis of the comp |
2010 | 250,00$ |
Berli Jucker Public Company Limited (BJC) - Strategic Analysis ReviewThis comprehensive SWOT profile of Berli Jucker Public Company Limited provides you an in-depth strategic analysis of the company’ |
2010 | 125,00$ |
3D Diagnostic Imaging plc (3DDP) - Strategic Analysis ReviewThis comprehensive SWOT profile of 3D Diagnostic Imaging plc provides you an in-depth strategic analysis of the company’s business |
2010 | 250,00$ |
CANTRONIC Systems Inc. - Strategic Analysis ReviewThis comprehensive SWOT profile of CANTRONIC Systems Inc. provides you an in-depth strategic analysis of the company’s businesses |
2010 | 250,00$ |
Dignitana AB (DIGN) - Strategic Analysis ReviewThis comprehensive SWOT profile of Dignitana AB provides you an in-depth strategic analysis of the company’s businesses and operat |
2010 | 250,00$ |
Resonance Health Limited (RHT) - Strategic Analysis ReviewThis comprehensive SWOT profile of Resonance Health Limited provides you an in-depth strategic analysis of the company’s businesse |
2010 | 125,00$ |
Toumaz Holdings Limited - Strategic Analysis ReviewThis comprehensive SWOT profile of Toumaz Holdings Limited provides you an in-depth strategic analysis of the company’s businesses |
2010 | 250,00$ |
HeartWare International, Inc. - Strategic Analysis ReviewThis comprehensive SWOT profile of HeartWare International, Inc. provides you an in-depth strategic analysis of the company’s busi |
2010 | 125,00$ |
ACTHERM INC. - Strategic Analysis ReviewThis comprehensive SWOT profile of ACTHERM INC. provides you an in-depth strategic analysis of the company’s businesses and operat |
2010 | 250,00$ |
Advanced BioMedical Technologies, Inc. (ABMT) - Strategic Analysis ReviewThis comprehensive SWOT profile of Advanced BioMedical Technologies, Inc. provides you an in-depth strategic analysis of the compa |
2010 | 250,00$ |
Avisio, Inc. - Strategic Analysis ReviewThis comprehensive SWOT profile of Avisio, Inc. provides you an in-depth strategic analysis of the company’s businesses and operat |
2010 | 250,00$ |
B2 Health Inc. (BTWO) - Strategic Analysis ReviewThis comprehensive SWOT profile of B2 Health Inc. provides you an in-depth strategic analysis of the company’s businesses and oper |
2010 | 250,00$ |
D.Western Therapeutics Institute, Inc. (4576) - Strategic Analysis ReviewThis comprehensive SWOT profile of D.Western Therapeutics Institute, Inc. provides you an in-depth strategic analysis of the compa |
2010 | 250,00$ |
HANS BIOMED CORPORATION (42520) - Strategic Analysis ReviewThis comprehensive SWOT profile of HANS BIOMED CORPORATION provides you an in-depth strategic analysis of the company’s businesses |
2010 | 250,00$ |
Healthcare Enterprise Group PLC (HCEG) - Strategic Analysis ReviewThis comprehensive SWOT profile of Healthcare Enterprise Group PLC provides you an in-depth strategic analysis of the company’s bu |
2010 | 250,00$ |
Microvision, Inc. (MVIS) - Strategic Analysis ReviewThis comprehensive SWOT profile of Microvision, Inc. provides you an in-depth strategic analysis of the company’s businesses and o |
2010 | 250,00$ |
Alexandria Medical Services Company (AMES) - Strategic Analysis ReviewAlexandria Medical Services Company is a company engaged in providing medical diagnostic and treatment services. Its facilities in |
2010 | 250,00$ |
biOasis Technologies Inc. (BTI.V) - Strategic Analysis ReviewbiOasis Technologies Inc. (formerly W.R. Partners Ltd.) is a biotechnology company engaged in the development of biomarkers for di |
2010 | 125,00$ |
Sun Life Corporation - Strategic Analysis ReviewThis comprehensive SWOT profile of Sun Life Corporation provides you an in-depth strategic analysis of the company’s businesses an |
2010 | 250,00$ |
Eldav Investments Ltd. (ELDAV) - Strategic Analysis ReviewEldav Investments Ltd. is a public investment company. It is seeking to invest in high potential industrial, service and commercia |
2010 | 250,00$ |
Aphton Corporation (APHTQ) - Financial and Strategic Analysis ReviewAphton Corporation (APHTQ) - Financial and Strategic Analysis Review / / Summary / / Aphton Corporation (Aphton) is a pennsylvan |
2010 | 125,00$ |
Ads Media Group Inc (AMGU) - Financial and Strategic Analysis ReviewAds Media Group Inc (AMGU) - Financial and Strategic Analysis Review / / Summary / / ADS Media Group (ADSMG) is principally enga |
2010 | 125,00$ |
CellMetrix, Inc. (CLMI) - Financial and Strategic Analysis ReviewCellMetrix, Inc. (CLMI) - Financial and Strategic Analysis Review / / Summary / / CellMetrix, Inc. (CellMetrix) is a medical tec |
2010 | 125,00$ |
Hi-Tech Pharmacal Co., Inc. (HITK) - Financial and Strategic Analysis ReviewHi-Tech Pharmacal Co., Inc. (HITK) - Financial and Strategic Analysis Review / / Summary / / Hi-Tech Pharmacal Co., Inc. (Hi-Tec |
2010 | 250,00$ |
OptimumCare Corporation (OPMC) - Financial and Strategic Analysis ReviewOptimumCare Corporation (OPMC) - Financial and Strategic Analysis Review / / Summary / / OptimumCare Corporation (OptimumCare) i |
2010 | 125,00$ |
IVI Communications, Inc. (IVII) - Financial and Strategic Analysis ReviewIVI Communications, Inc. (IVII) - Financial and Strategic Analysis Review / / Summary / / IVI Communications, Inc., (IVI) is an |
2010 | 125,00$ |
Sitestar Corporation (SYTE) - Financial and Strategic Analysis ReviewSitestar Corporation (SYTE) - Financial and Strategic Analysis Review / / Summary / / Sitestar Corporation operates is an Intern |
2010 | 125,00$ |
Orion HealthCorp, Inc. (ORNH) - Financial and Strategic Analysis ReviewOrion HealthCorp, Inc. (ORNH) - Financial and Strategic Analysis Review / / Summary / / Orion HealthCorp, Inc. (Orion HealthCorp |
2010 | 125,00$ |
Protide Pharmaceuticals, Inc. (PPMD) - Financial and Strategic Analysis ReviewProtide Pharmaceuticals, Inc. (PPMD) - Financial and Strategic Analysis Review / / Summary / / Protide Pharmaceuticals, Inc. (Pr |
2010 | 125,00$ |
Kalahari Greentech, Inc. (KHGT) - Financial and Strategic Analysis ReviewKalahari Greentech, Inc. (KHGT) - Financial and Strategic Analysis Review / / Summary / / Kalahari Greentech, Inc.(KGI) is a res |
2010 | 125,00$ |
Velcera, Inc. (VLCR) - Financial and Strategic Analysis ReviewVelcera, Inc. (VLCR) - Financial and Strategic Analysis Review / / Summary / / Velcera, Inc. (Velcera) is a is a development sta |
2010 | 125,00$ |
Viral Genetics, Inc. (VRAL) - Financial and Strategic Analysis ReviewViral Genetics, Inc. (VRAL) - Financial and Strategic Analysis Review / / Summary / / Viral Genetics, Inc. (Viral Genetics) is a |
2010 | 125,00$ |
Vital Living, Inc. (VTLV) - Financial and Strategic Analysis ReviewVital Living, Inc. (VTLV) - Financial and Strategic Analysis Review / / Summary / / Vital Living, Inc. (Vital Living) is a publi |
2010 | 125,00$ |
Millenia Hope Inc. (MLF) - Financial and Strategic Analysis ReviewMillenia Hope Inc. (MLF) - Financial and Strategic Analysis Review / / Summary / / Millenia Hope, Inc. (Millenia) is a research |
2010 | 125,00$ |
BioChem Solutions Inc. (BCHS) - Financial and Strategic Analysis ReviewBioChem Solutions Inc. (BCHS) - Financial and Strategic Analysis Review / / Summary / / BioChem Solutions Inc. (BioChem Solution |
2010 | 125,00$ |
Stem Cell Innovations, Inc. (SCLL) - Financial and Strategic Analysis ReviewStem Cell Innovations, Inc. (SCLL) - Financial and Strategic Analysis Review / / Summary / / Stem Cell Innovations, Inc. (SCI) i |
2010 | 125,00$ |
SinoFresh HealthCare, Inc. (SFSH) - Financial and Strategic Analysis ReviewSinoFresh HealthCare, Inc. (SFSH) - Financial and Strategic Analysis Review / / Summary / / SinoFresh HealthCare, Inc. (SinoFres |
2010 | 125,00$ |
Medistem, Inc. (MEDS) - Financial and Strategic Analysis ReviewMedistem, Inc. (MEDS) - Financial and Strategic Analysis Review / / Summary / / Medistem, Inc. (Medistem) is a research focused |
2010 | 125,00$ |
Swiss Medica, Inc. (SWME) - Financial and Strategic Analysis ReviewSwiss Medica, Inc. (SWME) - Financial and Strategic Analysis Review / / Summary / / Swiss Medica, Inc. (Swiss Medica) is a speci |
2010 | 125,00$ |
VasoActive Pharmaceuticals, Inc. (VAPHQ) - Financial and Strategic Analysis ReviewVasoActive Pharmaceuticals, Inc. (VAPHQ) - Financial and Strategic Analysis Review / / Summary / / VasoActive Pharmaceuticals, I |
2010 | 125,00$ |
AURELIUS AG (AR4) - Financial and Strategic Analysis ReviewAURELIUS AG (AR4) - Financial and Strategic Analysis Review / / Summary / / Aurelius AG (Aurelius) is a private equity firm that |
2010 | 125,00$ |
BackWeb Technologies Ltd. (BWEBF) - Financial and Strategic Analysis ReviewBackWeb Technologies Ltd. (BWEBF) - Financial and Strategic Analysis Review / / Summary / / BackWeb Technologies Ltd. (BackWeb) |
2010 | 125,00$ |
Healthcare Providers Direct, Inc. (HPRD) - Financial and Strategic Analysis ReviewHealthcare Providers Direct, Inc. (HPRD) - Financial and Strategic Analysis Review / / Summary / / Healthcare Providers Direct, |
2010 | 125,00$ |
Immunotech Laboratories, Inc. (IMMB) - Financial and Strategic Analysis ReviewImmunotech Laboratories, Inc. (IMMB) - Financial and Strategic Analysis Review / / Summary / / Immunotech Laboratories, Inc. (Im |
2010 | 125,00$ |
SSI Surgical Services, Inc. (SGSI) - Financial and Strategic Analysis ReviewSSI Surgical Services, Inc. (SGSI) - Financial and Strategic Analysis Review / / Summary / / SSI Surgical Services, Inc. (SSI) i |
2010 | 125,00$ |
RX for Africa, Inc. (RXAF) - Financial and Strategic Analysis ReviewRX for Africa, Inc. (RXAF) - Financial and Strategic Analysis Review / / Summary / / RX for Africa, Inc. (RXoA) is an investment |
2010 | 125,00$ |
Landela Pharmaceutical (RXEI) - Financial and Strategic Analysis ReviewLandela Pharmaceutical (RXEI) - Financial and Strategic Analysis Review / / Summary / / Landela Pharmaceutical (Landela) is a ph |
2010 | 125,00$ |
Omni Medical Holdings, Inc. (OMHI) - Financial and Strategic Analysis ReviewOmni Medical Holdings, Inc. (OMHI) - Financial and Strategic Analysis Review / / Summary / / Omni Medical Holdings Inc. (Omni) i |
2010 | 125,00$ |
The Arab Pharmaceutical Manufacturing Co. Ltd. (APMC) - Financial and Strategic Analysis ReviewThe Arab Pharmaceutical Manufacturing Co. Ltd. (APMC) - Financial and Strategic Analysis Review / / Summary / / The Arab Pharmac |
2010 | 125,00$ |
Select Medical Holdings Corporation (SEM) - Financial and Strategic Analysis ReviewSelect Medical Holdings Corporation (SEM) - Financial and Strategic Analysis Review / / Summary / / Select Medical Holdings Corp |
2010 | 125,00$ |
Optigenex Inc. (OPGX) - Financial and Strategic Analysis ReviewOptigenex Inc. (OPGX) - Financial and Strategic Analysis Review / / Summary / / Optigenex Inc. (Optigenex) is an applied life sc |
2010 | 125,00$ |
Biosynergy, Inc. (BSYN) - Financial and Strategic Analysis ReviewBiosynergy, Inc. (BSYN) - Financial and Strategic Analysis Review / / Summary / / Biosynergy, Inc.(Biosynergy) is publicly held |
2010 | 125,00$ |
Impreglon AG (I3M) - Financial and Strategic Analysis ReviewImpreglon AG (I3M) - Financial and Strategic Analysis Review / / Summary / / Impreglon AG (Impreglon) is a technology based comp |
2010 | 250,00$ |
Henley Healthcare, Inc. (HENL) - Financial and Strategic Analysis ReviewHenley Healthcare, Inc. (HENL) - Financial and Strategic Analysis Review / / Summary / / Henley Healthcare, Inc. (Henley), forme |
2010 | 125,00$ |
Auriga International SA (AURI) - Financial and Strategic Analysis ReviewAuriga International SA (AURI) - Financial and Strategic Analysis Review / / Summary / / Auriga International S.A. (Auriga) is a |
2010 | 125,00$ |
Easton Pharmaceuticals Inc. (LAIC) - Financial and Strategic Analysis ReviewEaston Pharmaceuticals Inc. (LAIC) - Financial and Strategic Analysis Review / / Summary / / Easton Pharmaceuticals Inc. (Easton |
2010 | 125,00$ |
Larrea Biosciences Corp (LRRA) - Financial and Strategic Analysis ReviewLarrea Biosciences Corp (LRRA) - Financial and Strategic Analysis Review / / Summary / / Larrea Biosciences Corp (Larrea Bioscie |
2010 | 125,00$ |
Jordan Emirates Insurance Co Psc (OASI) - Financial and Strategic Analysis ReviewJordan Emirates Insurance Co Psc (OASI) - Financial and Strategic Analysis Review / / Summary / / Jordan Emirates Insurance Co P |
2010 | 250,00$ |
Activar Technical Products Group (MGSR) - Financial and Strategic Analysis ReviewActivar Technical Products Group (MGSR) - Financial and Strategic Analysis Review / / Summary / / Activar Technical Products Gro |
2010 | 125,00$ |
China Bio-Immunity Corporation (CHHB) - Financial and Strategic Analysis ReviewChina Bio-Immunity Corporation (CHHB) - Financial and Strategic Analysis Review / / Summary / / China Bio-Immunity Corporation ( |
2010 | 125,00$ |
Orchestra Therapeutics, Inc. (OCHT) - Financial and Strategic Analysis ReviewOrchestra Therapeutics, Inc. (OCHT) - Financial and Strategic Analysis Review / / Summary / / Orchestra Therapeutics, Inc. (OCHT |
2010 | 125,00$ |
VitalCare Diabetes Treatment Centers, Inc. (VDTI) - Financial and Strategic Analysis ReviewVitalCare Diabetes Treatment Centers, Inc. (VDTI) - Financial and Strategic Analysis Review / / Summary / / VitalCare Diabetes T |
2010 | 250,00$ |
Xechem International, Inc (XKEMQ) - Financial and Strategic Analysis ReviewXechem International, Inc (XKEMQ) - Financial and Strategic Analysis Review / / Summary / / Xechem International, Inc. (Xechem) |
2010 | 125,00$ |
GlycoGenesys, Inc. (GLGSQ) - Financial and Strategic Analysis ReviewGlycoGenesys, Inc. (GLGSQ) - Financial and Strategic Analysis Review / / Summary / / GlycoGenesys, Inc. (formerly known as SafeS |
2010 | 125,00$ |
Micro Laboratories, Inc. (MLAR) - Financial and Strategic Analysis ReviewMicro Laboratories, Inc. (MLAR) - Financial and Strategic Analysis Review / / Summary / / Micro Laboratories, Inc. (Micro Lab) i |
2010 | 125,00$ |
Argonaut Technologies, Inc. (AGNT) - Financial and Strategic Analysis ReviewArgonaut Technologies, Inc. (AGNT) - Financial and Strategic Analysis Review / / Summary / / Argonaut Technologies, Inc. (Argona |
2010 | 125,00$ |
Kaken Pharmaceutical Co., Ltd. (4521) - Financial and Strategic Analysis ReviewKaken Pharmaceutical Co., Ltd. (4521) - Financial and Strategic Analysis Review / / Summary / / Kaken Pharmaceutical Co., Ltd. ( |
2010 | 125,00$ |
Egis Gyogyszergyar Nyrt. (EGIS) - Financial and Strategic Analysis ReviewEgis Gyogyszergyar Nyrt. (EGIS) - Financial and Strategic Analysis Review / / Summary / / Egis Gyogyszergyar Nyrt (Egis) is enga |
2010 | 125,00$ |
Hillestad Pharmaceuticals Inc. (HPH) - Financial and Strategic Analysis ReviewHillestad Pharmaceuticals Inc. (HPH) - Financial and Strategic Analysis Review / / Summary / / Hillestad Pharmaceuticals Inc. (H |
2010 | 125,00$ |
Xeno Transplants Corporation (XENO) - Financial and Strategic Analysis ReviewXeno Transplants Corporation (XENO) - Financial and Strategic Analysis Review / / Summary / / Xeno Transplants Corporation, (Xen |
2010 | 125,00$ |
Integrated Pharmaceuticals, Inc. (INTP) - Financial and Strategic Analysis ReviewIntegrated Pharmaceuticals, Inc. (INTP) - Financial and Strategic Analysis Review / / Summary / / Integrated Pharmaceuticals, In |
2010 | 125,00$ |
Naturade, Inc. (NRDCQ) - Financial and Strategic Analysis ReviewNaturade, Inc. (NRDCQ) - Financial and Strategic Analysis Review / / Summary / / Naturade, Inc. (Naturade) markets scientificall |
2010 | 125,00$ |
NanoRepro AG (NN6) - Financial and Strategic Analysis ReviewNanoRepro AG (NN6) - Financial and Strategic Analysis Review / / Summary / / NanoRepro AG (NanoRepro), a pan-European company fo |
2010 | 125,00$ |
Comprehensive Healthcare Solutions, Inc. (HYBE) - Financial and Strategic Analysis ReviewComprehensive Healthcare Solutions, Inc. (HYBE) - Financial and Strategic Analysis Review / / Summary / / Comprehensive Healthca |
2010 | 125,00$ |
Maxicare Health Plans, Inc. (MAXI) - Financial and Strategic Analysis ReviewMaxicare Health Plans, Inc. (MAXI) - Financial and Strategic Analysis Review / / Summary / / Maxicare Health Plans, Inc. (MHP) i |
2010 | 125,00$ |
Mednax, Inc. (MD) - Financial and Strategic Analysis ReviewMednax, Inc. (MD) - Financial and Strategic Analysis Review / / Summary / / Mednax, Inc. (Mednax) is a publicly held healthcare |
2010 | 125,00$ |
MedTech Holdings Limited (MEDTECH) - Financial and Strategic Analysis ReviewMedTech Holdings Limited (MEDTECH) - Financial and Strategic Analysis Review / / Summary / / MedTech Holdings Limited (MedTech) |
2010 | 125,00$ |
Union Dental Holdings, Inc. (UDHI) - Financial and Strategic Analysis ReviewUnion Dental Holdings, Inc. (UDHI) - Financial and Strategic Analysis Review / / Summary / / Union Dental Holdings, Inc. (Union |
2010 | 125,00$ |
VivoMedica plc - Financial and Strategic Analysis ReviewVivoMedica plc - Financial and Strategic Analysis Review / / Summary / / VivoMedica plc (VivoMedica) is engaged in research, dev |
2010 | 250,00$ |
InMedica Development Corporation (IMDD) - Financial and Strategic Analysis ReviewInMedica Development Corporation(IMDD) - Financial and Strategic Analysis Review / / Summary / / InMedica Development Corporatio |
2010 | 250,00$ |
Lady Drug Store Co., Ltd. (3027) - Strategic Analysis ReviewThis comprehensive SWOT profile of Lady Drug Store Co., Ltd. provides you an in-depth strategic analysis of the company’s business |
2010 | 250,00$ |
Familymeds Group Inc. - Strategic Analysis ReviewThis comprehensive SWOT profile of Familymeds Group Inc. provides you an in-depth strategic analysis of the company’s businesses a |
2010 | 250,00$ |
Skinwell Holdings Limited (SKW) - Strategic Analysis ReviewThis comprehensive SWOT profile of Skinwell Holdings Limited provides you an in-depth strategic analysis of the company’s business |
2010 | 250,00$ |
Actinogen LIMITED - Strategic Analysis ReviewActinogen Limited is a broad based biotechnology company engaged in the detection and isolation of soil actinomycetes found in Wes |
2010 | 250,00$ |
Aevum Limited (AVE) - Strategic Analysis ReviewAevum Limited (Aveum) is principally engaged in the development, operation and management of retirement villages and aged care fac |
2010 | 250,00$ |
Eyecare Partners Limited (EPL) - Strategic Analysis ReviewEyecare Partners Limited is healthcare company principally engaged in the operations of optometry practices providing optometric h |
2010 | 250,00$ |
Helicon Group Limited - Strategic Analysis ReviewHelicon Group Limited is a pharma company engaged in finding and providing oppopportunities for advanced western Biomedical produc |
2010 | 250,00$ |
Assura Group Limited - Strategic Analysis ReviewAssura Group Limited runs it business through 4 segments: Medical, Pharmacy, Property and Property Development. The medical depart |
2010 | 125,00$ |
American Biogenetic Sciences, Inc. (MABAA) - Strategic Analysis ReviewAmerican Biogenetic Sciences, Inc. (ABS) is a biopharmaceutical company focused in researching, developing and marketing cardiovas |
2010 | 250,00$ |
Anhui Fengyuan Pharmaceutical Co., Ltd. - Strategic Analysis ReviewThis comprehensive SWOT profile of Anhui Fengyuan Pharmaceutical Co., Ltd. provides you an in-depth strategic analysis of the comp |
2010 | 125,00$ |
Apeloa Company Limited (739) - Strategic Analysis ReviewThis comprehensive SWOT profile of Apeloa Company Limited provides you an in-depth strategic analysis of the company’s businesses |
2010 | 125,00$ |
IDT Australia Limited (IDT) - Strategic Analysis ReviewIDT Australia Limited (IDT), formerly Institute of Drug Technology Australia Limited, is an Australia-based pharmaceutical manufac |
2010 | 250,00$ |
Kiotech International plc (KIO) - Strategic Analysis ReviewKiotech International Plc is principally engaged in the development and marketing of biochemical stimulants. The company's mainly |
2010 | 250,00$ |
Life Therapeutics Limited (LFE) - Strategic Analysis ReviewLife Therapeutics Limited (Life Therapeutics) is a biotechnology company engaged in providing therapeutics products and diagnostic |
2010 | 250,00$ |
Lifebank Corp. (LBK) - Strategic Analysis ReviewLifebank Corp.(Lifebank) is a healthcare services company principally engaged in the business of processing and cryo-preservation |
2010 | 250,00$ |
BioProspect Limited (BPO) - Strategic Analysis ReviewBioProspect Limited, a brisbane based natural compound and product development company, engages in research and commercialization |
2010 | 250,00$ |
National Research Corporation (NRCI) - Strategic Analysis ReviewNational Research Corporation is a healthcare company principally engaged in providing ongoing survey-based performance measuremen |
2010 | 250,00$ |
OBJ LIMITED - Strategic Analysis ReviewOBJ LIMITED is formed with the compabination of medical, scientific and commercial specialists to deliver medical technology solut |
2010 | 125,00$ |
Clover Corporation Limited (CLV) - Strategic Analysis ReviewThis comprehensive SWOT profile of Clover Corporation Limited provides you an in-depth strategic analysis of the company’s busines |
2010 | 125,00$ |
PEARL HEALTHCARE LIMITED (PHL) - Strategic Analysis ReviewPearl Healthcare Limited is an Australia-based company which is principally engaged in the management, acquisition, consolidation |
2010 | 250,00$ |
Advanced Medical Institute Inc. (AVMD) - Strategic Analysis ReviewThis comprehensive SWOT profile of Advanced Medical Institute Inc. provides you an in-depth strategic analysis of the company’s bu |
2010 | 250,00$ |
NightHawk Radiology Holdings, Inc. (NHWK) - Strategic Analysis ReviewThis comprehensive SWOT profile of NightHawk Radiology Holdings, Inc. provides you an in-depth strategic analysis of the company’s |
2010 | 250,00$ |
Setiba Participacoes SA (SETI3B) - Strategic Analysis ReviewThis comprehensive SWOT profile of Setiba Participacoes SA provides you an in-depth strategic analysis of the company’s businesses |
2010 | 250,00$ |
Krebs Biochemicals & Industries Ltd - Strategic Analysis ReviewKrebs Biochemicals & Industries Limited is a pharmaceutical company engaged in the manufacture and sale of API. The company manufa |
2010 | 250,00$ |
Insas Berhad (INSAS) - Strategic Analysis ReviewThis comprehensive SWOT profile of Insas Berhad provides you an in-depth strategic analysis of the company’s businesses and operat |
2010 | 250,00$ |
NuRx Pharmaceuticals Inc - Strategic Analysis ReviewThis comprehensive SWOT profile of NuRx Pharmaceuticals Inc provides you an in-depth strategic analysis of the company’s businesse |
2010 | 125,00$ |
NL Industries, Inc. (NL) - Strategic Analysis ReviewNL Industries, Inc. (NL Industries) is primarily a holding company that operates through its subsidiaries namely, CompX Internatio |
2010 | 250,00$ |
Dimed S.A Distribuidora de Medicamentos (PNVL3) - Strategic Analysis ReviewThis comprehensive SWOT profile of Dimed S.A Distribuidora de Medicamentos provides you an in-depth strategic analysis of the comp |
2010 | 250,00$ |
Soprocal, Calerias e Industrias S.A. (SOPROCAL) - Strategic Analysis ReviewThis comprehensive SWOT profile of Soprocal, Calerias e Industrias S.A. provides you an in-depth strategic analysis of the company |
2010 | 250,00$ |
Arab Pharmaceuticals (ADCI) - Strategic Analysis ReviewThis comprehensive SWOT profile of Arab Pharmaceuticals provides you an in-depth strategic analysis of the company’s businesses an |
2010 | 250,00$ |
Divis Laboratories Limited - Strategic Analysis ReviewDivis Laboratories Limited (Divis), formerly known as Divi’s Research Center is a biotechnology company. It is engaged in the prod |
2010 | 125,00$ |
Anand Electric Supply Company Limited (501630) - Strategic Analysis ReviewThis comprehensive SWOT profile of Anand Electric Supply Company Limited provides you an in-depth strategic analysis of the compan |
2010 | 250,00$ |
Beijing SL Pharmaceutical Co., Ltd (2038) - Strategic Analysis ReviewBeijing SL Pharmaceutical Co., Ltd (SL Pharm) is a biotechnology-pharmaceutical company, engaged in developing and marketing of ge |
2010 | 250,00$ |
Adinath Bio-Labs Limited (590088) - Strategic Analysis ReviewThis comprehensive SWOT profile of Adinath Bio-Labs Limited provides you an in-depth strategic analysis of the company’s businesse |
2010 | 250,00$ |
Origio AS - Strategic Analysis ReviewOrigio A/S (Origio) operates through three companies, namely, MediCult, Humagen Fertility Diagnostics and MidAtlantic Diagnostics. |
2010 | 250,00$ |
Huadong Medicine Co., Ltd. (963) - Strategic Analysis ReviewHuadong Medicine Co., Ltd. is engaged in manufacture and sale of medical products. It provides provides Chinese medicine products, |
2010 | 125,00$ |
GreaterChina Technology Group Limited (8032) - Strategic Analysis ReviewThis comprehensive SWOT profile of GreaterChina Technology Group Limited provides you an in-depth strategic analysis of the compan |
2010 | 250,00$ |
Select Vaccines Ltd. - Strategic Analysis ReviewThis comprehensive SWOT profile of Select Vaccines Ltd. provides you an in-depth strategic analysis of the company’s businesses an |
2010 | 125,00$ |
Dr. Reddy's Laboratories Ltd. - Strategic Analysis ReviewThis comprehensive SWOT profile of Dr. Reddy's Laboratories Ltd. provides you an in-depth strategic analysis of the company’s busi |
2010 | 125,00$ |
I''rom Holdings Co. Ltd. (2372) - Strategic Analysis ReviewThis comprehensive SWOT profile of I''rom Holdings Co. Ltd. provides you an in-depth strategic analysis of the company’s businesse |
2010 | 250,00$ |
Bafna Pharmaceuticals Limited - Strategic Analysis ReviewThis comprehensive SWOT profile of Bafna Pharmaceuticals Limited provides you an in-depth strategic analysis of the company’s busi |
2010 | 250,00$ |
Daebong LS Co., Ltd. (78140) - Strategic Analysis ReviewThis comprehensive SWOT profile of Daebong LS Co., Ltd. provides you an in-depth strategic analysis of the company’s businesses an |
2010 | 250,00$ |
Bridgetech Holdings International, Inc. (BGTH) - Strategic Analysis ReviewBridgetech Holdings International, Inc. is an early-stage company focused primarily on the business of facilitating the transfer o |
2010 | 250,00$ |
Vivimed Labs Ltd (532660) - Strategic Analysis ReviewVivimed Labs (Vivimed) is an publicly held India based pharma company. It is engaged in the manufacture of ingredients used in the |
2010 | 125,00$ |
Chong Kun Dang Pharmaceutical - Strategic Analysis ReviewChong Kun Dang Pharmaceutical (CKD) is a Korean company, engaged in the manufacturing, distribution, import and export of pharmace |
2010 | 125,00$ |
Five Star Quality Care, Inc - Strategic Analysis ReviewFIVE STAR QUALITY CARE, INC. (FSQC) is basically a health care services company. It offers communities where it provides its guest |
2010 | 250,00$ |
Metropolitan Ambulance Services - Strategic Analysis ReviewMetropolitan Ambulance Service (MAS) is an Australia based emergency medical service provider. The company principally engaged in |
2010 | 250,00$ |
Select Medical Corporation - Strategic Analysis ReviewSelect Medical Corporation (Select Medical) is a US based company which provides specialty health care services in the US. Select |
2010 | 250,00$ |
Kaken Pharmaceutical Co.,Ltd. (4521) - Strategic Analysis ReviewKaken Pharmaceutical Co., Ltd. (Kaken Pharmaceutical) is a Japan based pharmaceutical company, which is engaged in the development |
2010 | 125,00$ |
KARMELSONIX LIMITED (KSX) - Strategic Analysis ReviewKarmel Sonix Limited (Karmel Sonix) is an Australian based company engaged in research, development and commercialization of medic |
2010 | 125,00$ |
Medicago Inc. (MDG) - Strategic Analysis ReviewMedicago Inc. (Medicago) is a publicly held Canada based biotechnology company. It is engaged in the development of vaccines based |
2010 | 250,00$ |
Mesoblast Ltd (MSB) - Strategic Analysis ReviewMesoblast Limited is an Australian biotechnology company which is committed to the development of novel treatments for orthopaedic |
2010 | 250,00$ |
Mednax, Inc - Strategic Analysis ReviewMednax, Inc (Mednax) is an US based health service provider. The company principally engages in providing of physician services wh |
2010 | 250,00$ |
Biovet JSC (53B) - Strategic Analysis ReviewBIOVET JSC (BIOVET) is a privately held biotechnology company that is engaged in the manufacture and marketing of medicated and n |
2010 | 250,00$ |
Movetis NV (MOVE ) - Strategic Analysis ReviewMovetis NV (Movetis) is a public traded pharmaceutical company engaged in the discovery, development and marketing of innovative d |
2010 | 250,00$ |
Kiwa Bio-Tech Products Group Corporation (KWBT) - Strategic Analysis ReviewKiwa Bio-Tech Products Group Corporation (Kiwa Bio-Tech) develops, manufactures, distributes and markets environmentally safe bio- |
2010 | 250,00$ |
Mach One Corporation (MNCN) - Strategic Analysis ReviewMach One Corporation (Mach One) is a veterinary services company that offers a variety of services ranging from improving the immu |
2010 | 250,00$ |
CellSeed Inc. (7776) - Strategic Analysis ReviewCellSeed Inc. (CellSeed) is a publicly held company that is engaged in developing, supplying and commercialization of cell culture |
2010 | 250,00$ |
Cellmid Ltd (CDY) - Strategic Analysis ReviewCellmid Ltd (Cellmid) is a privately held biotechnology company. It is principally engaged in the development of therapeutic and d |
2010 | 250,00$ |
London Pacific & Partners, Inc. (LDPP) - Strategic Analysis ReviewLondon Pacific & Partners, Inc. (London Pacific) is engaged in providing various services in the health care, hospitality, and fin |
2010 | 250,00$ |
ResCare, Inc (RSCR) - Strategic Analysis ReviewResCare, Inc (ResCare) is a healthcare services company involved in providing job training and educational supports to people disa |
2010 | 250,00$ |
The Medipattern Corporation (MKI) - Strategic Analysis ReviewThe Medipattern Corporation (Medipattern) is a medical technology company specializing in computer-aided detection (CAD) solutions |
2010 | 250,00$ |
Brain Resources Company Limited (The) - Strategic Analysis ReviewThis comprehensive SWOT profile of Brain Resources Company Limited (The) provides you an in-depth strategic analysis of the compan |
2010 | 250,00$ |
Summer Infant, Inc. - Strategic Analysis ReviewSummer Infant, Inc. is a consumer goods and baby care products manufacturing company. The company products includes nursery audio/ |
2010 | 250,00$ |
Allied Hearts Holdings Co., Ltd. - Strategic Analysis ReviewAllied Hearts Holdings Co., Ltd. is a pharmaceutical products, cosmetics and miscellaneous daily goods retailer. It is also engage |
2010 | 250,00$ |
BioScrip, Inc - Strategic Analysis ReviewBioScrip, Inc. is a provider of specialty pharmaceutical and pharmacy benefit management (PBM) services in the United States. It o |
2010 | 250,00$ |
China National Medicines Corp Ltd. - Strategic Analysis ReviewThis comprehensive SWOT profile of China National Medicines Corp Ltd. provides you an in-depth strategic analysis of the company’s |
2010 | 250,00$ |
Chongqing Tongjunge Co., Ltd. - Strategic Analysis ReviewThis comprehensive SWOT profile of Chongqing Tongjunge Co., Ltd. provides you an in-depth strategic analysis of the company’s busi |
2010 | 250,00$ |
CNTIC Trading Co. Ltd. - Strategic Analysis ReviewThis comprehensive SWOT profile of CNTIC Trading Co. Ltd. provides you an in-depth strategic analysis of the company’s businesses |
2010 | 250,00$ |
Kirindo Co Ltd - Strategic Analysis ReviewKirindo Co., Ltd. a drug store chains and dispensing pharmacies company. It offers medical products, healthcare products, cosmetic |
2010 | 250,00$ |
Medca Japan Co. Ltd. - Strategic Analysis ReviewThis comprehensive SWOT profile of Medca Japan Co. Ltd. provides you an in-depth strategic analysis of the company’s businesses an |
2010 | 250,00$ |
Orpea SA - Strategic Analysis ReviewThis comprehensive SWOT profile of Orpea SA provides you an in-depth strategic analysis of the company’s businesses and operations |
2010 | 250,00$ |
Dermisonics, Inc. (DMSI) - Financial and Strategic Analysis ReviewDermisonics, Inc. (DMSI) - Financial and Strategic Analysis Review / / Summary / / Dermisonics, Inc. (Dermisonics) is a drug del |
2010 | 125,00$ |
DiaSys Corporation (DYXC) - Financial and Strategic Analysis ReviewDiaSys Corporation (DYXC) - Financial and Strategic Analysis Review / / Summary / / DiaSys Corporation ( DiaSys ) is a medical d |
2010 | 125,00$ |
Diomed Holdings, Inc. (DIOMQ) - Financial and Strategic Analysis ReviewDiomed Holdings, Inc. (DIOMQ) - Financial and Strategic Analysis Review / / Summary / / Diomed Holdings, Inc. (Diomed) is engage |
2010 | 125,00$ |
Immunicon Corporation (IMMCQ) - Financial and Strategic Analysis ReviewImmunicon Corporation (IMMCQ) - Financial and Strategic Analysis Review / / Summary / / Immunicon Corporation (Immunicon) is eng |
2010 | 125,00$ |
Medwave, Inc. (MDWV) - Financial and Strategic Analysis ReviewMedwave, Inc. (MDWV) - Financial and Strategic Analysis Review / / Summary / / Medwave, Inc . ( Medwave ) is a medical devices c |
2010 | 125,00$ |
Forticell Bioscience, Inc. (FORBQ) - Financial and Strategic Analysis ReviewForticell Bioscience, Inc. (FORBQ) - Financial and Strategic Analysis Review / / Summary / / Forticell Bioscience, Inc. ( Fortic |
2010 | 125,00$ |
Cyberkinetics Neurotechnology Systems, Inc. (CYKN) - Financial and Strategic Analysis ReviewCyberkinetics Neurotechnology Systems, Inc. (CYKN) - Financial and Strategic Analysis Review / / Summary / / Cyberkinetics Neuro |
2010 | 125,00$ |
CareCentric, Inc. (CREC) - Financial and Strategic Analysis ReviewCareCentric, Inc. (CREC) - Financial and Strategic Analysis Review / / Summary / / CareCentric, Inc. (CareCentric) is engaged in |
2010 | 125,00$ |
Planar Systems, Inc. (PLNR) - Financial and Strategic Analysis ReviewPlanar Systems, Inc. (PLNR) - Financial and Strategic Analysis Review / / Summary / / Planar Systems, Inc. (Planar Systems) is e |
2010 | 125,00$ |
GRANT Life Sciences, Inc. (GLIF) - Financial and Strategic Analysis ReviewGRANT Life Sciences, Inc. (GLIF) - Financial and Strategic Analysis Review / / Summary / / Grant Life Sciences, Inc. (GLS) is a |
2010 | 125,00$ |
StatSure Diagnostic Systems, Inc. (SSUR) - Financial and Strategic Analysis ReviewStatSure Diagnostic Systems, Inc. (SSUR) - Financial and Strategic Analysis Review / / Summary / / StatSure Diagnostic Systems, |
2010 | 125,00$ |
DelSite, Inc. (CARN) - Financial and Strategic Analysis ReviewDelSite, Inc. (CARN) - Financial and Strategic Analysis Review / / Summary / / DelSite, Inc. (DelSite) is a global provider of m |
2010 | 125,00$ |
XTENT, Inc. (XTNT) - Financial and Strategic Analysis ReviewXTENT, Inc. (XTNT) - Financial and Strategic Analysis Review / / Summary / / XTENT, Inc. (XTENT), a development stage medical de |
2010 | 250,00$ |
Heart Tronics, Inc. (HRTT) - Financial and Strategic Analysis ReviewHeart Tronics, Inc. (HRTT) - Financial and Strategic Analysis Review / / Summary / / Heart Tronics, Inc. (Heart Tronics), former |
2010 | 125,00$ |
MedicalCV, Inc. (MCVI) - Financial and Strategic Analysis ReviewMedicalCV, Inc. (MCVI) - Financial and Strategic Analysis Review / / Summary / / MedicalCV, Inc. (MedicalCV) is engaged in the d |
2010 | 125,00$ |
Dmatek Ltd. (DTK) - Financial and Strategic Analysis ReviewDmatek Ltd. (DTK) - Financial and Strategic Analysis Review / / Summary / / Dmatek Ltd. (Dmatek) is principally engaged in the m |
2010 | 125,00$ |
Advanced Refractive Technologies, Inc. (ARFR) - Financial and Strategic Analysis ReviewAdvanced Refractive Technologies, Inc. (ARFR) - Financial and Strategic Analysis Review / / Summary / / Advanced Refractive Tech |
2010 | 125,00$ |
Obagi Medical Products, Inc. (OMPI) - Financial and Strategic Analysis ReviewObagi Medical Products, Inc. (OMPI) - Financial and Strategic Analysis Review / / Summary / / Obagi Medical Products, Inc. (Obag |
2010 | 250,00$ |
Lancer Orthodontics, Inc. (LANZ) - Financial and Strategic Analysis ReviewLancer Orthodontics, Inc. (LANZ) - Financial and Strategic Analysis Review / / Summary / / Lancer Orthodontics, Inc. (Lancer Ort |
2010 | 125,00$ |
Carpenter Technology Corporation (CRS) - Financial and Strategic Analysis ReviewCarpenter Technology Corporation (CRS) - Financial and Strategic Analysis Review / / Summary / / Carpenter Technology Corporatio |
2010 | 125,00$ |
QuadraMed Corporation (QDHC) - Financial and Strategic Analysis ReviewQuadraMed Corporation (QDHC) - Financial and Strategic Analysis Review / / Summary / / Quadramed Corporation (Quadramed) is a pu |
2010 | 125,00$ |
Telzuit Medical Technologies, Inc. (TZMT) - Financial and Strategic Analysis ReviewTelzuit Medical Technologies, Inc. (TZMT) - Financial and Strategic Analysis Review / / Summary / / Telzuit Medical Technologies |
2010 | 125,00$ |
Andover Medical, Inc. (ADOV) - Financial and Strategic Analysis ReviewAndover Medical, Inc. (ADOV) - Financial and Strategic Analysis Review / / Summary / / Andover Medical, Inc. (AMI) is engaged in |
2010 | 125,00$ |
Computerized Thermal Imaging, Inc. (COIB) - Financial and Strategic Analysis ReviewComputerized Thermal Imaging, Inc. (COIB) - Financial and Strategic Analysis Review / / Summary / / Computerized Thermal Imaging |
2010 | 125,00$ |
Exploit Technologies Pte Ltd (3544) - Financial and Strategic Analysis ReviewExploit Technologies Pte Ltd (3544) - Financial and Strategic Analysis Review / / Summary / / Exploit Technologies Pte Ltd (Expl |
2010 | 125,00$ |
Nano Mask, Inc. (NANM) - Financial and Strategic Analysis ReviewNano Mask, Inc. (NANM) - Financial and Strategic Analysis Review / / Summary / / Nano Mask, Inc. (formerly known as Emergency Fi |
2010 | 125,00$ |
E Med Future, Inc. (EMDF) - Financial and Strategic Analysis ReviewE Med Future, Inc. (EMDF) - Financial and Strategic Analysis Review / / Summary / / E Med Future, Inc. (E Med Future) is engaged |
2010 | 125,00$ |
Refocus Group, Inc. (RFCS) - Financial and Strategic Analysis ReviewRefocus Group, Inc. (RFCS) - Financial and Strategic Analysis Review / / Summary / / Refocus Group, Inc. is a medical device com |
2010 | 125,00$ |
Banyan International Corp. (BNYN) - Financial and Strategic Analysis ReviewBanyan International Corp. (BNYN) - Financial and Strategic Analysis Review / / Summary / / Banyan International Corp. (Banyan I |
2010 | 125,00$ |
ReGen Biologics, Inc. (RGBI) - Financial and Strategic Analysis ReviewReGen Biologics, Inc. (RGBI) - Financial and Strategic Analysis Review / / Summary / / ReGen Biologics, Inc. (ReGen) is a public |
2010 | 250,00$ |
ATS Automation Tooling Systems Inc. (ATA) - Financial and Strategic Analysis ReviewATS Automation Tooling Systems Inc. (ATA) - Financial and Strategic Analysis Review / / Summary / / ATS Automation Tooling Syste |
2010 | 250,00$ |
CSMG Technologies, Inc. (CTGI) - Financial and Strategic Analysis ReviewCSMG Technologies, Inc. (CTGI) - Financial and Strategic Analysis Review / / Summary / / CSMG Technologies, Inc. (CSMG Technolog |
2010 | 125,00$ |
Celera Corporation (CRA) - Financial and Strategic Analysis ReviewCelera Corporation (CRA) - Financial and Strategic Analysis Review / / Summary / / Celera Corporation (Celera) is a publicly hel |
2010 | 125,00$ |
Abviva, Inc. (ABVV) - Financial and Strategic Analysis ReviewAbviva, Inc. (ABVV) - Financial and Strategic Analysis Review / / Summary / / Abviva, Inc. (Abviva) is a biomedical company enga |
2010 | 125,00$ |
PreMD Inc. (PMD) - Financial and Strategic Analysis ReviewPreMD Inc. (PMD) - Financial and Strategic Analysis Review / / Summary / / PreMD Inc. (PreMD) a medical device company that is p |
2010 | 125,00$ |
DNAPrint Genomics, Inc. (DNAG) - Financial and Strategic Analysis ReviewDNAPrint Genomics, Inc. (DNAG) - Financial and Strategic Analysis Review / / Summary / / DNAPrint Genomics, Inc. (DNAPrint Genom |
2010 | 125,00$ |
Immunodiagnostic Systems Holdings PLC (IDH) - Financial and Strategic Analysis ReviewImmunodiagnostic Systems Holdings PLC (IDH) - Financial and Strategic Analysis Review / / Summary / / Immunodiagnostic Systems H |
2010 | 125,00$ |
Central Uni Co Ltd (7706) - Financial and Strategic Analysis ReviewCentral Uni Co Ltd (7706) - Financial and Strategic Analysis Review / / Summary / / Central Uni Co., Ltd. (C&U) is engaged in de |
2010 | 250,00$ |
Pace Medical, Inc. (PMDL) - Financial and Strategic Analysis ReviewPace Medical, Inc. (PMDL) - Financial and Strategic Analysis Review / / Summary / / Pace Medical, Inc. is a medical device compa |
2010 | 125,00$ |
Pacific Safety Products Inc (PSP) - Financial and Strategic Analysis ReviewPacific Safety Products Inc (PSP) - Financial and Strategic Analysis Review / / Summary / / Pacific Safety Products Inc. (Pacifi |
2010 | 250,00$ |
Simrad Optronics Asa (SIT) - Financial and Strategic Analysis ReviewSimrad Optronics Asa (SIT) - Financial and Strategic Analysis Review / / Summary / / Simrad Optronics ASA is one of the leading |
2010 | 250,00$ |
Universal Technology Systems Inc (5206) - Financial and Strategic Analysis ReviewUniversal Technology Systems Inc (5206) - Financial and Strategic Analysis Review / / Summary / / Universal Technology Systems I |
2010 | 125,00$ |
Telanetix Inc. (TNXI) - Financial and Strategic Analysis ReviewTelanetix Inc. (TNXI) - Financial and Strategic Analysis Review / / Summary / / Telanetix Inc. is a communications solutions pro |
2010 | 250,00$ |
Nuance Communications, Inc. (NUAN) - Financial and Strategic Analysis ReviewNuance Communications, Inc. (NUAN) - Financial and Strategic Analysis Review / / Summary / / Nuance Communications, Inc. (Nuance |
2010 | 125,00$ |
ALAPIS S.A. (ALAPIS) - Financial and Strategic Analysis ReviewALAPIS S.A. (ALAPIS) - Financial and Strategic Analysis Review / / Summary / / ALAPIS S.A. (ALAPIS) is a US based pharmaceutical |
2010 | 250,00$ |
Dialysis Corporation of America (DCAI) - Financial and Strategic Analysis ReviewDialysis Corporation of America (DCAI) - Financial and Strategic Analysis Review / / Summary / / Dialysis Corporation of America |
2010 | 250,00$ |
RCM Technologies, Inc. (RCMT) - Financial and Strategic Analysis ReviewRCM Technologies, Inc. (RCMT) - Financial and Strategic Analysis Review / / Summary / / RCM Technologies, Inc. (RCM) is a US bas |
2010 | 125,00$ |
Cimatron Ltd. (CIMT) - Financial and Strategic Analysis ReviewCimatron Ltd. (CIMT) - Financial and Strategic Analysis Review / / Summary / / Cimatron Ltd. (Cimatron) is a software tools prov |
2010 | 125,00$ |
The Quantum Group, Inc. (QNGPE) - Financial and Strategic Analysis ReviewThe Quantum Group, Inc. (QNGPE) - Financial and Strategic Analysis Review / / Summary / / The Quantum Group, Inc. (Quantum) is a |
2010 | 250,00$ |
IMPATH Bankruptcy Liquidating Trust (IBLTZ) - Financial and Strategic Analysis ReviewIMPATH Bankruptcy Liquidating Trust (IBLTZ) - Financial and Strategic Analysis Review / / Summary / / IMPATH Bankruptcy Liquidat |
2010 | 125,00$ |
Univec, Inc. (UNVC) - Financial and Strategic Analysis ReviewUnivec, Inc. (UNVC) - Financial and Strategic Analysis Review / / Summary / / Univec, Inc. (Univec) is a publicly held pharmaceu |
2010 | 125,00$ |
Clean Diesel Technologies, Inc. (CDTI) - Financial and Strategic Analysis ReviewClean Diesel Technologies, Inc. (CDTI) - Financial and Strategic Analysis Review / / Summary / / Clean Diesel Technologies, Inc. |
2010 | 250,00$ |
Curon Medical, Inc. (CRNM) - Financial and Strategic Analysis ReviewCuron Medical, Inc. (CRNM) - Financial and Strategic Analysis Review / / Summary / / Curon Medical, Inc. (Curon) is a publicly h |
2010 | 125,00$ |
Aksys, Ltd. (AKSY) - Financial and Strategic Analysis ReviewAksys, Ltd. (AKSY) - Financial and Strategic Analysis Review / / Summary / / Aksys, Ltd., (Aksys) is a publicly held pharmaceuti |
2010 | 125,00$ |
Ardana Plc (ARA) - Financial and Strategic Analysis ReviewArdana Plc (ARA) - Financial and Strategic Analysis Review / / Summary / / Ardana Plc (Ardana) is a publicly held UK based pharm |
2010 | 125,00$ |
Arterium Corporation (KMED) - Financial and Strategic Analysis ReviewArterium Corporation (KMED) - Financial and Strategic Analysis Review / / Summary / / Arterium Corporation (Arterium) is a publi |
2010 | 125,00$ |
Panacos Pharmaceuticals, Inc. (PANC) - Financial and Strategic Analysis ReviewPanacos Pharmaceuticals, Inc. (PANC) - Financial and Strategic Analysis Review / / Summary / / Panacos Pharmaceuticals, Inc. (Pa |
2010 | 125,00$ |
Rad Source Technologies, Inc (IRAD) - Financial and Strategic Analysis ReviewRad Source Technologies, Inc (IRAD) - Financial and Strategic Analysis Review / / Summary / / Rad Source Technologies, Inc (Rad |
2010 | 125,00$ |
Synvista Therapeutics, Inc. (SYNI) - Financial and Strategic Analysis ReviewSynvista Therapeutics, Inc. (SYNI) - Financial and Strategic Analysis Review / / Summary / / Synvista Therapeutics, Inc. (Synvis |
2010 | 125,00$ |
Extendicare Real Estate Investment Trust (EXE.UN) - Financial and Strategic Analysis ReviewExtendicare Real Estate Investment Trust (EXE.UN) - Financial and Strategic Analysis Review / / Summary / / Extendicare Real Est |
2010 | 125,00$ |
Life Sciences Research, Inc. (LSR) - Financial and Strategic Analysis ReviewLife Sciences Research, Inc. (LSR) - Financial and Strategic Analysis Review / / Summary / / Life Sciences Research, Inc. (Life |
2010 | 125,00$ |
PLIVA d.d. (PLVA-R-A) - Financial and Strategic Analysis ReviewPLIVA d.d. (PLVA-R-A) - Financial and Strategic Analysis Review / / Summary / / PLIVA d.d.( PLIVA), is a joint stock company, wh |
2010 | 125,00$ |
Symbion Health Limited (SYHTY) - Financial and Strategic Analysis ReviewSymbion Health Limited (SYHTY) - Financial and Strategic Analysis Review / / Summary / / Symbion Health Limited (Symbion Health) |
2010 | 125,00$ |
Tapestry Pharmaceuticals, Inc. (TPPHQ) - Financial and Strategic Analysis ReviewTapestry Pharmaceuticals, Inc. (TPPHQ) - Financial and Strategic Analysis Review / / Summary / / Tapestry Pharmaceuticals, Inc., |
2010 | 125,00$ |
GelStat Corporation (GSAC) - Financial and Strategic Analysis ReviewGelStat Corporation (GSAC) - Financial and Strategic Analysis Review / / Summary / / GelStat Corporation (GelStat) is a publicly |
2010 | 125,00$ |
Genitope Corporation (GTOP) - Financial and Strategic Analysis ReviewGenitope Corporation (GTOP) - Financial and Strategic Analysis Review / / Summary / / Genitope Corporation (Genitope) is a publi |
2010 | 125,00$ |
ICSGlobal Limited (ICS) - Financial and Strategic Analysis ReviewICSGlobal Limited (ICS) - Financial and Strategic Analysis Review / / Summary / / ICSGlobal Limited (ICSGlobal) is a medical ban |
2010 | 125,00$ |
AVAX Technologies, Inc. (AVXT) - Financial and Strategic Analysis ReviewAVAX Technologies, Inc. (AVXT) - Financial and Strategic Analysis Review / / Summary / / AVAX Technologies, Inc. (AVAX) is a pub |
2010 | 125,00$ |
Medical Therapies Limited (CDY) - Financial and Strategic Analysis ReviewMedical Therapies Limited (CDY) - Financial and Strategic Analysis Review / / Summary / / Medical Therapies Limited (Medical The |
2010 | 250,00$ |
MediSolution Ltd. (MSH) - Financial and Strategic Analysis ReviewMediSolution Ltd. (MSH) - Financial and Strategic Analysis Review / / Summary / / MediSolution Ltd. is a healthcare and public s |
2010 | 125,00$ |
BioForce Nanosciences Holdings, Inc. (BFNH) - Financial and Strategic Analysis ReviewBioForce Nanosciences Holdings, Inc. (BFNH) - Financial and Strategic Analysis Review / / Summary / / BioForce Nanosciences Hold |
2010 | 125,00$ |
MIGENIX Inc. (MGI) - Financial and Strategic Analysis ReviewMIGENIX Inc. (MGI) - Financial and Strategic Analysis Review / / Summary / / MIGENIX Inc. (MIGENIX) is a publicly held bio-pharm |
2010 | 125,00$ |
Chemokine Therapeutics Corp. (CTI) - Financial and Strategic Analysis ReviewChemokine Therapeutics Corp. (CTI) - Financial and Strategic Analysis Review / / Summary / / Chemokine Therapeutics Corp. (Chemo |
2010 | 125,00$ |
Peplin, Inc. (PLI) - Financial and Strategic Analysis ReviewPeplin, Inc. (PLI) - Financial and Strategic Analysis Review / / Summary / / Peplin, Inc. (Peplin) is a pharmaceutical company p |
2010 | 250,00$ |
VioQuest Pharmaceuticals, Inc. (VOQP) - Financial and Strategic Analysis ReviewVioQuest Pharmaceuticals, Inc. (VOQP) - Financial and Strategic Analysis Review / / Summary / / VioQuest Pharmaceuticals is a pu |
2010 | 125,00$ |
ACI Global Corp. (ACGJ) - Financial and Strategic Analysis ReviewACI Global Corp. (ACGJ) - Financial and Strategic Analysis Review / / Summary / / ACI Global Corp. (ACI Global) is a publicly he |
2010 | 125,00$ |
ADL plc (AD.) - Financial and Strategic Analysis ReviewADL plc (AD.) - Financial and Strategic Analysis Review / / Summary / / ADL plc (ADL) is a publicly held UK based company, that |
2010 | 250,00$ |
PharmaNet Development Group Inc. (PDGI) - Financial and Strategic Analysis ReviewPharmaNet Development Group Inc. (PDGI) - Financial and Strategic Analysis Review / / Summary / / PharmaNet Development Group In |
2010 | 125,00$ |
Davi Skin, Inc. (DAVN) - Financial and Strategic Analysis ReviewDavi Skin, Inc. (DAVN) - Financial and Strategic Analysis Review / / Summary / / Davi Skin, Inc. (Davi Skin) is a publicly held |
2010 | 125,00$ |
ATC Healthcare Services Inc. (AHNA) - Financial and Strategic Analysis ReviewATC Healthcare Services Inc. (AHNA) - Financial and Strategic Analysis Review / / Summary / / ATC Healthcare Services Inc. (ATC) |
2010 | 125,00$ |
Nanobac Pharmaceuticals, Inc. (NNBP) - Financial and Strategic Analysis ReviewNanobac Pharmaceuticals, Inc. (NNBP) - Financial and Strategic Analysis Review / / Summary / / Nanobac Pharmaceuticals, Inc (Nan |
2010 | 125,00$ |
Orthometrix, Inc. (OMRX) - Financial and Strategic Analysis ReviewOrthometrix, Inc. (OMRX) - Financial and Strategic Analysis Review / / Summary / / Orthometrix, Inc. (Orthometrix) is a pharmace |
2010 | 125,00$ |
Diapulse Corporation of America (DIAC) - Financial and Strategic Analysis ReviewDiapulse Corporation of America (DIAC) - Financial and Strategic Analysis Review / / Summary / / Diapulse Corporation of America |
2010 | 125,00$ |
Herborium Group, Inc. (HBRM) - Financial and Strategic Analysis ReviewHerborium Group, Inc. (HBRM) - Financial and Strategic Analysis Review / / Summary / / Herborium Group, Inc. (Herborium) is a no |
2010 | 125,00$ |
DOV Pharmaceutical, Inc. (DOVP) - Financial and Strategic Analysis ReviewDOV Pharmaceutical, Inc. (DOVP) - Financial and Strategic Analysis Review / / Summary / / DOV Pharmaceutical, Inc. (DOV) is a ph |
2010 | 125,00$ |
PainCare Holdings, Inc. (PRXZ) - Financial and Strategic Analysis ReviewPainCare Holdings, Inc. (PRXZ) - Financial and Strategic Analysis Review / / Summary / / PainCare Holdings, Inc. (PainCare), is |
2010 | 125,00$ |
Chongkundang Corp. (1630) - Financial and Strategic Analysis ReviewChongkundang Corp. (1630) - Financial and Strategic Analysis Review / / Summary / / Chong Kun Dang Pharmaceutical Corp. (Chong K |
2010 | 125,00$ |
New York Health Care, Inc. (BBAL) - Financial and Strategic Analysis ReviewNew York Health Care, Inc. (BBAL) - Financial and Strategic Analysis Review / / Summary / / wNew York Health Care, Inc. (New Yor |
2010 | 125,00$ |
ICP Biotechnology Limited (BIO) - Financial and Strategic Analysis ReviewICP Biotechnology Limited (BIO) - Financial and Strategic Analysis Review / / Summary / / ICP Biotechnology Limited (ICP) is a b |
2010 | 125,00$ |
Entelos, Inc. (ENTL) - Financial and Strategic Analysis ReviewEntelos, Inc. (ENTL) - Financial and Strategic Analysis Review / / Summary / / Entelos, Inc. (Entelos) is the US based life scie |
2010 | 125,00$ |
Pharco SA (PHAR) - Financial and Strategic Analysis ReviewPharco SA (PHAR) - Financial and Strategic Analysis Review / / Summary / / Pharco SA (Pharco) is principally engaged in the area |
2010 | 125,00$ |
CAPS Holdings Limited (CAPS) - Financial and Strategic Analysis ReviewCAPS Holdings Limited (CAPS) - Financial and Strategic Analysis Review / / Summary / / CAPS Holdings Limited (CAPS) is one of Af |
2010 | 125,00$ |
COLTENE Holding AG (CLTN) - Financial and Strategic Analysis ReviewCOLTENE Holding AG (CLTN) - Financial and Strategic Analysis Review / / Summary / / COLTENE Holding AG (COLTENE) is specialized |
2010 | 250,00$ |
BioXell S.p.A. (BXLN) - Financial and Strategic Analysis ReviewBioXell S.p.A. (BXLN) - Financial and Strategic Analysis Review / / Summary / / BioXell S.p.A. is a biopharmaceutical company fo |
2010 | 125,00$ |
Curidium Medica plc (CUR) - Financial and Strategic Analysis ReviewCuridium Medica plc (CUR) - Financial and Strategic Analysis Review / / Summary / / Curidium Medica plc (Curidium) is a personal |
2010 | 125,00$ |
Eternal Technologies Group, Inc. (ETLT) - Financial and Strategic Analysis ReviewEternal Technologies Group, Inc. (ETLT) - Financial and Strategic Analysis Review / / Summary / / Eternal Technologies Group, In |
2010 | 125,00$ |
Genex Pharmaceutical, Inc. (GENX) - Financial and Strategic Analysis ReviewGenex Pharmaceutical, Inc. (GENX) - Financial and Strategic Analysis Review / / Summary / / Genex Pharmaceutical, Inc. (Genex Ph |
2010 | 125,00$ |
Sinobiomed, Inc. (SOBM) - Financial and Strategic Analysis ReviewSinobiomed, Inc. (SOBM) - Financial and Strategic Analysis Review / / Summary / / Sinobiomed, Inc. (Sinobiomed) is a biotechnolo |
2010 | 125,00$ |
Pacer Health Corporation (PHLH) - Financial and Strategic Analysis ReviewPacer Health Corporation (PHLH) - Financial and Strategic Analysis Review / / Summary / / Pacer Health Corporation (Pacer Health |
2010 | 125,00$ |
PharmaFarm SA (NAFA) - Financial and Strategic Analysis ReviewPharmaFarm SA (NAFA) - Financial and Strategic Analysis Review / / Summary / / PharmaFarm SA is a pharmaceutical distribution co |
2010 | 125,00$ |
Global Pharmatech, Inc. (GBLP) - Financial and Strategic Analysis ReviewGlobal Pharmatech, Inc. (GBLP) - Financial and Strategic Analysis Review / / Summary / / Global Pharmatech, Inc. (Global Pharmat |
2010 | 125,00$ |
ER Urgent Care Holdings, Inc. (ERUC) - Financial and Strategic Analysis ReviewER Urgent Care Holdings, Inc. (ERUC) - Financial and Strategic Analysis Review / / Summary / / ER Urgent Care Holdings, Inc. (ER |
2010 | 125,00$ |
Skin Health Spa PLC (SHS) - Financial and Strategic Analysis ReviewSkin Health Spa PLC (SHS) - Financial and Strategic Analysis Review / / Summary / / Skin Health Spa PLC (Skin Health Spa) is an |
2010 | 125,00$ |
Accura Animal Health Plc (ACPO) - Financial and Strategic Analysis ReviewAccura Animal Health Plc (ACPO) - Financial and Strategic Analysis Review / / Summary / / Accura Animal Health Plc (Accura) is a |
2010 | 250,00$ |
The Avicena Group, Inc. (AVCEE) - Financial and Strategic Analysis ReviewThe Avicena Group, Inc. (AVCEE) - Financial and Strategic Analysis Review / / Summary / / The Avicena Group, Inc. (Avicena) is a |
2010 | 125,00$ |
Global Advanced Wound Management: Market Analysis and Opportunity AssessmentIntroduction
/
/ GlobalData’s “Global Advanced Wound Management: Market Analysis and Opportunity Assessment” report is an essen |
2009 | 3.500,00$ |
Global Endoscopes Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016Introduction / / GlobalData’s medical equipment report, “Global Endoscopes Equipment Pipeline Analysis, Opportunity Assessment an |
2010 | 3.500,00$ |
Global Hospital Information Systems (HIS) Opportunity Assessment, Competitive Landscape and Market Forecasts to 2016Introduction / / GlobalData’s medical equipment report, “Global Hospital Information Systems (HIS) Opportunity Assessment, Compet |
2010 | 3.500,00$ |
Medtronic to Acquire ATS MedicalIntroduction / / Medtronic, Inc., a medical device company, signed a definitive agreement to acquire ATS Medical, Inc., a cardiov |
2010 | 500,00$ |
Brazil Cardiovascular Devices Market Outlook to 2016Introduction / / GlobalData’s medical equipment report, “Brazil Cardiovascular Devices Market Outlook to 2016” provides key marke |
2010 | 2.500,00$ |
Mexico Cardiovascular Devices Market Outlook to 2016Introduction / / GlobalData’s medical equipment report, “Mexico Cardiovascular Devices Market Outlook to 2016” provides key marke |
2010 | 2.500,00$ |
Israel Cardiovascular Devices Market Outlook to 2016Introduction / / GlobalData’s medical equipment report, “Israel Cardiovascular Devices Market Outlook to 2016” provides key marke |
2010 | 2.500,00$ |
United States Diagnostic Imaging Market Outlook to 2016Introduction / / GlobalData’s medical equipment report, “US Diagnostic Imaging Market Outlook to 2016” provides key market data o |
2010 | 2.500,00$ |
China Diagnostic Imaging Market Outlook to 2016Introduction / / GlobalData’s medical equipment report, “China Diagnostic Imaging Market Outlook to 2016” provides key market dat |
2010 | 2.500,00$ |
Canada Diagnostic Imaging Market Outlook to 2016Introduction / / GlobalData’s medical equipment report, “Canada Diagnostic Imaging Market Outlook to 2016” provides key market da |
2010 | 2.500,00$ |
Italy Diagnostic Imaging Market Outlook to 2016Introduction / / GlobalData’s medical equipment report, “Italy Diagnostic Imaging Market Outlook to 2016” provides key market dat |
2010 | 2.500,00$ |
Brazil Diagnostic Imaging Market Outlook to 2016Introduction / / GlobalData’s medical equipment report, “Brazil Diagnostic Imaging Market Outlook to 2016” provides key market da |
2010 | 2.500,00$ |
Netherlands Diagnostic Imaging Market Outlook to 2016Introduction / / GlobalData’s medical equipment report, “Netherlands Diagnostic Imaging Market Outlook to 2016” provides key mark |
2010 | 2.500,00$ |
Mexico Diagnostic Imaging Market Outlook to 2016Introduction / / GlobalData’s medical equipment report, “Mexico Diagnostic Imaging Market Outlook to 2016” provides key market da |
2010 | 2.500,00$ |
Taiwan Diagnostic Imaging Market Outlook to 2016Introduction / / GlobalData’s medical equipment report, “Taiwan Diagnostic Imaging Market Outlook to 2016” provides key market da |
2010 | 2.500,00$ |
The UK Medical Devices Industry: Increasing Incidence of Lifestyle Disorders Driving GrowthIntroduction / / GlobalData’s report, “The UK Medical Devices Industry: Increasing Incidence of Lifestyle Disorders Driving Growt |
2010 | 500,00$ |
Insulet and Ypsomed Sign Distribution Agreement for Europe: Ypsomed Expected to Expand Market for Insulin Pump TherapyIntroduction / / Insulet is a start up company in the insulin delivery market. The company’s product, the Omnipod, which is a dis |
2010 | 500,00$ |
Canada Cardiovascular Devices Market Outlook to 2016Introduction / / GlobalData’s new report, “Canada Cardiovascular Devices Market Outlook to 2016” provides key market data on the |
2010 | 2.500,00$ |
Germany Cardiovascular Devices Market Outlook to 2016Introduction / / GlobalData’s new report, “Germany Cardiovascular Devices Market Outlook to 2016” provides key market data on the |
2010 | 2.500,00$ |
Spain Cardiovascular Devices Market Outlook to 2016Introduction / / GlobalData’s new report, “Spain Cardiovascular Devices Market Outlook to 2016” provides key market data on the S |
2010 | 2.500,00$ |
Netherlands Cardiovascular Devices Market Outlook to 2016Introduction / / GlobalData’s new report, “Netherlands Cardiovascular Devices Market Outlook to 2016” provides key market data on |
2010 | 2.500,00$ |
Belgium Cardiovascular Devices Market Outlook to 2016Introduction / / GlobalData’s new report, “Belgium Cardiovascular Devices Market Outlook to 2016” provides key market data on the |
2010 | 2.500,00$ |
South Africa Cardiovascular Devices Market Outlook to 2016Introduction / / GlobalData’s new report, “South Africa Cardiovascular Devices Market Outlook to 2016” provides key market data o |
2010 | 2.500,00$ |
United Kingdom Cardiovascular Devices Market Outlook to 2016Introduction / / GlobalData’s new report, “The UK Cardiovascular Devices Market Outlook to 2016” provides key market data on the |
2010 | 2.500,00$ |
Japan Cardiovascular Devices Market Outlook to 2016Introduction / / GlobalData’s new report, “Japan Cardiovascular Devices Market Outlook to 2016” provides key market data on the J |
2010 | 2.500,00$ |
United States Diabetes Care Devices Market Outlook to 2016Introduction / / GlobalData’s new report, “US Diabetes Care Devices Market Outlook to 2016” provides key market data on the US di |
2010 | 2.500,00$ |
United States Cardiovascular Devices Market Outlook to 2016Introduction / / GlobalData’s new report, “US Cardiovascular Devices Market Outlook to 2016” provides key market data on the US c |
2010 | 2.500,00$ |
Medical Equipment Quarterly Deals Analysis: M&A and Investments Trends - Q1 2010Introduction / / GlobalData's “Medical Equipment Quarterly Deals Analysis: M&A and Investments Trends - Q1 2010” report is an ess |
2010 | 1.500,00$ |
Medical Equipment Monthly Deals Analysis: M&A and Investments Trends - May 2010Introduction / / GlobalData's “Medical Equipment Monthly Deals Analysis: M&A and Investments Trends – May 2010” report is an esse |
2010 | 1.000,00$ |
Vacuum Assisted Breast Biopsy Systems: A Market SnapshotIntroduction / / GlobalData’s report, “Vacuum Assisted Breast Biopsy Systems: A Market Snapshot” provides key data, information a |
2010 | 500,00$ |
Healthcare Reform: Impact on Medical Device IndustryIntroduction / / GlobalData’s report, “Healthcare Reform: Impact on Medical Device Industry” provides key insights, information a |
2010 | 500,00$ |
European Union (EU) Medical Device Directive (MDD) Changes: Industry Impact AnalysisIntroduction / / Medical devices are primarily used for a physical effect on the body and are overseen by regulatory systems for |
2010 | 500,00$ |
Arteriotomy Closure Devices: A Market SnapshotIntroduction / / GlobalData’s report, “Arteriotomy Closure Devices: A Market Snapshot” provides key data, information and analysi |
2010 | 500,00$ |
Platelet Rich Plasma: A Market SnapshotIntroduction / / GlobalData’s report, “Platelet Rich Plasma (PRP): Market Snapshot” provides key data, information on the US plat |
2010 | 500,00$ |
Rigid Video Laryngoscopes: A Market SnapshotIntroduction / / GlobalData’s report, “Rigid Video Laryngoscopes: A Market Snapshot” provides key data, information and analysis |
2010 | 500,00$ |
Israel Patient Monitoring Market Outlook to 2016Introduction
/
/ GlobalData’s medical device report offering, “Israel Patient Monitoring Market Outlook to 2016” provides key m |
2010 | 2.500,00$ |
France Cardiovascular Devices Market Outlook to 2016Introduction
/
/ GlobalData’s medical device report offering, “France Cardiovascular Devices Market Outlook to 2016” provides k |
2010 | 2.500,00$ |
Italy Cardiovascular Devices Market Outlook to 2016Introduction
/
/ GlobalData’s medical device report offering, “Italy Cardiovascular Devices Market Outlook to 2016” provides ke |
2010 | 2.500,00$ |
Australia Cardiovascular Devices Market Outlook to 2016Introduction
/
/ GlobalData’s medical device report offering, “Australia Cardiovascular Devices Market Outlook to 2016” provide |
2010 | 2.500,00$ |
Argentina Cardiovascular Devices Market Outlook to 2016Introduction
/
/ GlobalData’s medical device report offering, “Argentina Cardiovascular Devices Market Outlook to 2016” provide |
2010 | 2.500,00$ |
Republic of Korea Cardiovascular Devices Market Outlook to 2016Introduction
/
/ GlobalData’s medical device report offering, “Republic of Korea Cardiovascular Devices Market Outlook to 2016” |
2010 | 2.500,00$ |
Taiwan Cardiovascular Devices Market Outlook to 2016Introduction
/
/ GlobalData’s medical device report offering, “Taiwan Cardiovascular Devices Market Outlook to 2016” provides k |
2010 | 2.500,00$ |
India Cardiovascular Devices Market Outlook to 2016Introduction
/
/ GlobalData’s medical device report offering, “India Cardiovascular Devices Market Outlook to 2016” provides ke |
2010 | 2.500,00$ |
Spain Diabetes Care Devices Market Outlook to 2016Introduction
/
/ GlobalData’s medical device report offering, “Spain Diabetes Care Devices Market Outlook to 2016” provides key |
2010 | 2.500,00$ |
Argentina Diabetes Care Devices Market Outlook to 2016Introduction
/
/ GlobalData’s medical device report offering, “Argentina Diabetes Care Devices Market Outlook to 2016” provides |
2010 | 2.500,00$ |
Israel Diabetes Care Devices Market Outlook to 2016Introduction
/
/ GlobalData’s medical device report offering, “Israel Diabetes Care Devices Market Outlook to 2016” provides ke |
2010 | 2.500,00$ |
Global Infusion Systems Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016Introduction
/
/ GlobalData’s new report, “Global Infusion Systems Pipeline Analysis, Opportunity Assessment and Market Forecas |
2010 | 3.500,00$ |
Angiotech Pharma Acquires Product Candidates and Technology Assets from Haemacure CorporationIntroduction
/
/ Angiotech Pharmaceuticals, Inc. a specialty pharmaceutical and medical device company, announced the closing o |
2010 | 500,00$ |
United Kingdom Diabetes Care Devices Market Outlook to 2016Introduction
/
/ GlobalData's medical equipment offering - “The UK Diabetes Care Devices Market Outlook to 2016” provides key m |
2010 | 2.500,00$ |
Canada Diabetes Care Devices Market Outlook to 2016Introduction
/
/ GlobalData’s medical equipment offering, “Canada Diabetes Care Devices Market Outlook to 2016” provides key ma |
2010 | 2.500,00$ |
Germany Diabetes Care Devices Market Outlook to 2016Introduction
/
/ GlobalData’s medical equipment offering, “Germany Diabetes Care Devices Market Outlook to 2016” provides key m |
2010 | 2.500,00$ |
France Diabetes Care Devices Market Outlook to 2016Introduction
/
/ GlobalData’s medical equipment offering, “France Diabetes Care Devices Market Outlook to 2016” provides key ma |
2010 | 2.500,00$ |
Italy Diabetes Care Devices Market Outlook to 2016Introduction
/
/ GlobalData’s medical equipment offering, “Italy Diabetes Care Devices Market Outlook to 2016” provides key mar |
2010 | 2.500,00$ |
Australia Diabetes Care Devices Market Outlook to 2016Introduction
/
/ GlobalData’s medical equipment offering, “Australia Diabetes Care Devices Market Outlook to 2016” provides key |
2010 | 2.500,00$ |
Brazil Diabetes Care Devices Market Outlook to 2016Introduction
/
/ GlobalData’s medical equipment offering, “Brazil Diabetes Care Devices Market Outlook to 2016” provides key ma |
2010 | 2.500,00$ |
Netherlands Diabetes Care Devices Market Outlook to 2016Introduction
/
/ GlobalData’s medical equipment offering, “Netherlands Diabetes Care Devices Market Outlook to 2016” provides k |
2010 | 2.500,00$ |
Belgium Diabetes Care Devices Market Outlook to 2016Introduction
/
/ GlobalData’s medical equipment offering, “Belgium Diabetes Care Devices Market Outlook to 2016” provides key m |
2010 | 2.500,00$ |
Mexico Diabetes Care Devices Market Outlook to 2016Introduction
/
/ GlobalData’s medical equipment offering, “Mexico Diabetes Care Devices Market Outlook to 2016” provides key ma |
2010 | 2.500,00$ |
South Africa Diabetes Care Devices Market Outlook to 2016Introduction
/
/ GlobalData’s medical equipment offering, “South Africa Diabetes Care Devices Market Outlook to 2016” provides |
2010 | 2.500,00$ |
Hepatitis C - Drug Pipeline Analysis and Market Forecasts to 2016Introduction
/
/ GlobalData has released a pharmaceutical and healthcare report, “hepatitis C – Drug Pipeline Analysis and Mark |
2010 | 2.000,00$ |
Germany Patient Monitoring Market Outlook to 2016Market size and company share data for seven patient monitoring market categories – Multiparameter Patient Monitoring, Remote Pati |
2010 | 2.500,00$ |
Belgium Patient Monitoring Market Outlook to 2016Market size and company share data for seven patient monitoring market categories – Multiparameter Patient Monitoring, Remote Pati |
2010 | 2.500,00$ |
Republic of Korea Patient Monitoring Market Outlook to 2016Market size and company share data for seven patient monitoring market categories – Multiparameter Patient Monitoring, Remote Pati |
2010 | 2.500,00$ |
Taiwan Patient Monitoring Market Outlook to 2016Market size and company share data for seven patient monitoring market categories – Multiparameter Patient Monitoring, Remote Pati |
2010 | 2.500,00$ |
South Africa Patient Monitoring Market Outlook to 2016Market size and company share data for seven patient monitoring market categories – Multiparameter Patient Monitoring, Remote Pati |
2010 | 2.500,00$ |
Japan Diabetes Care Devices Market Outlook to 2016Market size and company share data for two diabetes care devices market categories – Glucose Monitoring and Insulin Delivery.
/ A |
2010 | 2.500,00$ |
India Diabetes Care Devices Market Outlook to 2016Market size and company share data for two diabetes care devices market categories – Glucose Monitoring and Insulin Delivery.
/ A |
2010 | 2.500,00$ |
China Diabetes Care Devices Market Outlook to 2016Market size and company share data for two diabetes care devices market categories – Glucose Monitoring and Insulin Delivery.
/ A |
2010 | 2.500,00$ |
Republic of Korea Diabetes Care Devices Market Outlook to 2016Market size and company share data for two diabetes care devices market categories – Glucose Monitoring and Insulin Delivery.
/ A |
2010 | 2.500,00$ |
Taiwan Diabetes Care Devices Market Outlook to 2016Market size and company share data for two diabetes care devices market categories – Glucose Monitoring and Insulin Delivery.
/ A |
2010 | 2.500,00$ |
Canada Patient Monitoring Market Outlook to 2016Introduction
/
/ GlobalData’s new report, “Canada Patient Monitoring Market Outlook to 2016” provides key market data on the Ca |
2010 | 2.500,00$ |
France Patient Monitoring Market Outlook to 2016Introduction
/
/ GlobalData’s new report, “France Patient Monitoring Market Outlook to 2016” provides key market data on the Fr |
2010 | 2.500,00$ |
Italy Patient Monitoring Market Outlook to 2016Introduction
/
/ GlobalData’s new report, “Italy Patient Monitoring Market Outlook to 2016” provides key market data on the Ita |
2010 | 2.500,00$ |
Australia Patient Monitoring Market Outlook to 2016Introduction
/
/ GlobalData’s new report, “Australia Patient Monitoring Market Outlook to 2016” provides key market data on the |
2010 | 2.500,00$ |
Brazil Patient Monitoring Market Outlook to 2016Introduction
/
/ GlobalData’s new report, “Brazil Patient Monitoring Market Outlook to 2016” provides key market data on the Br |
2010 | 2.500,00$ |
Netherlands Patient Monitoring Market Outlook to 2016Introduction
/
/ GlobalData’s new report, “Netherlands Patient Monitoring Market Outlook to 2016” provides key market data on t |
2010 | 2.500,00$ |
Argentina Patient Monitoring Market Outlook to 2016Introduction
/
/ GlobalData’s new report, “Argentina Patient Monitoring Market Outlook to 2016” provides key market data on the |
2010 | 2.500,00$ |
Mexico Patient Monitoring Market Outlook to 2016Introduction
/
/ GlobalData’s new report, “Mexico Patient Monitoring Market Outlook to 2016” provides key market data on the Me |
2010 | 2.500,00$ |
Healthcare Information and Management Systems Society (HIMSS) 2010 - Conference Review and AnalysisIntroduction
/
/ GlobalData’s “Healthcare Information and Management Systems Society (HIMSS) 2010: Conference Review and Analys |
2010 | 1.000,00$ |
United Kingdom Patient Monitoring Market Outlook to 2016Introduction
/
/ GlobalData’s new report, “The UK Patient Monitoring Market Outlook to 2016” provides key market data on the Un |
2010 | 2.500,00$ |
Japan Patient Monitoring Market Outlook to 2016Introduction
/
/ GlobalData’s new report, “Japan Patient Monitoring Market Outlook to 2016” provides key market data on the Jap |
2010 | 2.500,00$ |
India Patient Monitoring Market Outlook to 2016Introduction
/
/ GlobalData’s new report, “India Patient Monitoring Market Outlook to 2016” provides key market data on the Ind |
2010 | 2.500,00$ |
China Patient Monitoring Market Outlook to 2016Introduction
/
/ GlobalData’s new report, “China Patient Monitoring Market Outlook to 2016” provides key market data on the Chi |
2010 | 2.500,00$ |
Global Orthopedic Devices Pipeline Landscape: Analysis of Key Upcoming Products and TechnologiesIntroduction
/
/ While the leading orthopedic device manufacturers continue to be impacted by economic and regulatory challenge |
2010 | 3.500,00$ |
Hepatitis B - Drug Pipeline Analysis and Market Forecasts to 2016Introduction
/
/ GlobalData\'s report, “Hepatitis B – Drug Pipeline Analysis and Market Forecasts to 2016” is an essential sour |
2010 | 2.000,00$ |
Candidiasis - Drug Pipeline Analysis and Market Forecasts to 2016Introduction
/
/ GlobalData’s report, “Candidiasis - Drug Pipeline Analysis and Market Forecasts to 2016”, provides an essentia |
2010 | 2.000,00$ |
Global Drug Eluting Balloons (DEB) Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016Introduction
/
/ GlobalData’s report, “Global Drug Eluting Balloons (DEB) Pipeline Analysis, Opportunity Assessment and Market |
2010 | 3.500,00$ |
American Academy of Orthopedic Surgeons (AAOS) 2010: Conference Review and AnalysisIntroduction
/
/ GlobalData’s “American Academy of Orthopedic Surgeons (AAOS) 2010: Conference Review and Analysis” report is a |
2010 | 1.000,00$ |
HIV/AIDS - Drug Pipeline Analysis and Market Forecasts to 2016Annualized global HIV/AIDS market revenues data from 2001 to 2009, forecast for seven years to 2016.
/ Geographies covered in th |
2010 | 2.000,00$ |
E. I. du Pont de Nemours and Company (DD) SWOT ProfileE. I. du Pont de Nemours and Company (DD) SWOT Profile / / Summary / / GlobalData’s E. I. du Pont de Nemours and Company (DD) SW |
2010 | 150,00$ |
Medical Equipment Monthly Deals Analysis: M&A and Investments Trends – April 2010Introduction
/
/ GlobalData's “Medical Equipment Monthly Deals Analysis M&A and Investments Trends – April 2010” report is an e |
2010 | 1.000,00$ |
Liver Cancer - Drug Pipeline Analysis and Market Forecasts to 2016Introduction
/
/ GlobalData, the industry analysis specialist’s new report, “Liver Cancer - Drug Pipeline Analysis and Market F |
2010 | 2.000,00$ |
Cyanoacrylates Tissue Adhesives - A Market SnapshotIntroduction
/
/ GlobalData’s report, “Cyanoacrylates Tissue Adhesives: A Market Snapshot” provides key data, information and a |
2010 | 500,00$ |
Gastroesophageal Reflux Disease - Drug Pipeline Analysis and Market Forecasts to 2016Introduction
/
/ GlobalData, the industry analysis specialist’s new report, “Gastroesophageal Reflux Disease (GERD) – Drug Pipe |
2010 | 2.000,00$ |
Polycystic Ovarian Syndrome - Drug Pipeline Analysis and Market Forecasts to 2016Introduction
/
/ GlobalData, the industry analysis specialist’s new report, “Polycystic Ovarian Syndrome– Drug Pipeline Analysi |
2010 | 2.000,00$ |
Medical Equipment Monthly Deals Analysis: M&A and Investments Trends - March 2010Introduction / / "GlobalData's “Medical Equipment Monthly Deals Analysis M&A and Investments Trends – March 2010” report is an es |
2010 | 1.000,00$ |
Huntington's Disease - Drug Pipeline Analysis and Market Forecasts to 2016Introduction / / GlobalData’s report on the pharmaceutical and healthcare industry - “Huntington’s disease – Drug Pipeline Analys |
2010 | 2.000,00$ |
Global Spinal Surgery Devices: Market Analysis and Opportunity AssessmentIntroduction / / GlobalData’s “Global Spinal Surgery Devices: Market Analysis and Opportunity Assessment report is an essential s |
2009 | 3.500,00$ |
Healthcare IT: A Market Poised for Strong Growth in the FutureIntroduction / / GlobalData’s report, “Healthcare IT: A Market Poised for Strong Growth in the Future” provides key data, informa |
2010 | 500,00$ |
Investment Opportunities in the Medical Devices SectorIntroduction / / GlobalData’s report, “Investment Opportunities in the Medical Device Sector” provides key insights, information |
2010 | 500,00$ |
Sterilization Wraps: A Market SnapshotIntroduction / / GlobalData’s report, “Sterilization Wraps: A Market Snapshot” provides key data, information and analysis on the |
2010 | 500,00$ |
Meningitis - Pipeline Analysis and Market Forecasts to 2016Introduction / / GlobalData’s report, “Meningitis – Pipeline Analysis and Market Forecasts to 2016” is an essential source of inf |
2010 | 2.000,00$ |
Amyotrophic Lateral Sclerosis (Lou Gehrig's) - Drug Pipeline Analysis and Market Forecasts to 2016Introduction / / GlobalData’s report, “Amyotrophic lateral sclerosis (Lou Gehrigs) - Drug Pipeline Analysis and Market Forecasts |
2010 | 2.000,00$ |
Medical Equipment Annual Deals Analysis 2010Introduction / / "GlobalData's “Medical Equipment Annual Deals Analysis 2010” report is an essential source of data and trend ana |
2010 | 3.500,00$ |
Medical Equipment Monthly Deals Analysis - February 2010Introduction / / "GlobalData's “Medical Equipment Monthly Deals Analysis – February 2010” report is an essential source of data a |
2010 | 1.000,00$ |
Asian Oil Companies Looking To Capitalize On the Opportunity in the Canadian Oil Sands IndustryIntroduction / / The decline in oil reserves worldwide is challenging oil and gas companies to seek new fields in order to mainta |
2010 | 500,00$ |
Medical Equipment Quarterly Deals Analysis Q4 2009Introduction
/
/ GlobalData's “Medical Equipment Quarterly Deal Analysis Q4 2009” report is an essential source of data and tre |
2010 | 1.500,00$ |
Dyslipidemia - Drug Pipeline Analysis and Market Forecasts to 2016Introduction
/
/ GlobalData, the industry analysis specialist’s new report, “Dyslipidemia - Drug Pipeline Analysis and Market F |
2010 | 2.000,00$ |
Pulmonary Arterial Hypertension (PAH) - Drug Pipeline Analysis and Market Forecasts to 2016Introduction
/
/ GlobalData, the industry analysis specialist’s new report, “Pulmonary Arterial Hypertension (PAH) - Drug Pipel |
2010 | 2.000,00$ |
Anti-hypertension - Drug Pipeline Analysis and Market Forecasts to 2016Introduction
/
/ GlobalData, the industry analysis specialist’s new report, “Anti-Hypertension - Drug Pipeline Analysis and Mar |
2010 | 2.000,00$ |
Autism - Drug Pipeline Analysis and Market Forecasts to 2016Introduction
/
/ GlobalData, the industry analysis specialist’s new report, “Autism - Drug Pipeline Analysis and Market Forecas |
2010 | 2.000,00$ |
Bone Morphogenic Proteins: Future Therapeutic ApplicationsIntroduction / / Stimulating the human body to generate and repair bone, reliably and quickly has been one of the greatest challe |
2010 | 500,00$ |
Diagnostic Imaging in Developing Economies: A Closer Look at AccessibilityIntroduction / / Patient access to diagnostic imaging in emerging economies varies across different economic regions within the s |
2010 | 500,00$ |
Global Cardiovascular Devices Pipeline Landscape: Analysis of Key Upcoming Products and TechnologiesIntroduction / / While the leading cardiovascular device manufacturers continue to be impacted by economic and regulatory challen |
2010 | 2.000,00$ |
Outsourcing in the Global Medical Equipment Industry - The Market Expected to Register High Growth in the FutureIntroduction / / GlobalData’s new report, “Outsourcing in the Global Medical Equipment Industry - The Market Expected to Register |
2010 | 3.500,00$ |
Global Peritoneal Dialysis Market: Strategic Analysis and Opportunity AssessmentThe report provides market size data and information on the global peritoneal dialysis market. / - Annualized market revenues data |
2010 | 3.500,00$ |
US Hip and Knee Implants: Strategic Market Analysis and Insight to 2015Introduction / / GlobalData has released its latest research on a key segment within the medical equipment industry. The “US Hip |
2009 | 3.500,00$ |
UK Orthopedic Devices Market Analysis and Forecasts to 2015Introduction / / GlobalData’s “UK Orthopedic Devices Market Analysis and Forecasts to 2015” report provides key data, information |
2010 | 3.500,00$ |
Medical Equipment Monthly Deals Analysis – January 2010Introduction / / "GlobalData's “Medical Equipment Monthly Deals Analysis – January 2010” report is an essential source of data an |
2010 | 1.000,00$ |
US Computed Tomography (CT) Systems Market: Strategic Analysis and Opportunity Assessment to 2015Introduction / / GlobalData has released its latest research on a key segment within the medical equipment industry. The “US Comp |
2009 | 3.500,00$ |
Europe Nuclear Imaging Equipment: Market Analysis and Opportunity AssessmentIntroduction / / GlobalData has released its latest research on a key segment within the medical equipment industry. The “Europe |
2009 | 3.500,00$ |
Flexible Endoscope Pipeline Technology and Market Forecasts to 2015Introduction / / GlobalData’s “Flexible Endoscope Pipeline Technology and Market Forecasts to 2015” report is an essential source |
2009 | 2.000,00$ |
US Surgical Sutures Market: Surgical Procedures Growth to Drive DemandIntroduction / / GlobalData’s “US Surgical Sutures Market: Surgical Procedures Growth to Drive Demand” report is an essential sou |
2009 | 3.500,00$ |
Europe Picture Archiving and Communication Systems (PACS) Market: Market Analysis and Opportunity AssessmentIntroduction / / GlobalData’s “Europe Picture Archiving and Communication Systems (PACS) Market: Increasing Adoption to Drive Gro |
2009 | 3.500,00$ |
Contrast Media: A Market SnapshotIntroduction / / The global contrast media market was valued at $5.4 billion in 2008, and is expected to grow to $7.9 billion in |
2009 | 500,00$ |
Small Medium Enterprises: The Powerhouse of Innovation for Medical Device IndustryIntroduction / / Rapid innovation is a pre-condition for survival of medical device companies, given the quick turnaround time of |
2009 | 500,00$ |
Trocars: A Market SnapshotIntroduction / / The global market for trocars was valued at $800m in 2008. Increasing use of trocars in laparoscopic surgeries i |
2009 | 500,00$ |
The US Cardiac Resynchronization Therapy Market: Positive Clinical Trial Results to Boost GrowthIntroduction / / Cardiac Resynchronization Therapy (CRT) devices have been studied clinically since 1998, and have been on the US |
2009 | 500,00$ |
The US Neurology Devices Market to Present Opportunities for GrowthIntroduction / / Some of the major markets like cardiovascular and orthopedic devices have witnessed immense innovation over the |
2009 | 500,00$ |
Australia Medical Equipment Market Analysis and Forecasts to 2015Introduction / / GlobalData’s “Australia Medical Equipment Market Analysis and Forecasts to 2015” report provides key data, infor |
2009 | 3.500,00$ |
Global Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015Introduction / / This Medical Device report is an essential source for key information and data relating to the global Anesthesia |
2009 | 4.000,00$ |
Global Cardiovascular Devices Market Analysis & Forecasts to 2015Introduction / / This Medical Device report is an essential source for key information and data relating to the global Cardiovasc |
2009 | 4.000,00$ |
Global Dental Devices Market Analysis and Forecasts to 2015Introduction / / This Medical Device report is an essential source for key information and data relating to the global dental dev |
2009 | 4.000,00$ |
Global Orthopedic Devices Market Analysis & Forecasts to 2015Introduction / / This Medical Device report is an essential source for key information and data relating to the global Orthopedic |
2009 | 4.000,00$ |
Global Wound Care Management Market Analysis and Forecasts to 2015Introduction / / This Medical Device report is an essential source for key information and data relating to the global Wound Care |
2009 | 4.000,00$ |
Brazil Medical Equipment Market Analysis and Forecasts to 2015Introduction / / GlobalData’s “Brazil Medical Equipment Market Analysis and Forecasts to 2015” report provides key data, informat |
2009 | 3.500,00$ |
US Small Joint Implants Market: The Underlying Demand Drivers Remain in PlaceIntroduction / / GlobalData’s “US Small Joint Implants Market: The Underlying Demand Drivers Remain in Place” report is an essent |
2009 | 3.500,00$ |
India Ultrasound Systems Market: Strategic Market Analysis and InsightIntroduction / / GlobalData’s “India Ultrasound Systems Market: Strategic Market Analysis and Insight” report is an essential sou |
2009 | 3.500,00$ |
Drug Eluting Stents (DES) Pipeline Technology and Market Forecasts to 2016Introduction / / GlobalData’s “Drug Eluting Stents (DES) Pipeline Technology and Market Forecasts to 2016” report is an essential |
2009 | 2.000,00$ |
Medical Equipment Monthly Deals Analysis – December 2009Introduction / / GlobalData's “Medical Equipment Monthly Deals Analysis – December 2009 ” report is an essential source of data a |
2009 | 1.000,00$ |
US Spinal Surgery Devices Market: Increasing Procedures to Drive GrowthIntroduction
/
/ GlobalData’s “US Spinal Surgery Devices Market: Increasing Procedures to Drive Growth” report is an essential |
2009 | 3.500,00$ |
Negative Pressure Wound Therapy (NPWT) Pipeline Technology and Market Forecasts to 2016Introduction
/
/ GlobalData’s “Negative Pressure Wound Therapy (NPWT)Pipeline Technology and Market Forecasts to 2016” report i |
2009 | 2.000,00$ |
23rd European Association for Cardio-Thoracic Surgeons (EACTS) Annual Meeting: Conference Review and AnalysisIntroduction / / GlobalData’s “23rd European Association for Cardio-Thoracic Surgeons (EACTS) Annual Meeting: Conference Review a |
2009 | 1.000,00$ |
Glucose Monitoring Systems Pipeline Technology and Market Forecasts to 2015Introduction / / GlobalData’s “Glucose monitoring systems Pipeline Technology and Market Forecasts to 2015” report is an essentia |
2009 | 2.000,00$ |
Attention Deficit Hyperactivity Disorder (ADHD) - Drug Pipeline Analysis and Market Forecasts to 2015Introduction / / GlobalData, the industry analysis specialist’s new report, “Attention Deficit Hyperactivity Disorder – Drug Pipe |
2009 | 2.000,00$ |
Major Depressive Disorder (MDD) - Drug Pipeline Analysis and Market Forecasts to 2015Introduction / / GlobalData, the industry analysis specialist’s new report, “Major Depressive Disorder – Drug Pipeline Analysis a |
2009 | 2.000,00$ |
Crohn's Disease - Drug Pipeline Analysis and Market Forecasts to 2015Introduction
/
/ GlobalData, the industry analysis specialist’s new report, “Crohn’s Disease – Drug Pipeline Analysis and Marke |
2009 | 2.000,00$ |
Alzheimer’s Disease - Drug Pipeline Analysis and Market Forecasts to 2015Introduction / / GlobalData, the industry analysis specialist’s new report, “Alzheimer’s Disease – Drug Pipeline Analysis and Mar |
2009 | 2.000,00$ |
Parkinson's Disease - Drug Pipeline Analysis and Market Forecasts to 2015Introduction / / GlobalData, the industry analysis specialist’s new report, “Parkinson’s Disease – Drug Pipeline Analysis and Mar |
2009 | 2.000,00$ |
Insomnia - Drug Pipeline Analysis and Market Forecasts to 2015Introduction / / GlobalData, the industry analysis specialist’s new report, “Insomnia – Drug Pipeline Analysis and Market Forecas |
2009 | 2.000,00$ |
Bipolar Disorder - Drug Pipeline Analysis and Market Forecasts to 2015Introduction / / GlobalData, the industry analysis specialist’s new report, “Bipolar Disorder – Drug Pipeline Analysis and Market |
2009 | 2.000,00$ |
Addiction Control - Drug Pipeline Analysis and Market Forecasts to 2015Introduction / / GlobalData, the industry analysis specialist, has released a new report “Addiction Control – Drug Pipeline Analy |
2009 | 2.000,00$ |
Acute Ischemic Stroke - Drug Pipeline Analysis and Market Forecasts to 2015Introduction / / GlobalData, the industry analysis specialist’s new report, “Acute Ischemic Stroke – Drug Pipeline Analysis and M |
2009 | 2.000,00$ |
Non-Hodgkin's Lymphoma (NHL) - Drug Pipeline Analysis and Market Forecasts to 2015Introduction / / GlobalData, the industry analysis specialist’s new report, “Non-Hodgkin's Lymphoma – Drug Pipeline Analysis and |
2010 | 2.000,00$ |
Ulcerative Colitis - Drug Pipeline Analysis and Market Forecasts to 2015Introduction / / GlobalData, the industry analysis specialist’s new report, “Ulcerative Colitis – Drug Pipeline Analysis and Mark |
2010 | 2.000,00$ |
Angina Pectoris - Drug Pipeline Analysis and Market Forecasts to 2015Introduction / / GlobalData, the industry analysis specialist’s new report, “Angina Pectoris – Drug Pipeline Analysis and Market |
2010 | 2.000,00$ |
Renal Cancer - Drug Pipeline Analysis and Market Forecasts to 2016Introduction / / GlobalData, the industry analysis specialist’s new report, “Renal Cancer – Drug Pipeline Analysis and Market For |
2010 | 2.000,00$ |
Breast Cancer - Drug Pipeline Analysis and Market Forecasts to 2016Introduction / / GlobalData, the industry analysis specialist’s new report, “Breast Cancer – Drug Pipeline Analysis and Market Fo |
2010 | 2.000,00$ |
Brain Tumor - Drug Pipeline Analysis and Market Forecasts to 2016Introduction / / GlobalData, the industry analysis specialist’s new report, “Brain Tumour – Drug Pipeline Analysis and Market For |
2010 | 2.000,00$ |
Cancer Vaccines - Pipeline Analysis and Market Forecasts to 2016Introduction / / GlobalData, the industry analysis specialist’s new report, “Cancer Vaccines – Pipeline Analysis and Market Forec |
2010 | 2.000,00$ |
Type 1 Diabetes - Drug Pipeline Analysis and Market Forecasts to 2016Introduction / / GlobalData, the industry analysis specialist’s new report, “Type 1 Diabetes – Drug Pipeline Analysis and Market |
2010 | 2.000,00$ |
North American Spine Society Annual Meeting 2009 – Post Conference ReviewIntroduction / / GlobalData’s “North American Spine Society (NASS) 24th Annual Meeting: Conference Review and Analysis” report is |
2009 | 1.000,00$ |
American Society of Anesthesiologists Annual Meeting 2009 – Post Conference ReviewIntroduction / / GlobalData’s “American Society of Anesthesiologists (2009 Annual Meeting): Conference Review and Analysis” repor |
2009 | 1.000,00$ |
A&D Medical Lifesource Market Share AnalysisIntroduction
/
/ This report is an essential source for data, analysis and strategic insight into the medical equipment busines |
2009 | 1.000,00$ |
Abbott Medical Optics, Inc. Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
ABIOMED, Inc. Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Accuray Incorporated Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
ACUTRONIC Medical Systems AG Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Advanced Bionics Corporation Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Advanced Medical Solutions Group plc Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Aerogen (Ireland) Ltd. Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Agfa-Gevaert N.V. Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
AIR LIQUIDE Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
ALCARE Co., Ltd. Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Allengers Medical Systems Ltd. Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Allosource Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Aloka Co., Ltd. Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Alpha Bio GmbH Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Animas Corporation Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Ansell Limited Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Anthogyr S.A. Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Apex Biotechnology Corp. Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
ARKRAY, Inc. Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Arthrex, Inc. Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Arthrocare Corporation Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
ASAHI ROENTGEN IND.CO., LTD. Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Asia Pacific Microsystems, Inc. Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Astro-Med, Inc. Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Atricure, Inc. Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
AViTA Corporation Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
B. Braun Melsungen AG Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
BASKO HEALTHCARE Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Bauerfeind AG Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Baxter International Inc. Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Bayer HealthCare AG Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Becton, Dickinson and Company Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Beijing Aerospace Changfeng Co., Ltd Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Bioject Medical Technologies Inc Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Biomet, Inc. Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
BIONIME Corporation Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
BIOTRONIK GmbH & Co. KG Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Boehringer Ingelheim GmbH Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Boss Instruments, Ltd. Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Boston Scientific Corporation Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Bovie Medical Corporation Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
BREG Incorporated Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
BSN medical GmbH Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
CAMLOG Biotechnologies AG Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Card Guard AG Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Cardiac Science Corporation Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Cardinal Health, Inc. Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Carestream Health, Inc. Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Carl Zeiss AG Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Cerner Corporation Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
CIBA Vision Corporation Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
CLINICARE Corporation Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Cochlear Limited Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Codman & Shurtleff, Inc. Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Coloplast A/S Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
CompuGROUP Holding AG Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Compumedics Limited Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Computer Programs and Systems, Inc. Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Conexao Sistemas de Protese Ltda. Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
CONMED Corporation Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Consort Medical plc Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
ConvaTec Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
CooperVision, Inc. Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Cordis Corporation Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Criticare Systems, Inc. Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Cryolife, Inc. Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Custom Ultrasonics Company Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Cyberonics, Inc. Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
DEKA M.E.L.A. s.r.l. Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
DePuy, Inc. Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
DeRoyal Industries, Inc. Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
DiaSorin S.p.A Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Digene Corporation Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Digene Corporation Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Dornier MedTech GmbH Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Edwards Lifesciences Corporation Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Elekta AB Medical Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Eli Lilly and Company Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Embla Systems Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
ERBE Elektromedizin GmbH Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
ESAOTE S.p.A Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Essilor International Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Ethicon, Inc. Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
ev3 Inc. Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
F. Hoffmann-La Roche Ltd. Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Fanem Ltda Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Fleming Medical Ltd Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
FUJIFILM Medical Systems USA, Inc. Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Fujinon Corporation Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Fujitsu Limited Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Gambro AB Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
GE Healthcare Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
GE Sensing & Inspection Technologies Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Geistlich Pharma AG Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Gendex Dental Systems Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Gen-Probe Incorporated Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Genzyme Corporation Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Getinge AB Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Ginevri s.r.l. Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
GN ReSound A/S Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
HAMILTON MEDICAL AG Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Hanger Orthopedic Group, Inc. Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Healthphone Solutions Limited Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
HealthTronics, Inc. Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Hindustan Syringes & Medical Devices Ltd Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Hitachi Medical Corporation Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Hologic, Inc. Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Hospira, Inc Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
HOYA ConBio Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Hoya Corporation Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
iMDsoft Inc. Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
IMECO S.A. Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Instrumentarium Dental Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Intersurgical Ltd. Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Invacare Corporation Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Invatec S.r.l. Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
iSOFT Group PLC Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Ivens S.A Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Ivoclar Vivadent AG Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Jackson Allison Medical & Surgical Ltd Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Japan Medical Materials Corporation Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Johnson & Johnson Vision Care, Inc Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
K. Takaoka Industria e Comercio Ltda. Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
KARL STORZ GmbH & Co. KG Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Kimberly-Clark Corporation Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Kinetic Concepts, Inc. Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
King Systems Corporation Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Klockner Implant System Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
KLS Martin, L.P. Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Lamprecht AG Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Larsen & Turbo Medical Equipment & Systems Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
LifeScan, Inc. Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
LMA International N.V. Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
MAQUET GmbH & Co. KG Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Masimo Corporation Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Matrix I.T. Ltd. Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
McKesson Corporation Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
MED-EL Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Medical Information Technology, Inc Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
MEDICON eG Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Medline Industries, Inc. Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Medtronic CryoCath, LP. Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Medtronic, Inc. Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Mennen Medical Ltd. Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Metaltronica S.r.l. Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Microlife Corporation Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Midmark Corporation Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Minntech Corporation Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Misys Healthcare Systems, Inc. Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Morepen Laboratories Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Nakanishi Inc. Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Natus Medical Incorporated Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
NEC Corporation Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Neodent S.A. Company Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Neurelec Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Nightingale Informatix Corporation Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Nihon Kohden Corporation Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
NIPRO CORPORATION Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Nobel Biocare Holding AG Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Noritake Co., Limited Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Novartis Medical Nutrition Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Novo Nordisk A/S Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
NxStage Medical, Inc. Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
OLYMPUS CORPORATION Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
OMRON HEALTHCARE Co., Ltd. Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
ONTEX International N.V. Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Oridion Systems Ltd. Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Ortho-Clinical Diagnostics Inc. Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
OSI Systems, Inc. Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
OSSTEM IMPLANT Co., Ltd Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Ossur hf. Medical Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Owandy S.A.S Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Parker Healthcare Pty Ltd Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Pelton & Crane Company Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Penlon Limited Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Perlong Medical Equipment Co., Ltd. Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Philips Healthcare Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Planmeca Oy Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Planmed Oy Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
PRAXIM medivision Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Profdoc ASA Market AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
PSP Corporation Company Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
QHR Technologies Inc. Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Qiagen N.V. Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
ResMed Inc. Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Rossmax International Co.Ltd. Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Rothacher & Partner Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
San Meditech(Huzhou)Co.,Ltd Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Sanofi- Aventis Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Scanlan International, Inc. Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Schick Technologies, Inc. Company Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Schiller AG Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Sectra AB Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
SEIKO OPTICAL PRODUCTS CO., LTD. Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Sepracor Inc. Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Shanghai Medical Instruments Co., Ltd. Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Shaoxing Haitian Medical Device Co.,Ltd Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Shimadzu Corporation Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Shree Pacetronix Ltd., Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Siemens Healthcare Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Sklar Instruments Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Smith & Nephew Plc Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Smiths Medical Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Sonic Innovations, Inc. Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
SonoSite, Inc. Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Sorin S.p.A. Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Spectrum Surgical Instruments Corporation Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
SSM Sterile Health Products Inc Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
St. Jude Medical, Inc. Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
STAAR Surgical Company Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Starkey Laboratories, Inc. Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
STERIS Corporation Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
STORZ MEDICAL AG Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Stryker Corporation Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Sunrise Medical Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Sutures India Private Limited Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Svenska Cellulosa Aktiebolaget SCA Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Sweden & Martina S.P.A. Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Synergetics USA, Inc Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Synthes, Inc. Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Taema Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Teleflex Incorporated Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Terumo Corporation Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Thoratec Corporation Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Thuasne Cr, S.R.O. Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
TietoEnator Corporation Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
TOSHIBA Medical Systems Corporation Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
TRACOE medical GmbH Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
TrakHealth Pty Limited Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Transasia Bio-Medicals Ltd. Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
VEPRO AG Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Vissco Rehabilitation Aids Pvt. Ltd Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
VITA In-Ceram Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Widex A/S Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
William Demant Holding A/S Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Wright Medical Group, Inc. Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Zimmer Holdings, Inc. Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Heinen + Löwenstein GmbH Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Ambu A/S Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
dbMotion Inc. Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Given Imaging Ltd. Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Shinhung Co., Ltd. Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Orthofix International N.V. Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Mindray Medical International Limited Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
GlaxoSmithKline plc Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Draegerwerk AG & Co. KGaA Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Global Health Pty Ltd Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Abbott Laboratories Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Alcon, Inc. Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
All Pro Oxygen Masks Co., Ltd. Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
bioMerieux S.A. Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Biosense Webster, Inc. Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
C. R. Bard, Inc. Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Fresenius Medical Care AG & Co. KGaA Market Share AnalysisIntroduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business |
2009 | 1.000,00$ |
Spain Orthopedic Devices Market Analysis and Forecasts to 2015Introduction / / This report is an essential source for in-depth information and data relating to the Spain orthopedic devices ma |
2009 | 3.500,00$ |
South and Central America Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015Introduction / / This report is an essential source for in-depth information and data relating to the the South and Central Ameri |
2009 | 3.500,00$ |
China Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015Introduction / / This report is an essential source for in-depth information and data relating to the the China anesthesia & resp |
2009 | 3.500,00$ |
Japan Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015Introduction / / This report is an essential source for in-depth information and data relating to the the Japan anesthesia & resp |
2009 | 3.500,00$ |
France Anesthesia and Respiratory Devices Market Analysis & Forecasts to 2015Introduction / / This report is an essential source for in-depth information and data relating to the the France anesthesia & res |
2009 | 3.500,00$ |
North America Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015Introduction / / This report is an essential source for in-depth information and data relating to the the North America anesthesi |
2009 | 3.500,00$ |
Global In Vitro Diagnostics Market Analysis and Forecasts to 2015Introduction / / GlobalData’s “Global In Vitro Diagnostics (IVD) Market Analysis and Forecasts to 2015” report provides key data, |
2009 | 4.000,00$ |
US Prosthetic Heart Valves Market: Tissue Valves to Emerge as the Largest SegmentIntroduction / / GlobalData’s “US Prosthetic Heart Valves Market: Tissue Valves to Emerge as the Largest Segment” report is an es |
2009 | 3.500,00$ |
Medical Weekly Deals Summaries 27 July 2009Introduction / / Global Data’s Medical Equipment weekly deals summary is an excellent source providing detailed information on Me |
2009 | 125,00$ |
Medical Weekly Deals Summaries 03 August 2009Introduction / / Global Data’s Medical Equipment weekly deals summary is an excellent source providing detailed information on Me |
2009 | 125,00$ |
Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive GrowthIntroduction / / GlobalData’s “Global Self Monitoring Blood Glucose (SMBG) Market: Increasing Adoption to Drive Growth” report is |
2009 | 3.500,00$ |
Global Automated External Defibrillators (AED) Market: Demand to Drive GrowthIntroduction / / GlobalData’s “Global Automated External Defibrillators (AED) Market: Demand to Drive Growth” report is an essent |
2009 | 3.500,00$ |
Germany Diabetes Care Devices Market Analysis & Forecasts to 2015Introduction / / This report is an essential source for in-depth information and data relating to the Germany diabetes care devic |
2009 | 3.500,00$ |
Intra Ocular Lenses Pipeline Technology and Market Forecasts to 2015Introduction / / GlobalData’s “Intra Ocular Lens (IOL) Pipeline Technology and Market Forecasts to 2015” report is an essential s |
2009 | 2.000,00$ |
Global Diagnostic Imaging Market Analysis & Forecasts to 2015Key Companies GE Healthcare, Philips Healthcare, Siemens Medical Solutions, TOSHIBA Medical Systems Corporation, and Hitachi Medic |
2009 | 4.000,00$ |
Italy Orthopedic Devices Market Analysis and Forecasts to 2015Introduction / / This report is an essential source for in-depth information and data relating to the Italy orthopedic devices ma |
2009 | 3.500,00$ |
Japan Orthopedic Devices Market Analysis and Forecasts to 2015Introduction / / This report is an essential source for in-depth information and data relating to the Japan orthopedic devices ma |
2009 | 3.500,00$ |
Italy Cardiovascular Devices Market Analysis and Forecasts to 2015Introduction / / GlobalData’s “Italy Cardiovascular Devices Market Analysis and Forecasts to 2015” report provides key data, info |
2009 | 3.500,00$ |
Mergers & Acquisitions and Financing Trends in Medical Equipment Q2 2009Introduction / / GlobalData's Medical Equipment Quarterly M&A and Financing Trends Report Q2 2009 is an excellent source providin |
2009 | 1.500,00$ |
Spain Cardiovascular Devices Market Analysis and Forecasts to 2015Introduction / / GlobalData’s “Spain Cardiovascular Devices Market Analysis and Forecasts to 2015” report provides key data, info |
2009 | 3.500,00$ |
Infusion Systems Pipeline Technology and Market Forecasts to 2015Introduction / / GlobalData’s “Infusion Systems Pipeline Technology and Market Forecasts to 2015” report is an essential source o |
2009 | 2.000,00$ |
Medical Equipment Monthly Deals Analysis – November 2009Introduction / / GlobalData's “Medical Equipment Monthly Deals Analysis – November 2009 ” report is an essential source of data a |
2009 | 1.000,00$ |
Transcatheter Cardiovascular Therapeutics (TCT) 2009: Conference Review and AnalysisIntroduction / / GlobalData’s “Transcatheter Therapeutics (TCT) 2009: Conference Review and Analysis” report is an essentially so |
2009 | 1.000,00$ |
Cardiac Markers Pipeline Technology and Market Forecasts to 2015Introduction / / GlobalData’s “Cardiac Markers Pipeline Technology and Market Forecasts to 2015” report is an essential source of |
2009 | 2.000,00$ |
India Medical Equipment Market Analysis and Forecasts to 2015Introduction / / GlobalData’s “India Medical Equipment Market Analysis and Forecasts to 2015” report provides key data, informati |
2009 | 3.500,00$ |
Medical Equipment Quarterly Deals Analysis Q3 2009Introduction / / GlobalData's “Medical Equipment Quarterly Deal Analysis Q3 2009” report is an essential source of data and trend |
2009 | 1.500,00$ |
Cardiac Resynchronization Therapy (CRT) Devices Pipeline Technology and Market Forecasts to 2015Introduction / / GlobalData’s “Cardiac Resynchronization Therapy (CRT) Devices Pipeline Technology and Market Forecasts to 2015” |
2009 | 2.000,00$ |
Insulin Delivery Devices Pipeline Technology and Market Forecasts to 2015Introduction / / GlobalData’s “Insulin Delivery Devices Pipeline Technology and Market Forecasts to 2015” report is an essential |
2009 | 2.000,00$ |
Japan Interventional Cardiology Devices: Coronary Stents to Drive GrowthIntroduction / / GlobalData’s “Japan Interventional Cardiology Devices Market: Coronary Stents to Drive Growth” report is an esse |
2009 | 3.500,00$ |
Global Medical Devices Industry Outlook to 2010: Marketing and Sales Strategies and the Impact of Recession and RecoveryIntroduction / / “Global Medical Devices Industry Outlook to 2010: Marketing & Sales Strategies and the Impact of Recession and R |
2009 | 2.000,00$ |
Germany Wound Care Management Market Analysis and Forecasts to 2015Introduction / / GlobalData’s “Germany Wound Care Management Market Analysis and Forecasts to 2015” report provides key data, inf |
2009 | 3.500,00$ |
China Medical Equipment Market Analysis and Forecasts to 2015Introduction / / GlobalData’s “China Medical Equipment Market Analysis and Forecasts to 2015” report provides key data, informati |
2009 | 3.500,00$ |
US Mammography Equipment Market: Product Innovations to Drive GrowthIntroduction / / GlobalData’s “US Mammography Equipment Market: Product Innovations to Drive Growth” report is an essential sourc |
2009 | 3.500,00$ |
Brazil Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015Introduction / / This report is an essential source for in-depth information and data relating to the the Brazil anesthesia & |
2009 | 3.500,00$ |
Canada Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015Introduction / / This report is an essential source for in-depth information and data relating to the the Canada anesthesia & |
2009 | 3.500,00$ |
Germany Diagnostic Imaging Market Analysis and Forecasts to 2015Introduction / / GlobalData’s “Germany Diagnostic Imaging Market Analysis and Forecasts to 2015” report provides key data, inform |
2009 | 3.500,00$ |
Italy Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015Introduction / / This report is an essential source for in-depth information and data relating to the the Italy anesthesia & |
2009 | 3.500,00$ |
Medical Equipment Industry Deals Analysis – September 2009Introduction / / GlobalData's “Medical Equipment Industry Deals Analysis – September 2009” report is an essential source of data |
2009 | 1.000,00$ |
Spain Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015Introduction / / This report is an essential source for in-depth information and data relating to the the Spain anesthesia & |
2009 | 3.500,00$ |
Spain Medical Equipment Market Analysis and Forecasts to 2015Introduction / / GlobalData’s “Spain Medical Equipment Market Analysis and Forecasts to 2015” report provides key data, informati |
2009 | 3.500,00$ |
UK Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015Introduction / / This report is an essential source for in-depth information and data relating to the the UK anesthesia & res |
2009 | 3.500,00$ |
Europe Remote Patient Monitoring Market: Strategic Analysis and Opportunity AssessmentIntroduction / / GlobalData’s “Europe Remote Patient Monitoring Market: Strategic Analysis and Opportunity Assessment” report is |
2009 | 3.500,00$ |
Global Diabetes Care Devices Market Analysis and Forecasts to 2015Key Companies F. Hoffmann-La Roche, LifeScan, Bayer HealthCare, Abbott Laboratories, and Medtronic
/ It gives key company share i |
2009 | 3.500,00$ |
Japan Dental Devices Market Analysis and Forecasts to 2015Introduction / / GlobalData’s “Japan Dental Devices Market Analysis and Forecasts to 2015” report provides key data, information |
2009 | 3.500,00$ |
Medical Weekly Deals Summaries 17 August 2009Introduction / / Global Data’s Medical Equipment weekly deals summary is an excellent source providing detailed information on Me |
2009 | 125,00$ |
Medical Weekly Deals Summaries 24 August 2009Introduction / / Global Data’s Medical Equipment weekly deals summary is an excellent source providing detailed information on Me |
2009 | 125,00$ |
UK Diagnostic Imaging Market Analysis and Forecasts to 2015Introduction / / GlobalData’s “UK Diagnostic Imaging Market Analysis and Forecasts to 2015” report provides key data, information |
2009 | 3.500,00$ |
Areva in a Global Expansion ModeGlobalData viewpoints cover the latest key events or important developments in the nuclear energy industry and provide our in-dept |
2009 | 500,00$ |
Canada Diabetes Care Devices Market Analysis and Forecasts to 2015Forecasts & Analysis of the Canada diabetes care devices market to 2015. Market segmentation by glucose monitoring and insulin del |
2009 | 3.500,00$ |
Canada Orthopedic Devices Market Analysis and Forecasts to 2015and latest news, financial deals and pipeline products information of each of the key sub-segments of the orthopedic devices marke |
2009 | 3.500,00$ |
Cardiac Assist Devices Pipeline Technology and Market Forecasts to 2015Annualized global cardiac assist devices market revenues data from 2001 to 2008, forecast forward for 7 years to 2015. Updated com |
2009 | 2.000,00$ |
China Orthopedic Devices Market Analysis and Forecasts to 2015and latest news, financial deals and pipeline products information of each of the key sub-segments of the orthopedic devices marke |
2009 | 3.500,00$ |
Computer Assisted Radiology and Surgery (CARS) 2009 Conference Review and AnalysisThe report covers information and analysis on product and technology launched at the conference. The report provides market size d |
2009 | 1.000,00$ |
Intra Ocular Lens Pipeline Technology and Market Forecasts to 2015Annualized global IOLs market revenues data from 2001 to 2008, forecast forward for 7 years to 2015. Updated company shares data f |
2009 | 2.000,00$ |
Medical Weekly Deals Summaries 20 July 2009Summary of Medical Equipment deals by segment during the week Information on rumored and upcoming deals before they occur Any upd |
2009 | 125,00$ |
Merger & Acquisition Deal Analysis - Bonavista Energy Trust To Acquire Non-Core Alberta Properties From EnCana CorporationIn depth analysis of the latest and the most important Mergers and Acquisitions deal |
2009 | 500,00$ |
International Society of Arthroscopy, Knee Surgery & Orthopedic Sports Medicine 2009 – Conference Review And AnalysisThe report covers information and analysis on product and technology launched at the conference. / The report provides market size |
2009 | 1.000,00$ |
The Dawn Of Consolidation In The Spinal Surgery Market: Nuvasive To Acquire CervitechIn depth analysis of the latest and the most important Mergers and Acquisitions deal; / Analysis of the operations of the companie |
2009 | 500,00$ |
Japan Diabetes Care Devices Market Analysis and Forecasts to 2015The report provides Diabetes care devices market information broken down into detailed categories and segments in Japan. / Total |
2009 | 3.500,00$ |
United States Diabetes Care Devices Market Analysis & Forecasts to 2015The report provides Diabetes care devices market information broken down into detailed categories and segments in the US. / Total |
2009 | 3.500,00$ |
Dental Implants Pipeline Technology and Market Forecasts to 2015Annualized global dental implants market revenues data from 2001 to 2008, forecast forward for 7 years to 2015. / Analysis and rev |
2009 | 2.000,00$ |
Medical Weekly Deals Summaries 27 April 2009Summary of Medical Equipment deals by segment during the week / Information on rumored and upcoming deals before they occur / Any |
2009 | 125,00$ |
Medical Device Clinical Trials: Destination IndiaViewpoints are a source of real-time and frequent updates on key events in the medical equipment sectors and provide insights on m |
2009 | 500,00$ |
Stem Cell Research and Tissue Engineering: A Boon for Dental Tissue RegenerationViewpoints are a source of real-time and frequent updates on key events in the medical equipment sectors and provide insights on m |
2009 | 500,00$ |
Bioject Medical Technologies Inc. - Healthcare - Medical Equipment SWOT ReportCritical appraisal of the company’s positioning using SWOT analysis. / Company information, including business descriptions, com |
2008 | 125,00$ |
Biliary Stents: Off – Label Use to Drive GrowthViewpoints are a source of realtime and frequent updates on key events in the medical equipment sectors and provide insights on ma |
2009 | 500,00$ |
Medical Weekly Deals Summaries 01 June 2009Summary of Medical Equipment deals by segment during the week / Information on rumored and upcoming deals before they occur / A |
2009 | 125,00$ |
Medical Weekly Deals Summaries 25 May 2009Summary of Medical Equipment deals by segment during the week / Information on rumored and upcoming deals before they occur / A |
2009 | 125,00$ |
The Medical Device Reprocessing Industry: Increasing Hospital SustainabilityViewpoints are a source of realtime and frequent updates on key events in the medical equipment sectors and provide insights on ma |
2009 | 500,00$ |
US Electrophysiology Devices Market: Opportunity Analysis and Market Assessment to 2015The report provides market size data and information on three electrophysiology devices market categories – Electrophysiology Lab |
2009 | 3.500,00$ |
Global X-Ray Systems Market: Strategic Market Analysis and Insight to 2015The report covers data and analysis on the x-ray systems market in the leading geographies of the world – United States, Canada, U |
2009 | 3.500,00$ |
SWOT Review of the Key Orthopedic Device CompaniesViewpoints are a source of real-time and frequent updates on key events in the medical equipment sectors and provide insights on m |
2009 | 500,00$ |
Transcatheter Cardiovascular Therapeutics 2008 – Post Conference ReviewThe report covers information and analysis on product and technology launched at the conference / The report provides market size |
2009 | 1.000,00$ |
Medtronic to Acquire Ablation Frontiers: A Move to Strengthen Stake in the Atrial Fibrillation MarketIn depth profiling of the latest and the most important Mergers & Acquisitions deal; / Historical deal analysis of the compani |
2009 | 500,00$ |
Cardiovascular Surgery Pipeline Technology and Market Forecasts To 2015Annualized global cardiovascular surgery market revenues data from 2001 to 2008, forecast forward for 7 years to 2015. / Analysis |
2009 | 2.000,00$ |
Global Patient Monitoring Investment Opportunities, Analysis and Forecasts to 2012This report provides detailed global, regional countries (United States, Germany, United Kingdom, France, Italy, Spain, Japan, Can |
2009 | 3.500,00$ |
United States Patient Monitoring Investment Opportunities, Analysis and Forecasts to 2015The report provides patient monitoring devices information broken down into detailed categories and segments in United States. / |
2009 | 3.500,00$ |
Aesthetics Devices Pipeline Product and Technology Analysis ReportAnalysis and review of the key pipeline devices that are likely to impact the treatment landscape globally; / Independent analysis |
2009 | 2.000,00$ |
Neurostimulation Devices Pipeline Product and Technology Analysis ReportAnalysis and review of the key pipeline devices that are likely to impact the treatment landscape globally; / Independent analysis |
2009 | 2.000,00$ |
Digital Mammography Pipeline Technology and Market Forecasts To 2015Analysis and review of the key pipeline devices that are likely to impact the treatment landscape globally; / Independent analysis |
2009 | 2.000,00$ |
Mergers & Acquisitions and Financing Trends in Medical Equipment Industry Q4 2008Comprehensive summary of Medical Equipment deals globally in the last four quarters / Trend analysis of deals by segments, region, |
2009 | 1.500,00$ |
Cell Therapy - A New Lease of Life for the HeartViewpoints are a source of real-time and frequent updates on key events in the medical equipment sectors and provide insights on m |
2009 | 500,00$ |
Combination Products - Evolution of the Medical Equipment IndustryViewpoints are a source of real-time and frequent updates on key events in the medical equipment sectors and provide insights on m |
2009 | 500,00$ |
Small Joints - Big InnovationsViewpoints are a source of real-time and frequent updates on key events in the medical equipment sectors and provide insights on m |
2009 | 500,00$ |
Key M&A Events in the Spinal Surgery Market in 2008Viewpoints are a source of real-time and frequent updates on key events in the medical equipment sectors and provide insights on m |
2009 | 500,00$ |
Orthopedic Devices Pipeline Product Analysis and Technology ReportAnalysis and review of the key pipeline devices that are likely to impact the treatment landscape globally;
/ Independent analysi |
2008 | 2.000,00$ |
Peripheral Vascular Devices Pipeline Product Analysis and Technology ReportAnalysis and review of the key pipeline devices that are likely to impact the treatment landscape globally;
/ Independent analysi |
2008 | 2.000,00$ |
Wound Care Management Pipeline Product Analysis and Technology ReportAnalysis and review of the key pipeline devices that are likely to impact the treatment landscape globally;
/ Independent analysi |
2008 | 2.000,00$ |
Medical Equipment Mergers & Acquisitions Trends – April 2009Comprehensive summary of Medical Equipment deals globally in the last six months
/ Trend analysis of deals by sector and type
/ |
2009 | 1.000,00$ |
Global X-Ray Systems Market: Strategic Market Analysis and Insight to 2015The report covers data and analysis on the xray systems market in the leading geographies of the world – United States, Canada, UK |
2009 | 3.500,00$ |
Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive GrowthThe report provides market size data and information on two global Self Monitoring Blood Glucose (SMBG) market categories – blood |
2009 | 3.500,00$ |
US Cardiac Rhythm Management Devices Market: Strategic Market Analysis and Insight to 2015The report provides market size data and information on three US cardiac rhythm management devices market categories – Cardiac Res |
2009 | 3.500,00$ |
Ultrasound Systems Pipeline Technology and Market Forecasts to 2015Annualized global ultrasound systems market revenues data from 2001 to 2008, forecast forward for 7 years to 2015.
/ Analysis and |
2009 | 2.000,00$ |
Electrosurgical Devices Pipeline Technology and Market Forecasts to 2015Develop business strategies by understanding the trends shaping and driving the global electrosurgical devices market. / Identify |
2009 | 2.000,00$ |
Mergers & Acquisitions and Financing Trends in Medical Equipment, 2008Comprehensive summary of Medical Equipment deals globally in the last four years / Trend analysis of deals by segments, region, an |
2009 | 3.500,00$ |
Italy’s nuclear renaissance helps the country to meet the electricity demandGlobalData viewpoints cover the latest key events or important developments in the nuclear energy industry and provide our indepth |
2009 | 500,00$ |
Middle East Will Drive Growth in the Global Refining Industry in the Next Five YearsGlobalData viewpoints cover the latest events or important trends in the global oil and gas industry and provide our in-depth anal |
2009 | 500,00$ |
US Electrophysiology Devices Market: Opportunity Analysis and Market Assessment to 2015The report provides market size data and information on three electrophysiology devices market categories – Electrophysiology Lab |
2009 | 3.500,00$ |
Global X-Ray Systems Market: Strategic Market Analysis and Insight to 2015The report covers data and analysis on the x-ray systems market in the leading geographies of the world – United States, Canada, U |
2009 | 3.500,00$ |
SWOT Review of the Key Orthopedic Device CompaniesViewpoints are a source of real-time and frequent updates on key events in the medical equipment sectors and provide insights on m |
2009 | 500,00$ |
United States Medical Equipment Market Analysis & Forecasts to 2015The report provides an overview of the medical equipment industry in the US and provides data and information on each of the key i |
2009 | 4.000,00$ |
Mexico Orthopedic Devices Market Analysis & Forecasts to 2015The report provides orthopedic devices information broken down into detailed categories and segments in Mexico. / Total revenues, |
2009 | 3.500,00$ |
Global Patient Monitoring Market Analysis & Forecasts to 2015Key Companies Philips Healthcare, GE Healthcare, OMRON HEALTHCARE, Draegerwerk Aktiengesellschaft, and OSI Systems.
/ It gives ke |
2009 | 4.000,00$ |
United States Patient Monitoring Market Analysis & Forecasts to 2015The report provides patient monitoring devices information broken down into detailed categories and segments in United States. / |
2009 | 3.500,00$ |
United Kingdom Cardiovascular Devices Market Analysis & Forecasts to 2015The report provides cardiovascular devices market information broken down into detailed categories and segments in UK. / Total re |
2009 | 3.500,00$ |
US Anesthesia and Respiratory Devices Market Analysis & Forecasts to 2015The report provides canesthesia & respiratory devices market information broken down into detailed categories and segments in |
2009 | 3.500,00$ |
United States Cardiovascular Devices Market Analysis & Forecasts to 2015The report provides cardiovascular devices market information broken down into detailed categories and segments in the US. / Tota |
2009 | 3.500,00$ |
United States Diagnostic Imaging Market Analysis & Forecasts to 2015The report provides diagnostic imaging market information broken down into detailed categories and segments in the US. / Total re |
2009 | 3.500,00$ |
Japan Patient Monitoring Market Analysis & Forecasts to 2015The report provides patient monitoring market information broken down into detailed categories and segments in Japan. / Total rev |
2009 | 3.500,00$ |
Germany Cardiovascular Devices Market Analysis & Forecasts to 2015The report provides cardiovascular devices market information broken down into detailed categories and segments in Germany. / Tot |
2009 | 3.500,00$ |
United States Orthopedic Devices Market Analysis & Forecasts to 2015The report provides orthopedic devices market information broken down into detailed categories and segments in the US. / Total re |
2009 | 3.500,00$ |
Japan Cardiovascular Devices Market Analysis & Forecasts to 2015The report provides cardiovascular devices market information broken down into detailed categories and segments in Japan. / Total |
2009 | 3.500,00$ |
Dynamic Stabilization Pipeline Technology and Market Forecasts to 2015Annualized global dynamic stabilization market revenues data from 2001 to 2008, forecast forward for 7 years to 2015. / Analysis a |
2009 | 2.000,00$ |
India Cardiovascular Devices Market Analysis & Forecasts to 2015The report provides cardiovascular devices market information broken down into detailed categories and segments in India. / Total |
2009 | 3.500,00$ |
Capsule Endoscopy: Small is EffectiveViewpoints are a source of real-time and frequent updates on key events in the medical equipment sectors and provide insights on m |
2009 | 500,00$ |
Kyphoplasty: Driving Growth in the Vertebral Compression Fracture Treatment Market in the USViewpoints are a source of real-time and frequent updates on key events in the medical equipment sectors and provide insights on m |
2009 | 500,00$ |
Medical Equipment M&A Trends - October 2008Comprehensive summary of Medical Equipment deals globally in the last six months
/ Trend analysis of deals by sector and type
/ |
2008 | 1.000,00$ |
US Electrophysiology Devices Market: Strategic Market Analysis and Insight to 2015The report provides market size data and information on three electrophysiology devices market categories – Electrophysiology Lab |
2009 | 3.500,00$ |
US Dental Implants Market: Growth Driver for the Dental Equipment SectorThe report provides market size data and information on two US dental implants market categories – Titanium Dental Implants, Zirco |
2009 | 3.500,00$ |
Dental Aesthetics Pipeline Technology and Market Forecasts to 2015Annualized global dental aesthetics market revenues data from 2001 to 2008, forecast forward for 7 years to 2015.
/ Analysis and |
2009 | 2.000,00$ |
Wound Closure Devices Pipeline Technology and Market Forecasts to 2015Annualized global wound closure devices market revenues data from 2001 to 2008, forecast forward for 7 years to 2015.
/ Analysis |
2009 | 2.000,00$ |
Medical Weekly Deals Summaries 06 April 2009Summary of Medical Equipment deals by segment during the week
/ Information on rumored and upcoming deals before they occur
/ A |
2009 | 125,00$ |
In Vitro Diagnostics Market - A Hotspot For Venture Capital FundingViewpoints are a source of realtime and frequent updates on key events in the medical equipment sectors and provide insights on ma |
2009 | 500,00$ |
US Ophthalmic Devices Market Analysis & Forecasts to 2015The report provides ophthalmic devices market information broken down into detailed categories and segments in the US.
/ Total r |
2009 | 3.500,00$ |
Knee Replacement Pipeline Technology and Market Forecasts to 2015Annualized global knee replacement market revenues data from 2001 to 2008, forecast forward for 7 years to 2015.
/ Analysis and r |
2009 | 2.000,00$ |
Global Respiratory Devices Market: The Home and Self Care Products to Drive GrowthThe report provides market size data and information on six respiratory devices market categories – Anesthesia Disposables, Anesth |
2009 | 3.500,00$ |
Germany Diabetes Care Devices Market Analysis & Forecasts to 2015The report provides Diabetes care devices market information broken down into detailed categories and segments in Germany.
/ Tot |
2009 | 3.500,00$ |
China Cardiovascular Devices Market Analysis & Forecasts to 2015The report provides cardiovascular devices market information broken down into detailed categories and segments in China. / Tota |
2009 | 3.500,00$ |
Europe Electrophysiology Devices Market: Increasing Demand to Drive GrowthThe report provides market size data and information on four Europe electrophysiology devices market categories – electrophysiolog |
2009 | 3.500,00$ |
Global Electrocardiogram (ECG) Data Management Systems Market: Increasing Demand to Drive GrowthThe report covers data and analysis on the ECG data management systems market in the leading geographies of the world – US, Canada |
2009 | 3.500,00$ |
Global Cardiopulmonary Stress Testing Systems: Market Opportunity Assessment and Insight to 2015The report covers data and analysis on the cardiopulmonary stress testing systems market in the leading geographies of the world – |
2009 | 3.500,00$ |
Global X-Ray Systems Market: Strategic Market Analysis and Insight to 2015The report covers data and analysis on the x-ray systems market in the leading geographies of the world – United States, Canada, U |
2009 | 3.500,00$ |


